Citrus Sinensis ID: 005587
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 689 | 2.2.26 [Sep-21-2011] | |||||||
| Q6R2K3 | 776 | Protein STRUBBELIG-RECEPT | yes | no | 0.908 | 0.806 | 0.635 | 0.0 | |
| Q06BH3 | 775 | Protein STRUBBELIG-RECEPT | no | no | 0.902 | 0.802 | 0.564 | 0.0 | |
| Q8RWZ1 | 768 | Protein STRUBBELIG OS=Ara | no | no | 0.894 | 0.802 | 0.413 | 1e-133 | |
| Q9C8M9 | 719 | Protein STRUBBELIG-RECEPT | no | no | 0.815 | 0.781 | 0.347 | 9e-97 | |
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | no | no | 0.179 | 0.176 | 0.621 | 5e-60 | |
| Q9LUL4 | 717 | Protein STRUBBELIG-RECEPT | no | no | 0.293 | 0.281 | 0.466 | 2e-49 | |
| Q6R2K2 | 687 | Protein STRUBBELIG-RECEPT | no | no | 0.346 | 0.347 | 0.417 | 5e-48 | |
| Q6R2K1 | 699 | Protein STRUBBELIG-RECEPT | no | no | 0.332 | 0.327 | 0.417 | 2e-46 | |
| Q9FG24 | 735 | Protein STRUBBELIG-RECEPT | no | no | 0.322 | 0.302 | 0.402 | 7e-44 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.233 | 0.226 | 0.478 | 7e-38 |
| >sp|Q6R2K3|SRF3_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 3 OS=Arabidopsis thaliana GN=SRF3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/655 (63%), Positives = 494/655 (75%), Gaps = 29/655 (4%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T+ S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATMINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVTVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNL 676
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQ+S L
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQL 650
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q06BH3|SRF1_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 1 OS=Arabidopsis thaliana GN=SRF1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 680 bits (1755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/662 (56%), Positives = 468/662 (70%), Gaps = 40/662 (6%)
Query: 20 FVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNAS 79
F+ F LI S A+TNP+DVAAINSL+ AL SP+LPGWVAS GDPCGESWQGV CNAS
Sbjct: 17 FLSFALISLPSLSLALTNPDDVAAINSLFLALESPLLPGWVASGGDPCGESWQGVLCNAS 76
Query: 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSG 139
+ IIL ANLGGELG L F+S++ +D SNNHIGGSIPS LPV++QN FLS N F+G
Sbjct: 77 QVETIILISANLGGELGVGLNMFTSLKAMDFSNNHIGGSIPSTLPVSLQNLFLSGNNFTG 136
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQL 199
+IP SL++L L+ MSLNNNLLSG+IPD FQ L +IN+DLSSNNLSG LPPS++NLS L
Sbjct: 137 TIPESLSSLKSLSVMSLNNNLLSGKIPDVFQDLGLMINIDLSSNNLSGPLPPSMQNLSTL 196
Query: 200 TTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPS 259
T+L LQNN LSG LDVLQDLPL+DLN+ENNLF+GPIPEK+L IPNF K GN FN T+APS
Sbjct: 197 TSLLLQNNHLSGELDVLQDLPLKDLNVENNLFNGPIPEKLLSIPNFIKGGNLFNVTIAPS 256
Query: 260 RPPTSSVTPPPAP-PFFGPRPVSGSSPVS----RTPPSQHTPGKQADGPTALEDSNSGKK 314
P + +P PFFGP + S+ R+PPS H P + PT GK+
Sbjct: 257 PSPETPPSPTSPKRPFFGPPSPNASAGHGQAHVRSPPSDHHPSR----PTP-----QGKE 307
Query: 315 KSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEA 374
S T+K+I+WISI G FV+LALV LL +C+++R + +++ K H + G RE +
Sbjct: 308 DSFTSKRIIWISILGAFSFVVLALVCLLCGRKCLRKREDSEQLSKPHLTSEY-GRAREGS 366
Query: 375 RDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEI 434
R N ++ P+N KD +PKE R+G ER+ + + +++ HEI
Sbjct: 367 RSNASMLPPSNTFNKDKEARPKE-------RVGGASKLHGGAERS---VGSESKQESHEI 416
Query: 435 DMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFT 494
DM+ M +M P PP +++VI K PAE + +T++K+ P T
Sbjct: 417 DMNGNAMDLMHPSSIPP---------------IKRVIAKATEPAEASLKRTTSKSHGPLT 461
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF 554
+ FT+ASLQQ+TNSFS ENLIG GMLGSVYRA+LP GKL AV+KLDK++ + +++ +F
Sbjct: 462 AVKHFTVASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLFAVRKLDKKSPNHEEEGKF 521
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
LELVNNIDRIRHANIV+L G+C+EH QRLLI+EYC NGTL D+LH DD LK LSWN R+
Sbjct: 522 LELVNNIDRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHDLLHIDDRLKIELSWNVRV 581
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
R+AL AA+ALEYLHEIC PP +HRNFKSANILLDDD+ V VSDCGLAPLISSG+VSQ+S
Sbjct: 582 RIALEAAKALEYLHEICDPPSIHRNFKSANILLDDDIRVHVSDCGLAPLISSGAVSQLSG 641
Query: 675 NL 676
L
Sbjct: 642 QL 643
|
Not essential for epidermal patterning and not redundant with STRUBBELIG. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q8RWZ1|SUB_ARATH Protein STRUBBELIG OS=Arabidopsis thaliana GN=SUB PE=1 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 289/699 (41%), Positives = 410/699 (58%), Gaps = 83/699 (11%)
Query: 13 WKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQ 72
W++ FF VL FS VTN DV+AIN+LY LG+P L W+A GDPCGE WQ
Sbjct: 6 WEV---FFGLSVLALTMPFSAGVTNLRDVSAINNLYITLGAPSLHHWLAFGGDPCGEKWQ 62
Query: 73 GVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFL 132
GV C++S+I I + G +GG L + L FSSI+V+D S+NHI G+IP LP +++N L
Sbjct: 63 GVVCDSSNITEIRIPGMKVGGGLSDTLADFSSIQVMDFSSNHISGTIPQALPSSIRNLSL 122
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
S N+F+G+IP +L+ L+ L+++SL +NLLSGEIPD FQ L+ L LDLSSN L G LP S
Sbjct: 123 SSNRFTGNIPFTLSFLSDLSELSLGSNLLSGEIPDYFQQLSKLTKLDLSSNILEGHLPSS 182
Query: 193 LENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPF 252
+ +L+ L L+LQ+N+L+GTLDV++DL L DLN+ENNLFSGPIP +L+IPNF+KDG PF
Sbjct: 183 MGDLASLKILYLQDNKLTGTLDVIEDLFLTDLNVENNLFSGPIPPNLLKIPNFKKDGTPF 242
Query: 253 NSTVAPSRPPTSSVTPPP---APPFFGPRPVSG--------------------SSPVSRT 289
N+++ PP PP APP PVSG S P+ +
Sbjct: 243 NTSIITPPPPPVVDPPPATHRAPPVPRIPPVSGVPPAPFAPFAPLQPQQHPPPSPPLVWS 302
Query: 290 PPSQHT----PGKQADGPTALE---DSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLL 342
PPS P G L+ S SG K +T++I+ + + ++ ++ L L
Sbjct: 303 PPSSDNGGGDPWNSVSGQPTLQISPPSGSGSGKFWSTQRIILVVSSVAIIVLVSGLCVTL 362
Query: 343 FMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLALPT-NQMEKDASVKPKEDHRS 401
+ RC + +I+ R+ GA + R + PT ++ ++ VKP + + +
Sbjct: 363 W--RCCR-----SKIYNRYYSGARKDLQRPYFNKPPSQPTPTMGKVSREPMVKPFDGYGA 415
Query: 402 EMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPP 461
R+ G P Q +E + +P + D+++ P P P
Sbjct: 416 GDRKYG-YPMPQRAEESRR----AMPPTSYYNKDVNT------PQKPLQQP--------- 455
Query: 462 PPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPF-------TTARSFTIASLQQYTNSFSQE 514
P + + T++K A F ++A FTIASLQQYTN+FS+E
Sbjct: 456 ---------------PRQFQSNDTASKRAAHFPPGLNSSSSATVFTIASLQQYTNNFSEE 500
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
N+IG G +G+VYRA+L GK LAVKKL + Q D EFL LV+N+ +++ +I+EL G
Sbjct: 501 NIIGEGSIGNVYRAELRHGKFLAVKKLSNTINRTQSDGEFLNLVSNVLKLKRGHILELLG 560
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
YC E GQRLL+YEYC NG+LQD LH D +L L+WN RI +ALGA++AL++LHE+CQPP
Sbjct: 561 YCNEFGQRLLVYEYCPNGSLQDALHLDRKLHKKLTWNVRINIALGASKALQFLHEVCQPP 620
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVS 673
+VH+NFKS+ +LLD L+V V+D GLA ++ SQ++
Sbjct: 621 VVHQNFKSSKVLLDGKLSVRVADSGLAYMLPPRPTSQMA 659
|
Regulates the expression of transcription factors that define the cell fates. Seems to be required for the regulation of cell shape and the orientation of the mitotic division plane. Involved in root hair specification, in the formation of the outer integument and the shape of organs such as carpels and petals and is necessary for the shape and height of the stem. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C8M9|SRF6_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 6 OS=Arabidopsis thaliana GN=SRF6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (910), Expect = 9e-97, Method: Compositional matrix adjust.
Identities = 229/659 (34%), Positives = 330/659 (50%), Gaps = 97/659 (14%)
Query: 11 KNWKIYANF---FVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPV-LPGWVASAGDP 66
+NW + A F VGF L + G T+ +D +A+N+L++ + SP L W A+AGDP
Sbjct: 3 ENWAVVALFTLCIVGFELRFIHG----ATDASDTSALNTLFSGMHSPAQLTQWTAAAGDP 58
Query: 67 CGESWQGVQCNASDIIAIILNGANLGGELG-ENLGAFSSIRVIDLSNNHIGGSIPSILPV 125
CG++W+GV C+ S + I L+G L G LG L +S+ +DLS+N++GG +P P
Sbjct: 59 CGQNWRGVTCSGSRVTQIKLSGLELSGTLGGYMLDKLTSLTELDLSSNNLGGDLPYQFPP 118
Query: 126 TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL 185
+Q L++NQF+G+ SL+ +T L ++L +N G+I F L L LD S N+
Sbjct: 119 NLQRLNLANNQFTGAASYSLSQITPLKYLNLGHNQFKGQIAIDFSKLDSLTTLDFSFNSF 178
Query: 186 SGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNF 245
+ LP + +L+ L +L+LQNNQ SGT+DVL LPL LNI NN F+G IP + I
Sbjct: 179 TNSLPATFSSLTSLKSLYLQNNQFSGTVDVLAGLPLETLNIANNDFTGWIPSSLKGI-TL 237
Query: 246 RKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQADGPTA 305
KDGN FN+ AP PP + R PS+ + G+++
Sbjct: 238 IKDGNSFNTGPAPPPPPGTPPI--------------------RGSPSRKSGGRESRSSDE 277
Query: 306 LEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGA 365
N KKS + I +L+ L + F LF + KR +D
Sbjct: 278 -STRNGDSKKSGIGAGAIAGIIISLLVVTALLVAFFLFRRKKSKRSSPMDI--------- 327
Query: 366 FRGNNREEARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMST 425
E DN L +N ++ S+ Q+ +++ T
Sbjct: 328 -------EKTDNQPFTLASNDFHENNSI-------------------QSSSSVETKKLDT 361
Query: 426 IPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKT 485
SL + + PPP P V + +V P
Sbjct: 362 ------------SLSINLRPPPIDRNKSFDDEDSTRKPIAVKKSTVVVP----------- 398
Query: 486 STKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRA 545
+ R +++A LQ T SFS +NL+G G G VYRA+ DGK+LAVKK+D A
Sbjct: 399 --------SNVRLYSVADLQIATGSFSVDNLLGEGTFGRVYRAEFDDGKVLAVKKIDSSA 450
Query: 546 SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
D+F+E+V+ I + H N+ +L GYCAEHGQ L++YE+ NG+L D LH +E
Sbjct: 451 LPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQHLVVYEFHKNGSLHDFLHLSEEES 510
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
L WN+R+++ALG ARALEYLHE+C P IV +N KSANILLD +L +SD GLA +
Sbjct: 511 KALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIKSANILLDSELNPHLSDSGLASFL 569
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (593), Expect = 5e-60, Method: Compositional matrix adjust.
Identities = 105/169 (62%), Positives = 133/169 (78%)
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF 554
TA +T++SLQ TNSFSQEN+IG G LG VYRA+ P+GK++A+KK+D A S Q++D F
Sbjct: 379 TASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNF 438
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
LE V+N+ R+RH NIV L GYC EHGQRLL+YEY NG L D LH++D+ NL+WN R+
Sbjct: 439 LEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARV 498
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663
++ALG A+ALEYLHE+C P IVHRNFKSANILLD++L +SD GLA L
Sbjct: 499 KVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAAL 547
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LUL4|SRF7_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 7 OS=Arabidopsis thaliana GN=SRF7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 98/210 (46%), Positives = 129/210 (61%), Gaps = 8/210 (3%)
Query: 455 PPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQE 514
PPP + + KPIV + V S ++T++ LQ TNSFS +
Sbjct: 371 PPPSERHKSFDDDDSTMRKPIVAKKAAVVVPSN--------VNTYTVSDLQVATNSFSVD 422
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
NL+G G G VYRAQ DGK+LAVKK+D A D+F E+V+ I + H N+ +L G
Sbjct: 423 NLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADDFTEIVSKIAHLDHENVTKLDG 482
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
YC+EHGQ L++YE+ NG+L D LH +E L WN R+++ALG ARALEYLHE+C P
Sbjct: 483 YCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPRVKIALGTARALEYLHEVCSPS 542
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
IVH+N KSANILLD +L +SD GLA +
Sbjct: 543 IVHKNIKSANILLDSELNPHLSDSGLASFL 572
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K2|SRF4_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 4 OS=Arabidopsis thaliana GN=SRF4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (489), Expect = 5e-48, Method: Compositional matrix adjust.
Identities = 103/247 (41%), Positives = 152/247 (61%), Gaps = 8/247 (3%)
Query: 24 VLIWAAGFSC------AVTNPNDVAAINSLYAALGSPV-LPGWVASAGDPCGESWQGVQC 76
VL++ A F A T+ DV+A+N Y ++ SP L GW +S GDPCG+SW G+ C
Sbjct: 9 VLVFIACFGIFTSVVLAKTDSQDVSALNDAYKSMNSPSKLKGWSSSGGDPCGDSWDGITC 68
Query: 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQ 136
S + I ++G L G LG LG S+ +D+S N++ G++P LP + S+N
Sbjct: 69 KGSSVTEIKVSGRGLSGSLGYQLGNLKSLTYLDVSKNNLNGNLPYQLPDKLTYLDGSEND 128
Query: 137 FSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL 196
F+G++P S++ + L+ ++L N L+GE+ D FQ L L +DLSSN L+G+LP S NL
Sbjct: 129 FNGNVPYSVSLMNDLSYLNLGRNNLNGELSDMFQKLPKLETIDLSSNQLTGKLPQSFANL 188
Query: 197 SQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNST 255
+ L TLHLQ NQ G+++ L+DLP + D+N+ NN F+G IP ++ I N GN ++S
Sbjct: 189 TGLKTLHLQENQFKGSINALRDLPQIDDVNVANNQFTGWIPNELKNIGNLETGGNKWSSG 248
Query: 256 VAPSRPP 262
APS PP
Sbjct: 249 RAPSPPP 255
|
Acts as a direct positive regulator of leaf size but not leaf shape. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q6R2K1|SRF5_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 5 OS=Arabidopsis thaliana GN=SRF5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 96/230 (41%), Positives = 144/230 (62%), Gaps = 1/230 (0%)
Query: 34 AVTNPNDVAAINSLYAALGSPV-LPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLG 92
A T+ +V+A+N ++ +L SP L GW A+ GDPC +SW+GV+C S + + L+G LG
Sbjct: 22 AKTDNQEVSALNVMFTSLNSPSKLKGWKANGGDPCEDSWEGVKCKGSSVTELQLSGFELG 81
Query: 93 GELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLT 152
G G L S+ DLS N++ G+IP LP + N S+N+ G++P SL+ + L
Sbjct: 82 GSRGYLLSNLKSLTTFDLSKNNLKGNIPYQLPPNIANLDFSENELDGNVPYSLSQMKNLQ 141
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212
++L N L+GE+PD FQ L+ L LD S N LSG+LP S NL+ L LHLQ+N+ +G
Sbjct: 142 SINLGQNKLNGELPDMFQKLSKLETLDFSLNKLSGKLPQSFANLTSLKKLHLQDNRFTGD 201
Query: 213 LDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPP 262
++VL++L + DLN+E+N F G IP ++ I + GN +++ AP PP
Sbjct: 202 INVLRNLAIDDLNVEDNQFEGWIPNELKDIDSLLTGGNDWSTETAPPPPP 251
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FG24|SRF2_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 2 OS=Arabidopsis thaliana GN=SRF2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (454), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 91/226 (40%), Positives = 140/226 (61%), Gaps = 4/226 (1%)
Query: 461 PPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAG 520
PPP P + + P+ + K+ + T + + A+ F+ A LQ TN FS+ENL+G G
Sbjct: 365 PPPAPQLRHLPSPPVRIDKSARRKSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEG 424
Query: 521 MLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580
LGSVYRA+LPDG+ V+ + + S ++++F E++ ++RH NIV L G+C E+G
Sbjct: 425 PLGSVYRAKLPDGQFAVVRNIPMSSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENG 484
Query: 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF 640
+ LL+YEY + +L + +H DE+ LSW R+R+A+G ARAL+YLH PPI H +
Sbjct: 485 EHLLVYEYVGHLSLYNAMH--DEVYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDL 542
Query: 641 KSANILLDDDLAVSVSDCGLAPL--ISSGSVSQVSHNLTIMRAGGV 684
K+ NILLD++L ++DCGLA L ++S SV + + I G +
Sbjct: 543 KATNILLDEELTPRIADCGLASLRPLTSNSVKLRASEIAIQNTGYI 588
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (402), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 79/165 (47%), Positives = 103/165 (62%), Gaps = 4/165 (2%)
Query: 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
FT L T FS+ N++G G G VY+ +L DGKL+AVK+L + S Q D EF V
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQL--KVGSGQGDREFKAEV 398
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
I R+ H ++V L GYC +RLLIYEY N TL+ LH + + L W R+R+A+
Sbjct: 399 EIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAI 456
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663
G+A+ L YLHE C P I+HR+ KSANILLDD+ V+D GLA L
Sbjct: 457 GSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKL 501
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 689 | ||||||
| 356547026 | 784 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.955 | 0.839 | 0.656 | 0.0 | |
| 356542131 | 784 | PREDICTED: protein STRUBBELIG-RECEPTOR F | 0.955 | 0.839 | 0.638 | 0.0 | |
| 297739262 | 781 | unnamed protein product [Vitis vinifera] | 0.955 | 0.842 | 0.676 | 0.0 | |
| 255553857 | 709 | lrr receptor-linked protein kinase, puta | 0.856 | 0.832 | 0.627 | 0.0 | |
| 449479018 | 791 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.968 | 0.843 | 0.647 | 0.0 | |
| 304281946 | 776 | strubbelig receptor family 3 [Arabidopsi | 0.908 | 0.806 | 0.635 | 0.0 | |
| 42566272 | 776 | STRUBBELIG-receptor family 3 [Arabidopsi | 0.908 | 0.806 | 0.635 | 0.0 | |
| 304281933 | 776 | SRF3 [Arabidopsis thaliana] | 0.908 | 0.806 | 0.635 | 0.0 | |
| 224124596 | 699 | predicted protein [Populus trichocarpa] | 0.854 | 0.842 | 0.674 | 0.0 | |
| 304281935 | 776 | SRF3 [Arabidopsis thaliana] | 0.908 | 0.806 | 0.633 | 0.0 |
| >gi|356547026|ref|XP_003541919.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/692 (65%), Positives = 530/692 (76%), Gaps = 34/692 (4%)
Query: 1 MGVKRSNIECKNWKIYANFFVGFV--LIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPG 58
MG +RS + K KIY +GF+ LI FS A T+P DVAAIN LY ALG+PVLPG
Sbjct: 1 MGEERSGSQNKRVKIYGEVLLGFIIMLICTVQFSLADTDPIDVAAINRLYTALGNPVLPG 60
Query: 59 WVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGS 118
WV+SAGDPCGE WQGVQCN S I IILNGANLGGELG++LG+F SIR I L+NNHIGG+
Sbjct: 61 WVSSAGDPCGEGWQGVQCNGSVIQEIILNGANLGGELGDSLGSFVSIRAIVLNNNHIGGN 120
Query: 119 IPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINL 178
IPS LPVT+Q+FFLSDNQF+GSIP+SL+TLT LTDMSLN NLL+GEIPDAFQSLT LINL
Sbjct: 121 IPSSLPVTLQHFFLSDNQFTGSIPASLSTLTELTDMSLNGNLLTGEIPDAFQSLTQLINL 180
Query: 179 DLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEK 238
DLS+NNLSGELPPS+ENLS LT++HLQNN LSGTLDVLQ LPL+DLN+ENN F+GPIP K
Sbjct: 181 DLSNNNLSGELPPSMENLSALTSVHLQNNNLSGTLDVLQGLPLQDLNVENNQFAGPIPPK 240
Query: 239 MLQIPNFRKDGNPF----NSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQH 294
+L IP+FRKDGNPF NST+AP+ PP S P PA P SG+ S TP S
Sbjct: 241 LLSIPSFRKDGNPFNLNGNSTIAPAHPPRS---PVPATP-------SGTV-ASVTPSSGR 289
Query: 295 TPGKQADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEV 354
P K +GPTA ++SNS K K + TKK+VWIS++G+L+F+IL L LLF+PRC KR V
Sbjct: 290 IPTKPTEGPTAAKESNSEKSKKN-TKKVVWISVSGILVFIILVLGLLLFVPRCSKREW-V 347
Query: 355 DRIFKRHQVGAFRGNNREEARDNGTLALPTNQME---KDASVKPKEDHRSEMRRMGAIPH 411
+R K+HQVGA+ G R+ R+ G P NQ E K A V+PK DH+ E RR+ AIP+
Sbjct: 348 NRSSKQHQVGAY-GVERQNPREYGAFVQPPNQTEKVPKGAIVRPKGDHQEEARRVRAIPN 406
Query: 412 AQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVI 471
Q EQE+++QRM TIP+ +HEIDMSSLD+ M P PPPPPPP VE+VI
Sbjct: 407 PQGEQEKDEQRMETIPKLLEHEIDMSSLDVFSM-----------PSPPPPPPPLPVERVI 455
Query: 472 VKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLP 531
V+P + + + K+ P T A++FTIASLQQYTNSFSQ+NLIG GMLGSVYRA+LP
Sbjct: 456 VEPTLFHKEANINPPKKSPVPPTFAKTFTIASLQQYTNSFSQDNLIGLGMLGSVYRAELP 515
Query: 532 DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591
DGK+LAVKKLDKR S QQ DDEFLEL+N+IDRIRH NIVEL GYCAEHGQRLLIYEYCSN
Sbjct: 516 DGKILAVKKLDKRVSDQQTDDEFLELINSIDRIRHPNIVELIGYCAEHGQRLLIYEYCSN 575
Query: 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651
G+LQD LHSDDE K LSWN RIR+ALGAARALEYLHE QP +VHRNFKSANILLDDD+
Sbjct: 576 GSLQDALHSDDEFKTRLSWNARIRIALGAARALEYLHEQFQPSVVHRNFKSANILLDDDV 635
Query: 652 AVSVSDCGLAPLISSGSVSQVSHNLTIMRAGG 683
+V VSDCGLAPLI+ GSVSQ+S L G
Sbjct: 636 SVRVSDCGLAPLITKGSVSQLSGQLLTAYGYG 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542131|ref|XP_003539524.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2146), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/692 (63%), Positives = 522/692 (75%), Gaps = 34/692 (4%)
Query: 1 MGVKRSNIECKNWKIYANFFVGFV--LIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPG 58
MG +RS ++ K KI+ +GF+ LI FS A T+P DVAAIN LY ALG+PVLPG
Sbjct: 1 MGEERSGLQNKRVKIHGEVLLGFIIMLICTIQFSVADTDPVDVAAINRLYTALGNPVLPG 60
Query: 59 WVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGS 118
WV+SAGDPCG+ WQGVQCN S I IILNGANLGGELG++LG+F SIR I L+NNHIGGS
Sbjct: 61 WVSSAGDPCGQGWQGVQCNGSVIQEIILNGANLGGELGDSLGSFVSIRAIVLNNNHIGGS 120
Query: 119 IPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINL 178
IPS LPVT+Q+FFLSDNQF+GSIP+SL+TLT LTDMSLN+NLL+GE+PDAFQSL LINL
Sbjct: 121 IPSSLPVTLQHFFLSDNQFTGSIPASLSTLTELTDMSLNDNLLTGEVPDAFQSLMQLINL 180
Query: 179 DLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEK 238
DLS+NNLSGELPPS+ENLS LT++HLQNN+LSGTLDVLQDLPL+DLN+ENN F+GPIP K
Sbjct: 181 DLSNNNLSGELPPSMENLSALTSVHLQNNKLSGTLDVLQDLPLQDLNVENNQFAGPIPPK 240
Query: 239 MLQIPNFRKDGNPF----NSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQH 294
+L IP+FRKDGNPF NST+AP+ PP S VT P + VS TP S
Sbjct: 241 LLSIPSFRKDGNPFNLNDNSTIAPAHPPHSPVTASPT-----------GTVVSVTPSSGR 289
Query: 295 TPGKQADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEV 354
P K GPTA ++SNSGK K + TKK+VWISI+G+L+F+IL L LLF+PRC RR V
Sbjct: 290 VPTKPTKGPTAAKESNSGKSKKN-TKKVVWISISGILVFIILVLGLLLFVPRC-SRRERV 347
Query: 355 DRIFKRHQVGAFRGNNREEARDNGTLALPTNQME---KDASVKPKEDHRSEMRRMGAIPH 411
+R K+HQVGA+ G R+ RD G P +Q E K A V+ K DH+ E RR+ IP
Sbjct: 348 NRSSKQHQVGAY-GGERQNPRDYGAFVQPPSQTEKVPKGAVVRLKGDHQEEARRLRTIPK 406
Query: 412 AQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVI 471
Q EQE+++QRM TIP+ +HEIDMSSLD+ M P PPPPPPP E+VI
Sbjct: 407 PQGEQEKDEQRMETIPKLLEHEIDMSSLDVFSM-----------PSPPPPPPPLPAERVI 455
Query: 472 VKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLP 531
V+ + + K+ P T ++FTIASLQQYTNSFSQ+NLIG GMLGSVYRA+LP
Sbjct: 456 VESASFHKEANINPPKKSPVPPTFVKTFTIASLQQYTNSFSQDNLIGLGMLGSVYRAELP 515
Query: 532 DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591
DGK+LAVKKLDKR S Q DDEFLEL+N+IDRIRH NIVEL GYCAEHGQRLLIYEYCSN
Sbjct: 516 DGKILAVKKLDKRVSDHQTDDEFLELINSIDRIRHPNIVELIGYCAEHGQRLLIYEYCSN 575
Query: 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651
G+LQD LHS DE K LSWN RIR+ALGAAR+LEYLHE QPP+VHRNFKSA+ILL DD+
Sbjct: 576 GSLQDALHSHDEFKTRLSWNARIRIALGAARSLEYLHEQFQPPVVHRNFKSASILLYDDV 635
Query: 652 AVSVSDCGLAPLISSGSVSQVSHNLTIMRAGG 683
+V VSDCGL+PLI+ GSVSQ+S L G
Sbjct: 636 SVRVSDCGLSPLITKGSVSQLSGQLLTAYGYG 667
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739262|emb|CBI28913.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 824 bits (2128), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/678 (67%), Positives = 539/678 (79%), Gaps = 20/678 (2%)
Query: 1 MGVKRSNIECKNWKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWV 60
MG KRS I+C N +IYA FVGFVLI+AA T+P DV AIN+LYAALGSP+LPGWV
Sbjct: 1 MGGKRSAIDCLNLEIYAQTFVGFVLIFAAQVLLGYTSPGDVTAINNLYAALGSPLLPGWV 60
Query: 61 ASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIP 120
++ GDPC ++WQGV CN S+I +IILNGANLGGELG++LG F+SI+VIDLSNN IGGSIP
Sbjct: 61 STGGDPCADAWQGVSCNGSEINSIILNGANLGGELGDSLGTFASIKVIDLSNNQIGGSIP 120
Query: 121 SILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDL 180
S LP+T+QNFFLS NQF+GSIP+SL++L+LLTDMSLNNNLL+GEIPDAFQ+L GLINLDL
Sbjct: 121 SSLPLTLQNFFLSANQFTGSIPTSLSSLSLLTDMSLNNNLLTGEIPDAFQALVGLINLDL 180
Query: 181 SSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKML 240
SSN+LSG+LPPS+ENLS LTTL LQ NQLSGTLDVLQDLPL+DLN+ENNLFSG IP+K+L
Sbjct: 181 SSNHLSGQLPPSMENLSSLTTLRLQINQLSGTLDVLQDLPLKDLNVENNLFSGTIPDKLL 240
Query: 241 QIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQA 300
IPNFRKDGNPF + AP PTS +T P PP P S PV K A
Sbjct: 241 SIPNFRKDGNPFGNVTAPLLAPTSPLTLPSPPPPLSGPPSSNQPPV-----------KPA 289
Query: 301 DGPTALEDSNS-GKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFK 359
DGP+A E+SNS GK K +TK+IVWISI VL+F+IL L +L + C R E D I K
Sbjct: 290 DGPSATEESNSGGKGKGLSTKRIVWISITVVLVFIILVLALVLLVKWCCGERQESDWISK 349
Query: 360 RHQVGAFRGNNREEARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERN 419
R++ GA++G +R RDNG+L Q+ K+A PKE+H+ +RR+G P QNEQ+RN
Sbjct: 350 RNETGAYKG-SRLNLRDNGSLE---QQVPKEAVGTPKEEHQEVVRRIGVAPKPQNEQDRN 405
Query: 420 KQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAE 479
+RM TIP++D HEID+S LD+MM PPPPPPPPPPPPPPPPP+VE VIV PIVP E
Sbjct: 406 VERMFTIPKQDSHEIDISGLDVMMP----PPPPPPPPPPPPPPPPPLVETVIVNPIVPVE 461
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVK 539
A K S KT P +ARSFTIASLQQYTNSFSQENLIG+GMLG+VYRAQLP GKLLAVK
Sbjct: 462 VNAEKPSMKTLNPPISARSFTIASLQQYTNSFSQENLIGSGMLGTVYRAQLPGGKLLAVK 521
Query: 540 KLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH 599
KLDK+ +QQKDDEF +LVN+ID IRHAN+VEL GYCAEHG+RLLIYEYCS+GTL D LH
Sbjct: 522 KLDKKICNQQKDDEFFDLVNSIDGIRHANVVELMGYCAEHGERLLIYEYCSDGTLHDALH 581
Query: 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659
SDDE K LSW+ R+RMALGAARAL+YLHE+C+PPIVHRNFKSAN+LLDD+L V VSDCG
Sbjct: 582 SDDEFKKKLSWSARVRMALGAARALQYLHEVCRPPIVHRNFKSANVLLDDELTVRVSDCG 641
Query: 660 LAPLISSGSVSQVSHNLT 677
LAPLIS SVSQ+S L+
Sbjct: 642 LAPLISRCSVSQLSGRLS 659
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255553857|ref|XP_002517969.1| lrr receptor-linked protein kinase, putative [Ricinus communis] gi|223542951|gb|EEF44487.1| lrr receptor-linked protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 792 bits (2046), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/684 (62%), Positives = 488/684 (71%), Gaps = 94/684 (13%)
Query: 1 MGVKRSNIECKN-WKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGW 59
MG KRS E + +IY FVGFVLI++A S VTNP+DVAAINSLY++LGSP+LPGW
Sbjct: 1 MGTKRSGKEEYSVLEIYLKVFVGFVLIYSATISYGVTNPSDVAAINSLYSSLGSPILPGW 60
Query: 60 VASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSI 119
VAS GDPCGE WQGV C ASDI +I DLS+N IGGSI
Sbjct: 61 VASGGDPCGELWQGVACEASDITSI------------------------DLSSNRIGGSI 96
Query: 120 PSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLD 179
PS LPVTMQNFFL+ N F+GSIP S+++LTLLT MSLNNN LSGEIPD+FQ L GLINLD
Sbjct: 97 PSNLPVTMQNFFLAANNFTGSIPDSISSLTLLTAMSLNNNFLSGEIPDSFQFLAGLINLD 156
Query: 180 LSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKM 239
LSSNN SG+LPPS ENL LTTL LQ NQLSGTL+VL+DLPL+DLNIENNLFSGPIPEK+
Sbjct: 157 LSSNNFSGQLPPSFENLIHLTTLRLQENQLSGTLNVLEDLPLKDLNIENNLFSGPIPEKL 216
Query: 240 LQIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQ 299
L IP+FRKDGNPFN++ AP PTS +TPPPAP +SG+ +P S TPGKQ
Sbjct: 217 LAIPDFRKDGNPFNNSTAPLPAPTSPLTPPPAPG------LSGAPSSPSSPSSGKTPGKQ 270
Query: 300 ADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFK 359
DGP++ E+S+SG+KK TTK++VWISIAGVLLFVILA+ +LFMPRC +RR E RIFK
Sbjct: 271 IDGPSSPEESSSGEKKFLTTKRVVWISIAGVLLFVILAIALVLFMPRCSRRREEAGRIFK 330
Query: 360 RHQVGAFRGNNREEARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERN 419
RHQVGA +GN RE RD+G+L PTN E E+
Sbjct: 331 RHQVGADKGN-RENPRDHGSLDQPTN-----------------------------ETEKV 360
Query: 420 KQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAE 479
+ +P+ D P P + VIV P VP E
Sbjct: 361 SKEALALPKEDH-------------------------------PKP--QTVIVTPTVPTE 387
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVK 539
+ K K P T+ARSFTIASLQQYTNSFSQENLIG GMLG+VYRA+LP+GKLLAVK
Sbjct: 388 ASTAKPPIKAQNPLTSARSFTIASLQQYTNSFSQENLIGGGMLGNVYRAELPNGKLLAVK 447
Query: 540 KLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH 599
KLD++ASSQQKDDEF+ELVNNIDRIRHAN+VEL GYCAEHGQRLLIYEYCSNGTLQD LH
Sbjct: 448 KLDQKASSQQKDDEFIELVNNIDRIRHANVVELMGYCAEHGQRLLIYEYCSNGTLQDALH 507
Query: 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659
SDDELK LSWNTRIRMALGAARALEYLHE+CQPP+VHRNFKS NILLDDDL V VSDCG
Sbjct: 508 SDDELKKKLSWNTRIRMALGAARALEYLHEVCQPPVVHRNFKSVNILLDDDLDVRVSDCG 567
Query: 660 LAPLISSGSVSQVSHNLTIMRAGG 683
LAPLISSGSVSQ+S +L G
Sbjct: 568 LAPLISSGSVSQLSGHLLTAYGYG 591
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449479018|ref|XP_004155482.1| PREDICTED: LOW QUALITY PROTEIN: protein STRUBBELIG-RECEPTOR FAMILY 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/689 (64%), Positives = 527/689 (76%), Gaps = 22/689 (3%)
Query: 1 MGVKRSNIECKNWKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWV 60
MG KRS+ N +I+ VGFV + AA +TNP D +AI+SL+ ALG P LPGW
Sbjct: 1 MGWKRSS-RNGNLRIWVQVLVGFV-VCAAQVLLGITNPGDFSAISSLHTALGLPSLPGW- 57
Query: 61 ASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIP 120
DPCG++WQGV CN S II II+N ANLGGELG+NLG FSSI+ IDLSNNHIGGSIP
Sbjct: 58 GIGQDPCGDAWQGVVCNDSSIIRIIINAANLGGELGDNLGLFSSIQTIDLSNNHIGGSIP 117
Query: 121 SILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDL 180
S LPVT+QNFFLS NQF+GSIPSSL++LT LT MSLN+N LSGEIPD+FQ ++ L+N DL
Sbjct: 118 SNLPVTLQNFFLSANQFTGSIPSSLSSLTQLTAMSLNDNKLSGEIPDSFQVISQLVNFDL 177
Query: 181 SSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKML 240
S+NNLSG LPPS+ NL LTTLHLQNNQLSGTLDVLQDLPL+DLNIENNLFSGPIPEK+L
Sbjct: 178 SNNNLSGPLPPSVSNLLALTTLHLQNNQLSGTLDVLQDLPLKDLNIENNLFSGPIPEKVL 237
Query: 241 QIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFF---GPRPVSGSSPVSRTPPSQHTPG 297
IPNFRKDGNPFNS+V+P+ PP S P P G PVSG+ P SQ P
Sbjct: 238 SIPNFRKDGNPFNSSVSPTSPPVSPSPPSKPAPAPPVSGGPPVSGAP-----PSSQQRPK 292
Query: 298 KQADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRI 357
KQADGP+A E+S+SGK K S TK++V I+IA VL F+IL L +LFMPRC +RR D +
Sbjct: 293 KQADGPSASEESSSGKNKKS-TKRVVLITIAVVLSFIILVLACVLFMPRCRRRR-RSDSV 350
Query: 358 FKRHQVGAFRGNNREEARDNGTLALPTNQM---EKDASVKPKEDHRSEMRRMGAIPHAQN 414
KRHQ+GA+RG RE + G + +Q+ K+ V+ K++ ++E+++ +P
Sbjct: 351 SKRHQIGAYRG-ERENVGNQGAMPQTNDQIPKVPKEPVVRMKQETQTEVQK---VPKDNV 406
Query: 415 EQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKP 474
E+E+N RMS IP++D HE+DMS+LD+ +M PPPPPPPPPPPPPPPPPPP VE+V P
Sbjct: 407 EREKNMPRMSAIPKKDHHEVDMSTLDVYLM--PPPPPPPPPPPPPPPPPPPPVEEVTAVP 464
Query: 475 IVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGK 534
VPAE +K TK AR +TIASLQQYTNSFSQENL+G GMLG+VYRA LP GK
Sbjct: 465 TVPAEVPPLKPLTKNKITLPFARPYTIASLQQYTNSFSQENLLGEGMLGNVYRAHLPSGK 524
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
+LAVKKLDKRA S QKDDEFLELVNNIDRIRHAN+VEL GYCAEHG+RLLI+EYCS GTL
Sbjct: 525 VLAVKKLDKRAFSLQKDDEFLELVNNIDRIRHANVVELSGYCAEHGERLLIFEYCSGGTL 584
Query: 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654
QD LHSD+E + LSWN RIRMALGAARALEYLHE+CQPP++HRNFKSANILLDDDL+V
Sbjct: 585 QDALHSDEEFRKKLSWNARIRMALGAARALEYLHEVCQPPVIHRNFKSANILLDDDLSVR 644
Query: 655 VSDCGLAPLISSGSVSQVSHNLTIMRAGG 683
VSDCGLAPLIS G+VSQ+S L G
Sbjct: 645 VSDCGLAPLISKGAVSQLSGQLLTAYGYG 673
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|304281946|gb|ADM21184.1| strubbelig receptor family 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/655 (63%), Positives = 494/655 (75%), Gaps = 29/655 (4%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATTINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R +++G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKVGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVAVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNL 676
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQ+S L
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQL 650
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42566272|ref|NP_192248.2| STRUBBELIG-receptor family 3 [Arabidopsis thaliana] gi|75127761|sp|Q6R2K3.1|SRF3_ARATH RecName: Full=Protein STRUBBELIG-RECEPTOR FAMILY 3; AltName: Full=Leucine-rich repeat receptor kinase-like protein SRF3; Flags: Precursor gi|41323405|gb|AAR99871.1| strubbelig receptor family 3 [Arabidopsis thaliana] gi|224589608|gb|ACN59337.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332656913|gb|AEE82313.1| STRUBBELIG-receptor family 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/655 (63%), Positives = 494/655 (75%), Gaps = 29/655 (4%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T+ S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATMINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVTVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNL 676
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQ+S L
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQL 650
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|304281933|gb|ADM21173.1| SRF3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1932), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/655 (63%), Positives = 493/655 (75%), Gaps = 29/655 (4%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GNPFN+T S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNPFNATTINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVTVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNL 676
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQ+S L
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQL 650
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124596|ref|XP_002319371.1| predicted protein [Populus trichocarpa] gi|222857747|gb|EEE95294.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/635 (67%), Positives = 486/635 (76%), Gaps = 46/635 (7%)
Query: 41 VAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLG 100
V AINSLY +LGSPVLPGWV + GDPCGE WQG+ CN S+I +I+LNGANLGGELG+NLG
Sbjct: 1 VTAINSLYISLGSPVLPGWVGTGGDPCGEGWQGIVCNVSEIQSIVLNGANLGGELGDNLG 60
Query: 101 AFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNL 160
F+SI I LSNNHIGGSIPS LPVTMQN FLSDN F+GSIP SL+TLTLL MSLN+N
Sbjct: 61 MFASIISIGLSNNHIGGSIPSNLPVTMQNLFLSDNNFTGSIPDSLSTLTLLKAMSLNDNF 120
Query: 161 LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP 220
LSGEIPDAFQ+L GLINLDLS+NNLSG+LP S +L+ LTTL LQ+NQLSGTLDVLQDLP
Sbjct: 121 LSGEIPDAFQALPGLINLDLSNNNLSGQLPSSFIDLASLTTLRLQDNQLSGTLDVLQDLP 180
Query: 221 LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPV 280
LRDLN+ENNLFSGPIP+K+L IPNFR DGNPFN++ AP PTS PP P P+
Sbjct: 181 LRDLNVENNLFSGPIPDKLLAIPNFRNDGNPFNTSSAPLPAPTSPSPSPPTP----TPPL 236
Query: 281 SGSSPVSRTPPSQHTPGKQADGPTALEDSNSGKKKSSTTKKIVWISIAGVLLFVILALVF 340
SG+ P +P S+ TPGKQAD P++ + K++VWISIAGVLLFVILAL
Sbjct: 237 SGAPP---SPSSRRTPGKQADAPSS----SEKSSSGGKNKRVVWISIAGVLLFVILALAL 289
Query: 341 LLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLALPTNQMEKDASVKPKEDHR 400
+L +PRC +RR E RIFKRHQVG E RDNG+L DH
Sbjct: 290 VLLIPRCSRRRWEDSRIFKRHQVG-------ENPRDNGSL-----------------DH- 324
Query: 401 SEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM-MMMPPPPPPPPPPPPPPP 459
P QN RN+ +M+ P RD+H + + D+ M P PPPPPPPPPPP
Sbjct: 325 ---------PKPQNMHMRNEPKMNPAPNRDNHLMAIGRADLDFMAPLSSPPPPPPPPPPP 375
Query: 460 PPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGA 519
PPPPPP VE VIVKPIVPAE ++ K S KT P T+ARSF IASLQQYT+SFSQENLIG
Sbjct: 376 PPPPPPPVENVIVKPIVPAEVSSGKPSRKTQIPLTSARSFNIASLQQYTSSFSQENLIGG 435
Query: 520 GMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH 579
GMLGSVYRAQLP+GKLLAVKKLDKR + QQKD EF+ELVNNIDRIRHAN+VEL GYCAEH
Sbjct: 436 GMLGSVYRAQLPNGKLLAVKKLDKRTAEQQKDVEFIELVNNIDRIRHANVVELMGYCAEH 495
Query: 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRN 639
GQRLLIYEYCSNG+LQD LHSDDE K LSWN RI+MAL AARALEYLHE+CQPP++HRN
Sbjct: 496 GQRLLIYEYCSNGSLQDALHSDDEFKKKLSWNARIKMALEAARALEYLHEVCQPPVIHRN 555
Query: 640 FKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
FKSAN+LLDDDL V VSDCGLA LISSGSVSQV++
Sbjct: 556 FKSANVLLDDDLDVRVSDCGLASLISSGSVSQVTY 590
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|304281935|gb|ADM21174.1| SRF3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/655 (63%), Positives = 492/655 (75%), Gaps = 29/655 (4%)
Query: 26 IWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAII 85
IW S A TNP+DVAAIN L+AALG+PVLPGW+AS GDPCGE+WQG+ CN SDII+I
Sbjct: 21 IWIPSISLAATNPDDVAAINGLFAALGAPVLPGWIASGGDPCGEAWQGIICNVSDIISIT 80
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+N ANL GELG+NL F+SIR ID SNN IGGSIPS LPVT+Q+FFLS NQF+GSIP SL
Sbjct: 81 VNAANLQGELGDNLAKFTSIRGIDFSNNRIGGSIPSTLPVTLQHFFLSANQFTGSIPESL 140
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL+ L DMSLN+NLLSGE+PD FQ+L GLINLD+SSNN+SG LPPS+ENL LTTL +Q
Sbjct: 141 GTLSFLNDMSLNDNLLSGELPDVFQNLVGLINLDISSNNISGTLPPSMENLLTLTTLRVQ 200
Query: 206 NNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSS 265
NNQLSGTLDVLQ LPL+DLNIENNLFSGPIP+K+L IP F +GN FN+T S S
Sbjct: 201 NNQLSGTLDVLQGLPLQDLNIENNLFSGPIPDKLLSIPKFLHEGNLFNATTINSTSTAPS 260
Query: 266 VTPPPAPPFFGP-RPVSGSSPVSRTPPSQHTPGKQADGPTALEDS---NSGKKKSSTTKK 321
++P +P P RP SG P PP++ GK ADGP+ E S NS K SS TKK
Sbjct: 261 LSPSLSPTKPAPTRPFSGVPP----PPNERNRGKVADGPSDSEGSSSENSKGKNSSHTKK 316
Query: 322 IVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+ I+ AGVL+F+IL L LL +P+C +RR +R+FK HQVGA RG +RE A +NGT
Sbjct: 317 IILIAFAGVLVFIILVLAILLLLPKCARRREHANRVFKPHQVGADRG-SRENALENGTPV 375
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
LP + ++ R ++ G P ++ ER + R + I R++ +ID S M
Sbjct: 376 LP-------PPGRSEKVQREPFKKAGEEPKVLHDLERLR-RPAPISRQESQDIDFS---M 424
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
+M PPPPPPPPPPPPP+ EKV V PI+ E KTS K P T+ + ++I
Sbjct: 425 LMP--------PPPPPPPPPPPPPLDEKVTVMPIISPERPVKKTSPKRL-PLTSVKHYSI 475
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDKRAS QQ+D EF+ELVNNI
Sbjct: 476 ASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDKRASEQQQDHEFIELVNNI 535
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
D IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE K LSWNTR+ MALGAA
Sbjct: 536 DMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDEFKKKLSWNTRVSMALGAA 595
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNL 676
RALEYLHE+C+PPI+HRNFKSAN+LLDDDL+V VSDCGLAPLISSGSVSQ+S L
Sbjct: 596 RALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPLISSGSVSQLSGQL 650
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 689 | ||||||
| TAIR|locus:2125566 | 776 | SRF3 "STRUBBELIG-receptor fami | 0.278 | 0.247 | 0.756 | 4.1e-165 | |
| TAIR|locus:2051404 | 775 | SRF1 "STRUBBELIG-receptor fami | 0.477 | 0.424 | 0.467 | 3.3e-145 | |
| TAIR|locus:2202084 | 768 | SUB "STRUBBELIG" [Arabidopsis | 0.345 | 0.309 | 0.473 | 5.7e-107 | |
| TAIR|locus:2120683 | 703 | SRF8 "STRUBBELIG-receptor fami | 0.258 | 0.253 | 0.581 | 1.9e-87 | |
| TAIR|locus:2024837 | 720 | SRF6 "STRUBBELIG-receptor fami | 0.268 | 0.256 | 0.481 | 3.4e-77 | |
| TAIR|locus:2091015 | 717 | SRF7 "STRUBBELIG-receptor fami | 0.253 | 0.244 | 0.485 | 3.2e-75 | |
| TAIR|locus:2207280 | 699 | SRF5 "STRUBBELIG-receptor fami | 0.249 | 0.246 | 0.462 | 2.4e-71 | |
| TAIR|locus:2089210 | 687 | SRF4 "STRUBBELIG-receptor fami | 0.262 | 0.263 | 0.434 | 6.1e-71 | |
| TAIR|locus:2170219 | 735 | SRF2 "STRUBBELIG-receptor fami | 0.285 | 0.268 | 0.407 | 1.9e-66 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.252 | 0.182 | 0.376 | 7e-45 |
| TAIR|locus:2125566 SRF3 "STRUBBELIG-receptor family 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 4.1e-165, Sum P(3) = 4.1e-165
Identities = 146/193 (75%), Positives = 165/193 (85%)
Query: 484 KTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDK 543
KTS K P T+ + ++IASLQQYT SF+QENLIG+GMLGSVYRA+LP+GKL AVKKLDK
Sbjct: 459 KTSPKRL-PLTSVKHYSIASLQQYTESFAQENLIGSGMLGSVYRARLPNGKLFAVKKLDK 517
Query: 544 RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE 603
RAS QQ+D EF+ELVNNID IRH+NIVEL GYCAEH QRLL+YEYCSNGTLQD LHSDDE
Sbjct: 518 RASEQQQDHEFIELVNNIDMIRHSNIVELVGYCAEHDQRLLVYEYCSNGTLQDGLHSDDE 577
Query: 604 LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPL 663
K LSWNTR+ MALGAARALEYLHE+C+PPI+HRNFKSAN+ +V VSDCGLAPL
Sbjct: 578 FKKKLSWNTRVSMALGAARALEYLHEVCEPPIIHRNFKSANVLLDDDLSVLVSDCGLAPL 637
Query: 664 ISSGSVSQVSHNL 676
ISSGSVSQ+S L
Sbjct: 638 ISSGSVSQLSGQL 650
|
|
| TAIR|locus:2051404 SRF1 "STRUBBELIG-receptor family 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 3.3e-145, Sum P(2) = 3.3e-145
Identities = 166/355 (46%), Positives = 218/355 (61%)
Query: 322 IVWISIAGXXXXXXXXXXXXXXMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLA 381
I+WISI G +C+++R + +++ K H + G RE +R N ++
Sbjct: 315 IIWISILGAFSFVVLALVCLLCGRKCLRKREDSEQLSKPHLTSEY-GRAREGSRSNASML 373
Query: 382 LPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDM 441
P+N KD +PKE R+G ER+ + + +++ HEIDM+ M
Sbjct: 374 PPSNTFNKDKEARPKE-------RVGGASKLHGGAERS---VGSESKQESHEIDMNGNAM 423
Query: 442 MMMXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAEGTAVKTSTKTAKPFTTARSFTI 501
+M AE + +T++K+ P T + FT+
Sbjct: 424 DLMHPSSIPPIKRVIAKATEP---------------AEASLKRTTSKSHGPLTAVKHFTV 468
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
ASLQQ+TNSFS ENLIG GMLGSVYRA+LP GKL AV+KLDK++ + +++ +FLELVNNI
Sbjct: 469 ASLQQHTNSFSHENLIGTGMLGSVYRAELPGGKLFAVRKLDKKSPNHEEEGKFLELVNNI 528
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
DRIRHANIV+L G+C+EH QRLLI+EYC NGTL D+LH DD LK LSWN R+R+AL AA
Sbjct: 529 DRIRHANIVQLVGFCSEHSQRLLIHEYCRNGTLHDLLHIDDRLKIELSWNVRVRIALEAA 588
Query: 622 RALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGSVSQVSHNL 676
+ALEYLHEIC PP +HRNFKSANI V VSDCGLAPLISSG+VSQ+S L
Sbjct: 589 KALEYLHEICDPPSIHRNFKSANILLDDDIRVHVSDCGLAPLISSGAVSQLSGQL 643
|
|
| TAIR|locus:2202084 SUB "STRUBBELIG" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 5.7e-107, Sum P(2) = 5.7e-107
Identities = 114/241 (47%), Positives = 148/241 (61%)
Query: 13 WKIYANFFVGFVLIWAAGFSCAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCGESWQ 72
W++ FF VL FS VTN DV+AIN+LY LG+P L W+A GDPCGE WQ
Sbjct: 6 WEV---FFGLSVLALTMPFSAGVTNLRDVSAINNLYITLGAPSLHHWLAFGGDPCGEKWQ 62
Query: 73 GVQCNASDIIAIIXXXXXXXXXXXXXXXXFSSIRVIDLSNNHIGGSIPSILPVTMQNFFL 132
GV C++S+I I FSSI+V+D S+NHI G+IP LP +++N L
Sbjct: 63 GVVCDSSNITEIRIPGMKVGGGLSDTLADFSSIQVMDFSSNHISGTIPQALPSSIRNLSL 122
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIXXXXXXXXXXGELPPS 192
S N+F+G+IP +L+ L+ L+++SL +NLLSGEIPD FQ L+ L G LP S
Sbjct: 123 SSNRFTGNIPFTLSFLSDLSELSLGSNLLSGEIPDYFQQLSKLTKLDLSSNILEGHLPSS 182
Query: 193 LEXXXXXXXXXXXXXXXXGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPF 252
+ GTLDV++DL L DLN+ENNLFSGPIP +L+IPNF+KDG PF
Sbjct: 183 MGDLASLKILYLQDNKLTGTLDVIEDLFLTDLNVENNLFSGPIPPNLLKIPNFKKDGTPF 242
Query: 253 N 253
N
Sbjct: 243 N 243
|
|
| TAIR|locus:2120683 SRF8 "STRUBBELIG-receptor family 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 1.9e-87, Sum P(2) = 1.9e-87
Identities = 104/179 (58%), Positives = 132/179 (73%)
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF 554
TA +T++SLQ TNSFSQEN+IG G LG VYRA+ P+GK++A+KK+D A S Q++D F
Sbjct: 379 TASQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNF 438
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
LE V+N+ R+RH NIV L GYC EHGQRLL+YEY NG L D LH++D+ NL+WN R+
Sbjct: 439 LEAVSNMSRLRHPNIVPLAGYCTEHGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNARV 498
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGSVSQVS 673
++ALG A+ALEYLHE+C P IVHRNFKSANI +SD GLA L + + QVS
Sbjct: 499 KVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAAL-TPNTERQVS 556
|
|
| TAIR|locus:2024837 SRF6 "STRUBBELIG-receptor family 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 3.4e-77, Sum P(2) = 3.4e-77
Identities = 90/187 (48%), Positives = 121/187 (64%)
Query: 482 AVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKL 541
AVK ST P + R +++A LQ T SFS +NL+G G G VYRA+ DGK+LAVKK+
Sbjct: 389 AVKKSTVVV-P-SNVRLYSVADLQIATGSFSVDNLLGEGTFGRVYRAEFDDGKVLAVKKI 446
Query: 542 DKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSD 601
D A D+F+E+V+ I + H N+ +L GYCAEHGQ L++YE+ NG+L D LH
Sbjct: 447 DSSALPHGMTDDFIEMVSKIANLDHPNVTKLVGYCAEHGQHLVVYEFHKNGSLHDFLHLS 506
Query: 602 DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLA 661
+E L WN+R+++ALG ARALEYLHE+C P IV +N KSANI +SD GLA
Sbjct: 507 EEESKALVWNSRVKIALGTARALEYLHEVCSPSIVDKNIKSANILLDSELNPHLSDSGLA 566
Query: 662 PLISSGS 668
+ + +
Sbjct: 567 SFLPTAN 573
|
|
| TAIR|locus:2091015 SRF7 "STRUBBELIG-receptor family 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 3.2e-75, Sum P(2) = 3.2e-75
Identities = 85/175 (48%), Positives = 115/175 (65%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE 553
+ ++T++ LQ TNSFS +NL+G G G VYRAQ DGK+LAVKK+D A D+
Sbjct: 402 SNVNTYTVSDLQVATNSFSVDNLLGEGTFGRVYRAQFEDGKVLAVKKIDSSALPTDTADD 461
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
F E+V+ I + H N+ +L GYC+EHGQ L++YE+ NG+L D LH +E L WN R
Sbjct: 462 FTEIVSKIAHLDHENVTKLDGYCSEHGQHLVVYEFHRNGSLHDFLHLAEEESKPLIWNPR 521
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGS 668
+++ALG ARALEYLHE+C P IVH+N KSANI +SD GLA + + +
Sbjct: 522 VKIALGTARALEYLHEVCSPSIVHKNIKSANILLDSELNPHLSDSGLASFLPTAN 576
|
|
| TAIR|locus:2207280 SRF5 "STRUBBELIG-receptor family 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 2.4e-71, Sum P(2) = 2.4e-71
Identities = 81/175 (46%), Positives = 110/175 (62%)
Query: 490 AKPFTTARS---FTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRAS 546
AK T+ RS F ++ LQ T +FS NL+G G +G VYRA+ DG+ LAVKK+D
Sbjct: 380 AKRTTSTRSAVEFELSDLQSATANFSPGNLLGEGSIGRVYRAKYSDGRTLAVKKIDSTLF 439
Query: 547 SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKN 606
K + +V ++ +IRH NI EL GYC+E G +L+YEY NG+L + LH D
Sbjct: 440 DSGKSEGITPIVMSLSKIRHQNIAELVGYCSEQGHNMLVYEYFRNGSLHEFLHLSDCFSK 499
Query: 607 NLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLA 661
L+WNTR+R+ALG ARA+EYLHE C P ++H+N KS+NI +SD GL+
Sbjct: 500 PLTWNTRVRIALGTARAVEYLHEACSPSVMHKNIKSSNILLDADLNPRLSDYGLS 554
|
|
| TAIR|locus:2089210 SRF4 "STRUBBELIG-receptor family 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 6.1e-71, Sum P(2) = 6.1e-71
Identities = 79/182 (43%), Positives = 115/182 (63%)
Query: 481 TAVKTSTKTAKPFTTA-RSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVK 539
T ++ST P T ++F++A LQ + FS L+G G +G VY+A+ DG+ AVK
Sbjct: 384 TPDRSSTSQDSPDTRGVKAFSLADLQNTASCFSPNRLLGEGTIGRVYKAKFQDGRKFAVK 443
Query: 540 KLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH 599
++D + +EF +V++I I H N+ EL GYC+E G+ +L+YEY ++G+L LH
Sbjct: 444 EIDSSLLGKGNPEEFSHIVSSISSIHHKNMAELVGYCSEQGRNMLVYEYFTSGSLHRFLH 503
Query: 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCG 659
D+ L+WNTRIR+ALG A+A+EYLHE C PP+VH+N KS+NI +SD G
Sbjct: 504 LSDDFSKPLTWNTRIRIALGTAKAIEYLHETCSPPLVHKNIKSSNILLDNELNPRLSDYG 563
Query: 660 LA 661
LA
Sbjct: 564 LA 565
|
|
| TAIR|locus:2170219 SRF2 "STRUBBELIG-receptor family 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 404 (147.3 bits), Expect = 1.9e-66, Sum P(2) = 1.9e-66
Identities = 82/201 (40%), Positives = 124/201 (61%)
Query: 484 KTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDK 543
K+ + T + + A+ F+ A LQ TN FS+ENL+G G LGSVYRA+LPDG+ V+ +
Sbjct: 388 KSFSATCQYPSFAKLFSAAELQLATNCFSEENLLGEGPLGSVYRAKLPDGQFAVVRNIPM 447
Query: 544 RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE 603
+ S ++++F E++ ++RH NIV L G+C E+G+ LL+YEY + +L + +H DE
Sbjct: 448 SSLSLHEEEQFTEVLQTASKLRHPNIVTLLGFCIENGEHLLVYEYVGHLSLYNAMH--DE 505
Query: 604 LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPL 663
+ LSW R+R+A+G ARAL+YLH PPI H + K+ NI ++DCGLA L
Sbjct: 506 VYKPLSWGLRLRIAIGVARALDYLHSSFCPPIAHSDLKATNILLDEELTPRIADCGLASL 565
Query: 664 --ISSGSVSQVSHNLTIMRAG 682
++S SV + + I G
Sbjct: 566 RPLTSNSVKLRASEIAIQNTG 586
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 348 (127.6 bits), Expect = 7.0e-45, Sum P(2) = 7.0e-45
Identities = 67/178 (37%), Positives = 108/178 (60%)
Query: 496 ARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFL 555
A++FT L++ T++FS+ N +G G G VYR LP+G+L+A+K+ + S Q EF
Sbjct: 616 AKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQ--GSLQGGLEFK 673
Query: 556 ELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIR 615
+ + R+ H N+V L G+C + +++L+YEY SNG+L+D L ++ L W R++
Sbjct: 674 TEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIR--LDWTRRLK 731
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANIXXXXXXAVSVSDCGLAPLISSGSVSQVS 673
+ALG+ + L YLHE+ PPI+HR+ KS NI V+D GL+ L+ + V+
Sbjct: 732 IALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVT 789
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q6R2K3 | SRF3_ARATH | No assigned EC number | 0.6351 | 0.9085 | 0.8067 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00026005001 | SubName- Full=Chromosome chr12 scaffold_36, whole genome shotgun sequence; (749 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 689 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-24 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-17 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-10 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-07 | |
| COG5178 | 2365 | COG5178, PRP8, U5 snRNP spliceosome subunit [RNA p | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-06 | |
| PHA01732 | 94 | PHA01732, PHA01732, proline-rich protein | 3e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-06 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 1e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-05 | |
| PHA01732 | 94 | PHA01732, PHA01732, proline-rich protein | 6e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 8e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-05 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 9e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| PRK13406 | 584 | PRK13406, bchD, magnesium chelatase subunit D; Pro | 1e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| pfam10138 | 98 | pfam10138, Tellurium_res, Tellurium resistance pro | 2e-04 | |
| TIGR02031 | 589 | TIGR02031, BchD-ChlD, magnesium chelatase ATPase s | 2e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-04 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 2e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-04 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 2e-04 | |
| PRK14952 | 584 | PRK14952, PRK14952, DNA polymerase III subunits ga | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-04 | |
| pfam10138 | 98 | pfam10138, Tellurium_res, Tellurium resistance pro | 4e-04 | |
| pfam10138 | 98 | pfam10138, Tellurium_res, Tellurium resistance pro | 4e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 4e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-04 | |
| PHA01732 | 94 | PHA01732, PHA01732, proline-rich protein | 5e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 5e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-04 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 5e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 6e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 6e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 8e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 8e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-04 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 9e-04 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 9e-04 | |
| pfam10138 | 98 | pfam10138, Tellurium_res, Tellurium resistance pro | 0.001 | |
| TIGR02031 | 589 | TIGR02031, BchD-ChlD, magnesium chelatase ATPase s | 0.001 | |
| COG0810 | 244 | COG0810, TonB, Periplasmic protein TonB, links inn | 0.001 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.001 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 0.001 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.001 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.001 | |
| PRK11633 | 226 | PRK11633, PRK11633, cell division protein DedD; Pr | 0.002 | |
| PRK13406 | 584 | PRK13406, bchD, magnesium chelatase subunit D; Pro | 0.002 | |
| PRK13406 | 584 | PRK13406, bchD, magnesium chelatase subunit D; Pro | 0.002 | |
| TIGR02031 | 589 | TIGR02031, BchD-ChlD, magnesium chelatase ATPase s | 0.002 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 0.002 | |
| pfam10146 | 215 | pfam10146, zf-C4H2, Zinc finger-containing protein | 0.002 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.002 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 0.002 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.002 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.002 | |
| smart00818 | 165 | smart00818, Amelogenin, Amelogenins, cell adhesion | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.003 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.003 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.003 | |
| pfam05308 | 248 | pfam05308, Mito_fiss_reg, Mitochondrial fission re | 0.003 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 0.003 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.003 | |
| pfam01213 | 313 | pfam01213, CAP_N, Adenylate cyclase associated (CA | 0.004 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.004 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.004 | |
| smart00818 | 165 | smart00818, Amelogenin, Amelogenins, cell adhesion | 0.004 | |
| pfam05308 | 248 | pfam05308, Mito_fiss_reg, Mitochondrial fission re | 0.004 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 7e-31
Identities = 52/147 (35%), Positives = 79/147 (53%), Gaps = 9/147 (6%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G G+VY A+ GK +A+K + K SS ++ E + + ++ H NIV+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLRE-IEILKKLNHPNIVKLYGV 59
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ L+ EYC G+L+D+L E + LS + +R+ L LEYLH I
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 636 VHRNFKSANILLDDDLA-VSVSDCGLA 661
+HR+ K NILLD D V ++D GL+
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLS 140
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 517 IGAGMLGSVYRAQLPDGKLL-----AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G VY+ L AVK L + AS +++++ FLE + + ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIVR 65
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G C + ++ EY G L D L + L+ ++MAL A+ +EYL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHN 675
VHR+ + N L+ ++L V +SD GL+ I +
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 517 IGAGMLGSVYRAQL--PDGKLL---AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G VY+ +L GK AVK L + AS QQ + EFL + ++ H N+V+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE-EFLREARIMRKLDHPNVVK 65
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G C E ++ EY G L L + + LS + + AL AR +EYL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
+HR+ + N L+ ++L V +SD GL+ +
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 157
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 13/170 (7%)
Query: 515 NLIGAGMLGSVYRAQL---PDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY+ +L AVK L + AS +++ D FL+ + ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-----DDELKNNLSWNTRIRMALGAARALE 625
L G C E L+ EY G L D L K+ LS + A+ A+ +E
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHN 675
YL VHR+ + N L+ +DL V +SD GL+ + +
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 517 IGAGMLGSVYRAQL----PDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G VY+ L ++ AVK L + AS QQ + EFL + ++ H NIV+
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE-EFLREARIMRKLDHPNIVK 65
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G C E +++ EY G L D L + LS + + AL AR +EYL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK- 122
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
+HR+ + N L+ ++L V +SD GL+ +
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/146 (36%), Positives = 77/146 (52%), Gaps = 8/146 (5%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G+G G+VY+A+ GK++AVK L KR+ +KD + + R+ H NIV L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ L+ EYC G L D L LS + ++AL R LEYLH I
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---GI 119
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLA 661
+HR+ K NILLD++ V ++D GLA
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLA 145
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-24
Identities = 75/220 (34%), Positives = 122/220 (55%), Gaps = 15/220 (6%)
Query: 31 FSCAVTNPNDVAAINSLYAALGSPV--LPGWVASAGDPCGESWQGVQC-NASDIIAIILN 87
FS + ++ + S +++ P+ L W +SA D C WQG+ C N+S +++I L+
Sbjct: 23 FSM--LHAEELELLLSFKSSINDPLKYLSNWNSSA-DVC--LWQGITCNNSSRVVSIDLS 77
Query: 88 GANLGGELGENLGAFSSIRVIDLSNNHIGGSIP---SILPVTMQNFFLSDNQFSGSIPSS 144
G N+ G++ + I+ I+LSNN + G IP +++ LS+N F+GSIP
Sbjct: 78 GKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR- 136
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204
++ L + L+NN+LSGEIP+ S + L LDL N L G++P SL NL+ L L L
Sbjct: 137 -GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 205 QNNQLSGTL--DVLQDLPLRDLNIENNLFSGPIPEKMLQI 242
+NQL G + ++ Q L+ + + N SG IP ++ +
Sbjct: 196 ASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ +G G G VY A+ GKL+A+K + K+ + ++ E + + +++H NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILRE-IKILKKLKHPNI 59
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V L + + L+ EYC G L D+L L + + ALEYLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLHS 115
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
IVHR+ K NILLD+D V ++D GLA
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-22
Identities = 57/152 (37%), Positives = 85/152 (55%), Gaps = 7/152 (4%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIP-SILPVTMQNFFLSDNQFSGSIPSSLATL 148
NL G + S++++ L+ N G +P S ++N LS NQFSG++P L +L
Sbjct: 439 NLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSL 498
Query: 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
+ L + L+ N LSGEIPD S L++LDLS N LSG++P S + L+ L L NQ
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 209 LSGTLDVLQDL----PLRDLNIENNLFSGPIP 236
LSG ++ ++L L +NI +N G +P
Sbjct: 559 LSG--EIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 52/163 (31%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 513 QENLIGAGMLGSVYRA-QLPDGKLLAVKKL----DKRASSQQKDDEFLELVNNIDRIRHA 567
+ N IG G G VY A L G+L+AVK++ + + ++ DE + ++ ++H
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADE----MKVLELLKHP 59
Query: 568 NIVELKGYCAE-HGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
N+V K Y E H +++ I+ EYCS GTL+++L E L + L L
Sbjct: 60 NLV--KYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLA 113
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
YLH IVHR+ K ANI LD + + + D G A + + +
Sbjct: 114 YLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 14/170 (8%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+++ L+G G GSVY A D G+L+AVK ++ S+++ + + + ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 569 IVELKGYC--AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RMALGAARAL 624
IV G E + EY S G+L +L +L + R R L L
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL---EGL 114
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
YLH IVHR+ K ANIL+D D V ++D G A + + +
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 5e-20
Identities = 73/207 (35%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 38 PNDVAAINSL-YAALGSPVLPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELG 96
PND+ + +SL LG VL G + N + + + L L G++
Sbjct: 157 PNDIGSFSSLKVLDLGGNVLVGKIP-----------NSLTNLTSLEFLTLASNQLVGQIP 205
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
LG S++ I L N++ G IP + ++ + L N +G IPSSL L L +
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD 214
L N LSG IP + SL LI+LDLS N+LSGE+P + L L LHL +N +G +
Sbjct: 266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
Query: 215 V-LQDLP-LRDLNIENNLFSGPIPEKM 239
V L LP L+ L + +N FSG IP+ +
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-19
Identities = 60/174 (34%), Positives = 93/174 (53%), Gaps = 9/174 (5%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPS-ILPVTMQNFF-LS 133
C++ ++ +IL +L GE+ ++LGA S+R + L +N G +PS + + F +S
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
+N G I S + L +SL N G +PD+F S L NLDLS N SG +P L
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495
Query: 194 ENLSQLTTLHLQNNQLSGTLDVLQDLP----LRDLNIENNLFSGPIPEKMLQIP 243
+LS+L L L N+LSG ++ +L L L++ +N SG IP ++P
Sbjct: 496 GSLSELMQLKLSENKLSG--EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMP 547
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-18
Identities = 53/157 (33%), Positives = 78/157 (49%), Gaps = 3/157 (1%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNF--FLSDNQFSGSIPSSLAT 147
GE+ +NLG +++ V+DLS N++ G IP L + F L N G IP SL
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
L + L +N SGE+P F L + LD+S+NNL G + ++ L L L N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 208 QLSGTL-DVLQDLPLRDLNIENNLFSGPIPEKMLQIP 243
+ G L D L +L++ N FSG +P K+ +
Sbjct: 463 KFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 516 LIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V G+ +AVK L +++ Q FL + + +RH N+V+L G
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA---FLAEASVMTTLRHPNLVQLLGV 68
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ ++ EY + G+L D L S L+ ++ AL +EYL E
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEE---KNF 123
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLA 661
VHR+ + N+L+ +DL VSD GLA
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 60/175 (34%), Positives = 91/175 (52%), Gaps = 6/175 (3%)
Query: 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIP---SILPVTMQNFFLS 133
+ +I++ L+ +L GE+ E + ++ ++ L +N+ G IP + LP +Q L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLW 340
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
N+FSG IP +L LT + L+ N L+GEIP+ S L L L SN+L GE+P SL
Sbjct: 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
Query: 194 ENLSQLTTLHLQNNQLSGTLDV-LQDLPLRD-LNIENNLFSGPIPEKMLQIPNFR 246
L + LQ+N SG L LPL L+I NN G I + +P+ +
Sbjct: 401 GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ 455
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 28/185 (15%)
Query: 511 FSQENLIGAGMLGSVYRAQL--PDGKL----LAVKKLDKRASSQQKDDEFLELVNNIDRI 564
F +E +G G G VY+ +L P+ +L +A+K L + A + + + F + + +
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAELMSDL 65
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML-----HSD-------DELKNNLSWNT 612
+H NIV L G C + +++EY ++G L + L HSD + +K++L +
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 613 RIRMALGAARALEYL--HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
+ +A+ A +EYL H VHR+ + N L+ + L V +SD GL+ I S
Sbjct: 126 FLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 671 QVSHN 675
+V
Sbjct: 181 RVQSK 185
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F IG G G VY+A GK +A+K + S++K ++ + + + + +H NI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDML----HSDDE------LKNNLSWNTRIRMALG 619
V+ G + + ++ E+CS G+L+D+L + E K L
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLK---------- 109
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
LEYLH I+HR+ K+ANILL D V + D GL+ +S
Sbjct: 110 ---GLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 11/162 (6%)
Query: 509 NSFSQENLIGAGMLGSVYRA--QLPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI 564
+ + E +IG G G V R +LP K +A+K L +S +Q+ D FL + + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQF 62
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H NI+ L+G + ++I EY NG+L L +D + + M G A +
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGM 119
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
+YL E+ VHR+ + NIL++ +L VSD GL+ +
Sbjct: 120 KYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 515 NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+LIG G G VY+ L G +A+K++ ++ ++ ++ + ++H NIV+
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G +I EY NG+L+ ++ +L + L + L YLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVL---QGLAYLHE---Q 118
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLA 661
++HR+ K+ANIL D V ++D G+A
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 5e-16
Identities = 42/158 (26%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLD-KRASSQQKDDEFLELVNNIDRIRHAN 568
+ IG G G VY + DGKL +K++D S ++++D E V + ++ H N
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNE-VKILKKLNHPN 60
Query: 569 IVELKGYCAEHGQRLLI-YEYCSNGTLQDMLHSDDELKNNLS----WNTRIRMALGAARA 623
I++ E +L I EY G L + + + +++ L A
Sbjct: 61 IIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----A 115
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L+YLH I+HR+ K NI L + V + D G++
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 28/164 (17%)
Query: 36 TNPNDVAAINSLYAALGSPVLPGWVASAGDPCG---ESWQGVQCNASDII-AIILNGANL 91
T +V+A+ +L ++LG P+ GW GDPC W G C ++G
Sbjct: 369 TLLEEVSALQTLKSSLGLPLRFGW---NGDPCVPQQHPWSGADCQFDSTKGKWFIDG--- 422
Query: 92 GGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT--MQNFFLSDNQFSGSIPSSLATLT 149
+ L N + G IP+ + +Q+ LS N G+IP SL ++T
Sbjct: 423 ----------------LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT 466
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
L + L+ N +G IP++ LT L L+L+ N+LSG +P +L
Sbjct: 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 9/160 (5%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G+V + + DGK+L K++D ++++ + + VN + ++H NIV Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY--Y 65
Query: 576 CAEH---GQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH--E 629
Q L I EYC G L ++ + + + R+ AL H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
++HR+ K ANI LD + V + D GLA ++ S
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F N IG G G V++ + D ++ A+K++D ++++ +E ++ + ++ + I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMALGAARALEYL 627
+ + G+ ++ EY NG L +L L + W I++ LG L +L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
H I+HR+ KS N+ LD V + D G+A L+S +
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G G+VY A+ + +++A+KK+ S +K + ++ V + ++RH N +E KG
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 575 -YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
Y EH L+ EYC G+ D+L + K L + GA + L YLH +
Sbjct: 83 CYLREH-TAWLVMEYCL-GSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+HR+ K+ NILL + V ++D G A L+S
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVS 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKK---LDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
L+G+G GSVY L DG AVK+ D + Q+ + + + + +++H NIV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 572 LKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
G L I+ E G+L +L + ++ LG LEYLH+
Sbjct: 67 YLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHD- 120
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
VHR+ K ANIL+D + V ++D G+A
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 515 NLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+G G G V + G+ +AVK L+ Q + D F + + + H NI
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHENI 68
Query: 570 VELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
V+ KG C + G R LI EY +G+L+D L ++ ++ + + + ++YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDYL 125
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+HR+ + NIL++ + V +SD GLA ++
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 8/156 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +GAG G V+ +AVK L K + + FL+ + ++RH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEA--FLQEAQIMKKLRHDK 62
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L C+E ++ EY S G+L D L S + L + MA A + YL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+HR+ + NIL+ ++L ++D GLA LI
Sbjct: 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 27/160 (16%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVK--KLDKRASSQQKDDEFLELVNNID---RIRHANIV 570
IG+G G VY+A+ + G+L+A+K KL+ D+F + I RH NIV
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP-------GDDFEIIQQEISMLKECRHPNIV 63
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI----RMALGAARALEY 626
G + ++ EYC G+LQD+ + LS +I R L + L Y
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLS-ELQIAYVCRETL---KGLAY 116
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
LHE + +HR+ K ANILL +D V ++D G++ +++
Sbjct: 117 LHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 517 IGAGMLGSV--YR---AQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G V Y A G+++AVK L KR QQ + + +N + + H NIV+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 572 LKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
KG C+E G + LI EY G+L+D L K+ L+ + A + YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLH- 124
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
+HR+ + N+LLD+D V + D GLA + G
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 2/102 (1%)
Query: 93 GELGENLGAFSSIRVIDLSNNHIGGSIPSILPV--TMQNFFLSDNQFSGSIPSSLATLTL 150
G + LG+ S + + LS N + G IP L + + LS NQ SG IP+S + + +
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
L+ + L+ N LSGEIP ++ L+ +++S N+L G LP +
Sbjct: 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 516 LIGAGMLGSVYRAQLPDGKLLAVK--KLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G VY+ L +AVK + ++K FL+ + + H NIV+L
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK---FLQEAEILKQYDHPNIVKLI 58
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G C + ++ E G+L L KN L+ ++M+L AA +EYL
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLA 661
+HR+ + N L+ ++ + +SD G++
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 72.1 bits (175), Expect = 2e-13
Identities = 59/176 (33%), Positives = 85/176 (48%), Gaps = 9/176 (5%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE-FLELVNNIDRIRHA- 567
S+ +G G G VY A+ D KL+A+K L K+ S+ K+ E FL + + + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
NIV+L + + G L+ EY G+L+D+L K LS + + + ALEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGR-KGPLSESEALFILAQILSALEYL 117
Query: 628 HEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSGSVSQVSHNLTIMRAG 682
H I+HR+ K NILLD D V + D GLA L+ + L G
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
|
Length = 384 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRA--QLPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI 564
+ +++ +IGAG G V+R ++P K +A+K L + +Q+ D FL + + +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQF 63
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H NI+ L+G + ++I EY NG L L D S + M G A +
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGM 120
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+YL ++ VHR+ + NIL++ +L VSD GL+
Sbjct: 121 KYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ QE IG+G G V+ + + +A+K + + A S++ +F+E + ++ H +
Sbjct: 7 TLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKL 61
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L G C E L++E+ +G L D L + + S T + M L + YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLES 118
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
++HR+ + N L+ ++ V VSD G+ +
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV 150
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 29/168 (17%)
Query: 516 LIGAGMLGSVYRAQL-----PDGKL-LAVKKLDKRASSQQKDDEFLELVNNIDRI----R 565
+G G G V +A+ P+ +AVK L A+ + + +LV+ ++ + +
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EKDLSDLVSEMEMMKMIGK 74
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS------------DDELKNNLSWNTR 613
H NI+ L G C + G ++ EY ++G L+D L + + L+
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ A AR +E+L +HR+ + N+L+ +D + ++D GLA
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 7/154 (4%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
F+ E +G+G G V+ + +A+K L ++ K +F + V + R+RH +++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKIL--KSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
L C+ +I E G+L L S + L + I MA A + YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE- 122
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+HR+ + NIL+ +DL V+D GLA LI
Sbjct: 123 --QNSIHRDLAARNILVGEDLVCKVADFGLARLI 154
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 43/161 (26%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 516 LIGAGMLGSVYRAQLPDG--KLLAVKK-----LDKRASSQQKDDEFLELVNNI----DRI 564
+G+G G VY+ + + LLA+K+ +++D ++V+ + +++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLS----WNTRIRMALGA 620
RH NIV E+ + ++ + L + +S E K + WN ++M L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
AL YLH+ + IVHR+ NI+L +D V+++D GLA
Sbjct: 125 --ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 517 IGAGMLGSVYRAQLPDGKLLA---VKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G V + G A VK+L + +++ + FL+ V + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSW-NTRIRMALGAARALEYLHEICQ 632
G C E LL+ E+C G L++ L S+ + ++ + RMA A L +LH Q
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---Q 118
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+H + N L DL+V + D GLA
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 34/165 (20%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEF----LELVNNIDRIRHANIVE 571
IG G G VY+A+ G+L+A+KK+ + + + F + + + ++RH NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM----ENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 572 LKGYCAEH--GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR------- 622
LK G +++EY + L +L + ++ +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDH-DLTGLLD-----------SPEVKFTESQIKCYMKQLL 110
Query: 623 -ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
L+YLH I+HR+ K +NIL+++D + ++D GLA +
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 25/177 (14%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
LIG+G GSVY G+L+AVK+++ + S D +++ + R ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 568 NIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
NIV+ G + L I+ EY G++ +L++ + L N +R L + L Y
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF-VRQIL---KGLNY 121
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIMRAGG 683
LH I+HR+ K ANIL+D+ + +SD G++ ++ N + G
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGIS--------KKLEANSLSTKTNG 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+F +E +G+G G V+ + +A+K + + A S+ D+F+E + ++ H N+
Sbjct: 7 TFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNL 61
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L G C + ++ EY +NG L + L E K L + M A+EYL
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+HR+ + N L+ +D V VSD GLA
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 32/185 (17%)
Query: 517 IGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLE--LVNNIDRIRHAN 568
IG G G V++A+ P ++AVK L + AS+ + D E L+ D H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD---HPN 69
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDEL------KNNLSW 610
IV+L G CA L++EY + G L + L HS LS
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 611 NTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
++ +A A + YL E VHR+ + N L+ +++ V ++D GL+ I S
Sbjct: 130 TEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 671 QVSHN 675
+ S N
Sbjct: 187 KASEN 191
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 48/180 (26%), Positives = 75/180 (41%), Gaps = 34/180 (18%)
Query: 504 LQQYTNSFSQENLIGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEF--- 554
+Q+ T +E +G G G V+ + + L+AVK L K +S +F
Sbjct: 2 VQRDTIVLKRE--LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFERE 58
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWN--- 611
EL+ N H NIV+ G C E ++++EY +G L L S L
Sbjct: 59 AELLTNFQ---HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115
Query: 612 ----TRIRM---ALGAARALEYL---HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
T ++ A+ A + YL H VHR+ + N L+ DL V + D G++
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F +G G GSVY+ + L D + A+K++D + SQ++ ++ + + + + H NI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 570 VELKGYCAEHGQRLLI-YEYCSNGTLQDMLHSDDELKNNLS----WNTRIRMALGAARAL 624
+ K + G +L I EY G L + + + + W I++ G L
Sbjct: 62 ISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----L 116
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
+ LHE I+HR+ KSANILL + V + D G++ ++
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 514 ENLIGAGMLGSVYRAQL-PDGK---LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
E +IGAG G V R +L GK +A+K L + +Q+ D FL + + + H NI
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ L+G + ++I E+ NG L L +D + + M G A ++YL E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ VHR+ + NIL++ +L VSD GL+ + +
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
F + N IG G G VYRA+ G+++A+KK+ ++D + + I +RH
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRH 65
Query: 567 ANIVELKGYCAEHGQRL----LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
NIVELK G+ L L+ EYC QD+ D + S + + L R
Sbjct: 66 PNIVELKEVVV--GKHLDSIFLVMEYCE----QDLASLLDNMPTPFSESQVKCLMLQLLR 119
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
L+YLHE I+HR+ K +N+LL D + ++D GLA
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 517 IGAGMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G V +++ + VK+L ASS+++++ FL+ + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNE-FLQQGDPYRILQHPNILQCL 61
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G C E LL++EYC G L+ L + + N RMA A + ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH--- 118
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAP 662
+H + N L DL V V D G+ P
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGP 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 38/167 (22%), Positives = 74/167 (44%), Gaps = 37/167 (22%)
Query: 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RI 564
F +G G GSVY+A G+++A+K + +++ E++ I +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-------PVEEDLQEIIKEISILKQC 55
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------SDDE----LKNNLSWNTRI 614
IV+ G ++ ++ EYC G++ D++ +++E L L
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL------ 109
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ LEYLH +HR+ K+ NILL+++ ++D G++
Sbjct: 110 -------KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (159), Expect = 2e-11
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEF----LELVNNIDR 563
+ + +G G G VY+A+ G+++A+KK LD +++ L ++ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTALREISLLKE 54
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
++H NIV+L + L++EYC L+ L LS N + R
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK---RPGPLSPNLIKSIMYQLLRG 110
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L Y H I+HR+ K NIL++ D + ++D GLA
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 512 SQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+ ++ +G G G VY +AVK L + + +EFL+ + I+H N+V
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLV 65
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
+L G C +I E+ + G L D L + + ++ + MA + A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLE-- 121
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+ +HR+ + N L+ ++ V V+D GL+ L+
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 154
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 516 LIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
++G G GSV QL DG L AVK + + + +EFL + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 572 LKGYCAEHGQR------LLIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMALGAARA 623
L G C E ++I + +G L L L L T ++ + A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+EYL +HR+ + N +L +D+ V V+D GL+ I SG
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 22/165 (13%)
Query: 514 ENLIGAGMLGSVYRAQLP-DG-KLLAVKKLDKRASSQQKDDEF---LELVNNIDRIRHAN 568
E++IG G G V RA + DG K+ A K+ K +S+ +F LE++ + H N
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH--HPN 64
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN------------LSWNTRIRM 616
I+ L G C G + EY G L D L L+ + L+ ++
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
A A ++YL E +HR+ + N+L+ ++LA ++D GL+
Sbjct: 125 ASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS 166
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 12/138 (8%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDK-RASSQQKDDEFLELVNNI---DRIRHANIV 570
+G G S Y+A+ + G L+AVK++ R +S ++++ L I R+ H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
+ G E L E+ + G++ +L K + I R L YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYLHE- 121
Query: 631 CQPPIVHRNFKSANILLD 648
I+HR+ K AN+L+D
Sbjct: 122 --NQIIHRDVKGANLLID 137
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 8e-11
Identities = 36/154 (23%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 517 IGAGMLGS--VYRAQLPDGKLLAVKKLD-KRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G G +YR + D L+ K+++ R S +++ D E + + ++H NI+
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNE-IVILSLLQHPNIIAYY 65
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDML-HSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
+ + L+ EY + GTL D + +L + A+ Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL---FEEEMVLWYLFQIVSAVSYIHKA-- 120
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
I+HR+ K+ NI L + + D G++ ++ S
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+GAG G V+ +A+K L + + S + FL N + +++H +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+ +I EY NG+L D L + + +K L+ N I MA A + ++ + +
Sbjct: 71 TQE-PIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNYI 124
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLI 664
HR+ ++ANIL+ + L ++D GLA LI
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 17/154 (11%)
Query: 496 ARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKL-LAVKKLDKRASSQQKDDEF 554
++S TI + +S +EN+I G G+ Y+ + + VK+++ S +
Sbjct: 680 SKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE--- 733
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
+ ++ +++H NIV+L G C LI+EY L ++L NLSW R
Sbjct: 734 ---IADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRR 783
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLD 648
++A+G A+AL +LH C P +V N I++D
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 22/164 (13%)
Query: 515 NLIGAGMLGSVYRAQLP-DG-KLLAVKKLDKRASSQQKDDEF---LELVNNIDRIRHANI 569
++IG G G V +A++ DG ++ A K K +S+ +F LE++ + H NI
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 58
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN------------LSWNTRIRMA 617
+ L G C G L EY +G L D L L+ + LS + A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
AR ++YL + +HR+ + NIL+ ++ ++D GL+
Sbjct: 119 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 29/163 (17%)
Query: 516 LIGAGMLGSVYRAQ---LPD--GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G GSV + L D G+++AVKKL + +D F + + ++H NIV
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD--FEREIEILKSLQHDNIV 68
Query: 571 ELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ KG C G+R L+ EY G+L+D L K+ R L + L Y
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-----KH--------RERLDHRKLLLYAS 115
Query: 629 EICQ-------PPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+IC+ VHR+ + NIL++ + V + D GL ++
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 8/154 (5%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G V + + G+++A+KK + + L V + ++RH NIV LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
G+ L++EY L+ + + L + +A+ Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH---SHN 120
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
I+HR+ K NIL+ + + + D G A + +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 39/141 (27%), Positives = 68/141 (48%), Gaps = 12/141 (8%)
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
L+AVK L + ++D FL+ + + R+++ NI+ L G C +I EY NG L
Sbjct: 46 LVAVKMLRADVTKTARND-FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 595 -----QDMLHSDDELKNNL---SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646
Q + S NN+ S + MA+ A ++YL + VHR+ + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161
Query: 647 LDDDLAVSVSDCGLAPLISSG 667
+ + + ++D G++ + SG
Sbjct: 162 VGNHYTIKIADFGMSRNLYSG 182
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 39/148 (26%), Positives = 64/148 (43%), Gaps = 8/148 (5%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+GAG G V+ + +AVK L K + KD FL + ++RH +++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVC 70
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
++ E G+L + L L I MA A + YL +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLE---AQNYI 125
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLI 664
HR+ + N+L+ ++ V+D GLA +I
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 20/159 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
F+ IG G G VY+A +++A+K +D + +DE ++ I +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIEDIQQEIQFLSQC 56
Query: 568 NIVELKGY--CAEHGQRL-LIYEYCSNGTLQDMLHS--DDELKNNLSWNTRIRMALGAAR 622
+ Y G +L +I EYC G+ D+L DE ++ +R L
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE--TYIA--FILREVL---L 109
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LEYLHE + I HR+ K+ANILL ++ V ++D G++
Sbjct: 110 GLEYLHE--EGKI-HRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 34/178 (19%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNN----IDR 563
+ F +IG G +V A+ K A+K LDKR ++K ++ V + R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY---VKIEKEVLTR 57
Query: 564 I-RHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
+ H I++L Y + + L + EY NG ++L ++ S + +
Sbjct: 58 LNGHPGIIKLY-YTFQDEENLYFVLEYAPNG---ELLQY---IRKYGSLDEKC------T 104
Query: 622 R--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
R ALEYLH I+HR+ K NILLD D+ + ++D G A ++ S +
Sbjct: 105 RFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 38/172 (22%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G VY A LP+ + +A+K+ L+K +S DE + V + + H N+V K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV---DELRKEVQAMSQCNHPNVV--K 63
Query: 574 GYCA--EHGQRLLIYEYCSNGTLQDMLHSD------DE------LKNNLSWNTRIRMALG 619
Y + + L+ Y S G+L D++ S DE LK L
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL----------- 112
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
+ LEYLH Q +HR+ K+ NILL +D +V ++D G++ ++ G
Sbjct: 113 --KGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
L+G+G+ G+V++ +P+G + A+K + R S +Q E + + + + HA IV
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
L G C G L L+ + G+L D + +++L + + A+ + YL E
Sbjct: 73 RLLGICP--GASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+VHRN + NILL D V ++D G+A L+
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHAN 568
F+ IG G G+VY A+ + +++A+KK+ S +K + ++ V + RI+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 569 IVELKG-YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+E KG Y EH L+ EYC G+ D+L K L + GA + L YL
Sbjct: 87 SIEYKGCYLREH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYL 141
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
H ++HR+ K+ NILL + V ++D G A + S
Sbjct: 142 H---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 514 ENLIGAGMLGSVY--RAQLPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
E +IGAG G V R +LP + +A+K L + +Q+ D FL + + + H NI
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ L+G + +++ EY NG+L L D + + M G A ++YL +
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD 124
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+ VHR+ + NIL++ +L VSD GL+ ++
Sbjct: 125 M---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V++A+ G+ +A+KK+ R ++ L + + +H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66
Query: 576 CAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
HG L+ EY L ++L ++ + +RM L + + Y+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN---G 119
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
I+HR+ K AN+L+ D + ++D GLA L S SH
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 18/170 (10%)
Query: 511 FSQENL-----IGAGMLGSVYRAQL-----PDGKL-LAVKKLDKRASSQQKDDEFLELVN 559
F + NL +GAG G V A D + +AVK L A S +++ EL
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
H NIV L G C G L+I EYC G L + L E + L+ + +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQ 149
Query: 620 AARALEYL-HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
A+ + +L + C +HR+ + N+LL V + D GLA I + S
Sbjct: 150 VAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 16/154 (10%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFL--ELVNNIDRIRHANIVELK 573
+G+G G VY+A+ L G+L AVK + + DD L + + + +H NIV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII----KLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKN-NLSWNTRIRMALGAARALEYLHEICQ 632
G + + EYC G+LQD+ H L +++ R + + L YLH +
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK 127
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
+HR+ K ANILL D+ V ++D G+A I++
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITA 158
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 31/85 (36%), Positives = 49/85 (57%), Gaps = 2/85 (2%)
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
+ L+N L G IP+ L L +++LS N++ G +PPSL +++ L L L N +G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 214 -DVLQDL-PLRDLNIENNLFSGPIP 236
+ L L LR LN+ N SG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 11/149 (7%)
Query: 516 LIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G G V R + GK++ AVK L K D+FL+ + + H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G H +++ E G+L D L + + +T A+ A + YL
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGL 660
+HR+ + NILL D V + D GL
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGL 143
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIR 565
+F E IG G VY+A L DG+++A+KK+ K + L+ ++ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
H N+++ E+ + ++ E G L M+ + K + T + + ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
++H I+HR+ K AN+ + V + D GL SS
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 13/156 (8%)
Query: 517 IGAGMLGSVYRA--QLPDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+G G GSV + + GK + AVK L + + K EFL + + ++ H IV L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK-EFLREASVMAQLDHPCIVRL 61
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
G C +L+ E G L L E+ + +A A + YL
Sbjct: 62 IGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVS----DLKELAHQVAMGMAYLESK-- 114
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
VHR+ + N+LL + +SD G++ + +GS
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 39/145 (26%), Positives = 65/145 (44%), Gaps = 9/145 (6%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+G G G V + +A+K + + + S+ DEF+E + ++ H +V+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+ ++ EY SNG L + L E + + M + YL +
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFI 122
Query: 637 HRNFKSANILLDDDLAVSVSDCGLA 661
HR+ + N L+DD V VSD GL+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 8/148 (5%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+GAG G V+ + +AVK L S Q FLE N + ++H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 70
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+ +I EY + G+L D L SD+ K L I + A + Y+ + +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYI 125
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLI 664
HR+ ++AN+L+ + L ++D GLA +I
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 46/171 (26%), Positives = 69/171 (40%), Gaps = 32/171 (18%)
Query: 508 TNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR- 565
T F +IG G G VY+A G+L+A+K +D DE E+ + +R
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRK 58
Query: 566 ---HANIVE------LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM 616
H NI K Q L+ E C G++ D++ K R++
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKE 112
Query: 617 AL------GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
R L YLHE ++HR+ K NILL + V + D G++
Sbjct: 113 EWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHAN 568
FS IG G G+VY A+ + + +++A+KK+ S +K + ++ V + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 569 IVELKG-YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
++ +G Y EH L+ EYC G+ D+L K L + GA + L YL
Sbjct: 77 TIQYRGCYLREH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL 131
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
H ++HR+ K+ NILL + V + D G A +++
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 9/156 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S +G G G V+ +AVK L S + FLE + ++RH
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDK 62
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L +E ++ EY S G+L D L + L + MA A + Y+
Sbjct: 63 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIE 119
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+ +HR+ +SANIL+ D L ++D GLA LI
Sbjct: 120 RM---NYIHRDLRSANILVGDGLVCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNID---RI 564
++ + L+G G G VY D G+ LAVK++ S + E L I +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 565 RHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTR--IRMALGAA 621
+H IV+ G C + L I+ EY G+++D L + L + TR R L
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TRKYTRQIL--- 114
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+EYLH IVHR+ K ANIL D V + D G +
Sbjct: 115 EGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G G+VY A +++AVKK+ + +K + ++ V + +++H N +E KG
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 575 -YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
Y EH L+ EYC G+ D+L K L + GA + L YLH
Sbjct: 89 CYLKEH-TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
++HR+ K+ NILL + V ++D G A S
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 517 IGAGMLGSV----YRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
IG G G V YR G +AVK + A++Q FL + + ++RH+N+V+L
Sbjct: 14 IGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQL 64
Query: 573 KGYCAE-HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
G E G ++ EY + G+L D L S ++ L + ++ +L A+EYL
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE--- 119
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
VHR+ + N+L+ +D VSD GL SS
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 517 IGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G G +Y+ L +L+A+K L K ++ Q+ EF + + + + H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDML-----HSD-----DE---LKNNLSWNTRIRMAL 618
L G + +++EY + G L + L HSD DE +K++L + +A+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHN 675
A +EYL VH++ + NIL+ + L V +SD GL+ I S +V
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 18/168 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIR 565
N +++IG G G V +A++ DG + A+K++ + AS D EL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN------------LSWNTR 613
H NI+ L G C G L EY +G L D L L+ + LS
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ A AR ++YL Q +HR+ + NIL+ ++ ++D GL+
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
IG G G+V + + G+ +AVK + ++Q FLE + ++ H N+V L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGVI 68
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+G +++ E S G L + L + ++ ++ +L A +EYL +V
Sbjct: 69 LHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLE---SKKLV 122
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
HR+ + NIL+ +D VSD GLA + S G
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMG 153
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G VY+A+ G+++A+KK+ R S+ L + + + H NI++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
G L++E+ + + L +L + ++ + L + H I
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLL----QGLAFCH---SHGI 119
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
+HR+ K N+L++ + + ++D GLA S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGS 150
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 32/178 (17%)
Query: 511 FSQENLI-----GAGMLGSVYRA-------QLPDGKL-LAVKKLDKRASSQQKDDEF--L 555
F ++ L+ G G G V RA PD + +AVK L A+ + D +
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 556 ELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS------DDEL----- 604
EL+ I + H NI+ L G C + G +I EY + G L++ L + D
Sbjct: 69 ELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 605 -KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ LS+ + A AR +EYL +HR+ + N+L+ +D + ++D GLA
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK-G 574
+G G G V + DGK +KKL+ R +S+++ + + +++H NIV +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNL-------SWNTRIRMALGAARALEYL 627
+ E G ++ +C G D+ H E K L W +I MAL +YL
Sbjct: 68 WEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYL 118
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
HE I+HR+ K+ N+ L + V D G+A ++ +
Sbjct: 119 HE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 8/150 (5%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
IG+G G VY+A+ + LA K+ K + E++ D +H+NIV G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKD-CKHSNIVAYFGSY 75
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+ + E+C G+LQD+ H L + ++A + L+ L+ + +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPL-------SESQIAYVSRETLQGLYYLHSKGKM 128
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISS 666
HR+ K ANILL D+ V ++D G++ I++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITA 158
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 9e-09
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 22/158 (13%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI---DRIRHANIVEL 572
IG G G VY+A GK +A+KK+ R +++ ++N I +H NIV+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKHPNIVDY 80
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDML-HSDDELKNNLSWNTRI-RMALGAARALEYLHE 629
G L ++ EY G+L D++ + + +I + + LEYLH
Sbjct: 81 YD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNE-----PQIAYVCREVLQGLEYLH- 133
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
++HR+ KS NILL D +V ++D G A ++
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQ---QKDDEFLELVNNIDRIRHANIV 570
IG G G+VY+A+ L G+ +A+KK+ S + + L+ ++ H NIV
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 571 ELKGYCAEHGQRL-------LIYEYCSNGTLQDMLHS--DDELKNNLSWNTRIRMALGAA 621
L C HG R L++E+ QD L + K L T +
Sbjct: 65 RLLDVC--HGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
R +++LH IVHR+ K NIL+ D V ++D GLA
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 516 LIGAGMLGSVYRA--QLPDGKLLAVK-KLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
IG G G VY+ P+ + +AV K K +S ++FL+ + + H +IV+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
G E+ ++ E G L+ L + K +L + I + + AL YL
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-- 126
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVS 673
VHR+ + N+L+ V + D GL+ + S + S
Sbjct: 127 -RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS 166
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 52/157 (33%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKG 574
+G G G V + D GKL A+K L K+ ++K+ E NI RI H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 575 YCAEHGQ-RL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------AL 624
+ A + +L L+ EY G L L R + AR AL
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSK------------EGRFSEERARFYAAEIVLAL 106
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
EYLH + I++R+ K NILLD D + ++D GLA
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 13/158 (8%)
Query: 510 SFSQENLIGAGMLGSVYRA--QLPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
S E ++G G G + R +LP + +A+ L S +Q+ FL + +
Sbjct: 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFD 64
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
H+NIV L+G +++ EY SNG L L + L + M G A ++
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMK 121
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663
YL E+ VH+ + +L++ DL +S G L
Sbjct: 122 YLSEM---GYVHKGLAAHKVLVNSDLVCKIS--GFRRL 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 517 IGAGMLGSVYRAQLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G V ++ G + VK+L AS Q++ +FLE ++H+N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLLQCL 61
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RMALGAARALEYLHEIC 631
G C E LL+ E+C G L+ L S ++ + RMA A L +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRS-CRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ +H + N LL DL V + D GL+
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 15/169 (8%)
Query: 511 FSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
F+ ++G G GSV AQL + +AVK L S +EFL + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 567 ANIVELKGYC--AEHGQRL----LIYEYCSNGTLQDMLHSDDELKN--NLSWNTRIRMAL 618
N+++L G + RL +I + +G L L + L T +R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
A +EYL +HR+ + N +L++++ V V+D GL+ I SG
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG 166
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
S E +G G G V+ +A+K L S + FL+ + ++RH +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKL 63
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L +E ++ EY S G+L D L E+ L + MA A + Y+
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+ VHR+ ++ANIL+ ++L V+D GLA LI
Sbjct: 121 M---NYVHRDLRAANILVGENLVCKVADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 43/130 (33%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 103 SSIRVIDLSNNHIGGSIPSI-LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
S+++ +DLS+N I + ++N LS N S +P L+ L+ L ++ L+ N +
Sbjct: 140 SNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP- 220
S ++P + L+ L LDLS+N++ EL SL NL L+ L L NN+L + + +L
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
Query: 221 LRDLNIENNL 230
L L++ NN
Sbjct: 257 LETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 515 NLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+IG G G VY L DG+ + AVK L+ R + ++ ++FL+ + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 571 ELKGYC-AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
L G C G L++ Y +G L++ + S+ +N + I L A+ +EYL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYL-- 114
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
VHR+ + N +LD+ V V+D GLA
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLA 145
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+G G G VY+AQ + L A K+ + S ++ +D +E ++ + +H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-IDILSECKHPNIVGLYEAY 71
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIR-MALGAARALEYLHEICQPPI 635
+ ++ E+C G L ++ EL+ L+ +IR + AL +LH +
Sbjct: 72 FYENKLWILIEFCDGGALDSIM---LELERGLT-EPQIRYVCRQMLEALNFLHS---HKV 124
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLA 661
+HR+ K+ NILL D V ++D G++
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 38/140 (27%), Positives = 68/140 (48%), Gaps = 11/140 (7%)
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
L+AVK L + A+ ++D FL+ + + R++ NI+ L C +I EY NG L
Sbjct: 48 LVAVKMLREDANKNARND-FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 595 QDML-------HSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647
L ++ +S++T I MA A ++YL + VHR+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163
Query: 648 DDDLAVSVSDCGLAPLISSG 667
+ + ++D G++ + SG
Sbjct: 164 GKNYTIKIADFGMSRNLYSG 183
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 517 IGAGMLGSVYRAQ-LPDG---KL-LAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
+G+G G+VY+ +P+G K+ +A+K L + +S + + E L+ + + H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSD-DELKNN--LSWNTRIRMALGAARALEYLH 628
L G C Q LI + G L D + + D + + L+W +I A+ + YL
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
E +VHR+ + N+L+ V ++D GLA L+
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 27/180 (15%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYR-AQLPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+ SL T+++ IG G G VY+ DG L AVK LD + DE +E
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEY 69
Query: 560 NIDRI--RHANIVELKG--YCAEH---GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT 612
NI + H N+V+ G Y A+ GQ L+ E C+ G++ +++ K L
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV------KGLLICGQ 123
Query: 613 RIRMAL------GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
R+ A+ GA L++LH I+HR+ K NILL + V + D G++ ++S
Sbjct: 124 RLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 38/146 (26%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V+ +L D +AVK + K +FL+ + + H NIV L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLIGV 61
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
C + ++ E G L ++ L I+M AA +EYL
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLA 661
+HR+ + N L+ + + +SD G++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 7/146 (4%)
Query: 516 LIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
L+G G G V++ L D +AVK K Q+ +FL + + H NIV+L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
C + ++ E G D L + K+ L ++ AL AA + YL
Sbjct: 61 CTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLA 661
+HR+ + N L+ ++ + +SD G++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 38/138 (27%), Positives = 70/138 (50%), Gaps = 13/138 (9%)
Query: 533 GKLLAVKKLDKRASSQQKDD--EFLELVNNIDRIRHANIVELKGYCAEHGQR--LLIYEY 588
G+ +AVK L + D + +E++ N+ H NIV+ KG C E G LI E+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNL---YHENIVKYKGICTEDGGNGIKLIMEF 89
Query: 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD 648
+G+L++ L + KN ++ +++ A+ + ++YL VHR+ + N+L++
Sbjct: 90 LPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVE 143
Query: 649 DDLAVSVSDCGLAPLISS 666
+ V + D GL I +
Sbjct: 144 SEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKL---DKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+G G G VY+ + P GK+ A+KK+ +Q E L+ + +V+
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRE-LK---TLRSCESPYVVKC 64
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RMALGAARALEYLHEI 630
G + G+ ++ EY G+L D+L K + +A + L+YLH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
I+HR+ K +N+L++ V ++D G++ ++ +
Sbjct: 119 RH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 38/139 (27%), Positives = 62/139 (44%), Gaps = 19/139 (13%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVEL 572
+GAG G V + P GK++AVK + + +++ +D + IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVK----TIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSW-NTRI--RMALGAARALEYLHE 629
G +G + EY G+L D LK RI ++A+ + L YLHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL------DKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 630 ICQPPIVHRNFKSANILLD 648
+ I+HR+ K +NIL++
Sbjct: 119 --KHKIIHRDVKPSNILVN 135
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 29/170 (17%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKL-----DKRASSQQKDDEFLELVNNIDRI 564
+ + LIG G G+VYR +P G+++A+K + D S Q++ L ++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLS------QL 56
Query: 565 RHA---NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMAL 618
R + NI + G G RL +I EY G+++ ++ + E ++ IR L
Sbjct: 57 RQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI----IREVL 111
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
AL+Y+H++ ++HR+ K+ANIL+ + V + D G+A L++ S
Sbjct: 112 ---VALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 45/147 (30%), Positives = 78/147 (53%), Gaps = 11/147 (7%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL-KGY 575
+G G G VY+AQ + +LA K+ S ++ +D +E ++ + H NIV+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-IDILASCDHPNIVKLLDAF 71
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA-RALEYLHEICQPP 634
E+ +LI E+C+ G + ++ EL+ L+ +IR+ AL YLHE
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVML---ELERPLT-EPQIRVVCKQTLEALNYLHE---NK 123
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLA 661
I+HR+ K+ NIL D + ++D G++
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 44/167 (26%), Positives = 69/167 (41%), Gaps = 20/167 (11%)
Query: 510 SFSQENL-----IGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELV 558
+F + NL +G G G V+ A+ L+ VK L K + EF +
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRREL 59
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML----HSDDELK-NNLSWNTR 613
+ ++ H N+V L G C E +I EY G L+ L D++LK LS +
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
+ + A +++L VHR+ + N L+ V VS L
Sbjct: 120 VALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSL 163
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 42/158 (26%), Positives = 80/158 (50%), Gaps = 20/158 (12%)
Query: 517 IGAGMLG-SVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G ++ DGK +K+++ S ++ +E + V + ++H NIV+ +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 576 CAEHGQRLLIYEYCSNGTL-------QDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
E+G ++ +YC G L + +L +D++ L W +I + AL+++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFVQICL------ALKHVH 118
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
+ I+HR+ KS NI L D + + D G+A +++S
Sbjct: 119 D---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 7e-08
Identities = 23/59 (38%), Positives = 30/59 (50%)
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
L + L+NN L+ AF+ L L LDLS NNL+ P + L L +L L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 34/173 (19%)
Query: 517 IGAGMLGSVYRAQ------LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V +A +AVK L + ASS + D E N + ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF-NLLKQVNHPHVI 66
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLH----------------------SDDELKNNL 608
+L G C++ G LLI EY G+L+ L + DE L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE--RAL 124
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ I A +R ++YL E+ +VHR+ + N+L+ + + +SD GL+
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLS 174
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 19/156 (12%)
Query: 510 SFSQENLIGAGMLGSV----YRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
+F +E +G+G G V +RAQ+ +A+K +++ A S+ ++F+E + ++
Sbjct: 7 TFMKE--LGSGQFGVVHLGKWRAQIK----VAIKAINEGAMSE---EDFIEEAKVMMKLS 57
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
H +V+L G C + ++ E+ NG L + L + + LS + + M +E
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR---QRQGKLSKDMLLSMCQDVCEGME 114
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
YL + +HR+ + N L+ V VSD G+
Sbjct: 115 YLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 49/163 (30%), Positives = 74/163 (45%), Gaps = 13/163 (7%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLEL---VNNIDRIR 565
++ L+G G G VY D G+ LAVK++ SQ+ E L + + +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 566 HANIVELKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
H IV+ G + ++ L EY G+++D L + L N+ TR R +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV---TR-RYTRQILQG 118
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
+ YLH IVHR+ K ANIL D V + D G + I +
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 9e-08
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 53/176 (30%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR------ 563
+ + +G G VY+A G+++A+KK+ K E E + I+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI--------KLGERKEAKDGINFTALREI 53
Query: 564 -----IRHANIVELKG-YCAEHGQRL-LIYEYCSNGTLQDMLHSDDE--LKNNL------ 608
++H NI+ L + H + L++E+ + +D E +K+
Sbjct: 54 KLLQELKHPNIIGLLDVFG--HKSNINLVFEF---------METDLEKVIKDKSIVLTPA 102
Query: 609 ---SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
S+ + M L R LEYLH I+HR+ K N+L+ D + ++D GLA
Sbjct: 103 DIKSY---MLMTL---RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 49/168 (29%), Positives = 72/168 (42%), Gaps = 35/168 (20%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQK-------DDEFLELVNNIDRIRHAN 568
+G G G V Q+ GK+ A KKLDK+ ++K + + LE V++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
IV L Y E L L+ + G L+ +++ E ARA+ Y
Sbjct: 55 IVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGE------------PGFPEARAIFYA 101
Query: 628 HEIC-------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+I Q IV+R+ K N+LLDD V +SD GLA + G
Sbjct: 102 AQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 29/165 (17%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTM-------------------------QNFF 131
ENL + +DL+ N + +I +L +T +
Sbjct: 87 ENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELD 146
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
LSDN+ S+PS L L L ++ L+ N LS ++P +L+ L NLDLS N +S +LPP
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203
Query: 192 SLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPI 235
+E LS L L L NN + L L +L L L + NN
Sbjct: 204 EIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP 248
|
Length = 394 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 21/154 (13%)
Query: 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G +Y A+ D + +K++D ++ + + V + +++H NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 576 CAEHGQRLLIYEYCSNGTL-------QDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
E+G+ ++ EYC G L + +L S+D++ LSW +I +LG L+++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI---LSWFVQI--SLG----LKHIH 118
Query: 629 EICQPPIVHRNFKSANILLDDDLAVS-VSDCGLA 661
+ I+HR+ KS NI L + V+ + D G+A
Sbjct: 119 D---RKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 40/161 (24%), Positives = 66/161 (40%), Gaps = 18/161 (11%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG-Y 575
+G G GSV + +L + ++ K + + L + + IV+ G +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 576 CAEHGQRLLI-YEYCSNGTLQDMLHSDDELKNNLSWNTRI------RMALGAARALEYLH 628
E + I EYC G+L D K RI ++A + L YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSL------DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISSGS 668
I+HR+ K +NILL V + D G++ L++S +
Sbjct: 123 S---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 29/160 (18%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKG 574
IG G G V A G+ +AVKK+D R Q+++ F E+V I R +H NIVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVV--IMRDYQHPNIVEMYS 83
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM--------ALGAARALEY 626
+ ++ E+ G L D++ T RM L +AL +
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIV-------------THTRMNEEQIATVCLAVLKALSF 130
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
LH ++HR+ KS +ILL D V +SD G +S
Sbjct: 131 LH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLD-KRASSQQKDDEFLELVNNIDR-------IRH 566
LIG G G VY A + G+++AVK+++ + + D ++V + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 567 ANIVELKGYCAEHGQRLL-IY-EYCSNGTLQDMLHS----DDELKNNLSWNTRIRMALGA 620
NIV+ G+ E + L I+ EY G++ L + +++L +
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV-------- 117
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L YLH I+HR+ K+ N+L+D D +SD G++
Sbjct: 118 LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 47/151 (31%), Positives = 63/151 (41%), Gaps = 17/151 (11%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKG 574
+G G G V + GK A+K L K + K E + I IRH +V L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 575 YCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---ALEYLHEI 630
+ L L+ EY G L L + R AA+ ALEYLH
Sbjct: 69 -SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV---ARFY----AAQVVLALEYLHS- 119
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
IV+R+ K N+LLD D + ++D G A
Sbjct: 120 LD--IVYRDLKPENLLLDSDGYIKITDFGFA 148
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 536 LAVKKLDKRASSQQKDDEF--LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT 593
+AVK L A+ + D +E++ I + H NI+ L G C + G +I EY S G
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 594 LQDMLHS------------DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFK 641
L++ L + + LS+ + A AR +EYL +HR+
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167
Query: 642 SANILLDDDLAVSVSDCGLA 661
+ N+L+ +D + ++D GLA
Sbjct: 168 ARNVLVTEDNVMKIADFGLA 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 524 SVYRAQLPDGKLLAVKKLDK-RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582
S+Y+ + K + ++ K + D + N+ RI NI+++ G+ +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 583 L----LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHR 638
L LI EYC+ G L+++L D E +LS+ T++ MA+ + L L++ P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVL--DKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 639 NFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672
N S + L+ ++ + + GL ++SS V
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV 181
|
Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEF-LELVNNIDRIRHA 567
+F Q ++G G G V Q+ GK+ A KKL+K+ ++K + L ++++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+V L Y E L L+ + G L+ ++ E RA+ Y
Sbjct: 61 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGE------------AGFEEGRAVFY 107
Query: 627 LHEIC-------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
EIC Q IV+R+ K NILLDD + +SD GLA + G
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 16/160 (10%)
Query: 517 IGAGMLGSVYR---AQLPDGKL---LAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY + G+ +A+K +++ AS +++ EFL + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS---DDELKNNLSWNTR---IRMALGAARAL 624
L G + L++ E + G L+ L S + E L T I+MA A +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
YL VHR+ + N ++ +DL V + D G+ I
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 19/142 (13%)
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
L+AVK L A+ ++D FL+ V + R++ NI+ L G C + +I EY NG L
Sbjct: 48 LVAVKILRPDANKNARND-FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 595 QDML---HSDDELKNN------------LSWNTRIRMALGAARALEYLHEICQPPIVHRN 639
L H DD+ +N +S+++ + +AL A ++YL + VHR+
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163
Query: 640 FKSANILLDDDLAVSVSDCGLA 661
+ N L+ ++L + ++D G++
Sbjct: 164 LATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
S E +GAG G V+ A +AVK + + S + FL N + ++H +
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKL 63
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L + +I E+ + G+L D L SD+ K L ++ +A+ E +
Sbjct: 64 VKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLP-----KLIDFSAQIAEGMAF 117
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
I Q +HR+ ++ANIL+ L ++D GLA +I
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 22/167 (13%)
Query: 517 IGAGMLGSVYRAQ----LPDGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V+ A+ LP+ L+AVK L + + S ++D F + ++H +IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIV 70
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-----------DDELKNNLSWNTRIRMALG 619
G C E L+++EY +G L L S +D L+ + +A
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
A + YL + VHR+ + N L+ L V + D G++ I S
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 23/142 (16%)
Query: 536 LAVKKLDKRASSQQKDDEFLELVNNIDRIR----HANIVELKGYCAEHGQRLLIYEYCSN 591
+AVK L A+ D + +LV+ ++ ++ H NI+ L G C + G ++ EY S
Sbjct: 47 VAVKMLKDDAT----DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASK 102
Query: 592 GTLQDML---------HSDDELK---NNLSWNTRIRMALGAARALEYLHEICQPPIVHRN 639
G L++ L +S D K L++ + A AR +EYL +HR+
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159
Query: 640 FKSANILLDDDLAVSVSDCGLA 661
+ N+L+ +D + ++D GLA
Sbjct: 160 LAARNVLVTEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 517 IGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANI 569
+G G G V+ A+ D L+AVK L + + +KD EL+ N+ +H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL---QHEHI 69
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDML--HSDDEL-------KNNLSWNTRIRMALGA 620
V+ G C E ++++EY +G L L H D + L+ + + +A
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
A + YL VHR+ + N L+ ++L V + D G++
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 515 NLIGAGMLGSVYRAQLPD------GKL-LAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
N +G+G G VY D G + +AVK L K A+ Q+K EFL+ + + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHP 59
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN---LSWNTRIRMALGAARAL 624
NIV+L G C + + +I E G L L + L+ + + L A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 625 EYLHEICQPPIVHRNFKSANILL-----DDDLAVSVSDCGLA 661
YL ++ +HR+ + N L+ D D V + D GLA
Sbjct: 120 VYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 17/152 (11%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELK 573
+G G G V+ + A+K + + K ++ + + + H I+ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66
Query: 574 GYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLS--WNTRIRMALGAARALEYLHE 629
+ EH QR L + EY G L L + N+ + + I ALEYLH
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI------VCALEYLHS 119
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
IV+R+ K NILLD + + ++D G A
Sbjct: 120 K---EIVYRDLKPENILLDKEGHIKLTDFGFA 148
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 9/148 (6%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+G G G V+ +A+K L + FL+ + ++RH +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYAVV 70
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
+E ++ E+ G+L D L D L + MA A + Y+ + +
Sbjct: 71 SEE-PIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYI 124
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLI 664
HR+ ++ANIL+ D+L ++D GLA LI
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 28/173 (16%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
T F +E +G G VY+ L + +A+K L +A ++ EF
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE-EFKHEAMMR 62
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML-----HS-------DDELKNNLS 609
R++H NIV L G + +I+ YCS+ L + L HS D +K+ L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 610 WNTRIRMALGAARALEYL--HEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
+ + A +E+L H + H++ + N+L+ D L V +SD GL
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
+G G G VY+A+ + LA K+ + S ++ +D +E + + H IV+L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-IEILATCNHPYIVKLLGAF 78
Query: 577 AEHGQRLLIYEYCSNGTLQD-MLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
G+ ++ E+C G + ML D L R L AL+YLH + I
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQVICRQML---EALQYLHSM---KI 131
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLA 661
+HR+ K+ N+LL D + ++D G++
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 8/161 (4%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGK-LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
N F ++G G G V + + + K ++A+KK +++ + L + + ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
NIVELK G+ L++EY ++ML +E+ N + +A+ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
H + IVHR+ K N+L+ + + + D G A +S GS
Sbjct: 117 H---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|227505 COG5178, PRP8, U5 snRNP spliceosome subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 21/43 (48%), Positives = 23/43 (53%), Gaps = 5/43 (11%)
Query: 441 MMMMPP--PPPPPPPP---PPPPPPPPPPPVVEKVIVKPIVPA 478
M +PP PPPPPPPP PP PPPPPPP V +
Sbjct: 1 MASLPPGNPPPPPPPPGFEPPSQPPPPPPPGVNVKKRSRKQLS 43
|
Length = 2365 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 17/174 (9%)
Query: 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK------LDKRASSQQKDDEFLELVNNID 562
+F E IG G VYRA L DG +A+KK +D +A + + ++ ++ +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-----DCIKEIDLLK 57
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
++ H N+++ E + ++ E G L M+ + K + T + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNL 676
ALE++H ++HR+ K AN+ + V + D GL SS + + +H+L
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSL 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 26/184 (14%)
Query: 517 IGAGMLGSVYRAQ------LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANI 569
+G G G V+ A+ D L+AVK L + +KD EL+ N+ +H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL---QHEHI 69
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDML--HSDDEL----------KNNLSWNTRIRMA 617
V+ G C + ++++EY +G L L H D + K L + + +A
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV-SHNL 676
A + YL VHR+ + N L+ +L V + D G++ + S +V H +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 677 TIMR 680
+R
Sbjct: 187 LPIR 190
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEF-LELVNNIDRIRHA 567
+F Q ++G G G V Q+ GK+ A K+L+K+ ++K + L ++++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+V L Y E L L+ + G L+ +++ N + R AA L
Sbjct: 61 FVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYN----MGNPGFEEE-RALFYAAEILCG 114
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
L ++ + V+R+ K NILLDD + +SD GLA I G
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 41/132 (31%), Positives = 60/132 (45%), Gaps = 11/132 (8%)
Query: 535 LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594
L+AVK L AS ++D FL+ V + R+ NI L G C +I EY NG L
Sbjct: 48 LVAVKVLRPDASDNARED-FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 595 QDMLHS----DDELKNN---LSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647
L L N LS++T + MA A + YL + VHR+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163
Query: 648 DDDLAVSVSDCG 659
+ + ++D G
Sbjct: 164 GKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G V+ + D KL+ +K++ ++ + + + H NI+E
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSD-----DELKNNLSWNTRIRMALGAARALEYLHE 629
E +++ EY GTL + + DE L + +I +AL H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE-DTILHFFVQILLAL---------HH 116
Query: 630 ICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISSGS 668
+ I+HR+ K+ NILLD + V + D G++ ++SS S
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 43/149 (28%), Positives = 64/149 (42%), Gaps = 32/149 (21%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-------HAN 568
IG G V +AQ GK A+K + K S LE VNN+ I+ H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-------LEQVNNLREIQALRRLSPHPN 59
Query: 569 IVELKG--YCAEHGQRLLIYEYCSNGTLQDMLHSDDEL----KNNLSWNTRIRMALGAAR 622
I+ L + + G+ L++E L DM + EL K L +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFE------LMDM--NLYELIKGRKRPLPEKRVKSYMYQLLK 111
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDL 651
+L+++H + I HR+ K NIL+ DD+
Sbjct: 112 SLDHMH---RNGIFHRDIKPENILIKDDI 137
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 5/147 (3%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G G V Q+ GKL A KKL+K+ ++K E + I H+ + Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 576 CAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
+ L L+ + G L+ +++ DE LE+LH Q
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLA 661
I++R+ K N+LLD+D V +SD GLA
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLEL---VNNIDRIRHANIVE 571
L+G G G VY D G+ LA K++ S + E L + + ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 572 LKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
G + ++ L EY G+++D L + L +++ ++ G + YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEG----MSYLH- 123
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCG 659
IVHR+ K ANIL D V + D G
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 14/162 (8%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
++Y +SF + IG G G V A + GK +AVKK+D R QQ+ + V +
Sbjct: 21 REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRD 75
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
H N+V++ + ++ E+ G L D++ + ++ + L RA
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRA 130
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
L YLH ++HR+ KS +ILL D + +SD G +S
Sbjct: 131 LSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|222828 PHA01732, PHA01732, proline-rich protein | Back alignment and domain information |
|---|
Score = 45.9 bits (108), Expect = 3e-06
Identities = 21/41 (51%), Positives = 24/41 (58%), Gaps = 1/41 (2%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVK 484
P PP P PP P PPPPP PP V + VKP V AE ++
Sbjct: 9 PPEPPAPLPPAPVPPPPPAPPAPVPEPTVKP-VNAEAPKIR 48
|
Length = 94 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ---QKDDEFL-ELVNNIDRIRHANIV 570
++G G G+VY G+L+AVK+++ S+ +K+ E L E V+ + ++H NIV
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
+ G C + + E+ G++ +L+ L + ++ G A YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
C +VHR+ K N++L + + + D G A
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCA 149
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 37/180 (20%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
TI S+ +++ IG G G+VY A + G+ +A+K+++ QQ E + +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL---QQQPKKELI--I 64
Query: 559 NNIDRIR---HANIVE-LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
N I +R H NIV L Y G L ++ EY + G+L D++ T
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVV-------------TE 109
Query: 614 IRMALG--AA------RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
M G AA +ALE+LH ++HR+ KS NILL D +V ++D G I+
Sbjct: 110 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 4e-06
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHAN 568
F L+G G G VY+ + + G+L A+K +D + +++E + +N + + H N
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRN 64
Query: 569 IVELKGYCAEHG------QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
I G + Q L+ E+C G++ D++ + W I + R
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI--LR 122
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L +LH Q ++HR+ K N+LL ++ V + D G++
Sbjct: 123 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 11/150 (7%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V A + GKL+AVKK+D R QQ+ + V + +H N+VE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ ++ E+ G L D++ + ++ + L +AL LH +
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH---AQGV 137
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+HR+ KS +ILL D V +SD G +S
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 36/180 (20%)
Query: 511 FSQENL-----IGAGMLGSVYRAQL--------PDGKLLAVKKLDKRASSQQKDDEFLEL 557
FS++ L +G G G V A+ + +AVK L A+ + D L
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD----L 67
Query: 558 VNNIDRI----RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
V+ ++ + +H NI+ L G C + G +I EY S G L++ L + S++
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127
Query: 614 ------------IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ AR +EYL +HR+ + N+L+ ++ + ++D GLA
Sbjct: 128 RVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 49/190 (25%), Positives = 71/190 (37%), Gaps = 48/190 (25%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQK-------DDEFLELVNNIDRIRHA 567
L+G G +G V+ +L GKL A+K LDK+ ++ + E L ++ H
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD------HP 61
Query: 568 NIVELKGYCAEHGQRLLIY--EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
+ L Y + + L +YC G L +L LS AR
Sbjct: 62 FLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPG--KCLSEE--------VARFYA 109
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILL---------DDDLAVSVSDCGLAPLISSGS 668
ALEYLH IV+R+ K NILL D DL+ +
Sbjct: 110 AEVLLALEYLH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 669 VSQVSHNLTI 678
S+ S +I
Sbjct: 167 GSRRSSVNSI 176
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G VY A+ L +A+K++ +R S + E + ++H NIV+ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSD-DELKNNLSWNTRIRMALGAARALEYLHEICQP 633
+E+G + E G+L +L S LK+N T I L+YLH+
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN--EQTIIFYTKQILEGLKYLHDN--- 127
Query: 634 PIVHRNFKSANILLDDDLAV-SVSDCG 659
IVHR+ K N+L++ V +SD G
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFG 154
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 517 IGAGMLGSVYRAQL-PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G GSV QL D +L AVK + ++ + ++FL + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 574 GYCAEHGQR------LLIYEYCSNGTLQD-MLHSD-DELKNNLSWNTRIRMALGAARALE 625
G C + + ++I + +G L +L+S + L ++ A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
YL +HR+ + N +L++++ V V+D GL+ I +G
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 28/164 (17%)
Query: 95 LGENLGAFSSIRVIDLSNNHIG----GSIPSIL-PVTMQNFFLSDNQFSGSIPSSLATLT 149
L + L ++ +DLS+N +G G + S+L ++Q L++N LA
Sbjct: 73 LLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL 132
Query: 150 L-----LTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENL 196
L + L N L G + A ++ L L+L++N + L L+
Sbjct: 133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKAN 192
Query: 197 SQLTTLHLQNN--------QLSGTLDVLQDLPLRDLNIENNLFS 232
L L L NN L+ TL L+ L LN+ +N +
Sbjct: 193 CNLEVLDLNNNGLTDEGASALAETLASLKS--LEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 13/156 (8%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKG 574
+G G G V ++ + A+K + KR + E + I + H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 575 YCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
Y ++ + + EYC G L +L + R +A A EYLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEYLHNR-- 112
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
I++R+ K N+LLD + V + D G A + SG
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 21/56 (37%), Positives = 23/56 (41%), Gaps = 1/56 (1%)
Query: 437 SSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
SLD + PP P P P P PP P P VEK KP + A KP
Sbjct: 83 PSLDPATVAPPNTPVEPEPAPVEPPKPKP-VEKPKPKPKPQQKVEAPPAPKPEPKP 137
|
Length = 226 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 41/161 (25%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 511 FSQENLIGAGMLGSVYRA-QLPDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDRIR 565
F + ++G+G G+VY+ +P+G+ + A+K+L + A+S + + E L+ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVD 67
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
+ ++ L G C +L I + G L D + E K+N+ + + A+ +
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMN 123
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
YL E +VHR+ + N+L+ V ++D GLA L+ +
Sbjct: 124 YLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 47/150 (31%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR---HANIVE 571
L+G G G VY D G+ LAVK++ S + E L I ++ H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 572 LKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
G + +R L E+ G+++D L S L N+ TR + + YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV---TR-KYTRQILEGVSYLH- 123
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCG 659
IVHR+ K ANIL D V + D G
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLE-----LVNNIDRIRHANIV 570
IG G G V A+ DGK AVK L K+A ++K+ + + L+ N+ +H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV---KHPFLV 59
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLH 628
L Y + +L + +Y + G L L + R R A A AL YLH
Sbjct: 60 GLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE-----PRARFYAAEIASALGYLH 113
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
+ I++R+ K NILLD V ++D GL
Sbjct: 114 SL---NIIYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 1e-05
Identities = 14/44 (31%), Positives = 21/44 (47%), Gaps = 5/44 (11%)
Query: 37 NPNDVAAINSLYAALGSP---VLPGWVASAGDPCGESWQGVQCN 77
+D A+ + ++L L W S+ DPC SW GV C+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 3/122 (2%)
Query: 112 NNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQS 171
+ + GS + + + + L+ N+ +I S L LT LT + L+NN ++ P
Sbjct: 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLL 138
Query: 172 LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNL 230
+ L LDLS N + LP L NL L L L N LS +L +L L +L++ N
Sbjct: 139 KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNK 197
Query: 231 FS 232
S
Sbjct: 198 IS 199
|
Length = 394 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVK---KLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
++G+G G+VY+ +P+G+ + + K+ + + + EF++ + + H ++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G C +L + + +G L D +H E K+N+ + + A+ + YL E
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE-- 127
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+VHR+ + N+L+ V ++D GLA L+
Sbjct: 128 -RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 24/167 (14%)
Query: 516 LIGAGMLGSVYRAQLPDG----KLLAVKKLDKRA-SSQQKDDEFLELVNNI-DRIRHANI 569
++G G G V++ + G K+ A+K L K QKD + NI + ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 570 VELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDE---LKNNLSWN-TRIRMALGAARAL 624
V+L Y + G +L LI EY S G L +H + E +++ + + I +AL
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLAL------ 113
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP-LISSGSVS 670
E+LH Q I++R+ K NILLD V ++D GL I G+V+
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 42/170 (24%), Positives = 79/170 (46%), Gaps = 9/170 (5%)
Query: 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLD--KRASSQQKDDEFLELVNNIDRIRH 566
+F E IG G VYRA L D K +A+KK+ + ++ + D E ++ + ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE-IDLLKQLNH 61
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
N+++ E + ++ E G L M+ + K + T + + A+E+
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNL 676
+H ++HR+ K AN+ + V + D GL SS + + +H+L
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSL 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 19/166 (11%)
Query: 520 GMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL---VNNIDRIRHANIVELKGYC 576
M+ + + + P L+AVKK++ + S ++ L + +++H NI+
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCS---KEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL-GAARALEYLHEICQPPI 635
+ ++ + G+ +D+L L I L AL+Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLL--KTHFPEGLP-ELAIAFILKDVLNALDYIH---SKGF 122
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLA---PLISSGSVSQVSHNLTI 678
+HR+ K+++ILL D V +S GL +I G +V H+
Sbjct: 123 IHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPK 166
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 10/154 (6%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKK-LDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
L+G G G V + + + G+++A+KK L+ K E + + ++RH N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE-IRMLKQLRHENLVNLI 66
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
+ L++E+ + L D+ N L + + R +E+ H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCH---SH 119
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
I+HR+ K NIL+ V + D G A +++
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL--VNNIDRI-RHANIVEL 572
+G G GSVY A+ G+L+A+KK+ K+ S +E + L V ++ ++ H NIV+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNEHPNIVKL 63
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIR-MALGAARALEYLHEIC 631
K E+ + ++EY Q M + S + IR + + L ++H+
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKP---FS-ESVIRSIIYQILQGLAHIHKH- 118
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
HR+ K N+L+ V ++D GLA
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-05
Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 174 GLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNL 230
L +LDLS+N L+ +P + + L L L L N L+ + + LP LR L++ N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 231 F 231
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 36/112 (32%), Positives = 47/112 (41%), Gaps = 11/112 (9%)
Query: 511 FSQENL-----IGAGMLGSVYRAQL-----PDGKL-LAVKKLDKRASSQQKDDEFLELVN 559
F ++NL +GAG G V A D L +AVK L A + +++ EL
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKI 94
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWN 611
+H NIV L G C G L+I EYC G L + L E N
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMA 146
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 16/160 (10%)
Query: 510 SFSQENLIGAGMLGSVY---RAQLPD-GKLLAVKKLDKRASSQQ-KDDEFLELVNNI-DR 563
+F ++G G G V+ + D GKL A+K L K A Q+ K E N+ +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 564 IRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA- 621
+R + + Y + +L LI +Y S G + L+ D + +R G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-----EVRFYSGEII 115
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
ALE+LH++ IV+R+ K NILLD + V ++D GL+
Sbjct: 116 LALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 23/168 (13%)
Query: 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEF-LELVNNIDRIRHA 567
+F ++G G G V Q+ GK+ A KKL+K+ ++K + L ++++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+V L Y E L L+ + G L+ +++ + N RA+ Y
Sbjct: 61 FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYN---MGNP---------GFDEQRAIFY 107
Query: 627 LHEIC-------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
E+C + IV+R+ K NILLDD + +SD GLA I G
Sbjct: 108 AAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 39/169 (23%), Positives = 79/169 (46%), Gaps = 16/169 (9%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+++L+ F ++G G G VY+ + + G+L A+K +D ++ +++E +N
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEIN 64
Query: 560 NIDRI-RHANIVELKGYCAEHG------QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT 612
+ + H NI G + Q L+ E+C G++ D++ + N L +
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDW 122
Query: 613 RIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ R L +LH ++HR+ K N+LL ++ V + D G++
Sbjct: 123 IAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 48/174 (27%), Positives = 73/174 (41%), Gaps = 35/174 (20%)
Query: 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQK-------DDEFLELVNNI 561
+F ++G G G V Q+ GK+ A KKL+K+ ++K + + LE VN+
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 562 DRIRHANIVELK-GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
+ A E K C L+ + G L+ ++ N+
Sbjct: 61 FVVSLAYAYETKDALC-------LVLTLMNGGDLKFHIY-------NMG-----NPGFDE 101
Query: 621 ARALEYLHEIC-------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
RA+ Y EI + IV+R+ K NILLDD + +SD GLA I G
Sbjct: 102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 49/152 (32%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL-KG 574
IG G G V A + G+ +AVK +D R Q+++ F E+V D +H N+VE+ K
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRD-YQHQNVVEMYKS 86
Query: 575 YCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
Y G+ L ++ E+ G L D++ + L+ + +AL YLH
Sbjct: 87 YLV--GEELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLH---SQ 136
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
++HR+ KS +ILL D V +SD G IS
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD--DEFLELVNNIDRIRHANIVELK 573
I G G V+ A+ G + A+K + K+A +K+ D+ L + + + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 574 GYCAEHGQRL-LIYEYCSNGTLQDMLHS----DDELKNNLSWNTRIRMALGAARALEYLH 628
Y + + L L+ EY G L +L + D+++ I +AL EYLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI--AEIVLAL------EYLH 110
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
I+HR+ K NIL+D + + ++D GL
Sbjct: 111 SN---GIIHRDLKPDNILIDSNGHLKLTDFGL 139
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 20/160 (12%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLA-----VKKLDKRASSQQKD---DEFLELVNNIDRIRH 566
+L+ G G ++ L D K VK + AS Q E L + H
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG----LSH 67
Query: 567 ANIVELKGYCAE-HGQRLLIYEYCSNGTLQDML----HSDDELKNNLSWNTRIRMALGAA 621
NI+ + C E ++Y Y + G L+ L + LS + MA+ A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ YLH+ ++H++ + N ++D++L V ++D L+
Sbjct: 128 CGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALS 164
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 27/156 (17%)
Query: 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDK-------RASSQQKDDEFLELVNNIDRIRHAN 568
+G G G V A+ G+L A+K L K S + E N RH
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPF 63
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---AL 624
+V L C + + + EY + G L M+H ++ + R AA L
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV------FSEPRAVFYAACVVLGL 114
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
+YLHE IV+R+ K N+LLD + V ++D GL
Sbjct: 115 QYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 37/156 (23%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+F + IG G G VY+A+ G+++A+KK+ ++ + ++ + + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
IV+L + L++E+ LH D + + S + I + L + + L
Sbjct: 61 IVKLLDVIHTENKLYLVFEF---------LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111
Query: 629 EI--CQP-PIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ C ++HR+ K N+L++ + A+ ++D GLA
Sbjct: 112 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|222828 PHA01732, PHA01732, proline-rich protein | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-05
Identities = 15/47 (31%), Positives = 19/47 (40%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
PP P PP P PPPPP PP P V + ++ +
Sbjct: 12 PPAPLPPAPVPPPPPAPPAPVPEPTVKPVNAEAPKIREAQSKRGQKQ 58
|
Length = 94 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 46/168 (27%), Positives = 71/168 (42%), Gaps = 35/168 (20%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-----LELVNNIDRIRHANIV 570
IG G G+VY+A+ P G +A+K + R + + + L+ ++ H NIV
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 571 ELKGYCA-----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLS--------WNTRIRMA 617
L CA + L++E H D +L+ L T +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFE-----------HVDQDLRTYLDKVPPPGLPAETIKDLM 114
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
R L++LH C IVHR+ K NIL+ V ++D GLA + S
Sbjct: 115 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
F +IG G G V Q GK+ A+K L K S K D+ + D + +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLK--SEMFKKDQLAHVKAERDVLAES 58
Query: 568 N---IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ +V L Y + Q L LI E+ G L ML D ++ TR MA A
Sbjct: 59 DSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMA-ECVLA 113
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+E +H++ +HR+ K NIL+D + +SD GL+
Sbjct: 114 IEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 8e-05
Identities = 20/45 (44%), Positives = 27/45 (60%), Gaps = 3/45 (6%)
Query: 173 TGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQ 217
T L LDLS+N ++ +LPP L NL L TL L N+++ L L
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT-DLSPLS 42
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 36/141 (25%), Positives = 55/141 (39%), Gaps = 11/141 (7%)
Query: 515 NLIGAGMLGSVYRAQL----PDGKLLAVK-KLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+G G G VY D L V K + S+Q + +FL + + H NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN---LSWNTRIRMALGAARALEY 626
V L G E R ++ E + G L+ L + L+ + A A+ +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 627 LHEICQPPIVHRNFKSANILL 647
L E +HR+ + N LL
Sbjct: 132 LEE---NHFIHRDIAARNCLL 149
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 33/159 (20%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE-----FLELVNNIDRIRHANIV 570
IG G G VY+A+ G+++A+KK+ R + +DE + ++ + + H NIV
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI--RLET---EDEGVPSTAIREISLLKELNHPNIV 61
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
L +L L++E+ L D LK + ++ L YL++
Sbjct: 62 RLLDVVHS-ENKLYLVFEF---------LDLD--LKKYM--DSSPLTGLDPPLIKSYLYQ 107
Query: 630 ICQP-------PIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ Q ++HR+ K N+L+D + A+ ++D GLA
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 18/50 (36%), Positives = 19/50 (38%)
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
MM PPPP PP PP P P P P A K+S K
Sbjct: 152 MMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLK 201
|
Length = 274 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE-----FLELVNNIDRIRHANIV 570
IG G G+V++A+ +++A+K++ DDE L + + ++H NIV
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 571 ELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
L Y H + L++EYC QD+ D ++ + L + H
Sbjct: 63 RL--YDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
++HR+ K N+L++ + + ++D GLA
Sbjct: 117 ---SHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 43/181 (23%), Positives = 76/181 (41%), Gaps = 39/181 (21%)
Query: 505 QQYTNSFSQE-------NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLE 556
QY F E IG G G V++A+ +++A+KK+ + L
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60
Query: 557 LVNNIDRIRHANIVELKGYC-----AEHGQR---LLIYEYCSNGTLQDMLHSDDELKNNL 608
+ + ++H N+V L C + + L++E+C + +L L
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----------EHDLAGLL 109
Query: 609 SWNTRIRMALGAARA--------LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
S N ++ L + L Y+H + I+HR+ K+ANIL+ D + ++D GL
Sbjct: 110 S-NKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165
Query: 661 A 661
A
Sbjct: 166 A 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 25/82 (30%), Positives = 36/82 (43%), Gaps = 22/82 (26%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+++ +DLSNN + + D F G L L + L+ N L+
Sbjct: 1 NLKSLDLSNNRLT--------------VIPDGAFKG--------LPNLKVLDLSGNNLTS 38
Query: 164 EIPDAFQSLTGLINLDLSSNNL 185
P+AF L L +LDLS NNL
Sbjct: 39 ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|237378 PRK13406, bchD, magnesium chelatase subunit D; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 13/24 (54%), Positives = 14/24 (58%)
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPP 465
+P PP PP PPPPPPPP
Sbjct: 256 TRLPAPPQPPEEEPPPPPPPPEDD 279
|
Length = 584 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 37/153 (24%), Positives = 64/153 (41%), Gaps = 10/153 (6%)
Query: 517 IGAGMLGSVYRAQLPDGKL--LAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANIVELK 573
+G G G V A + +A+K+ +K +QK D ++ I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G + L+ E+ G L + N++ ++ L EYL +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYLQSL--- 150
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
IV+R+ K N+LLD D + ++D G A ++ +
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183
|
Length = 340 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 52/237 (21%), Positives = 101/237 (42%), Gaps = 40/237 (16%)
Query: 443 MMPPPPPPPPPPPPPPPP--------------PPPPPVVEKVIVKPIVPAEGTAVKTSTK 488
M P PPP P P P P + P+ P S+
Sbjct: 1 MKPIQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPP-------PSSS 53
Query: 489 TAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASS 547
++ +++ S + S + + + N IG+G G+VY+ P G+L A+K +
Sbjct: 54 SSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI----YG 109
Query: 548 QQKDDEFLELVNNIDRIR---HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDEL 604
+D ++ I+ +R H N+V+ +G+ ++ E+ G+L+ +D++
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF 169
Query: 605 KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+++ R L + YLH + IVHR+ K +N+L++ V ++D G++
Sbjct: 170 LADVA-----RQILSG---IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G VY+ + G+++A+KK+ + + + ++ + ++H NIV L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP-- 633
+ + LI+E+ S D+ D L + A YL++I Q
Sbjct: 68 LMQESRLYLIFEFLS----MDLKKYLDSLPKGQY--------MDAELVKSYLYQILQGIL 115
Query: 634 -----PIVHRNFKSANILLDDDLAVSVSDCGLA 661
++HR+ K N+L+D+ + ++D GLA
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|220596 pfam10138, Tellurium_res, Tellurium resistance protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 14/22 (63%), Positives = 14/22 (63%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPV 466
P PPP P PP P PPP PPV
Sbjct: 3 APVPPPAPAPPAPAPPPAAPPV 24
|
Members of this family confer resistance to the metalloid element tellurium and its salts. Length = 98 |
| >gnl|CDD|233692 TIGR02031, BchD-ChlD, magnesium chelatase ATPase subunit D | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 14/22 (63%), Positives = 15/22 (68%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPP 465
+P P P PPPPPPPP PP P
Sbjct: 266 LPEPEPQPPPPPPPPEPPEPEE 287
|
This model represents one of two ATPase subunits of the trimeric magnesium chelatase responsible for insertion of magnesium ion into protoporphyrin IX. This is an essential step in the biosynthesis of both chlorophyll and bacteriochlorophyll. This subunit is found in green plants, photosynthetic algae, cyanobacteria and other photosynthetic bacteria. Unlike subunit I (TIGR02030), this subunit is not found in archaea [Biosynthesis of cofactors, prosthetic groups, and carriers, Chlorophyll and bacteriochlorphyll]. Length = 589 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 43/156 (27%), Positives = 84/156 (53%), Gaps = 23/156 (14%)
Query: 516 LIGAGMLGSVY---RAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIV 570
++G G G V+ + PD G+L A+K L K+A+ + +D ++ +I + H IV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTL-----QDMLHSDDELKNNLSWNTRIRMALGAARALE 625
+L G+ LI ++ G L ++++ +++++K L+ +AL AL+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELAL----ALD 112
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+LH + I++R+ K NILLD++ + ++D GL+
Sbjct: 113 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 13/155 (8%)
Query: 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHAN 568
F +G G G V A+ G+ A+K L KR + K + + +I + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 569 IVE-LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV + + E R+ + E+ G L L N+++ + L A EY
Sbjct: 80 IVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL----AFEY 133
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LH I++R+ K N+LLD+ V V+D G A
Sbjct: 134 LHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFA 165
|
Length = 329 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 27/105 (25%), Positives = 42/105 (40%), Gaps = 8/105 (7%)
Query: 251 PFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQADGPTALEDSN 310
+T PS + T PAP P +G++P + P+ TPG P +
Sbjct: 217 SPETTPTPSTTTSPPSTTIPAPSTTIAAPQAGTTPEAEGTPAPPTPGGGEAPPANATPAP 276
Query: 311 SGKKKSSTTKKIVWISIAGVLLFVILALVFL----LFMPRCIKRR 351
+ T +I+ I+I I+A VFL + R +RR
Sbjct: 277 EASRYELTVTQIIQIAIPA----SIIACVFLGSCACCLHRRCRRR 317
|
Length = 401 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKG 574
+G G G V Q+ + GK+ A KKLDK+ ++ ++ L I +++ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 575 YCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
Y E L L+ + G L+ H + + L I + + +LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSM--- 114
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQ 671
IV+R+ K N+LLDD +SD GLA + G +++Q
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 16/66 (24%), Positives = 23/66 (34%)
Query: 427 PRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTS 486
+ + + L ++ P P P P PP P PP + +P P K
Sbjct: 32 VGIELVPLAVFLLAAKVLEAPTEEPQPEPEPPEEQPKPPTEPETPPEPTPPKPKEKPKPE 91
Query: 487 TKTAKP 492
K KP
Sbjct: 92 KKPKKP 97
|
Length = 244 |
| >gnl|CDD|237866 PRK14952, PRK14952, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 24/93 (25%), Positives = 32/93 (34%), Gaps = 1/93 (1%)
Query: 409 IPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVE 468
+P A + + QR+ I R D I + L P P P P P P P V
Sbjct: 362 LPSASDAESALLQRVERIETRLDMSIPANLLHNAPQAAPAPSAAAPEPKHQPAPEPRPVL 421
Query: 469 KVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
P AV++ T + RS T
Sbjct: 422 APTPASGEP-NAAAVRSMWSTVRDKVRQRSRTT 453
|
Length = 584 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 25/155 (16%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN--IDRIRHANIVEL 572
L+G G G V + GK A+K L K+ KD+ L + + RH + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKIL-KKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 573 KGYCAEHGQRLLIYEYCSNGTL-----QDMLHSDDELKNNLSWNTRIRMALGA--ARALE 625
K H + + EY + G L ++ + S+D R R GA AL
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED----------RARF-YGAEIVSALG 109
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
YLH C +V+R+ K N++LD D + ++D GL
Sbjct: 110 YLHS-CD--VVYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 546 SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
S + F E + + ++ H ++V+L G C +++ EY G L LH + K
Sbjct: 40 SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHRE---K 95
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647
NN+S + ++ +A A AL YL + +VH N NIL+
Sbjct: 96 NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 15/150 (10%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN---IVEL 572
+G G G V+ A+ D G+++A+K++ K S K +E ++ D + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK--SLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
Y + + L L EY G + +L++ L + + R MA A++ LHE+
Sbjct: 67 L-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFE-AVDALHEL- 120
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+HR+ K N L+D + ++D GL+
Sbjct: 121 --GYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 45/169 (26%), Positives = 70/169 (41%), Gaps = 31/169 (18%)
Query: 517 IGAGMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR---HANIV 570
IG G G VY+A+ DGK A+KK + +Q I +R H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 571 ELKGYCAEHGQRL--LIYEYCSNGTLQDM-LHSDDELKNNLSWNTRIRMAL------GAA 621
L EH + L+++Y + Q + H +S + +L G
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQ---AKRVSIPPSMVKSLLWQILNG-- 120
Query: 622 RALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISS 666
+ YLH ++HR+ K ANIL+ + V + D GLA L ++
Sbjct: 121 --VHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|220596 pfam10138, Tellurium_res, Tellurium resistance protein | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
P P PPP P PP P PPP
Sbjct: 1 PAAPVPPPAPAPPAPAPPPAA 21
|
Members of this family confer resistance to the metalloid element tellurium and its salts. Length = 98 |
| >gnl|CDD|220596 pfam10138, Tellurium_res, Tellurium resistance protein | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 13/23 (56%), Positives = 13/23 (56%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVV 467
P PPP P PP P PPP P V
Sbjct: 2 AAPVPPPAPAPPAPAPPPAAPPV 24
|
Members of this family confer resistance to the metalloid element tellurium and its salts. Length = 98 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 16/38 (42%), Positives = 18/38 (47%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTA 482
P P PPPPPPP PP P + P PA+ A
Sbjct: 53 AAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPNA 90
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 21/172 (12%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
+I S+ +++ IG G G+VY A + G+ +A+++++ + QQ E + +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELI--I 65
Query: 559 NNIDRIR---HANIVE-LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
N I +R + NIV L Y G L ++ EY + G+L D++ + ++ R
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 123
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+ALE+LH ++HR+ KS NILL D +V ++D G I+
Sbjct: 124 -----ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 40/167 (23%), Positives = 81/167 (48%), Gaps = 11/167 (6%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
TI S+ +++ IG G G+V+ A + G+ +A+K+++ + Q K + + +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEI 67
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
+ +++ NIV + ++ EY + G+L D++ + ++ R
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR----- 122
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+ALE+LH ++HR+ KS N+LL D +V ++D G I+
Sbjct: 123 ECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
+IG G G V A+ DG AVK L K+ ++K+ + N+ ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLHEI 630
Y + ++L + +Y + G L H E R R A A A+ YLH +
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGEL--FFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL 115
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
I++R+ K NILLD V ++D GL
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 28/152 (18%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S++ +DLSNN I + SSL+ L L+ + L+NN L
Sbjct: 209 SALEELDLSNNSI-----------------------IELLSSLSNLKNLSGLELSNNKLE 245
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLR 222
++P++ +L+ L LDLS+N +S SL +L+ L L L N LS L ++ L L
Sbjct: 246 -DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALLLLL 302
Query: 223 DLNIENNLFSGPIPEK--MLQIPNFRKDGNPF 252
+ N L + E + N N
Sbjct: 303 LELLLNLLLTLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|222828 PHA01732, PHA01732, proline-rich protein | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 5e-04
Identities = 16/47 (34%), Positives = 19/47 (40%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
PP P PPPPP PP P P P V P + + + A
Sbjct: 16 LPPAPVPPPPPAPPAPVPEPTVKPVNAEAPKIREAQSKRGQKQQKAG 62
|
Length = 94 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 13/38 (34%), Positives = 14/38 (36%)
Query: 446 PPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAV 483
PPPPPP P P PPP P + A
Sbjct: 43 PPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAA 80
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 20/56 (35%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLT 677
+AL+Y+H ++HR+ K +NILL+ D V ++D GLA +S + + LT
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 13/156 (8%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLEL--VNNIDRIR 565
+S+ + +G G +VY+ + +GKL+A+K + + +++ F + + + ++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ---EEEGTPFTAIREASLLKGLK 61
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
HANIV L L++EY Q M D+ L R L
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYM----DKHPGGLHPENVKLFLFQLLRGLS 117
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
Y+H Q I+HR+ K N+L+ D + ++D GLA
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 42/163 (25%), Positives = 80/163 (49%), Gaps = 20/163 (12%)
Query: 511 FSQENL-----IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI 564
F+ E+L IG G G+V + P G ++AVK++ R++ +K+ + L+ ++D +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQK--RLLMDLDVV 56
Query: 565 RHA----NIVELKGYCAEHGQRLLIYEY--CSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
+ IV+ G G + E S ++ + LK+ + ++A+
Sbjct: 57 MRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY--EVLKSVIPEEILGKIAV 114
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+AL YL E + I+HR+ K +NILLD + + + D G++
Sbjct: 115 ATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 21/172 (12%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
+I S+ +++ IG G G+VY A + G+ +A+K+++ + QQ E + +
Sbjct: 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKKELI--I 64
Query: 559 NNIDRIR---HANIVE-LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
N I +R + NIV L Y G L ++ EY + G+L D++ + ++ R
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 122
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+AL++LH ++HR+ KS NILL D +V ++D G I+
Sbjct: 123 -----ECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 12/18 (66%), Positives = 13/18 (72%)
Query: 449 PPPPPPPPPPPPPPPPPV 466
P PPPPPPPPPP P +
Sbjct: 230 PSAPPPPPPPPPPSVPTI 247
|
Length = 313 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 32/113 (28%), Positives = 41/113 (36%), Gaps = 28/113 (24%)
Query: 131 FLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP 190
LS N +G IP L +L GL LDLS N L +
Sbjct: 57 CLSLN-ETGRIPRGLQSL-----------------LQGLTKGCGLQELDLSDNALGPDGC 98
Query: 191 PSLENLSQLTTL---HLQNNQLSGT-----LDVLQDLP--LRDLNIENNLFSG 233
LE+L + ++L L NN L L+DLP L L + N G
Sbjct: 99 GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEG 151
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
PPPPPP P P PPPP
Sbjct: 43 PPPPPPSTAAAAPAPAAPPPP 63
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
++G G G Q + + A+K++ SS +D E V + +++H NIV K
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL-LAKMKHPNIVAFKE 65
Query: 575 YCAEHGQRLLIYEYCSNGTL-------QDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
G ++ EYC G L + L +D + L W + M LG ++++
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI---LQWFVQ--MCLG----VQHI 116
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
HE ++HR+ KS NI L + V + D G A L++S
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 18/152 (11%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-----RHANI 569
++G G G V A+L +L AVK L K Q D +E R+ +H +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD---VECTMTEKRVLALAGKHPFL 58
Query: 570 VELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+L C + RL + EY + G L + + A L++LH
Sbjct: 59 TQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA----RFYAAEIVLGLQFLH 113
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
E I++R+ K N+LLD + + ++D G+
Sbjct: 114 E---RGIIYRDLKLDNVLLDSEGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 31/128 (24%), Positives = 42/128 (32%), Gaps = 11/128 (8%)
Query: 373 EARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDH 432
E + +P + +D + RR+G A + +R PRR
Sbjct: 2637 EPDPHPPPTVPPPERPRDDPAPGRVSRPRRARRLGRAAQASSPPQR--------PRRRAA 2688
Query: 433 EIDMSSLDMMMMPPPPPP---PPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKT 489
+ SL + PPPPPP P P P PP P +PA
Sbjct: 2689 RPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVPAGP 2748
Query: 490 AKPFTTAR 497
A P AR
Sbjct: 2749 ATPGGPAR 2756
|
Length = 3151 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 26/66 (39%), Positives = 31/66 (46%)
Query: 536 LAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQ 595
+AVK L A S +K EL H NIV L G C + G +I EYC G L
Sbjct: 70 VAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLV 129
Query: 596 DMLHSD 601
D LH +
Sbjct: 130 DYLHRN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 9/105 (8%)
Query: 558 VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSW-NTRIRM 616
V+ + ++HANIV L L++EY + D+ D N +S N +I M
Sbjct: 54 VSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFM 109
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
R L Y H+ I+HR+ K N+L+++ + ++D GLA
Sbjct: 110 -FQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
PPPP P P PPPPPP
Sbjct: 45 PPPPSTAAAAPAPAAPPPPPP 65
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
PPPPP P P PPPPP
Sbjct: 44 PPPPPSTAAAAPAPAAPPPPP 64
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-04
Identities = 12/22 (54%), Positives = 13/22 (59%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPP 465
+PP P PP P PPPP P P
Sbjct: 2900 LPPDQPERPPQPQAPPPPQPQP 2921
|
Length = 3151 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 26/94 (27%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
F E + + ++ H +IV L G C + +++ E+ G L +H ++ L+ +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV---LTTPWK 107
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILL 647
++A A AL YL + +VH N + NILL
Sbjct: 108 FKVAKQLASALSYLED---KDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
+IG G G V A+ DGK AVK L K+ +K+ + + N+ ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLHEI 630
Y + ++L + ++ + G L L + R R A A AL YLH I
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE-----PRARFYAAEIASALGYLHSI 115
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
IV+R+ K NILLD V ++D GL
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 9e-04
Identities = 12/22 (54%), Positives = 12/22 (54%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPV 466
PPP P P PPPPPPP
Sbjct: 46 PPPSTAAAAPAPAAPPPPPPPA 67
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 9e-04
Identities = 14/23 (60%), Positives = 14/23 (60%)
Query: 446 PPPPPPPPPPPPPPPPPPPPVVE 468
P PPPPPPPPPP P VE
Sbjct: 230 PSAPPPPPPPPPPSVPTISNSVE 252
|
Length = 313 |
| >gnl|CDD|220596 pfam10138, Tellurium_res, Tellurium resistance protein | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.001
Identities = 13/24 (54%), Positives = 13/24 (54%)
Query: 447 PPPPPPPPPPPPPPPPPPPVVEKV 470
P P PPP P PP P PPP V
Sbjct: 1 PAAPVPPPAPAPPAPAPPPAAPPV 24
|
Members of this family confer resistance to the metalloid element tellurium and its salts. Length = 98 |
| >gnl|CDD|233692 TIGR02031, BchD-ChlD, magnesium chelatase ATPase subunit D | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 13/29 (44%), Positives = 15/29 (51%)
Query: 437 SSLDMMMMPPPPPPPPPPPPPPPPPPPPP 465
++ P PPPPPPPP PP P P
Sbjct: 263 ATRLPEPEPQPPPPPPPPEPPEPEEEPDE 291
|
This model represents one of two ATPase subunits of the trimeric magnesium chelatase responsible for insertion of magnesium ion into protoporphyrin IX. This is an essential step in the biosynthesis of both chlorophyll and bacteriochlorophyll. This subunit is found in green plants, photosynthetic algae, cyanobacteria and other photosynthetic bacteria. Unlike subunit I (TIGR02030), this subunit is not found in archaea [Biosynthesis of cofactors, prosthetic groups, and carriers, Chlorophyll and bacteriochlorphyll]. Length = 589 |
| >gnl|CDD|223880 COG0810, TonB, Periplasmic protein TonB, links inner and outer membranes [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 14/47 (29%), Positives = 15/47 (31%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
PP P PP P PP P P +K P K K
Sbjct: 69 PPTEPETPPEPTPPKPKEKPKPEKKPKKPKPKPKPKPKPKPKVKPQP 115
|
Length = 244 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 11/21 (52%), Positives = 11/21 (52%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
P PPPPPP P P PP
Sbjct: 41 PAPPPPPPSTAAAAPAPAAPP 61
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 12/17 (70%), Positives = 12/17 (70%)
Query: 445 PPPPPPPPPPPPPPPPP 461
P PPPPPPPPPP P
Sbjct: 230 PSAPPPPPPPPPPSVPT 246
|
Length = 313 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 13/32 (40%), Positives = 15/32 (46%)
Query: 436 MSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVV 467
+ +P P PPPPPPPPPP V
Sbjct: 214 PVAAAKSALPAVSSSAPSAPPPPPPPPPPSVP 245
|
Length = 313 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 13/34 (38%), Positives = 14/34 (41%)
Query: 446 PPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAE 479
PP P PP P PPPP P +P P
Sbjct: 2901 PPDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPP 2934
|
Length = 3151 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
+IG G G V A+ + K AVK L K+A ++K+++ + N+ ++H +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLHEIC 631
+ + +Y + G L L + R R A A AL YLH +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSL- 115
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGL 660
IV+R+ K NILLD + ++D GL
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN-----IV 570
IG G G VY+ + D ++ A+K L K+ +K+ NI +R IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI-LVRTLLDESPFIV 59
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA-ARALEYLHE 629
LK L+ +Y S G L L + + R + + ALE+LH+
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-----RAKFYIAELVLALEHLHK 114
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
IV+R+ K NILLD +++ D GL+
Sbjct: 115 ---YDIVYRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 22/164 (13%)
Query: 517 IGAGMLGSVYRAQLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G G VY+A+ DG + A+K+++ S E L ++H N++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALL----RELKHPNVISLQ 64
Query: 574 GYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY----- 626
H R L+++Y + D+ H + + + +++ G ++L Y
Sbjct: 65 KVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 627 LHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISS 666
+H + ++HR+ K ANIL+ + V ++D G A L +S
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 516 LIGAGMLGSVYRA-QLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571
++G+G G+VY+ +PDG K+ K+ + +S + + E L+ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSD-DELKNN--LSWNTRIRMALGAARALEYLH 628
L G C +L + + G L D + + D + + L+W +I A+ + YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
E+ +VHR+ + N+L+ V ++D GLA L+
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 13/154 (8%)
Query: 517 IGAGMLGSVYRA---QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G+G G+V + K +AVK L + DE L N + ++ + IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK-NNLSWNTRIRMALGAARALEYLHEICQ 632
G C E +L+ E G L L + + N+ + + ++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEE--- 113
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
VHR+ + N+LL +SD GL+ + +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|236940 PRK11633, PRK11633, cell division protein DedD; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 14/46 (30%), Positives = 17/46 (36%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTA 490
P P P PP P P P P P ++ + P P K A
Sbjct: 99 PEPAPVEPPKPKPVEKPKPKPKPQQKVEAPPAPKPEPKPVVEEKAA 144
|
Length = 226 |
| >gnl|CDD|237378 PRK13406, bchD, magnesium chelatase subunit D; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 12/25 (48%), Positives = 13/25 (52%)
Query: 441 MMMMPPPPPPPPPPPPPPPPPPPPP 465
+ PP PP PPPPPPPP
Sbjct: 256 TRLPAPPQPPEEEPPPPPPPPEDDD 280
|
Length = 584 |
| >gnl|CDD|237378 PRK13406, bchD, magnesium chelatase subunit D; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 12/23 (52%), Positives = 12/23 (52%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPPP 465
P PP PPPPPPPP P
Sbjct: 260 APPQPPEEEPPPPPPPPEDDDDP 282
|
Length = 584 |
| >gnl|CDD|233692 TIGR02031, BchD-ChlD, magnesium chelatase ATPase subunit D | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 13/21 (61%), Positives = 13/21 (61%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
PPPPPPPP PP P P P
Sbjct: 273 PPPPPPPPEPPEPEEEPDEPD 293
|
This model represents one of two ATPase subunits of the trimeric magnesium chelatase responsible for insertion of magnesium ion into protoporphyrin IX. This is an essential step in the biosynthesis of both chlorophyll and bacteriochlorophyll. This subunit is found in green plants, photosynthetic algae, cyanobacteria and other photosynthetic bacteria. Unlike subunit I (TIGR02030), this subunit is not found in archaea [Biosynthesis of cofactors, prosthetic groups, and carriers, Chlorophyll and bacteriochlorphyll]. Length = 589 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 12/35 (34%), Positives = 12/35 (34%)
Query: 446 PPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEG 480
P PPPPPP P P P P P
Sbjct: 41 PAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPD 75
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 14/34 (41%), Positives = 15/34 (44%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPA 478
P PP P PPPP P P PP + P P
Sbjct: 2904 QPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPP 2937
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 13/36 (36%), Positives = 14/36 (38%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEG 480
P P PP P PPPP P P +P P
Sbjct: 2902 PDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPP 2937
|
Length = 3151 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
ALEYLH I+HR+ K NILLD+ V ++D +A ++ +++
Sbjct: 112 ALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|204405 pfam10146, zf-C4H2, Zinc finger-containing protein | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 22/91 (24%), Positives = 33/91 (36%), Gaps = 17/91 (18%)
Query: 385 NQMEKDASVKPKEDHRSEM---RRMGAIPHAQNEQERNKQRMSTIPR--------RDDHE 433
Q+ D + E +S+ RRMG I E K+ ++ + + HE
Sbjct: 56 RQIHADINDMETEIKQSKSELERRMGKIARMHGEYNPLKESINEMRKLELGLEELPQLHE 115
Query: 434 IDMSSLDMMMMPPPPPPPPPPPPPPPPPPPP 464
+ + P P PP P P PP P
Sbjct: 116 EERQKIS------PATSPVPPVPLPDPPAFP 140
|
This is a family of proteins which appears to have a highly conserved zinc finger domain at the C terminal end, described as -C-X2-CH-X3-H-X5-C-X2-C-. The structure is predicted to contain a coiled coil. Members are annotated as being tumour-associated antigen HCA127 in humans but this could not confirmed. Length = 215 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 38/165 (23%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEF----LELVNNIDRIRHANIVE 571
+G G G VY+A Q+ G+++A+KK+ +KD F L + + +++H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDG-FPITALREIKILKKLKHPNVVP 71
Query: 572 LKGYCAEHG-----QRLLIYEYCSNGTLQDML--HSDDELKNNLSWNTRIR--------M 616
L E +R +Y M+ + D +L L N ++
Sbjct: 72 LIDMAVERPDKSKRKRGSVY----------MVTPYMDHDLSGLLE-NPSVKLTESQIKCY 120
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L + YLHE I+HR+ K+ANIL+D+ + ++D GLA
Sbjct: 121 MLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 28/161 (17%)
Query: 511 FSQENLIGAGMLGSVY-----RAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
F++ IG G G V+ R Q +++A+K +D ++ +DE ++ I +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQ----QVVAIKIID----LEEAEDEIEDIQQEITVLS 57
Query: 566 HANIVELKGYCAEH--GQRL-LIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMALGA 620
+ + Y + G +L +I EY G+ D+L + DE + T ++ L
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ----IATMLKEIL-- 111
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ L+YLH +HR+ K+AN+LL + V ++D G+A
Sbjct: 112 -KGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.002
Identities = 15/40 (37%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
R L+YLH ++HR+ K +NIL++ + + + D GLA
Sbjct: 114 RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 16/160 (10%)
Query: 510 SFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRASSQQ-KDDEFLELVNNI-DR 563
+F ++G G G V+ + GKL A+K L K Q+ K E + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 564 IRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA-A 621
IR + + Y + +L LI +Y + G L L + K +++ G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EVQIYSGEIV 115
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
ALE+LH++ I++R+ K NILLD + V ++D GL+
Sbjct: 116 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|197891 smart00818, Amelogenin, Amelogenins, cell adhesion proteins, play a role in the biomineralisation of teeth | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 13/22 (59%), Positives = 13/22 (59%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPP 464
M P PP P PP PP PP PP
Sbjct: 113 PMQPQPPVHPIPPLPPQPPLPP 134
|
They seem to regulate formation of crystallites during the secretory stage of tooth enamel development and are thought to play a major role in the structural organisation and mineralisation of developing enamel. The extracellular matrix of the developing enamel comprises two major classes of protein: the hydrophobic amelogenins and the acidic enamelins. Circular dichroism studies of porcine amelogenin have shown that the protein consists of 3 discrete folding units: the N-terminal region appears to contain beta-strand structures, while the C-terminal region displays characteristics of a random coil conformation. Subsequent studies on the bovine protein have indicated the amelogenin structure to contain a repetitive beta-turn segment and a "beta-spiral" between Gln112 and Leu138, which sequester a (Pro, Leu, Gln) rich region. The beta-spiral offers a probable site for interactions with Ca2+ ions. Muatations in the human amelogenin gene (AMGX) cause X-linked hypoplastic amelogenesis imperfecta, a disease characterised by defective enamel. A 9bp deletion in exon 2 of AMGX results in the loss of codons for Ile5, Leu6, Phe7 and Ala8, and replacement by a new threonine codon, disrupting the 16-residue (Met1-Ala16) amelogenin signal peptide. Length = 165 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 42/170 (24%), Positives = 63/170 (37%), Gaps = 39/170 (22%)
Query: 83 AIILNGANLGGELGENL-GAFSSIR---VIDLSNNHIGGS-IPSILPVTMQNFFLSDNQF 137
++L L G E L A + R ++L+NN IG + I ++
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE------------- 187
Query: 138 SGSIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----- 188
L L + LNNN L+ E + + SL L L+L NNL+
Sbjct: 188 ------GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241
Query: 189 LPPSLENLSQLTTLHLQNNQL--SGTLDVLQDLP----LRDLNIENNLFS 232
L L TL L N + G D+ + L L +L++ N F
Sbjct: 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 36/147 (24%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 517 IGAGMLGSVY--RAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
+G G +VY R++L D L+A+K++ + + + V+ + ++HANIV L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
L++EY +D+ D+ N+++ + R L Y H +
Sbjct: 72 IIHTEKSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRK 124
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLA 661
++HR+ K N+L+++ + ++D GLA
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 22/156 (14%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEF----LELVNNIDRIRHANI 569
N I G G VYRA+ G+++A+KKL ++ + F L +N + +++H NI
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKME----KEKEGFPITSLREINILLKLQHPNI 66
Query: 570 VELK----GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
V +K G + + ++ EY + L+ ++ + +K + + L +
Sbjct: 67 VTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLM---ETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+LH I+HR+ K++N+LL++ + + D GLA
Sbjct: 121 HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 14/150 (9%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN--IDRIRHANIVEL 572
L+G G G V + G+ A+K L K+ KD+ L N + RH + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKIL-KKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA--ARALEYLHEI 630
K H + + EY + G L L + + R R GA AL+YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARF-YGAEIVSALDYLHS- 113
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
+ +V+R+ K N++LD D + ++D GL
Sbjct: 114 -EKNVVYRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 16/160 (10%)
Query: 517 IGAGMLGSVY----RAQLPDGKLLAVKKLDKRASSQ-QKDDEFLELVNNI-DRIRHANIV 570
+G G G V+ GKL A+K L K Q K E + + +R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA-ARALEYLH 628
Y + +L LI +Y + G L L+ + + +R+ + AL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----EVRVYIAEIVLALDHLH 122
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
Q I++R+ K NILLD + V ++D GL+ +
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|218549 pfam05308, Mito_fiss_reg, Mitochondrial fission regulator | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 14/23 (60%), Positives = 15/23 (65%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVV 467
P PPPPPPPPPPPPP +
Sbjct: 177 EEPVLEVPPPPPPPPPPPPPSLQ 199
|
In eukaryotes, this family of proteins induces mitochondrial fission. Length = 248 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 16/155 (10%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDGK-LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F++ IG G G VY+ K ++A+K +D ++ +DE ++ I + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61
Query: 570 VELKGYCAEH--GQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ Y + G +L +I EY G+ D+L + ++ T +R L + L+Y
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA--TILREIL---KGLDY 116
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LH + +HR+ K+AN+LL + V ++D G+A
Sbjct: 117 LHSERK---IHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 35/142 (24%), Positives = 66/142 (46%), Gaps = 17/142 (11%)
Query: 514 ENLIGAGMLGSVYRA----QLPDGKL----LAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
E+L G G +++ G+L + +K LDK S + + F E + + ++
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLS 57
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
H ++V G C + +++ EY G+L D ++ N+SW ++ +A A AL
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISW--KLEVAKQLAWALH 114
Query: 626 YLHEICQPPIVHRNFKSANILL 647
+L + + H N + N+LL
Sbjct: 115 FLED---KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|216368 pfam01213, CAP_N, Adenylate cyclase associated (CAP) N terminal | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 11/32 (34%), Positives = 15/32 (46%)
Query: 435 DMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPV 466
+++ + P PPPPPPPPPP
Sbjct: 214 PVAAAKSALPAVSSSAPSAPPPPPPPPPPSVP 245
|
Length = 313 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 23/76 (30%), Positives = 31/76 (40%), Gaps = 9/76 (11%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKP------IVPAEGTAVKTSTKTAKPFTTAR 497
+PPP P PPPPP PPPP + V P P+ A K + P R
Sbjct: 2828 LPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPP---VR 2884
Query: 498 SFTIASLQQYTNSFSQ 513
++ + T SF+
Sbjct: 2885 RLARPAVSRSTESFAL 2900
|
Length = 3151 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 12/21 (57%), Positives = 12/21 (57%)
Query: 445 PPPPPPPPPPPPPPPPPPPPP 465
P PP P PP P PPPP P
Sbjct: 2611 PAPPSPLPPDTHAPDPPPPSP 2631
|
Length = 3151 |
| >gnl|CDD|197891 smart00818, Amelogenin, Amelogenins, cell adhesion proteins, play a role in the biomineralisation of teeth | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 13/38 (34%), Positives = 19/38 (50%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGT 481
PP PP PP PP P P PP++ + ++ + T
Sbjct: 122 PIPPLPPQPPLPPMFPMQPLPPLLPDLPLEAWPATDKT 159
|
They seem to regulate formation of crystallites during the secretory stage of tooth enamel development and are thought to play a major role in the structural organisation and mineralisation of developing enamel. The extracellular matrix of the developing enamel comprises two major classes of protein: the hydrophobic amelogenins and the acidic enamelins. Circular dichroism studies of porcine amelogenin have shown that the protein consists of 3 discrete folding units: the N-terminal region appears to contain beta-strand structures, while the C-terminal region displays characteristics of a random coil conformation. Subsequent studies on the bovine protein have indicated the amelogenin structure to contain a repetitive beta-turn segment and a "beta-spiral" between Gln112 and Leu138, which sequester a (Pro, Leu, Gln) rich region. The beta-spiral offers a probable site for interactions with Ca2+ ions. Muatations in the human amelogenin gene (AMGX) cause X-linked hypoplastic amelogenesis imperfecta, a disease characterised by defective enamel. A 9bp deletion in exon 2 of AMGX results in the loss of codons for Ile5, Leu6, Phe7 and Ala8, and replacement by a new threonine codon, disrupting the 16-residue (Met1-Ala16) amelogenin signal peptide. Length = 165 |
| >gnl|CDD|218549 pfam05308, Mito_fiss_reg, Mitochondrial fission regulator | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 14/22 (63%), Positives = 14/22 (63%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPV 466
P P PPPPPPPPPPPP
Sbjct: 175 PTEEPVLEVPPPPPPPPPPPPP 196
|
In eukaryotes, this family of proteins induces mitochondrial fission. Length = 248 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 13/163 (7%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG+G G V A GK +A+KK+ L + + +H NI+ ++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 576 C---AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA-RALEYLHEIC 631
+ + + L ++HSD L IR L R L+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH-----IRYFLYQLLRGLKYIHSAN 127
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
++HR+ K +N+L+++D + + D G+A +SS
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 689 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.98 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.98 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.95 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.93 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.92 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.92 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.92 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.92 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.91 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.91 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.91 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.91 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.91 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.91 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.91 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.91 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.91 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.91 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.91 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.91 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.9 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.9 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.9 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.9 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.9 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.9 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.9 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.9 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.9 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.9 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.9 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.9 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.9 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.9 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.9 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.9 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.9 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.9 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.9 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.9 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.9 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.9 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.89 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.89 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.89 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.89 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.89 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.89 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.89 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.89 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.89 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.89 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.89 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.89 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.89 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.89 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.89 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.89 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.89 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.89 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.89 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.88 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.88 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.88 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.88 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.88 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.88 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.88 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.88 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.88 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.88 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.87 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.87 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.87 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.87 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.87 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.86 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.86 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.85 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.85 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.85 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.85 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.85 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.84 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.83 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.82 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.82 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.8 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.79 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.79 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.78 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.69 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.69 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.69 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.63 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.62 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.61 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.56 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.55 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.55 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.55 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.52 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.49 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.42 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.37 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.36 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.23 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.2 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.19 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.18 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.18 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.16 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.07 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.06 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.05 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.99 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.97 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.97 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.93 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.84 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.79 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.77 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.75 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.61 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.42 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.31 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.31 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.31 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.31 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.12 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.1 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=450.52 Aligned_cols=441 Identities=27% Similarity=0.449 Sum_probs=313.5
Q ss_pred CCCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEEE
Q 005587 78 ASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155 (689)
Q Consensus 78 ~~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (689)
..+++.|+|++|++++.+|..+.++++|+.|+|++|++++.+|..+. .+|+.|+|++|++.+.+|..+ .+++|+.|+
T Consensus 403 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ 481 (968)
T PLN00113 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLD 481 (968)
T ss_pred CCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEE
Confidence 35799999999999999999999999999999999999999887665 789999999999999999876 458999999
Q ss_pred ccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeeccccccccccc-ccCCcc-ccccccccccCCC
Q 005587 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDLNIENNLFSG 233 (689)
Q Consensus 156 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~-L~~L~Ls~N~l~g 233 (689)
|++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|++++.++ .+..++ |+.|+|++|+++|
T Consensus 482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (968)
T PLN00113 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561 (968)
T ss_pred CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence 99999999999999999999999999999999999999999999999999999998774 567776 9999999999999
Q ss_pred CCccccCC---CCCccccCCcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccCCC
Q 005587 234 PIPEKMLQ---IPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGPRPVSGSSPVSRTPPSQHTPGKQADGPTALEDSN 310 (689)
Q Consensus 234 ~ip~~l~~---l~~l~~~~N~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 310 (689)
.+|..+.+ |..|++++|++.+..|....... .....+.+++..++..+. .+. ++ +
T Consensus 562 ~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~----~~~~~~~~n~~lc~~~~~-----~~~--------~~-----c 619 (968)
T PLN00113 562 EIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLA----INASAVAGNIDLCGGDTT-----SGL--------PP-----C 619 (968)
T ss_pred cCChhHhcCcccCEEeccCCcceeeCCCcchhcc----cChhhhcCCccccCCccc-----cCC--------CC-----C
Confidence 99987765 55577899999876654321110 011111122222211100 000 00 0
Q ss_pred CCCCCCCCCcceeeehhHHHHHHHHHHHHHHHHHhHHHhhcCccccccccccccccccCcchhccCCCCcCCCccccccc
Q 005587 311 SGKKKSSTTKKIVWISIAGVLLFVILALVFLLFMPRCIKRRGEVDRIFKRHQVGAFRGNNREEARDNGTLALPTNQMEKD 390 (689)
Q Consensus 311 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (689)
....+ ... .+++++++++++++++++++++++ +++|+.. + ....+ .. . ..
T Consensus 620 ~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~---~~~~~--------~~-~-~~----------- 669 (968)
T PLN00113 620 KRVRK--TPS--WWFYITCTLGAFLVLALVAFGFVF-IRGRNNL-E---LKRVE--------NE-D-GT----------- 669 (968)
T ss_pred ccccc--cce--eeeehhHHHHHHHHHHHHHHHHHH-HHhhhcc-c---ccccc--------cc-c-cc-----------
Confidence 00101 111 112222222222222222222222 2222211 0 00000 00 0 00
Q ss_pred cCCCCccchhhhhhhccccccchhhhhhhhcccCCCCCCCCcccccccccccCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 005587 391 ASVKPKEDHRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKV 470 (689)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (689)
. + ...
T Consensus 670 -----------------------------------~------~--~~~-------------------------------- 674 (968)
T PLN00113 670 -----------------------------------W------E--LQF-------------------------------- 674 (968)
T ss_pred -----------------------------------c------c--ccc--------------------------------
Confidence 0 0 000
Q ss_pred ccccCCCCCCCccccCCCCCCCCCcccccchhhHhhhccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChh
Q 005587 471 IVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQ 549 (689)
Q Consensus 471 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~ 549 (689)
... .....++++++ ...|...++||+|+||.||+|+. .+|..||||++.....
T Consensus 675 -----~~~---------------~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--- 728 (968)
T PLN00113 675 -----FDS---------------KVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--- 728 (968)
T ss_pred -----ccc---------------ccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---
Confidence 000 00011222222 23466778999999999999976 5789999999864321
Q ss_pred hHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005587 550 KDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629 (689)
Q Consensus 550 ~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~ 629 (689)
...+|++++++++|||||+++++|...+..|+|||||++|+|.++++. ++|..+.+|+.|+++||+|||+
T Consensus 729 ---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~ 798 (968)
T PLN00113 729 ---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHC 798 (968)
T ss_pred ---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhcc
Confidence 112457889999999999999999999999999999999999999962 7899999999999999999997
Q ss_pred CCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcceeecccceEEeccccc
Q 005587 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 630 ~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
.+.++|+||||||+||+++.++..++. ||.+....... ...++..|+|||++.
T Consensus 799 ~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~---~~~~t~~y~aPE~~~ 851 (968)
T PLN00113 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT---KCFISSAYVAPETRE 851 (968)
T ss_pred CCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC---CccccccccCccccc
Confidence 767799999999999999999988875 77766543222 125678899999874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=327.78 Aligned_cols=187 Identities=46% Similarity=0.782 Sum_probs=167.0
Q ss_pred cccccchhhHhhhccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecE
Q 005587 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574 (689)
Q Consensus 495 ~~~~~~~~~l~~~~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~ 574 (689)
..+.|++.++..+|++|...++||+|+||.||+|.+.+|..||||++....... .++|..|+.++.+++|||||+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456799999999999999999999999999999999999999999886543321 566999999999999999999999
Q ss_pred EEEeCC-eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcE
Q 005587 575 YCAEHG-QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAV 653 (689)
Q Consensus 575 ~~~~~~-~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~ 653 (689)
||.+.+ +.+||||||++|+|.++|+..... .++|..|++|+.++|+||+|||+.+.++|||||||++|||||+++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 999998 599999999999999999975432 78999999999999999999999988899999999999999999999
Q ss_pred EEEeecCCccccC-CCcceee-cccceEEecccc
Q 005587 654 SVSDCGLAPLISS-GSVSQVS-HNLTIMRAGGVT 685 (689)
Q Consensus 654 kl~DFGla~~~~~-~~~~~~~-~~~~~~~apE~~ 685 (689)
||+|||+|+.... ....... .++..|+|||..
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYA 250 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhh
Confidence 9999999987765 4333333 788899999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.07 Aligned_cols=174 Identities=26% Similarity=0.456 Sum_probs=158.4
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.+|...+.||+|+||+||+|+++ ++..||||.+.+........+-+..|+++|+.++|||||.++++++.++++|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 56888888999999999999764 68999999998876556667788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC------CcEEEEeecCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD------LAVSVSDCGLA 661 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~------~~~kl~DFGla 661 (689)
||.||||.++|+.. ..+++..+..++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999874 4789999999999999999999998 89999999999999764 45899999999
Q ss_pred ccccCCCcceeecccceEEecccc-ccCC
Q 005587 662 PLISSGSVSQVSHNLTIMRAGGVT-HRNF 689 (689)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~apE~~-~~~~ 689 (689)
+.+.++......+|++.||||||+ .++|
T Consensus 163 R~L~~~~~a~tlcGSplYMAPEV~~~~~Y 191 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSPLYMAPEVIMSQQY 191 (429)
T ss_pred hhCCchhHHHHhhCCccccCHHHHHhccc
Confidence 999999999999999999999999 3444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=288.59 Aligned_cols=172 Identities=26% Similarity=0.397 Sum_probs=152.2
Q ss_pred ccCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChh-----hHHHHHHHHHHHhcCCCCCcceecEEEEeCCe
Q 005587 508 TNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQ-----KDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~-----~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (689)
.+.|.+.+.||+|+||.|-+| +.++|+.||||++.+...... ......+|+++|++|+|||||+++++|...++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 456778899999999999999 566899999999987643221 23345799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC---CcEEEEee
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD---LAVSVSDC 658 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kl~DF 658 (689)
.|||||||+||+|++.+-.. ..+.+.....+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999874 4566777788999999999999998 89999999999999655 77999999
Q ss_pred cCCccccCCCcceeecccceEEeccccc
Q 005587 659 GLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|+|+...+++.-...+||+.|.||||+.
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~ 351 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLA 351 (475)
T ss_pred chhhccccceehhhhcCCccccChhhee
Confidence 9999999999888899999999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=282.22 Aligned_cols=171 Identities=25% Similarity=0.327 Sum_probs=152.4
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.++||+|+||+||+++. .+++.+|+|++++..... .+.+....|..+|.+++||+||+++-.|++.+++|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 5789999999999999999965 468999999998775433 34667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc-c
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI-S 665 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~-~ 665 (689)
||+.||+|+.+|.. ...+++..+.-|+.+|+.||.|||+. +||||||||+|||||++|+++|+||||++.. .
T Consensus 105 d~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999986 34688999999999999999999998 8999999999999999999999999999954 4
Q ss_pred CCCcceeecccceEEeccccc
Q 005587 666 SGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~apE~~~ 686 (689)
.+.....-+||+.|||||++.
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~ 198 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILL 198 (357)
T ss_pred CCCccccccCCccccChHHHh
Confidence 445555569999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=280.73 Aligned_cols=179 Identities=25% Similarity=0.367 Sum_probs=157.5
Q ss_pred cCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecE-EEEeCCe-EEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG-YCAEHGQ-RLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~-~~~~~~~-~~lV 585 (689)
.+|++.++||+|.||.||++ ...+|..||.|.+.-...+......+..|+.+|++|+|||||++++ .+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 35788899999999999999 5679999999999877777777888999999999999999999998 4444445 8999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP-PIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||.+|||.++++..+...+.+++..++++..|++.||..+|..... -|+||||||.||+|+++|.+||+||||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999998777788899999999999999999999984321 3899999999999999999999999999999
Q ss_pred cCCC-cceeecccceEEecccccc
Q 005587 665 SSGS-VSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 665 ~~~~-~~~~~~~~~~~~apE~~~~ 687 (689)
.... ......||+|||+||+++.
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~ 202 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHE 202 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhc
Confidence 7654 4455678999999999973
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=275.25 Aligned_cols=171 Identities=21% Similarity=0.351 Sum_probs=150.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.|+...++|+|+||+||+|+.+ +|+.||||++.....++...+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777789999999999999765 69999999998776656666778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc-C
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS-S 666 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~-~ 666 (689)
||+.--|. -|. .....++...+.+|..|+++|+.|+|+. +||||||||+|||+..+|.+||||||+|+.+. +
T Consensus 82 ~~dhTvL~-eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLH-ELE---RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHH-HHH---hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99874333 333 2356788999999999999999999998 89999999999999999999999999999998 6
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
++...+...|.+|||||.+-
T Consensus 155 gd~YTDYVATRWYRaPELLv 174 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLV 174 (396)
T ss_pred cchhhhhhhhhhccChhhhc
Confidence 77777788899999999984
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=289.28 Aligned_cols=172 Identities=29% Similarity=0.464 Sum_probs=149.3
Q ss_pred CccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-eEEEEEeccC
Q 005587 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-QRLLIYEYCS 590 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey~~ 590 (689)
...+.||+|+||+||+|.+.....||||++..........++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 344569999999999999965555999999876544444779999999999999999999999999987 7999999999
Q ss_pred CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEEecccCCCeEecCCC-cEEEEeecCCccccCC-
Q 005587 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP-IVHRNFKSANILLDDDL-AVSVSDCGLAPLISSG- 667 (689)
Q Consensus 591 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~- 667 (689)
+|+|.++++.. ....+++..+++|+.|||+||.|||+. + ||||||||+|||++.++ .+||+|||+++.....
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999874 256799999999999999999999998 5 99999999999999997 9999999999987754
Q ss_pred CcceeecccceEEeccccccC
Q 005587 668 SVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~~~ 688 (689)
.......+|..|||||++..+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~ 219 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGE 219 (362)
T ss_pred ccccCCCCCccccChhhhcCC
Confidence 222336788899999999743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=284.91 Aligned_cols=171 Identities=25% Similarity=0.397 Sum_probs=149.8
Q ss_pred cCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 585 (689)
+.|+..++||+|+||.||+|+ ..+|+.||+|+++.............+||.+|++|+|||||+|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 467778899999999999995 56899999999988766566667788999999999999999999998876 789999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
+|||++ ||.-++... .-.+++.++..|+.|++.||+|||+. +|+|||||.+|||||++|.+||+|||||+++.
T Consensus 197 FeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 898888753 34689999999999999999999998 89999999999999999999999999999987
Q ss_pred CCCcc--eeecccceEEeccccc
Q 005587 666 SGSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~--~~~~~~~~~~apE~~~ 686 (689)
..... ..-.-|.+|++||++.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLL 292 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLL 292 (560)
T ss_pred CCCCcccccceEEeeccChHHhc
Confidence 76533 2234568899999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=273.33 Aligned_cols=166 Identities=22% Similarity=0.357 Sum_probs=147.8
Q ss_pred ccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-eEEEEEeccC
Q 005587 513 QENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-QRLLIYEYCS 590 (689)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~Ey~~ 590 (689)
....||+|..|+||+++++ +++.+|+|.+... .+....+++.+|+++++..+||+||++||.|...+ .+.|+||||.
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 3578999999999999765 6899999999443 34566789999999999999999999999999998 5999999999
Q ss_pred CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc
Q 005587 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (689)
Q Consensus 591 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (689)
+|||.+++... ..+++...-+|+.+|++||.|||+. .+||||||||+|||++..|++||||||.++.+... ..
T Consensus 162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence 99999999863 5689999999999999999999974 28999999999999999999999999999998766 55
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....||..|||||=+.
T Consensus 235 ~tfvGT~~YMsPERi~ 250 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERIS 250 (364)
T ss_pred ccccccccccChhhhc
Confidence 5578899999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=286.39 Aligned_cols=171 Identities=22% Similarity=0.431 Sum_probs=156.3
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
..|...++||+|+|+.||.++. .+|+.||+|++.+.... ....+...+|+++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999976 78999999999875432 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
|+|++|+|..+++. .+.+++.+++.+++||+.||.|||+. +|||||||..|++|+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999985 56899999999999999999999998 899999999999999999999999999999884
Q ss_pred -CCcceeecccceEEeccccc
Q 005587 667 -GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 -~~~~~~~~~~~~~~apE~~~ 686 (689)
++.....+||+-|.||||+.
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred cccccceecCCCcccChhHhc
Confidence 47888899999999999984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=259.91 Aligned_cols=170 Identities=24% Similarity=0.360 Sum_probs=150.5
Q ss_pred cCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|...++||+|.||.||+|+ .++|+.||||+++.....+.-....++|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357778899999999999995 5689999999998776555556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
||+. +|+.+++.. ...+....+..|+.++++||+|||.. .|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9975 999999864 35688899999999999999999998 7999999999999999999999999999998765
Q ss_pred Ccc-eeecccceEEecccc
Q 005587 668 SVS-QVSHNLTIMRAGGVT 685 (689)
Q Consensus 668 ~~~-~~~~~~~~~~apE~~ 685 (689)
... ....-|.+|+|||++
T Consensus 155 ~~~~~~~V~TRWYRAPELL 173 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELL 173 (318)
T ss_pred CcccccceeeeeccChHHh
Confidence 533 334678999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=278.53 Aligned_cols=172 Identities=24% Similarity=0.362 Sum_probs=153.7
Q ss_pred ccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCC-eEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHG-QRLL 584 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~-~~~l 584 (689)
.++|...+.||.|+||.||+|+ ..+|+.||||++++..... .+..=+||++.|++|. |||||++.+.+.+++ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4678889999999999999995 5679999999998776543 3344468999999998 999999999999988 9999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
|||||+. +|+++++++ .+.+++..++.|+.||++||+|+|.. |+.|||+||+|||+.....+||+||||||.+
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999965 999999875 56899999999999999999999998 8999999999999998889999999999999
Q ss_pred cCCCcceeecccceEEecccccc
Q 005587 665 SSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 665 ~~~~~~~~~~~~~~~~apE~~~~ 687 (689)
........-.-|.+|||||++.+
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLr 183 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLR 183 (538)
T ss_pred ccCCCcchhhhcccccchHHhhh
Confidence 88887777788999999999953
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=269.46 Aligned_cols=171 Identities=22% Similarity=0.355 Sum_probs=158.2
Q ss_pred cCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
.+|++.+.||+|.||.|-+|. ...|+.||||.+++... +.++...+.+|+++|+.|+||||+.+|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 467888999999999999994 57899999999987653 3456778899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||..+|.|+|++.+ ...+++.++.++++||..|+.|+|.. +++|||||.+|||+|.++++||+||||+-++..
T Consensus 133 EYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999987 45789999999999999999999987 899999999999999999999999999999999
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
+..-+.-++.+.|.+|||+.
T Consensus 206 ~kfLqTFCGSPLYASPEIvN 225 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVN 225 (668)
T ss_pred ccHHHHhcCCcccCCccccC
Confidence 99999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=255.41 Aligned_cols=169 Identities=24% Similarity=0.348 Sum_probs=151.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|+....||.|+||.|.+++.+ +|..+|+|++.+...-+ ...+....|.++|+.+.||+++++++.|.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999754 68999999998764322 33456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||++||.|+.+++.. .++++..++-++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999873 4688999999999999999999998 899999999999999999999999999999876
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
. ....+||+-|+|||++.
T Consensus 197 r--T~TlCGTPeYLAPEii~ 214 (355)
T KOG0616|consen 197 R--TWTLCGTPEYLAPEIIQ 214 (355)
T ss_pred c--EEEecCCccccChHHhh
Confidence 5 56689999999999984
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=272.97 Aligned_cols=170 Identities=25% Similarity=0.385 Sum_probs=154.3
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....+.+.+.+.+|++++++++|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788899999999999999654 68999999998877666777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+.| +|+.+|.. ...++++.+..|+.++..||.|||+. +|+|||+||.|||++..|.+|+||||+|+-+..+
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99999986 45799999999999999999999998 8999999999999999999999999999998775
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......|++.|||||+..
T Consensus 154 t~vltsikGtPlYmAPElv~ 173 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVE 173 (808)
T ss_pred ceeeeeccCcccccCHHHHc
Confidence 4 444567889999999974
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=273.38 Aligned_cols=174 Identities=27% Similarity=0.393 Sum_probs=154.2
Q ss_pred hccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCe
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQ 581 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~---~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~ 581 (689)
....|.+.+.||+|+||.||.|.. .+|+.||+|++.+.... ......+.+|+.+++.++ ||||+++++++....+
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346788999999999999999954 57899999987664221 123456668999999999 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC-CcEEEEeecC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGL 660 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGl 660 (689)
+|+||||+.||+|++++.. ...+.+..+.+++.|++.|++|||+. +|+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999987 34678899999999999999999998 89999999999999999 9999999999
Q ss_pred Cccc-cCCCcceeecccceEEecccccc
Q 005587 661 APLI-SSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 661 a~~~-~~~~~~~~~~~~~~~~apE~~~~ 687 (689)
+... ..+......+|++.|+|||++..
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~ 195 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSG 195 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCC
Confidence 9999 57788888999999999999953
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=256.13 Aligned_cols=171 Identities=26% Similarity=0.320 Sum_probs=147.1
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCeEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV 585 (689)
++|+..+.|++|+||.||+|+. ++++.||+|+++.......-.-.-++|+.+|.+++|||||.+..+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4678889999999999999965 478999999998665433445567899999999999999999888765 4679999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
||||++ ||..+++.. .+++...++..++.|+++|++|||.. .|+|||||++|+|+.+.|.+||+|||||+.+.
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 999999864 36788999999999999999999998 69999999999999999999999999999998
Q ss_pred CCCcc-eeecccceEEeccccc
Q 005587 666 SGSVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~-~~~~~~~~~~apE~~~ 686 (689)
+.-.. .....|.+|+|||++.
T Consensus 229 sp~k~~T~lVVTLWYRaPELLL 250 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLL 250 (419)
T ss_pred CCcccCcceEEEeeecCHHHhc
Confidence 76432 3356678899999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=269.82 Aligned_cols=175 Identities=27% Similarity=0.345 Sum_probs=151.2
Q ss_pred ccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChh-hHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQ-KDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~-~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 584 (689)
.++|..++.||+|+|++||+|+ ..+++.||||++.+...-.+ ..+-..+|-..|.+| .||.||+|+..|.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3678899999999999999995 56799999999987654333 234456788888888 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
|+||++||+|.++|+.. ..+++..++.++.+|+.||+|||+. |||||||||+|||||++|++||+|||-|+.+
T Consensus 152 vLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 99999999999999974 4688999999999999999999998 8999999999999999999999999999998
Q ss_pred cCCCcc--------------eeecccceEEeccccccCC
Q 005587 665 SSGSVS--------------QVSHNLTIMRAGGVTHRNF 689 (689)
Q Consensus 665 ~~~~~~--------------~~~~~~~~~~apE~~~~~~ 689 (689)
.+.... ..-.||..|.+||++.+++
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~ 263 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP 263 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCC
Confidence 654333 2245778899999997653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=255.82 Aligned_cols=169 Identities=30% Similarity=0.423 Sum_probs=145.7
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC--eEEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG--QRLLIY 586 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 586 (689)
+|...+.||+|+||.||++... +|...|||.+....... .+.+.+|+++|.+++|||||+++|...... .+++.|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4666789999999999999664 59999999987653222 567899999999999999999999866554 689999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-CCcEEEEeecCCcccc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLIS 665 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~ 665 (689)
||+++|+|.+++...+. .+++..++++++||++||+|||++ +||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999987542 699999999999999999999987 8999999999999999 7999999999999877
Q ss_pred C----CCcceeecccceEEeccccc
Q 005587 666 S----GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~----~~~~~~~~~~~~~~apE~~~ 686 (689)
. ........++++|||||++.
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred cccccccccccccCCccccCchhhc
Confidence 3 22333467889999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=265.01 Aligned_cols=175 Identities=29% Similarity=0.460 Sum_probs=152.2
Q ss_pred hHhhhccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 503 SLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 503 ~l~~~~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
+.....+.+.+.+.||+|.||+||+|+|.. .||||.+......+...+.|..|+.++++-||.||+-+.|||..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 333344556778999999999999999853 59999999888777888999999999999999999999999999887
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
.||+.+|+|.+|+.+||..+ ..++..+.+.|++|||+||.|||.+ +|||||||..||++++++.|||+||||+.
T Consensus 463 AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999999753 5688999999999999999999997 89999999999999999999999999986
Q ss_pred ccc---CCCcceeecccceEEeccccc
Q 005587 663 LIS---SGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~---~~~~~~~~~~~~~~~apE~~~ 686 (689)
.-. -.......++..-|||||+++
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIR 563 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIR 563 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHh
Confidence 432 223334466777899999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=269.73 Aligned_cols=171 Identities=25% Similarity=0.345 Sum_probs=157.0
Q ss_pred cCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccc-cCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKR-ASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~-~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
.-|++++-||+|+.|.|..|+ ..+|+.+|||++.+. .........+.+|+.+|+-+.||||+++|++|++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 347788999999999999995 468999999999876 334445567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||++||.|++++.. +..+++.++.++++||+.|+.|+|.. +|+||||||+|+|||..+.+||+|||+|.+-.+
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999986 45788999999999999999999998 899999999999999999999999999999999
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
+..-+..+|.++|.+|||+.
T Consensus 165 gklLeTSCGSPHYA~PEIV~ 184 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVS 184 (786)
T ss_pred CccccccCCCcccCCchhhc
Confidence 99999999999999999995
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=252.81 Aligned_cols=171 Identities=22% Similarity=0.357 Sum_probs=150.6
Q ss_pred cCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.|++.++||.|..++||+|+ ...++.||||++..+.... ..+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 578899999999999999995 5678999999998776543 36889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
||.+||+.++++..- ...+++..+..|.+++++||.|||.+ |.||||||+.|||||.+|.+||+|||.+..+.+.
T Consensus 105 fMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999998743 45689999999999999999999988 8999999999999999999999999987665443
Q ss_pred Ccc-----eeecccceEEecccc
Q 005587 668 SVS-----QVSHNLTIMRAGGVT 685 (689)
Q Consensus 668 ~~~-----~~~~~~~~~~apE~~ 685 (689)
... ....++++|||||++
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred CceeeEeeccccCcccccChHHh
Confidence 322 223678899999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=253.73 Aligned_cols=172 Identities=25% Similarity=0.419 Sum_probs=147.4
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+...+.++||+|.||.|..|+...+.+||||+++.... .....+|.+|+++|.+++|||||.++|+|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34566789999999999999998889999999976543 34468999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
|++|+|.+++..+.. ..+.-...++|+.||+.||+||.+. ++|||||.+.|+|+|.++++||+|||+++-+-.++
T Consensus 617 mEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999987542 2234456778999999999999998 89999999999999999999999999999887777
Q ss_pred cceeeccc---ceEEeccccc
Q 005587 669 VSQVSHNL---TIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~---~~~~apE~~~ 686 (689)
........ .-|||+|.+.
T Consensus 692 yy~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred ceeeecceeeeeeehhHHHHH
Confidence 55433222 3499999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=251.51 Aligned_cols=173 Identities=24% Similarity=0.339 Sum_probs=145.7
Q ss_pred CCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCC-cceecEEEEeCC------e
Q 005587 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN-IVELKGYCAEHG------Q 581 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpn-Iv~l~~~~~~~~------~ 581 (689)
.|...++||+|+||+||+|+ ..+|+.||+|+++.....+.......+|+.+++.++|+| ||.+++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45666789999999999995 457899999999876543344556789999999999999 999999998877 8
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.++|+||++. +|.+++.........++...+..+++|+++||+|||+. +|+||||||.|||+++.|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999954 99999987542224577788999999999999999998 8999999999999999999999999999
Q ss_pred cccc-CCCcceeecccceEEeccccc
Q 005587 662 PLIS-SGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~-~~~~~~~~~~~~~~~apE~~~ 686 (689)
+.+. +.........|-+|+|||++.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLl 193 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLL 193 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhc
Confidence 9776 333344456678899999984
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=256.48 Aligned_cols=167 Identities=25% Similarity=0.336 Sum_probs=141.0
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-----eEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-----QRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 583 (689)
.|...+++|.|+||.||+|... +++.||||++-.... .--+|+++|++++|||||++.-+|.... +..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4566789999999999999754 579999999854321 2236889999999999999988887532 335
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC-CcEEEEeecCCc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGLAP 662 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~ 662 (689)
+|||||+. +|+++++.....+..++...+.-++.|+.+||.|||+. +|+||||||.|||+|.+ |.+||||||-|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 99999986433456778888889999999999999996 89999999999999965 899999999999
Q ss_pred cccCCCcceeecccceEEeccccc
Q 005587 663 LISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
.+..++.+..-.-+.+|||||.+-
T Consensus 175 ~L~~~epniSYicSRyYRaPELif 198 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIF 198 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHc
Confidence 999999888788899999999983
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=261.56 Aligned_cols=169 Identities=26% Similarity=0.449 Sum_probs=146.3
Q ss_pred CCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccC
Q 005587 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
+...+.||+|.||.||.|.+.....||+|.+..... ..+.|.+|+++|++|+|+|||+++++|..++.+|||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345678999999999999998777999999976533 35678999999999999999999999999989999999999
Q ss_pred CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc
Q 005587 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (689)
Q Consensus 591 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (689)
.|+|.++|+... ...+...+.+.|+.|||+||+||++. ++|||||.+.|||++++..+||+||||||.+.++...
T Consensus 285 ~GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 285 KGSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cCcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999998733 45688899999999999999999998 8999999999999999999999999999976665544
Q ss_pred eeeccc-ce-EEecccccc
Q 005587 671 QVSHNL-TI-MRAGGVTHR 687 (689)
Q Consensus 671 ~~~~~~-~~-~~apE~~~~ 687 (689)
....+. +. +.|||.+++
T Consensus 360 ~~~~~kfPIkWtAPEa~~~ 378 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNY 378 (468)
T ss_pred ecCCCCCCceecCHHHHhh
Confidence 433333 22 779999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=262.87 Aligned_cols=168 Identities=25% Similarity=0.381 Sum_probs=150.9
Q ss_pred cCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
..|.....||+|+.|.||.| +..+++.||||++..... ...+-+..|+.+|+..+|+|||.+++.|...+++|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 45777789999999999999 456789999999977643 445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
||+||+|.|++.. ..+++.++..|.+++++||+|||.. +|||||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999875 3589999999999999999999998 8999999999999999999999999999988765
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......||+||||||+..
T Consensus 423 ~~KR~TmVGTPYWMAPEVvt 442 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVT 442 (550)
T ss_pred cCccccccCCCCccchhhhh
Confidence 5 666688999999999985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=257.75 Aligned_cols=149 Identities=23% Similarity=0.335 Sum_probs=134.4
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
.++|++..+||+|+||.||+|+. .+|..+|+|++++..... ...+..+.|-.+|...++|+||+++..|.+.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 46899999999999999999965 569999999998765432 3345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
|||++|||+..+|.. ...+++..+..++.+++-|++-||.. |+|||||||+|+|||..|++||+||||++-
T Consensus 220 MEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 999999999999986 45789999999999999999999988 999999999999999999999999999863
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=254.94 Aligned_cols=176 Identities=27% Similarity=0.368 Sum_probs=145.5
Q ss_pred hhhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChh------------hHHHHHHHHHHHhcCCCCCcce
Q 005587 505 QQYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQ------------KDDEFLELVNNIDRIRHANIVE 571 (689)
Q Consensus 505 ~~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~------------~~~~~~~e~~~l~~l~HpnIv~ 571 (689)
....++|++.+.||+|.||.|-+|+.. +++.||||++.+.....+ ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345588999999999999999999754 689999999976422111 1247889999999999999999
Q ss_pred ecEEEEe--CCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC
Q 005587 572 LKGYCAE--HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD 649 (689)
Q Consensus 572 l~~~~~~--~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~ 649 (689)
|+++..+ .+++|||+|||..|.+...=. ....+.+.++++|.+++..||+|||.+ +||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 9999876 468999999999998854321 122389999999999999999999998 8999999999999999
Q ss_pred CCcEEEEeecCCccccCC------CcceeecccceEEecccccc
Q 005587 650 DLAVSVSDCGLAPLISSG------SVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 650 ~~~~kl~DFGla~~~~~~------~~~~~~~~~~~~~apE~~~~ 687 (689)
+|.+||+|||.+-....+ ..-..+.||+.|+|||..+.
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 999999999999877333 22244789999999998753
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-30 Score=243.05 Aligned_cols=174 Identities=22% Similarity=0.311 Sum_probs=154.2
Q ss_pred hccCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 507 YTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
+++.|++.++||+|.|+.||++ ...+|+.+|+|++........+.+++.+|+++.+.|+|||||++.+.+.+.+..|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4578889999999999999999 567899999999987665566778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec---CCCcEEEEeecCCc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAP 662 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kl~DFGla~ 662 (689)
+|+|.||+|..-|-. ...+++..+..+++||++||.|+|.. +|||||+||+|+|+- ....+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999766554 24577888999999999999999998 899999999999994 34468999999999
Q ss_pred cccCCCcceeecccceEEecccccc
Q 005587 663 LISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~apE~~~~ 687 (689)
.+..+....--.++++||||||+.+
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrk 186 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKK 186 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhc
Confidence 9998887777889999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=237.44 Aligned_cols=174 Identities=26% Similarity=0.384 Sum_probs=154.0
Q ss_pred hhccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCC------hhhHHHHHHHHHHHhcC-CCCCcceecEEEE
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASS------QQKDDEFLELVNNIDRI-RHANIVELKGYCA 577 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~------~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~ 577 (689)
.+.+.|...+.||.|..++|.++. .++|+++|+|++...... ..-.++-.+|+.+|+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 445678888999999999999984 567899999998643211 12234556889999887 6999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEe
Q 005587 578 EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (689)
Q Consensus 578 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~D 657 (689)
++...++|+|.|+.|.|+|+|.+ .-.++++...+|++|+.+|++|||.. +||||||||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999986 45789999999999999999999998 899999999999999999999999
Q ss_pred ecCCccccCCCcceeecccceEEeccccc
Q 005587 658 CGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
||+|..+.+|..-...++|+.|.|||++.
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIK 195 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhhee
Confidence 99999999999999999999999999984
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=234.13 Aligned_cols=172 Identities=23% Similarity=0.302 Sum_probs=151.6
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++++.||+|.||.||.|+. +++..||+|++.+.... .+...++.+|+++-+.|+||||.++|++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 6789999999999999999964 56889999998765432 234678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||..+|+|+..|.+.. ...+++.....++.|+|.||.|+|.. +||||||||+|+|++..+.+||+|||.+..-.
T Consensus 102 Eya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999998644 45678888999999999999999987 89999999999999999999999999999876
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
.......++|--|.+||...
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~ 195 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVE 195 (281)
T ss_pred CCCceeeecccccCCHhhcC
Confidence 44455578888999999873
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=255.87 Aligned_cols=150 Identities=23% Similarity=0.318 Sum_probs=132.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|+.. +++.||||++.+... .......+.+|+.++.+++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999654 689999999975432 1233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
||++||+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999975 34688999999999999999999987 89999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=256.76 Aligned_cols=171 Identities=23% Similarity=0.302 Sum_probs=148.9
Q ss_pred ccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 584 (689)
.++|....+||+|.||+|+++..+ +++.+|||.+++...- .++.+....|.+++... +||.++.++.+|.+.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 468999999999999999999765 5889999999887533 34456677777777655 59999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+.||++..+.+ ...+++..+.-|+..|+.||.|||++ +|||||||.+|||||.+|.+||+||||+|..
T Consensus 447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999654444 35689999999999999999999998 8999999999999999999999999999975
Q ss_pred c-CCCcceeecccceEEeccccc
Q 005587 665 S-SGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~-~~~~~~~~~~~~~~~apE~~~ 686 (689)
- .+......+||+.||||||+.
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~ 541 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLT 541 (694)
T ss_pred CCCCCccccccCChhhcChhhhc
Confidence 4 677777889999999999984
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=240.59 Aligned_cols=163 Identities=34% Similarity=0.522 Sum_probs=139.2
Q ss_pred CccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHh--cCCCCCcceecEEEEeCC----eEEEE
Q 005587 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID--RIRHANIVELKGYCAEHG----QRLLI 585 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~--~l~HpnIv~l~~~~~~~~----~~~lV 585 (689)
++.++||+|.||.||+|++. ++.||||++.. +....|..|-++.+ .++|+||++++++-+... +++||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34578999999999999984 59999999864 34567777777765 568999999999876655 89999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC------QPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
+||.+.|+|.++|+. ..++|....+|+..+++||+|||+.. .++|+|||||..|||+.+|+.+.|+|||
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999985 57999999999999999999999753 3579999999999999999999999999
Q ss_pred CCccccCCCccee---ecccceEEecccc
Q 005587 660 LAPLISSGSVSQV---SHNLTIMRAGGVT 685 (689)
Q Consensus 660 la~~~~~~~~~~~---~~~~~~~~apE~~ 685 (689)
||..+..+....+ ..||.-|||||++
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvL 390 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVL 390 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHH
Confidence 9998876543322 5677789999998
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=255.32 Aligned_cols=173 Identities=18% Similarity=0.238 Sum_probs=147.9
Q ss_pred hhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
...++|++.+.||+|+||.||+++.. +++.||+|++.+... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34568999999999999999999765 588999999865322 2233456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999964 2478889999999999999999987 899999999999999999999999999998
Q ss_pred ccCCCc--ceeecccceEEeccccc
Q 005587 664 ISSGSV--SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~--~~~~~~~~~~~apE~~~ 686 (689)
+..... .....++..|+|||++.
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~ 216 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHh
Confidence 754332 12345788999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=244.44 Aligned_cols=172 Identities=25% Similarity=0.296 Sum_probs=147.0
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.|+..+.||+|+||.||+|.. .+|+.||||.+...... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999965 57999999998754322 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998886432 34589999999999999999999987 8999999999999999999999999999987655
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
.......++..|+|||++.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVIN 174 (285)
T ss_pred CeecCCCCCCCccCHhhhc
Confidence 5444456788899999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=255.09 Aligned_cols=149 Identities=25% Similarity=0.312 Sum_probs=131.6
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|.+.+.||+|+||.||+|+. .+++.||||++.+... .......+.+|++++++++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999965 4789999999865422 2233467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||++||+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999998753 4678899999999999999999987 8999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=251.79 Aligned_cols=172 Identities=26% Similarity=0.376 Sum_probs=153.9
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEE
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRL 583 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~ 583 (689)
....|++.+.||+|.||.||+|+.+ +|+.+|+|.+.+..... .....+.+|+++|+++. |||||.+++.|++.+.++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457888899999999999999665 59999999998765422 24568899999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC----CCcEEEEeec
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD----DLAVSVSDCG 659 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~----~~~~kl~DFG 659 (689)
+|||+|.||.|++.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999764 389999999999999999999997 8999999999999953 3579999999
Q ss_pred CCccccCCCcceeecccceEEeccccc
Q 005587 660 LAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+|+....+..-....++++|+|||++.
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhc
Confidence 999999988888899999999999997
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=254.06 Aligned_cols=150 Identities=23% Similarity=0.341 Sum_probs=133.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|+.. +|+.||||++..... .......+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999764 689999999975422 1233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
||+++|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999999753 3589999999999999999999987 89999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=241.70 Aligned_cols=171 Identities=23% Similarity=0.342 Sum_probs=146.1
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe-----CCe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-----HGQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-----~~~ 581 (689)
...|...+.||+|+||.|..|.. .+|+.||||++..........++..+|+++|+.++|+|||.+++.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34566678899999999999954 579999999998666666677888999999999999999999998865 357
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
+|+|+|+| +-+|.++++. .+.++...+..++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||||
T Consensus 101 vYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 89999999 5699999986 34588899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCC---CcceeecccceEEeccccc
Q 005587 662 PLISSG---SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~---~~~~~~~~~~~~~apE~~~ 686 (689)
+..... ..-.....|.+|+|||+..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll 200 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLL 200 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHh
Confidence 998642 2212245688999999984
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=248.27 Aligned_cols=165 Identities=25% Similarity=0.308 Sum_probs=141.2
Q ss_pred ceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
+.||+|+||.||+|+. .+|+.||||++..... .......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 4789999999875432 2234456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC-CCcce
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-GSVSQ 671 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~~ 671 (689)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... +....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 99999875 34688999999999999999999987 899999999999999999999999999986432 23333
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
...++..|+|||++.
T Consensus 154 ~~~gt~~y~aPE~~~ 168 (323)
T cd05571 154 TFCGTPEYLAPEVLE 168 (323)
T ss_pred ceecCccccChhhhc
Confidence 456788999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=254.09 Aligned_cols=148 Identities=20% Similarity=0.268 Sum_probs=131.3
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.|+..+.||+|+||+||+|+. .+++.||||++..... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999965 4689999999976432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
|++||+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999998753 4588899999999999999999987 8999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=249.46 Aligned_cols=165 Identities=20% Similarity=0.325 Sum_probs=139.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|+..+.||+|+||.||+|+.. +|+.||||++.... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 45667789999999999999754 68999999986543 23445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999986432 345677889999999999999987 8999999999999999999999999999887543
Q ss_pred Cc-ceeecccceEEecccc
Q 005587 668 SV-SQVSHNLTIMRAGGVT 685 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~ 685 (689)
.. .....++..|+|||++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~ 240 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERI 240 (353)
T ss_pred cccccccccCccccCcccc
Confidence 22 2234577889999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=249.62 Aligned_cols=169 Identities=22% Similarity=0.305 Sum_probs=147.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999765 689999999875432 1233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999763 4578899999999999999999997 899999999999999999999999999998755
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
... ...++..|+|||++.
T Consensus 171 ~~~--~~~gt~~y~aPE~~~ 188 (329)
T PTZ00263 171 RTF--TLCGTPEYLAPEVIQ 188 (329)
T ss_pred Ccc--eecCChhhcCHHHHc
Confidence 432 346788899999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=245.95 Aligned_cols=169 Identities=22% Similarity=0.278 Sum_probs=146.4
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|... +|+.||+|++..... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999765 689999999865422 1234556889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999999753 4688999999999999999999987 899999999999999999999999999998754
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
... ...++..|+|||++.
T Consensus 154 ~~~--~~~gt~~y~aPE~~~ 171 (291)
T cd05612 154 RTW--TLCGTPEYLAPEVIQ 171 (291)
T ss_pred Ccc--cccCChhhcCHHHHc
Confidence 432 245788999999874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=245.63 Aligned_cols=167 Identities=25% Similarity=0.349 Sum_probs=148.0
Q ss_pred cceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
.++||+|.||+||-|. .++|+.||||++.+.......+.+++.|+.+|++++||.||.+.-.|++.+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5789999999999995 56899999999998877777788999999999999999999999999999999999999955
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC---CCcEEEEeecCCccccCCCc
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl~DFGla~~~~~~~~ 669 (689)
+..++|-..+ ...+++.....++.||+.||.|||.. +|+|+||||+|||+.. .-++||||||+|+++.+.+.
T Consensus 648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 5555544322 45788888888999999999999987 8999999999999953 44799999999999999998
Q ss_pred ceeecccceEEeccccc
Q 005587 670 SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~~~~~~~~~~apE~~~ 686 (689)
...-.+|+.|.|||++.
T Consensus 723 RrsVVGTPAYLaPEVLr 739 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLR 739 (888)
T ss_pred hhhhcCCccccCHHHHh
Confidence 88899999999999995
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=249.66 Aligned_cols=169 Identities=22% Similarity=0.314 Sum_probs=145.7
Q ss_pred cCCCccceEeecCCeEEEEEEeCC--CcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD--GKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~--g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
++|++.+.||+|+||.||+|.... +..||+|.+..... .......+.+|+++++.++||||+++++++...+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568889999999999999997543 36899999865432 223345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999753 4688999999999999999999987 89999999999999999999999999999875
Q ss_pred CCCcceeecccceEEeccccc
Q 005587 666 SGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~apE~~~ 686 (689)
... ....++..|+|||++.
T Consensus 183 ~~~--~~~~gt~~y~aPE~~~ 201 (340)
T PTZ00426 183 TRT--YTLCGTPEYIAPEILL 201 (340)
T ss_pred CCc--ceecCChhhcCHHHHh
Confidence 433 3356788899999974
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=248.23 Aligned_cols=169 Identities=21% Similarity=0.267 Sum_probs=146.7
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|+.. +++.||||++...... ......+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999765 5899999998754321 233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||++||+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999975 34588999999999999999999987 899999999999999999999999999987655
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
. .....++..|+|||++.
T Consensus 154 ~--~~~~~gt~~y~aPE~~~ 171 (333)
T cd05600 154 Y--ANSVVGSPDYMAPEVLR 171 (333)
T ss_pred c--cCCcccCccccChhHhc
Confidence 2 23346788899999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=250.81 Aligned_cols=173 Identities=24% Similarity=0.417 Sum_probs=157.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCe-EEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ-RLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~ 586 (689)
++|...+++|+|+||.++.++.+ ++..|++|.+..........+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999654 67899999998777666666688999999999999999999999999888 99999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
+||+||++.+.|.+.+ ...++++.++.|+.|++.|+.|||+. .|+|||||+.||++..++.+||.|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 45689999999999999999999977 899999999999999999999999999999988
Q ss_pred CC-cceeecccceEEeccccc
Q 005587 667 GS-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~-~~~~~~~~~~~~apE~~~ 686 (689)
.. ......+|++||.||++-
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~ 179 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILS 179 (426)
T ss_pred chhhhheecCCCcccCHHHhC
Confidence 76 777789999999999983
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=249.09 Aligned_cols=175 Identities=26% Similarity=0.410 Sum_probs=141.6
Q ss_pred ccCCCccceEeecCCeEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC-
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH- 579 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~- 579 (689)
.++|++.++||+|+||.||+|.+ .+++.||||++.... .......+.+|++++.++ +|||||+++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 35788899999999999999963 235689999987543 233456789999999999 899999999988764
Q ss_pred CeEEEEEeccCCCCHHHHHhcCccc-------------------------------------------------------
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDEL------------------------------------------------------- 604 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~~------------------------------------------------------- 604 (689)
+..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999999753210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcce---eecccce
Q 005587 605 ---KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ---VSHNLTI 678 (689)
Q Consensus 605 ---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~---~~~~~~~ 678 (689)
...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.+....... ...++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23588889999999999999999987 89999999999999999999999999998764432211 1223357
Q ss_pred EEeccccc
Q 005587 679 MRAGGVTH 686 (689)
Q Consensus 679 ~~apE~~~ 686 (689)
|+|||++.
T Consensus 242 y~aPE~~~ 249 (338)
T cd05102 242 WMAPESIF 249 (338)
T ss_pred ccCcHHhh
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=251.05 Aligned_cols=148 Identities=20% Similarity=0.284 Sum_probs=130.4
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+|++.+.||+|+||.||+|+. .+++.||||++.+... .......+.+|++++++++||||+++++.+...+..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688899999999999999965 4689999999865422 12234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|..+
T Consensus 82 ~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 82 YIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999753 3578888999999999999999987 8999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=245.40 Aligned_cols=165 Identities=24% Similarity=0.285 Sum_probs=140.8
Q ss_pred ceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
+.||+|+||.||+++. .+|+.||||++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999965 4689999999975432 2234567888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC-Ccce
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVSQ 671 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~~~ 671 (689)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 99998865 34688999999999999999999987 8999999999999999999999999999864332 2222
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
...++..|+|||++.
T Consensus 154 ~~~gt~~y~aPE~~~ 168 (328)
T cd05593 154 TFCGTPEYLAPEVLE 168 (328)
T ss_pred cccCCcCccChhhhc
Confidence 345788999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=249.16 Aligned_cols=174 Identities=25% Similarity=0.339 Sum_probs=159.1
Q ss_pred hhccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
.-...|.+...||+|.|+.|..|+. .++..||||.+.+..........+.+|+++|..++|||||+++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3456789999999999999999965 479999999999887766666678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+.+|.+++++...+ ...+..+..+..|+.+|++|||+. .|+|||||++||||+.+.++||+|||++.++
T Consensus 133 V~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceee
Confidence 999999999999998754 344578888999999999999998 7999999999999999999999999999999
Q ss_pred cCCCcceeecccceEEeccccc
Q 005587 665 SSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~~~~~~~~~~~apE~~~ 686 (689)
..+...+..++++.|.|||++.
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~ 227 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFN 227 (596)
T ss_pred cccccccccCCCCCccChHhhc
Confidence 9999999999999999999984
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=251.30 Aligned_cols=148 Identities=20% Similarity=0.282 Sum_probs=130.5
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.|+..+.||+|+||.||+|+. .+++.||+|++.+... .......+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999965 4688999999875432 12335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999998753 3578889999999999999999987 8999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=245.66 Aligned_cols=165 Identities=24% Similarity=0.286 Sum_probs=140.4
Q ss_pred ceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
+.||+|+||.||+++. .+|+.||+|++..... .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999965 4689999999875432 2234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-cce
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-VSQ 671 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~~ 671 (689)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 99998875 34688999999999999999999987 89999999999999999999999999998643322 223
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
...++..|+|||++.
T Consensus 154 ~~~gt~~y~aPE~~~ 168 (323)
T cd05595 154 TFCGTPEYLAPEVLE 168 (323)
T ss_pred cccCCcCcCCccccc
Confidence 345778899999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=250.65 Aligned_cols=172 Identities=19% Similarity=0.255 Sum_probs=146.2
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
..++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+.+++.++||||+++++++...+..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467899999999999999999764 688999999865322 12334557889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||++||+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999874 2478888999999999999999987 8999999999999999999999999999877
Q ss_pred cCCCc--ceeecccceEEeccccc
Q 005587 665 SSGSV--SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~--~~~~~~~~~~~apE~~~ 686 (689)
..... .....++..|+|||++.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~ 216 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLK 216 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhc
Confidence 54322 12345788899999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=249.92 Aligned_cols=176 Identities=18% Similarity=0.238 Sum_probs=148.8
Q ss_pred hHhhhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC
Q 005587 503 SLQQYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580 (689)
Q Consensus 503 ~l~~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~ 580 (689)
++....++|++.+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 33444578999999999999999999765 688999999865322 2233456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
..|+||||++||+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999874 3478888999999999999999987 899999999999999999999999999
Q ss_pred CccccCCCc--ceeecccceEEeccccc
Q 005587 661 APLISSGSV--SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~--~~~~~~~~~~~apE~~~ 686 (689)
++.+..... .....++..|+|||++.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLK 216 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHh
Confidence 987754332 12345788899999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=243.48 Aligned_cols=166 Identities=24% Similarity=0.298 Sum_probs=140.1
Q ss_pred ceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
+.||+|+||.||++.. .+|+.||+|++..... .......+..|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 5789999999975432 2233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC-CCcce
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-GSVSQ 671 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~~ 671 (689)
+|.+++.. ...+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 99998865 34689999999999999999999972 2899999999999999999999999999986432 22233
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
...++..|+|||++.
T Consensus 155 ~~~gt~~y~aPE~~~ 169 (325)
T cd05594 155 TFCGTPEYLAPEVLE 169 (325)
T ss_pred cccCCcccCCHHHHc
Confidence 345788999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=248.74 Aligned_cols=171 Identities=22% Similarity=0.287 Sum_probs=148.4
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|.+.+.||+|+||.||+|+.. +|+.||||++....... .....+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999765 68999999987543222 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999763 4688999999999999999999997 899999999999999999999999999987765
Q ss_pred CC------------------------------cceeecccceEEeccccc
Q 005587 667 GS------------------------------VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~------------------------------~~~~~~~~~~~~apE~~~ 686 (689)
.. ......++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 43 223345788899999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=241.35 Aligned_cols=174 Identities=25% Similarity=0.417 Sum_probs=143.4
Q ss_pred cCCCccceEeecCCeEEEEEEeCC-----------------CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcce
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD-----------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~ 571 (689)
++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+|.+|++++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 468888999999999999997532 3479999986543 2344567999999999999999999
Q ss_pred ecEEEEeCCeEEEEEeccCCCCHHHHHhcCcc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 005587 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE---------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636 (689)
Q Consensus 572 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ii 636 (689)
+++++...+..++||||+++|+|.+++..... ....++|..+.+++.|++.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999865321 113578899999999999999999987 899
Q ss_pred EecccCCCeEecCCCcEEEEeecCCccccCCCcce---eecccceEEeccccc
Q 005587 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 637 HrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
||||||+|||+++++.+||+|||+++.+..+.... ....+..|+|||++.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL 213 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh
Confidence 99999999999999999999999998775543221 122245699999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=243.39 Aligned_cols=165 Identities=23% Similarity=0.272 Sum_probs=141.5
Q ss_pred ceEeecCCeEEEEEEe----CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccC
Q 005587 515 NLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~----~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
+.||+|+||.||+++. .+|+.||+|++............+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 358899999997654333344567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-c
Q 005587 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-V 669 (689)
Q Consensus 591 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~ 669 (689)
+|+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 9999999865 34689999999999999999999987 89999999999999999999999999998765442 2
Q ss_pred ceeecccceEEeccccc
Q 005587 670 SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~~~~~~~~~~apE~~~ 686 (689)
.....++..|+|||++.
T Consensus 155 ~~~~~g~~~y~aPE~~~ 171 (318)
T cd05582 155 AYSFCGTVEYMAPEVVN 171 (318)
T ss_pred eecccCChhhcCHHHHc
Confidence 23345678899999874
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=244.33 Aligned_cols=172 Identities=20% Similarity=0.280 Sum_probs=147.7
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|+.. +|+.||||++..... .......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999654 689999999976432 2234566888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999763 24689999999999999999999997 899999999999999999999999999988755
Q ss_pred CCcc--eeecccceEEeccccc
Q 005587 667 GSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~--~~~~~~~~~~apE~~~ 686 (689)
.... ....++..|+|||++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred CCceeeecccCCccccCHHHhc
Confidence 4322 2235778899999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=247.43 Aligned_cols=150 Identities=24% Similarity=0.336 Sum_probs=132.3
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|+..+.||+|+||.||+|+.. +++.||||++..... .......+.+|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999654 689999999875322 1233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
||++||+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999975 34588999999999999999999987 89999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=242.53 Aligned_cols=163 Identities=21% Similarity=0.255 Sum_probs=139.4
Q ss_pred EeecCCeEEEEEEeC-CCcEEEEEEecccc-CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
||+|+||.||+|+.. +++.||+|++.... ........+.+|++++.+++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999764 68899999986542 1233456788899999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-cceee
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-VSQVS 673 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~ 673 (689)
.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 999975 34588999999999999999999987 89999999999999999999999999998653322 22334
Q ss_pred cccceEEeccccc
Q 005587 674 HNLTIMRAGGVTH 686 (689)
Q Consensus 674 ~~~~~~~apE~~~ 686 (689)
.++..|+|||++.
T Consensus 154 ~gt~~y~aPE~~~ 166 (312)
T cd05585 154 CGTPEYLAPELLL 166 (312)
T ss_pred cCCcccCCHHHHc
Confidence 5788899999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=244.23 Aligned_cols=172 Identities=20% Similarity=0.272 Sum_probs=146.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+++.. +++.||||++.+... .......+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999754 689999999875321 2233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||++||+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999652 24588999999999999999999987 899999999999999999999999999987654
Q ss_pred CCcc--eeecccceEEeccccc
Q 005587 667 GSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~--~~~~~~~~~~apE~~~ 686 (689)
.... ....++..|+|||++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQ 176 (331)
T ss_pred CCCccccceeccccccCHHHHh
Confidence 3322 2245788899999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=243.43 Aligned_cols=172 Identities=20% Similarity=0.251 Sum_probs=146.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|.+.+.||+|+||.||+++.. +++.||+|++.+... .......+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999765 688999999865321 2233455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||++||+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999753 23588999999999999999999987 899999999999999999999999999987754
Q ss_pred CCcc--eeecccceEEeccccc
Q 005587 667 GSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~--~~~~~~~~~~apE~~~ 686 (689)
.... ....++..|+|||++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQ 176 (331)
T ss_pred CCceeeccccCCcccCCHHHHh
Confidence 4322 2235788899999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=247.68 Aligned_cols=175 Identities=25% Similarity=0.407 Sum_probs=143.9
Q ss_pred hhccCCCccceEeecCCeEEEEEEeCC--C--cE-EEEEEecc-ccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQLPD--G--KL-LAVKKLDK-RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH 579 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~~~~--g--~~-vAvK~l~~-~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~ 579 (689)
...++-...++||+|+||.||+|+++. + .. ||||.... .........+|.+|.++|++++|||||++||++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 334455566899999999999997643 3 23 89999875 334566778999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
..+++|||+|.||+|.++|+... ..++..+.++++.+.|.||+|||+. ++|||||-.+|+|++.++.+||+|||
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999998753 2689999999999999999999997 89999999999999999999999999
Q ss_pred CCccccCCCcceeeccc-ceEEeccccc
Q 005587 660 LAPLISSGSVSQVSHNL-TIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~-~~~~apE~~~ 686 (689)
|++.-..-......... .-|+|||.+.
T Consensus 308 Ls~~~~~~~~~~~~~klPirWLAPEtl~ 335 (474)
T KOG0194|consen 308 LSRAGSQYVMKKFLKKLPIRWLAPETLN 335 (474)
T ss_pred cccCCcceeeccccccCcceecChhhhc
Confidence 98875421111101112 3489999874
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=242.60 Aligned_cols=170 Identities=26% Similarity=0.294 Sum_probs=143.6
Q ss_pred CCCccceEeecCCeEEEEEEe----CCCcEEEEEEeccccC--ChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQR 582 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~----~~g~~vAvK~l~~~~~--~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 582 (689)
+|++.+.||+|+||.||+++. .+++.||+|++.+... .....+.+..|++++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999965 3588999999865321 122345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999875 34688999999999999999999987 89999999999999999999999999998
Q ss_pred cccCCCc--ceeecccceEEeccccc
Q 005587 663 LISSGSV--SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~--~~~~~~~~~~~apE~~~ 686 (689)
.+..... .....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 179 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIR 179 (332)
T ss_pred cccccCCCccccccCCccccCHHHhc
Confidence 7644332 22345788999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=241.47 Aligned_cols=165 Identities=28% Similarity=0.332 Sum_probs=139.1
Q ss_pred ceEeecCCeEEEEEEe----CCCcEEEEEEeccccC--ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 515 NLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~----~~g~~vAvK~l~~~~~--~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+.||+|+||.||+++. .+++.||||++..... .......+..|+++++.++||||+++++++...+..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999965 3578999999875422 122345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC-C
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-G 667 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~ 667 (689)
+++|+|.+++... ..+.+..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.... .
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999998753 3578888999999999999999987 899999999999999999999999999985433 2
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
.......++..|+|||++.
T Consensus 155 ~~~~~~~gt~~y~aPE~~~ 173 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILM 173 (323)
T ss_pred CcccccCCCccccChhhcc
Confidence 2233345778899999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=257.44 Aligned_cols=172 Identities=23% Similarity=0.354 Sum_probs=143.6
Q ss_pred CCCccceEeecCCeEEEEEEeCCC-cEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecE-EEEeC------C
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPDG-KLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKG-YCAEH------G 580 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~-~~~~~------~ 580 (689)
++.+.+.|.+|+|+.||.|+...+ ..||+|++-.. +....+.+.+|+++|++|+ |+|||.+++ ..... -
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 456788999999999999987665 99999998655 4567788999999999997 999999999 33321 2
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
+++|.||||.||+|-|++..+. ...|++.++++|+.++++|+.+||.. +++|||||||.+||||+.+|..||||||-
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 6789999999999999998643 34599999999999999999999987 67899999999999999999999999998
Q ss_pred CccccCCC----------cceeecccceEEeccccc
Q 005587 661 APLISSGS----------VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~----------~~~~~~~~~~~~apE~~~ 686 (689)
|.-.-... ......+|..|||||++.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID 228 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID 228 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHh
Confidence 86432222 112356788899999983
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-27 Score=247.48 Aligned_cols=159 Identities=27% Similarity=0.452 Sum_probs=143.5
Q ss_pred ccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 513 QENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
..+.||.|+-|.||+|+++ ++.||||+++... ..+++.|++|+|||||.+.|+|.....++||||||..|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3578999999999999984 5789999985422 24688999999999999999999999999999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCccee
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (689)
.|+.+|+. ...+.....+.|..+||.||.|||.. .|||||||.-||||..+-.+||+|||-++.+.+.++...
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhh
Confidence 99999987 35677788899999999999999987 799999999999999999999999999999998888888
Q ss_pred ecccceEEeccccccC
Q 005587 673 SHNLTIMRAGGVTHRN 688 (689)
Q Consensus 673 ~~~~~~~~apE~~~~~ 688 (689)
-.+|-.|||||+|+.+
T Consensus 271 FaGTVaWMAPEvIrne 286 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNE 286 (904)
T ss_pred hhhhHhhhCHHHhhcC
Confidence 8899999999999754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=236.58 Aligned_cols=171 Identities=22% Similarity=0.362 Sum_probs=144.9
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||+|+.. +++.||||++..........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999765 68899999987654434445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|++++.+..+... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998877655432 34688999999999999999999987 8999999999999999999999999999987543
Q ss_pred Ccc--eeecccceEEeccccc
Q 005587 668 SVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~--~~~~~~~~~~apE~~~ 686 (689)
... ....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~ 174 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLL 174 (287)
T ss_pred ccccccccccccccCCcHHHc
Confidence 321 2235678899999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-26 Score=240.71 Aligned_cols=165 Identities=20% Similarity=0.273 Sum_probs=140.1
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
++||+|+||.||+|+.. +++.||||++...... ......+.+|..++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999654 6899999999764322 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc-cCCCcc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI-SSGSVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~-~~~~~~ 670 (689)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.. ..+...
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 999998865 34689999999999999999999987 8999999999999999999999999999853 333333
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (329)
T cd05588 154 STFCGTPNYIAPEILR 169 (329)
T ss_pred ccccCCccccCHHHHc
Confidence 4456788899999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=235.42 Aligned_cols=172 Identities=25% Similarity=0.298 Sum_probs=146.2
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.|+..++||+|+||.||++.. .+++.||||++...... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377789999999999999975 46899999998654322 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886432 34689999999999999999999987 8999999999999999999999999999887655
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
.......++..|+|||++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVK 174 (285)
T ss_pred CccccccCCCCccCcHHhc
Confidence 4433345678899999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=252.16 Aligned_cols=172 Identities=18% Similarity=0.156 Sum_probs=144.7
Q ss_pred CCCccceEeecCCeEEEEEEeC-C-CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-D-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.|.+.+.||+|+||.||+|... + ++.||+|.+... .......+.+|+++++.++|||||++++++...+..|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3778899999999999999543 4 678888876433 23444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|++||+|.++++........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999998865332344688999999999999999999987 8999999999999999999999999999987543
Q ss_pred Cc---ceeecccceEEeccccc
Q 005587 668 SV---SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~---~~~~~~~~~~~apE~~~ 686 (689)
.. .....++..|+|||++.
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~ 244 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWE 244 (478)
T ss_pred cccccccccCCCccccCHhHhC
Confidence 22 22345788899999874
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=239.42 Aligned_cols=170 Identities=18% Similarity=0.220 Sum_probs=142.2
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCC-CcceecEEEEeCCeEEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHA-NIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~ 586 (689)
+|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+..|.+++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999765 578999999875432 223456678889999999765 5888999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999998753 3578999999999999999999987 899999999999999999999999999975432
Q ss_pred -CCcceeecccceEEeccccc
Q 005587 667 -GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 -~~~~~~~~~~~~~~apE~~~ 686 (689)
........++..|+|||++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred CCCceeeecCCccccChhhhc
Confidence 22333456788999999875
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=239.44 Aligned_cols=165 Identities=21% Similarity=0.279 Sum_probs=138.9
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 688999999976532 223345677888888766 899999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc-CCCcc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS-SGSVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~~ 670 (689)
|+|.+++.. ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++... .....
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 999988865 34689999999999999999999987 89999999999999999999999999998643 23333
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (329)
T cd05618 154 STFCGTPNYIAPEILR 169 (329)
T ss_pred ccccCCccccCHHHHc
Confidence 3456788899999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=239.12 Aligned_cols=171 Identities=19% Similarity=0.277 Sum_probs=147.7
Q ss_pred ccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
.++|++.+.||+|+||.||+++.. +|..||+|.+.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 367899999999999999999765 68899999987543 2344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 83 EHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999999753 35889999999999999999999852 699999999999999999999999999987754
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
... ....++..|+|||++.
T Consensus 157 ~~~-~~~~g~~~y~aPE~~~ 175 (331)
T cd06649 157 SMA-NSFVGTRSYMSPERLQ 175 (331)
T ss_pred ccc-ccCCCCcCcCCHhHhc
Confidence 432 2245778899999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=252.82 Aligned_cols=177 Identities=21% Similarity=0.271 Sum_probs=149.6
Q ss_pred hccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-----
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----- 580 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~----- 580 (689)
..++|.+.+.||+|+||.||+|+. .+|+.||||++............+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346899999999999999999964 57999999999776555566677889999999999999999988775432
Q ss_pred ---eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEe
Q 005587 581 ---QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (689)
Q Consensus 581 ---~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~D 657 (689)
.+++||||+++|+|.++++........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 36899999999999999976443345789999999999999999999987 899999999999999999999999
Q ss_pred ecCCccccCC---CcceeecccceEEeccccc
Q 005587 658 CGLAPLISSG---SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 658 FGla~~~~~~---~~~~~~~~~~~~~apE~~~ 686 (689)
||+++.+... .......++..|+|||++.
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 218 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhC
Confidence 9999876542 2223345788899999985
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-27 Score=242.53 Aligned_cols=169 Identities=26% Similarity=0.398 Sum_probs=148.7
Q ss_pred CCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
.|...++||+|.||.||+|. .++++.||+|++..... ....+++.+|+.++..++++||.++|+.|.....+|++|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 46667899999999999995 56789999999987654 34567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
|.||++.+.++.. ..+.+....-|+++++.||.|||+. +.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999753 2346777788899999999999998 89999999999999999999999999999887655
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. ....+|++||||||+.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~ 184 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIK 184 (467)
T ss_pred hccccccccccccchhhhc
Confidence 33 6678899999999995
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=239.67 Aligned_cols=168 Identities=26% Similarity=0.326 Sum_probs=138.9
Q ss_pred CCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHH---HhcCCCCCcceecEEEEeCCeEEEE
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNN---IDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~---l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+++ ++.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999654 689999999975432 12233456666555 4677899999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++|+|..+++. ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988863 3589999999999999999999987 89999999999999999999999999988643
Q ss_pred C-CCcceeecccceEEeccccc
Q 005587 666 S-GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~-~~~~~~~~~~~~~~apE~~~ 686 (689)
. ........++..|+|||++.
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~ 174 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLT 174 (324)
T ss_pred CCCCcccccccCccccCHhHhc
Confidence 2 22223345778899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=240.37 Aligned_cols=172 Identities=20% Similarity=0.258 Sum_probs=145.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+++.. +++.||+|++.+... .......+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999765 578899999865321 1223445788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999753 23588999999999999999999987 899999999999999999999999999986644
Q ss_pred CCcc--eeecccceEEeccccc
Q 005587 667 GSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~--~~~~~~~~~~apE~~~ 686 (689)
.... ....++..|+|||++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred CCcceecccccCccccCHHHHh
Confidence 3322 2245788999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=237.08 Aligned_cols=170 Identities=24% Similarity=0.334 Sum_probs=142.4
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||+|+.. +++.||||++..... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 57889999999999999999765 689999999875432 2233457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+. ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 6888887643 24578899999999999999999987 8999999999999999999999999999865432
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......++..|+|||++.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~ 176 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLL 176 (303)
T ss_pred CccCCCCcccCCCCChHHHc
Confidence 2 222245677899999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-27 Score=246.55 Aligned_cols=167 Identities=30% Similarity=0.453 Sum_probs=145.1
Q ss_pred CCCccceEeecCCeEEEEEE-eCCCcEEEEEEecccc-CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
-|...+.||.|+||.||-|+ ..+.+.||||++.... .+.....+++.|++.|.+++|||+|.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667889999999999995 4578899999987543 234567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
||- ||-.|++.-. ++++.+.++..|..+.++||.|||+. +.||||||..|||+.+.|.+||+|||-|.++.+.
T Consensus 107 YCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 995 5888887643 46788888999999999999999998 8999999999999999999999999999987544
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
. .-.||+||||||||.
T Consensus 180 n---sFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 180 N---SFVGTPYWMAPEVIL 195 (948)
T ss_pred h---cccCCccccchhHhe
Confidence 3 357899999999993
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-27 Score=232.98 Aligned_cols=167 Identities=24% Similarity=0.419 Sum_probs=148.4
Q ss_pred cCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+-|++.++||+|+||.||+| +.++|+.+|||.+... .+..++..|+.++++++.|+||++||.|.....+|+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 34677889999999999999 5567999999998653 457789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
||.-|+..++++.. .+++.++++..+.+..++||+|||.. .-||||||..|||++.+|.+||+|||.|..+.+.
T Consensus 109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999999999864 57899999999999999999999987 6799999999999999999999999999988764
Q ss_pred Ccc-eeecccceEEecccc
Q 005587 668 SVS-QVSHNLTIMRAGGVT 685 (689)
Q Consensus 668 ~~~-~~~~~~~~~~apE~~ 685 (689)
-.. -.-.+|++||||||+
T Consensus 183 MAKRNTVIGTPFWMAPEVI 201 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVI 201 (502)
T ss_pred HHhhCccccCcccccHHHH
Confidence 322 235688999999998
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=239.02 Aligned_cols=170 Identities=18% Similarity=0.222 Sum_probs=141.6
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
+|++.+.||+|+||.||+|+.. +++.||||++.+.... ......+..|.+++..+ +|++|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999765 5789999998764321 22334566777777776 5899999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999988753 4588999999999999999999987 899999999999999999999999999986542
Q ss_pred -CCcceeecccceEEeccccc
Q 005587 667 -GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 -~~~~~~~~~~~~~~apE~~~ 686 (689)
........++..|+|||++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred CCCccccCCCChhhcCHHHhc
Confidence 22333345788899999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-26 Score=241.25 Aligned_cols=169 Identities=22% Similarity=0.356 Sum_probs=140.8
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC-----CeEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 583 (689)
+|++.+.||+|+||.||+|.. .+|+.||||++............+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999965 4689999999875433334456788999999999999999999988643 2579
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+|||||. ++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 6999988752 3589999999999999999999997 899999999999999999999999999986
Q ss_pred ccCCCcc----eeecccceEEeccccc
Q 005587 664 ISSGSVS----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~----~~~~~~~~~~apE~~~ 686 (689)
....... ....++..|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~ 179 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCG 179 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHh
Confidence 5432211 2345778899999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=235.76 Aligned_cols=170 Identities=22% Similarity=0.327 Sum_probs=142.7
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|.+.+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46888999999999999999654 689999999865432 2234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+.+ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 999988653 23578899999999999999999987 8999999999999999999999999999865433
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......++..|+|||++.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~ 176 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLL 176 (288)
T ss_pred CccccCceecccccChHHhc
Confidence 2 222345678899999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=238.06 Aligned_cols=165 Identities=27% Similarity=0.335 Sum_probs=135.9
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHH-HHhcCCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVN-NIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||+||+|+.. +|+.||||++...... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999764 6899999998754321 122334445544 56789999999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC-Ccc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~~ 670 (689)
|+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 999999875 34688999999999999999999987 8999999999999999999999999999864332 222
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (323)
T cd05575 154 STFCGTPEYLAPEVLR 169 (323)
T ss_pred ccccCChhhcChhhhc
Confidence 3345788899999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=238.02 Aligned_cols=165 Identities=25% Similarity=0.322 Sum_probs=135.4
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHH-HHhcCCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVN-NIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
++||+|+||.||+|+.. +|+.||+|++.+... .......+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 688999999875432 1222344555544 57889999999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC-CCcc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-GSVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~ 670 (689)
|+|.+.+.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 999988865 34578888999999999999999987 899999999999999999999999999986432 2222
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (321)
T cd05603 154 STFCGTPEYLAPEVLR 169 (321)
T ss_pred ccccCCcccCCHHHhc
Confidence 3345678899999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=238.37 Aligned_cols=165 Identities=27% Similarity=0.329 Sum_probs=136.5
Q ss_pred ceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHH-HHhcCCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVN-NIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||+||+|+. .+|+.||+|++..... .......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999965 4689999999875432 1223345555554 46789999999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC-CCcc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-GSVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~ 670 (689)
|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.... ....
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 999988865 34688999999999999999999987 899999999999999999999999999986432 2223
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (325)
T cd05604 154 TTFCGTPEYLAPEVIR 169 (325)
T ss_pred ccccCChhhCCHHHHc
Confidence 3345788899999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=272.55 Aligned_cols=215 Identities=31% Similarity=0.595 Sum_probs=137.7
Q ss_pred CHhhHHHHHHHHHHhCCC--CCCCCCCCCCCCCCCCCccEEee-CCCeEEEEecCCCCCcccCccccCCCCCCEEEccCC
Q 005587 37 NPNDVAAINSLYAALGSP--VLPGWVASAGDPCGESWQGVQCN-ASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNN 113 (689)
Q Consensus 37 ~~~d~~aL~~~~~~l~~~--~l~~W~~~~~~~C~~~w~gv~C~-~~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N 113 (689)
+++|..||+.||+++.++ .+.+|+. ..|+| .|.||.|+ ..+|+.|+|++|+++|.++..|..+++|+.|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c--~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-SADVC--LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCC--cCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 568999999999999876 5788974 46777 89999997 468999999999999998888888888888888888
Q ss_pred cCCCCCCCccc---cccccccccCccCCCCC----------------------CcccCCCCCccEEEccCCcCCCCCChh
Q 005587 114 HIGGSIPSILP---VTMQNFFLSDNQFSGSI----------------------PSSLATLTLLTDMSLNNNLLSGEIPDA 168 (689)
Q Consensus 114 ~l~~~~p~~~~---~~L~~L~Ls~N~l~~~~----------------------p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 168 (689)
+++|.+|..+. .+|++|+|++|++++.+ |..|+++++|++|+|++|.+.+.+|..
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 88887776543 45666666666655544 444444555555555555555455555
Q ss_pred hcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccc-cccCCcc-ccccccccccCCCCCccccCCC---C
Q 005587 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQI---P 243 (689)
Q Consensus 169 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~-L~~L~Ls~N~l~g~ip~~l~~l---~ 243 (689)
|+++++|++|+|++|++++.+|..++++++|++|+|++|++++.+ ..+..+. |++|+|++|++++.+|..+.++ .
T Consensus 184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 263 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263 (968)
T ss_pred hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCC
Confidence 555555555555555555445555555555555555555554433 2333333 5555555555555555444433 2
Q ss_pred CccccCCcCCC
Q 005587 244 NFRKDGNPFNS 254 (689)
Q Consensus 244 ~l~~~~N~~~~ 254 (689)
.|++.+|.+.+
T Consensus 264 ~L~L~~n~l~~ 274 (968)
T PLN00113 264 YLFLYQNKLSG 274 (968)
T ss_pred EEECcCCeeec
Confidence 33445555443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=234.16 Aligned_cols=172 Identities=23% Similarity=0.336 Sum_probs=139.4
Q ss_pred cCCCccceEeecCCeEEEEEEe-C-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC---CCCCcceecEEEEe-----
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-P-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI---RHANIVELKGYCAE----- 578 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l---~HpnIv~l~~~~~~----- 578 (689)
++|++.+.||+|+||.||+|+. . +++.||||.+............+.+|+++++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688889999999999999975 3 468899999875443333334555666666554 79999999999863
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 579 ~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
....++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 69999987532 34589999999999999999999987 8999999999999999999999999
Q ss_pred cCCccccCCCcceeecccceEEeccccc
Q 005587 659 GLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|+++............++..|+|||++.
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLL 182 (290)
T ss_pred cceEeccCCcccccccccccccChHHHh
Confidence 9998876554444456788899999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=237.92 Aligned_cols=171 Identities=18% Similarity=0.281 Sum_probs=146.6
Q ss_pred ccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... .......+.+|++++++++||||++++++|...+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 367899999999999999999765 68889999886543 2344567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999753 35788999999999999999999742 699999999999999999999999999987644
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
... ....++..|+|||++.
T Consensus 157 ~~~-~~~~~~~~y~aPE~~~ 175 (333)
T cd06650 157 SMA-NSFVGTRSYMSPERLQ 175 (333)
T ss_pred hcc-ccCCCCccccCHHHhc
Confidence 322 2235677899999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=244.23 Aligned_cols=166 Identities=24% Similarity=0.338 Sum_probs=144.0
Q ss_pred CCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-C-----CCcceecEEEEeCCeE
Q 005587 510 SFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-H-----ANIVELKGYCAEHGQR 582 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-H-----pnIv~l~~~~~~~~~~ 582 (689)
+|.+.++||+|+||+|.+| +.++++.||||+++.. .....+-..|+.+|..|+ | -|+|++++||..+++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 7889999999999999999 5667999999999754 234456678899998887 3 4899999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC--CcEEEEeecC
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD--LAVSVSDCGL 660 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~--~~~kl~DFGl 660 (689)
+||+|.++ -+|+++|+... -..++...++.|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.
T Consensus 264 ciVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 99999995 59999999865 35689999999999999999999987 89999999999999753 3799999999
Q ss_pred CccccCCCcceeecccceEEeccccc
Q 005587 661 APLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|.+....-. ......+|||||||.
T Consensus 338 Sc~~~q~vy--tYiQSRfYRAPEVIL 361 (586)
T KOG0667|consen 338 SCFESQRVY--TYIQSRFYRAPEVIL 361 (586)
T ss_pred ccccCCcce--eeeeccccccchhhc
Confidence 999876665 456789999999994
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=233.12 Aligned_cols=167 Identities=25% Similarity=0.280 Sum_probs=140.3
Q ss_pred EeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
||+|+||+||++... +|+.||||.+...... ....+.+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999654 7899999998754322 22335678899999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc-eee
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS-QVS 673 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~ 673 (689)
.+++.........+++..++.++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++.+..+... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 988865333345689999999999999999999987 8999999999999999999999999999877554322 223
Q ss_pred cccceEEeccccc
Q 005587 674 HNLTIMRAGGVTH 686 (689)
Q Consensus 674 ~~~~~~~apE~~~ 686 (689)
.++..|+|||++.
T Consensus 158 ~g~~~y~aPE~~~ 170 (280)
T cd05608 158 AGTPGFMAPELLQ 170 (280)
T ss_pred CCCcCccCHHHhc
Confidence 5667899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=243.37 Aligned_cols=174 Identities=26% Similarity=0.366 Sum_probs=142.8
Q ss_pred cCCCccceEeecCCeEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQ 581 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 581 (689)
++|++.+.||+|+||.||+|.+ .++..||||++..... ....+.+.+|++++..+ +|||||+++++|...+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 4688889999999999999953 2456899999865432 23456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc----------------------------------------------------------
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDE---------------------------------------------------------- 603 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~---------------------------------------------------------- 603 (689)
.++|||||++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999875321
Q ss_pred -------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc
Q 005587 604 -------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (689)
Q Consensus 604 -------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (689)
....++|..+++++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 012578999999999999999999987 8999999999999999999999999999877544321
Q ss_pred e---eecccceEEeccccc
Q 005587 671 Q---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~---~~~~~~~~~apE~~~ 686 (689)
. ....+..|+|||++.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~ 289 (375)
T cd05104 271 VVKGNARLPVKWMAPESIF 289 (375)
T ss_pred cccCCCCCCcceeChhHhc
Confidence 1 112234699999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=237.15 Aligned_cols=165 Identities=21% Similarity=0.264 Sum_probs=138.1
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
++||+|+||.||+|+.. +++.||||++.+... .....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999764 688999999875432 123345667788888766 699999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC-CCcc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-GSVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~ 670 (689)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 9999988753 4588999999999999999999987 899999999999999999999999999986432 2233
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (320)
T cd05590 154 STFCGTPDYIAPEILQ 169 (320)
T ss_pred cccccCccccCHHHHc
Confidence 3345788899999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=228.22 Aligned_cols=174 Identities=21% Similarity=0.285 Sum_probs=143.7
Q ss_pred cCCCccceEeecCCeEEEEEEeCC-----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe-CCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD-----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~~ 582 (689)
..|+....||+|+||.||+|..++ .+.+|+|.++.............+|+..++.++|||||.+..++.+ +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 467888899999999999995432 2479999997664434445667899999999999999999998887 7889
Q ss_pred EEEEeccCCCCHHHHHhcCcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC----CcEEEEe
Q 005587 583 LLIYEYCSNGTLQDMLHSDDE-LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD----LAVSVSD 657 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~----~~~kl~D 657 (689)
||++||.++ +|.++|+.++. ..+.++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 99999876542 235788899999999999999999998 49999999999999766 8999999
Q ss_pred ecCCccccCCCccee----ecccceEEeccccc
Q 005587 658 CGLAPLISSGSVSQV----SHNLTIMRAGGVTH 686 (689)
Q Consensus 658 FGla~~~~~~~~~~~----~~~~~~~~apE~~~ 686 (689)
||+|+++...-.... -..|.+|+|||.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLL 212 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLL 212 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhc
Confidence 999999876443321 34567899999984
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=237.21 Aligned_cols=165 Identities=19% Similarity=0.240 Sum_probs=137.8
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
++||+|+||.||+|+.. +++.||||++..... .......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999765 588999999875432 123345677788888765 799999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC-Ccc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~~ 670 (689)
|+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 9999988753 4688999999999999999999987 8999999999999999999999999999864322 222
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (321)
T cd05591 154 TTFCGTPDYIAPEILQ 169 (321)
T ss_pred cccccCccccCHHHHc
Confidence 3345778899999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=237.20 Aligned_cols=170 Identities=17% Similarity=0.213 Sum_probs=141.3
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 586 (689)
+|+..+.||+|+||.||+|+.. +|+.||+|++.+... .......+..|.+++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667889999999999999754 689999999875432 1233456778888888775 577888999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998752 4689999999999999999999987 899999999999999999999999999986533
Q ss_pred CC-cceeecccceEEeccccc
Q 005587 667 GS-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~-~~~~~~~~~~~~apE~~~ 686 (689)
.. ......++..|+|||++.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIA 174 (323)
T ss_pred CCccccCccCCccccCHHHHc
Confidence 22 223345778899999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=236.19 Aligned_cols=172 Identities=22% Similarity=0.300 Sum_probs=157.2
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.-|++++.||+|.|.+|-+|++ -+|..||||++.+...+......+.+|++.|+-++|||||++|++...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3577788999999999999954 489999999999888777777789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec-CCCcEEEEeecCCccccC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~ 666 (689)
+-.+|+|+++|-.+. ..+.+..+.+|+.||..|+.|+|+. .+|||||||+||.+. .-|-+||+|||++-.+.+
T Consensus 98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999997653 4688999999999999999999988 699999999999875 578999999999999999
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
+..-...++...|.||||+.
T Consensus 172 G~kL~TsCGSLAYSAPEILL 191 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILL 191 (864)
T ss_pred cchhhcccchhhccCchhhh
Confidence 99888899999999999995
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=236.90 Aligned_cols=165 Identities=25% Similarity=0.318 Sum_probs=134.8
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHH-HHHhcCCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELV-NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||.||+|+.. +++.||+|++...... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999765 5788999998754321 12233444444 456789999999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC-CCcc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS-GSVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~ 670 (689)
|+|.+++... ..+.+..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 9999998752 3577888889999999999999987 899999999999999999999999999986433 2223
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (325)
T cd05602 154 STFCGTPEYLAPEVLH 169 (325)
T ss_pred ccccCCccccCHHHHc
Confidence 3345788999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=247.51 Aligned_cols=172 Identities=27% Similarity=0.427 Sum_probs=147.8
Q ss_pred CCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC------CeEE
Q 005587 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------GQRL 583 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~ 583 (689)
|...+.||+|+||.||+|+ .++|+.||||.++... .....+...+|++++++++|+|||++++.=++. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3445789999999999998 5679999999987654 234566778999999999999999999876543 3568
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec--CCCc--EEEEeec
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD--DDLA--VSVSDCG 659 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~--~~~~--~kl~DFG 659 (689)
+|||||.||||+.++.+... ...+++.+.+.+...+..||.|||++ +|+||||||.||++- ++|+ .||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999987544 35799999999999999999999987 899999999999983 4454 5999999
Q ss_pred CCccccCCCcceeecccceEEecccccc
Q 005587 660 LAPLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~apE~~~~ 687 (689)
.||-+.+++.-....||..|.+||+.++
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~ 197 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYER 197 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhh
Confidence 9999999998888899999999999863
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=242.27 Aligned_cols=174 Identities=26% Similarity=0.389 Sum_probs=142.4
Q ss_pred cCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQ 581 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 581 (689)
++|++.+.||+|+||.||+|... ++..||||++..... ......+.+|+++++.+ +|+|||+++++|...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 57888999999999999998632 245799999975433 23456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc----------------------------------------------------------
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDE---------------------------------------------------------- 603 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~---------------------------------------------------------- 603 (689)
.++|||||++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864211
Q ss_pred --------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCccee---
Q 005587 604 --------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV--- 672 (689)
Q Consensus 604 --------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--- 672 (689)
....+++..+++|+.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.+........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 013478899999999999999999987 899999999999999999999999999987654432211
Q ss_pred ecccceEEeccccc
Q 005587 673 SHNLTIMRAGGVTH 686 (689)
Q Consensus 673 ~~~~~~~~apE~~~ 686 (689)
...+..|+|||++.
T Consensus 274 ~~~~~~y~aPE~~~ 287 (374)
T cd05106 274 ARLPVKWMAPESIF 287 (374)
T ss_pred CCCccceeCHHHhc
Confidence 11234699999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=235.87 Aligned_cols=165 Identities=20% Similarity=0.260 Sum_probs=136.0
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhc-CCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDR-IRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
++||+|+||.||+|+.. +++.||||.+..... .....+.+..|..++.. .+||||+++++++...+..|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999764 588999999875432 12233445566666654 5899999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-cc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-VS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 670 (689)
|+|.+++... ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 9999998753 3588899999999999999999997 89999999999999999999999999998654322 22
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (316)
T cd05592 154 STFCGTPDYIAPEILK 169 (316)
T ss_pred ccccCCccccCHHHHc
Confidence 3345788999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=208.23 Aligned_cols=169 Identities=21% Similarity=0.353 Sum_probs=145.4
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..++||+|.||+||+|+. .+++.||+|+++....++......++|+-+++.++|.|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999964 5689999999987766566667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
|. .+|..+...- ...++.+.+..++.|+++||.|+|+. +++|||+||.|+||+.+|++|++|||+|+-+.-.-
T Consensus 83 cd-qdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 95 4888887653 45688899999999999999999997 89999999999999999999999999999875443
Q ss_pred -cceeecccceEEecccc
Q 005587 669 -VSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 669 -~~~~~~~~~~~~apE~~ 685 (689)
--.....+.+|+.|.++
T Consensus 156 rcysaevvtlwyrppdvl 173 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVL 173 (292)
T ss_pred EeeeceeeeeeccCccee
Confidence 22234567889999887
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=236.14 Aligned_cols=165 Identities=21% Similarity=0.272 Sum_probs=139.4
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||.||+|+.. +++.||+|++...... ......+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 6789999999765322 23345678888888887 699999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc-CCCcc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS-SGSVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~~ 670 (689)
|+|.+++.. ...+++..+..|+.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++... .....
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 999998865 24689999999999999999999997 89999999999999999999999999998632 23333
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (327)
T cd05617 154 STFCGTPNYIAPEILR 169 (327)
T ss_pred ecccCCcccCCHHHHC
Confidence 3356788899999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=228.08 Aligned_cols=171 Identities=23% Similarity=0.378 Sum_probs=143.0
Q ss_pred cCCCccceEeecCCeEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
++|++.+.||+|+||.||+|.+. .+..||+|.+..... ......|.+|+..+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46888899999999999999653 357899999876432 3445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998753 23689999999999999999999987 8999999999999999999999999988765
Q ss_pred cCCCcce--eecccceEEeccccc
Q 005587 665 SSGSVSQ--VSHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~~--~~~~~~~~~apE~~~ 686 (689)
....... ....+..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~ 181 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQ 181 (266)
T ss_pred cccchhcccCCCCceeecCHHHHh
Confidence 3332111 122345799999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=233.39 Aligned_cols=165 Identities=21% Similarity=0.265 Sum_probs=136.6
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhc-CCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDR-IRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||.||+|+.. +++.||||++..... .......+..|..++.. ++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999765 578999999876432 11233456667777765 5999999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC-Ccc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~~ 670 (689)
|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 999999875 24588999999999999999999987 8999999999999999999999999999864322 222
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (316)
T cd05619 154 CTFCGTPDYIAPEILL 169 (316)
T ss_pred eeecCCccccCHHHHc
Confidence 3345778899999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=240.43 Aligned_cols=162 Identities=21% Similarity=0.213 Sum_probs=139.3
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++|||||++++++...+..++|||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 5799999999999999999965 578999999743 2346789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+. ++|.+++.. ...+++..++.|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 164 ~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 995 689888865 34688999999999999999999987 8999999999999999999999999999865332
Q ss_pred C--cceeecccceEEeccccc
Q 005587 668 S--VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~--~~~~~~~~~~~~apE~~~ 686 (689)
. ......++..|+|||++.
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~ 256 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLA 256 (391)
T ss_pred cccccccccCccCCCChhhhc
Confidence 2 222346788999999984
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=233.74 Aligned_cols=165 Identities=19% Similarity=0.250 Sum_probs=136.5
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhc-CCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDR-IRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||.||+|+.. +|+.||+|.+...... ......+..|.+++.. .+||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999765 6889999998754321 1233456667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC-Ccc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~~ 670 (689)
|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 9999998752 4578899999999999999999987 8999999999999999999999999999854322 222
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (316)
T cd05620 154 STFCGTPDYIAPEILQ 169 (316)
T ss_pred eccCCCcCccCHHHHc
Confidence 3345788999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=245.44 Aligned_cols=169 Identities=24% Similarity=0.299 Sum_probs=138.4
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC-------
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------- 579 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------- 579 (689)
..+|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 35789999999999999999975 468999999885432 2234789999999999999999887542
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC-cEEEEe
Q 005587 580 -GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSD 657 (689)
Q Consensus 580 -~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~D 657 (689)
...++||||+++ +|.+++.........+++..+..|+.||++||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999975 78777754333345789999999999999999999997 899999999999999654 799999
Q ss_pred ecCCccccCCCcceeecccceEEeccccc
Q 005587 658 CGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
||+|+.+..+.......++..|+|||++.
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~ 243 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELML 243 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhc
Confidence 99999876655544456788999999874
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=228.87 Aligned_cols=171 Identities=25% Similarity=0.308 Sum_probs=145.2
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
|+..+.||+|+||.||++.. .+++.||||.+...... ......+.+|+.++++++|+||+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999965 46899999998654322 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.....+.
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999886432 34588999999999999999999987 89999999999999999999999999998765544
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
......++..|+|||++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVK 174 (285)
T ss_pred cccCCCCCccccChHHHc
Confidence 333346778899999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=228.25 Aligned_cols=165 Identities=24% Similarity=0.303 Sum_probs=140.5
Q ss_pred EeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
||+|+||.||+++.. +|+.||+|.+...... ......+..|++++++++||||+++++++......++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999754 6899999998654322 12344566799999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcceeec
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (689)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++..+..........
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 98886532 34588999999999999999999987 89999999999999999999999999998876655444456
Q ss_pred ccceEEeccccc
Q 005587 675 NLTIMRAGGVTH 686 (689)
Q Consensus 675 ~~~~~~apE~~~ 686 (689)
++..|+|||++.
T Consensus 156 ~~~~y~aPE~~~ 167 (277)
T cd05607 156 GTNGYMAPEILK 167 (277)
T ss_pred CCCCccCHHHHc
Confidence 778899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=256.22 Aligned_cols=181 Identities=18% Similarity=0.316 Sum_probs=150.7
Q ss_pred hhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCeE
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQR 582 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~ 582 (689)
...++|.+.+.||+|+||.||+|... ++..||+|.+............|..|+.++++++|||||+++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999654 57889999987655555556788999999999999999999998865 4578
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCcEEecccCCCeEecC---------
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ----PPIVHRNFKSANILLDD--------- 649 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~iiHrDlKp~NILl~~--------- 649 (689)
||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997533333568999999999999999999998531 35999999999999964
Q ss_pred --------CCcEEEEeecCCccccCCCcceeecccceEEeccccc
Q 005587 650 --------DLAVSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 650 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
.+.+||+|||+++.+..........++..|+|||++.
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ 214 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL 214 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHh
Confidence 2348999999999886655555567888999999874
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=241.94 Aligned_cols=163 Identities=18% Similarity=0.199 Sum_probs=138.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
..|.+.+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|+|||++++++...+..++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 36889999999999999999765 588999996421 235689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+. ++|.+++... ...++|.+++.|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 6898888643 23689999999999999999999987 8999999999999999999999999999876543
Q ss_pred Cc---ceeecccceEEeccccc
Q 005587 668 SV---SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~---~~~~~~~~~~~apE~~~ 686 (689)
.. .....++..|+|||++.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~ 335 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLA 335 (461)
T ss_pred cccccccccCCCcCCcCHHHHc
Confidence 21 12245788899999874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.8e-25 Score=239.10 Aligned_cols=175 Identities=25% Similarity=0.362 Sum_probs=143.1
Q ss_pred ccCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCC
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHG 580 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~ 580 (689)
.+.|.+.++||+|+||.||+|... .+..||||++..... ....+.+.+|+++++++. |||||+++++|...+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 357888999999999999999642 235799999865432 334567899999999996 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCcc---------------------------------------------------------
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDE--------------------------------------------------------- 603 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~--------------------------------------------------------- 603 (689)
..|+|||||++|+|.++++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999875311
Q ss_pred -----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec
Q 005587 604 -----------------------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD 648 (689)
Q Consensus 604 -----------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~ 648 (689)
....+++..++.++.|+++||.|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 013478889999999999999999987 899999999999999
Q ss_pred CCCcEEEEeecCCccccCCCcc---eeecccceEEeccccc
Q 005587 649 DDLAVSVSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
+++.+||+|||+++.+...... ....++..|+|||++.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 312 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF 312 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc
Confidence 9999999999999876443221 1123345699999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=228.25 Aligned_cols=171 Identities=25% Similarity=0.286 Sum_probs=145.2
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
|+..+.||+|+||+||+|.. .+++.||+|.+....... .....+.+|++++++++|+||+.+++++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999965 468999999986543222 2345578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886532 34689999999999999999999987 89999999999999999999999999998765544
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
......++..|+|||++.
T Consensus 157 ~~~~~~g~~~~~aPE~~~ 174 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLN 174 (285)
T ss_pred cccCCCCCcCccChHHhc
Confidence 433446778899999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=238.80 Aligned_cols=169 Identities=21% Similarity=0.290 Sum_probs=142.3
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-----eEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-----QRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 583 (689)
+|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999975 57899999998654433445567889999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 588888764 34689999999999999999999987 899999999999999999999999999987
Q ss_pred ccCCCcc--eeecccceEEeccccc
Q 005587 664 ISSGSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~--~~~~~~~~~~apE~~~ 686 (689)
....... ....++..|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILM 177 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHc
Confidence 6443221 1234567899999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=234.72 Aligned_cols=163 Identities=26% Similarity=0.279 Sum_probs=134.0
Q ss_pred EeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcC---CCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRI---RHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
||+|+||.||+|+.. +++.||||++.+.... ......+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999754 6899999998653221 12233445566666554 699999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC-Ccc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~~ 670 (689)
|+|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 999998875 34688999999999999999999987 8999999999999999999999999999864332 223
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~gt~~y~aPE~~~ 169 (330)
T cd05586 154 NTFCGTTEYLAPEVLL 169 (330)
T ss_pred cCccCCccccCHHHHc
Confidence 3345788999999874
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=252.82 Aligned_cols=175 Identities=24% Similarity=0.270 Sum_probs=145.6
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.++||+|+||.||+|... +|+.||||++...... ....+.|.+|++++++++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999764 6899999998754322 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCc-------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 587 EYCSNGTLQDMLHSDD-------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~-------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
||++||+|.+++.... .....+++..+++++.||++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 1123467788899999999999999987 89999999999999999999999999
Q ss_pred CCccccCCC-------------------cceeecccceEEeccccc
Q 005587 660 LAPLISSGS-------------------VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~-------------------~~~~~~~~~~~~apE~~~ 686 (689)
+|+...... ......++..|+|||++.
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~ 204 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL 204 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc
Confidence 998762111 011134788899999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=228.32 Aligned_cols=163 Identities=22% Similarity=0.361 Sum_probs=139.3
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEe----CCeEEEEEecc
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAE----HGQRLLIYEYC 589 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~ 589 (689)
..||+|++|.||+|.+ +|+.||||.+....... ...+.|.+|++++++++|||||++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 78999999987643322 224678899999999999999999999977 45789999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
++|+|.+++... ..++|....+++.|++.||.|||... +++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999763 46889999999999999999999742 68899999999999999999999999999775433
Q ss_pred ceeecccceEEeccccc
Q 005587 670 SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 178 -~~~~~~~~y~aPE~~~ 193 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLN 193 (283)
T ss_pred -ccccCcccccCHHHhh
Confidence 2345678899999984
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=237.19 Aligned_cols=169 Identities=23% Similarity=0.270 Sum_probs=142.5
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC------
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG------ 580 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~------ 580 (689)
.++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46889999999999999999965 46899999999765444455677889999999999999999999986543
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
..|+||||+.+ +|.+.++. .+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999965 67666642 478888999999999999999987 899999999999999999999999999
Q ss_pred CccccCCCcceeecccceEEeccccc
Q 005587 661 APLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
++............++..|+|||++.
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~ 195 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVIL 195 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhcc
Confidence 98765544444456678899999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=231.73 Aligned_cols=170 Identities=23% Similarity=0.395 Sum_probs=140.9
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCc----EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
.+|++.+.||+|+||.||+|++. +|. .||+|.+.... .....+++.+|+.+++.++||||++++++|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46888999999999999999753 343 48999986432 234556788999999999999999999999865 577
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+|+||+++|+|.+++... ...+++...+.++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999999864 23588999999999999999999987 899999999999999999999999999998
Q ss_pred ccCCCcceeec---ccceEEeccccc
Q 005587 664 ISSGSVSQVSH---NLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~~~~~---~~~~~~apE~~~ 686 (689)
+.......... .+..|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~ 184 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESIL 184 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhc
Confidence 76544332222 234699999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-26 Score=233.23 Aligned_cols=173 Identities=27% Similarity=0.301 Sum_probs=154.1
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
+.|...++||+|+||.||.++. .+|+.+|.|++.+..... ..+...+.|-.+|.++..+.||.+--.|++.+.+++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5688899999999999999965 479999999987654432 34556678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
..|.||||.-+|...+ ...+++..++-|+.+|+.||++||.. +||+|||||+|||+|+.|+++|+|.|||..+.+
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999988776544 46799999999999999999999998 899999999999999999999999999999999
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
+.....-.+|.+||||||+.
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQ 359 (591)
T ss_pred CCccccccCcccccCHHHHc
Confidence 88777668999999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-26 Score=224.00 Aligned_cols=172 Identities=26% Similarity=0.307 Sum_probs=150.3
Q ss_pred cCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|+..++||+|.||.|-+++ ..+|+.+|+|++++...-. .....-+.|-++|+..+||.+..+.-.|...+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 567888999999999999995 5579999999998775432 23344567889999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc-cc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL-IS 665 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~-~~ 665 (689)
||..||.|+-+|.. .+.+++...+-+...|..||.|||+. +||.||||.+|+|+|.+|++||+||||++. +.
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999988865 45688888888999999999999997 899999999999999999999999999985 45
Q ss_pred CCCcceeecccceEEecccccc
Q 005587 666 SGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~apE~~~~ 687 (689)
.+.....-++++.|.||||+.+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLED 342 (516)
T ss_pred ccceeccccCChhhcCchhhcc
Confidence 5666677889999999999954
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=231.57 Aligned_cols=165 Identities=21% Similarity=0.276 Sum_probs=137.9
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||.||+|+.. +++.||||++.+... .......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 588999999875432 123345667888888877 799999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC-Ccc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG-SVS 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~~ 670 (689)
|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 9999988753 3689999999999999999999987 8999999999999999999999999999764222 222
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 154 ~~~~g~~~y~aPE~~~ 169 (318)
T cd05570 154 STFCGTPDYIAPEILS 169 (318)
T ss_pred cceecCccccCHHHhc
Confidence 2345678899999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=232.72 Aligned_cols=164 Identities=19% Similarity=0.227 Sum_probs=140.1
Q ss_pred ccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
..+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++...+..++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 357999999999999999999765 5788999975432 2346888999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+. ++|.+++... ...+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 6888888643 34689999999999999999999987 899999999999999999999999999987554
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
........++..|+|||++.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~ 229 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLA 229 (357)
T ss_pred CcccccccccccccCCeecC
Confidence 44333456788899999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=218.99 Aligned_cols=169 Identities=20% Similarity=0.222 Sum_probs=141.4
Q ss_pred hccCCCc-cceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHH-hcCCCCCcceecEEEEe----C
Q 005587 507 YTNSFSQ-ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKGYCAE----H 579 (689)
Q Consensus 507 ~~~~f~~-~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l-~~l~HpnIv~l~~~~~~----~ 579 (689)
.+++|.+ .++||-|-.|.|..+. ..+|+.+|+|++... ...++|++.. ..-.|||||.++++|++ .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3456654 3679999999999995 457999999998543 2345666653 44479999999999875 4
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC---CCcEEEE
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVS 656 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kl~ 656 (689)
..+.+|||+|+||.|+..+.+++ ...+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+||+
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 67889999999999999998765 56799999999999999999999998 8999999999999964 5578999
Q ss_pred eecCCccccCCCcceeecccceEEecccccc
Q 005587 657 DCGLAPLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~~~~apE~~~~ 687 (689)
|||+|+.-.+...-+..+-|+||.|||++..
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~ 237 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGP 237 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCc
Confidence 9999999887777777889999999999953
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=223.58 Aligned_cols=169 Identities=21% Similarity=0.372 Sum_probs=143.1
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
++|++.+.||+|+||.||+++++++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 35777889999999999999988888999998764432 245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|.++++... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 81 MENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999999987532 3588999999999999999999987 89999999999999999999999999998765433
Q ss_pred ccee--ecccceEEeccccc
Q 005587 669 VSQV--SHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~--~~~~~~~~apE~~~ 686 (689)
.... ......|+|||++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFN 174 (256)
T ss_pred eeccCCCCCchhhCChhhcc
Confidence 2211 12234699999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=235.45 Aligned_cols=170 Identities=21% Similarity=0.251 Sum_probs=143.5
Q ss_pred hccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC------
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------ 579 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------ 579 (689)
..++|++.+.||+|+||.||+|.. .+++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 456899999999999999999965 4689999999976544445566788999999999999999999988653
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
...|+||||+++ +|.+.+.. .+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 67766642 478889999999999999999987 89999999999999999999999999
Q ss_pred CCccccCCCcceeecccceEEeccccc
Q 005587 660 LAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+++............++..|+|||++.
T Consensus 165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~ 191 (355)
T cd07874 165 LARTAGTSFMMTPYVVTRYYRAPEVIL 191 (355)
T ss_pred ccccCCCccccCCccccCCccCHHHHc
Confidence 999876554444456788999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=223.12 Aligned_cols=175 Identities=22% Similarity=0.323 Sum_probs=147.8
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEecccc-CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|+. .+++.||||.+.... ........+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788899999999999999975 478999999876432 23344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++.........+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865333345688899999999999999999987 899999999999999999999999999998765
Q ss_pred CCcc-eeecccceEEeccccc
Q 005587 667 GSVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~-~~~~~~~~~~apE~~~ 686 (689)
.... ....+...|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~ 179 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred hhHHHhcCCCCccccChhhhc
Confidence 4322 2235667899999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=240.09 Aligned_cols=169 Identities=26% Similarity=0.438 Sum_probs=145.7
Q ss_pred CCccceEeecCCeEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 511 FSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
..++++||.|.||.||+|+++- ...||||.++.... ....++|+.|..+|++..||||++|.|+.......+||.
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4678899999999999998753 35799999976543 456789999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
|||++|+|..+|+..+ ..+.+.+...|.++||.||.||-+. ++|||||-..|||++.+..+|++||||+|.+.+
T Consensus 710 EyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999865 3488899999999999999999987 899999999999999999999999999999877
Q ss_pred CCcce-eeccc-c--eEEeccccc
Q 005587 667 GSVSQ-VSHNL-T--IMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~-~~~~~-~--~~~apE~~~ 686 (689)
++... .+.++ . -|.|||.|-
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa 807 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIA 807 (996)
T ss_pred CCCccccccCCccceeecChhHhh
Confidence 66222 22222 2 277999983
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=222.42 Aligned_cols=171 Identities=22% Similarity=0.339 Sum_probs=145.5
Q ss_pred ccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.++|++.+.||+|+||.||+|...+++.||+|.+..... ...++.+|++++++++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 356888899999999999999887788999999865432 34678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997633 34689999999999999999999987 8999999999999999999999999999987644
Q ss_pred Ccceeec--ccceEEeccccc
Q 005587 668 SVSQVSH--NLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~--~~~~~~apE~~~ 686 (689)
....... ....|+|||++.
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAAL 177 (261)
T ss_pred cccccCCCcCceeccCccccc
Confidence 3222111 123699999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=226.04 Aligned_cols=171 Identities=27% Similarity=0.363 Sum_probs=137.6
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhc---CCCCCcceecEEEEe-----CC
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDR---IRHANIVELKGYCAE-----HG 580 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~---l~HpnIv~l~~~~~~-----~~ 580 (689)
+|++.+.||+|+||.||+|+.. +|+.||+|.+............+.+|+++++. ++||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999654 68999999987543322223345566666554 479999999998864 34
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999974 8988887532 24589999999999999999999997 899999999999999999999999999
Q ss_pred CccccCCCcceeecccceEEeccccc
Q 005587 661 APLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
++.+..........++..|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLL 180 (288)
T ss_pred cccccCcccCCCccccccccCchHhh
Confidence 99876544433445678899999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=225.25 Aligned_cols=169 Identities=30% Similarity=0.464 Sum_probs=144.3
Q ss_pred CCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|++.+.||+|+||.||+++.. +++.||+|++..............+|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999765 5678999999876543333344566999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc-cCCC
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI-SSGS 668 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~-~~~~ 668 (689)
.+++|.+++.. ...+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||.+..+ ....
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999983 35689999999999999999999997 8999999999999999999999999999864 2233
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
......++..|+|||+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp EBSSSSSSGGGSCHHHHT
T ss_pred cccccccccccccccccc
Confidence 334456677899999964
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=234.32 Aligned_cols=169 Identities=20% Similarity=0.247 Sum_probs=142.7
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC------C
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------G 580 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------~ 580 (689)
.++|++.+.||+|+||.||+|.. .+++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46799999999999999999965 4688999999976544444556788999999999999999999987643 3
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
..|+||||+.+ +|.+.+.. .+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999965 77777642 478889999999999999999987 899999999999999999999999999
Q ss_pred CccccCCCcceeecccceEEeccccc
Q 005587 661 APLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
++............++..|+|||++.
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~ 198 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVIL 198 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHh
Confidence 99876554444456788899999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=233.17 Aligned_cols=170 Identities=21% Similarity=0.295 Sum_probs=143.2
Q ss_pred hhccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC-----
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH----- 579 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~----- 579 (689)
...++|.+.+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999965 5688999999876543334456678999999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 580 -GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 580 -~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
...|++||++ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 4578999998 7899988763 3589999999999999999999997 8999999999999999999999999
Q ss_pred cCCccccCCCcceeecccceEEeccccc
Q 005587 659 GLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|+++........ ..++..|+|||++.
T Consensus 163 g~~~~~~~~~~~--~~~t~~y~aPE~~~ 188 (343)
T cd07878 163 GLARQADDEMTG--YVATRWYRAPEIML 188 (343)
T ss_pred ccceecCCCcCC--ccccccccCchHhc
Confidence 999987554322 35678899999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=246.90 Aligned_cols=172 Identities=28% Similarity=0.426 Sum_probs=145.2
Q ss_pred CccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 512 SQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
+..+.||+|+||+||+|+.. +...||||.+++... .+...+|++|+++++.++|||||+++|.|...+.++||
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 34578999999999999643 346899999976543 45678999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCccc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEE
Q 005587 586 YEYCSNGTLQDMLHSDDEL----------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl 655 (689)
+|||..|||.++|...... +.+++..+.+.||.|||.||+||-+. .+|||||-..|+|+.++..+||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 9999999999999864321 23388899999999999999999987 7999999999999999999999
Q ss_pred EeecCCccccCCCcceeeccc---ceEEecccccc
Q 005587 656 SDCGLAPLISSGSVSQVSHNL---TIMRAGGVTHR 687 (689)
Q Consensus 656 ~DFGla~~~~~~~~~~~~~~~---~~~~apE~~~~ 687 (689)
+||||+|.+-..+......++ .-||+||.|.+
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly 679 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY 679 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhc
Confidence 999999987665544433333 22999999853
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=226.22 Aligned_cols=170 Identities=19% Similarity=0.275 Sum_probs=145.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||++... ++..+|+|.+.... ......++.+|++++.+++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888999999999999999654 68889999886542 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.++++.. ..+++..+..++.|+++||.|||+.+ +++||||||+|||+++++.+||+|||++..+...
T Consensus 80 y~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 80 HMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999999753 45889999999999999999999742 7999999999999999999999999999876543
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
... ...++..|+|||++.
T Consensus 154 ~~~-~~~~~~~~~aPE~~~ 171 (308)
T cd06615 154 MAN-SFVGTRSYMSPERLQ 171 (308)
T ss_pred ccc-cCCCCcCccChhHhc
Confidence 322 235667899999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=220.38 Aligned_cols=175 Identities=23% Similarity=0.348 Sum_probs=148.9
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEecccc-CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|... +|+.||+|.+.... ........+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999765 79999999886432 22334667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++|+|.+++.........+++..++.++.|+++||.|||+. +|+||||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875433345689999999999999999999987 899999999999999999999999999987654
Q ss_pred CCc-ceeecccceEEeccccc
Q 005587 667 GSV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~-~~~~~~~~~~~apE~~~ 686 (689)
... .....++..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~ 179 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred CCcccceecCCccccCHHHhc
Confidence 332 22235667899999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=219.53 Aligned_cols=172 Identities=23% Similarity=0.353 Sum_probs=148.6
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|...+.||+|+||.||+|... +++.|++|.+............+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999764 689999999876554455677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.++++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998642 34688999999999999999999987 89999999999999999999999999999876543
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. ....++..|+|||+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08529 156 NFANTIVGTPYYLSPELCE 174 (256)
T ss_pred chhhccccCccccCHHHhc
Confidence 22 2234567799999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=224.28 Aligned_cols=176 Identities=22% Similarity=0.291 Sum_probs=144.1
Q ss_pred hccCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~ 580 (689)
..++|++.+.||+|+||.||+|... ++..||||.+.... ......++.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3467889999999999999998642 35679999986432 2334567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEE
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDEL------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k 654 (689)
..++||||+++|+|.+++...... ...+++..++.++.|+++||.|||+. +++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998753211 23467889999999999999999987 899999999999999999999
Q ss_pred EEeecCCccccCCCccee---ecccceEEeccccc
Q 005587 655 VSDCGLAPLISSGSVSQV---SHNLTIMRAGGVTH 686 (689)
Q Consensus 655 l~DFGla~~~~~~~~~~~---~~~~~~~~apE~~~ 686 (689)
|+|||+++.+........ ..++..|+|||++.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence 999999987654432221 12345699999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=227.43 Aligned_cols=170 Identities=21% Similarity=0.313 Sum_probs=142.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.|.+.+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 46888899999999999999764 688999999875432 2234467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9975 888887653 23578899999999999999999987 8999999999999999999999999999865433
Q ss_pred Cc-ceeecccceEEeccccc
Q 005587 668 SV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~~ 686 (689)
.. .....++..|+|||++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~ 177 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLL 177 (309)
T ss_pred ccccccccccccccCCHHHh
Confidence 22 22334577899999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=222.29 Aligned_cols=150 Identities=27% Similarity=0.364 Sum_probs=134.1
Q ss_pred cCCCccceEeecCCeEEEEEEeCC-CcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
+.|++.+.||+|.-|+||++++++ +..+|+|++.+.... .....+...|.++|+.++||.+++||+.++.+.+.++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456778899999999999998764 689999999876543 344566778889999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
|||+||+|+.+.+.+. .+.+++..++-|+.+|+-||+|||.. |||+|||||+||||-++|++-|+||-|+..
T Consensus 157 eyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred ecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999988754 56799999999999999999999998 999999999999999999999999998753
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=220.18 Aligned_cols=171 Identities=27% Similarity=0.436 Sum_probs=143.4
Q ss_pred cCCCccceEeecCCeEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
++|++.+.||+|+||.||+|.+.. ...||||.+..... ......|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 468889999999999999997642 45799998865432 3445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+++|+|.+++.... ..+++..+++++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++.+
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999997532 3689999999999999999999987 8999999999999999999999999999988
Q ss_pred cCCCccee---ecccceEEeccccc
Q 005587 665 SSGSVSQV---SHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~~~---~~~~~~~~apE~~~ 686 (689)
........ ...+..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~ 181 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIA 181 (266)
T ss_pred cccccceeccCCCCCccccChhhhc
Confidence 52221111 12234699999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=219.11 Aligned_cols=171 Identities=24% Similarity=0.345 Sum_probs=144.6
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~---~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
++|++.+.||+|++|.||+|.. .+++.||+|.+...... ......+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999965 46899999998654322 1234568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.+
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998753 3578899999999999999999987 8999999999999999999999999999876
Q ss_pred cCCCcc----eeecccceEEeccccc
Q 005587 665 SSGSVS----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~----~~~~~~~~~~apE~~~ 686 (689)
...... ....+...|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 180 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVIS 180 (263)
T ss_pred cccccccccccCCCcCccccCcceec
Confidence 443211 1234567899999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=222.77 Aligned_cols=174 Identities=18% Similarity=0.295 Sum_probs=142.0
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHH-HhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNN-IDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|+.. +|+.||+|++....... ....+..|+.. ++.++||||+++++++...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36888899999999999999764 69999999987654322 23445555554 66779999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||++ |+|.+++.........+++..+..++.|++.||+|||+.+ +++||||||+||+++.++.+||+|||+++.+..
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 6898888654333457899999999999999999999752 799999999999999999999999999998754
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
........++..|+|||++.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERIN 176 (283)
T ss_pred ccccccccCCccccChhhcC
Confidence 43333345677899999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=221.83 Aligned_cols=172 Identities=27% Similarity=0.406 Sum_probs=147.3
Q ss_pred ccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
..+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+..|+.+++.++|+||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45688889999999999999988889999999986543 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++..+...
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999997643 34689999999999999999999987 8999999999999999999999999999887654
Q ss_pred Ccceee-cccceEEeccccc
Q 005587 668 SVSQVS-HNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~-~~~~~~~apE~~~ 686 (689)
...... ..+..|++||+..
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~ 177 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAAS 177 (261)
T ss_pred cccccCCCCceEecCHHHHc
Confidence 332222 2234699999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=221.80 Aligned_cols=170 Identities=25% Similarity=0.398 Sum_probs=141.3
Q ss_pred cCCCccceEeecCCeEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQ 581 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~ 581 (689)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4678889999999999999964 257899999986532 3445678999999999999999999998754 346
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 89999999999999999753 23589999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCcce----eecccceEEeccccc
Q 005587 662 PLISSGSVSQ----VSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~~~~----~~~~~~~~~apE~~~ 686 (689)
+.+....... ......+|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLT 184 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhc
Confidence 9875443211 112335699999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=222.66 Aligned_cols=174 Identities=25% Similarity=0.375 Sum_probs=143.0
Q ss_pred cCCCccceEeecCCeEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
++|++.+.||+|+||.||+|.. .++..||+|.+..... ......+.+|++++++++||||+++++++...+..|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4577789999999999999964 2467899999875432 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC
Q 005587 584 LIYEYCSNGTLQDMLHSDDE-------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~ 650 (689)
+||||+.+|+|.+++..... ....+++...+.++.|++.||.|||+. +|+||||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999863211 123578999999999999999999987 89999999999999999
Q ss_pred CcEEEEeecCCccccCCCcc---eeecccceEEeccccc
Q 005587 651 LAVSVSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 651 ~~~kl~DFGla~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
+.+||+|||+++.+...... .....+..|+|||.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM 199 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhc
Confidence 99999999999876543321 1122345699999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=221.19 Aligned_cols=170 Identities=24% Similarity=0.388 Sum_probs=145.2
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 5688899999999999999988888899999876432 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|.++++... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999997532 34678899999999999999999987 89999999999999999999999999999876543
Q ss_pred cce--eecccceEEeccccc
Q 005587 669 VSQ--VSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~--~~~~~~~~~apE~~~ 686 (689)
... ...++..|+|||.+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAIN 177 (261)
T ss_pred eeccCCCccceecCCHHHhc
Confidence 221 122345699999873
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=220.09 Aligned_cols=168 Identities=27% Similarity=0.380 Sum_probs=144.0
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 4688899999999999999975 5688999999864422 234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.++++. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999999875 24578999999999999999999987 8999999999999999999999999999877543
Q ss_pred Cc-ceeecccceEEecccc
Q 005587 668 SV-SQVSHNLTIMRAGGVT 685 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~ 685 (689)
.. .....++..|+|||++
T Consensus 160 ~~~~~~~~~~~~y~~PE~~ 178 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred ccccCccccCccccCHhHc
Confidence 22 1223466789999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=220.41 Aligned_cols=168 Identities=24% Similarity=0.387 Sum_probs=142.3
Q ss_pred CCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4677889999999999999887778899999865432 2456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
++++|.+++.... ..+++..++.|+.|+++||.|||+. +|+||||||+||++++++.+||+|||+++...+...
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999997532 3689999999999999999999987 899999999999999999999999999987754332
Q ss_pred cee--ecccceEEeccccc
Q 005587 670 SQV--SHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~~--~~~~~~~~apE~~~ 686 (689)
... ......|+|||.+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~ 174 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFD 174 (256)
T ss_pred cccCCCCCCccccCHHHhc
Confidence 211 11123599999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=221.21 Aligned_cols=166 Identities=26% Similarity=0.354 Sum_probs=134.7
Q ss_pred eEeecCCeEEEEEEeCC---CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 516 LIGAGMLGSVYRAQLPD---GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
.||+|+||.||+|...+ ...+|+|.+.... .......|.+|++.++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996543 3568888775432 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc--
Q 005587 593 TLQDMLHSDDEL-KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV-- 669 (689)
Q Consensus 593 sL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-- 669 (689)
+|.+++...... ....++...+.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764321 23456788899999999999999987 899999999999999999999999999976543321
Q ss_pred -ceeecccceEEecccc
Q 005587 670 -SQVSHNLTIMRAGGVT 685 (689)
Q Consensus 670 -~~~~~~~~~~~apE~~ 685 (689)
......+..|+|||+.
T Consensus 158 ~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 158 TKDCHAVPLRWLAPELV 174 (269)
T ss_pred ccCCCCCcccccCHHHH
Confidence 1112234569999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=222.40 Aligned_cols=171 Identities=19% Similarity=0.345 Sum_probs=145.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999765 68999999986543323334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|++++.|..++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988887754 23589999999999999999999997 8999999999999999999999999999987654
Q ss_pred Cc-ceeecccceEEeccccc
Q 005587 668 SV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~~ 686 (689)
.. .....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~ 173 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLV 173 (286)
T ss_pred cccccCcccccccCCHHHHh
Confidence 42 22234567899999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=233.03 Aligned_cols=174 Identities=26% Similarity=0.377 Sum_probs=142.0
Q ss_pred cCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQ 581 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~ 581 (689)
++|.+.+.||+|+||.||+|++. .++.||||++..... ......+.+|++++.++. |||||+++++|...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 45777899999999999999753 346899999975432 233457889999999997 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc----------------------------------------------------------
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDE---------------------------------------------------------- 603 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~---------------------------------------------------------- 603 (689)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred ------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe
Q 005587 604 ------------------------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (689)
Q Consensus 604 ------------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl 647 (689)
....+++...+.|+.|++.||+|||+. +|+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 112477888999999999999999987 89999999999999
Q ss_pred cCCCcEEEEeecCCccccCCCcc---eeecccceEEeccccc
Q 005587 648 DDDLAVSVSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
++++.+||+|||+++.+...... ....++..|+|||.+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 314 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence 99999999999999876433211 1123345699999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=223.67 Aligned_cols=182 Identities=24% Similarity=0.321 Sum_probs=149.3
Q ss_pred cchhhHhhhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEE
Q 005587 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYC 576 (689)
Q Consensus 499 ~~~~~l~~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~ 576 (689)
+.++++....++|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 445667778889999999999999999999654 68899999875432 2245677899999998 699999999988
Q ss_pred E-----eCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC
Q 005587 577 A-----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (689)
Q Consensus 577 ~-----~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~ 651 (689)
. ..+..++||||+++|+|.+++.........+++..+..++.|+++||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4 34578999999999999998864322245688999999999999999999987 899999999999999999
Q ss_pred cEEEEeecCCccccCCCc-ceeecccceEEeccccc
Q 005587 652 AVSVSDCGLAPLISSGSV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 652 ~~kl~DFGla~~~~~~~~-~~~~~~~~~~~apE~~~ 686 (689)
.+||+|||+++.+..... .....++..|+|||++.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhc
Confidence 999999999987654332 22335677899999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=222.40 Aligned_cols=169 Identities=26% Similarity=0.353 Sum_probs=146.5
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|.+.+.||+|+||.||++... +++.||+|.+..... .......+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999764 689999999865432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+|+||+|+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999999763 4688999999999999999999987 899999999999999999999999999998765
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
.. ....++..|+|||.+.
T Consensus 154 ~~--~~~~~~~~y~aPE~~~ 171 (290)
T cd05580 154 RT--YTLCGTPEYLAPEIIL 171 (290)
T ss_pred CC--CCCCCCccccChhhhc
Confidence 52 2345678899999863
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=220.15 Aligned_cols=164 Identities=18% Similarity=0.285 Sum_probs=140.9
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..++||+|+||.||+|.. .+++.||+|.+.... ......++.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 577889999999999999965 578999999986543 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999996542 367888899999999999999987 89999999999999999999999999998765443
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
.. ...++..|+|||++.
T Consensus 150 ~~-~~~~~~~y~aPE~~~ 166 (279)
T cd06619 150 AK-TYVGTNAYMAPERIS 166 (279)
T ss_pred cc-CCCCChhhcCceeec
Confidence 22 245677899999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=223.72 Aligned_cols=166 Identities=27% Similarity=0.397 Sum_probs=139.3
Q ss_pred CCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhc--CCCCCcceecEEEEeC----CeEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR--IRHANIVELKGYCAEH----GQRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~--l~HpnIv~l~~~~~~~----~~~~ 583 (689)
...+.+.||+|.||.||+|+| .|+.||||++.. .+++.+.+|.++.+. |||+||..+++.-..+ .++|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeeccc-cCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 345678999999999999999 578899999853 345678888888765 5999999998876543 3689
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI-----CQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-----~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
||+||.++|||+|+|.. ..++-...++++..+|.||+|||.. +.|.|.|||||+.|||+..++.+.|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999985 5688999999999999999999963 3567999999999999999999999999
Q ss_pred cCCccccCCC-----cceeecccceEEeccccc
Q 005587 659 GLAPLISSGS-----VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~-----~~~~~~~~~~~~apE~~~ 686 (689)
|||....+.. ..-...||.-|||||++.
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd 393 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD 393 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence 9998765542 122356778899999984
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=219.63 Aligned_cols=172 Identities=22% Similarity=0.381 Sum_probs=139.1
Q ss_pred CccceEeecCCeEEEEEEeCC-Cc--EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC------CeE
Q 005587 512 SQENLIGAGMLGSVYRAQLPD-GK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------GQR 582 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------~~~ 582 (689)
.+.+.||+|+||.||+|++.+ +. .||+|.+..........+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999997654 33 689999876544455667889999999999999999999987532 246
Q ss_pred EEEEeccCCCCHHHHHhcCc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 583 LLIYEYCSNGTLQDMLHSDD--ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
++||||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999875322 1234589999999999999999999987 899999999999999999999999999
Q ss_pred CccccCCCcc---eeecccceEEeccccc
Q 005587 661 APLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
++.+...... .....+..|+|||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 187 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLA 187 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHcc
Confidence 9987554321 1123345699999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=220.94 Aligned_cols=175 Identities=22% Similarity=0.332 Sum_probs=148.3
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|.. .+++.+|||.+..... ......++.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999975 5789999998865332 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++++|.+++.........+++..++.++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875333345689999999999999999999987 899999999999999999999999999988765
Q ss_pred CCcc-eeecccceEEeccccc
Q 005587 667 GSVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~-~~~~~~~~~~apE~~~ 686 (689)
.... ....++..|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~ 179 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred CCcccccccCCcCccCHHHhc
Confidence 4322 2235677899999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=217.30 Aligned_cols=172 Identities=18% Similarity=0.306 Sum_probs=148.1
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..+.||+|+||.||.++. .+++.+++|.+............+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999964 4689999999876554455567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|.+++.... ...+++..+..++.|+++||.|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997542 34688999999999999999999987 89999999999999999999999999998775543
Q ss_pred -cceeecccceEEeccccc
Q 005587 669 -VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 -~~~~~~~~~~~~apE~~~ 686 (689)
......++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~y~ape~~~ 174 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQ 174 (256)
T ss_pred ccccccCCCccccCHhhcC
Confidence 222344677899999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=216.85 Aligned_cols=165 Identities=24% Similarity=0.383 Sum_probs=137.9
Q ss_pred ceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCC
Q 005587 515 NLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT 593 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 593 (689)
+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36899999999999764 78999999876443 23445678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCccee-
Q 005587 594 LQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV- 672 (689)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 672 (689)
|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....+.....
T Consensus 80 L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 80 FLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99998753 23588999999999999999999987 899999999999999999999999999987654322111
Q ss_pred --ecccceEEeccccc
Q 005587 673 --SHNLTIMRAGGVTH 686 (689)
Q Consensus 673 --~~~~~~~~apE~~~ 686 (689)
......|+|||.+.
T Consensus 154 ~~~~~~~~y~aPE~~~ 169 (252)
T cd05084 154 GMKQIPVKWTAPEALN 169 (252)
T ss_pred CCCCCceeecCchhhc
Confidence 11124599999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=219.74 Aligned_cols=167 Identities=28% Similarity=0.314 Sum_probs=137.0
Q ss_pred eEeecCCeEEEEEEeCC---CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 516 LIGAGMLGSVYRAQLPD---GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~---g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
.||+|+||.||+|...+ +..+|+|.+..... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997543 46799998865432 334457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcce
Q 005587 593 TLQDMLHSDDE-LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (689)
Q Consensus 593 sL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (689)
+|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 123567788889999999999999987 89999999999999999999999999998654433211
Q ss_pred ---eecccceEEeccccc
Q 005587 672 ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ---~~~~~~~~~apE~~~ 686 (689)
...++..|+|||++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 158 TPDQLWVPLRWIAPELVD 175 (269)
T ss_pred cCCCcCCcccccCHhHhc
Confidence 123456699999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-24 Score=226.24 Aligned_cols=170 Identities=19% Similarity=0.266 Sum_probs=140.2
Q ss_pred ccceEeec--CCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 513 QENLIGAG--MLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 513 ~~~~iG~G--~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
+.++||+| +|++||++.. .+|+.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6889999965 57899999999765544445567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS- 668 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 668 (689)
++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++++|||.+..+....
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986532 23588999999999999999999987 89999999999999999999999998755432211
Q ss_pred -------cceeecccceEEecccccc
Q 005587 669 -------VSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 669 -------~~~~~~~~~~~~apE~~~~ 687 (689)
......++..|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred cccccccccccccceecccChHHhhc
Confidence 1122344566999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=219.61 Aligned_cols=168 Identities=23% Similarity=0.374 Sum_probs=142.7
Q ss_pred CCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
+|.+.+.||+|+||.||+|++.++..+|||.+..... ....|.+|+.++.+++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 5677889999999999999887777899999865432 2457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
.+|+|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+.....
T Consensus 82 ~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999987532 2589999999999999999999987 899999999999999999999999999987755432
Q ss_pred cee--ecccceEEeccccc
Q 005587 670 SQV--SHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~~--~~~~~~~~apE~~~ 686 (689)
... ..++..|++||.+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~ 174 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLL 174 (256)
T ss_pred eecCCCccChhhCCHHHHh
Confidence 211 12234699999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=224.94 Aligned_cols=174 Identities=25% Similarity=0.420 Sum_probs=140.6
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCc--EEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~--~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 584 (689)
++|++.+.||+|+||.||+|.+. ++. .+|+|.+.... .......+.+|++++.++ +||||+++++++...+..|+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 57888899999999999999764 454 45777765432 234556788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCc
Q 005587 585 IYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~ 652 (689)
||||+++|+|.++++.... ....+++.+++.++.|+++||+|||+. +|+||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975431 123578999999999999999999987 8999999999999999999
Q ss_pred EEEEeecCCccccCCCcceeecccceEEeccccc
Q 005587 653 VSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+||+|||+++................|+|||.+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 196 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHh
Confidence 9999999997543222111122234699999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=223.24 Aligned_cols=174 Identities=23% Similarity=0.385 Sum_probs=142.5
Q ss_pred cCCCccceEeecCCeEEEEEEeCC---------------CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD---------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~---------------g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~ 573 (689)
++|++.+.||+|+||.||+|+... ...||+|.+.... .......|.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 478889999999999999986532 2358999987543 234456789999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHhcCcc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCe
Q 005587 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDE--------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANI 645 (689)
Q Consensus 574 ~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NI 645 (689)
+++...+..++||||+.+++|.+++..... ....+++..++.++.|+++||.|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999865321 012478899999999999999999987 899999999999
Q ss_pred EecCCCcEEEEeecCCccccCCCccee---ecccceEEeccccc
Q 005587 646 LLDDDLAVSVSDCGLAPLISSGSVSQV---SHNLTIMRAGGVTH 686 (689)
Q Consensus 646 Ll~~~~~~kl~DFGla~~~~~~~~~~~---~~~~~~~~apE~~~ 686 (689)
++++++.+||+|||+++.+........ ..+...|+|||+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhc
Confidence 999999999999999987654432211 12245799999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=218.34 Aligned_cols=171 Identities=25% Similarity=0.433 Sum_probs=142.7
Q ss_pred cCCCccceEeecCCeEEEEEEeC-C---CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-D---GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~---g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
++|++.+.||+|+||.||+|... + +..+|+|.+..... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999653 2 34799999865432 3345688999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+++|+|.+++.... ..+++.+++.|+.|++.||.|||+. +++||||||+|||++.++.++|+|||+++.+
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997532 3578999999999999999999987 8999999999999999999999999999987
Q ss_pred cCCCcceee-c---ccceEEeccccc
Q 005587 665 SSGSVSQVS-H---NLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~~~~-~---~~~~~~apE~~~ 686 (689)
......... . .+..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~ 182 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIA 182 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhc
Confidence 654322111 1 124699999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=223.25 Aligned_cols=175 Identities=22% Similarity=0.394 Sum_probs=143.7
Q ss_pred ccCCCccceEeecCCeEEEEEEeC--------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAE 578 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~ 578 (689)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 356788899999999999999631 24579999886542 234456788999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeE
Q 005587 579 HGQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646 (689)
Q Consensus 579 ~~~~~lV~Ey~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NIL 646 (689)
.+..|+||||+++|+|.+++..... ....+++..++.++.|+++||.|||+. +|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999976421 123578899999999999999999987 8999999999999
Q ss_pred ecCCCcEEEEeecCCccccCCCccee---ecccceEEeccccc
Q 005587 647 LDDDLAVSVSDCGLAPLISSGSVSQV---SHNLTIMRAGGVTH 686 (689)
Q Consensus 647 l~~~~~~kl~DFGla~~~~~~~~~~~---~~~~~~~~apE~~~ 686 (689)
+++++.+||+|||+++.+........ ..++..|+|||++.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 212 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF 212 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhc
Confidence 99999999999999998755332221 22335699999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-25 Score=236.56 Aligned_cols=169 Identities=22% Similarity=0.370 Sum_probs=142.8
Q ss_pred cceEeecCCeEEEEEEe-CCCcEEEEEEecccc--CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCe--EEEEEec
Q 005587 514 ENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA--SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ--RLLIYEY 588 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~--~~lV~Ey 588 (689)
.++||+|+|-+||+|.. .+|.+||--.++... ......+.|..|+.+|+.|+|||||++|.+|.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 46899999999999954 468888765444322 233445889999999999999999999999987554 7799999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec-CCCcEEEEeecCCccccCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~ 667 (689)
|..|+|..|.++. +.++......|++||++||.|||++ .|+|||||||-+||+|+ ..|.+||+|.|||+.+...
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999875 3577889999999999999999997 68999999999999997 5789999999999998765
Q ss_pred CcceeecccceEEeccccccC
Q 005587 668 SVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~~~ 688 (689)
.... ..||+.|||||+.--+
T Consensus 200 ~aks-vIGTPEFMAPEmYEE~ 219 (632)
T KOG0584|consen 200 HAKS-VIGTPEFMAPEMYEEN 219 (632)
T ss_pred ccce-eccCccccChHHHhhh
Confidence 5444 7899999999997433
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=219.84 Aligned_cols=167 Identities=28% Similarity=0.458 Sum_probs=139.7
Q ss_pred CCccceEeecCCeEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeEE
Q 005587 511 FSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRL 583 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~ 583 (689)
|+..+.||+|+||+||++.. .++..||+|.+..... ......+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 37789999999999988642 3578899999865432 33456788999999999999999999998764 4689
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+||||+++|+|.+++.. ..+++..++.|+.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999999874 3589999999999999999999987 899999999999999999999999999998
Q ss_pred ccCCCc----ceeecccceEEeccccc
Q 005587 664 ISSGSV----SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~----~~~~~~~~~~~apE~~~ 686 (689)
+..+.. .....+..+|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhc
Confidence 765432 12234456799999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=223.97 Aligned_cols=174 Identities=25% Similarity=0.394 Sum_probs=142.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC--------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~ 579 (689)
++|.+.+.||+|+||.||+|... ++..+|+|.+..... .....++.+|++++.++ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 46888999999999999999642 235799999875432 33456788899999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl 647 (689)
+..|+||||+++|+|.+++..... ....++|.++++++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999976431 123589999999999999999999987 89999999999999
Q ss_pred cCCCcEEEEeecCCccccCCCcceee---cccceEEeccccc
Q 005587 648 DDDLAVSVSDCGLAPLISSGSVSQVS---HNLTIMRAGGVTH 686 (689)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~~---~~~~~~~apE~~~ 686 (689)
+.++.+||+|||+++.+......... .....|+|||++.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 215 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhc
Confidence 99999999999999876543322111 1234699999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=222.29 Aligned_cols=175 Identities=23% Similarity=0.410 Sum_probs=144.6
Q ss_pred ccCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCC
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG 580 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~ 580 (689)
.++|+..+.||+|+||.||++... ....+|+|.+..... ......+.+|++++.++ +|+||+++++++...+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 356888899999999999999753 236899999875433 33456788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDD------------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD 648 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~ 648 (689)
..++||||+++|+|.++++... .....+++..++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999997532 1234689999999999999999999987 899999999999999
Q ss_pred CCCcEEEEeecCCccccCCCcceee---cccceEEeccccc
Q 005587 649 DDLAVSVSDCGLAPLISSGSVSQVS---HNLTIMRAGGVTH 686 (689)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~~~~~~~---~~~~~~~apE~~~ 686 (689)
+++.+||+|||+++.+......... .....|+|||++.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 207 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF 207 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc
Confidence 9999999999999987654332211 1234699999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=218.36 Aligned_cols=173 Identities=25% Similarity=0.409 Sum_probs=141.5
Q ss_pred CCccceEeecCCeEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCe-----
Q 005587 511 FSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ----- 581 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~----- 581 (689)
|.+.+.||+|+||.||+|.... +..||||++............+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999997542 3689999987655445556789999999999999999999999876554
Q ss_pred -EEEEEeccCCCCHHHHHhcCcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 582 -RLLIYEYCSNGTLQDMLHSDDE--LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 582 -~~lV~Ey~~ggsL~~~l~~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
.++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999865321 234689999999999999999999987 8999999999999999999999999
Q ss_pred cCCccccCCCcce---eecccceEEeccccc
Q 005587 659 GLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
|+++.+....... ....+..|+|||++.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA 188 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcc
Confidence 9998775443211 112234699999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=220.44 Aligned_cols=174 Identities=26% Similarity=0.428 Sum_probs=143.5
Q ss_pred cCCCccceEeecCCeEEEEEEeCC------CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
++|++.+.||+|+||.||+|.... ...||+|.+.... .......|.+|++.+++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 367788999999999999997533 2579999986543 234456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC
Q 005587 583 LLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~ 650 (689)
+++|||+++|+|.+++..... ....+++...+.++.|++.||.|||+. +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999975321 114588899999999999999999997 89999999999999999
Q ss_pred CcEEEEeecCCccccCCCcce---eecccceEEeccccc
Q 005587 651 LAVSVSDCGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 651 ~~~kl~DFGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
+.+||+|||+++......... ...++..|+|||.+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL 199 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhc
Confidence 999999999998764433211 123346699999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=228.13 Aligned_cols=174 Identities=27% Similarity=0.393 Sum_probs=140.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC-C
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH-G 580 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~-~ 580 (689)
++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++.++ +|+||++++++|... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 47888999999999999999532 357899999865432 33446678899999999 899999999988754 5
Q ss_pred eEEEEEeccCCCCHHHHHhcCccc--------------------------------------------------------
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDEL-------------------------------------------------------- 604 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~-------------------------------------------------------- 604 (689)
..+++|||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998643210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcce---eecccceEE
Q 005587 605 -KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ---VSHNLTIMR 680 (689)
Q Consensus 605 -~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~---~~~~~~~~~ 680 (689)
...++|..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....... ...++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 13689999999999999999999987 89999999999999999999999999999875433211 112234699
Q ss_pred eccccc
Q 005587 681 AGGVTH 686 (689)
Q Consensus 681 apE~~~ 686 (689)
|||++.
T Consensus 243 aPE~~~ 248 (337)
T cd05054 243 APESIF 248 (337)
T ss_pred CcHHhc
Confidence 999763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=227.52 Aligned_cols=173 Identities=25% Similarity=0.391 Sum_probs=139.3
Q ss_pred cCCCccceEeecCCeEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC-C
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH-G 580 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~-~ 580 (689)
++|++.+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 5788999999999999999963 3578899999875432 23456788999999999 689999999988764 4
Q ss_pred eEEEEEeccCCCCHHHHHhcCcc---------------------------------------------------------
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDE--------------------------------------------------------- 603 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~--------------------------------------------------------- 603 (689)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999875321
Q ss_pred ------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcce---eec
Q 005587 604 ------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ---VSH 674 (689)
Q Consensus 604 ------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~---~~~ 674 (689)
....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012478889999999999999999987 89999999999999999999999999998764332111 112
Q ss_pred ccceEEecccc
Q 005587 675 NLTIMRAGGVT 685 (689)
Q Consensus 675 ~~~~~~apE~~ 685 (689)
.+..|+|||++
T Consensus 243 ~~~~y~aPE~~ 253 (343)
T cd05103 243 LPLKWMAPETI 253 (343)
T ss_pred CCcceECcHHh
Confidence 23469999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=222.35 Aligned_cols=174 Identities=25% Similarity=0.393 Sum_probs=140.5
Q ss_pred cCCCccceEeecCCeEEEEEEeCC-Cc--EEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD-GK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 584 (689)
++|++.+.||+|+||.||+|...+ +. .+++|.+.... .....+.+.+|++++.++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 578889999999999999997653 33 47888876422 234456788999999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCc
Q 005587 585 IYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~ 652 (689)
||||+++|+|.++++.... ....+++..++.|+.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 9999999999999975321 123588999999999999999999987 8999999999999999999
Q ss_pred EEEEeecCCccccCCCcceeecccceEEeccccc
Q 005587 653 VSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 653 ~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+||+|||++.................|+|||+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 191 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLN 191 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhc
Confidence 9999999997543222111122234599999863
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=244.35 Aligned_cols=170 Identities=22% Similarity=0.285 Sum_probs=146.4
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|.+.+.||+|+||.||+|... +++.||||++..... .......+.+|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999765 689999999875432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+.|++|.+++... ..+++..++.|+.||+.||.|||.. +||||||||+|||++.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999999753 3578899999999999999999987 899999999999999999999999999998765
Q ss_pred CC-cceeecccceEEecccc
Q 005587 667 GS-VSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 667 ~~-~~~~~~~~~~~~apE~~ 685 (689)
.. ......+++.|++||..
T Consensus 157 ~~~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 157 RELNMMDILTTPSMAKPKND 176 (669)
T ss_pred CcccccccccCccccCcccc
Confidence 43 22345677788888865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=220.21 Aligned_cols=172 Identities=21% Similarity=0.318 Sum_probs=143.1
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|++.+.||+|+||.||+|+.. ++..||||.+............+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999764 689999999865443333456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
++ ++|.+++..... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 689888865322 34689999999999999999999987 89999999999999999999999999998664332
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. ....++..|+|||++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLL 174 (285)
T ss_pred ccccCCcccccccChHHhc
Confidence 11 1223467799999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=216.80 Aligned_cols=170 Identities=22% Similarity=0.388 Sum_probs=143.5
Q ss_pred CCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCC----hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASS----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
+|...+.||+|+||.||+|...+|+.+|||.+...... ......+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36778999999999999998888999999988654221 22335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++..+.
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999753 3578899999999999999999987 89999999999999999999999999998653
Q ss_pred CCC-------cceeecccceEEeccccc
Q 005587 666 SGS-------VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~-------~~~~~~~~~~~~apE~~~ 686 (689)
... ......++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 181 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVIN 181 (265)
T ss_pred hccccccccccccccCCCccccChhhhc
Confidence 211 111234667899999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=218.08 Aligned_cols=167 Identities=26% Similarity=0.376 Sum_probs=134.4
Q ss_pred eEeecCCeEEEEEEeCCC---cEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 516 LIGAGMLGSVYRAQLPDG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~g---~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
.||+|+||.||+|+..++ ..+++|.+..... ....+.|.+|+.+++.++||||+++++++......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 589999999999975443 3456666654322 344678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC---c
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS---V 669 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---~ 669 (689)
+|.++++.........++.....++.||++||+|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986433334567778889999999999999987 89999999999999999999999999987532211 1
Q ss_pred ceeecccceEEeccccc
Q 005587 670 SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~~~~~~~~~~apE~~~ 686 (689)
.....++..|+|||++.
T Consensus 158 ~~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 158 EDDKCVPLRWLAPELVG 174 (268)
T ss_pred ccCCcCcccccCchhcc
Confidence 11234456799999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-24 Score=220.43 Aligned_cols=173 Identities=18% Similarity=0.307 Sum_probs=145.9
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||+|... +|+.||+|.+.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 35788899999999999999765 78999999886542 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++.... ....+++..+..++.|+++||.|||+. .+|+||||||+||+++.++.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999887532 123689999999999999999999974 27999999999999999999999999999876443
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
.. ....++..|+|||.+.
T Consensus 157 ~~-~~~~~~~~y~aPE~~~ 174 (286)
T cd06622 157 LA-KTNIGCQSYMAPERIK 174 (286)
T ss_pred cc-ccCCCccCccCcchhc
Confidence 32 2234667899999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=220.08 Aligned_cols=174 Identities=24% Similarity=0.397 Sum_probs=144.4
Q ss_pred cCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
++|.+.+.||+|+||.||+|... +++.||||.+..... ......+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45778899999999999999653 347899999865432 33457899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcc----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDE----------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~ 652 (689)
++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976421 124578999999999999999999987 8999999999999999999
Q ss_pred EEEEeecCCccccCCCc---ceeecccceEEeccccc
Q 005587 653 VSVSDCGLAPLISSGSV---SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 653 ~kl~DFGla~~~~~~~~---~~~~~~~~~~~apE~~~ 686 (689)
+||+|||+++.+..... ......+..|+|||++.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM 197 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhc
Confidence 99999999986543321 11222345699999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=214.68 Aligned_cols=170 Identities=26% Similarity=0.371 Sum_probs=145.9
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC---ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS---SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
+|+..+.||+|+||.||+|... +++.|++|.+..... .....+.+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999765 789999998865321 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999753 3578999999999999999999987 89999999999999999999999999998876
Q ss_pred CCCcceeecccceEEeccccc
Q 005587 666 SGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~apE~~~ 686 (689)
.........++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~ 174 (258)
T cd06632 154 EFSFAKSFKGSPYWMAPEVIA 174 (258)
T ss_pred ccccccccCCCcceeCHHHhc
Confidence 554333345677899999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=219.98 Aligned_cols=168 Identities=38% Similarity=0.580 Sum_probs=137.1
Q ss_pred ccceEeecCCeEEEEEEeC-----CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 513 QENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.+.||.|.||.||+|.+. .+..|+||.+... ......+.|.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4578999999999999775 2578999999553 334457889999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.++|+... ...+++..+..|+.||++||.|||+. +|+|+||+++|||+++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999998742 35689999999999999999999997 8999999999999999999999999999987433
Q ss_pred Ccc---eeecccceEEeccccc
Q 005587 668 SVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~---~~~~~~~~~~apE~~~ 686 (689)
... ........|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~ 178 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLK 178 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHH
T ss_pred cccccccccccccccccccccc
Confidence 222 1122345588999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=220.30 Aligned_cols=173 Identities=23% Similarity=0.380 Sum_probs=143.4
Q ss_pred cCCCccceEeecCCeEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
++|.+.+.||+|+||.||++.. .++..+|+|.+... .......+.+|++++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4688889999999999999964 23456899988643 234456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcc---------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcE
Q 005587 583 LLIYEYCSNGTLQDMLHSDDE---------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAV 653 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~---------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~ 653 (689)
++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999999975321 123589999999999999999999987 89999999999999999999
Q ss_pred EEEeecCCccccCCCcce---eecccceEEeccccc
Q 005587 654 SVSDCGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 654 kl~DFGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
||+|||+++.+....... ...++..|+|||++.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 195 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 195 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhc
Confidence 999999998765433211 122345799999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=249.29 Aligned_cols=178 Identities=24% Similarity=0.257 Sum_probs=154.2
Q ss_pred hhHhhhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeC
Q 005587 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEH 579 (689)
Q Consensus 502 ~~l~~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~ 579 (689)
.+++.-.++|.+.++||+|+||.|..++++ +++.||+|++.+..+- ......|.+|-.+|...+.+-||.++-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 345555678999999999999999999765 6889999999875433 23445688888999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
.++|+|||||+||||-.++...+ .+++..++.|+..|.-||.-||+. |+|||||||+|||||..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 99999999999999999998642 689999999999999999999998 89999999999999999999999999
Q ss_pred CCccccC-CC-cceeecccceEEeccccc
Q 005587 660 LAPLISS-GS-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~-~~-~~~~~~~~~~~~apE~~~ 686 (689)
-+-.+.. |. .+....||+-|.+|||+.
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLq 249 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQ 249 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHH
Confidence 9887774 44 345577888899999983
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=219.41 Aligned_cols=170 Identities=23% Similarity=0.398 Sum_probs=141.9
Q ss_pred CCCccceEeecCCeEEEEEEe-----CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQR 582 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~ 582 (689)
.|++.+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|++++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 467789999999999999964 357889999986543 233456789999999999999999999999875 578
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
++||||++|++|.+++... ...++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998653 23589999999999999999999987 89999999999999999999999999998
Q ss_pred cccCCCcc----eeecccceEEeccccc
Q 005587 663 LISSGSVS----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~~----~~~~~~~~~~apE~~~ 686 (689)
.+...... ....+...|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhc
Confidence 77543321 1233455699999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=219.14 Aligned_cols=168 Identities=27% Similarity=0.380 Sum_probs=143.8
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|.+.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 4677889999999999999965 468999999986543 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++... ..+++.+++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++..+...
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 87 FCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999998753 4688999999999999999999987 8999999999999999999999999999866433
Q ss_pred Cc-ceeecccceEEecccc
Q 005587 668 SV-SQVSHNLTIMRAGGVT 685 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~ 685 (689)
.. .....++..|+|||++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~ 178 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred ccccccccCcccccChhhh
Confidence 21 2224567889999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=217.66 Aligned_cols=169 Identities=25% Similarity=0.402 Sum_probs=142.8
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|.+.+.||+|+||.||+|... +++.||+|.+.... ....++.+|++++++++|+||+++++++...+..++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 4677889999999999999654 58899999986432 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999987533 34689999999999999999999987 89999999999999999999999999999876543
Q ss_pred ccee--ecccceEEeccccc
Q 005587 669 VSQV--SHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~--~~~~~~~~apE~~~ 686 (689)
.... ...+..|+|||.+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~ 178 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLA 178 (263)
T ss_pred eeccCCCCCccccCCHHHhc
Confidence 2221 11234599999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=218.10 Aligned_cols=168 Identities=26% Similarity=0.410 Sum_probs=141.1
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
++|.+.+.||+|+||.||+|...++..||+|++..... ....+.+|++++++++||||+++++++. .+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 46888999999999999999887777899999875332 3457889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|.+++.... ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.+....
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999997532 34578999999999999999999987 89999999999999999999999999998776544
Q ss_pred cce--eecccceEEecccc
Q 005587 669 VSQ--VSHNLTIMRAGGVT 685 (689)
Q Consensus 669 ~~~--~~~~~~~~~apE~~ 685 (689)
... ...+...|++||..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~ 175 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAA 175 (262)
T ss_pred cccccCCcccceecCHhHh
Confidence 221 12234569999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=218.31 Aligned_cols=170 Identities=24% Similarity=0.292 Sum_probs=148.1
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+|++.+.||+|+||.||+|... +++.||+|.+.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999765 6899999998764332 2456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+.+++|.+++... ..+++..+..|+.|+++||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999753 4688999999999999999999987 8999999999999999999999999999887665
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
.......+...|+|||++.
T Consensus 154 ~~~~~~~~~~~y~~PE~~~ 172 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLC 172 (258)
T ss_pred ccccccCCChhhcCHHHHc
Confidence 4434455667799999874
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=214.06 Aligned_cols=165 Identities=24% Similarity=0.407 Sum_probs=139.1
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
++||+|+||.||+|...++..||+|.+..... ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999888889999999865432 34455788999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCccee--
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV-- 672 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-- 672 (689)
.+++.... ..+++..++.++.|++.||.|+|+. +++||||||+||+++.++.+||+|||++.....+.....
T Consensus 80 ~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 80 LSFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 99986532 3578999999999999999999987 899999999999999999999999999986554332211
Q ss_pred ecccceEEeccccc
Q 005587 673 SHNLTIMRAGGVTH 686 (689)
Q Consensus 673 ~~~~~~~~apE~~~ 686 (689)
......|+|||++.
T Consensus 154 ~~~~~~y~aPE~~~ 167 (250)
T cd05085 154 KQIPIKWTAPEALN 167 (250)
T ss_pred CCCcccccCHHHhc
Confidence 12234599999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=215.60 Aligned_cols=163 Identities=22% Similarity=0.348 Sum_probs=136.1
Q ss_pred eEeecCCeEEEEEEe---CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 516 LIGAGMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
.||+|+||.||+|.+ .++..+|+|++..........+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999964 357899999987554444556789999999999999999999998864 5678999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCccee
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 672 (689)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999752 4688999999999999999999987 899999999999999999999999999988755432211
Q ss_pred ----ecccceEEeccccc
Q 005587 673 ----SHNLTIMRAGGVTH 686 (689)
Q Consensus 673 ----~~~~~~~~apE~~~ 686 (689)
...+..|+|||.+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05116 154 AKTHGKWPVKWYAPECMN 171 (257)
T ss_pred ecCCCCCCccccCHhHhc
Confidence 11135799999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=215.93 Aligned_cols=177 Identities=23% Similarity=0.372 Sum_probs=148.4
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCeEEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLIY 586 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 586 (689)
+|++.+.||.|+||.||++.. .+++.||+|.+..........+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999964 568899999987655555566778899999999999999999998764 45689999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC--QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||+++++|.+++.........+++..++.++.|+++||.|||..+ ..+|+|+||||+||++++++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764333457899999999999999999999332 238999999999999999999999999999988
Q ss_pred cCCCc-ceeecccceEEeccccc
Q 005587 665 SSGSV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~-~~~~~~~~~~~apE~~~ 686 (689)
..... .....++..|++||++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~ 183 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLN 183 (265)
T ss_pred cCCcccccccccCCCccChhhhc
Confidence 66543 22345678899999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=220.28 Aligned_cols=169 Identities=23% Similarity=0.345 Sum_probs=143.3
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC---hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
+|+..+.||+|+||.||+|... +|+.||||.+...... ......+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3777889999999999999764 6899999998765432 22345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+ +|+|.+++.... ..+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997532 3689999999999999999999987 89999999999999999999999999998876
Q ss_pred CCCc-ceeecccceEEecccc
Q 005587 666 SGSV-SQVSHNLTIMRAGGVT 685 (689)
Q Consensus 666 ~~~~-~~~~~~~~~~~apE~~ 685 (689)
.... ......+..|+|||++
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELL 174 (298)
T ss_pred CCCccccccccceeeeCHHHH
Confidence 5432 2223446779999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=220.41 Aligned_cols=175 Identities=22% Similarity=0.292 Sum_probs=142.0
Q ss_pred ccCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (689)
.++|++.+.||+|+||.||+|..+ .+..||+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 467889999999999999999643 245899998865432 2344568889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEE
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDE------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl 655 (689)
.++||||+++|+|.+++..... ......+..+..++.|++.||.|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 123456778899999999999999987 8999999999999999999999
Q ss_pred EeecCCccccCCCcce---eecccceEEeccccc
Q 005587 656 SDCGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 656 ~DFGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
+|||+++.+....... ...+...|+|||.+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 194 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhc
Confidence 9999998764433211 112245699999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=223.60 Aligned_cols=165 Identities=21% Similarity=0.301 Sum_probs=132.7
Q ss_pred cceEeecCCeEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCeEEEEEec
Q 005587 514 ENLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLIYEY 588 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey 588 (689)
.++||+|+||.||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999754 467899999865432 3456789999999999999999998864 4578999999
Q ss_pred cCCCCHHHHHhcCcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe----cCCCcEEEEeec
Q 005587 589 CSNGTLQDMLHSDDE-----LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCG 659 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~-----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl----~~~~~~kl~DFG 659 (689)
+. ++|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +..+.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 95 588888764321 123588999999999999999999987 89999999999999 456789999999
Q ss_pred CCccccCCCcc----eeecccceEEeccccc
Q 005587 660 LAPLISSGSVS----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~----~~~~~~~~~~apE~~~ 686 (689)
+|+.+...... ....++..|+|||++.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 188 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLL 188 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHc
Confidence 99887543221 2235577899999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=213.74 Aligned_cols=171 Identities=20% Similarity=0.310 Sum_probs=145.0
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|++.+.||+|+||.||+++.. +++.+|+|.+..... ....+.+.+|+.+++.++|+||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4778899999999999999654 689999999865432 33456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|.+++.... ...+++...+.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 80 CDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999999886532 34578899999999999999999987 89999999999999999999999999998775433
Q ss_pred c-ceeecccceEEeccccc
Q 005587 669 V-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~-~~~~~~~~~~~apE~~~ 686 (689)
. .....++..|+|||++.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~ 173 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWE 173 (255)
T ss_pred cccccccCCccccCHHHHc
Confidence 2 22345667799999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=218.42 Aligned_cols=170 Identities=23% Similarity=0.324 Sum_probs=147.1
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|++.+.||+|+||.||+|... +|+.||||++............+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999764 689999999876544344456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987532 5689999999999999999999987 89999999999999999999999999999876543
Q ss_pred c--ceeecccceEEeccccc
Q 005587 669 V--SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~--~~~~~~~~~~~apE~~~ 686 (689)
. .....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLY 173 (286)
T ss_pred CCccccccCcccccCceeee
Confidence 2 22345677899999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=219.70 Aligned_cols=182 Identities=28% Similarity=0.396 Sum_probs=150.0
Q ss_pred cchhhHhhhccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEE
Q 005587 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYC 576 (689)
Q Consensus 499 ~~~~~l~~~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~ 576 (689)
+++.++..+.++|.+.+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 45566667788999999999999999999976 468899999986432 2345677888999988 899999999998
Q ss_pred EeC-----CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC
Q 005587 577 AEH-----GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (689)
Q Consensus 577 ~~~-----~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~ 651 (689)
... +..++||||+++|+|.++++........+++..++.++.|++.||+|||+. +|+||||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 754 368999999999999998875333345689999999999999999999987 899999999999999999
Q ss_pred cEEEEeecCCccccCCCc-ceeecccceEEeccccc
Q 005587 652 AVSVSDCGLAPLISSGSV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 652 ~~kl~DFGla~~~~~~~~-~~~~~~~~~~~apE~~~ 686 (689)
.+||+|||+++.+..... .....++..|+|||++.
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhhc
Confidence 999999999987654332 22234567799999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=218.76 Aligned_cols=172 Identities=24% Similarity=0.404 Sum_probs=143.4
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC-----
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH----- 579 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~----- 579 (689)
+.+.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 4567888899999999999999754 68899999986542 2345678899999988 799999999998753
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 580 -GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 580 -~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
...|+||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 46899999999999999987632 34688999999999999999999987 8999999999999999999999999
Q ss_pred cCCccccCCC-cceeecccceEEeccccc
Q 005587 659 GLAPLISSGS-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~-~~~~~~~~~~~~apE~~~ 686 (689)
|+++.+.... ......++..|+|||++.
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhc
Confidence 9998764432 222345677899999873
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=214.73 Aligned_cols=167 Identities=28% Similarity=0.438 Sum_probs=144.0
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
++|++.+.||+|+||.||+|... |+.||+|.+..... ...++.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 46788899999999999999874 78999999865432 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999997633 23689999999999999999999987 89999999999999999999999999999874433
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
. .......|+|||.+.
T Consensus 157 ~--~~~~~~~~~ape~~~ 172 (256)
T cd05039 157 D--SGKLPVKWTAPEALR 172 (256)
T ss_pred c--cCCCcccccCchhhc
Confidence 2 223345699999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=214.20 Aligned_cols=172 Identities=23% Similarity=0.385 Sum_probs=144.5
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe-CCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 587 (689)
+|++.+.||+|++|.||++... +++.||+|.+..........+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999654 57899999987654444556678899999999999999999988764 446899999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997532 34589999999999999999999987 8999999999999999999999999999877543
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......++..|+|||+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~ 175 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFS 175 (257)
T ss_pred CCccccccCCcCccChhHhc
Confidence 2 222334567899999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=216.86 Aligned_cols=169 Identities=26% Similarity=0.419 Sum_probs=142.2
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 46888899999999999999888888999999875433 2456889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.++++... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.++|+|||++..+....
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999997532 34589999999999999999999987 89999999999999999999999999998775543
Q ss_pred ccee--ecccceEEeccccc
Q 005587 669 VSQV--SHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~--~~~~~~~~apE~~~ 686 (689)
.... ..+...|+|||++.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~ 176 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred cccccCCCCCccccChHHHh
Confidence 2211 12234699999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=216.20 Aligned_cols=160 Identities=24% Similarity=0.369 Sum_probs=133.6
Q ss_pred ceEeecCCeEEEEEEeCCCc-----------EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 515 NLIGAGMLGSVYRAQLPDGK-----------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
+.||+|+||.||+|.+.+.. .|++|.+..... ....|.+|+.++++++||||+++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999775432 577787654321 25788899999999999999999999988 7889
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC-------cEEEE
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-------AVSVS 656 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-------~~kl~ 656 (689)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 9999999999999997632 2688999999999999999999987 899999999999999887 79999
Q ss_pred eecCCccccCCCcceeecccceEEecccccc
Q 005587 657 DCGLAPLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~~~~apE~~~~ 687 (689)
|||++..+.... ...+...|+|||++..
T Consensus 151 Dfg~a~~~~~~~---~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 151 DPGIPITVLSRE---ERVERIPWIAPECIRN 178 (259)
T ss_pred CCCccccccccc---ccccCCCccChhhhcC
Confidence 999999865522 2334567999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-24 Score=245.62 Aligned_cols=173 Identities=29% Similarity=0.466 Sum_probs=145.6
Q ss_pred CCCccceEeecCCeEEEEEEeCC--Cc----EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPD--GK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~--g~----~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
+-...+.||+|+||.||.|.+.+ |. .||||.+.+.. +.+...+|++|..+|++++|||||+++|.|.+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 44567889999999999997643 43 48999987654 4677889999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 584 LIYEYCSNGTLQDMLHSDDE---LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
|++|||+||||..+|++.+. ....+.....+.++.|||+|+.||++. ++|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999997532 134688899999999999999999998 799999999999999999999999999
Q ss_pred CccccCCCcceeecc-cc--eEEeccccc
Q 005587 661 APLISSGSVSQVSHN-LT--IMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~~~~~~~-~~--~~~apE~~~ 686 (689)
|+.+-..+....... +. -|||||.+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHh
Confidence 996554443332222 32 289999985
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=218.21 Aligned_cols=174 Identities=22% Similarity=0.292 Sum_probs=143.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
++|.+.+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 57888899999999999999653 246899999865432 33456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEE
Q 005587 583 LLIYEYCSNGTLQDMLHSDDEL------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVS 656 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~ 656 (689)
++||||+++|+|.+++...... ...++|..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321 22478999999999999999999987 89999999999999999999999
Q ss_pred eecCCccccCCCcc---eeecccceEEeccccc
Q 005587 657 DCGLAPLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 657 DFGla~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
|||+++.+...... ....++..|+|||.+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHh
Confidence 99999876543321 1223346799999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=219.27 Aligned_cols=174 Identities=25% Similarity=0.373 Sum_probs=144.3
Q ss_pred cCCCccceEeecCCeEEEEEEeCC-----------------CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcce
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD-----------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~-----------------g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~ 571 (689)
++|++.+.||+|+||.||+|.... +..||+|.+..... ......+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeE
Confidence 578889999999999999986532 24589999875533 345678899999999999999999
Q ss_pred ecEEEEeCCeEEEEEeccCCCCHHHHHhcCcc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCC
Q 005587 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE-------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSAN 644 (689)
Q Consensus 572 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~N 644 (689)
+++++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976431 123689999999999999999999987 89999999999
Q ss_pred eEecCCCcEEEEeecCCccccCCCcce---eecccceEEeccccc
Q 005587 645 ILLDDDLAVSVSDCGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 645 ILl~~~~~~kl~DFGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
|++++++.++|+|||+++.+....... ....+..|+|||++.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL 205 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh
Confidence 999999999999999998765443221 122345799999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=213.74 Aligned_cols=172 Identities=22% Similarity=0.342 Sum_probs=148.6
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..+.||+|+||.||+|.. .+++.+|||.+............+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999965 4688999999876554445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC-CcEEEEeecCCccccCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGLAPLISSG 667 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~~~ 667 (689)
+++++|.+++.... ...+++..++.++.|+++||.|||+. +|+|+||||+||+++++ +.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997632 34588999999999999999999987 89999999999999854 46899999999988766
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
.......++..|+|||++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08220 156 SKAYTVVGTPCYISPELCE 174 (256)
T ss_pred ccccccccCCcccCchhcc
Confidence 5555556677899999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=218.27 Aligned_cols=170 Identities=25% Similarity=0.388 Sum_probs=137.5
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCc----EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
++|++.+.||+|+||.||+|.+. +++ .+++|.+.... ......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46777899999999999999764 444 47777775332 23344677888889999999999999998764 4578
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+++||+++|+|.+++... ...++|..+..|+.||+.||.|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 85 ~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999999753 24689999999999999999999987 899999999999999999999999999987
Q ss_pred ccCCCcce---eecccceEEeccccc
Q 005587 664 ISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
+....... ...+...|++||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~ 184 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESIL 184 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhc
Confidence 75443221 122345699999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=214.74 Aligned_cols=171 Identities=23% Similarity=0.307 Sum_probs=141.0
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~---~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~ 582 (689)
++|++.+.||+|+||.||+|.. .+|+.||||.+...... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999965 46899999988643211 22346788899999999999999999988763 568
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
++||||+++++|.+++... ..+++...+.++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998753 3478888999999999999999987 89999999999999999999999999998
Q ss_pred cccCCCc----ceeecccceEEeccccc
Q 005587 663 LISSGSV----SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~----~~~~~~~~~~~apE~~~ 686 (689)
.+..... .....++..|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVIS 182 (265)
T ss_pred ccccccccccccccCCCCccccChhhhc
Confidence 7643211 11234566899999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=219.06 Aligned_cols=173 Identities=24% Similarity=0.347 Sum_probs=141.9
Q ss_pred CCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
.|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++.+++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667788999999999999753 257899999875432 233567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC
Q 005587 584 LIYEYCSNGTLQDMLHSDD------------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~ 651 (689)
+++||+.+++|.+++.... .....+++..+..++.|+++||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123588899999999999999999987 899999999999999999
Q ss_pred cEEEEeecCCccccCCCcce---eecccceEEeccccc
Q 005587 652 AVSVSDCGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
.+||+|||+++.+....... ....+..|+|||.+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM 199 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHh
Confidence 99999999998765443221 122345799999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=218.53 Aligned_cols=173 Identities=25% Similarity=0.389 Sum_probs=140.9
Q ss_pred CCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
+|++.+.||+|+||.||+|... ....+|+|.+..... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4677889999999999999642 235788888865432 344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCC
Q 005587 584 LIYEYCSNGTLQDMLHSDDE--------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSA 643 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~ 643 (689)
+||||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 99999999999999865321 123588999999999999999999987 8999999999
Q ss_pred CeEecCCCcEEEEeecCCccccCCCcc---eeecccceEEeccccc
Q 005587 644 NILLDDDLAVSVSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 644 NILl~~~~~~kl~DFGla~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
|||+++++.+||+|||+++.+...... .....+..|+|||.+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 999999999999999999876433211 1122345799999763
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=231.91 Aligned_cols=179 Identities=24% Similarity=0.397 Sum_probs=153.1
Q ss_pred chhhHhhhccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEE
Q 005587 500 TIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCA 577 (689)
Q Consensus 500 ~~~~l~~~~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~ 577 (689)
.++.+...++-|++.+.||+|.+|.||+++ .++++.+|||++.... ..++++..|.++++.. .|||++.++|+|.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 445555667789999999999999999995 5679999999986543 3456777888888776 6999999999997
Q ss_pred e-----CCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCc
Q 005587 578 E-----HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (689)
Q Consensus 578 ~-----~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~ 652 (689)
. .+++|||||||.|||.-|+++... ...+.|..+..|.+.+++|+.+||.. .+||||||-.|||++.++.
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence 4 578999999999999999998755 56799999999999999999999987 7999999999999999999
Q ss_pred EEEEeecCCccccCCC-cceeecccceEEeccccc
Q 005587 653 VSVSDCGLAPLISSGS-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 653 ~kl~DFGla~~~~~~~-~~~~~~~~~~~~apE~~~ 686 (689)
+|++|||++..+...- ......++++|||||++-
T Consensus 162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEVia 196 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIA 196 (953)
T ss_pred EEEeeeeeeeeeecccccccCcCCCcccccceeee
Confidence 9999999999887643 334467889999999983
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=219.83 Aligned_cols=173 Identities=24% Similarity=0.401 Sum_probs=141.9
Q ss_pred cCCCccceEeecCCeEEEEEEeC-----------------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcce
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-----------------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVE 571 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-----------------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~ 571 (689)
++|++.+.||+|+||.||+++.. +...||+|.+.... .......|.+|++++++++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 56888999999999999998532 23468999986543 2344568899999999999999999
Q ss_pred ecEEEEeCCeEEEEEeccCCCCHHHHHhcCccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCC
Q 005587 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDEL-------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSAN 644 (689)
Q Consensus 572 l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~N 644 (689)
+++++...+..++||||+.+|+|.+++...... ...+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998764311 13478889999999999999999987 89999999999
Q ss_pred eEecCCCcEEEEeecCCccccCCCccee---ecccceEEecccc
Q 005587 645 ILLDDDLAVSVSDCGLAPLISSGSVSQV---SHNLTIMRAGGVT 685 (689)
Q Consensus 645 ILl~~~~~~kl~DFGla~~~~~~~~~~~---~~~~~~~~apE~~ 685 (689)
||++.++.++|+|||+++.+........ ......|++||+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 204 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI 204 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH
Confidence 9999999999999999987654432211 1223568999965
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=214.14 Aligned_cols=162 Identities=20% Similarity=0.344 Sum_probs=133.8
Q ss_pred EeecCCeEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCC
Q 005587 517 IGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT 593 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 593 (689)
||+|+||.||+|.+. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 899999999999653 35679999986543 23445678999999999999999999998864 57899999999999
Q ss_pred HHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcceee
Q 005587 594 LQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVS 673 (689)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 673 (689)
|.+++... ...+++..+++++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++.+.........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998743 34689999999999999999999987 8999999999999999999999999999876544322111
Q ss_pred ----cccceEEeccccc
Q 005587 674 ----HNLTIMRAGGVTH 686 (689)
Q Consensus 674 ----~~~~~~~apE~~~ 686 (689)
..+..|+|||++.
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (257)
T cd05115 155 RSAGKWPLKWYAPECIN 171 (257)
T ss_pred cCCCCCCcccCCHHHHc
Confidence 1135699999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=218.30 Aligned_cols=173 Identities=22% Similarity=0.368 Sum_probs=143.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+.... ......+.+|++.+++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 35777889999999999999642 35568999875432 33456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC
Q 005587 583 LLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~ 650 (689)
++||||+++++|.+++..... ....++|..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999975321 123589999999999999999999987 89999999999999999
Q ss_pred CcEEEEeecCCccccCCCc---ceeecccceEEeccccc
Q 005587 651 LAVSVSDCGLAPLISSGSV---SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 651 ~~~kl~DFGla~~~~~~~~---~~~~~~~~~~~apE~~~ 686 (689)
+.+||+|||+++....... .....++..|+|||++.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 198 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 198 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhc
Confidence 9999999999987654332 12233456799999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=217.10 Aligned_cols=170 Identities=22% Similarity=0.404 Sum_probs=140.3
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCc----EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~----~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
++|+..+.||+|+||.||+|.+ .+|+ .||+|.+.... .......+.+|+.+++.+.||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 4678889999999999999974 3454 48999986543 23446678899999999999999999999875 4578
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
++|||+++|+|.++++.. ...+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999753 23589999999999999999999987 899999999999999999999999999998
Q ss_pred ccCCCcceee---cccceEEeccccc
Q 005587 664 ISSGSVSQVS---HNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~~~~---~~~~~~~apE~~~ 686 (689)
+......... .....|++||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESIL 184 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhc
Confidence 7644332222 1235699999874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=221.20 Aligned_cols=174 Identities=25% Similarity=0.406 Sum_probs=142.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC--------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~ 579 (689)
++|.+.+.||+|+||.||+|+.. ....+|+|.+..... ......+..|+++++++ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 46778899999999999999642 245799998865432 34456788999999999 699999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl 647 (689)
+..++||||+++|+|.+++..... ....++|..+++++.|++.||.|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999976321 124589999999999999999999987 89999999999999
Q ss_pred cCCCcEEEEeecCCccccCCCcce---eecccceEEeccccc
Q 005587 648 DDDLAVSVSDCGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
++++.+||+|||+++.+....... .......|+|||++.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 209 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF 209 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHc
Confidence 999999999999998775432211 112234699999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=215.39 Aligned_cols=168 Identities=25% Similarity=0.418 Sum_probs=135.1
Q ss_pred ceEeecCCeEEEEEEeCC-Cc--EEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEeccC
Q 005587 515 NLIGAGMLGSVYRAQLPD-GK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~-g~--~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
+.||+|+||.||+|...+ +. .+|+|.+.... .......+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999997653 43 46888876432 234456788999999999 89999999999999999999999999
Q ss_pred CCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 591 NGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 591 ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
+|+|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence 9999999975431 123578999999999999999999987 8999999999999999999999999
Q ss_pred cCCccccCCCcceeecccceEEeccccc
Q 005587 659 GLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|++..............+..|+|||++.
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~ 184 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLN 184 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHc
Confidence 9987433222121122234599999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=219.34 Aligned_cols=171 Identities=21% Similarity=0.348 Sum_probs=145.3
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999775 58999999986654433345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.++... ...+++..++.++.|+++||.|||+. +|+|+||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999887754 23589999999999999999999987 8999999999999999999999999999876543
Q ss_pred Ccc-eeecccceEEeccccc
Q 005587 668 SVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~-~~~~~~~~~~apE~~~ 686 (689)
... ....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLV 173 (286)
T ss_pred ccccCcccceeeccCcHHhc
Confidence 322 2234567799999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=219.09 Aligned_cols=168 Identities=23% Similarity=0.350 Sum_probs=144.6
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.+|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4788889999999999999965 5689999999875443 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999999864 3478899999999999999999987 8999999999999999999999999999876543
Q ss_pred Cc-ceeecccceEEeccccc
Q 005587 668 SV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~~ 686 (689)
.. .....++..|+|||.+.
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~ 189 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVT 189 (296)
T ss_pred ccccCcccCCccccCHHHHc
Confidence 32 22245677899999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=216.86 Aligned_cols=170 Identities=22% Similarity=0.361 Sum_probs=144.9
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 56888999999999999999765 5899999998653 23456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|..++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999887643 23589999999999999999999987 8999999999999999999999999998765432
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......++..|+|||++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred ccccceecCCccccCceeec
Confidence 2 122344667899999873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=220.11 Aligned_cols=170 Identities=21% Similarity=0.327 Sum_probs=142.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.|.+.+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46888899999999999999764 688999999865432 2234467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+. ++|.+++... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 5999888653 24578999999999999999999987 8999999999999999999999999999875433
Q ss_pred Cc-ceeecccceEEeccccc
Q 005587 668 SV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~~ 686 (689)
.. ......+..|+|||++.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~ 177 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILL 177 (301)
T ss_pred CCcccccceeecccCcHHHh
Confidence 22 12234567899999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=215.09 Aligned_cols=170 Identities=27% Similarity=0.462 Sum_probs=141.5
Q ss_pred CCCccceEeecCCeEEEEEEeCC-C---cEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPD-G---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~-g---~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
.|++.+.||+|+||.||+|.... + ..||||.+.... ......+|..|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46778999999999999997643 3 369999986543 244567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998753 23588999999999999999999987 89999999999999999999999999998775
Q ss_pred CCCccee---ecc---cceEEeccccc
Q 005587 666 SGSVSQV---SHN---LTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~~~---~~~---~~~~~apE~~~ 686 (689)
....... ..+ ...|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIA 184 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhc
Confidence 4332111 111 23599999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=213.03 Aligned_cols=168 Identities=29% Similarity=0.471 Sum_probs=142.7
Q ss_pred ceEeecCCeEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccC
Q 005587 515 NLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
+.||+|+||.||+|.... +..||+|.+....... ..+.+.+|++.+..++|+||+++++++...+..++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 468999999999997653 7899999987654322 46788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 591 NGTLQDMLHSDDEL-----KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 591 ggsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
+++|.+++...... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||.+..+.
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999864211 25689999999999999999999987 89999999999999999999999999999876
Q ss_pred CCC---cceeecccceEEeccccc
Q 005587 666 SGS---VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~---~~~~~~~~~~~~apE~~~ 686 (689)
... .......+..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~ 180 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLK 180 (262)
T ss_pred cccccccccCCCcCccccCHHHhc
Confidence 543 122233456799999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=214.76 Aligned_cols=169 Identities=24% Similarity=0.400 Sum_probs=140.7
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
++|.+.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4578889999999999999988777789999876433 23456889999999999999999998875 4568999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+.+|+|.++++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++.+....
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999997532 34578999999999999999999987 89999999999999999999999999998775543
Q ss_pred cce--eecccceEEeccccc
Q 005587 669 VSQ--VSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~--~~~~~~~~~apE~~~ 686 (689)
... ....+..|+|||...
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~ 176 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAAL 176 (260)
T ss_pred ccccCCCccchhhCCHHHhc
Confidence 221 122345699999763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=218.97 Aligned_cols=168 Identities=23% Similarity=0.348 Sum_probs=145.3
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 5788899999999999999975 5799999999865432 334668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999864 3578899999999999999999987 8999999999999999999999999999876544
Q ss_pred Ccc-eeecccceEEeccccc
Q 005587 668 SVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~-~~~~~~~~~~apE~~~ 686 (689)
... ....++..|+|||.+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~ 188 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVT 188 (297)
T ss_pred ccCcCcccCCccccCHHHHc
Confidence 322 2245677899999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=218.02 Aligned_cols=171 Identities=23% Similarity=0.363 Sum_probs=145.5
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||+|... +++.||||.+............+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999765 58899999987654434445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|++++.+..+... ...+++..+..++.||+.||.|||+. +|+|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777666543 24588999999999999999999987 8999999999999999999999999999987665
Q ss_pred Cc--ceeecccceEEeccccc
Q 005587 668 SV--SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~--~~~~~~~~~~~apE~~~ 686 (689)
.. .....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~ 174 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLV 174 (288)
T ss_pred ccccccCcccccCCcCCchhc
Confidence 42 22344567799999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=215.46 Aligned_cols=168 Identities=23% Similarity=0.352 Sum_probs=142.6
Q ss_pred CCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 567788999999999999765 57888999885432 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS- 668 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 668 (689)
++|+|..++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 85 AGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 999999887642 24689999999999999999999987 89999999999999999999999999998764332
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
......++..|+|||++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred ccccccccccccCHhhcc
Confidence 122234677899999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=217.35 Aligned_cols=174 Identities=24% Similarity=0.315 Sum_probs=142.3
Q ss_pred ccCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (689)
.++|.+.+.||+|+||.||+|.+. .+..||+|.+.... .......|.+|+.++++++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 467888999999999999999764 35689999876443 23445678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC---cEEE
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDEL---KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL---AVSV 655 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl 655 (689)
.++||||+++|+|.++++..... ...++|..+++++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999764321 23589999999999999999999987 899999999999998654 5999
Q ss_pred EeecCCccccCCCcce---eecccceEEecccc
Q 005587 656 SDCGLAPLISSGSVSQ---VSHNLTIMRAGGVT 685 (689)
Q Consensus 656 ~DFGla~~~~~~~~~~---~~~~~~~~~apE~~ 685 (689)
+|||+++.+....... .......|+|||++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence 9999999874333211 11223469999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=230.18 Aligned_cols=163 Identities=18% Similarity=0.182 Sum_probs=139.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
.+|.+.+.||+|+||.||+|... .+..||+|.+... ..+.+|++++++++|||||++++++...+..++|
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 46889999999999999999643 3578999987542 2345799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+. ++|.+++.. ...+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 688888843 34689999999999999999999987 89999999999999999999999999998776
Q ss_pred CCCcc---eeecccceEEeccccc
Q 005587 666 SGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~---~~~~~~~~~~apE~~~ 686 (689)
..... ....++..|+|||++.
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~ 260 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLA 260 (392)
T ss_pred cccccccccccccccCccCHhHhc
Confidence 54322 2245778899999984
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=214.51 Aligned_cols=171 Identities=27% Similarity=0.439 Sum_probs=145.8
Q ss_pred ccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.++|.+.+.||+|+||.||+|...+++.||||.+..... ...++.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 367888999999999999999887888999999875432 34678899999999999999999999999899999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.+...
T Consensus 82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999997643 34689999999999999999999987 8999999999999999999999999999887643
Q ss_pred Ccce--eecccceEEeccccc
Q 005587 668 SVSQ--VSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~--~~~~~~~~~apE~~~ 686 (689)
.... .......|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~ 177 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAAN 177 (261)
T ss_pred hhhhhhccCCCccccCHHHhc
Confidence 2211 112234699999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=217.13 Aligned_cols=160 Identities=23% Similarity=0.302 Sum_probs=131.0
Q ss_pred eEeecCCeEEEEEEeCC-------------------------CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcc
Q 005587 516 LIGAGMLGSVYRAQLPD-------------------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv 570 (689)
.||+|+||.||+|.+.. ...||+|.+.... ......|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999996421 1358889886432 23456788899999999999999
Q ss_pred eecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC
Q 005587 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (689)
Q Consensus 571 ~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~ 650 (689)
++++++...+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++..
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 9999999999999999999999999998653 24688999999999999999999987 89999999999999764
Q ss_pred C-------cEEEEeecCCccccCCCcceeecccceEEeccccc
Q 005587 651 L-------AVSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 651 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+ .+|++|||++....... ...++..|+|||.+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~aPe~~~ 193 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSRE---ERVERIPWIAPECVP 193 (274)
T ss_pred CcccCccceeeecCCcccccccccc---ccccCCcccCchhhc
Confidence 3 38999999987553322 124567799999774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=219.36 Aligned_cols=172 Identities=26% Similarity=0.381 Sum_probs=142.6
Q ss_pred cCCCccceEeecCCeEEEEEEe------CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQ 581 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 581 (689)
++|.+.+.||+|+||.||+|.. .++..||||.+..... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 4688889999999999999963 1356899998865432 33456788999999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.++||||+.+|+|.++++... ...+++.+++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999997532 23489999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCcce---eecccceEEeccccc
Q 005587 662 PLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
+.+....... ....+..|+|||.+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 216 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIF 216 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhc
Confidence 8765443211 122345699999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=217.39 Aligned_cols=170 Identities=24% Similarity=0.343 Sum_probs=146.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||+|... ++..||+|.+... .......|.+|++++++++||||+++++++...+..|+|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 56888899999999999999764 6889999998643 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999998753 24689999999999999999999987 8999999999999999999999999998776443
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......++..|++||++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVA 176 (280)
T ss_pred ccccceeecchhhcCHHHHh
Confidence 2 223345677899999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=214.57 Aligned_cols=170 Identities=25% Similarity=0.405 Sum_probs=143.1
Q ss_pred ccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.+.|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 357888999999999999999988899999999875433 3457889999999999999999999864 567899999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+.+|+|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999987533 34688999999999999999999987 8999999999999999999999999999877643
Q ss_pred Cccee--ecccceEEeccccc
Q 005587 668 SVSQV--SHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~--~~~~~~~~apE~~~ 686 (689)
..... ..+...|+|||++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~ 176 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred CcccccCCcccccccCHHHhc
Confidence 32211 22234699999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=215.47 Aligned_cols=170 Identities=24% Similarity=0.401 Sum_probs=141.3
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCc----EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
.+|++.+.||+|+||.||+|... +|+ .||+|.+..... .....++.+|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 46778899999999999999754 333 589998765432 4455778899999999999999999999987 7889
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999997642 3489999999999999999999987 899999999999999999999999999998
Q ss_pred ccCCCcceeecc---cceEEeccccc
Q 005587 664 ISSGSVSQVSHN---LTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~~~~~~---~~~~~apE~~~ 686 (689)
+..........+ ...|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESIL 184 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhh
Confidence 765443222111 34699999763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=212.65 Aligned_cols=171 Identities=22% Similarity=0.314 Sum_probs=141.6
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC---hhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS---QQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~---~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~ 582 (689)
.+|+..+.||+|+||.||+|.. .++..||+|.+...... ......+.+|+.++++++||||+++++++.. .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999965 46899999988654221 2334568899999999999999999999876 3678
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
+++|||+++++|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999999753 3578899999999999999999987 89999999999999999999999999998
Q ss_pred cccCCC----cceeecccceEEeccccc
Q 005587 663 LISSGS----VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~----~~~~~~~~~~~~apE~~~ 686 (689)
.+.... ......++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVIS 182 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhC
Confidence 764321 112234567799999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=218.96 Aligned_cols=152 Identities=30% Similarity=0.409 Sum_probs=134.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|+..+.||+|+||.||+|... +++.||+|.+....... .....+.+|+++++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999765 58999999987654332 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
||+.+++|.+++.... ...+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999987532 34689999999999999999999987 89999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=213.85 Aligned_cols=171 Identities=26% Similarity=0.466 Sum_probs=142.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CC---cEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g---~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
++|+..+.||+|+||.||+|... ++ ..+|+|.+..... ......+..|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46777899999999999999764 33 3799998865432 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999998753 23589999999999999999999987 8999999999999999999999999999877
Q ss_pred cCCCcceee----cccceEEeccccc
Q 005587 665 SSGSVSQVS----HNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~~~~----~~~~~~~apE~~~ 686 (689)
......... .....|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 183 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIA 183 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhh
Confidence 544322211 1123599999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=215.88 Aligned_cols=175 Identities=21% Similarity=0.291 Sum_probs=144.7
Q ss_pred ccCCCccceEeecCCeEEEEEEeCC-----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe-CCe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPD-----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~ 581 (689)
.++|.+.+.||+|+||.||+|.... +..|++|.+.... .......+.+|+.++++++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3578889999999999999997655 6889999886432 34456778899999999999999999998876 567
Q ss_pred EEEEEeccCCCCHHHHHhcCccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEe
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDEL----KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~D 657 (689)
.++++||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998764322 14689999999999999999999987 899999999999999999999999
Q ss_pred ecCCccccCCCcce---eecccceEEeccccc
Q 005587 658 CGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 658 FGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
||+++.+....... ...++..|+|||.+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 192 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLV 192 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHh
Confidence 99998765443221 122345699999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=212.81 Aligned_cols=176 Identities=23% Similarity=0.273 Sum_probs=143.6
Q ss_pred hhhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 505 QQYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 505 ~~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
+..++++.....||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 344556666778999999999999754 67889999886543 345567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-CCcEEEEeecCCc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAP 662 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~ 662 (689)
+||||+++++|.+++..... ....++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999975321 11227888899999999999999987 8999999999999986 6799999999998
Q ss_pred cccCCCc-ceeecccceEEeccccc
Q 005587 663 LISSGSV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~-~~~~~~~~~~~apE~~~ 686 (689)
.+..... .....++..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~ 182 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVID 182 (268)
T ss_pred ecccCCCccccCCCCccccChhhhc
Confidence 7643322 22234567899999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=221.93 Aligned_cols=174 Identities=24% Similarity=0.390 Sum_probs=141.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC--------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~ 579 (689)
.+|.+.+.||+|+||.||+|+.. .+..||+|.+.... ......++.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35788899999999999999642 12368999876432 234456888999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl 647 (689)
+..++||||+++|+|.+++..... ....++|..++.++.|+++||.|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 999999999999999999975321 123588999999999999999999987 89999999999999
Q ss_pred cCCCcEEEEeecCCccccCCCccee---ecccceEEeccccc
Q 005587 648 DDDLAVSVSDCGLAPLISSGSVSQV---SHNLTIMRAGGVTH 686 (689)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~---~~~~~~~~apE~~~ 686 (689)
+.++.+||+|||+++.+........ ......|+|||++.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 209 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF 209 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhc
Confidence 9999999999999987654332111 11234699999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=213.99 Aligned_cols=170 Identities=23% Similarity=0.365 Sum_probs=143.2
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC----hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ......+.+|++++++++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999964 57899999998654321 1234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC-cEEEEeecCCcc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPL 663 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~ 663 (689)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999999753 4678999999999999999999987 899999999999998776 599999999988
Q ss_pred ccCCCcc-----eeecccceEEeccccc
Q 005587 664 ISSGSVS-----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~-----~~~~~~~~~~apE~~~ 686 (689)
+...... ....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 181 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLR 181 (268)
T ss_pred cccccccCCccccccccccceeCHhHhc
Confidence 7643211 1234567899999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=212.47 Aligned_cols=166 Identities=28% Similarity=0.424 Sum_probs=139.5
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEE-eCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCA-EHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||++.. .|..||+|.+... ...+.+.+|+.++++++|+||+++++++. ..+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 4678889999999999999976 4788999988543 23457889999999999999999999765 4567899999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999997643 23588999999999999999999987 8999999999999999999999999999876543
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
... ......|+|||++.
T Consensus 156 ~~~--~~~~~~y~aPE~~~ 172 (256)
T cd05082 156 QDT--GKLPVKWTAPEALR 172 (256)
T ss_pred CCC--CccceeecCHHHHc
Confidence 321 23345799999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=218.36 Aligned_cols=171 Identities=23% Similarity=0.302 Sum_probs=143.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 585 (689)
++|+..+.||+|+||.||+|... +++.+|+|.+............+.+|+.++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999765 588999999875543333345677899999999999999999999887 899999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+. ++|.+++.... ..+++..++.++.|+++||+|||+. +|+|+||||+||++++++.+||+|||+++.+.
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 49999887532 3689999999999999999999987 89999999999999999999999999999876
Q ss_pred CCCc-ceeecccceEEeccccc
Q 005587 666 SGSV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~-~~~~~~~~~~~apE~~~ 686 (689)
.... .....++..|+|||++.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~ 179 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLL 179 (293)
T ss_pred CCccccccccccccccCchhhc
Confidence 5422 22234567799999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=229.61 Aligned_cols=171 Identities=18% Similarity=0.242 Sum_probs=133.0
Q ss_pred HhhhccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC------CCCCcceecEEE
Q 005587 504 LQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI------RHANIVELKGYC 576 (689)
Q Consensus 504 l~~~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l------~HpnIv~l~~~~ 576 (689)
+....++|++.++||+|+||.||+|.. .+++.||||+++... ...+.+..|++++..+ .|.+|+++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 334567899999999999999999965 468899999986421 1223344455555554 455688999988
Q ss_pred EeC-CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC----
Q 005587 577 AEH-GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL---- 651 (689)
Q Consensus 577 ~~~-~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---- 651 (689)
... +..++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence 764 5789999998 77899888753 4689999999999999999999973 2899999999999998765
Q ss_pred ------------cEEEEeecCCccccCCCcceeecccceEEeccccc
Q 005587 652 ------------AVSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 652 ------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
.+||+|||++....... ....++..|+|||++.
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~~--~~~~gt~~Y~APE~~~ 318 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHSR--TAIVSTRHYRSPEVVL 318 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcccc--ccccCCccccCcHHhh
Confidence 49999999987543322 2356788999999984
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=220.94 Aligned_cols=160 Identities=18% Similarity=0.187 Sum_probs=124.7
Q ss_pred ccCCCccceEeecCCeEEEEEEeC--CCcEEEEEEeccccC---ChhhHHHHHHHHHHHhcCCCCCcce-ecEEEEeCCe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP--DGKLLAVKKLDKRAS---SQQKDDEFLELVNNIDRIRHANIVE-LKGYCAEHGQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~--~g~~vAvK~l~~~~~---~~~~~~~~~~e~~~l~~l~HpnIv~-l~~~~~~~~~ 581 (689)
.+.|.+.+.||+|+||+||+|.+. +++.||||++..... .....+.|.+|++++++++|+||+. +++ .+.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCC
Confidence 357889999999999999999654 577789998753311 2234567899999999999999985 443 246
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecc-cCCCeEecCCCcEEEEeecC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF-KSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDl-Kp~NILl~~~~~~kl~DFGl 660 (689)
.|+|||||+|++|... .. .. ...++.|+++||.|||+. +|+|||| ||+|||++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~----~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP----HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc----cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 8999999999999732 11 00 146788999999999987 8999999 99999999999999999999
Q ss_pred CccccCCCccee---------ecccceEEecccc
Q 005587 661 APLISSGSVSQV---------SHNLTIMRAGGVT 685 (689)
Q Consensus 661 a~~~~~~~~~~~---------~~~~~~~~apE~~ 685 (689)
|+.+...+.... ..++..|+|||.+
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence 998766543322 2234458899987
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-25 Score=249.41 Aligned_cols=175 Identities=29% Similarity=0.394 Sum_probs=150.3
Q ss_pred hhhccCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 505 ~~~~~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
+..+-+++....||.|.||.||-| ...+|...|+|.+..............+|+.++..++|||+|+++|+=.+++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 344557788899999999999999 4668999999988766554555667889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
|.||||++|+|.+++... ...++.....+..|++.|+.|||+. +||||||||+||+||.+|.+|++|||-|+.
T Consensus 1311 IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999753 3455666677889999999999997 899999999999999999999999999998
Q ss_pred ccCCC-----cceeecccceEEeccccc
Q 005587 664 ISSGS-----VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~-----~~~~~~~~~~~~apE~~~ 686 (689)
+...- .-+...||+.|||||++-
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhc
Confidence 76532 224578999999999983
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=213.75 Aligned_cols=161 Identities=24% Similarity=0.325 Sum_probs=133.0
Q ss_pred ceEeecCCeEEEEEEeCC-------------CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCe
Q 005587 515 NLIGAGMLGSVYRAQLPD-------------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (689)
+.||+|+||.||+|.+.+ ...|++|.+.... ......|.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999997532 2358888875432 2344578889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCc-------EE
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA-------VS 654 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~-------~k 654 (689)
.++||||+++|+|..+++.. ...+++..++.++.||++||+|||+. +|+||||||+|||++.++. +|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 99999999999999888643 23589999999999999999999987 8999999999999987664 89
Q ss_pred EEeecCCccccCCCcceeecccceEEeccccc
Q 005587 655 VSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 655 l~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
++|||++..+.... ...++..|+|||++.
T Consensus 153 l~d~g~~~~~~~~~---~~~~~~~y~aPE~~~ 181 (262)
T cd05077 153 LSDPGIPITVLSRQ---ECVERIPWIAPECVE 181 (262)
T ss_pred eCCCCCCccccCcc---cccccccccChhhhc
Confidence 99999998764332 234567799999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=208.49 Aligned_cols=163 Identities=25% Similarity=0.353 Sum_probs=137.5
Q ss_pred cceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 514 ENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
.+.||+|+|+.|--+ ...+|.+||||++.+.. ........+|++++... .|+||+.+++||+++...|||||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 478999999999998 57799999999998763 34456778999999888 599999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC---cEEEEeecCCccccCCC
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL---AVSVSDCGLAPLISSGS 668 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~~~~~~ 668 (689)
|+|..+|++ .+.+++.++.++..+|+.||.|||.. +|.||||||+|||-.+.. -+|||||.|+--+....
T Consensus 161 GplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 161 GPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred chHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999987 45789999999999999999999987 899999999999996543 48999999876543211
Q ss_pred --------cceeecccceEEecccc
Q 005587 669 --------VSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 669 --------~~~~~~~~~~~~apE~~ 685 (689)
.-....+...|||||+.
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHH
Confidence 11224566679999997
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=211.83 Aligned_cols=170 Identities=28% Similarity=0.430 Sum_probs=146.9
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|++.+.||+|+||.||+|... +++.||+|.+..........+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999754 689999999876654444667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++... ..+++..+..|+.|+++||.|||+. +|+|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999999752 3478899999999999999999987 89999999999999999999999999998876543
Q ss_pred cce-----eecccceEEeccccc
Q 005587 669 VSQ-----VSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~-----~~~~~~~~~apE~~~ 686 (689)
... ...++..|++||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~ 176 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVIT 176 (264)
T ss_pred CcccccccCCcCCcCccChhhcc
Confidence 322 134567799999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=233.72 Aligned_cols=177 Identities=16% Similarity=0.225 Sum_probs=135.1
Q ss_pred hhccCCCccceEeecCCeEEEEEEeCC--CcEEEEEEe--------------ccc-cCChhhHHHHHHHHHHHhcCCCCC
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQLPD--GKLLAVKKL--------------DKR-ASSQQKDDEFLELVNNIDRIRHAN 568 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~~~~--g~~vAvK~l--------------~~~-~~~~~~~~~~~~e~~~l~~l~Hpn 568 (689)
...++|++.+.||+|+||+||+|..+. +..+++|.+ .+. .........+.+|++++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999986532 222332211 110 111223456889999999999999
Q ss_pred cceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe
Q 005587 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDE-LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (689)
Q Consensus 569 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl 647 (689)
||++++++...+..|+|+|++. ++|.+++..... ......+..+..|+.||+.||+|||+. +||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999995 577777654221 112234566778999999999999987 89999999999999
Q ss_pred cCCCcEEEEeecCCccccCCCcc--eeecccceEEeccccc
Q 005587 648 DDDLAVSVSDCGLAPLISSGSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~~~~apE~~~ 686 (689)
+.++.+||+|||+++.+...... ....++..|+|||++.
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 341 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA 341 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhc
Confidence 99999999999999987654322 2245788899999984
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=211.21 Aligned_cols=172 Identities=22% Similarity=0.367 Sum_probs=146.2
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|++.+.||+|+||.||++.. .+|+.||+|.+...........++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999965 4689999999875544444556889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+.+++|.+++.... ...+++.+++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999987532 23578999999999999999999987 89999999999999999999999999998765533
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. ....++..|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~ 174 (256)
T cd08218 156 ELARTCIGTPYYLSPEICE 174 (256)
T ss_pred hhhhhccCCccccCHHHhC
Confidence 21 2234566799999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=218.67 Aligned_cols=170 Identities=19% Similarity=0.343 Sum_probs=141.6
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..+.||+|+||.||+|... +|+.||+|.+............+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999764 689999999875433333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+. ++|.+++... ...+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 5888877643 24589999999999999999999987 89999999999999999999999999998765432
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. ....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~y~aPE~~~ 172 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLF 172 (284)
T ss_pred CCcCCCccccCCcChHHHh
Confidence 21 1223467799999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=212.26 Aligned_cols=169 Identities=26% Similarity=0.416 Sum_probs=141.4
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCCh-------hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-------QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~-------~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
|.+...||+|+||.||+|.. .+++.||+|.+....... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 66778999999999999965 468899999886543221 1235678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999753 4578889999999999999999987 89999999999999999999999999998
Q ss_pred cccCCCcc-------eeecccceEEeccccc
Q 005587 663 LISSGSVS-------QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~~-------~~~~~~~~~~apE~~~ 686 (689)
.+...... ....+...|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~ 185 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhc
Confidence 87632211 1123566799999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=216.67 Aligned_cols=170 Identities=22% Similarity=0.334 Sum_probs=141.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|+..+.||+|+||.||+|..+ +++.||||.+..... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999765 689999999865432 1223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+.+ +|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9975 9999887532 3678999999999999999999987 8999999999999999999999999999765332
Q ss_pred Cc-ceeecccceEEeccccc
Q 005587 668 SV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~~ 686 (689)
.. ......+..|+|||+..
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~ 176 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLL 176 (291)
T ss_pred CccccccccccccCCcHHhh
Confidence 21 11223466799999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=211.16 Aligned_cols=170 Identities=26% Similarity=0.406 Sum_probs=146.0
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|+..+.||+|+||.||+|... +++.+++|.+..... .....+.+|++++++++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 57888999999999999999764 678899999875432 245778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999998753 24688999999999999999999987 8999999999999999999999999999876543
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......++.+|+|||++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~ 174 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAA 174 (262)
T ss_pred hhccccccCCccccCchhhc
Confidence 2 222235567899999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=217.32 Aligned_cols=170 Identities=18% Similarity=0.270 Sum_probs=144.9
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||+||++... +|+.||+|++..... ......+.+|+++++.++||||+++++++...+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46778899999999999999654 688999998865432 3345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+||++++++.++|+|||++..+...
T Consensus 84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999998752 35889999999999999999999742 7999999999999999999999999998766433
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
... ...++..|+|||++.
T Consensus 158 ~~~-~~~~~~~~~aPE~~~ 175 (284)
T cd06620 158 IAD-TFVGTSTYMSPERIQ 175 (284)
T ss_pred ccC-ccccCcccCCHHHHc
Confidence 322 235678899999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=216.53 Aligned_cols=175 Identities=27% Similarity=0.386 Sum_probs=143.7
Q ss_pred ccCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 581 (689)
.++|+..+.||+|+||.||+|... ++..||+|.+..... .....++.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 357888999999999999999753 467899999865432 3445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhcCcc------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDE------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSA 643 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~ 643 (689)
.++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999974321 123578899999999999999999987 8999999999
Q ss_pred CeEecCCCcEEEEeecCCccccCCCcc---eeecccceEEeccccc
Q 005587 644 NILLDDDLAVSVSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 644 NILl~~~~~~kl~DFGla~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
||++++++.+||+|||+++.+...... ........|+|||++.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 999999999999999999876443221 1112234599999763
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=212.91 Aligned_cols=170 Identities=24% Similarity=0.349 Sum_probs=141.2
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC--------hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS--------QQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~--------~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~ 580 (689)
+|...+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466788999999999999965 46899999988542111 112346788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999763 4688899999999999999999987 899999999999999999999999999
Q ss_pred CccccCCCcc---eeecccceEEeccccc
Q 005587 661 APLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
++........ ....++..|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 183 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183 (272)
T ss_pred cccccccccccccccccCCccccCHHHhc
Confidence 9876432211 1234566799999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=216.54 Aligned_cols=168 Identities=22% Similarity=0.364 Sum_probs=145.2
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.+|+..+.||.|+||.||+|.. .+++.||+|.+..... ...+.+.+|+++++.++||||+++++++...+..|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4688889999999999999964 5789999999865432 335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++.. ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..+...
T Consensus 97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999998864 3589999999999999999999987 8999999999999999999999999999876544
Q ss_pred Cc-ceeecccceEEeccccc
Q 005587 668 SV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~~ 686 (689)
.. .....++..|+|||.+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~ 188 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVT 188 (296)
T ss_pred cccCCCcCCCccccCcchhc
Confidence 32 22245677899999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=218.72 Aligned_cols=165 Identities=21% Similarity=0.308 Sum_probs=132.2
Q ss_pred cceEeecCCeEEEEEEeC---CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCeEEEEEec
Q 005587 514 ENLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLIYEY 588 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~Ey 588 (689)
..+||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 367999999999999764 457899999865422 3457789999999999999999998854 5678999999
Q ss_pred cCCCCHHHHHhcCcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe----cCCCcEEEEeec
Q 005587 589 CSNGTLQDMLHSDDE-----LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCG 659 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~-----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl----~~~~~~kl~DFG 659 (689)
+.+ +|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 864 88887753211 123588999999999999999999987 89999999999999 567789999999
Q ss_pred CCccccCCCcc----eeecccceEEeccccc
Q 005587 660 LAPLISSGSVS----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~----~~~~~~~~~~apE~~~ 686 (689)
+++.+...... ....++..|+|||++.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 188 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLL 188 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhc
Confidence 99987543321 1234567899999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=211.64 Aligned_cols=170 Identities=24% Similarity=0.392 Sum_probs=142.7
Q ss_pred ccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.+.|++.+.||+|+||.||++...++..+|+|.+... ......+.+|++++++++|+||+++++++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3578889999999999999998877888999988643 2235678899999999999999999999887 77899999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999997643 34578899999999999999999987 8999999999999999999999999999876544
Q ss_pred Cccee--ecccceEEeccccc
Q 005587 668 SVSQV--SHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~--~~~~~~~~apE~~~ 686 (689)
..... ......|+|||++.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~ 176 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred CcccccCCcccccccCHhHhc
Confidence 32221 12234599999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=210.94 Aligned_cols=168 Identities=22% Similarity=0.391 Sum_probs=146.7
Q ss_pred cCCCccceEeecCCeEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|+..+.||+|+||.||+|...+ ++.|++|.+.... ...++.+|++++++++|+||+++++++......|++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578889999999999999997764 8899999986532 25789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+.+++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++..+...
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999998653 34689999999999999999999987 8999999999999999999999999999987654
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......++..|+|||++.
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~ 172 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQ 172 (256)
T ss_pred ccccccccCCccccCHHHHh
Confidence 4 223344667899999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=241.03 Aligned_cols=175 Identities=26% Similarity=0.406 Sum_probs=140.9
Q ss_pred hhhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC----
Q 005587 505 QQYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH---- 579 (689)
Q Consensus 505 ~~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~---- 579 (689)
.++..+|+..++||+|+||.||+++.+ ||+.||||++.... +......+.+|+..+++|+|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 456778999999999999999999765 89999999998776 455567788999999999999999987521000
Q ss_pred --------------------------------------------------------------------------------
Q 005587 580 -------------------------------------------------------------------------------- 579 (689)
Q Consensus 580 -------------------------------------------------------------------------------- 579 (689)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHH
Q 005587 580 -----------------------------------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624 (689)
Q Consensus 580 -----------------------------------~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL 624 (689)
-.+||-||||+.-.|.++++...... .-...++++++|++||
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGL 710 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHH
Confidence 12578899999988888887532111 3577889999999999
Q ss_pred HHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc----------------C---CCcceeecccceEEecccc
Q 005587 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS----------------S---GSVSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 625 ~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~----------------~---~~~~~~~~~~~~~~apE~~ 685 (689)
.|+|+. +||||||||.||++|++..+||+|||+|+... . ........||..|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999998 89999999999999999999999999999721 0 1112235677889999998
Q ss_pred c
Q 005587 686 H 686 (689)
Q Consensus 686 ~ 686 (689)
.
T Consensus 788 ~ 788 (1351)
T KOG1035|consen 788 S 788 (1351)
T ss_pred c
Confidence 4
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=211.57 Aligned_cols=165 Identities=25% Similarity=0.323 Sum_probs=138.7
Q ss_pred ceEeecCCeEEEEEEeCC--C--cEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccC
Q 005587 515 NLIGAGMLGSVYRAQLPD--G--KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~--g--~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
+.||+|+||.||+|.+.+ + ..||||.+...... ...+.+.+|++.+++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999997643 3 36999998765543 456788999999999999999999999988 88999999999
Q ss_pred CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc
Q 005587 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (689)
Q Consensus 591 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (689)
+|+|.+++..... ..++|.....++.|+++||+|||+. +++|+||||+||+++.++.+||+|||+++.+......
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 9999999986432 4689999999999999999999987 8999999999999999999999999999987553221
Q ss_pred e----eecccceEEeccccc
Q 005587 671 Q----VSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~----~~~~~~~~~apE~~~ 686 (689)
. ...++..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~ 173 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLR 173 (257)
T ss_pred eecccCCCCCceecCHHHhc
Confidence 1 123345799999864
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=216.15 Aligned_cols=168 Identities=21% Similarity=0.340 Sum_probs=142.9
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+|++++++++||||+++++++...+..|+||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 356678899999999999965 4678999999865432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++.. ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++|+|||+++.+....
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999998863 3578999999999999999999987 89999999999999999999999999998776543
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. ....++.+|+|||.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIK 174 (277)
T ss_pred hhhhcccCcccccCHHHhC
Confidence 22 1224567899999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=214.94 Aligned_cols=170 Identities=24% Similarity=0.284 Sum_probs=142.7
Q ss_pred CCCccceEeecCCeEEEEEEe----CCCcEEEEEEeccccC--ChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQR 582 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~----~~g~~vAvK~l~~~~~--~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 582 (689)
+|++.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+.+|++++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999965 3689999999865322 122346678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999998752 4578899999999999999999987 89999999999999999999999999998
Q ss_pred cccCCCcc--eeecccceEEeccccc
Q 005587 663 LISSGSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~~--~~~~~~~~~~apE~~~ 686 (689)
.+...... ....++..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVR 179 (290)
T ss_pred ecccccccccccccCCcccCChhhcc
Confidence 77553322 2234667799999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=225.41 Aligned_cols=165 Identities=25% Similarity=0.317 Sum_probs=139.5
Q ss_pred eEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
+||+|.||+||.|+.. +...+|||.+..... +...-+.+|+...++++|.|||+++|.+.+.++.-|.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6999999999999754 466899999876542 3445678999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec-CCCcEEEEeecCCccccC-CCccee
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISS-GSVSQV 672 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~-~~~~~~ 672 (689)
.++|+..-+. -.-.+.+.-.+.+||++||.|||.. .|||||||-+|||++ -.|.+||+|||-++.+.. ......
T Consensus 660 SsLLrskWGP-lKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 660 SSLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHHhccCC-CccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9999864321 1226777888999999999999998 799999999999997 588999999999988754 334455
Q ss_pred ecccceEEeccccc
Q 005587 673 SHNLTIMRAGGVTH 686 (689)
Q Consensus 673 ~~~~~~~~apE~~~ 686 (689)
-+||..|||||||.
T Consensus 736 FTGTLQYMAPEvID 749 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVID 749 (1226)
T ss_pred cccchhhhChHhhc
Confidence 67788899999995
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-23 Score=215.24 Aligned_cols=148 Identities=22% Similarity=0.335 Sum_probs=130.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|+..+.||+|+||.||++... +++.||+|.+...... ......+.+|+++++.++||||+++++.+...++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999764 5789999998754321 233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
||++|++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999999753 3588999999999999999999987 899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=215.42 Aligned_cols=171 Identities=20% Similarity=0.344 Sum_probs=143.5
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..+.||+|+||.||+|+.. +|+.||||.+............+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999764 689999999875443333446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+. ++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 68998887533 34689999999999999999999987 89999999999999999999999999998765432
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. .....+..|+|||++.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~ 173 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILL 173 (284)
T ss_pred cccccccccccccCCeEEe
Confidence 21 2223466799999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-24 Score=230.31 Aligned_cols=169 Identities=22% Similarity=0.325 Sum_probs=143.4
Q ss_pred cCCCccceEeecCCeEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.|.+...||.|+||.||+|..++ +-..|.|.+... +....++|+-|+++|..+.||+||++++.|...+.+||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 345667789999999999997654 455677777543 24567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC-
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS- 666 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~- 666 (689)
||.||-...++-+. ...+.+.++..+.+|++.||.|||+. +|||||||..|||+.-+|.++|+|||.+.....
T Consensus 110 FC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred ecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 99999998887754 46799999999999999999999998 899999999999999999999999998765543
Q ss_pred CCcceeecccceEEecccc
Q 005587 667 GSVSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~ 685 (689)
....-.-.||+|||||||.
T Consensus 184 ~qkRDsFIGTPYWMAPEVv 202 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVV 202 (1187)
T ss_pred HhhhccccCCcccccchhe
Confidence 2233335789999999997
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=210.16 Aligned_cols=170 Identities=20% Similarity=0.360 Sum_probs=148.1
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|++|.||+|... +++.|+||++...... .....+.+|++.+.+++|+||+++++++...+..++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888899999999999999765 5999999998765432 456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
|+++++|.+++... ..+++..+..++.|+++||.|||+ . +++|+||+|+||+++.++.++|+|||++..+..
T Consensus 80 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999753 468999999999999999999998 7 899999999999999999999999999998765
Q ss_pred CCcce-eecccceEEeccccc
Q 005587 667 GSVSQ-VSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~-~~~~~~~~~apE~~~ 686 (689)
..... ...+...|+|||++.
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~ 173 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQ 173 (264)
T ss_pred CCCcccceeecccccCHhhhC
Confidence 44332 345567899999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=214.38 Aligned_cols=165 Identities=27% Similarity=0.307 Sum_probs=139.6
Q ss_pred EeecCCeEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 517 IGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 517 iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
||+|+||.||+|.. .+|+.||+|.+...... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999965 46899999998654321 22345667899999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcceeec
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (689)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++..+..........
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 99987643 24689999999999999999999987 89999999999999999999999999998776544333345
Q ss_pred ccceEEeccccc
Q 005587 675 NLTIMRAGGVTH 686 (689)
Q Consensus 675 ~~~~~~apE~~~ 686 (689)
+...|++||++.
T Consensus 156 ~~~~y~~PE~~~ 167 (277)
T cd05577 156 GTPGYMAPEVLQ 167 (277)
T ss_pred CCCCcCCHHHhc
Confidence 567799999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=215.51 Aligned_cols=174 Identities=22% Similarity=0.280 Sum_probs=141.3
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCe-----
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQ----- 581 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~----- 581 (689)
++|++.+.||+|+||.||+|... +++.||||.+............+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999764 6899999998654333334467888999999995 6999999999987665
Q ss_pred EEEEEeccCCCCHHHHHhcCccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-CCcEEEEeec
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDEL-KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCG 659 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFG 659 (689)
.|+||||+++ +|.+++...... ...+++..++.++.||++||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 898888654322 34689999999999999999999987 8999999999999998 8899999999
Q ss_pred CCccccCCC-cceeecccceEEeccccc
Q 005587 660 LAPLISSGS-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~-~~~~~~~~~~~~apE~~~ 686 (689)
+++.+.... .......+..|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 184 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLL 184 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhh
Confidence 998664322 112234567799999763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=212.37 Aligned_cols=174 Identities=22% Similarity=0.331 Sum_probs=142.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
++|++...||+|+||.||+|+.+ +.+.|++|.+..... ......+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 46788899999999999999754 246799998764322 22456789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEe
Q 005587 583 LLIYEYCSNGTLQDMLHSDDEL-----KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~D 657 (689)
++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999764321 12589999999999999999999987 899999999999999999999999
Q ss_pred ecCCccccCCCcc--eeecccceEEeccccc
Q 005587 658 CGLAPLISSGSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 658 FGla~~~~~~~~~--~~~~~~~~~~apE~~~ 686 (689)
||+++........ ....++..|++||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 191 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ 191 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhc
Confidence 9998765332211 1123345699999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=209.94 Aligned_cols=173 Identities=24% Similarity=0.361 Sum_probs=147.7
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||+|... ++..+|+|++....... ....+.+|++.++.++|+||+++++.+...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 46888999999999999999754 68899999987654333 56778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 80 YLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred ccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999975321 24589999999999999999999987 8999999999999999999999999999877654
Q ss_pred Ccc-----eeecccceEEeccccc
Q 005587 668 SVS-----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~-----~~~~~~~~~~apE~~~ 686 (689)
... ....++..|++||++.
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~ 179 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVME 179 (267)
T ss_pred ccccccccccccCChhhcChHHHc
Confidence 322 2234567799999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.8e-23 Score=214.40 Aligned_cols=171 Identities=22% Similarity=0.281 Sum_probs=140.5
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
+++|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+|+++++.++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46788999999999999999965 4689999999865432 223346678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+. ++|.+.+... ...+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 6777776542 23577888999999999999999987 899999999999999999999999999986543
Q ss_pred CC-cceeecccceEEeccccc
Q 005587 667 GS-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~-~~~~~~~~~~~~apE~~~ 686 (689)
.. ......++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~ 176 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLL 176 (291)
T ss_pred CCCCCCCccccccccCCceee
Confidence 22 122234567899999873
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=209.65 Aligned_cols=163 Identities=24% Similarity=0.323 Sum_probs=135.3
Q ss_pred ceEeecCCeEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccC
Q 005587 515 NLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
++||+|+||.||+|.+.. +..||+|.+...... ...+++.+|+++++++.|+||+++++++.. +..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 468999999999996432 268999998765432 456788999999999999999999998764 56899999999
Q ss_pred CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc
Q 005587 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (689)
Q Consensus 591 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (689)
+|+|.+++... ..+++..++.++.|++.||.|||.. +++|+||||+|||++.++.+||+|||+++.+......
T Consensus 79 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 79 LGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999999763 3688999999999999999999987 8999999999999999999999999999987554432
Q ss_pred eeec----ccceEEeccccc
Q 005587 671 QVSH----NLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~----~~~~~~apE~~~ 686 (689)
.... .+..|+|||.+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05060 152 YRATTAGRWPLKWYAPECIN 171 (257)
T ss_pred cccccCccccccccCHHHhc
Confidence 2111 123699999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=209.85 Aligned_cols=171 Identities=25% Similarity=0.331 Sum_probs=141.7
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEecccc---CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA---SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~ 582 (689)
.+|++.+.||+|+||.||+|.. .+++.||+|.+.... ........+.+|++++++++|+||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999965 468999999875432 1223456788999999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
++||||+++++|.+++... ..+++...++++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998752 3578899999999999999999987 89999999999999999999999999998
Q ss_pred cccCCC----cceeecccceEEeccccc
Q 005587 663 LISSGS----VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~----~~~~~~~~~~~~apE~~~ 686 (689)
...... ......++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVIS 182 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhc
Confidence 764321 112234667899999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=213.30 Aligned_cols=173 Identities=20% Similarity=0.314 Sum_probs=144.5
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCeEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV 585 (689)
++|+..+.||.|++|.||+|... +++.+|+|.+..... ......+.+|++++++++||||++++++|.. .+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 35778899999999999999764 688999999875432 2446778999999999999999999999865 3478999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++++|.+++.........+++.....++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999998765333345688899999999999999999987 89999999999999999999999999998765
Q ss_pred CCCcceeecccceEEeccccc
Q 005587 666 SGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~apE~~~ 686 (689)
..... ...++..|+|||.+.
T Consensus 157 ~~~~~-~~~~~~~y~~pE~~~ 176 (287)
T cd06621 157 NSLAG-TFTGTSFYMAPERIQ 176 (287)
T ss_pred ccccc-cccCCccccCHHHhc
Confidence 43322 245677899999763
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=210.61 Aligned_cols=173 Identities=24% Similarity=0.380 Sum_probs=149.4
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|++.+.||+|+||.||++.. .+++.+|+|.+............+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999964 4788999999876554445567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++.........+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999876433345789999999999999999999987 89999999999999999999999999999886653
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
.....++..|++||.+.
T Consensus 158 -~~~~~~~~~~~~Pe~~~ 174 (256)
T cd08530 158 -AKTQIGTPHYMAPEVWK 174 (256)
T ss_pred -cccccCCccccCHHHHC
Confidence 23345677899999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=202.30 Aligned_cols=176 Identities=27% Similarity=0.326 Sum_probs=147.4
Q ss_pred ccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC-----Ce
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~ 581 (689)
.++|.+.+.+|+|+|+-||.++ ..+++.+|+|++.... .++.+..++|++..++++||||++++++.... .+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 4678999999999999999996 6789999999987654 45677889999999999999999999887543 35
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.||+++|...|+|.+.+.........+++.+.++|+.+|++||++||+. .++..||||||.|||+.+.+.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999987655556799999999999999999999997 346999999999999999999999999998
Q ss_pred ccccCCCcc----------eeecccceEEeccccc
Q 005587 662 PLISSGSVS----------QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~~~----------~~~~~~~~~~apE~~~ 686 (689)
....-.-.+ ....=+..|+|||.++
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~ 211 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN 211 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence 765321110 1122356799999984
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-24 Score=216.44 Aligned_cols=172 Identities=23% Similarity=0.352 Sum_probs=143.2
Q ss_pred cCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhh-----HHHHHHHHHHHhcCCCCCcceecEEEEe-CCe
Q 005587 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQK-----DDEFLELVNNIDRIRHANIVELKGYCAE-HGQ 581 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~-----~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~ 581 (689)
++|-...+||+|+|+.||+| .+...+.||||+-......... -+...+|.++.+.|.||.||++|+|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 35667788999999999999 5667889999986544332222 1345688999999999999999999974 567
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec---CCCcEEEEee
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD---DDLAVSVSDC 658 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kl~DF 658 (689)
.+-|+|||+|.+|.-+|+.. +.+++.++..|+.||..||.||.+. .++|||-||||.|||+. ..|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 88999999999999999874 4688999999999999999999987 57899999999999995 4688999999
Q ss_pred cCCccccCCCcc--------eeecccceEEecccc
Q 005587 659 GLAPLISSGSVS--------QVSHNLTIMRAGGVT 685 (689)
Q Consensus 659 Gla~~~~~~~~~--------~~~~~~~~~~apE~~ 685 (689)
||++++...+.. ..-.+|.+|..||.+
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF 652 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECF 652 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCccee
Confidence 999999876544 334577789999987
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=212.49 Aligned_cols=169 Identities=25% Similarity=0.371 Sum_probs=145.8
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|+..+.||.|+||.||+|... +++.||+|.+..... ......+.+|+++++.++|+||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 35778889999999999999754 689999999865432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.+...
T Consensus 80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 99999999998752 689999999999999999999987 8999999999999999999999999999888654
Q ss_pred C-cceeecccceEEeccccc
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~apE~~~ 686 (689)
. ......++..|+|||.+.
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~ 171 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIK 171 (274)
T ss_pred ccccccccCCccccChhhhc
Confidence 2 222345567799999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=213.57 Aligned_cols=163 Identities=28% Similarity=0.245 Sum_probs=132.6
Q ss_pred eEeecCCeEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHH---HHhcCCCCCcceecEEEEeCCeEEEEEeccC
Q 005587 516 LIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVN---NIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~e~~---~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
+||+|+||.||++... +++.+|+|.+....... .....+.+|.. .+...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 68999999987543322 22233344443 3344579999999999999999999999999
Q ss_pred CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc
Q 005587 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (689)
Q Consensus 591 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (689)
+|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 99999988753 4689999999999999999999987 899999999999999999999999999986654332
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 153 ~~~~~~~~y~aPE~~~ 168 (279)
T cd05633 153 HASVGTHGYMAPEVLQ 168 (279)
T ss_pred cCcCCCcCccCHHHhc
Confidence 2345778899999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=211.56 Aligned_cols=169 Identities=20% Similarity=0.335 Sum_probs=144.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
..|+..+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 34677788999999999999764 688999999865432 3445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++|+|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 83 YLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 9999999999864 3578899999999999999999987 8999999999999999999999999999876543
Q ss_pred Ccc-eeecccceEEeccccc
Q 005587 668 SVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~-~~~~~~~~~~apE~~~ 686 (689)
... ....++.+|+|||++.
T Consensus 155 ~~~~~~~~~~~~y~apE~~~ 174 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQ 174 (277)
T ss_pred ccccccccCcccccCHhHhc
Confidence 322 2234567899999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=207.44 Aligned_cols=174 Identities=24% Similarity=0.403 Sum_probs=150.2
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|++.+.||+|+||.||++... +++.||+|++............+.+|+++++.++|+|++++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999764 689999999976655445667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++.........+++..+..++.++++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999986432236789999999999999999999987 89999999999999999999999999998876554
Q ss_pred -cceeecccceEEeccccc
Q 005587 669 -VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 -~~~~~~~~~~~~apE~~~ 686 (689)
......++..|+|||...
T Consensus 158 ~~~~~~~~~~~y~~pe~~~ 176 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQ 176 (258)
T ss_pred ceecceeeeecccChhHhc
Confidence 223345667799999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=203.63 Aligned_cols=170 Identities=21% Similarity=0.351 Sum_probs=141.4
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.+....||.|+.|+|++++++ +|..+|||.+.+... ....++++..+.++.+.+ .|.||+.+|||..+..+++.||
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3445667999999999999664 689999999987643 344556666677666554 8999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
.|.- -+..+++. ...++++...-++...+.+||.||.+.+ +|||||+||+|||+|+.|++|+||||++.++.+.
T Consensus 172 lMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9842 34444443 2457888888899999999999999885 8999999999999999999999999999999888
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
.....+.+-..|||||-+.
T Consensus 246 kAhtrsAGC~~YMaPERid 264 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERID 264 (391)
T ss_pred cccccccCCccccCccccC
Confidence 8777788899999999873
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=220.65 Aligned_cols=170 Identities=21% Similarity=0.263 Sum_probs=142.6
Q ss_pred hccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC------
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------ 579 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------ 579 (689)
..+.|+..+.||+|+||.||+|.. .+|+.||||.+............+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 346799999999999999999965 4789999999875443344456778899999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999996 588888753 278889999999999999999987 89999999999999999999999999
Q ss_pred CCccccCCCcceeecccceEEeccccc
Q 005587 660 LAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+++............++..|+|||.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVIL 190 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHh
Confidence 999876554433345667899999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=207.72 Aligned_cols=165 Identities=25% Similarity=0.405 Sum_probs=138.9
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
++||+|+||.||+|...+++.||+|.+...... .....+.+|++++++++|+||+++++++...+..++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999998766999999998765432 3456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCccee--
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV-- 672 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-- 672 (689)
.+++.... ..+++..++.++.++++||.|||+. +++||||||+||+++.++.+||+|||+++....+.....
T Consensus 80 ~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 99987532 3578899999999999999999987 899999999999999999999999999987654332211
Q ss_pred -ecccceEEeccccc
Q 005587 673 -SHNLTIMRAGGVTH 686 (689)
Q Consensus 673 -~~~~~~~~apE~~~ 686 (689)
......|+|||.+.
T Consensus 154 ~~~~~~~y~~PE~~~ 168 (251)
T cd05041 154 LKQIPIKWTAPEALN 168 (251)
T ss_pred cCcceeccCChHhhc
Confidence 11133499999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=196.40 Aligned_cols=173 Identities=19% Similarity=0.285 Sum_probs=142.5
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHh-cCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNID-RIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~-~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
...-.+.||+|+||.|-+-++ .+|...|+|++..... .+...+.+.|+.+.. ...+|.+|++||.+...+..|+.||
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 344457799999999988854 5799999999976544 345566777777654 4579999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
.|.- ||..+.++--.....+++...=+|+..|.+||.|||++ ..|||||+||+|||++.+|++||||||++..+.+.
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9954 88777654333356789999999999999999999987 47999999999999999999999999999988765
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
-......+-..|||||.+.
T Consensus 203 iAkt~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERIN 221 (282)
T ss_pred hHHHHhcCCCccCChhhcC
Confidence 5444456778899999984
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=212.55 Aligned_cols=173 Identities=24% Similarity=0.367 Sum_probs=142.0
Q ss_pred cCCCccceEeecCCeEEEEEEeC------CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
.+|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45677889999999999999532 35689999876432 34566899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCccc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC
Q 005587 583 LLIYEYCSNGTLQDMLHSDDEL-----------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~ 651 (689)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 9999999999999999754310 13588999999999999999999987 899999999999999999
Q ss_pred cEEEEeecCCccccCCCcce---eecccceEEeccccc
Q 005587 652 AVSVSDCGLAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
.+||+|||+++.+....... ....+..|+|||.+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 197 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhc
Confidence 99999999998664433211 112235699999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=211.01 Aligned_cols=170 Identities=24% Similarity=0.336 Sum_probs=139.4
Q ss_pred cCCCccceEeecCCeEEEEEEeCC----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
++|.+.+.||+|+||.||+|...+ ...||||....... ....+.+.+|+.++++++||||+++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457788999999999999997543 24689998764432 3455688999999999999999999998875 45789
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999999753 23589999999999999999999987 8999999999999999999999999999877
Q ss_pred cCCCcceee--cccceEEeccccc
Q 005587 665 SSGSVSQVS--HNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~~~~--~~~~~~~apE~~~ 686 (689)
......... .....|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~ 181 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESIN 181 (270)
T ss_pred ccccceecCCCCccccccChhhhc
Confidence 554322211 1224699999763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=216.29 Aligned_cols=172 Identities=30% Similarity=0.402 Sum_probs=141.6
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLL 584 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~l 584 (689)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+............+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35788999999999999999976 4689999999875433223334567899999999999999999998765 56899
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
||||+.+ +|.+++... ...+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++.+
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 888888653 24689999999999999999999997 8999999999999999999999999999987
Q ss_pred cCCCcc-eeecccceEEeccccc
Q 005587 665 SSGSVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~-~~~~~~~~~~apE~~~ 686 (689)
...... .....+..|+|||++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~ 181 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLL 181 (309)
T ss_pred CCccCCCCcccccccccChhhhc
Confidence 654221 1223456799999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=210.59 Aligned_cols=168 Identities=21% Similarity=0.346 Sum_probs=143.0
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
-|+..+.||+|+||.||+|.. .+++.||||.+..... ......+.+|++++.+++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 466778999999999999965 4688999998865432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999999863 3588999999999999999999987 89999999999999999999999999998765533
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. ....++..|++||.+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~ 174 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIK 174 (277)
T ss_pred hhhccccCCccccChhhhc
Confidence 21 1234567899999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=216.31 Aligned_cols=173 Identities=24% Similarity=0.338 Sum_probs=139.8
Q ss_pred CCCccceEeecCCeEEEEEEeC---CCcEEEEEEecccc-CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~ 583 (689)
.|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3777889999999999999764 47899999987633 1122345677899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHhcCccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC----CCcEEEEee
Q 005587 584 LIYEYCSNGTLQDMLHSDDEL-KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD----DLAVSVSDC 658 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~----~~~~kl~DF 658 (689)
+||||+++ +|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777776543322 23688999999999999999999987 8999999999999999 999999999
Q ss_pred cCCccccCCCcc----eeecccceEEeccccc
Q 005587 659 GLAPLISSGSVS----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~----~~~~~~~~~~apE~~~ 686 (689)
|+++.+...... ....++..|+|||++.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLL 188 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHh
Confidence 999987543321 1123466799999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=212.42 Aligned_cols=179 Identities=23% Similarity=0.399 Sum_probs=145.8
Q ss_pred chhhHhhhccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEE
Q 005587 500 TIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCA 577 (689)
Q Consensus 500 ~~~~l~~~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~ 577 (689)
++.++....+.|++.+.||+|+||.||+|.. .+++.||+|.+... .....++..|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 3344445567888899999999999999976 46889999988543 23345678889999888 6999999999985
Q ss_pred e------CCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC
Q 005587 578 E------HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (689)
Q Consensus 578 ~------~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~ 651 (689)
. .+..|+||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 3 467899999999999999987533 34578888999999999999999987 899999999999999999
Q ss_pred cEEEEeecCCccccCC-CcceeecccceEEeccccc
Q 005587 652 AVSVSDCGLAPLISSG-SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 652 ~~kl~DFGla~~~~~~-~~~~~~~~~~~~~apE~~~ 686 (689)
.++|+|||++...... .......++..|+|||++.
T Consensus 159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred CEEEeeCcchhhhhccccCCCcccccccccCHhhcC
Confidence 9999999999876432 1222345677899999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=215.86 Aligned_cols=166 Identities=27% Similarity=0.366 Sum_probs=140.3
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|.....||+|+||.||++.. .++..||||.+.... ....+.+.+|+..++.++|+||+++++.+...+..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34456799999999999965 468899999986432 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++..+.....
T Consensus 102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999998853 3578999999999999999999987 899999999999999999999999999986643322
Q ss_pred -ceeecccceEEeccccc
Q 005587 670 -SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 -~~~~~~~~~~~apE~~~ 686 (689)
.....++..|+|||.+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~ 191 (292)
T cd06658 174 KRKSLVGTPYWMAPEVIS 191 (292)
T ss_pred cCceeecCccccCHHHHc
Confidence 12235667899999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=209.02 Aligned_cols=168 Identities=23% Similarity=0.432 Sum_probs=141.9
Q ss_pred CCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
+|+..+.||+|+||.||+|.+.++..+|+|.+..... ....|.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 5677889999999999999887788999999865432 2456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999987532 3578999999999999999999987 899999999999999999999999999987654332
Q ss_pred ce--eecccceEEeccccc
Q 005587 670 SQ--VSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~--~~~~~~~~~apE~~~ 686 (689)
.. ....+..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~ 174 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFS 174 (256)
T ss_pred cccCCCccchhhcCHhHhc
Confidence 11 112234699999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=208.98 Aligned_cols=165 Identities=27% Similarity=0.411 Sum_probs=138.6
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
++|.+.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++||||+++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4578889999999999999975 67889999986432 245788999999999999999999998764 57999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++|+|.+++.... ...+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 80 MSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 99999999997543 34578999999999999999999987 89999999999999999999999999998754432
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
. .......|+|||.+.
T Consensus 155 ~--~~~~~~~y~~pe~~~ 170 (254)
T cd05083 155 D--NSKLPVKWTAPEALK 170 (254)
T ss_pred C--CCCCCceecCHHHhc
Confidence 1 123346799999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=211.41 Aligned_cols=163 Identities=28% Similarity=0.247 Sum_probs=133.0
Q ss_pred eEeecCCeEEEEEEe-CCCcEEEEEEeccccCCh-hhHHHHHHHH---HHHhcCCCCCcceecEEEEeCCeEEEEEeccC
Q 005587 516 LIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELV---NNIDRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~-~~~~~~~~e~---~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
+||+|+||.||+|.. .+++.||+|.+.+..... .....+..|. +.++...||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 468999999987643221 2222233333 34555689999999999999999999999999
Q ss_pred CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc
Q 005587 591 NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670 (689)
Q Consensus 591 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 670 (689)
||+|.+++.. ...+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.+.....
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999998864 34689999999999999999999987 899999999999999999999999999987654332
Q ss_pred eeecccceEEeccccc
Q 005587 671 QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 671 ~~~~~~~~~~apE~~~ 686 (689)
....++..|+|||++.
T Consensus 153 ~~~~~~~~y~aPE~~~ 168 (278)
T cd05606 153 HASVGTHGYMAPEVLQ 168 (278)
T ss_pred cCcCCCcCCcCcHHhc
Confidence 2346778899999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=212.62 Aligned_cols=172 Identities=21% Similarity=0.310 Sum_probs=140.6
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|++|.||+|... +|+.||+|.+............+.+|++++++++||||+++++++...+..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999765 68999999986544333344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-CCcEEEEeecCCccccC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISS 666 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~ 666 (689)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 58888876432 23467888889999999999999987 8999999999999985 56799999999987643
Q ss_pred CCcc-eeecccceEEeccccc
Q 005587 667 GSVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~-~~~~~~~~~~apE~~~ 686 (689)
.... ....++..|+|||++.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~ 176 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILL 176 (294)
T ss_pred CccccccCceeecccCHHHHh
Confidence 3211 1223467799999863
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=218.15 Aligned_cols=177 Identities=20% Similarity=0.279 Sum_probs=147.2
Q ss_pred cchhhHhhhccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEE
Q 005587 499 FTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCA 577 (689)
Q Consensus 499 ~~~~~l~~~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~ 577 (689)
....++..+.++|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|++++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 44566777889999999999999999999964 57899999998764433334567888999999999999999999886
Q ss_pred eC------CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC
Q 005587 578 EH------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (689)
Q Consensus 578 ~~------~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~ 651 (689)
.. ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 43 3468888887 7899988763 3588999999999999999999987 899999999999999999
Q ss_pred cEEEEeecCCccccCCCcceeecccceEEeccccc
Q 005587 652 AVSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 652 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
.+||+|||+++...... ....++..|+|||+..
T Consensus 158 ~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~ 190 (345)
T cd07877 158 ELKILDFGLARHTDDEM--TGYVATRWYRAPEIML 190 (345)
T ss_pred CEEEecccccccccccc--cccccCCCccCHHHHh
Confidence 99999999998764432 2234567799999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=210.38 Aligned_cols=175 Identities=23% Similarity=0.357 Sum_probs=143.9
Q ss_pred CCCccceEeecCCeEEEEEEeCC--CcEEEEEEecccc--------CChhhHHHHHHHHHHHhc-CCCCCcceecEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPD--GKLLAVKKLDKRA--------SSQQKDDEFLELVNNIDR-IRHANIVELKGYCAE 578 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~--g~~vAvK~l~~~~--------~~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~ 578 (689)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999997654 6889999875321 112234567788887764 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 579 ~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998865333345689999999999999999999963 27999999999999999999999999
Q ss_pred cCCccccCCCcceeecccceEEeccccc
Q 005587 659 GLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|++.............++..|++||.+.
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 186 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVK 186 (269)
T ss_pred cceeecccccccccccCcccCcChhhhc
Confidence 9999876654333455667799999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=215.06 Aligned_cols=170 Identities=24% Similarity=0.418 Sum_probs=138.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCc----EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~----~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 583 (689)
++|+..+.||+|+||.||+|.+. +|. .||+|.+..... .....++.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 46777889999999999999653 454 578888765432 33345788999999999999999999998764 467
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+++||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 999999999999998753 23578999999999999999999987 899999999999999999999999999997
Q ss_pred ccCCCccee---ecccceEEeccccc
Q 005587 664 ISSGSVSQV---SHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~~~---~~~~~~~~apE~~~ 686 (689)
+........ ...+..|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIH 184 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhc
Confidence 754332211 12245699999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=208.60 Aligned_cols=163 Identities=23% Similarity=0.308 Sum_probs=141.4
Q ss_pred EeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
||.|+||.||+|+.. +++.||+|.+...... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999764 5899999998764332 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcceeec
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 674 (689)
.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||+++.+..........
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~ 153 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence 9999753 3588899999999999999999987 89999999999999999999999999999887654334445
Q ss_pred ccceEEeccccc
Q 005587 675 NLTIMRAGGVTH 686 (689)
Q Consensus 675 ~~~~~~apE~~~ 686 (689)
++..|++||.+.
T Consensus 154 ~~~~~~~PE~~~ 165 (262)
T cd05572 154 GTPEYVAPEIIL 165 (262)
T ss_pred CCcCccChhHhc
Confidence 677899999863
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-23 Score=210.65 Aligned_cols=173 Identities=27% Similarity=0.401 Sum_probs=145.2
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCC----
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG---- 580 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~---- 580 (689)
.+++|++.+.||+|+||.||+|... +++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4578999999999999999999764 67899999986543 2346788999999998 7999999999997644
Q ss_pred --eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 581 --QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 581 --~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
..++||||+++++|.+++.........+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999999875432345789999999999999999999987 8999999999999999999999999
Q ss_pred cCCccccCCC-cceeecccceEEecccc
Q 005587 659 GLAPLISSGS-VSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 659 Gla~~~~~~~-~~~~~~~~~~~~apE~~ 685 (689)
|++....... ......++..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVI 185 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHh
Confidence 9998764432 22234466789999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=207.88 Aligned_cols=165 Identities=27% Similarity=0.424 Sum_probs=132.3
Q ss_pred ceEeecCCeEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe-CCeEEEEEecc
Q 005587 515 NLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQRLLIYEYC 589 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~Ey~ 589 (689)
+.||+|+||.||+|.+. +...||+|.+.... .......+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999753 24579999875432 23445678899999999999999999998764 55689999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
.+|+|.+++... .....+..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999753 23467788899999999999999987 899999999999999999999999999986644321
Q ss_pred ce-----eecccceEEeccccc
Q 005587 670 SQ-----VSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~-----~~~~~~~~~apE~~~ 686 (689)
.. ....+..|+|||...
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~ 175 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQ 175 (262)
T ss_pred eeecccccCcCCccccChhHhc
Confidence 11 112345699999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=209.95 Aligned_cols=171 Identities=23% Similarity=0.399 Sum_probs=142.6
Q ss_pred cCCCccceEeecCCeEEEEEEeC-----CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--CCe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQ 581 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--~~~ 581 (689)
+.|+..+.||+|+||.||+|.+. ++..||||.+...... .....|.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 35677789999999999999753 3689999998765432 346789999999999999999999999887 557
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 899999999999999997542 3589999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCcce----eecccceEEeccccc
Q 005587 662 PLISSGSVSQ----VSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~~~~----~~~~~~~~~apE~~~ 686 (689)
..+....... .......|++||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHc
Confidence 9876432211 123345689999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=211.01 Aligned_cols=169 Identities=21% Similarity=0.329 Sum_probs=145.9
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..+.||+|+||.||+|... +++.||+|.+..... .....++.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999765 689999999876543 34567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
+++++|.+++.... ..+++.....++.|+++||.|||+ . +++|+||||+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999997632 568889999999999999999998 5 8999999999999999999999999999877543
Q ss_pred CcceeecccceEEeccccc
Q 005587 668 SVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~~ 686 (689)
.... ..++..|++||.+.
T Consensus 155 ~~~~-~~~~~~y~~PE~~~ 172 (265)
T cd06605 155 LAKT-FVGTSSYMAPERIQ 172 (265)
T ss_pred Hhhc-ccCChhccCHHHHc
Confidence 3222 55667899999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=209.86 Aligned_cols=168 Identities=24% Similarity=0.412 Sum_probs=143.1
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC---CCCcceecEEEEeCCeEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR---HANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~---HpnIv~l~~~~~~~~~~~lV 585 (689)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... .....++.+|++++++++ ||||+++++++...+..++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999975 5789999999865432 234456888999988886 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++++|.+++.. ..+++...+.++.|+++||.|||+. +|+|+||+|+||++++++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 81 MEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999999864 2688999999999999999999987 89999999999999999999999999998876
Q ss_pred CCCc-ceeecccceEEeccccc
Q 005587 666 SGSV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~-~~~~~~~~~~~apE~~~ 686 (689)
.... .....++..|+|||.+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVIT 174 (277)
T ss_pred CCccccccccCCcceeCHHHhc
Confidence 5432 22234667899999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=209.26 Aligned_cols=173 Identities=27% Similarity=0.379 Sum_probs=139.4
Q ss_pred CCccceEeecCCeEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC------
Q 005587 511 FSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG------ 580 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~------ 580 (689)
|.+.+.||+|+||.||+|.+. +++.||||++..........+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999653 3688999998765544555677899999999999999999999886532
Q ss_pred eEEEEEeccCCCCHHHHHhcCc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDD--ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
..++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875422 1123578899999999999999999987 8999999999999999999999999
Q ss_pred cCCccccCCCcc---eeecccceEEeccccc
Q 005587 659 GLAPLISSGSVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~---~~~~~~~~~~apE~~~ 686 (689)
|+++.+...... ........|++||.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 188 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLA 188 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHh
Confidence 999977543321 1123345689999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=206.80 Aligned_cols=169 Identities=29% Similarity=0.468 Sum_probs=141.9
Q ss_pred CCccceEeecCCeEEEEEEeCC-----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 511 FSQENLIGAGMLGSVYRAQLPD-----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~~-----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
|++.+.||+|+||.||+|+..+ +..||+|.+..... ......+..|++.+..++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3456889999999999997653 38899999865432 22567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++...
T Consensus 80 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 80 MEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999997632 12289999999999999999999987 89999999999999999999999999998876
Q ss_pred CCCccee--ecccceEEecccc
Q 005587 666 SGSVSQV--SHNLTIMRAGGVT 685 (689)
Q Consensus 666 ~~~~~~~--~~~~~~~~apE~~ 685 (689)
....... ...+..|+|||.+
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~ 176 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESL 176 (258)
T ss_pred cccccccccCCCcccccChHHh
Confidence 5532221 2244679999976
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=217.15 Aligned_cols=169 Identities=21% Similarity=0.306 Sum_probs=142.4
Q ss_pred hccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-----
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----- 580 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~----- 580 (689)
..++|++.+.||+|+||.||+|. ..+|..||||++............+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 45789999999999999999996 457899999998654433344567889999999999999999999987643
Q ss_pred -eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 581 -QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 581 -~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 468999999 7799988863 3588999999999999999999987 89999999999999999999999999
Q ss_pred CCccccCCCcceeecccceEEeccccc
Q 005587 660 LAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
++......... ..++..|+|||.+.
T Consensus 164 ~~~~~~~~~~~--~~~~~~y~aPE~~~ 188 (343)
T cd07880 164 LARQTDSEMTG--YVVTRWYRAPEVIL 188 (343)
T ss_pred cccccccCccc--cccCCcccCHHHHh
Confidence 99877543322 34567899999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=204.47 Aligned_cols=169 Identities=24% Similarity=0.395 Sum_probs=147.3
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|++.+.||+|++|.||++... +++.|++|.+............+.+|++++.+++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999654 688999999976654445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998753 4689999999999999999999987 89999999999999999999999999999876654
Q ss_pred cc-eeecccceEEecccc
Q 005587 669 VS-QVSHNLTIMRAGGVT 685 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~ 685 (689)
.. ....++..|+|||..
T Consensus 154 ~~~~~~~~~~~y~~pe~~ 171 (254)
T cd06627 154 KDDASVVGTPYWMAPEVI 171 (254)
T ss_pred ccccccccchhhcCHhhh
Confidence 31 224566779999976
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=208.20 Aligned_cols=172 Identities=20% Similarity=0.346 Sum_probs=144.6
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..+.||+|+||.||+|... +|..||+|.+..........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999765 588999999876543334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC-cEEEEeecCCccccCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSG 667 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~ 667 (689)
+++++|.+++.... ...+++..++.++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+..+...
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999987532 23578999999999999999999987 899999999999999875 5699999999877543
Q ss_pred Cc-ceeecccceEEeccccc
Q 005587 668 SV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~-~~~~~~~~~~~apE~~~ 686 (689)
.. .....++..|+|||+..
T Consensus 156 ~~~~~~~~~~~~~~ape~~~ 175 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQ 175 (257)
T ss_pred cccccccCCCccccCHHHHc
Confidence 32 22234667799999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=211.73 Aligned_cols=161 Identities=20% Similarity=0.344 Sum_probs=133.6
Q ss_pred ceEeecCCeEEEEEEeCC-C-------cEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 515 NLIGAGMLGSVYRAQLPD-G-------KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~-g-------~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999996532 2 348888775432 234567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCc--------EEEEee
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA--------VSVSDC 658 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--------~kl~DF 658 (689)
||+++|+|.++++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999997542 3688999999999999999999987 8999999999999987664 699999
Q ss_pred cCCccccCCCcceeecccceEEeccccc
Q 005587 659 GLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|++....... ...++..|+|||++.
T Consensus 153 g~~~~~~~~~---~~~~~~~y~aPE~~~ 177 (258)
T cd05078 153 GISITVLPKE---ILLERIPWVPPECIE 177 (258)
T ss_pred ccccccCCch---hccccCCccCchhcc
Confidence 9998765432 234567799999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=210.43 Aligned_cols=170 Identities=21% Similarity=0.326 Sum_probs=142.0
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|++.+.||+|++|.||+|.. .+|..||+|++............+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678999999999999965 47999999998755433334467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
+ ++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||+++.+.....
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 69999987533 24689999999999999999999987 899999999999999999999999999987643321
Q ss_pred c-eeecccceEEeccccc
Q 005587 670 S-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~-~~~~~~~~~~apE~~~ 686 (689)
. ....++..|+|||++.
T Consensus 155 ~~~~~~~~~~~~aPE~~~ 172 (283)
T cd07835 155 TYTHEVVTLWYRAPEILL 172 (283)
T ss_pred ccCccccccCCCCCceee
Confidence 1 1223467799999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=210.15 Aligned_cols=171 Identities=21% Similarity=0.369 Sum_probs=142.3
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+|+..+.||+|++|.||+|+.. +|+.||||.+..... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4788899999999999999765 689999999875432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++ +|.+++..... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++.+....
T Consensus 80 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 80 MDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred CCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 985 89888865332 34689999999999999999999987 89999999999999999999999999998764432
Q ss_pred cc-eeecccceEEeccccc
Q 005587 669 VS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~-~~~~~~~~~~apE~~~ 686 (689)
.. ....++..|++||++.
T Consensus 155 ~~~~~~~~~~~y~~PE~~~ 173 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLL 173 (284)
T ss_pred cccccccccccccChHHhc
Confidence 11 1223456799999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=213.55 Aligned_cols=173 Identities=25% Similarity=0.351 Sum_probs=142.2
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-----
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----- 580 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~----- 580 (689)
..++|++.+.||+|+||.||+|... +|+.||+|.+............+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567899999999999999999765 5889999998754332333456778999999999999999999987654
Q ss_pred -----eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEE
Q 005587 581 -----QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (689)
Q Consensus 581 -----~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl 655 (689)
..++||||+++ ++.+.+... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 777777643 34689999999999999999999987 8999999999999999999999
Q ss_pred EeecCCccccCCCcc--eeecccceEEeccccc
Q 005587 656 SDCGLAPLISSGSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 656 ~DFGla~~~~~~~~~--~~~~~~~~~~apE~~~ 686 (689)
+|||++..+...... ........|+|||++.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 190 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhc
Confidence 999999987654321 1123356799999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=220.65 Aligned_cols=148 Identities=20% Similarity=0.289 Sum_probs=127.9
Q ss_pred CCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
-|...+.||-|+||.|.+++ ..+...||.|.+++...- .........|-.+|.....+-||+||-.|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 45666789999999999995 556788999998765321 2233456678889999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
|++||++..+|.. ...+++..++.|+.++..|+++.|.. |+|||||||+|||||.+|++||+||||+.-+
T Consensus 710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999876 34678888999999999999999987 8999999999999999999999999998744
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=204.56 Aligned_cols=170 Identities=28% Similarity=0.390 Sum_probs=149.5
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeEEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLLIY 586 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 586 (689)
+|...+.||+|++|.||+|... +++.|++|.+..........+.+.+|+..+++++|+||+++++++... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999765 689999999876554345567889999999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999753 2789999999999999999999997 899999999999999999999999999998876
Q ss_pred CCc---ceeecccceEEeccccc
Q 005587 667 GSV---SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~---~~~~~~~~~~~apE~~~ 686 (689)
... .....++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~ 176 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIR 176 (260)
T ss_pred ccccccccCCCCCccccCHhhhc
Confidence 653 34456778899999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=214.16 Aligned_cols=166 Identities=27% Similarity=0.326 Sum_probs=140.2
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|+....||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 33445799999999999965 4689999999865432 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 101 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 101 QGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999998753 3578999999999999999999987 899999999999999999999999999986654332
Q ss_pred -ceeecccceEEeccccc
Q 005587 670 -SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 -~~~~~~~~~~~apE~~~ 686 (689)
.....++..|+|||++.
T Consensus 173 ~~~~~~~~~~y~aPE~~~ 190 (297)
T cd06659 173 KRKSLVGTPYWMAPEVIS 190 (297)
T ss_pred cccceecCccccCHHHHc
Confidence 12244667899999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=213.12 Aligned_cols=171 Identities=23% Similarity=0.362 Sum_probs=139.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-------
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG------- 580 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~------- 580 (689)
++|++.+.||+|+||.||+|... +++.||||.+............+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56888999999999999999764 6899999998654333333445678999999999999999999987653
Q ss_pred -eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 581 -QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 581 -~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
..++||||+. ++|.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999996 4888887643 23589999999999999999999987 89999999999999999999999999
Q ss_pred CCccccCCCcc-----eeecccceEEeccccc
Q 005587 660 LAPLISSGSVS-----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~-----~~~~~~~~~~apE~~~ 686 (689)
++..+...... ....++..|+|||++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhc
Confidence 99877543321 1123456699999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=208.48 Aligned_cols=167 Identities=24% Similarity=0.300 Sum_probs=137.9
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeC--CeEEEEE
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEH--GQRLLIY 586 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~ 586 (689)
|++.+.||+|+||.||+|.. .+++.||+|++....... ......+|+.++.++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 56678899999999999965 468999999987543222 2234457888888885 99999999999987 8999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||++ |+|.+.+... ...++|..++.++.|+++||+|||+. +|+||||||+||+++. +.+||+|||+++.+..
T Consensus 80 e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 9997 5888887653 24689999999999999999999987 8999999999999999 9999999999998765
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
........++..|+|||...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLL 171 (282)
T ss_pred CCCcCCCCCCcccCChhHhh
Confidence 54433345677899999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=210.38 Aligned_cols=168 Identities=30% Similarity=0.445 Sum_probs=142.1
Q ss_pred ccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEecccc-CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
.+.|+..+.||+|+||.||+|... +|+.||+|.+.... ........+.+|+++++.++||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999764 68999999986432 2234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+. |++.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 5777776532 24589999999999999999999987 89999999999999999999999999998765
Q ss_pred CCCcceeecccceEEecccc
Q 005587 666 SGSVSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~apE~~ 685 (689)
... ...++..|+|||++
T Consensus 167 ~~~---~~~~~~~y~aPE~~ 183 (307)
T cd06607 167 PAN---SFVGTPYWMAPEVI 183 (307)
T ss_pred CCC---CccCCccccCceee
Confidence 443 23456789999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-23 Score=217.60 Aligned_cols=169 Identities=25% Similarity=0.436 Sum_probs=144.4
Q ss_pred CCCccceEeecCCeEEEEEEeCC---Cc--EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPD---GK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~---g~--~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
.....++||+|-||.||+|.+.+ |+ .||||..+.... ..+.+.|+.|.-+|++++|||||+++|.|.+. ..|+
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 34456789999999999996532 33 588888765443 45578899999999999999999999999875 6899
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
|||.++-|.|..+|+.. +..++......++.||..||.|||+. .+|||||-..|||+...--+||+||||++.+
T Consensus 468 vmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 99999999999999875 35688889999999999999999998 8999999999999999999999999999999
Q ss_pred cCCCcceeecccce--EEeccccc
Q 005587 665 SSGSVSQVSHNLTI--MRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~~~~~~~~~--~~apE~~~ 686 (689)
.+......+.+... |||||.+.
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESIN 565 (974)
T ss_pred cccchhhccccccceeecCccccc
Confidence 88776655544432 99999985
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=215.94 Aligned_cols=169 Identities=22% Similarity=0.333 Sum_probs=139.5
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC-----Ce
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~ 581 (689)
.++|++.+.||+|+||.||+|.. .+|+.||||.+..... ......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 46899999999999999999965 5789999999864322 23445678899999999999999999987654 35
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.|+||||+. ++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 488888763 4689999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCcc----eeecccceEEeccccc
Q 005587 662 PLISSGSVS----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~~~----~~~~~~~~~~apE~~~ 686 (689)
+........ ....++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIML 182 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhh
Confidence 876543221 1234567799999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=217.54 Aligned_cols=169 Identities=21% Similarity=0.345 Sum_probs=140.8
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe----CCeEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE----HGQRL 583 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~ 583 (689)
++|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788899999999999999965 469999999987654333445667789999999999999999998763 35789
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+||||+. |+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 689998865 23589999999999999999999987 899999999999999999999999999987
Q ss_pred ccCCCcc-----eeecccceEEecccc
Q 005587 664 ISSGSVS-----QVSHNLTIMRAGGVT 685 (689)
Q Consensus 664 ~~~~~~~-----~~~~~~~~~~apE~~ 685 (689)
+...... ....++..|+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELL 183 (334)
T ss_pred ecccCcCCCcccccccccccccChHHh
Confidence 6543221 123456779999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=210.40 Aligned_cols=168 Identities=24% Similarity=0.365 Sum_probs=143.3
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
++|.+.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 5788889999999999999964 468899999986432 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..+...
T Consensus 97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999999864 3478899999999999999999987 8999999999999999999999999998876543
Q ss_pred Ccc-eeecccceEEeccccc
Q 005587 668 SVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~-~~~~~~~~~~apE~~~ 686 (689)
... ....++..|++||++.
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~ 188 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVT 188 (293)
T ss_pred ccccccccCChhhcCchhhc
Confidence 321 2234566799999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=209.36 Aligned_cols=169 Identities=26% Similarity=0.380 Sum_probs=142.9
Q ss_pred CCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEEec
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
|++.+.||+|+||.||+|... +++.||||++...... .......+|+..+++++ |+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 566789999999999999875 5789999998654332 22334567889999999 99999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+ +|+|.+++.... ...+++..++.++.|++.+|.|||+. +++|+||||+||++++++.++|+|||+++......
T Consensus 80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 9 889999887643 24689999999999999999999987 89999999999999999999999999999876554
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
......++..|+|||++.
T Consensus 154 ~~~~~~~~~~~~aPE~~~ 171 (283)
T cd07830 154 PYTDYVSTRWYRAPEILL 171 (283)
T ss_pred CcCCCCCcccccCceeee
Confidence 433345677899999873
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=222.28 Aligned_cols=176 Identities=20% Similarity=0.265 Sum_probs=132.4
Q ss_pred ccCCCccceEeecCCeEEEEEEe-----------------CCCcEEEEEEeccccCCh------------hhHHHHHHHH
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-----------------PDGKLLAVKKLDKRASSQ------------QKDDEFLELV 558 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~------------~~~~~~~~e~ 558 (689)
.++|++.++||+|+||.||+|.+ ..++.||||++....... ...+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999953 235689999986432110 0112234466
Q ss_pred HHHhcCCCCCc-----ceecEEEEe--------CCeEEEEEeccCCCCHHHHHhcCcc--------------------cC
Q 005587 559 NNIDRIRHANI-----VELKGYCAE--------HGQRLLIYEYCSNGTLQDMLHSDDE--------------------LK 605 (689)
Q Consensus 559 ~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~Ey~~ggsL~~~l~~~~~--------------------~~ 605 (689)
.++.+++|.++ ++++++|.. .+..||||||+++|+|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777776654 677777753 3568999999999999999875211 01
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcce--eecccceEEecc
Q 005587 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ--VSHNLTIMRAGG 683 (689)
Q Consensus 606 ~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~~~~apE 683 (689)
..++|..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.+..+.... ....++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2457888999999999999999987 89999999999999999999999999998765433211 123367899999
Q ss_pred ccc
Q 005587 684 VTH 686 (689)
Q Consensus 684 ~~~ 686 (689)
++.
T Consensus 381 ~l~ 383 (507)
T PLN03224 381 ELV 383 (507)
T ss_pred hhc
Confidence 874
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=211.73 Aligned_cols=174 Identities=22% Similarity=0.320 Sum_probs=139.9
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+|...+.||+|+||.||++.. .+++.||+|.+...... .....+.+|+.++.++. |+||+++++++...+..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 455667899999999999965 46899999998754332 44567889999999996 9999999999999999999999
Q ss_pred ccCCCCHHHHHhcC-cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 588 YCSNGTLQDMLHSD-DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 588 y~~ggsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
|+.. ++.++.... ......+++..+..++.|+++||+|||+. .+|+||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 655543210 01135689999999999999999999974 2799999999999999999999999999987655
Q ss_pred CCcceeecccceEEecccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~~ 687 (689)
........++..|+|||++..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDP 181 (288)
T ss_pred CCccccccCccCccCHHHhcc
Confidence 443344456778999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=214.17 Aligned_cols=168 Identities=24% Similarity=0.273 Sum_probs=137.1
Q ss_pred ceEeec--CCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAG--MLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G--~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+| +||+||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999975 4799999999876554444557788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcc-
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS- 670 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~- 670 (689)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987642 24588999999999999999999987 8999999999999999999999999865433221111
Q ss_pred -------eeecccceEEecccccc
Q 005587 671 -------QVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 671 -------~~~~~~~~~~apE~~~~ 687 (689)
.....+..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred cccccccccccCccCccChhhhcC
Confidence 11123456999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-23 Score=217.32 Aligned_cols=171 Identities=20% Similarity=0.210 Sum_probs=145.0
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCCh------hhHHHHHHHHHHHhcCC---CCCcceecEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ------QKDDEFLELVNNIDRIR---HANIVELKGYCAE 578 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~------~~~~~~~~e~~~l~~l~---HpnIv~l~~~~~~ 578 (689)
.+|.....+|+|+||.|+.|.++ +...|+||.+.++..-. .+.-..-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35778899999999999999654 57789999987653211 11122346899999987 9999999999999
Q ss_pred CCeEEEEEecc-CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEe
Q 005587 579 HGQRLLIYEYC-SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657 (689)
Q Consensus 579 ~~~~~lV~Ey~-~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~D 657 (689)
++++||+||-- +|-+|+++|.. +..+++.++..|.+||+.|+++||+. +|||||||-+|+.+|.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999955 46689999965 56789999999999999999999998 899999999999999999999999
Q ss_pred ecCCccccCCCcceeecccceEEecccccc
Q 005587 658 CGLAPLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~apE~~~~ 687 (689)
||-|.....+.... -.+|..|.|||++..
T Consensus 714 fgsaa~~ksgpfd~-f~gtv~~aapevl~g 742 (772)
T KOG1152|consen 714 FGSAAYTKSGPFDV-FVGTVDYAAPEVLGG 742 (772)
T ss_pred ccchhhhcCCCcce-eeeeccccchhhhCC
Confidence 99999998887654 467788999999964
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=208.32 Aligned_cols=169 Identities=25% Similarity=0.382 Sum_probs=142.1
Q ss_pred CCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--CeEEEEEe
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH--GQRLLIYE 587 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 587 (689)
|++.+.||+|+||.||+|+.. +++.+|+|++............+.+|++++++++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999765 588999999976542333456788999999999999999999999988 89999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+++ +|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 898888653 24689999999999999999999987 8999999999999999999999999999887654
Q ss_pred Cc--ceeecccceEEeccccc
Q 005587 668 SV--SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~--~~~~~~~~~~~apE~~~ 686 (689)
.. ......+..|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLL 174 (287)
T ss_pred CcccccccccccccCCceeeE
Confidence 31 12234466799999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-23 Score=218.30 Aligned_cols=171 Identities=25% Similarity=0.406 Sum_probs=146.2
Q ss_pred CCCccceEeecCCeEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+.....+||-|.||.||.|.|+. .-.||||.++...+ ..++|+.|..+|+.++|||+|+++|+|......|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34456789999999999998865 67899999976543 468899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
|..|+|.++|++.. +..++--..+.|+.||+.||+||... ++|||||-..|.|+.++..+||+||||++++..+.
T Consensus 345 M~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 99999999998754 33456667788999999999999987 89999999999999999999999999999998776
Q ss_pred cceeeccc--ceEEeccccccC
Q 005587 669 VSQVSHNL--TIMRAGGVTHRN 688 (689)
Q Consensus 669 ~~~~~~~~--~~~~apE~~~~~ 688 (689)
...+.... .-|.|||-+-+|
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyN 441 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYN 441 (1157)
T ss_pred eecccCccCcccccCccccccc
Confidence 55543333 228899988654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=209.23 Aligned_cols=168 Identities=27% Similarity=0.381 Sum_probs=136.6
Q ss_pred ceEeecCCeEEEEEEeCC-------CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 515 NLIGAGMLGSVYRAQLPD-------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~-------g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+.||+|+||.||+|+..+ +..+|||.+..... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997542 25799998865422 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC-----cEEEEeec
Q 005587 588 YCSNGTLQDMLHSDDE---LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-----AVSVSDCG 659 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-----~~kl~DFG 659 (689)
|+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 9999999999975321 123478999999999999999999987 899999999999999877 89999999
Q ss_pred CCccccCCCcce---eecccceEEeccccc
Q 005587 660 LAPLISSGSVSQ---VSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~~---~~~~~~~~~apE~~~ 686 (689)
+++.+....... ....+..|+|||++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 186 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLL 186 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHc
Confidence 998765433211 122346799999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=213.19 Aligned_cols=172 Identities=23% Similarity=0.327 Sum_probs=143.7
Q ss_pred HhhhccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe-CCe
Q 005587 504 LQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQ 581 (689)
Q Consensus 504 l~~~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~-~~~ 581 (689)
+..++++|++.+.||+|+||.||+|.. .+++.||||++.+........+.+.+|++++.+++||||+++++++.. .+.
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345678899999999999999999965 479999999986544333445678899999999999999999999876 567
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.++||||+ +++|.++++. ..+++.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999999 5699988863 3578888889999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCcceeecccceEEeccccc
Q 005587 662 PLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
......... ..++..|+|||++.
T Consensus 156 ~~~~~~~~~--~~~~~~y~aPE~~~ 178 (328)
T cd07856 156 RIQDPQMTG--YVSTRYYRAPEIML 178 (328)
T ss_pred cccCCCcCC--CcccccccCceeee
Confidence 876443322 34567799999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=200.44 Aligned_cols=169 Identities=29% Similarity=0.468 Sum_probs=147.6
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
.|...+.||+|++|.||++... +++.+++|++..... .....+.+|++.+++++|+||+++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3677889999999999999765 688999999876432 3557888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+++++|.+++.... ..+++..+..++.|+++||.|||.. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 79 CSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 99999999987632 4689999999999999999999986 89999999999999999999999999999887654
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
......+...|++||++.
T Consensus 153 ~~~~~~~~~~~~~PE~~~ 170 (253)
T cd05122 153 ARNTMVGTPYWMAPEVIN 170 (253)
T ss_pred cccceecCCcccCHHHHc
Confidence 333456677899999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=206.37 Aligned_cols=170 Identities=28% Similarity=0.343 Sum_probs=138.9
Q ss_pred CCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhc---CCCCCcceecEEEEeCCe-----
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDR---IRHANIVELKGYCAEHGQ----- 581 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~---l~HpnIv~l~~~~~~~~~----- 581 (689)
|++.+.||+|+||.||+|+.. +++.||+|++............+.+|+.++.+ ++|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999876 48999999997544333334456667666554 469999999999998776
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 999999997 48999887532 23589999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCcceeecccceEEeccccc
Q 005587 662 PLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
..+..........++..|+|||++.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~ 179 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLL 179 (287)
T ss_pred eeccCCcccccccccccccChHHhc
Confidence 8876554433344567799999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-24 Score=220.32 Aligned_cols=171 Identities=23% Similarity=0.274 Sum_probs=151.1
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCc-EEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGK-LLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~-~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
.+++....||-|+||.|=+++..... .+|+|++++... +....+....|-++|..++.|.||++|..|.+..++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 35556677999999999998765433 489999987653 3344567788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
|-|-||.|..++... ..++..++..|+..+.+|++|||+. +||+|||||+|.++|.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999874 4577788888999999999999998 899999999999999999999999999999999
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
+...-.-++|+.|.||||+.
T Consensus 573 g~KTwTFcGTpEYVAPEIIL 592 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIIL 592 (732)
T ss_pred CCceeeecCCcccccchhhh
Confidence 99888899999999999994
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=214.47 Aligned_cols=171 Identities=23% Similarity=0.320 Sum_probs=141.2
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC--CeE
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH--GQR 582 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~--~~~ 582 (689)
..++|++.+.||+|+||.||+|... +|+.+|||++............+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999765 688999998865433334445677899999999 999999999998754 368
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
|+||||+. ++|.+++.. ..++|..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599988864 2678899999999999999999987 89999999999999999999999999998
Q ss_pred cccCCCcc------eeecccceEEeccccc
Q 005587 663 LISSGSVS------QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~~------~~~~~~~~~~apE~~~ 686 (689)
.+...... ....++..|+|||++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 185 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILL 185 (337)
T ss_pred ccccccccccCcchhcccccccccCceeee
Confidence 77543321 1234566799999763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-24 Score=207.20 Aligned_cols=170 Identities=24% Similarity=0.397 Sum_probs=137.5
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe--------CC
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--------HG 580 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~--------~~ 580 (689)
.|....+||+|.||.||+|+.+ +|+.||+|++-.+.....-....++|+++|..++|+|++.+++.|.. +.
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3555678999999999999654 57889998765433223344567899999999999999999988864 24
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
..|+||++|++ +|+-+|... ...++..++.+++.++..||.|+|.. .|+|||+|++|+||+.+|.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 58999999987 899888653 35688899999999999999999987 899999999999999999999999999
Q ss_pred CccccCCCcc-----eeecccceEEeccccc
Q 005587 661 APLISSGSVS-----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~~~-----~~~~~~~~~~apE~~~ 686 (689)
|+.+...... ..-..|.+|+.||.+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllL 201 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLL 201 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhh
Confidence 9876543221 2233478899999984
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=214.65 Aligned_cols=171 Identities=21% Similarity=0.329 Sum_probs=141.5
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC-----Ce
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQ 581 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~ 581 (689)
.+.|.+.+.||+|+||.||+|+. .+++.||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35788899999999999999965 4689999999875433333455677899999999999999999988654 35
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 689988875 24689999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCC-cceeecccceEEeccccc
Q 005587 662 PLISSGS-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~-~~~~~~~~~~~~apE~~~ 686 (689)
+...... ......++..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLL 181 (337)
T ss_pred cccCCCcccccccccccCccChHHHh
Confidence 9775542 122234567799999763
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=204.77 Aligned_cols=163 Identities=24% Similarity=0.303 Sum_probs=138.1
Q ss_pred EeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
||+|+||.||+++.. +|+.+++|.+..... .......+.+|++++++++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999776 489999999865432 223456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC------
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS------ 668 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~------ 668 (689)
.+++... ..+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999763 3689999999999999999999987 89999999999999999999999999988654432
Q ss_pred ---cceeecccceEEeccccc
Q 005587 669 ---VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ---~~~~~~~~~~~~apE~~~ 686 (689)
......+...|++||...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~ 174 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVIL 174 (265)
T ss_pred ccccccCcccCccccCHHHhc
Confidence 112234566799999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=207.69 Aligned_cols=170 Identities=23% Similarity=0.276 Sum_probs=141.4
Q ss_pred CCCccceEeecCCeEEEEEEe----CCCcEEEEEEeccccC--ChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeE
Q 005587 510 SFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQR 582 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~----~~g~~vAvK~l~~~~~--~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 582 (689)
+|++.+.||+|+||.||+++. .+++.||||.+.+... .......+.+|++++.++ +||||+++++.+...+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467789999999999999864 3578899999865322 122345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999875 24588999999999999999999987 89999999999999999999999999998
Q ss_pred cccCCCcc--eeecccceEEeccccc
Q 005587 663 LISSGSVS--QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~~--~~~~~~~~~~apE~~~ 686 (689)
.+...... ....+...|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIR 179 (288)
T ss_pred ccccccccccccccCCccccCHHHhc
Confidence 76543321 1234567899999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=210.64 Aligned_cols=167 Identities=17% Similarity=0.184 Sum_probs=136.1
Q ss_pred cceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCC
Q 005587 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT 593 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggs 593 (689)
.+.+|.|+++.||++.. +++.||||++............+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455555555555544 78999999997654445566789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc----
Q 005587 594 LQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV---- 669 (689)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~---- 669 (689)
|.+++.... ...+++.....++.|+++||+|||+. +|+||||||+||+++.++.+||+|||.+..+.....
T Consensus 86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999997532 34578899999999999999999987 899999999999999999999999999876543221
Q ss_pred ----ceeecccceEEeccccc
Q 005587 670 ----SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ----~~~~~~~~~~~apE~~~ 686 (689)
.....++..|+|||++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~ 181 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQ 181 (314)
T ss_pred cccccccccccccccCHHHhc
Confidence 12234456799999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-23 Score=211.28 Aligned_cols=173 Identities=20% Similarity=0.244 Sum_probs=143.6
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhH-HHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~-~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 585 (689)
.+|....+||+|+||.|.+|+.+ +.+.+|||++++...-+.+. +--+.|-++|.-. +-|.+++++.+|...+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 35777899999999999999655 57889999998765433332 2234566666655 578999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc-
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI- 664 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~- 664 (689)
|||+.||+|.-.+++.+ .+.+..++-+|.+||-||=|||+. +||+||||.+|||+|.+|++||+|||+++.-
T Consensus 429 MEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999998887643 456677889999999999999998 8999999999999999999999999999864
Q ss_pred cCCCcceeecccceEEeccccccC
Q 005587 665 SSGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 665 ~~~~~~~~~~~~~~~~apE~~~~~ 688 (689)
-.+.+...-++|+-|+||||+.|+
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~Yq 525 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQ 525 (683)
T ss_pred cCCcceeeecCCCcccccceEEec
Confidence 344566667899999999999654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=206.55 Aligned_cols=172 Identities=24% Similarity=0.357 Sum_probs=147.2
Q ss_pred hhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEE
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 584 (689)
...+.|+..+.||+|+||.||+|... ++..|++|.+..... ....+.+|++.+++++|+||+++++++...+..|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45567888899999999999999765 688999999865432 45678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
|+||+++++|.+++.... ..+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999999999998632 3689999999999999999999987 8999999999999999999999999998766
Q ss_pred cCCCcc-eeecccceEEeccccc
Q 005587 665 SSGSVS-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 665 ~~~~~~-~~~~~~~~~~apE~~~ 686 (689)
...... ....++..|++||++.
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~ 189 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIK 189 (286)
T ss_pred ccchhhhccccCCcccCCHhHhc
Confidence 543211 2234567799999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=207.80 Aligned_cols=166 Identities=30% Similarity=0.452 Sum_probs=140.5
Q ss_pred CCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.|+..+.||+|+||.||+|+. .++..||+|.+..... .......+.+|++++++++|||++++++++...+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 467788999999999999975 4688999999865422 22345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+. |+|.+++... ...++|..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 997 5888877543 34589999999999999999999987 8999999999999999999999999999876543
Q ss_pred CcceeecccceEEecccc
Q 005587 668 SVSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~ 685 (689)
. ...++..|+|||.+
T Consensus 179 ~---~~~~~~~y~aPE~~ 193 (317)
T cd06635 179 N---SFVGTPYWMAPEVI 193 (317)
T ss_pred c---cccCCccccChhhh
Confidence 3 23566789999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-22 Score=202.66 Aligned_cols=162 Identities=20% Similarity=0.207 Sum_probs=132.1
Q ss_pred ceEeecCCeEEEEEEe-CCCcEEEEEEeccccCC-hhhHHHHHHHHHH-HhcCCCCCcceecEEEEeCCeEEEEEeccCC
Q 005587 515 NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNN-IDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+.||+|+||.||+|.. .+|+.||||.+...... ......+..|..+ ....+|+||+++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999966 46899999998654321 1222334444443 4556899999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcce
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (689)
++|.+++... ..+++..+..++.|+++||.|||+. +|+|+||+|+||++++++.+||+|||+++..... .
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 151 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---K 151 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc---c
Confidence 9999999753 3578999999999999999999987 8999999999999999999999999999875442 2
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
...+...|+|||.+.
T Consensus 152 ~~~~~~~y~~pe~~~ 166 (260)
T cd05611 152 KFVGTPDYLAPETIL 166 (260)
T ss_pred cCCCCcCccChhhhc
Confidence 234567799999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=206.69 Aligned_cols=171 Identities=26% Similarity=0.354 Sum_probs=145.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 585 (689)
++|.+.+.||+|+||.||+|... +|+.||+|++..... .......+.+|++++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999764 789999999875432 2334567888999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++++|.+++... ..+++..+..|+.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999763 3689999999999999999999987 89999999999999999999999999998775
Q ss_pred CCCcc---------------------eeecccceEEeccccc
Q 005587 666 SGSVS---------------------QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~~---------------------~~~~~~~~~~apE~~~ 686 (689)
..... ....++..|++||+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 195 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN 195 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhC
Confidence 43321 1123456799999864
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=213.19 Aligned_cols=169 Identities=22% Similarity=0.309 Sum_probs=143.8
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC-----eEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG-----QRL 583 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 583 (689)
+|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999765 5899999998765433445567889999999999999999999998775 789
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+||||++ ++|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 5899888752 3689999999999999999999987 899999999999999999999999999998
Q ss_pred ccCCCc----ceeecccceEEeccccc
Q 005587 664 ISSGSV----SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~----~~~~~~~~~~~apE~~~ 686 (689)
...... .....++..|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 179 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLL 179 (330)
T ss_pred ecccccccccccccccccCcCCceeee
Confidence 766531 22234567899999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-23 Score=203.76 Aligned_cols=170 Identities=24% Similarity=0.336 Sum_probs=139.3
Q ss_pred ccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHH-hcCCCCCcceecEEEEeCCeEEEEEeccC
Q 005587 513 QENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKGYCAEHGQRLLIYEYCS 590 (689)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l-~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ 590 (689)
....||.|+||+|++-.+ +.|+..|||+++.... .....+++.|.+.. +.-+.||||++||.+...+..|+.||+|.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 356799999999999954 5799999999987654 34556777777654 55579999999999999999999999995
Q ss_pred CCCHHHHHhcC-cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 591 NGTLQDMLHSD-DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 591 ggsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
-||..+.+.- ...+..+++...-.|..-..+||.||.... .|||||+||+|||+|..|.+||||||++..+.+.-.
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 4776554321 112456888888888889999999999763 899999999999999999999999999999877666
Q ss_pred ceeecccceEEeccccc
Q 005587 670 SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~~~~~~~~~~~apE~~~ 686 (689)
.....+-..|||||-+.
T Consensus 224 kT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERID 240 (361)
T ss_pred hhhccCCccccChhccC
Confidence 66667788999999873
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=202.35 Aligned_cols=168 Identities=21% Similarity=0.241 Sum_probs=135.5
Q ss_pred hhHhhhccCCCccceE--eecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhc-CCCCCcceecEEEE
Q 005587 502 ASLQQYTNSFSQENLI--GAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKGYCA 577 (689)
Q Consensus 502 ~~l~~~~~~f~~~~~i--G~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~ 577 (689)
.+.....++|++.+.+ |+|+||.||+++. .++..+|+|.+........ |+..... .+||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEe
Confidence 3444555677777776 9999999999965 4688999999865432111 1111111 27999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC-cEEEE
Q 005587 578 EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVS 656 (689)
Q Consensus 578 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~ 656 (689)
..+..++||||+++|+|.+++... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 999999999999999999999753 3789999999999999999999987 899999999999999988 99999
Q ss_pred eecCCccccCCCcceeecccceEEeccccc
Q 005587 657 DCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|||+++...... ...++..|+|||++.
T Consensus 153 dfg~~~~~~~~~---~~~~~~~y~aPE~~~ 179 (267)
T PHA03390 153 DYGLCKIIGTPS---CYDGTLDYFSPEKIK 179 (267)
T ss_pred cCccceecCCCc---cCCCCCcccChhhhc
Confidence 999998765433 234677899999874
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=205.57 Aligned_cols=171 Identities=23% Similarity=0.364 Sum_probs=140.8
Q ss_pred cCCCccceEeecCCeEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|...+ ++.||||.+...... ....++.+|+.++.+.. ||||+++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 567888999999999999998764 899999998754332 23455666777666664 999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
||+. ++|.+++... ...+++..+..++.|+++||.|||+. .+|+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 5787776542 23689999999999999999999974 2799999999999999999999999999988765
Q ss_pred CCcceeecccceEEeccccc
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~apE~~~ 686 (689)
........+...|+|||.+.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~ 187 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERID 187 (296)
T ss_pred CCcccCCCCCccccCHhhcC
Confidence 54444445667899999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.52 Aligned_cols=166 Identities=27% Similarity=0.363 Sum_probs=140.7
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|...+.||+|++|.||++.. .+++.+++|.+.... ....+.+.+|+.+++.++||||+++++++...++.++|+||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44457899999999999975 468899999885432 234566889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999999875 3578899999999999999999987 899999999999999999999999999886644321
Q ss_pred -ceeecccceEEeccccc
Q 005587 670 -SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 -~~~~~~~~~~~apE~~~ 686 (689)
.....++..|+|||.+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~ 188 (285)
T cd06648 171 RRKSLVGTPYWMAPEVIS 188 (285)
T ss_pred ccccccCCccccCHHHhc
Confidence 22234677899999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=210.09 Aligned_cols=169 Identities=21% Similarity=0.250 Sum_probs=137.1
Q ss_pred CCCccceEeecCCeEEEEEEeC-C--CcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC----Ce
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-D--GKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH----GQ 581 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~--g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~----~~ 581 (689)
+|.+.+.||+|+||.||+++.. + +..||+|++............+.+|+++++++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999764 4 78899999875433333456778899999999 599999999876432 45
Q ss_pred EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCC
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla 661 (689)
.|++|||+. ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 789999985 689998865 34688999999999999999999987 8999999999999999999999999999
Q ss_pred ccccCCCcc-----eeecccceEEeccccc
Q 005587 662 PLISSGSVS-----QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 662 ~~~~~~~~~-----~~~~~~~~~~apE~~~ 686 (689)
+.+...... ....++..|+|||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 182 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIML 182 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHh
Confidence 876543221 1234677899999763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=198.47 Aligned_cols=172 Identities=19% Similarity=0.270 Sum_probs=146.8
Q ss_pred ccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCCh-hhHHHHHHHHHHHh-cCCCCCcceecEEEEeCCeEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQ-QKDDEFLELVNNID-RIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~~~e~~~l~-~l~HpnIv~l~~~~~~~~~~~l 584 (689)
.++|.+.++||+|+|.+|..++++ +.+.+|+|+++++.... .+..-...|-.+.. .-+||.+|.++.+|.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999764 67899999998764332 22233344444444 3479999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc-
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL- 663 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~- 663 (689)
|.||++||+|.-+++. +..++++.+..+...|.-||.|||+. +||.||||.+|+|+|..|++||+|||+++.
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999777665 45789999999999999999999998 899999999999999999999999999985
Q ss_pred ccCCCcceeecccceEEeccccc
Q 005587 664 ISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+.++.....-++|+-|.|||+++
T Consensus 402 l~~gd~tstfcgtpnyiapeilr 424 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILR 424 (593)
T ss_pred CCCCcccccccCCCcccchhhhc
Confidence 56777888889999999999996
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=210.44 Aligned_cols=168 Identities=22% Similarity=0.320 Sum_probs=138.7
Q ss_pred hccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC------
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------ 579 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------ 579 (689)
..++|...+.||+|+||.||+|.. .+|+.||||++............+.+|+++++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 346888899999999999999975 4689999999876443333345688999999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
...++||||+.. +|.+++. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred ceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 346999999964 7776652 3578999999999999999999987 89999999999999999999999999
Q ss_pred CCccccCCCcceeecccceEEeccccc
Q 005587 660 LAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+++........ ..++..|+|||++.
T Consensus 163 ~~~~~~~~~~~--~~~~~~y~aPE~~~ 187 (342)
T cd07879 163 LARHADAEMTG--YVVTRWYRAPEVIL 187 (342)
T ss_pred CCcCCCCCCCC--ceeeecccChhhhc
Confidence 99876443322 24467799999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=205.08 Aligned_cols=163 Identities=28% Similarity=0.368 Sum_probs=138.8
Q ss_pred cceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 514 ENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
...||+|+||.||++.. .+++.||||.+.... ......+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999966 478999999885432 334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc-ce
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV-SQ 671 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 671 (689)
+|.+++.. ..+++.....++.|++.||+|||+. +++|+||||+||++++++.++|+|||++..+..... ..
T Consensus 103 ~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 103 ALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 99998753 3578999999999999999999987 899999999999999999999999999887654332 22
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
...++..|++||.+.
T Consensus 175 ~~~~~~~y~~pE~~~ 189 (292)
T cd06657 175 SLVGTPYWMAPELIS 189 (292)
T ss_pred ccccCccccCHHHhc
Confidence 234567799999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=203.87 Aligned_cols=169 Identities=22% Similarity=0.353 Sum_probs=143.5
Q ss_pred CCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|+..+.||+|++|.||+|... +++.+++|.+............+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999764 6899999998765444345667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS- 668 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 668 (689)
++ +|.+++... ...+++..++.++.|+++||.|||+. +|+|+||||+||++++++.+||+|||.+..+....
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 888888653 24689999999999999999999987 89999999999999999999999999998876544
Q ss_pred cceeecccceEEeccccc
Q 005587 669 VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~~ 686 (689)
......+...|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~PE~~~ 171 (283)
T cd05118 154 PYTHYVVTRWYRAPELLL 171 (283)
T ss_pred cccCccCcccccCcHHHh
Confidence 222234667799999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-23 Score=203.59 Aligned_cols=166 Identities=21% Similarity=0.306 Sum_probs=137.2
Q ss_pred CccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC-----CeEEEE
Q 005587 512 SQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----GQRLLI 585 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV 585 (689)
+..+.||-|+||.||.+.. ++|+.||+|++......-...+.+.+|++++...+|.|+...++...-. .++|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999954 5799999999865443334456788999999999999999998877653 256889
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
+|.|. .+|.++|-. .+.++-+.+.-+..||++||.|||+. +|+||||||.|+|++.+..+||||||||+...
T Consensus 136 TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 99995 488888865 56788888899999999999999998 89999999999999999999999999999765
Q ss_pred CCCcce--eecccceEEecccc
Q 005587 666 SGSVSQ--VSHNLTIMRAGGVT 685 (689)
Q Consensus 666 ~~~~~~--~~~~~~~~~apE~~ 685 (689)
.+.... ....|.||+|||++
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiL 229 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELL 229 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHh
Confidence 544322 23456889999998
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-22 Score=207.86 Aligned_cols=172 Identities=23% Similarity=0.350 Sum_probs=138.6
Q ss_pred ccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC-------
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------- 579 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~------- 579 (689)
.++|++.+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999754 689999999865433233334667899999999999999999987543
Q ss_pred -CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEee
Q 005587 580 -GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 580 -~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DF 658 (689)
...++||||+.+ +|...+... ...+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999965 777777642 24689999999999999999999987 8999999999999999999999999
Q ss_pred cCCccccCCCccee------------ecccceEEeccccc
Q 005587 659 GLAPLISSGSVSQV------------SHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~~------------~~~~~~~~apE~~~ 686 (689)
|+++.......... ..++..|+|||++.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence 99987654332111 12356699999763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=209.23 Aligned_cols=170 Identities=22% Similarity=0.258 Sum_probs=137.7
Q ss_pred cCCC-ccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChh------------hHHHHHHHHHHHhcCCCCCcceecE
Q 005587 509 NSFS-QENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQ------------KDDEFLELVNNIDRIRHANIVELKG 574 (689)
Q Consensus 509 ~~f~-~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~------------~~~~~~~e~~~l~~l~HpnIv~l~~ 574 (689)
++|. +.+.||+|+||.||+|... +++.||||.+........ ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 4577999999999999754 689999999865432110 0124778999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEE
Q 005587 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654 (689)
Q Consensus 575 ~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k 654 (689)
++...+..++||||+. |+|.+++.. ...+++.....++.|+++||+|||+. +|+|+||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 699998865 34588999999999999999999987 899999999999999999999
Q ss_pred EEeecCCccccCCC---------------cceeecccceEEeccccc
Q 005587 655 VSDCGLAPLISSGS---------------VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 655 l~DFGla~~~~~~~---------------~~~~~~~~~~~~apE~~~ 686 (689)
|+|||+++.+.... ......++..|+|||.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 206 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM 206 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcc
Confidence 99999998765111 111123456799999873
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=202.93 Aligned_cols=165 Identities=29% Similarity=0.433 Sum_probs=138.7
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccC-ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRAS-SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
|...+.||+|+||.||+|.. .+|+.|++|.+..... .......+.+|+++++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999975 4688999999865432 223445788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+. |+|.+++... ...+++.+++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~ 175 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN 175 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC
Confidence 96 5788877643 24689999999999999999999987 89999999999999999999999999987654332
Q ss_pred cceeecccceEEecccc
Q 005587 669 VSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 669 ~~~~~~~~~~~~apE~~ 685 (689)
...++..|+|||++
T Consensus 176 ---~~~~~~~y~aPE~~ 189 (313)
T cd06633 176 ---SFVGTPYWMAPEVI 189 (313)
T ss_pred ---CccccccccChhhc
Confidence 23566789999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=203.76 Aligned_cols=169 Identities=25% Similarity=0.378 Sum_probs=142.4
Q ss_pred CCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|+..+.||+|.||.||+|... +++.||+|.+............+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999765 5899999998765433334567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCc
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 669 (689)
+ ++|.+++.... ..+++..+..++.|+++||.|||+. +|+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997632 3689999999999999999999997 899999999999999999999999999988755432
Q ss_pred c-eeecccceEEeccccc
Q 005587 670 S-QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 670 ~-~~~~~~~~~~apE~~~ 686 (689)
. .....+..|+|||++.
T Consensus 154 ~~~~~~~~~~~~aPE~~~ 171 (282)
T cd07829 154 TYTHEVVTLWYRAPEILL 171 (282)
T ss_pred ccCccccCcCcCChHHhc
Confidence 1 1233456799999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=197.40 Aligned_cols=163 Identities=31% Similarity=0.371 Sum_probs=139.8
Q ss_pred EeecCCeEEEEEEeC-CCcEEEEEEeccccCC-hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCH
Q 005587 517 IGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTL 594 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL 594 (689)
||+|+||.||++... +++.+|+|.+...... ......+..|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 5899999998765332 22456788999999999999999999999999999999999999999
Q ss_pred HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-cceee
Q 005587 595 QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS-VSQVS 673 (689)
Q Consensus 595 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~ 673 (689)
.+++... ..+++.....++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 9999753 3589999999999999999999987 89999999999999999999999999998875542 22334
Q ss_pred cccceEEeccccc
Q 005587 674 HNLTIMRAGGVTH 686 (689)
Q Consensus 674 ~~~~~~~apE~~~ 686 (689)
.++..|++||.+.
T Consensus 154 ~~~~~~~~Pe~~~ 166 (250)
T cd05123 154 CGTPEYLAPEVLL 166 (250)
T ss_pred cCCccccChHHhC
Confidence 5677899999874
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.6e-22 Score=211.04 Aligned_cols=169 Identities=21% Similarity=0.311 Sum_probs=142.7
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCe----
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ---- 581 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~---- 581 (689)
..++|++.+.||+|+||.||+|+.. +++.||||++............+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999765 58899999986543333445667889999999999999999998876554
Q ss_pred --EEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeec
Q 005587 582 --RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 582 --~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFG 659 (689)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 6799998864 3589999999999999999999987 89999999999999999999999999
Q ss_pred CCccccCCCcceeecccceEEeccccc
Q 005587 660 LAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
++........ ...++..|+|||++.
T Consensus 164 ~~~~~~~~~~--~~~~~~~y~aPE~~~ 188 (343)
T cd07851 164 LARHTDDEMT--GYVATRWYRAPEIML 188 (343)
T ss_pred cccccccccc--CCcccccccCHHHHh
Confidence 9998754422 234566799999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=191.28 Aligned_cols=143 Identities=17% Similarity=0.179 Sum_probs=109.7
Q ss_pred cceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhh------------------------HHHHHHHHHHHhcCCCCCc
Q 005587 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQK------------------------DDEFLELVNNIDRIRHANI 569 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~------------------------~~~~~~e~~~l~~l~HpnI 569 (689)
...||+|+||.||+|...+|+.||||+++........ ......|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998879999999998754221111 1122358899999988877
Q ss_pred ceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEecccCCCeEec
Q 005587 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL-HEICQPPIVHRNFKSANILLD 648 (689)
Q Consensus 570 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiHrDlKp~NILl~ 648 (689)
.....+... ..+|||||++|+++...... ...+++.....++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 544333222 23899999999877654322 23578899999999999999999 565 899999999999998
Q ss_pred CCCcEEEEeecCCccccC
Q 005587 649 DDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 649 ~~~~~kl~DFGla~~~~~ 666 (689)
++.++|+|||+|.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=200.10 Aligned_cols=173 Identities=18% Similarity=0.261 Sum_probs=139.0
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccc---cCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKR---ASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 585 (689)
+|.+.+.||+|+||.||++... .+..+++|.+... .........+.+|+.++++++||||+++++++...+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999654 3455666655432 22223445677889999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
|||+++++|.+++.........+++..++.++.|+++||.|||+. +++|+||||+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875433345789999999999999999999987 8999999999999975 569999999998775
Q ss_pred CCCc-ceeecccceEEeccccc
Q 005587 666 SGSV-SQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 666 ~~~~-~~~~~~~~~~~apE~~~ 686 (689)
.... .....++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALK 178 (260)
T ss_pred CCcccccCCCCCcCccCHHHHc
Confidence 4332 22334567799999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=189.97 Aligned_cols=163 Identities=20% Similarity=0.334 Sum_probs=142.1
Q ss_pred ccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeC--CeEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEH--GQRL 583 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~--~~~~ 583 (689)
.++|++.+++|+|.|+.||.|. ..+.+.++||+++. ...+.+.+|+.+|..|+ |||||++++...++ ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 3678999999999999999994 56788999999864 34577889999999997 99999999998875 3567
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-CCcEEEEeecCCc
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAP 662 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~ 662 (689)
||+||+.+-+...+.. .++...+..++.+++.||.|+|+. ||+|||+||.|++||. ...++|+|+|||.
T Consensus 112 LiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 9999999998887754 466677888999999999999998 8999999999999996 5579999999999
Q ss_pred cccCCCcceeecccceEEecccc
Q 005587 663 LISSGSVSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~apE~~ 685 (689)
++.++..-..-....+|.-||.+
T Consensus 182 FYHp~~eYnVRVASRyfKGPELL 204 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELL 204 (338)
T ss_pred hcCCCceeeeeeehhhcCCchhe
Confidence 99988777667778899999988
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=201.77 Aligned_cols=166 Identities=28% Similarity=0.451 Sum_probs=139.5
Q ss_pred CCCccceEeecCCeEEEEEEeC-CCcEEEEEEecccc-CChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.|+..+.||+|+||.||+|... ++..||+|.+.... .......++.+|+++++.++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666788999999999999764 67899999986432 223345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|+. |+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 6888877543 24578999999999999999999987 8999999999999999999999999999876543
Q ss_pred CcceeecccceEEecccc
Q 005587 668 SVSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 668 ~~~~~~~~~~~~~apE~~ 685 (689)
. ...++..|+|||.+
T Consensus 169 ~---~~~~~~~y~aPE~~ 183 (308)
T cd06634 169 N---XFVGTPYWMAPEVI 183 (308)
T ss_pred c---cccCCccccCHHHH
Confidence 2 23456789999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=199.47 Aligned_cols=170 Identities=19% Similarity=0.245 Sum_probs=125.2
Q ss_pred cCCCccceEeecCCeEEEEEEeCC----CcEEEEEEeccccCChhh---------HHHHHHHHHHHhcCCCCCcceecEE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQK---------DDEFLELVNNIDRIRHANIVELKGY 575 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~----g~~vAvK~l~~~~~~~~~---------~~~~~~e~~~l~~l~HpnIv~l~~~ 575 (689)
+.|++.++||+|+||.||+|...+ +..+|+|........... ......+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578999999999999999997654 456677654322211101 1112234455677899999999998
Q ss_pred EEeCC----eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC
Q 005587 576 CAEHG----QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (689)
Q Consensus 576 ~~~~~----~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~ 651 (689)
+.... ..+++||++. .++.+.+... ...++..+..|+.|+++||+|||+. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 76543 4578888874 4677666542 2357788899999999999999987 899999999999999999
Q ss_pred cEEEEeecCCccccCCC--------cceeecccceEEeccccc
Q 005587 652 AVSVSDCGLAPLISSGS--------VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 652 ~~kl~DFGla~~~~~~~--------~~~~~~~~~~~~apE~~~ 686 (689)
.++|+|||+|+.+.... ......++..|+|||+..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~ 206 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN 206 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence 99999999998764321 111235788899999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-21 Score=204.83 Aligned_cols=170 Identities=20% Similarity=0.276 Sum_probs=147.1
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEEe
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 587 (689)
..|++.+.||+|+.+.||++...+.+.||+|++.....+.+....|..|+..|.+|+ |.+||.+++|-..++++|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 468889999999999999999888889999988777666777889999999999995 9999999999999999999999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
|= ..||.++|..... ....| .++.|..||++|+.++|.. +|||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus 441 ~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 76 5699999987542 22334 6777899999999999987 8999999999999975 58999999999999877
Q ss_pred Ccc---eeecccceEEeccccc
Q 005587 668 SVS---QVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~~~---~~~~~~~~~~apE~~~ 686 (689)
.++ ....||.-||+||-+-
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~ 534 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALT 534 (677)
T ss_pred ccceeeccccCcccccCHHHHh
Confidence 654 4467888899999873
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-22 Score=211.86 Aligned_cols=168 Identities=25% Similarity=0.368 Sum_probs=141.0
Q ss_pred CccceEeecCCeEEEEEEeC--CCc--EEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 512 SQENLIGAGMLGSVYRAQLP--DGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~--~g~--~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
.+.++||+|.||.|++|.|. .|+ .||||.++...... ....|++|+.+|.+|+|||+|+|||...+ ....||||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 44678999999999999875 343 68999997665432 57789999999999999999999999888 57789999
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCC
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 667 (689)
+++.|+|.+.|+. .....+.......|+.|||.||.||.++ ++|||||-..|||+.....+||+||||.+-+..+
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999987 2345677788899999999999999987 8999999999999999999999999999998776
Q ss_pred Ccceeeccc---ce-EEeccccc
Q 005587 668 SVSQVSHNL---TI-MRAGGVTH 686 (689)
Q Consensus 668 ~~~~~~~~~---~~-~~apE~~~ 686 (689)
+..+..... ++ |-|||.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLr 288 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLR 288 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhc
Confidence 644432222 22 55999885
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=185.51 Aligned_cols=143 Identities=20% Similarity=0.176 Sum_probs=112.6
Q ss_pred cceEeecCCeEEEEEEeCCCcEEEEEEeccccCChh------------------------hHHHHHHHHHHHhcCCCCCc
Q 005587 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQ------------------------KDDEFLELVNNIDRIRHANI 569 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~------------------------~~~~~~~e~~~l~~l~HpnI 569 (689)
...||+|+||+||+|...+|+.||||+++....... ....+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999877899999999875421100 01224578899999999998
Q ss_pred ceecEEEEeCCeEEEEEeccCCCCHHHH-HhcCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEecccCCCeEe
Q 005587 570 VELKGYCAEHGQRLLIYEYCSNGTLQDM-LHSDDELKNNLSWNTRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILL 647 (689)
Q Consensus 570 v~l~~~~~~~~~~~lV~Ey~~ggsL~~~-l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDlKp~NILl 647 (689)
.....+.... .+|||||++|+++... +.. ..++......++.|++.++.|+|+ . +|+||||||+|||+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 6554444332 4899999998865433 332 346778899999999999999998 6 89999999999999
Q ss_pred cCCCcEEEEeecCCccccCC
Q 005587 648 DDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~ 667 (689)
+ ++.++|+|||+|+.+...
T Consensus 152 ~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred E-CCCEEEEEcccceecCCC
Confidence 9 789999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=192.71 Aligned_cols=151 Identities=21% Similarity=0.182 Sum_probs=126.3
Q ss_pred cCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCHHHHH
Q 005587 520 GMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML 598 (689)
Q Consensus 520 G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l 598 (689)
|.||.||+++. .+++.||+|.+.... .+.+|...+....||||+++++++...+..++||||++||+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999965 578999999986532 2234445555667999999999999999999999999999999998
Q ss_pred hcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcceeecccce
Q 005587 599 HSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTI 678 (689)
Q Consensus 599 ~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 678 (689)
... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||++..+...... ...+..
T Consensus 77 ~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~ 147 (237)
T cd05576 77 SKF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG--EAVENM 147 (237)
T ss_pred HHh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccccc--CCcCcc
Confidence 753 3589999999999999999999987 8999999999999999999999999998776554322 234567
Q ss_pred EEeccccc
Q 005587 679 MRAGGVTH 686 (689)
Q Consensus 679 ~~apE~~~ 686 (689)
|+|||...
T Consensus 148 y~aPE~~~ 155 (237)
T cd05576 148 YCAPEVGG 155 (237)
T ss_pred ccCCcccC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=205.00 Aligned_cols=166 Identities=24% Similarity=0.337 Sum_probs=135.9
Q ss_pred cCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeC--------
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-------- 579 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~-------- 579 (689)
.+|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 5788899999999999999965 4689999999865432 3456788999999999999999999876653
Q ss_pred ------CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-CCc
Q 005587 580 ------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLA 652 (689)
Q Consensus 580 ------~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~ 652 (689)
...++||||++ ++|.+++.. ..+++..++.++.|+++||.|||+. +|+||||||+||+++. ++.
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 35789999997 589888763 3588999999999999999999987 8999999999999984 567
Q ss_pred EEEEeecCCccccCCCc----ceeecccceEEecccc
Q 005587 653 VSVSDCGLAPLISSGSV----SQVSHNLTIMRAGGVT 685 (689)
Q Consensus 653 ~kl~DFGla~~~~~~~~----~~~~~~~~~~~apE~~ 685 (689)
+||+|||+++.+..... .....++..|+|||++
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 190 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHH
Confidence 89999999987643211 1123456789999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-22 Score=216.03 Aligned_cols=169 Identities=27% Similarity=0.393 Sum_probs=147.0
Q ss_pred ccCCCccceEeecCCeEEEEEEe-CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
.++|+....+|.|+||.|||++. .+++..|||.++.... .+.....+|+-+++..+|||||.+++.|..++..|+.|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 36788889999999999999964 5799999999976543 23455678898999999999999999999999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
|||.||+|+++.+. ...+++.++..+.+..++||.|||+. +=+|||||-.|||+.+.|.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999998876 45788888999999999999999997 679999999999999999999999999988765
Q ss_pred CC-cceeecccceEEecccc
Q 005587 667 GS-VSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 667 ~~-~~~~~~~~~~~~apE~~ 685 (689)
.- ....-.+++|+||||+.
T Consensus 165 ti~KrksfiGtpywmapEva 184 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVA 184 (829)
T ss_pred hhhhhhcccCCccccchhHH
Confidence 33 33446789999999986
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-21 Score=211.90 Aligned_cols=167 Identities=23% Similarity=0.402 Sum_probs=141.4
Q ss_pred CccceEeecCCeEEEEEEe-CCC----cEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 512 SQENLIGAGMLGSVYRAQL-PDG----KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~-~~g----~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
...++||+|+||+||+|.+ ..| .+||+|++.... ......++++|+-+|.+++|||+++++++|.... ..||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3457899999999999954 444 468999886543 3456788999999999999999999999999876 88999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
+||++|.|.++++.++ ..+-.+..+.|..|||+||.|||.+ .++||||-..|||+.....+||.|||+|+++..
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999998753 4577788999999999999999987 899999999999999999999999999999988
Q ss_pred CCcceeecccce---EEeccccc
Q 005587 667 GSVSQVSHNLTI---MRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~---~~apE~~~ 686 (689)
.+......+..+ +||=|.++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~ 873 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIR 873 (1177)
T ss_pred ccccccccccccCcHHHHHHHhh
Confidence 776655444433 66777764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=190.93 Aligned_cols=169 Identities=19% Similarity=0.295 Sum_probs=140.4
Q ss_pred hccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCC--C----CcceecEEEEeC
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH--A----NIVELKGYCAEH 579 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~H--p----nIv~l~~~~~~~ 579 (689)
..++|.+...+|+|+||.|-.+. .+.+..||||+++.- ....+..+-|++++.++.+ | -+|.+.+||.-+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 36789999999999999999994 456899999998643 2234556678999999842 2 278888999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC----------
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---------- 649 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~---------- 649 (689)
++.++|+|.+ |-|+++++.... ..+++...+..|+.|+++++.|||+. +++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999988 779999998755 45788899999999999999999998 8999999999999921
Q ss_pred ----------CCcEEEEeecCCccccCCCcceeecccceEEeccccc
Q 005587 650 ----------DLAVSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 650 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+..+||+|||-|++-.+... ...-|.+|+||||+.
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs--~iVsTRHYRAPEViL 282 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHHS--TIVSTRHYRAPEVIL 282 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCcc--eeeeccccCCchhee
Confidence 23589999999999877663 356689999999984
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=210.63 Aligned_cols=170 Identities=19% Similarity=0.227 Sum_probs=119.4
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-C----CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEE------
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-D----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY------ 575 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~------ 575 (689)
..++|++.+.||+|+||.||+|.+. + +..||||++..... .+.+..+ .+....+.+++.+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 3568999999999999999999764 4 68999998754321 1111111 1222223333322221
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhcCccc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEec
Q 005587 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDEL----------------KNNLSWNTRIRMALGAARALEYLHEICQPPIVHRN 639 (689)
Q Consensus 576 ~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrD 639 (689)
+...+..++||||+.+++|.+++...... .....+..+..|+.|+++||+|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 23556899999999999999998753210 00112334567999999999999987 899999
Q ss_pred ccCCCeEecC-CCcEEEEeecCCccccCCC--cceeecccceEEecccc
Q 005587 640 FKSANILLDD-DLAVSVSDCGLAPLISSGS--VSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 640 lKp~NILl~~-~~~~kl~DFGla~~~~~~~--~~~~~~~~~~~~apE~~ 685 (689)
|||+|||+++ ++.+||+|||+|+.+..+. ......+++.|+|||.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 9999999986 6799999999998765432 22334567889999965
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=180.22 Aligned_cols=168 Identities=33% Similarity=0.497 Sum_probs=143.6
Q ss_pred CCccceEeecCCeEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 511 FSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... .....+.+|++.+.+++|+|++++++++...+..++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999997764 899999998765432 24568889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC-
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS- 668 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 668 (689)
++++|.+++..... .+++.....++.++++++.|||.. +++|+||+|+||+++.++.++|+|||++..+....
T Consensus 80 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 80 EGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999976321 178999999999999999999987 89999999999999999999999999999886653
Q ss_pred -cceeecccceEEecccc
Q 005587 669 -VSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 669 -~~~~~~~~~~~~apE~~ 685 (689)
......+...|++||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVL 171 (225)
T ss_pred ccccceeccCCcCCHhHh
Confidence 22334556779999975
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=206.72 Aligned_cols=175 Identities=26% Similarity=0.428 Sum_probs=144.2
Q ss_pred cCCCccceEeecCCeEEEEEEeC----C----CcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeC
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP----D----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~----~----g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~ 579 (689)
++..+.+.||+|.||.|++|... . ...||||.++..... ...+.+..|+++|..+ +|+||+.++|+|..+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 44456679999999999999642 1 357999998776554 6678899999999988 599999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhcCc---cc-------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDD---EL-------K--NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (689)
Q Consensus 580 ~~~~lV~Ey~~ggsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl 647 (689)
+..++|+||+..|+|.++++..+ .. . ..+.....+.++.|||.|++||++. ++|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999998765 11 1 2388899999999999999999998 79999999999999
Q ss_pred cCCCcEEEEeecCCccccCCCcceee--cccce--EEecccccc
Q 005587 648 DDDLAVSVSDCGLAPLISSGSVSQVS--HNLTI--MRAGGVTHR 687 (689)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~~~~~~~--~~~~~--~~apE~~~~ 687 (689)
.++..+||+|||+|+........... .++.. +||||.+.+
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 99999999999999976554433321 11123 999999854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=195.41 Aligned_cols=164 Identities=23% Similarity=0.263 Sum_probs=135.0
Q ss_pred hccCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhc-CCCCCcceecEEEEeCCeEEE
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~l 584 (689)
+++.|.....+|.|+|+.|-.+. ..+++..+||++.+.... -.+|+.++.. -.||||+++.+.+.+..+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 45678888889999999999995 457899999999776322 2345544443 479999999999999999999
Q ss_pred EEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEe-cCCCcEEEEeecCCcc
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL-DDDLAVSVSDCGLAPL 663 (689)
Q Consensus 585 V~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl-~~~~~~kl~DFGla~~ 663 (689)
|||++.||-+.+.+.... ....++..|+.+|+.|+.|||++ +||||||||+|||+ ++.+.++|+|||.++.
T Consensus 394 v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 999999999988876532 22267778999999999999997 89999999999999 5899999999999999
Q ss_pred ccCCCcceeecccceEEeccccc
Q 005587 664 ISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 664 ~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
+... .....-+..|.|||+..
T Consensus 466 ~~~~--~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 466 LERS--CDTPALTLQYVAPEVLA 486 (612)
T ss_pred Cchh--hcccchhhcccChhhhc
Confidence 8766 23345678899999984
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.5e-20 Score=201.17 Aligned_cols=165 Identities=27% Similarity=0.356 Sum_probs=129.9
Q ss_pred CCccceEeecCCeE-EEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEEec
Q 005587 511 FSQENLIGAGMLGS-VYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 511 f~~~~~iG~G~~G~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
|...+++|.|+-|+ ||+|.+ +|+.||||++-... .....+|+..|+.- +|||||++++.-.++...||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44467889998875 799988 67899999985432 23456889888877 699999999888889999999999
Q ss_pred cCCCCHHHHHhcC-cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC---C--CcEEEEeecCCc
Q 005587 589 CSNGTLQDMLHSD-DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---D--LAVSVSDCGLAP 662 (689)
Q Consensus 589 ~~ggsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~---~--~~~kl~DFGla~ 662 (689)
|. .+|.+++... ..... ..-...+.+..|++.||++||+. +||||||||.||||+. + ..++|+|||+++
T Consensus 585 C~-~sL~dlie~~~~d~~~-~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEM-QSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hh-hhHHHHHhccccchhh-cccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 95 5999999874 11111 11033567788999999999997 8999999999999975 3 468999999999
Q ss_pred cccCCCcce----eecccceEEeccccc
Q 005587 663 LISSGSVSQ----VSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~~~----~~~~~~~~~apE~~~ 686 (689)
.+..+..+. ...|+.+|+|||.+.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHh
Confidence 997765432 346788999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=170.27 Aligned_cols=163 Identities=34% Similarity=0.546 Sum_probs=139.0
Q ss_pred EeecCCeEEEEEEeCC-CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCHH
Q 005587 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQ 595 (689)
Q Consensus 517 iG~G~~G~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~ 595 (689)
||+|.+|.||++...+ ++.+++|++....... ....+.+|++.++.++|++|+++++++......+++|||+.+++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999997754 8999999987543221 3467899999999999999999999999999999999999999999
Q ss_pred HHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-CCcEEEEeecCCccccCCC-cceee
Q 005587 596 DMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISSGS-VSQVS 673 (689)
Q Consensus 596 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~-~~~~~ 673 (689)
+++.... ..+++..+..++.++++++.|||+. +++|+||+|.||+++. ++.++|+|||.+....... .....
T Consensus 80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9987531 3588999999999999999999987 8999999999999999 8999999999998776543 12234
Q ss_pred cccceEEeccccc
Q 005587 674 HNLTIMRAGGVTH 686 (689)
Q Consensus 674 ~~~~~~~apE~~~ 686 (689)
.....|++||.+.
T Consensus 154 ~~~~~~~~pe~~~ 166 (215)
T cd00180 154 VGTPAYMAPEVLL 166 (215)
T ss_pred cCCCCccChhHhc
Confidence 5667799999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.5e-19 Score=172.70 Aligned_cols=138 Identities=19% Similarity=0.248 Sum_probs=106.4
Q ss_pred CccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-----CCCCcceecEEEEeCC---eEE
Q 005587 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-----RHANIVELKGYCAEHG---QRL 583 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-----~HpnIv~l~~~~~~~~---~~~ 583 (689)
...+.||+|+||.||. ...++.. +||++..... ...+.+.+|+++++.+ .||||++++|++++.. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 3457899999999996 3334444 7998865432 2456789999999999 5799999999999863 444
Q ss_pred -EEEec--cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCcEEecccCCCeEecC----CCcEEE
Q 005587 584 -LIYEY--CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL-EYLHEICQPPIVHRNFKSANILLDD----DLAVSV 655 (689)
Q Consensus 584 -lV~Ey--~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~iiHrDlKp~NILl~~----~~~~kl 655 (689)
+|||| +.+|+|.+++... .+++. ..++.|++.++ +|||+. +|+||||||+|||++. ++.++|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 5589999999652 24444 35678888888 999998 8999999999999974 347999
Q ss_pred Ee-ecCCcc
Q 005587 656 SD-CGLAPL 663 (689)
Q Consensus 656 ~D-FGla~~ 663 (689)
+| ||...+
T Consensus 151 iDg~G~~~~ 159 (210)
T PRK10345 151 CDNIGESTF 159 (210)
T ss_pred EECCCCcce
Confidence 99 555444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-19 Score=177.23 Aligned_cols=158 Identities=32% Similarity=0.472 Sum_probs=136.6
Q ss_pred CCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCHHHHHh
Q 005587 521 MLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH 599 (689)
Q Consensus 521 ~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~ 599 (689)
+||.||+|... +|+.+|+|++........ .+.+.+|++.+++++|+||+++++++......+++|||+.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999776 589999999875533221 5788999999999999999999999999999999999999999999987
Q ss_pred cCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcceeecccceE
Q 005587 600 SDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIM 679 (689)
Q Consensus 600 ~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~ 679 (689)
... .+++..+..++.++++++.|||.. +|+|+||+|+||++++++.++|+|||++.............+...|
T Consensus 80 ~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 80 KRG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred hcc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCC
Confidence 532 388999999999999999999987 8999999999999999999999999999988765444445567789
Q ss_pred Eeccccc
Q 005587 680 RAGGVTH 686 (689)
Q Consensus 680 ~apE~~~ 686 (689)
++||...
T Consensus 153 ~~pE~~~ 159 (244)
T smart00220 153 MAPEVLL 159 (244)
T ss_pred CCHHHHc
Confidence 9999763
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.6e-20 Score=182.30 Aligned_cols=166 Identities=22% Similarity=0.273 Sum_probs=136.8
Q ss_pred CCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCC------eE
Q 005587 510 SFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG------QR 582 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~------~~ 582 (689)
+|.....+|.|.- .|..+ ..-.++.||+|++..........+...+|...+..+.|+||++++.+|.-.. +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555667788877 45555 3346899999998766554555677789999999999999999999987543 57
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
|+|||||. ++|...++- .++-.....|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+
T Consensus 97 y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 99999995 599988862 356678889999999999999998 89999999999999999999999999999
Q ss_pred cccCCCcceeecccceEEeccccc
Q 005587 663 LISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
.-...-.-.....+.+|+|||++.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil 190 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVIL 190 (369)
T ss_pred ccCcccccCchhheeeccCchhee
Confidence 876664555567889999999984
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-18 Score=196.41 Aligned_cols=137 Identities=35% Similarity=0.629 Sum_probs=93.1
Q ss_pred cccCCHhhHHHHHHHHHHhCCCCCCCCCCCCCCCCC---CCCccEEeeCC------CeEEEEecCCCCCcccCccccCCC
Q 005587 33 CAVTNPNDVAAINSLYAALGSPVLPGWVASAGDPCG---ESWQGVQCNAS------DIIAIILNGANLGGELGENLGAFS 103 (689)
Q Consensus 33 ~~~~~~~d~~aL~~~~~~l~~~~l~~W~~~~~~~C~---~~w~gv~C~~~------~l~~L~L~~n~l~g~~p~~l~~l~ 103 (689)
...+.++|++||+.+|+.++++...+|. +|+|. +.|.||.|+.. .++.|+|++|+|.|.+|+.|+.|+
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~~~W~---g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLRFGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcccCCCC---CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 3456788999999999999876445785 35663 47999999632 266666666666666666666666
Q ss_pred CCCEEEccCCcCCCCCCCccccccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCC
Q 005587 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183 (689)
Q Consensus 104 ~L~~L~Ls~N~l~~~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 183 (689)
+|+.|+|++|+|+| .+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|
T Consensus 443 ~L~~L~Ls~N~l~g----------------------~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 443 HLQSINLSGNSIRG----------------------NIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred CCCEEECCCCcccC----------------------cCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence 66666665555543 44445666666666777777666666666666666666666666
Q ss_pred CCCCCCCCCcc
Q 005587 184 NLSGELPPSLE 194 (689)
Q Consensus 184 ~l~g~~p~~~~ 194 (689)
+|+|.+|..++
T Consensus 501 ~l~g~iP~~l~ 511 (623)
T PLN03150 501 SLSGRVPAALG 511 (623)
T ss_pred cccccCChHHh
Confidence 66666666554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-19 Score=171.28 Aligned_cols=166 Identities=16% Similarity=0.297 Sum_probs=130.7
Q ss_pred hccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEE-EEeCCeEE
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGY-CAEHGQRL 583 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~-~~~~~~~~ 583 (689)
..+.|.+.+.+|+|.||.+-+++++ +...+++|.+.... ...++|.+|...--.| .|.||+.-|+. |+..+.+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3467889999999999999999765 57789999987653 4467888887654444 58999987654 67788899
Q ss_pred EEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec--CCCcEEEEeecCC
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD--DDLAVSVSDCGLA 661 (689)
Q Consensus 584 lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~--~~~~~kl~DFGla 661 (689)
++|||++-|+|.+-+.. ..+-+....+++.|++.|++|+|+. ++||||||.+||||- +...+||||||+.
T Consensus 99 F~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 99999999999887654 3467788899999999999999997 899999999999993 3448999999999
Q ss_pred ccccCCCcceeecccceEEecccc
Q 005587 662 PLISSGSVSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~apE~~ 685 (689)
+.... .-...-....|-+||+.
T Consensus 171 ~k~g~--tV~~~~~~~~y~~pe~~ 192 (378)
T KOG1345|consen 171 RKVGT--TVKYLEYVNNYHAPELC 192 (378)
T ss_pred cccCc--eehhhhhhcccCCcHHH
Confidence 86532 22222334446677764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=170.09 Aligned_cols=162 Identities=17% Similarity=0.250 Sum_probs=132.9
Q ss_pred cCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
-+|.++++||+|+||.++.| .+-+++.||||.-.... +..++..|.+..+.| ..++|..++-|..+..+-.|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 47899999999999999999 46789999999865432 345666777777776 4689999988888888889999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC-----CcEEEEeecCC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-----LAVSVSDCGLA 661 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~-----~~~kl~DFGla 661 (689)
|++ |.||+|++.-. ...++.+++..||.|++.-++|+|+. .+|.|||||+|+||... ..+.|+|||+|
T Consensus 104 dLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 988 88999998753 56799999999999999999999998 79999999999999643 35899999999
Q ss_pred ccccCCCccee--------ecccceEEe
Q 005587 662 PLISSGSVSQV--------SHNLTIMRA 681 (689)
Q Consensus 662 ~~~~~~~~~~~--------~~~~~~~~a 681 (689)
+.+.+..+.++ ..+|.-||+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred hhhcCccccccCccccccccccceeeeE
Confidence 99877654432 345555665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=164.45 Aligned_cols=149 Identities=21% Similarity=0.340 Sum_probs=126.4
Q ss_pred cCCCccceEeecCCeEEEEE-EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCC-CCcceecEEEEeCCeEEEEE
Q 005587 509 NSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH-ANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~-~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~ 586 (689)
..|.+.++||.|+||.+|.| ...+|..||||.-.... .-.++..|.++.+.|+| ..|..+..|..+..+-.+||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 57899999999999999999 56789999999865432 23456778888888875 67888888889999999999
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec---CCCcEEEEeecCCcc
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAPL 663 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kl~DFGla~~ 663 (689)
|.+ |.||++++.- +...++..+++..+-|++.-++|+|.. +.|||||||+|+|.. ....+.++|||||+.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 988 8899999864 346788999999999999999999988 799999999999986 345789999999998
Q ss_pred ccCCC
Q 005587 664 ISSGS 668 (689)
Q Consensus 664 ~~~~~ 668 (689)
+.+-.
T Consensus 164 y~d~~ 168 (341)
T KOG1163|consen 164 YRDIR 168 (341)
T ss_pred hcccc
Confidence 86544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-18 Score=172.00 Aligned_cols=147 Identities=17% Similarity=0.126 Sum_probs=112.6
Q ss_pred CCCccceEeecCCeEEEEEE--eCCCcEEEEEEeccccCCh--------------------h--hHHHHHHHHHHHhcCC
Q 005587 510 SFSQENLIGAGMLGSVYRAQ--LPDGKLLAVKKLDKRASSQ--------------------Q--KDDEFLELVNNIDRIR 565 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~--~~~g~~vAvK~l~~~~~~~--------------------~--~~~~~~~e~~~l~~l~ 565 (689)
-|.+.+.||+|+||.||+|. ..+|+.||||++....... . ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999997 5689999999986432100 0 1133568999999997
Q ss_pred CCC--cceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEEecccC
Q 005587 566 HAN--IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP-IVHRNFKS 642 (689)
Q Consensus 566 Hpn--Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-iiHrDlKp 642 (689)
+.. +.+++++ ...++||||+.|++|...... ...+.......++.|++.++.|||.. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3333332 235899999999888765422 12345556788999999999999987 7 99999999
Q ss_pred CCeEecCCCcEEEEeecCCccccCCC
Q 005587 643 ANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 643 ~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
+||+++ ++.++|+|||.|.......
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCCcc
Confidence 999999 8899999999999766544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=181.12 Aligned_cols=173 Identities=17% Similarity=0.244 Sum_probs=142.3
Q ss_pred hhhccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC------CCCcceecEEEE
Q 005587 505 QQYTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR------HANIVELKGYCA 577 (689)
Q Consensus 505 ~~~~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~------HpnIv~l~~~~~ 577 (689)
+.....|.+....|+|-|++|.+|... .|..||||+|.... ...+.=+.|+++|++|. --++++++..|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 344567888888899999999999654 58899999997542 22334467899999985 347899999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC-cEEEE
Q 005587 578 EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVS 656 (689)
Q Consensus 578 ~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~ 656 (689)
..++++||+|-+ .-+|.++|+..+. .-.+....+..|+.|+.-||..|... +|+|.||||+|||+++.. .+|||
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence 999999999988 4599999987543 45678889999999999999999987 899999999999999754 67999
Q ss_pred eecCCccccCCCcceeecccceEEeccccc
Q 005587 657 DCGLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~~~~apE~~~ 686 (689)
|||-|-+..+..+... ....+|+||||+.
T Consensus 580 DfGSA~~~~eneitPY-LVSRFYRaPEIiL 608 (752)
T KOG0670|consen 580 DFGSASFASENEITPY-LVSRFYRAPEIIL 608 (752)
T ss_pred cCccccccccccccHH-HHHHhccCcceee
Confidence 9999999988775542 3567899999994
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-20 Score=170.02 Aligned_cols=172 Identities=27% Similarity=0.479 Sum_probs=153.4
Q ss_pred eCCCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEE
Q 005587 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154 (689)
Q Consensus 77 ~~~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 154 (689)
+..+++.|.|++|.|+ .+|+.+..|.+|+.|++++|+|+ .+|..+. ++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3468899999999998 67889999999999999999999 5565665 89999999999999 899999999999999
Q ss_pred EccCCcCCC-CCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccccccCCcc-ccccccccccCC
Q 005587 155 SLNNNLLSG-EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 155 ~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~-L~~L~Ls~N~l~ 232 (689)
||.+|++.. .+|..|..|..|+.|+|+.|.+. .+|..+++|++|+.|.+.+|.|-..+..++.+. |++|.+++|+++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee
Confidence 999999974 69999999999999999999998 899999999999999999999999998888887 999999999999
Q ss_pred CCCccccCCCC------CccccCCcCC
Q 005587 233 GPIPEKMLQIP------NFRKDGNPFN 253 (689)
Q Consensus 233 g~ip~~l~~l~------~l~~~~N~~~ 253 (689)
.+|.+++++. .++...|||-
T Consensus 187 -vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 187 -VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred -ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 7787776654 2456777774
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=160.91 Aligned_cols=137 Identities=15% Similarity=0.109 Sum_probs=108.2
Q ss_pred ccceEeecCCeEEEEEEeCCCcEEEEEEeccccCC--hhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEEecc
Q 005587 513 QENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASS--QQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
....|++|+||+||.+.. .+..++.+.+...... ......+.+|+++|+++. |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 357899999999998766 6778887777544321 112235789999999995 5889999886 4579999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecc-cCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF-KSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDl-Kp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
.|.+|.+.+.. ....++.|++++|+|+|.. +|+|||| ||+|||++.++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99999765421 1134678999999999998 8999999 7999999999999999999999665443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=164.63 Aligned_cols=138 Identities=19% Similarity=0.304 Sum_probs=115.3
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCCh------hhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ------QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~------~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
+.||+|++|.||+|.+ +|..|++|+........ .....+.+|++++..++|++|+....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 67789999765332111 1234678899999999999998888888778888999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
++|++|.+++... .+ .+..++.+++.+|.++|+. +++|+|++|+|||++ ++.++|+|||+++...
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999998642 12 7788999999999999987 899999999999999 7889999999998743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=164.67 Aligned_cols=142 Identities=15% Similarity=0.176 Sum_probs=115.8
Q ss_pred hccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhh-H------HHHHHHHHHHhcCCCCCcceecEEEEeC
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQK-D------DEFLELVNNIDRIRHANIVELKGYCAEH 579 (689)
Q Consensus 507 ~~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~-~------~~~~~e~~~l~~l~HpnIv~l~~~~~~~ 579 (689)
..++|+..+++|+|+||.||.+.. ++..+|||.+......... . +.+.+|++.+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999866 5778999999765432221 1 2267899999999999999999887643
Q ss_pred --------CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC
Q 005587 580 --------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651 (689)
Q Consensus 580 --------~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~ 651 (689)
+..+|||||++|.+|.++.. ++. ....+++.+|..+|.. +++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 35789999999999988732 222 2456899999999987 899999999999999988
Q ss_pred cEEEEeecCCcccc
Q 005587 652 AVSVSDCGLAPLIS 665 (689)
Q Consensus 652 ~~kl~DFGla~~~~ 665 (689)
++|+|||..+...
T Consensus 173 -i~liDfg~~~~~~ 185 (232)
T PRK10359 173 -LRIIDLSGKRCTA 185 (232)
T ss_pred -EEEEECCCccccc
Confidence 9999999988664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=163.52 Aligned_cols=142 Identities=18% Similarity=0.129 Sum_probs=110.3
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCCh--------------------hhHHHHHHHHHHHhcCCCCC
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ--------------------QKDDEFLELVNNIDRIRHAN 568 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~--------------------~~~~~~~~e~~~l~~l~Hpn 568 (689)
.-|.+.+.||+|+||.||+|..++|+.||||++....... .....+..|...+.++.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3477789999999999999988889999999876432110 01123567888888888874
Q ss_pred --cceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeE
Q 005587 569 --IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646 (689)
Q Consensus 569 --Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NIL 646 (689)
++..++ .+..++||||++|++|.++... .....++.++++++.++|+. +|+||||||+||+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL 157 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence 344433 2456899999999999765421 23457888999999999987 8999999999999
Q ss_pred ecCCCcEEEEeecCCccccCC
Q 005587 647 LDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 647 l~~~~~~kl~DFGla~~~~~~ 667 (689)
+++++.++|+|||++......
T Consensus 158 l~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred EcCCCcEEEEECCccccCCCc
Confidence 999999999999999766553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=186.26 Aligned_cols=141 Identities=17% Similarity=0.267 Sum_probs=113.6
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEE-eccccCC-----hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKK-LDKRASS-----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~-l~~~~~~-----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 582 (689)
..|...+.||+|+||.||+|.+.... +++|+ +.+.... ....+.+.+|++++..++|++++....++...+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34566789999999999999875543 44443 3221111 12235688999999999999999888888887788
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 662 (689)
++||||++|++|.+++. ....++.+++++|.|||+. +|+||||||+|||+ +++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999998875 2467899999999999987 89999999999999 57789999999999
Q ss_pred cccC
Q 005587 663 LISS 666 (689)
Q Consensus 663 ~~~~ 666 (689)
....
T Consensus 476 ~~~~ 479 (535)
T PRK09605 476 YSDL 479 (535)
T ss_pred cCCc
Confidence 7643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=160.81 Aligned_cols=135 Identities=19% Similarity=0.299 Sum_probs=109.8
Q ss_pred eEeecCCeEEEEEEeCCCcEEEEEEeccccC-C-----hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEecc
Q 005587 516 LIGAGMLGSVYRAQLPDGKLLAVKKLDKRAS-S-----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 516 ~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~-~-----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~ 589 (689)
.||+|+||.||+|.+ +|..|++|....... . ......+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 678899998643221 1 112356778999999999988766666666777789999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
+|++|.+++.... ..++.+++++|.++|+. +++|+|++|+||+++ ++.++++|||+++....
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~~ 141 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSDE 141 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCCc
Confidence 9999998875421 07889999999999987 899999999999999 78999999999987543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=164.95 Aligned_cols=134 Identities=19% Similarity=0.357 Sum_probs=113.3
Q ss_pred cCCCccceEeecCCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-----C---CCcceecEEEEeC
Q 005587 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-----H---ANIVELKGYCAEH 579 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-----H---pnIv~l~~~~~~~ 579 (689)
.+|.+.++||-|.|++||+|. ..+.+.||+|+++.. +...+..+.|+++|++++ | ..||+|+++|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 678899999999999999995 456789999998653 234556778999998774 3 3699999999864
Q ss_pred ----CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC
Q 005587 580 ----GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD 650 (689)
Q Consensus 580 ----~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~ 650 (689)
.+++||+|++ |.+|..+|.... .+.++...+.+|++||+.||.|||..| +|||-||||+|||+...
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 4899999999 779999998654 567899999999999999999999987 99999999999999543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-16 Score=164.53 Aligned_cols=171 Identities=32% Similarity=0.458 Sum_probs=144.2
Q ss_pred CCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChh-hHHHHHHHHHHHhcCCCC-CcceecEEEEeCCeEEEEEec
Q 005587 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQ-KDDEFLELVNNIDRIRHA-NIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~-~~~~~~~e~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~Ey 588 (689)
|...+.||.|+||.||++... ..+++|.+........ ....+.+|+..+..+.|+ +|+++++++...+..+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 7899999876654332 567899999999999988 799999999888888999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC-cEEEEeecCCccccCC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSG 667 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~ 667 (689)
+.++++.+++...... ..+.......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||+++.+...
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777653211 2688899999999999999999998 799999999999999988 7999999999866554
Q ss_pred C-------cceeecccceEEecccccc
Q 005587 668 S-------VSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 668 ~-------~~~~~~~~~~~~apE~~~~ 687 (689)
. ......++..|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred CccccccccccccccccccCCHHHhcC
Confidence 3 2355678889999998753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.9e-17 Score=168.49 Aligned_cols=145 Identities=26% Similarity=0.390 Sum_probs=125.4
Q ss_pred HhhhccCCCccceEeecCCeEEEEEEeC----CCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEe
Q 005587 504 LQQYTNSFSQENLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAE 578 (689)
Q Consensus 504 l~~~~~~f~~~~~iG~G~~G~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~ 578 (689)
+....+.|...++||+|.|++||++... ..+.||+|.+.... ....+..|+++|..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3345567889999999999999999542 46889999986543 244578899999888 48999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-CCcEEEEe
Q 005587 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-DLAVSVSD 657 (689)
Q Consensus 579 ~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kl~D 657 (689)
++...+||||+++-+..+++.. ++...+..+++.++.||.|+|.. |||||||||+|+|.+. .+.-.|+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 9999999999999999988764 66788999999999999999998 9999999999999985 55678999
Q ss_pred ecCCc
Q 005587 658 CGLAP 662 (689)
Q Consensus 658 FGla~ 662 (689)
||||.
T Consensus 177 FgLA~ 181 (418)
T KOG1167|consen 177 FGLAQ 181 (418)
T ss_pred chhHH
Confidence 99998
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=167.92 Aligned_cols=146 Identities=21% Similarity=0.304 Sum_probs=119.9
Q ss_pred CCCccceEeecCCeEEEEEEeCCC--cEEEEEEeccccCChhhHHHHHHHHHHHhcCCC----CCcceecEEE-EeCCeE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPDG--KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH----ANIVELKGYC-AEHGQR 582 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~H----pnIv~l~~~~-~~~~~~ 582 (689)
.|.+.+.||+|+||.||.|..... ..+|+|......... ...+..|+.++..+.+ +++..+++.. ...++.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 788999999999999999976543 578888875532211 1156677777777762 6888999998 477889
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC-----CcEEEEe
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-----LAVSVSD 657 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~-----~~~kl~D 657 (689)
|+||+.+ |.+|.++..... ...++..++++|+.|++.+|++||+. |++||||||+|+++... ..+.|.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 9999988 889999886543 56799999999999999999999998 89999999999999754 4689999
Q ss_pred ecCCcc
Q 005587 658 CGLAPL 663 (689)
Q Consensus 658 FGla~~ 663 (689)
||+|+.
T Consensus 171 fGlar~ 176 (322)
T KOG1164|consen 171 FGLARR 176 (322)
T ss_pred cCCCcc
Confidence 999993
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.4e-16 Score=149.92 Aligned_cols=140 Identities=23% Similarity=0.255 Sum_probs=98.6
Q ss_pred cceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHH----------------------HHHHHHHhcCCCCC--c
Q 005587 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF----------------------LELVNNIDRIRHAN--I 569 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~----------------------~~e~~~l~~l~Hpn--I 569 (689)
.+.||+|+||.||+|...+|+.||||++............+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988789999999886532211111111 24555555554433 3
Q ss_pred ceecEEEEeCCeEEEEEeccCCCCHHH-HHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEEecccCCCeEe
Q 005587 570 VELKGYCAEHGQRLLIYEYCSNGTLQD-MLHSDDELKNNLSWNTRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILL 647 (689)
Q Consensus 570 v~l~~~~~~~~~~~lV~Ey~~ggsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~iiHrDlKp~NILl 647 (689)
.+.+++ ...++||||++++.+.. .+... ... .....++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 24589999999954422 11110 001 4577899999999999998 5 89999999999999
Q ss_pred cCCCcEEEEeecCCccccCC
Q 005587 648 DDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 648 ~~~~~~kl~DFGla~~~~~~ 667 (689)
+ ++.++|+|||.+......
T Consensus 149 ~-~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred E-CCcEEEEECcccccccCc
Confidence 9 889999999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-17 Score=176.62 Aligned_cols=171 Identities=24% Similarity=0.287 Sum_probs=152.9
Q ss_pred ccEEeeCCCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCC
Q 005587 72 QGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLT 149 (689)
Q Consensus 72 ~gv~C~~~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~ 149 (689)
.|++-...++.+|+|..|+++..-..++.+|+.|+.||||+|.|...-++.+. .+|++|+|++|+|+..-+..|..|.
T Consensus 262 DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~ 341 (873)
T KOG4194|consen 262 DGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS 341 (873)
T ss_pred CcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence 46777778999999999999988888999999999999999999987777665 8999999999999988888999999
Q ss_pred CccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCC---CccCCcccceeecccccccccc-cccCCcc-cccc
Q 005587 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP---SLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDL 224 (689)
Q Consensus 150 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~-L~~L 224 (689)
.|++|+|++|++...-...|..+.+|+.|||++|.|++.+-+ .|..|++|+.|+|.+|+|..++ ..|..++ |++|
T Consensus 342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL 421 (873)
T ss_pred HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence 999999999999977777899999999999999999987654 4778999999999999999887 4677777 9999
Q ss_pred ccccccCCCCCccccCCC
Q 005587 225 NIENNLFSGPIPEKMLQI 242 (689)
Q Consensus 225 ~Ls~N~l~g~ip~~l~~l 242 (689)
||.+|.|...-|..|..+
T Consensus 422 dL~~NaiaSIq~nAFe~m 439 (873)
T KOG4194|consen 422 DLGDNAIASIQPNAFEPM 439 (873)
T ss_pred cCCCCcceeecccccccc
Confidence 999999998888887765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=141.20 Aligned_cols=135 Identities=20% Similarity=0.229 Sum_probs=113.4
Q ss_pred cceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCC--CCcceecEEEEeCCeEEEEEeccCC
Q 005587 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH--ANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 514 ~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| ..++++++++...+..+++|||+.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 4679999999999998754 7899998765432 4568889999999876 5889999888888899999999998
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
+.+..+ +......++.++++++.++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 777533 44566778999999999999864457999999999999999899999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.5e-17 Score=174.41 Aligned_cols=170 Identities=28% Similarity=0.439 Sum_probs=121.0
Q ss_pred CCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc---cccccccccCccCCCCCCcccCCCCCccEEE
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155 (689)
Q Consensus 79 ~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 155 (689)
..++.|||++|+|. ..|..+..-.++-+|+||+|+|. .||..+. ..|-.||||+|+|. .+|+.+.+|..|+.|+
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 56788888888887 46777888888888888888887 5665554 45667788888887 6777778888888888
Q ss_pred ccCCcCC-------------------------CCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeeccccccc
Q 005587 156 LNNNLLS-------------------------GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210 (689)
Q Consensus 156 Ls~N~l~-------------------------g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 210 (689)
|++|-|. ..+|..+..|.+|..+|||.|+|. .+|+.+.++.+|+.|+||+|+|+
T Consensus 180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence 8877552 246666777778888888888887 78888888888888888888877
Q ss_pred ccccccCCcc-ccccccccccCCCCCccccCCCCCc---cccCCcCC
Q 005587 211 GTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNF---RKDGNPFN 253 (689)
Q Consensus 211 ~~~~~~~~l~-L~~L~Ls~N~l~g~ip~~l~~l~~l---~~~~N~~~ 253 (689)
..--...... |+.|+||.|+|+ .+|+.++.|+.| ...+|.++
T Consensus 259 eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 259 ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 5443333333 777777777777 667666655543 33444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-15 Score=151.95 Aligned_cols=182 Identities=20% Similarity=0.278 Sum_probs=144.8
Q ss_pred hhhHhhhccCCCccceEeecCCeEEEEEEeCC------CcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecE
Q 005587 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQLPD------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574 (689)
Q Consensus 501 ~~~l~~~~~~f~~~~~iG~G~~G~Vy~~~~~~------g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~ 574 (689)
..++.....+++...++-+|.||.||+|-|.+ .+.|-||.++.... +-....++.|--.+..+.|||+..+.+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34555666778888899999999999995543 35677787765433 444567888888899999999999999
Q ss_pred EEEe-CCeEEEEEeccCCCCHHHHHhcCc----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC
Q 005587 575 YCAE-HGQRLLIYEYCSNGTLQDMLHSDD----ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD 649 (689)
Q Consensus 575 ~~~~-~~~~~lV~Ey~~ggsL~~~l~~~~----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~ 649 (689)
.+.+ .+..++++.++.-|+|..++..-+ ...+.+.-.+...++.|++.|++|||.. +|||.||...|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 9876 457789999999999999998322 2245677788889999999999999998 8999999999999999
Q ss_pred CCcEEEEeecCCccccCCCcceeec--ccc-eEEeccccc
Q 005587 650 DLAVSVSDCGLAPLISSGSVSQVSH--NLT-IMRAGGVTH 686 (689)
Q Consensus 650 ~~~~kl~DFGla~~~~~~~~~~~~~--~~~-~~~apE~~~ 686 (689)
..++||+|=.|+|.+-+++....-. +.+ -||++|.+-
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~ 471 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ 471 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHh
Confidence 9999999999999887666543322 222 389999873
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.1e-17 Score=164.18 Aligned_cols=193 Identities=23% Similarity=0.366 Sum_probs=142.8
Q ss_pred CCCCCCCCC---ccEEeeC-----------CCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cc
Q 005587 63 AGDPCGESW---QGVQCNA-----------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VT 126 (689)
Q Consensus 63 ~~~~C~~~w---~gv~C~~-----------~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~ 126 (689)
.+.+|.|+- .-|+|.. ...++|+|..|+|+...+..|+.|.+|+.||||+|.|+.+-|..|. .+
T Consensus 37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred CCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 467787776 5688975 3568999999999999999999999999999999999988888776 44
Q ss_pred cccc-cccCccCCCCCCcccCCCCCccEEEccCCcCC-------------------------------------------
Q 005587 127 MQNF-FLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS------------------------------------------- 162 (689)
Q Consensus 127 L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~------------------------------------------- 162 (689)
|..| ++++|+|+......|++|..|+.|.+.-|++.
T Consensus 117 l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA 196 (498)
T KOG4237|consen 117 LLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLA 196 (498)
T ss_pred hhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhh
Confidence 4444 34447777544444555544443333322221
Q ss_pred ------------------------------------------------------------------CCCC-hhhcCCCCC
Q 005587 163 ------------------------------------------------------------------GEIP-DAFQSLTGL 175 (689)
Q Consensus 163 ------------------------------------------------------------------g~~p-~~~~~l~~L 175 (689)
+.-| ..|..|++|
T Consensus 197 ~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L 276 (498)
T KOG4237|consen 197 QNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL 276 (498)
T ss_pred cCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc
Confidence 1112 246778889
Q ss_pred CEEEccCCCCCCCCCCCccCCcccceeecccccccccc-cccCCcc-ccccccccccCCCCCccccC---CCCCccccCC
Q 005587 176 INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKML---QIPNFRKDGN 250 (689)
Q Consensus 176 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~-L~~L~Ls~N~l~g~ip~~l~---~l~~l~~~~N 250 (689)
+.|+|++|+|++.-+.+|..+..|++|+|..|+|...- ..|.+++ |+.|+|.+|+|+-.-|..|. .|..|.+..|
T Consensus 277 ~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N 356 (498)
T KOG4237|consen 277 RKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN 356 (498)
T ss_pred eEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC
Confidence 99999999998888888888899999999999887655 3566776 88999999999877776554 4566778899
Q ss_pred cCCCC
Q 005587 251 PFNST 255 (689)
Q Consensus 251 ~~~~~ 255 (689)
||+|.
T Consensus 357 p~~Cn 361 (498)
T KOG4237|consen 357 PFNCN 361 (498)
T ss_pred cccCc
Confidence 99884
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-17 Score=149.59 Aligned_cols=154 Identities=27% Similarity=0.388 Sum_probs=136.4
Q ss_pred cccCCCCCCEEEccCCcCCCCCCCccc-cccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChhhcCCCCCC
Q 005587 98 NLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLI 176 (689)
Q Consensus 98 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 176 (689)
.+.++++++.|.||+|+|+...|..-. .+|+.|++++|+|+ .+|..+++|+.|+.|+++-|++. .+|..|+.++.|+
T Consensus 28 gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 356788899999999999955444333 89999999999999 88999999999999999999998 9999999999999
Q ss_pred EEEccCCCCCC-CCCCCccCCcccceeecccccccccccccCCcc-ccccccccccCCCCCccccCC---CCCccccCCc
Q 005587 177 NLDLSSNNLSG-ELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ---IPNFRKDGNP 251 (689)
Q Consensus 177 ~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~-L~~L~Ls~N~l~g~ip~~l~~---l~~l~~~~N~ 251 (689)
.|||..|+|+. .+|..|..|..|+.|+|++|.|.-.++..+.+. |+.|.+..|.+- .+|.+++. |+.|.+.||.
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 99999999975 789999999999999999999999998888887 999999999998 78887765 4556788888
Q ss_pred CCC
Q 005587 252 FNS 254 (689)
Q Consensus 252 ~~~ 254 (689)
+.-
T Consensus 185 l~v 187 (264)
T KOG0617|consen 185 LTV 187 (264)
T ss_pred eee
Confidence 763
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.1e-15 Score=148.12 Aligned_cols=139 Identities=17% Similarity=0.198 Sum_probs=107.0
Q ss_pred cceEe-ecCCeEEEEEEeCCCcEEEEEEeccccC-----------ChhhHHHHHHHHHHHhcCCCCCc--ceecEEEEeC
Q 005587 514 ENLIG-AGMLGSVYRAQLPDGKLLAVKKLDKRAS-----------SQQKDDEFLELVNNIDRIRHANI--VELKGYCAEH 579 (689)
Q Consensus 514 ~~~iG-~G~~G~Vy~~~~~~g~~vAvK~l~~~~~-----------~~~~~~~~~~e~~~l~~l~HpnI--v~l~~~~~~~ 579 (689)
...|| .|+.|+||.++.. +..++||++..... .......+.+|++++.+++|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999874 67899998753210 11233567889999999998885 6667665443
Q ss_pred -Ce---EEEEEeccCC-CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEE
Q 005587 580 -GQ---RLLIYEYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654 (689)
Q Consensus 580 -~~---~~lV~Ey~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k 654 (689)
.. .++||||++| .+|.+++... .++.. ...+++++|.+||.. +|+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 3599999997 6999988642 34433 356899999999998 899999999999999988999
Q ss_pred EEeecCCcccc
Q 005587 655 VSDCGLAPLIS 665 (689)
Q Consensus 655 l~DFGla~~~~ 665 (689)
|+|||.+....
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999998854
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-15 Score=162.26 Aligned_cols=153 Identities=20% Similarity=0.220 Sum_probs=78.7
Q ss_pred CeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEEEcc
Q 005587 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (689)
Q Consensus 80 ~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 157 (689)
++++|+|++|.|+..--..|.+|.+|..|.|++|+++...+..|. +.|+.|+|..|+|.-.---.|..|++|+.|.|.
T Consensus 174 ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklq 253 (873)
T KOG4194|consen 174 NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQ 253 (873)
T ss_pred CceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhh
Confidence 455566666666555555566666666666666666644444443 455555555555552223344445555544455
Q ss_pred CCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccc-cccCCcc-ccccccccccCC
Q 005587 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 158 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~-L~~L~Ls~N~l~ 232 (689)
.|.++..-...|..|.++++|+|+.|+++..--.++.+|+.|+.|+||+|.|..+- +.+.... |++|+|++|+|+
T Consensus 254 rN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~ 330 (873)
T KOG4194|consen 254 RNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT 330 (873)
T ss_pred hcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc
Confidence 55544444444555555555555555555333344555555555555555554433 2222222 555555555555
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.5e-14 Score=160.85 Aligned_cols=214 Identities=22% Similarity=0.311 Sum_probs=148.4
Q ss_pred HHHHhhhccccCCHhhHHHHHHHHHHhCCC-CCCC----CCCCCCCCCCC--------------CCccEEeeCC------
Q 005587 25 LIWAAGFSCAVTNPNDVAAINSLYAALGSP-VLPG----WVASAGDPCGE--------------SWQGVQCNAS------ 79 (689)
Q Consensus 25 ~~~~~~~~~~~~~~~d~~aL~~~~~~l~~~-~l~~----W~~~~~~~C~~--------------~w~gv~C~~~------ 79 (689)
.++..+...+.+.+++.+.+++..+.|..| .+.+ |.. +.|.|.- .-.-|.|...
T Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~-~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~ 127 (754)
T PRK15370 49 CIAYLCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGG-ADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTR 127 (754)
T ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCC-CCcccccCCcchhhheeeecCCceEEecCCCcccccc
Confidence 444445567788899999999999999988 5555 875 5788852 1223667432
Q ss_pred ---------------------------------------------------CeEEEEecCCCCCcccCccccCCCCCCEE
Q 005587 80 ---------------------------------------------------DIIAIILNGANLGGELGENLGAFSSIRVI 108 (689)
Q Consensus 80 ---------------------------------------------------~l~~L~L~~n~l~g~~p~~l~~l~~L~~L 108 (689)
+.+.|+|++++++. +|..+. ++|+.|
T Consensus 128 ~~g~~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L 204 (754)
T PRK15370 128 VTESEQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTL 204 (754)
T ss_pred cccccccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEE
Confidence 34567777777774 555443 478888
Q ss_pred EccCCcCCCCCCCccccccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCC
Q 005587 109 DLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE 188 (689)
Q Consensus 109 ~Ls~N~l~~~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 188 (689)
+|++|+|+ .+|..+..+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|. .+|..+. .+|+.|+|++|+|+ .
T Consensus 205 ~Ls~N~Lt-sLP~~l~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~ 276 (754)
T PRK15370 205 ILDNNELK-SLPENLQGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-C 276 (754)
T ss_pred EecCCCCC-cCChhhccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-c
Confidence 88888888 456666678888888888888 5666553 36888888888887 6776664 47888888888888 5
Q ss_pred CCCCccCCcccceeecccccccccccccCCccccccccccccCCCCCcc-ccCCCCCccccCCcCCC
Q 005587 189 LPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPE-KMLQIPNFRKDGNPFNS 254 (689)
Q Consensus 189 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~L~~L~Ls~N~l~g~ip~-~l~~l~~l~~~~N~~~~ 254 (689)
+|..+. .+|+.|+|++|+|++.+..+. ..|+.|+|++|+|+. +|. ...+|..|.+.+|.+.+
T Consensus 277 LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp-~sL~~L~Ls~N~Lt~-LP~~l~~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 277 LPENLP--EELRYLSVYDNSIRTLPAHLP-SGITHLNVQSNSLTA-LPETLPPGLKTLEAGENALTS 339 (754)
T ss_pred cccccC--CCCcEEECCCCccccCcccch-hhHHHHHhcCCcccc-CCccccccceeccccCCcccc
Confidence 676654 478888888888887654332 136777777777774 443 33456666666766654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.2e-17 Score=165.16 Aligned_cols=182 Identities=21% Similarity=0.308 Sum_probs=155.2
Q ss_pred CCCCCCccEEeeC------CCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc-cccccccccCccCC
Q 005587 66 PCGESWQGVQCNA------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFS 138 (689)
Q Consensus 66 ~C~~~w~gv~C~~------~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~Ls~N~l~ 138 (689)
+|.|++....|-. ..+..++..+|+++ .+|+.++++.+|..|++.+|++....|..+. ..|++||...|.++
T Consensus 118 ~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 118 KLDCSSNELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE 196 (565)
T ss_pred hhhccccceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh
Confidence 4555655554432 25677788889888 6888999999999999999999988887777 88999999999998
Q ss_pred CCCCcccCCCCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCcc-CCcccceeecccccccccccccC
Q 005587 139 GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLE-NLSQLTTLHLQNNQLSGTLDVLQ 217 (689)
Q Consensus 139 ~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~ 217 (689)
.+|..++.|.+|.-|||.+|+|. .+| +|.++..|+.|+++.|+|+ .+|.+.+ .|.+|..|||.+|+++..|+.+.
T Consensus 197 -tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~c 272 (565)
T KOG0472|consen 197 -TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEIC 272 (565)
T ss_pred -cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHH
Confidence 88999999999999999999998 788 8999999999999999998 7887766 89999999999999999998887
Q ss_pred Ccc-ccccccccccCCCCCccccCCC--CCccccCCcCC
Q 005587 218 DLP-LRDLNIENNLFSGPIPEKMLQI--PNFRKDGNPFN 253 (689)
Q Consensus 218 ~l~-L~~L~Ls~N~l~g~ip~~l~~l--~~l~~~~N~~~ 253 (689)
.+. |++||||+|.++ .+|-+++++ ..|.+.|||+.
T Consensus 273 lLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred HhhhhhhhcccCCccc-cCCcccccceeeehhhcCCchH
Confidence 777 999999999999 566677765 45677899875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-16 Score=165.95 Aligned_cols=171 Identities=22% Similarity=0.385 Sum_probs=109.2
Q ss_pred CeEEEEecCCCCC-cccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEEEc
Q 005587 80 DIIAIILNGANLG-GELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (689)
Q Consensus 80 ~l~~L~L~~n~l~-g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (689)
-|..+|+++|.++ +..|.....+++++.|.|...+|. .+|+.++ .+|++|.+++|+|. .+-..++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3556677777776 456666667777777777666666 5666665 56777777777766 44455666667777777
Q ss_pred cCCcCCC-CCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeeccccccccccc-ccCCcc-ccccccccccCCC
Q 005587 157 NNNLLSG-EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDLNIENNLFSG 233 (689)
Q Consensus 157 s~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~-L~~L~Ls~N~l~g 233 (689)
.+|+|.. -||..+..|..|..||||+|+|. ..|..+.+-+++-.|+||+|+|..++. .+.++. |-.||||+|+|..
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~ 164 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM 164 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh
Confidence 7776643 36666666777777777777776 666666666677777777777766663 334444 6667777777763
Q ss_pred CCc--cccCCCCCccccCCcCC
Q 005587 234 PIP--EKMLQIPNFRKDGNPFN 253 (689)
Q Consensus 234 ~ip--~~l~~l~~l~~~~N~~~ 253 (689)
..| ..+..|..|.+++||++
T Consensus 165 LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 165 LPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred cCHHHHHHhhhhhhhcCCChhh
Confidence 333 12445556666666655
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-14 Score=166.58 Aligned_cols=147 Identities=25% Similarity=0.371 Sum_probs=116.7
Q ss_pred hhccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC---CCCcceecEEEEeCCeE
Q 005587 506 QYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR---HANIVELKGYCAEHGQR 582 (689)
Q Consensus 506 ~~~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~---HpnIv~l~~~~~~~~~~ 582 (689)
...+.|.+...||+|+||+||+|...+|+.||+|+-....... |.--.+++.+|+ -+-|..+...+...+.-
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3446788889999999999999988789999999876543321 111122333443 34566677777778888
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec-------CCCcEEE
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD-------DDLAVSV 655 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~-------~~~~~kl 655 (689)
+||+||.+.|+|.+++.. .+.++|..++.++.|+++-++.||.. +|||+||||+|+||. +..-++|
T Consensus 770 ~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 999999999999999984 46789999999999999999999997 899999999999993 2345899
Q ss_pred EeecCCccc
Q 005587 656 SDCGLAPLI 664 (689)
Q Consensus 656 ~DFGla~~~ 664 (689)
+|||-+-.+
T Consensus 843 IDfG~siDm 851 (974)
T KOG1166|consen 843 IDFGRSIDM 851 (974)
T ss_pred Eecccceee
Confidence 999998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-15 Score=163.65 Aligned_cols=160 Identities=21% Similarity=0.244 Sum_probs=134.2
Q ss_pred EeecCCeEEEEEE----eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEEeccCC
Q 005587 517 IGAGMLGSVYRAQ----LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 517 iG~G~~G~Vy~~~----~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~Ey~~g 591 (689)
+|+|.||.|+.++ ...|..+|+|.+.+.............|..++...+ ||.+|+++..++.+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999873 234788999988765443333334556677788886 99999999999999999999999999
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcce
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (689)
|+|...+... ..+.+.....+...++-+++++|.. +|+|||+|++||+++.+|++++.|||+++...+....
T Consensus 82 g~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 9999888753 3456667777888899999999998 8999999999999999999999999999998777655
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
+++..||||||+.
T Consensus 154 --cgt~eymApEI~~ 166 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN 166 (612)
T ss_pred --ccchhhhhhHhhh
Confidence 7899999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-14 Score=171.76 Aligned_cols=117 Identities=11% Similarity=0.101 Sum_probs=86.0
Q ss_pred cCCC-CCcceecEEE-------EeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 005587 563 RIRH-ANIVELKGYC-------AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634 (689)
Q Consensus 563 ~l~H-pnIv~l~~~~-------~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 634 (689)
.++| +||++++++| ...+..+++|||+ +++|+++|... ...+++.+++.|+.||++||.|||+. +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 5788888877 2334567888988 66999999743 34589999999999999999999987 8
Q ss_pred cEEecccCCCeEecC-------------------CCcEEEEeecCCccccCCC-----------------cceeecccce
Q 005587 635 IVHRNFKSANILLDD-------------------DLAVSVSDCGLAPLISSGS-----------------VSQVSHNLTI 678 (689)
Q Consensus 635 iiHrDlKp~NILl~~-------------------~~~~kl~DFGla~~~~~~~-----------------~~~~~~~~~~ 678 (689)
|+||||||+||||+. ++.+|++|||+++...... ......++++
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4456666777766432100 0011246778
Q ss_pred EEeccccc
Q 005587 679 MRAGGVTH 686 (689)
Q Consensus 679 ~~apE~~~ 686 (689)
|||||++.
T Consensus 181 Y~APE~~~ 188 (793)
T PLN00181 181 YTSPEEDN 188 (793)
T ss_pred eEChhhhc
Confidence 99999974
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-13 Score=151.79 Aligned_cols=148 Identities=24% Similarity=0.295 Sum_probs=101.8
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChh--------------------------------------h
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQ--------------------------------------K 550 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~--------------------------------------~ 550 (689)
..|+ .+.||.|++|+||+|++++|+.||||+.+......- .
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 368999999999999999999999999754311000 0
Q ss_pred HHHHHHHHHHHhcC----CCCCcceecEEE-EeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHH-HH
Q 005587 551 DDEFLELVNNIDRI----RHANIVELKGYC-AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR-AL 624 (689)
Q Consensus 551 ~~~~~~e~~~l~~l----~HpnIv~l~~~~-~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~-aL 624 (689)
+-+|.+|.+.+.++ +|.+-|.+-..| ...+..+|||||++|++|.++..... ...+ +.+++.++++ .+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFL 270 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHH
Confidence 11244555555544 233323332233 23456799999999999988765321 1122 3456666665 46
Q ss_pred HHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 625 ~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
..+|.. +++|+|+||.||++++++.++++|||++..+.+
T Consensus 271 ~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 778876 899999999999999999999999999988764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.6e-14 Score=159.99 Aligned_cols=167 Identities=22% Similarity=0.238 Sum_probs=126.3
Q ss_pred CccceEeecCCeEEEEEEe-CCCcEEEEEEecc----ccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 512 SQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDK----RASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 512 ~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~----~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
...+++|.|++|.|+.+.. .....++.|.... ..........+..|+.+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998887743 3344455554331 1111111222566777778899999988877777766666669
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
|||++ +|+.++... ..+....+..++.|++.|+.|+|+. +|.|||+|++|+++..+|.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999999763 2466778888999999999999998 899999999999999999999999999987654
Q ss_pred CC-----cceeecccceEEeccccc
Q 005587 667 GS-----VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~-----~~~~~~~~~~~~apE~~~ 686 (689)
+. ......+...|+|||++.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~ 497 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLT 497 (601)
T ss_pred CcchhhhhhcCcccCCcCcCccccc
Confidence 32 223456778899999985
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-13 Score=157.40 Aligned_cols=160 Identities=28% Similarity=0.461 Sum_probs=113.3
Q ss_pred CCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccccccccccccCccCCCCCCcccCCCCCccEEEccC
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (689)
Q Consensus 79 ~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 158 (689)
..++.|+|++|+|+. +|..+. .+|+.|+|++|+|+ .+|..++.+|+.|+|++|+|. .+|..+. .+|+.|+|++
T Consensus 199 ~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~ 271 (754)
T PRK15370 199 EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFH 271 (754)
T ss_pred cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECcC
Confidence 578999999999994 666554 58999999999998 567777778999999999988 6777664 4789999999
Q ss_pred CcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccccccCCccccccccccccCCCCCccc
Q 005587 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEK 238 (689)
Q Consensus 159 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~L~~L~Ls~N~l~g~ip~~ 238 (689)
|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..+..+. ..|+.|++++|.|++ +|..
T Consensus 272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~-~sL~~L~Ls~N~Lt~-LP~~ 343 (754)
T PRK15370 272 NKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP-PGLKTLEAGENALTS-LPAS 343 (754)
T ss_pred CccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc-ccceeccccCCcccc-CChh
Confidence 9998 5777654 47899999999888 4565443 356777777777765543222 235666666666653 4433
Q ss_pred c-CCCCCccccCCcCC
Q 005587 239 M-LQIPNFRKDGNPFN 253 (689)
Q Consensus 239 l-~~l~~l~~~~N~~~ 253 (689)
+ .+|..|++++|.+.
T Consensus 344 l~~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 344 LPPELQVLDVSKNQIT 359 (754)
T ss_pred hcCcccEEECCCCCCC
Confidence 3 24555555665554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.9e-15 Score=158.31 Aligned_cols=169 Identities=30% Similarity=0.457 Sum_probs=150.1
Q ss_pred CCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEEEc
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (689)
Q Consensus 79 ~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (689)
...+..||+.|.+. .+|.++..+..|+.|.|..|.|. .+|..+. ..|++|||+.|+++ .+|..++.|+ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 45677899999998 68889999999999999999998 5666555 77999999999999 8898999887 899999
Q ss_pred cCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccccccCCccccccccccccCCCCCc
Q 005587 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIP 236 (689)
Q Consensus 157 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~L~~L~Ls~N~l~g~ip 236 (689)
++|+++ .+|+.++.+..|..||.+.|++. .+|..+++|.+|+.|.+..|++...++.+..++|..||+|.|+++ .||
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLP 227 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecc
Confidence 999998 89999999999999999999998 789999999999999999999999998888999999999999999 899
Q ss_pred cccCCCCC---ccccCCcCCC
Q 005587 237 EKMLQIPN---FRKDGNPFNS 254 (689)
Q Consensus 237 ~~l~~l~~---l~~~~N~~~~ 254 (689)
-.|.+|+. |.+.+||+..
T Consensus 228 v~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhhhhhhhheeeeeccCCCCC
Confidence 88776655 5678999874
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.1e-13 Score=154.45 Aligned_cols=98 Identities=27% Similarity=0.419 Sum_probs=52.1
Q ss_pred CccEEEccCCcCCCCCChhhcC-----------------CCCCCEEEccCCCCCCCCCCCccCCcccceeeccccccccc
Q 005587 150 LLTDMSLNNNLLSGEIPDAFQS-----------------LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212 (689)
Q Consensus 150 ~L~~L~Ls~N~l~g~~p~~~~~-----------------l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~ 212 (689)
+|++|+|++|+|+ .+|....+ +.+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|++.
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~LssI 417 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTSL 417 (788)
T ss_pred ccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCCC
Confidence 5666777777666 34432111 123455555555555 23332 23455666666666554
Q ss_pred ccccCCccccccccccccCCCCCccccCC---CCCccccCCcCCCC
Q 005587 213 LDVLQDLPLRDLNIENNLFSGPIPEKMLQ---IPNFRKDGNPFNST 255 (689)
Q Consensus 213 ~~~~~~l~L~~L~Ls~N~l~g~ip~~l~~---l~~l~~~~N~~~~~ 255 (689)
+.... .|+.|+|++|+|+ .+|..+.+ +..|++++|++++.
T Consensus 418 P~l~~--~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 418 PMLPS--GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred Ccchh--hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCch
Confidence 33211 2566777777776 56665543 34456777777654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.1e-15 Score=152.87 Aligned_cols=168 Identities=26% Similarity=0.390 Sum_probs=95.4
Q ss_pred eEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc-cccccccccCccCCCCCCcccCC------------
Q 005587 81 IIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLAT------------ 147 (689)
Q Consensus 81 l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~Ls~N~l~~~~p~~~~~------------ 147 (689)
+..++.+.|++. .+|+.++++.+|..|++++|.+...+++... ..|..|+..+|+++ .+|+.+.+
T Consensus 93 l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n 170 (565)
T KOG0472|consen 93 LKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGN 170 (565)
T ss_pred HHHhhcccchHh-hccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhcccc
Confidence 445666666666 4666666666666666666666633332222 34444444555544 34444444
Q ss_pred -----------CCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeeccccccccccc-c
Q 005587 148 -----------LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-V 215 (689)
Q Consensus 148 -----------l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~ 215 (689)
++.|+.||..+|.++ .+|..++.|.+|+.|+|.+|+|. .+| +|.++..|.+|+++.|+|+-.+. .
T Consensus 171 ~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~ 247 (565)
T KOG0472|consen 171 KLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEH 247 (565)
T ss_pred chhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHH
Confidence 555555555555554 55555555555555566666555 444 55555556666666665555442 2
Q ss_pred cCCcc-ccccccccccCCCCCccccCCC---CCccccCCcCCC
Q 005587 216 LQDLP-LRDLNIENNLFSGPIPEKMLQI---PNFRKDGNPFNS 254 (689)
Q Consensus 216 ~~~l~-L~~L~Ls~N~l~g~ip~~l~~l---~~l~~~~N~~~~ 254 (689)
++.++ +..|||..|++. ..|++++-+ ..|++++|.+++
T Consensus 248 ~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 248 LKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS 289 (565)
T ss_pred hcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc
Confidence 33555 677777777777 677765543 346677776654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.3e-13 Score=151.39 Aligned_cols=149 Identities=14% Similarity=0.180 Sum_probs=95.2
Q ss_pred ccCCCccceEeecCCeEEEEEEeCC-CcEEEEEEeccccCC----------------------------h----hhH---
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASS----------------------------Q----QKD--- 551 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~~-g~~vAvK~l~~~~~~----------------------------~----~~~--- 551 (689)
...|+. +.||+|++|+||+|++++ |+.||||+++..... . +..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 789999999999999887 999999998643100 0 001
Q ss_pred ---HHHHHHHHHHhcCC----CCCcceecEEEEe-CCeEEEEEeccCCCCHHHH--HhcCcccCCCCCHHHHHHHHHHHH
Q 005587 552 ---DEFLELVNNIDRIR----HANIVELKGYCAE-HGQRLLIYEYCSNGTLQDM--LHSDDELKNNLSWNTRIRMALGAA 621 (689)
Q Consensus 552 ---~~~~~e~~~l~~l~----HpnIv~l~~~~~~-~~~~~lV~Ey~~ggsL~~~--l~~~~~~~~~l~~~~~~~i~~qia 621 (689)
-+|.+|...+.+++ +.+.+.+-..|.+ ....+|||||+.|+.+.++ +...+.....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 12344444444442 4444444333333 4567899999999999875 22211000112222222233333
Q ss_pred HHHHHHHhCCCCCcEEecccCCCeEecCCC----cEEEEeecCCccccCC
Q 005587 622 RALEYLHEICQPPIVHRNFKSANILLDDDL----AVSVSDCGLAPLISSG 667 (689)
Q Consensus 622 ~aL~yLH~~~~~~iiHrDlKp~NILl~~~~----~~kl~DFGla~~~~~~ 667 (689)
+.. +++|+|+||.||+++.++ .++++|||++..+.+.
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 223 899999999999999888 9999999999987554
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.6e-14 Score=157.10 Aligned_cols=157 Identities=29% Similarity=0.437 Sum_probs=131.3
Q ss_pred ccCccccCCCCCCEEEccCCcCCCCCCCccc---------------------------cccccccccCccCCCCCCcccC
Q 005587 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILP---------------------------VTMQNFFLSDNQFSGSIPSSLA 146 (689)
Q Consensus 94 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---------------------------~~L~~L~Ls~N~l~~~~p~~~~ 146 (689)
.+|+.+..++.|++|||..|+|...++..+. ..|+.|+|.+|+|+...=+.|.
T Consensus 301 yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~ 380 (1081)
T KOG0618|consen 301 YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLV 380 (1081)
T ss_pred hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhc
Confidence 4777788899999999999999843332211 3477899999999988877899
Q ss_pred CCCCccEEEccCCcCCCCCCh-hhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccccccCCcc-cccc
Q 005587 147 TLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDL 224 (689)
Q Consensus 147 ~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~-L~~L 224 (689)
+..+|+.|+|++|+|. .+|+ .+.++..|+.|+||+|+|+ .+|..+.++..|++|...+|+|...| .+..++ |+.+
T Consensus 381 ~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~l 457 (1081)
T KOG0618|consen 381 NFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVL 457 (1081)
T ss_pred cccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEE
Confidence 9999999999999998 6665 5789999999999999999 89999999999999999999999888 555555 9999
Q ss_pred ccccccCCC-CCcccc--CCCCCccccCCcCC
Q 005587 225 NIENNLFSG-PIPEKM--LQIPNFRKDGNPFN 253 (689)
Q Consensus 225 ~Ls~N~l~g-~ip~~l--~~l~~l~~~~N~~~ 253 (689)
||+.|+|+- .+|... .+|+.|+++||.+.
T Consensus 458 DlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 458 DLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999999973 445443 47889999999863
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=2e-12 Score=148.86 Aligned_cols=153 Identities=24% Similarity=0.378 Sum_probs=81.9
Q ss_pred CeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccccccccccccCccCCCCCCcccCCCCCccEEEccCC
Q 005587 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159 (689)
Q Consensus 80 ~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 159 (689)
+++.|+|.+|+|+. +|. .+++|++|+|++|+|+. +|. +..+|+.|+|++|.|+ .+|..+ .+|+.|+|++|
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~-lp~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N 292 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV-LPPGLLELSIFSNPLT-HLPALP---SGLCKLWIFGN 292 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccC-cccccceeeccCCchh-hhhhch---hhcCEEECcCC
Confidence 45555666665553 332 13556666666666653 332 2345666666666655 333322 34556666666
Q ss_pred cCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccccccCCccccccccccccCCCCCcccc
Q 005587 160 LLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKM 239 (689)
Q Consensus 160 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~L~~L~Ls~N~l~g~ip~~l 239 (689)
+|+ .+|. .+++|+.|+|++|+|++ +|... .+|+.|++++|+|++.+... ..|+.|+|++|+|+ .+|...
T Consensus 293 ~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~LP~lp--~~Lq~LdLS~N~Ls-~LP~lp 361 (788)
T PRK15387 293 QLT-SLPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTSLPTLP--SGLQELSVSDNQLA-SLPTLP 361 (788)
T ss_pred ccc-cccc---cccccceeECCCCcccc-CCCCc---ccccccccccCccccccccc--cccceEecCCCccC-CCCCCC
Confidence 666 3443 23567777777777763 44322 24555566666665543211 12666666666666 345444
Q ss_pred CCCCCccccCCcCC
Q 005587 240 LQIPNFRKDGNPFN 253 (689)
Q Consensus 240 ~~l~~l~~~~N~~~ 253 (689)
.++..|.+.+|.+.
T Consensus 362 ~~L~~L~Ls~N~L~ 375 (788)
T PRK15387 362 SELYKLWAYNNRLT 375 (788)
T ss_pred cccceehhhccccc
Confidence 55555566666554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.3e-13 Score=131.51 Aligned_cols=165 Identities=20% Similarity=0.332 Sum_probs=130.9
Q ss_pred ccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCC
Q 005587 513 QENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
...+|.+...|..|+|++. |..+++|++..........++|.+|.-.|+...||||..+++.|.......++..||+-|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456888999999999995 556778888777666677789999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc-cCCCcce
Q 005587 593 TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI-SSGSVSQ 671 (689)
Q Consensus 593 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~-~~~~~~~ 671 (689)
+|+.++++.. ...++-.++++++.+||+|++|||+.. +-|.---|....+++|++.+++|+ .+-+++- ++..
T Consensus 273 slynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsfqe~g--- 345 (448)
T KOG0195|consen 273 SLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVG--- 345 (448)
T ss_pred HHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeeeeccc---
Confidence 9999999854 334667789999999999999999983 335555789999999999988763 2222321 1111
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
..-.+.||+||.+.
T Consensus 346 -r~y~pawmspealq 359 (448)
T KOG0195|consen 346 -RAYSPAWMSPEALQ 359 (448)
T ss_pred -cccCcccCCHHHHh
Confidence 12346689999873
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1e-11 Score=118.93 Aligned_cols=131 Identities=20% Similarity=0.140 Sum_probs=95.4
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcc-eecEEEEeCCeEEEEEeccCCCC
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV-ELKGYCAEHGQRLLIYEYCSNGT 593 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~Ey~~ggs 593 (689)
+.|+.|.++.||+++.. ++.|++|....... ....+..|++.+..+.+.+++ +++.+. .+..++||||++|.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 56789999999999864 77899998754321 123456788888877665544 444443 334589999999988
Q ss_pred HHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 594 LQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC--QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 594 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
+.+. . .....++.+++++|..||... ...++|+|++|.||+++ ++.++++|||.+..-
T Consensus 78 l~~~-~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 78 LLTE-D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc-c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 7542 0 011245678999999999873 12369999999999999 668999999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-11 Score=141.34 Aligned_cols=107 Identities=31% Similarity=0.526 Sum_probs=92.2
Q ss_pred CccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeeccccccccccc-ccCCcc-ccccccc
Q 005587 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDLNIE 227 (689)
Q Consensus 150 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~-L~~L~Ls 227 (689)
.++.|+|++|.|.|.+|..|+.|++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.++ .+..+. |+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999998764 566666 9999999
Q ss_pred cccCCCCCccccCCC----CCccccCCcCCCCC
Q 005587 228 NNLFSGPIPEKMLQI----PNFRKDGNPFNSTV 256 (689)
Q Consensus 228 ~N~l~g~ip~~l~~l----~~l~~~~N~~~~~~ 256 (689)
+|+|+|.+|..+..+ ..+.+.+|+..|+.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~ 531 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI 531 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCC
Confidence 999999999877543 35678888888753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.3e-11 Score=113.94 Aligned_cols=139 Identities=15% Similarity=0.149 Sum_probs=97.7
Q ss_pred ceEeecCCeEEEEEEeCC-------CcEEEEEEeccccC-----------C---------hhhHHHH----HHHHHHHhc
Q 005587 515 NLIGAGMLGSVYRAQLPD-------GKLLAVKKLDKRAS-----------S---------QQKDDEF----LELVNNIDR 563 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~-------g~~vAvK~l~~~~~-----------~---------~~~~~~~----~~e~~~l~~ 563 (689)
..||.|.=+.||.|...+ +..+|||+.+.... + ......+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47999998743210 0 0001122 278888888
Q ss_pred CCC--CCcceecEEEEeCCeEEEEEeccCCCCHHH-HHhcCcccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEec
Q 005587 564 IRH--ANIVELKGYCAEHGQRLLIYEYCSNGTLQD-MLHSDDELKNNLSWNTRIRMALGAARALEYL-HEICQPPIVHRN 639 (689)
Q Consensus 564 l~H--pnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiHrD 639 (689)
+.. -++...+++ ...++||||+.++.+.. .++. ..++......+..+++.+|.++ |.. +|||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 753 455566654 45689999997754422 2322 1234455667789999999999 665 899999
Q ss_pred ccCCCeEecCCCcEEEEeecCCccccC
Q 005587 640 FKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 640 lKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
|++.|||++ ++.+.|+|||.|.....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999997 46799999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-11 Score=125.13 Aligned_cols=112 Identities=26% Similarity=0.320 Sum_probs=81.6
Q ss_pred CCCCcceecEEEEeC---------------------------CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHH
Q 005587 565 RHANIVELKGYCAEH---------------------------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA 617 (689)
Q Consensus 565 ~HpnIv~l~~~~~~~---------------------------~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~ 617 (689)
+|||||.+.++|.+. ...|+||.-... +|.+++... ..+......|.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 699999998876432 356899988754 999998753 34555667788
Q ss_pred HHHHHHHHHHHhCCCCCcEEecccCCCeEe--cCCC--cEEEEeecCCccccC------CCcceeeccc-ceEEecccc
Q 005587 618 LGAARALEYLHEICQPPIVHRNFKSANILL--DDDL--AVSVSDCGLAPLISS------GSVSQVSHNL-TIMRAGGVT 685 (689)
Q Consensus 618 ~qia~aL~yLH~~~~~~iiHrDlKp~NILl--~~~~--~~kl~DFGla~~~~~------~~~~~~~~~~-~~~~apE~~ 685 (689)
.|+++|+.|||.+ +|.|||+|.+|||+ |+|+ .+.|+|||.+---.. -+......++ --.|||||.
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 9999999999987 89999999999998 4444 468999996532111 1222222333 448899986
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.6e-11 Score=144.71 Aligned_cols=88 Identities=22% Similarity=0.351 Sum_probs=44.2
Q ss_pred CCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc-cccccccccCccCCCCCCcccCCCCCccEEEcc
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (689)
Q Consensus 79 ~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 157 (689)
.+++.|+|.+|.|. .++..+..+++|+.|+|++|...+.+|..-. .+|+.|+|++|.....+|..+.++++|+.|+|+
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 35556666665554 3455555555666666655443334443221 455555555554444555555555555555555
Q ss_pred CCcCCCCCCh
Q 005587 158 NNLLSGEIPD 167 (689)
Q Consensus 158 ~N~l~g~~p~ 167 (689)
+|..-+.+|.
T Consensus 690 ~c~~L~~Lp~ 699 (1153)
T PLN03210 690 RCENLEILPT 699 (1153)
T ss_pred CCCCcCccCC
Confidence 5432234443
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.4e-12 Score=146.13 Aligned_cols=157 Identities=26% Similarity=0.435 Sum_probs=113.9
Q ss_pred CCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEEEc
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (689)
Q Consensus 79 ~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (689)
.++++++++.|++++ +|++++.+.+|+.|+..+|+|+ .+|..+. .+|+.|++.+|.++ -+|.....++.|+.|+|
T Consensus 241 ~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 468889999999986 5599999999999999999996 5555544 77888888888888 67777788888888888
Q ss_pred cCCcCCCCCChhhc--------------------------CCCCCCEEEccCCCCCCCCCCCccCCcccceeeccccccc
Q 005587 157 NNNLLSGEIPDAFQ--------------------------SLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210 (689)
Q Consensus 157 s~N~l~g~~p~~~~--------------------------~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 210 (689)
..|+|. .+|+.|. .+..|+.|+|.+|.|+...-+.|-+..+|+.|+|++|+|.
T Consensus 318 ~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 318 QSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred hhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 888886 5554221 1234566677777776654455666777777777777777
Q ss_pred cccc-ccCCcc-ccccccccccCCCCCccccC
Q 005587 211 GTLD-VLQDLP-LRDLNIENNLFSGPIPEKML 240 (689)
Q Consensus 211 ~~~~-~~~~l~-L~~L~Ls~N~l~g~ip~~l~ 240 (689)
.++. .+..+. |++|+||+|+|+ .+|+.+.
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva 427 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLT-TLPDTVA 427 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhh-hhhHHHH
Confidence 6663 455555 777777777777 5555443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.9e-13 Score=143.23 Aligned_cols=130 Identities=32% Similarity=0.520 Sum_probs=64.7
Q ss_pred eCCCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEE
Q 005587 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154 (689)
Q Consensus 77 ~~~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 154 (689)
+...++.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..+. ..|..|+.+.|.+. .+|..++.|.+|+.|
T Consensus 119 ~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l 194 (722)
T KOG0532|consen 119 NLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDL 194 (722)
T ss_pred hhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHH
Confidence 3344455555555554 3444444443 455555555554 3333333 44445555555555 444555555555555
Q ss_pred EccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccc
Q 005587 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213 (689)
Q Consensus 155 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~ 213 (689)
++..|++. .+|.++..|+ |..||+|+|+++ .+|-.|.+|..|++|.|.+|.|...+
T Consensus 195 ~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 195 NVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred HHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence 55555555 4444444333 555555555555 45555555555555555555555444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.3e-12 Score=136.65 Aligned_cols=176 Identities=23% Similarity=0.358 Sum_probs=129.0
Q ss_pred CCCeEEEEecCCCCCcccCccccCCCC---CCEEEccCCcCCCCC----CCccc---cccccccccCccCCCC----CCc
Q 005587 78 ASDIIAIILNGANLGGELGENLGAFSS---IRVIDLSNNHIGGSI----PSILP---VTMQNFFLSDNQFSGS----IPS 143 (689)
Q Consensus 78 ~~~l~~L~L~~n~l~g~~p~~l~~l~~---L~~L~Ls~N~l~~~~----p~~~~---~~L~~L~Ls~N~l~~~----~p~ 143 (689)
..+++.|+|++|.+.+..+..+..+.. |++|+|++|++++.. ...+. .+|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 458999999999998877777766666 999999999988421 11121 5789999999999843 344
Q ss_pred ccCCCCCccEEEccCCcCCCC----CChhhcCCCCCCEEEccCCCCCCC----CCCCccCCcccceeecccccccccc--
Q 005587 144 SLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGTL-- 213 (689)
Q Consensus 144 ~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~-- 213 (689)
.+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. +...+..+++|++|++++|.+++..
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 567778899999999999852 444566778999999999998743 3445667889999999999988521
Q ss_pred c---ccC--CccccccccccccCCC----CCcc---ccCCCCCccccCCcCC
Q 005587 214 D---VLQ--DLPLRDLNIENNLFSG----PIPE---KMLQIPNFRKDGNPFN 253 (689)
Q Consensus 214 ~---~~~--~l~L~~L~Ls~N~l~g----~ip~---~l~~l~~l~~~~N~~~ 253 (689)
. .+. ...|++|++++|.++. .+.. .+.++..+++++|.+.
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 1 111 1349999999999872 1222 2345677788888776
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-10 Score=115.13 Aligned_cols=143 Identities=21% Similarity=0.308 Sum_probs=108.8
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCC--CcceecEEEEeC---CeEEEEEecc
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA--NIVELKGYCAEH---GQRLLIYEYC 589 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~Hp--nIv~l~~~~~~~---~~~~lV~Ey~ 589 (689)
+.|+.|.++.||+++..+|+.+++|........ .....+..|.++++.+++. ++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998877789999987543321 1345678889999888763 456677776654 3678999999
Q ss_pred CCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC-------------------------------------- 631 (689)
Q Consensus 590 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------------- 631 (689)
+|+++.+.+.. ..++......++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888765421 24566777788888888888888531
Q ss_pred ---------------CCCcEEecccCCCeEecC--CCcEEEEeecCCcc
Q 005587 632 ---------------QPPIVHRNFKSANILLDD--DLAVSVSDCGLAPL 663 (689)
Q Consensus 632 ---------------~~~iiHrDlKp~NILl~~--~~~~kl~DFGla~~ 663 (689)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 66789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.5e-12 Score=134.34 Aligned_cols=175 Identities=23% Similarity=0.333 Sum_probs=125.1
Q ss_pred CCeEEEEecCCCCCc------ccCccccCCCCCCEEEccCCcCCCCCCCccc--cc---cccccccCccCCC----CCCc
Q 005587 79 SDIIAIILNGANLGG------ELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VT---MQNFFLSDNQFSG----SIPS 143 (689)
Q Consensus 79 ~~l~~L~L~~n~l~g------~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~---L~~L~Ls~N~l~~----~~p~ 143 (689)
..++.|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+. .. |++|++++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 457888888887762 3455677888999999999999865555444 33 9999999999873 3334
Q ss_pred ccCCC-CCccEEEccCCcCCCC----CChhhcCCCCCCEEEccCCCCCCC----CCCCccCCcccceeecccccccccc-
Q 005587 144 SLATL-TLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGTL- 213 (689)
Q Consensus 144 ~~~~l-~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~- 213 (689)
.+..+ ++|+.|+|++|.+++. ++..+..+.+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 55666 8899999999999843 344567778899999999998842 3334555678999999999887432
Q ss_pred ----cccCCcc-ccccccccccCCCCCc----cc----cCCCCCccccCCcCC
Q 005587 214 ----DVLQDLP-LRDLNIENNLFSGPIP----EK----MLQIPNFRKDGNPFN 253 (689)
Q Consensus 214 ----~~~~~l~-L~~L~Ls~N~l~g~ip----~~----l~~l~~l~~~~N~~~ 253 (689)
..+..++ |++|++++|.+++... .. ..+|..|++.+|.+.
T Consensus 211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 2233344 8999999999885222 12 246777788887664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-10 Score=119.49 Aligned_cols=169 Identities=20% Similarity=0.258 Sum_probs=105.7
Q ss_pred CCccceEeecCCeEEEEEEe-CCCcEEEEEEecccc-CChhhHHHHHHHHHHHhcCCC----------CCcceecEEEE-
Q 005587 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRA-SSQQKDDEFLELVNNIDRIRH----------ANIVELKGYCA- 577 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~~~e~~~l~~l~H----------pnIv~l~~~~~- 577 (689)
+...+.||.|+++.||.+.+ .+|+.+|||+..... ......+++.+|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34568899999999999966 469999999875443 223345667777655544332 12222222221
Q ss_pred --------eC---C-----eEEEEEeccCCCCHHHHHhc---CcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEe
Q 005587 578 --------EH---G-----QRLLIYEYCSNGTLQDMLHS---DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHR 638 (689)
Q Consensus 578 --------~~---~-----~~~lV~Ey~~ggsL~~~l~~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHr 638 (689)
.. + ..+++|+-+ .+||.+++.. .......+....++.+..|+++.+++||+. +|+|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 1 236788877 4589888653 111112234455677779999999999998 89999
Q ss_pred cccCCCeEecCCCcEEEEeecCCccccCCCcceeecccceEEecccc
Q 005587 639 NFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVT 685 (689)
Q Consensus 639 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~apE~~ 685 (689)
||||+|++++.+|.++|+||+.....++.... ...+..|.+||+.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~ 214 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELE 214 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhh
Confidence 99999999999999999999877765443322 3445678888876
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.5e-10 Score=104.41 Aligned_cols=136 Identities=22% Similarity=0.320 Sum_probs=102.4
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEE-eccccCChh-----hHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEec
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKK-LDKRASSQQ-----KDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~-l~~~~~~~~-----~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey 588 (689)
..+++|+=+.+|.+.+.+ ..+++|. +++..-.+. ..+.-.+|.+++.+++--.|..-.=|..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997744 3466664 333322121 234556889999888766666555566777888999999
Q ss_pred cCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccC
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 589 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 666 (689)
++|-.|.+.+... ...++..|-.-+.-||.. +|+|+||.++||++..+. +.++||||+.+-..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 9999998888752 245677777888899998 899999999999998775 89999999996543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-11 Score=121.85 Aligned_cols=126 Identities=24% Similarity=0.298 Sum_probs=79.6
Q ss_pred cccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeec
Q 005587 125 VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204 (689)
Q Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 204 (689)
..|++||||+|.|+ .+.++..-++.++.|++|+|.|. .+. .+..|++|+.||||+|.|+ .+-.+-..|-++++|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 56777777777777 56666677777777777777776 333 3666777777777777776 45555566677777777
Q ss_pred ccccccccccccCCccccccccccccCCCCCc-cccCCCCC---ccccCCcCCC
Q 005587 205 QNNQLSGTLDVLQDLPLRDLNIENNLFSGPIP-EKMLQIPN---FRKDGNPFNS 254 (689)
Q Consensus 205 s~N~l~~~~~~~~~l~L~~L~Ls~N~l~g~ip-~~l~~l~~---l~~~~N~~~~ 254 (689)
+.|.|...-..-+..+|..||+++|++...-- ..+++|+- +.+.+||+..
T Consensus 360 a~N~iE~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 360 AQNKIETLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhHhhhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 77776543322222347777777777752111 23445444 4567777654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.3e-10 Score=137.80 Aligned_cols=172 Identities=19% Similarity=0.243 Sum_probs=130.7
Q ss_pred CCeEEEEecCC------CCCcccCccccCCC-CCCEEEccCCcCCCCCCCccc-cccccccccCccCCCCCCcccCCCCC
Q 005587 79 SDIIAIILNGA------NLGGELGENLGAFS-SIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATLTL 150 (689)
Q Consensus 79 ~~l~~L~L~~n------~l~g~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~ 150 (689)
.++..|.+..+ ++...+|+.|..++ +|+.|++.+|.+. .+|..+. .+|+.|+|++|+|. .++..+..+++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~~~~L~~L~L~~s~l~-~L~~~~~~l~~ 635 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFRPENLVKLQMQGSKLE-KLWDGVHSLTG 635 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCCccCCcEEECcCcccc-ccccccccCCC
Confidence 34555655443 33445777777775 5899999998887 5565555 78999999999988 67888889999
Q ss_pred ccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccc-cccccccccCCccccccccccc
Q 005587 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN-QLSGTLDVLQDLPLRDLNIENN 229 (689)
Q Consensus 151 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~l~L~~L~Ls~N 229 (689)
|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+.+|++|+.|+|++| .+...+..+....|+.|+|++|
T Consensus 636 Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc 714 (1153)
T PLN03210 636 LRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGC 714 (1153)
T ss_pred CCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCC
Confidence 99999998776567774 888899999999988766688999999999999999986 4554444443233888999888
Q ss_pred cCCCCCccccCCCCCccccCCcCC
Q 005587 230 LFSGPIPEKMLQIPNFRKDGNPFN 253 (689)
Q Consensus 230 ~l~g~ip~~l~~l~~l~~~~N~~~ 253 (689)
...+.+|....+|..|++.+|.+.
T Consensus 715 ~~L~~~p~~~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 715 SRLKSFPDISTNISWLDLDETAIE 738 (1153)
T ss_pred CCccccccccCCcCeeecCCCccc
Confidence 777778877777888888887754
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-10 Score=127.53 Aligned_cols=148 Identities=32% Similarity=0.495 Sum_probs=66.3
Q ss_pred eEEEEecCCCCCcccCccccCCC-CCCEEEccCCcCCCCC-CCccccccccccccCccCCCCCCcccCCCCCccEEEccC
Q 005587 81 IIAIILNGANLGGELGENLGAFS-SIRVIDLSNNHIGGSI-PSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (689)
Q Consensus 81 l~~L~L~~n~l~g~~p~~l~~l~-~L~~L~Ls~N~l~~~~-p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 158 (689)
++.|++.+|.++ .+++..+.+. +|+.|++++|++.... +....++|+.|++++|+++ .+|...+.+++|+.|++++
T Consensus 118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~ 195 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSG 195 (394)
T ss_pred eeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccC
Confidence 444444444444 2333344442 4455555555444221 1112244444555555544 3333333444444555555
Q ss_pred CcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccccccCCcc-ccccccccccCC
Q 005587 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 159 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~-L~~L~Ls~N~l~ 232 (689)
|+++ .+|..+..+..|+.|++++|++. .++..+.++.++..|.+.+|++...+..+..+. ++.|++++|+++
T Consensus 196 N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 196 NKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred Cccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc
Confidence 5554 44443333344445555444322 233444444455555555555444333333333 555666666555
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.5e-11 Score=135.56 Aligned_cols=166 Identities=19% Similarity=0.184 Sum_probs=123.5
Q ss_pred CCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccC--ChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEe
Q 005587 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRAS--SQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 587 (689)
+|...+.||.+.|=+|.+|+.++|. |+||++-+... +-....+-++|++ ..-++|||.+.+.-+-......|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4666788999999999999988887 89998765431 1122233334444 566789999998777666777788989
Q ss_pred ccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCc--ccc
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP--LIS 665 (689)
Q Consensus 588 y~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~--~~~ 665 (689)
|+.+ +|+|.|.. +.-+..-+.+-|+.|++.||.-+|.. +|.|+|||.+|||+..-.-+.|+||.--| .+.
T Consensus 102 yvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9965 99999875 33456667778999999999999998 89999999999999998889999997544 222
Q ss_pred CCCcc-----ee-ecccceEEecccc
Q 005587 666 SGSVS-----QV-SHNLTIMRAGGVT 685 (689)
Q Consensus 666 ~~~~~-----~~-~~~~~~~~apE~~ 685 (689)
++... .+ ....+-|.|||-+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERF 199 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERF 199 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhh
Confidence 22221 11 2233559999976
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.2e-10 Score=132.85 Aligned_cols=135 Identities=25% Similarity=0.335 Sum_probs=94.5
Q ss_pred ccCCCccceEeecCCeEEEEEEeC-CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
..+|+.++.|..|+||.||.++++ +.+.+|+| +.+... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------
Confidence 357888999999999999999776 46778884 433221 1110 23333344443
Q ss_pred eccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcccc-
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS- 665 (689)
Q Consensus 587 Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~- 665 (689)
||-.+.++..+ .++-. ++.+++|+|+. +|+|||+||+|.+|..-|++|++|||+.+...
T Consensus 136 -----gDc~tllk~~g----~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG----PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhcccCC----CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 56666665422 23222 26799999998 89999999999999999999999999987532
Q ss_pred -------CCC--------cceeecccceEEeccccccC
Q 005587 666 -------SGS--------VSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 666 -------~~~--------~~~~~~~~~~~~apE~~~~~ 688 (689)
++. ....-+++++|+||||++++
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq 233 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ 233 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhh
Confidence 111 12334889999999999865
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-10 Score=126.68 Aligned_cols=155 Identities=31% Similarity=0.479 Sum_probs=133.4
Q ss_pred CeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCc-cccccccccccCccCCCCCCcccCCCCCccEEEccC
Q 005587 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI-LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (689)
Q Consensus 80 ~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 158 (689)
+++.|++++|.+. .+|..++.+++|+.|++++|+++...+.. ....|+.|++++|+++ .+|..+..+..|++|++++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~ 218 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcC
Confidence 7999999999998 46678999999999999999999544444 4489999999999999 7888777778899999999
Q ss_pred CcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccccccCCcc-ccccccccccCCCCCcc
Q 005587 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPE 237 (689)
Q Consensus 159 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~-L~~L~Ls~N~l~g~ip~ 237 (689)
|.+. .++..+.++.++..|.+++|++. .++..++.+++|++|++++|+++.... +..+. ++.|++++|.++..+|.
T Consensus 219 N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 219 NSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred Ccce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc-ccccCccCEEeccCccccccchh
Confidence 9755 67778999999999999999998 558889999999999999999998776 44444 99999999999977775
Q ss_pred cc
Q 005587 238 KM 239 (689)
Q Consensus 238 ~l 239 (689)
..
T Consensus 296 ~~ 297 (394)
T COG4886 296 IA 297 (394)
T ss_pred hh
Confidence 44
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.8e-11 Score=118.18 Aligned_cols=138 Identities=27% Similarity=0.399 Sum_probs=112.0
Q ss_pred CCcccCccccCCCCCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChh
Q 005587 91 LGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDA 168 (689)
Q Consensus 91 l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 168 (689)
.+|..-..+.....|++||||+|.|+ .+..... +.++.|++|+|.|. .+. .+..|++|+.||||+|.++ .+..+
T Consensus 272 ~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gw 347 (490)
T KOG1259|consen 272 SNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGW 347 (490)
T ss_pred cCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhh
Confidence 34444455666778999999999998 5555544 78999999999998 333 3889999999999999998 66667
Q ss_pred hcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccc--cccCCcc-ccccccccccCCCC
Q 005587 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSGP 234 (689)
Q Consensus 169 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~l~-L~~L~Ls~N~l~g~ 234 (689)
-..|.+++.|.|+.|.|.. + ..+..|-+|..||+++|+|...- ..++.++ |+.|.|.+|.+.+.
T Consensus 348 h~KLGNIKtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 348 HLKLGNIKTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred HhhhcCEeeeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 7788999999999999973 3 46788899999999999998644 5677888 99999999999954
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.3e-10 Score=120.63 Aligned_cols=122 Identities=24% Similarity=0.437 Sum_probs=102.3
Q ss_pred HhcCCCCCcceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecc
Q 005587 561 IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNF 640 (689)
Q Consensus 561 l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDl 640 (689)
|+.+.|.|+.+++|.+.+....+.|.+||.-|+|.|.+... ...++|.....++++++.||+|+|.- +--.|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 45788999999999999999999999999999999999863 46789999999999999999999985 22399999
Q ss_pred cCCCeEecCCCcEEEEeecCCccccC---CCcceeecccceEEecccccc
Q 005587 641 KSANILLDDDLAVSVSDCGLAPLISS---GSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 641 Kp~NILl~~~~~~kl~DFGla~~~~~---~~~~~~~~~~~~~~apE~~~~ 687 (689)
+..|.++|..+.+||+|||+..+..+ ............|.|||++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 99999999999999999999988753 112222334456889998853
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.4e-10 Score=107.86 Aligned_cols=82 Identities=30% Similarity=0.434 Sum_probs=21.6
Q ss_pred ccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChhh-cCCCCCCEEEccCCCCCCCC-CCCccCCcccceee
Q 005587 126 TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAF-QSLTGLINLDLSSNNLSGEL-PPSLENLSQLTTLH 203 (689)
Q Consensus 126 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~ 203 (689)
+|+.|+|++|.|+. +. .+..+++|+.|+|++|+|+ .+...+ ..+++|+.|+|++|+|...- =..+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~ 119 (175)
T PF14580_consen 43 KLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLS 119 (175)
T ss_dssp T--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE
T ss_pred CCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceee
Confidence 34444444444442 21 2444555555555555555 232223 23555555555555554210 02234445555555
Q ss_pred ccccccc
Q 005587 204 LQNNQLS 210 (689)
Q Consensus 204 Ls~N~l~ 210 (689)
|.+|.++
T Consensus 120 L~~NPv~ 126 (175)
T PF14580_consen 120 LEGNPVC 126 (175)
T ss_dssp -TT-GGG
T ss_pred ccCCccc
Confidence 5555444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.5e-09 Score=104.41 Aligned_cols=77 Identities=27% Similarity=0.224 Sum_probs=66.2
Q ss_pred CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCCcce
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (689)
Q Consensus 592 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 671 (689)
|+|.++++.. ...++|.+++.|+.|+++||.|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 7899999753 24699999999999999999999987 3 999999999999999 99999875543
Q ss_pred eecccceEEeccccc
Q 005587 672 VSHNLTIMRAGGVTH 686 (689)
Q Consensus 672 ~~~~~~~~~apE~~~ 686 (689)
..++..|||||++.
T Consensus 64 -~~g~~~y~aPE~~~ 77 (176)
T smart00750 64 -SRVDPYFMAPEVIQ 77 (176)
T ss_pred -CCCcccccChHHhc
Confidence 25679999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.4e-08 Score=94.95 Aligned_cols=146 Identities=20% Similarity=0.242 Sum_probs=103.0
Q ss_pred ccceEeecCCeEEEEEEeCCCcEEEEEE-eccccCC-----hhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEE
Q 005587 513 QENLIGAGMLGSVYRAQLPDGKLLAVKK-LDKRASS-----QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 513 ~~~~iG~G~~G~Vy~~~~~~g~~vAvK~-l~~~~~~-----~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 586 (689)
...+|-+|+-+.|+++.+ .|+.+.||. +.+..-- +-......+|++.+.+++--.|.--.=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 567767764 3332111 112456678999998886555544444555666667899
Q ss_pred eccCC-CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCC---cEEEEeecCCc
Q 005587 587 EYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL---AVSVSDCGLAP 662 (689)
Q Consensus 587 Ey~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~ 662 (689)
||++| -++.+++..... ...........+..|-+.+.-||.. +|||+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 477888765432 1122222256788888999999987 899999999999996544 45899999987
Q ss_pred cc
Q 005587 663 LI 664 (689)
Q Consensus 663 ~~ 664 (689)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 54
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-10 Score=132.75 Aligned_cols=172 Identities=22% Similarity=0.258 Sum_probs=131.5
Q ss_pred CCCccceEeecCCeEEEEEEeC--CCcEEEEEEeccccCChhhHHHHHHHHHHHhcCC-CCCcceecEEEEeCCeEEEEE
Q 005587 510 SFSQENLIGAGMLGSVYRAQLP--DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 510 ~f~~~~~iG~G~~G~Vy~~~~~--~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 586 (689)
.|.+.+.||+|+|+.|-..... ....+|+|.+...............|..+-..+. |.|++++++.....+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4555667999999999888543 3456777776554322233334445666656665 999999999999999999999
Q ss_pred eccCCCCHHHHH-hcCcccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEEecccCCCeEecCCC-cEEEEeecCCcc
Q 005587 587 EYCSNGTLQDML-HSDDELKNNLSWNTRIRMALGAARALEYLH-EICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPL 663 (689)
Q Consensus 587 Ey~~ggsL~~~l-~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~ 663 (689)
||..||++++.+ +... ...+....-.+..|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 4321 13444566788999999999999 65 899999999999999999 999999999987
Q ss_pred ccC-CC---cceeecc-cceEEecccccc
Q 005587 664 ISS-GS---VSQVSHN-LTIMRAGGVTHR 687 (689)
Q Consensus 664 ~~~-~~---~~~~~~~-~~~~~apE~~~~ 687 (689)
+.. .. ......+ +..|+|||+...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccc
Confidence 765 22 2233556 788999999853
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.9e-10 Score=106.25 Aligned_cols=104 Identities=37% Similarity=0.529 Sum_probs=40.4
Q ss_pred cccccccccCccCCCCCCcccC-CCCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCc-cCCccccee
Q 005587 125 VTMQNFFLSDNQFSGSIPSSLA-TLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTL 202 (689)
Q Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L 202 (689)
..+++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+ .++ .+..++.|+.|+|++|+|+ .+...+ ..+++|++|
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 45677777777776 343 455 5789999999999999 444 5888999999999999998 455445 468999999
Q ss_pred ecccccccccc--cccCCcc-ccccccccccCCC
Q 005587 203 HLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSG 233 (689)
Q Consensus 203 ~Ls~N~l~~~~--~~~~~l~-L~~L~Ls~N~l~g 233 (689)
+|++|+|...- ..+..++ |+.|+|.+|.++.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 99999997643 3455555 8889999998873
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.1e-08 Score=101.65 Aligned_cols=143 Identities=17% Similarity=0.096 Sum_probs=100.4
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCCh---------hhHHHHHHHHHHHhcCCCCCc--ceecEEEEe-----
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ---------QKDDEFLELVNNIDRIRHANI--VELKGYCAE----- 578 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~---------~~~~~~~~e~~~l~~l~HpnI--v~l~~~~~~----- 578 (689)
+++-+-....|++.++ +|+.|.||......... .....+.+|.+.+.++..-+| +..+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556777766 67789999764322100 001146788888877754443 344556543
Q ss_pred CCeEEEEEeccCCC-CHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecC-------C
Q 005587 579 HGQRLLIYEYCSNG-TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-------D 650 (689)
Q Consensus 579 ~~~~~lV~Ey~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~-------~ 650 (689)
...-+||||++++- +|.+++.... ....+......++.++++.+.-||.. ||+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999886 8999885321 12345566778999999999999998 8999999999999975 4
Q ss_pred CcEEEEeecCCcc
Q 005587 651 LAVSVSDCGLAPL 663 (689)
Q Consensus 651 ~~~kl~DFGla~~ 663 (689)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999999865
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.3e-10 Score=116.43 Aligned_cols=136 Identities=31% Similarity=0.428 Sum_probs=85.0
Q ss_pred CCCCccccccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChhhcCCCCCCEEEcc-CCCCCCCCCCCccCC
Q 005587 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLS-SNNLSGELPPSLENL 196 (689)
Q Consensus 118 ~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls-~N~l~g~~p~~~~~l 196 (689)
.+|..++.....|+|..|+|+...|.+|+.+.+|+.||||+|.|+-+-|++|.+|.+|..|-+- +|+|+...-..|++|
T Consensus 60 eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL 139 (498)
T KOG4237|consen 60 EVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGL 139 (498)
T ss_pred cCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhH
Confidence 5566666666667777777776666667777777777777777776777777777766554443 377764333557777
Q ss_pred cccceeecccccccccc-cccCCcc-ccccccccccCCCCCcc-cc---CCCCCccccCCcCCC
Q 005587 197 SQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPE-KM---LQIPNFRKDGNPFNS 254 (689)
Q Consensus 197 ~~L~~L~Ls~N~l~~~~-~~~~~l~-L~~L~Ls~N~l~g~ip~-~l---~~l~~l~~~~N~~~~ 254 (689)
..|+.|.+.-|++.-.. ..+..++ +..|.+-.|.+. .++. .| ..++.+.+.-|+|-|
T Consensus 140 ~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic 202 (498)
T KOG4237|consen 140 SSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC 202 (498)
T ss_pred HHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc
Confidence 77777777777776555 3455555 666666666665 3443 22 233445556666554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.8e-09 Score=83.57 Aligned_cols=61 Identities=43% Similarity=0.594 Sum_probs=40.7
Q ss_pred CCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccc
Q 005587 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209 (689)
Q Consensus 149 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 209 (689)
++|++|+|++|+|+...+..|..+++|++|+|++|+|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566677777777655445666677777777777777655556667777777777777654
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.9e-08 Score=97.37 Aligned_cols=129 Identities=26% Similarity=0.300 Sum_probs=83.0
Q ss_pred EEEEEEeCCCcEEEEEEeccccCC------------------------hhhHHHHHHHHHHHhcCCCC--CcceecEEEE
Q 005587 524 SVYRAQLPDGKLLAVKKLDKRASS------------------------QQKDDEFLELVNNIDRIRHA--NIVELKGYCA 577 (689)
Q Consensus 524 ~Vy~~~~~~g~~vAvK~l~~~~~~------------------------~~~~~~~~~e~~~l~~l~Hp--nIv~l~~~~~ 577 (689)
.||.|...+|..+|||+.+..... ........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999889999999987532100 01123456899999999766 456665442
Q ss_pred eCCeEEEEEeccC--CCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEEecccCCCeEecCCCcEE
Q 005587 578 EHGQRLLIYEYCS--NGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL-HEICQPPIVHRNFKSANILLDDDLAVS 654 (689)
Q Consensus 578 ~~~~~~lV~Ey~~--ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiHrDlKp~NILl~~~~~~k 654 (689)
...|||||++ |..+..+.... ++......+..++++.+..+ |.. +|+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 65554443321 11233456677788866665 555 89999999999999988 899
Q ss_pred EEeecCCccccC
Q 005587 655 VSDCGLAPLISS 666 (689)
Q Consensus 655 l~DFGla~~~~~ 666 (689)
|+|||.|.....
T Consensus 147 iIDf~qav~~~~ 158 (188)
T PF01163_consen 147 IIDFGQAVDSSH 158 (188)
T ss_dssp E--GTTEEETTS
T ss_pred EEecCcceecCC
Confidence 999999886653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-08 Score=111.63 Aligned_cols=171 Identities=27% Similarity=0.287 Sum_probs=131.2
Q ss_pred cCCCccceEee--cCCeEEEEEEe---CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCCeE
Q 005587 509 NSFSQENLIGA--GMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQR 582 (689)
Q Consensus 509 ~~f~~~~~iG~--G~~G~Vy~~~~---~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 582 (689)
..|.....+|. |.+|.||.+.. +++..+|+|.-+...........=.+|.....++ .|+|.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666778999 99999999855 5688999998443322222222223455555555 499999999999999999
Q ss_pred EEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCcEEecccCCCeEecCC-CcEEEEe
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSD 657 (689)
Q Consensus 583 ~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~D 657 (689)
|+-+|+|. .+|.++.+... ..++....+.+..+..+ ||.++|+. +|+|-|+||+||+...+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999994 78888877532 23566667777777778 99999987 89999999999999988 7899999
Q ss_pred ecCCccccCCCcceee------cccceEEeccccc
Q 005587 658 CGLAPLISSGSVSQVS------HNLTIMRAGGVTH 686 (689)
Q Consensus 658 FGla~~~~~~~~~~~~------~~~~~~~apE~~~ 686 (689)
||+...+.++...... .+...|++||++.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~ 301 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN 301 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc
Confidence 9999999887744322 4667899999984
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.9e-10 Score=115.17 Aligned_cols=178 Identities=21% Similarity=0.215 Sum_probs=116.1
Q ss_pred EEeeCCCeEEEEecCCCCCccc--CccccCCCCCCEEEccCCcCCCCCCCccc---cccccccccCccCCCC-CCcccCC
Q 005587 74 VQCNASDIIAIILNGANLGGEL--GENLGAFSSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGS-IPSSLAT 147 (689)
Q Consensus 74 v~C~~~~l~~L~L~~n~l~g~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~Ls~N~l~~~-~p~~~~~ 147 (689)
+.=...+++.|||+.|-+...- -.....|++|+.|+|+.|+|.-....... ..|+.|.|+.+.|+-. +-..+..
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 3334567888888888776532 23456788888888888888744433332 6788888888887721 1123456
Q ss_pred CCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCC--CCccCCcccceeecccccccccc--cc--c---CC
Q 005587 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP--PSLENLSQLTTLHLQNNQLSGTL--DV--L---QD 218 (689)
Q Consensus 148 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~~~~--~~--~---~~ 218 (689)
+++|+.|+|..|...+.--.....+..|+.|||++|++- ..+ ...+.|+.|+.|+++.+.+...- +. . ..
T Consensus 221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~ 299 (505)
T KOG3207|consen 221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHT 299 (505)
T ss_pred CCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcc
Confidence 788888888888643333334555678888999988886 344 45677888888888888887542 11 1 22
Q ss_pred c-cccccccccccCCCCCc-----cccCCCCCccccCCcCC
Q 005587 219 L-PLRDLNIENNLFSGPIP-----EKMLQIPNFRKDGNPFN 253 (689)
Q Consensus 219 l-~L~~L~Ls~N~l~g~ip-----~~l~~l~~l~~~~N~~~ 253 (689)
. .|++|+++.|++. ..+ ..+.++..|.+..|+++
T Consensus 300 f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 300 FPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cccceeeecccCccc-cccccchhhccchhhhhhccccccc
Confidence 2 2888999999886 222 12334555555666655
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.5e-09 Score=82.36 Aligned_cols=60 Identities=40% Similarity=0.571 Sum_probs=51.4
Q ss_pred ccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCC
Q 005587 126 TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL 185 (689)
Q Consensus 126 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 185 (689)
+|+.|+|++|+|+...+..|..+++|++|+|++|.|+...|..|..+++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 567777777877766667889999999999999999977788899999999999999976
|
... |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.2e-08 Score=106.81 Aligned_cols=123 Identities=18% Similarity=0.243 Sum_probs=100.5
Q ss_pred EeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCC
Q 005587 529 QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNL 608 (689)
Q Consensus 529 ~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l 608 (689)
+..++.+|.|...+.... .......+.++.|+.+|||||+++++.++..+..|||+|-+. -|..++++..
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------ 102 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------
Confidence 455788888888765432 223446677889999999999999999999999999999885 5777776532
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccc
Q 005587 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 609 ~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 664 (689)
.....-.+.||+.||.|||..| +++|++|.-+.|++++.|+.||.+|-++...
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKA 155 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence 3455667889999999999875 8999999999999999999999999887544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.6e-09 Score=113.36 Aligned_cols=99 Identities=20% Similarity=0.293 Sum_probs=85.3
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecC
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGl 660 (689)
+.|+.|++|.-.+|.++|...+. ...-+|.....++.|++.|++| . +.+|||+||.||++..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999975432 3456788899999999999999 3 789999999999999999999999999
Q ss_pred CccccCCC-------cceeecccceEEeccccc
Q 005587 661 APLISSGS-------VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 661 a~~~~~~~-------~~~~~~~~~~~~apE~~~ 686 (689)
.......+ ......++..||+||-++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~ 435 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIR 435 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHh
Confidence 98887766 445567888999999886
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.1e-08 Score=111.66 Aligned_cols=153 Identities=21% Similarity=0.219 Sum_probs=120.1
Q ss_pred HhhhccCCCccceEeecCCeEEEEEEe--CCCcEEEEEEeccccCChhhHHHHHHHHHHHhcC-CCCCcceecEEEEeCC
Q 005587 504 LQQYTNSFSQENLIGAGMLGSVYRAQL--PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG 580 (689)
Q Consensus 504 l~~~~~~f~~~~~iG~G~~G~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l-~HpnIv~l~~~~~~~~ 580 (689)
......+|.....||.|.|+.||.... .++..|++|.+.........+..-..|+-+...+ -|.+++.....|....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 344556888899999999999999854 4678999998765543333333334455444444 5889999888888777
Q ss_pred eEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCC-CcEEEEeec
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCG 659 (689)
Q Consensus 581 ~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kl~DFG 659 (689)
..|+--|||+++++...+.. ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 88899999999998776532 34567788899999999999999976 89999999999999886 788999999
Q ss_pred CCcc
Q 005587 660 LAPL 663 (689)
Q Consensus 660 la~~ 663 (689)
.++.
T Consensus 413 ~~t~ 416 (524)
T KOG0601|consen 413 CWTR 416 (524)
T ss_pred cccc
Confidence 9875
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.5e-09 Score=117.27 Aligned_cols=125 Identities=26% Similarity=0.357 Sum_probs=73.1
Q ss_pred cccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCC-ccCCcccceee
Q 005587 125 VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLH 203 (689)
Q Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~ 203 (689)
..|...+.++|+|. .+..++.-++.|+.|||++|+++..- .+..|+.|++|||+.|.|. .+|.. ...+ .|+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence 34556666777766 55556666667777777777776332 5666777777777777776 44432 2223 367777
Q ss_pred cccccccccccccCCcc-ccccccccccCCCCC---c-cccCCCCCccccCCcCCCC
Q 005587 204 LQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPI---P-EKMLQIPNFRKDGNPFNST 255 (689)
Q Consensus 204 Ls~N~l~~~~~~~~~l~-L~~L~Ls~N~l~g~i---p-~~l~~l~~l~~~~N~~~~~ 255 (689)
|++|.++..... .++. |..|||++|-|++.- | ..+..|..|.+.|||+.|.
T Consensus 239 lrnN~l~tL~gi-e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 239 LRNNALTTLRGI-ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ecccHHHhhhhH-HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 777766644322 2222 666777777665421 1 1234455566677776654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.4e-08 Score=111.79 Aligned_cols=170 Identities=24% Similarity=0.241 Sum_probs=106.2
Q ss_pred CCCeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCCCccccccccccccCccCCCCCCcccCCCCCccEEEcc
Q 005587 78 ASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (689)
Q Consensus 78 ~~~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 157 (689)
..++..|+|.+|.|.+... .+..+++|++|+|++|+|+...+-.....|+.|++++|.|+.. ..+..+.+|+.++++
T Consensus 94 ~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~ 170 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEGLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLS 170 (414)
T ss_pred ccceeeeeccccchhhccc-chhhhhcchheeccccccccccchhhccchhhheeccCcchhc--cCCccchhhhcccCC
Confidence 3567777777777775332 2666777777777777777555444445577777777777732 345557777777777
Q ss_pred CCcCCCCCChh-hcCCCCCCEEEccCCCCCCCCCCCccCCcccceeecccccccccccccCCc--cccccccccccCCCC
Q 005587 158 NNLLSGEIPDA-FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDL--PLRDLNIENNLFSGP 234 (689)
Q Consensus 158 ~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l--~L~~L~Ls~N~l~g~ 234 (689)
+|++...-+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..|.++..-+..... .|+.+++++|.+.-.
T Consensus 171 ~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~ 247 (414)
T KOG0531|consen 171 YNRIVDIEN-DELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISRS 247 (414)
T ss_pred cchhhhhhh-hhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccccc
Confidence 777773333 2 466677777777777775 2344555556666677777766433322222 267888888888732
Q ss_pred --CccccCCCCCccccCCcCC
Q 005587 235 --IPEKMLQIPNFRKDGNPFN 253 (689)
Q Consensus 235 --ip~~l~~l~~l~~~~N~~~ 253 (689)
....+.+++.|++.+|...
T Consensus 248 ~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 248 PEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred cccccccccccccchhhcccc
Confidence 2344556666676666554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4e-07 Score=90.82 Aligned_cols=141 Identities=21% Similarity=0.171 Sum_probs=96.4
Q ss_pred CCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCC--------------------hhhHHHHHHHHHHHhcCCCC--C
Q 005587 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASS--------------------QQKDDEFLELVNNIDRIRHA--N 568 (689)
Q Consensus 511 f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~--------------------~~~~~~~~~e~~~l~~l~Hp--n 568 (689)
..++..||.|.=+.||.|....|.++|||.=+....+ ........+|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999999999999964322110 01123456788888888654 5
Q ss_pred cceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEec
Q 005587 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD 648 (689)
Q Consensus 569 Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~ 648 (689)
|.+.+++ +...+||||++|-.|...= ++-...-.+...|++-+.-+-.. ||||+|+.+=||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 6666554 5668999999997665321 11112223333333433333343 899999999999999
Q ss_pred CCCcEEEEeecCCccccCC
Q 005587 649 DDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 649 ~~~~~kl~DFGla~~~~~~ 667 (689)
++|.+.++||--+......
T Consensus 237 ~dg~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 237 EDGDIVVIDWPQAVPISHP 255 (304)
T ss_pred cCCCEEEEeCcccccCCCC
Confidence 9999999999776654433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.1e-07 Score=103.34 Aligned_cols=150 Identities=20% Similarity=0.260 Sum_probs=94.9
Q ss_pred cCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCCh----------------------------hh----------
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ----------------------------QK---------- 550 (689)
Q Consensus 509 ~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~----------------------------~~---------- 550 (689)
.+|+. +.|+.++-|+||+|++++|+.||||+.+..-... ..
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34442 6799999999999999999999999875431100 00
Q ss_pred HHHHHHHHHHHhcC-----CCCCcceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHH-
Q 005587 551 DDEFLELVNNIDRI-----RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL- 624 (689)
Q Consensus 551 ~~~~~~e~~~l~~l-----~HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL- 624 (689)
+-++.+|...+.++ ..++|.--.=|++-.+...|+|||++|-.+.++..-. ...++ +..++..++++.
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d---~k~ia~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGID---RKELAELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCC---HHHHHHHHHHHHH
Confidence 01233444444433 2344332222334456778999999999888874221 12233 223333333321
Q ss_pred HHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCccccCCC
Q 005587 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 625 ~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 668 (689)
..+-. .+++|.|..|.||+++.+|.+.+.|||+...+.+..
T Consensus 279 ~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~ 319 (517)
T COG0661 279 RQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF 319 (517)
T ss_pred HHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence 11111 279999999999999999999999999998876543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-06 Score=86.65 Aligned_cols=108 Identities=24% Similarity=0.284 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHhcCCCCC--cceecEEEEeCC----eEEEEEeccCCC-CHHHHHhcCcccCCCCCHHHHHHHHHHHHHH
Q 005587 551 DDEFLELVNNIDRIRHAN--IVELKGYCAEHG----QRLLIYEYCSNG-TLQDMLHSDDELKNNLSWNTRIRMALGAARA 623 (689)
Q Consensus 551 ~~~~~~e~~~l~~l~Hpn--Iv~l~~~~~~~~----~~~lV~Ey~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~a 623 (689)
.....+|.+.+..+..-. +...+++.+... ..+||+|++++- +|.+++.... ..+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 345667777776665333 445666666532 458999999984 7999887522 14455677889999999
Q ss_pred HHHHHhCCCCCcEEecccCCCeEecCCC---cEEEEeecCCcccc
Q 005587 624 LEYLHEICQPPIVHRNFKSANILLDDDL---AVSVSDCGLAPLIS 665 (689)
Q Consensus 624 L~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kl~DFGla~~~~ 665 (689)
+.-||.. +|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999998 899999999999999876 89999999888754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.6e-06 Score=92.90 Aligned_cols=143 Identities=17% Similarity=0.301 Sum_probs=111.1
Q ss_pred CCeEEEEEE-eCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCCcceecEEEEe----CCeEEEEEeccCC-CCH
Q 005587 521 MLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE----HGQRLLIYEYCSN-GTL 594 (689)
Q Consensus 521 ~~G~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~Ey~~g-gsL 594 (689)
.-.+.|++. ..||..|++|++...... ........++.++++.|+|||++.+.+.. +..+.+||+|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 345789994 568999999999433211 11122345778899999999999998873 4568899999986 578
Q ss_pred HHHHhcCcc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCcEEEEeecCCcc
Q 005587 595 QDMLHSDDE-----------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 595 ~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
.++...... .....++...+.|+.|+..||.++|+. |..-+-|.+.+||++.+.+++|+..|+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 876543221 123577889999999999999999997 788899999999999999999999999888
Q ss_pred ccCCC
Q 005587 664 ISSGS 668 (689)
Q Consensus 664 ~~~~~ 668 (689)
+.++.
T Consensus 443 l~~d~ 447 (655)
T KOG3741|consen 443 LQEDP 447 (655)
T ss_pred ecCCC
Confidence 87665
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.3e-08 Score=107.94 Aligned_cols=168 Identities=26% Similarity=0.286 Sum_probs=108.3
Q ss_pred CeEEEEecCCCCCcccCccccCCCCCCEEEccCCcCCCCCC-CccccccccccccCccCCCCCCcccCCCCCccEEEccC
Q 005587 80 DIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIP-SILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (689)
Q Consensus 80 ~l~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 158 (689)
.+..+.|..|.+.. +-..+..+.+|+.|+|.+|+|..... .....+|+.|+|++|+|+... .+..++.|+.|++++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccchhhhhcchheecccccccccc--chhhccchhhheecc
Confidence 34445566666664 33447778888888888888885544 333378888888888887543 366677788888888
Q ss_pred CcCCCCCChhhcCCCCCCEEEccCCCCCCCCCCC-ccCCcccceeecccccccccccccCCccccccccccccCCCCCcc
Q 005587 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPE 237 (689)
Q Consensus 159 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~L~~L~Ls~N~l~g~ip~ 237 (689)
|.|+ .+. .+..+..|+.+++++|.+.. +... ...+.+|+.+++.+|.+...-..-....+..+++..|.++-.-+-
T Consensus 150 N~i~-~~~-~~~~l~~L~~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~~~~~l 226 (414)
T KOG0531|consen 150 NLIS-DIS-GLESLKSLKLLDLSYNRIVD-IENDELSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKISKLEGL 226 (414)
T ss_pred Ccch-hcc-CCccchhhhcccCCcchhhh-hhhhhhhhccchHHHhccCCchhcccchHHHHHHHHhhcccccceeccCc
Confidence 8887 332 45557788888888888873 3332 467778888888888776443222222245557778877633321
Q ss_pred c-cC--CCCCccccCCcCC
Q 005587 238 K-ML--QIPNFRKDGNPFN 253 (689)
Q Consensus 238 ~-l~--~l~~l~~~~N~~~ 253 (689)
. +. .++.+++.+|+..
T Consensus 227 ~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 227 NELVMLHLRELYLSGNRIS 245 (414)
T ss_pred ccchhHHHHHHhcccCccc
Confidence 1 11 1566777777765
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.4e-06 Score=83.97 Aligned_cols=139 Identities=14% Similarity=0.176 Sum_probs=84.9
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCCC--cceecEEEEeCCeEEEEEeccCCC
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN--IVELKGYCAEHGQRLLIYEYCSNG 592 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~Ey~~gg 592 (689)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 24567888875432 2334578888888776443 456777777777888999999986
Q ss_pred C-HHHHH---------------------hcCcccCCCCCHHHHH-HHHH----------HHHH-HHHHHHhCC-CCCcEE
Q 005587 593 T-LQDML---------------------HSDDELKNNLSWNTRI-RMAL----------GAAR-ALEYLHEIC-QPPIVH 637 (689)
Q Consensus 593 s-L~~~l---------------------~~~~~~~~~l~~~~~~-~i~~----------qia~-aL~yLH~~~-~~~iiH 637 (689)
+ +...+ |.... ......... ++.. .+.+ ...+|.... ...++|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~--~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC--DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC--CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 3 22111 11000 011111100 0000 0111 122332221 235789
Q ss_pred ecccCCCeEecCCCcEEEEeecCCcc
Q 005587 638 RNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 638 rDlKp~NILl~~~~~~kl~DFGla~~ 663 (689)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.6e-07 Score=65.31 Aligned_cols=38 Identities=42% Similarity=0.941 Sum_probs=28.7
Q ss_pred HhhHHHHHHHHHHhCC-C--CCCCCCCCC-CCCCCCCCccEEee
Q 005587 38 PNDVAAINSLYAALGS-P--VLPGWVASA-GDPCGESWQGVQCN 77 (689)
Q Consensus 38 ~~d~~aL~~~~~~l~~-~--~l~~W~~~~-~~~C~~~w~gv~C~ 77 (689)
++|++||+.||+++.+ + .+.+|+.+. .+|| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C--~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC--SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC--CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe--eeccEEeC
Confidence 5799999999999984 4 789999754 7888 89999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.3e-07 Score=91.88 Aligned_cols=96 Identities=25% Similarity=0.494 Sum_probs=83.0
Q ss_pred HHHhcCCCCCcceecEEEEeC-----CeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 005587 559 NNIDRIRHANIVELKGYCAEH-----GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633 (689)
Q Consensus 559 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 633 (689)
..|-.+.|.|||+++.|+.+. .+..++.|||+.|++.++|++.......+....-.+|.-||+.||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345566799999999998654 357899999999999999998766666777778889999999999999986 78
Q ss_pred CcEEecccCCCeEecCCCcEEE
Q 005587 634 PIVHRNFKSANILLDDDLAVSV 655 (689)
Q Consensus 634 ~iiHrDlKp~NILl~~~~~~kl 655 (689)
+|+|+++.-+-|++..+|-+||
T Consensus 198 piihgnlTc~tifiq~ngLIki 219 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKI 219 (458)
T ss_pred ccccCCcchhheeecCCceEEe
Confidence 9999999999999999998886
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.1e-08 Score=110.30 Aligned_cols=122 Identities=29% Similarity=0.356 Sum_probs=96.8
Q ss_pred CCCEEEccCCcCCCCCCCccc--cccccccccCccCCCCCCcccCCCCCccEEEccCCcCCCCCCh-hhcCCCCCCEEEc
Q 005587 104 SIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDL 180 (689)
Q Consensus 104 ~L~~L~Ls~N~l~~~~p~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~L 180 (689)
.|...+.++|.|. .....+. +.|+.|+|++|+++..- .+..|+.|++|||++|.|+ .+|. ....+. |+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4677888899887 4444444 78999999999999543 7899999999999999998 6664 223343 999999
Q ss_pred cCCCCCCCCCCCccCCcccceeeccccccccccc--ccCCcc-ccccccccccCC
Q 005587 181 SSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD--VLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 181 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~l~-L~~L~Ls~N~l~ 232 (689)
++|.++. + ..+.+|.+|+.|||++|-|++.-. .+..+. |..|+|.+|.+.
T Consensus 240 rnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9999984 3 468899999999999999987542 233343 999999999987
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.7e-08 Score=88.39 Aligned_cols=101 Identities=25% Similarity=0.306 Sum_probs=43.7
Q ss_pred eEEEEecCCCCCcccCc---cccCCCCCCEEEccCCcCCCCCCCccc---cccccccccCccCCCCCCcccCCCCCccEE
Q 005587 81 IIAIILNGANLGGELGE---NLGAFSSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154 (689)
Q Consensus 81 l~~L~L~~n~l~g~~p~---~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 154 (689)
+..++|+++.|. .++. .+.....|+..+|++|.|.. +|..|. +.++.|+|++|.|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 344555555543 2222 23333444455555555552 222222 23444444444444 344444444444444
Q ss_pred EccCCcCCCCCChhhcCCCCCCEEEccCCCC
Q 005587 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNL 185 (689)
Q Consensus 155 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 185 (689)
+++.|.|. ..|..|..|.+|-.||..+|.+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 44444444 3344444444444444444444
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.5e-08 Score=88.60 Aligned_cols=132 Identities=22% Similarity=0.310 Sum_probs=100.1
Q ss_pred CCCEEEccCCcCCCCCCCccc-----cccccccccCccCCCCCCcccC-CCCCccEEEccCCcCCCCCChhhcCCCCCCE
Q 005587 104 SIRVIDLSNNHIGGSIPSILP-----VTMQNFFLSDNQFSGSIPSSLA-TLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177 (689)
Q Consensus 104 ~L~~L~Ls~N~l~~~~p~~~~-----~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 177 (689)
.+..|||+++.|. .+++... ..|+.++|++|.|. .+|..|. ..+.++.|+|++|+|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4567888888775 3443332 56788899999999 5565554 4558999999999999 88999999999999
Q ss_pred EEccCCCCCCCCCCCccCCcccceeecccccccccccccCCcc-ccccccccccCCCCCcccc
Q 005587 178 LDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKM 239 (689)
Q Consensus 178 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~-L~~L~Ls~N~l~g~ip~~l 239 (689)
|+++.|.|. ..|..+..|.+|..|+..+|.+..++-.+...+ ....++.+|.+.+.-+..+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~~kl 166 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETKKKL 166 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCcccc
Confidence 999999998 678888889999999999999876653222222 3445667888877665443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.1e-07 Score=97.36 Aligned_cols=155 Identities=20% Similarity=0.259 Sum_probs=114.1
Q ss_pred CCCeEEEEecCCCCCcccCcc-ccCCCCCCEEEccCCcCCCCCCCcc---ccccccccccCccCCCCCCcccCCCCCccE
Q 005587 78 ASDIIAIILNGANLGGELGEN-LGAFSSIRVIDLSNNHIGGSIPSIL---PVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153 (689)
Q Consensus 78 ~~~l~~L~L~~n~l~g~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~---~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 153 (689)
..+++.|+|+.|.+.-..... -..+++|+.|.|+.+.|+..--..+ .++|+.|+|..|...+.-.....-+..|+.
T Consensus 171 Lp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~ 250 (505)
T KOG3207|consen 171 LPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE 250 (505)
T ss_pred cccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence 478999999999987544332 3367899999999999983211111 178999999999644344445566788999
Q ss_pred EEccCCcCCCCCC--hhhcCCCCCCEEEccCCCCCCC-CCCC-----ccCCcccceeecccccccccc--cccCCcc-cc
Q 005587 154 MSLNNNLLSGEIP--DAFQSLTGLINLDLSSNNLSGE-LPPS-----LENLSQLTTLHLQNNQLSGTL--DVLQDLP-LR 222 (689)
Q Consensus 154 L~Ls~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~g~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~--~~~~~l~-L~ 222 (689)
|||++|++- ..+ ...+.++.|..|+++.+.+... .|+. ...+++|++|+++.|++.... ..+..+. |+
T Consensus 251 LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk 329 (505)
T KOG3207|consen 251 LDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLK 329 (505)
T ss_pred ccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhh
Confidence 999999997 444 4678899999999999998752 3433 356789999999999996433 3444444 88
Q ss_pred ccccccccCCC
Q 005587 223 DLNIENNLFSG 233 (689)
Q Consensus 223 ~L~Ls~N~l~g 233 (689)
.|....|.|+.
T Consensus 330 ~l~~~~n~ln~ 340 (505)
T KOG3207|consen 330 HLRITLNYLNK 340 (505)
T ss_pred hhhcccccccc
Confidence 88888888874
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.6e-05 Score=77.69 Aligned_cols=140 Identities=16% Similarity=0.127 Sum_probs=100.5
Q ss_pred eecCCeEEEEEEeCCCcEEEEEEeccc-cCC---hhhHHHHHHHHHHHhcCCCCC--cceecEEEE-eC----CeEEEEE
Q 005587 518 GAGMLGSVYRAQLPDGKLLAVKKLDKR-ASS---QQKDDEFLELVNNIDRIRHAN--IVELKGYCA-EH----GQRLLIY 586 (689)
Q Consensus 518 G~G~~G~Vy~~~~~~g~~vAvK~l~~~-~~~---~~~~~~~~~e~~~l~~l~Hpn--Iv~l~~~~~-~~----~~~~lV~ 586 (689)
|+|+-+-||+-.+. |+.+=+|+-... ..+ +.....|.+|...|.++..-+ +.+.. ++. .. -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 67888889988764 446888875411 111 235678999999988885433 44444 333 21 1357999
Q ss_pred eccCC-CCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCc--EEEEeecCCcc
Q 005587 587 EYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA--VSVSDCGLAPL 663 (689)
Q Consensus 587 Ey~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~ 663 (689)
|-+.| -+|.+++.... ....+......+..++++.+.-||.. ++.|+|+-+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 58988886432 22456677788999999999999998 8999999999999986666 99999987664
Q ss_pred c
Q 005587 664 I 664 (689)
Q Consensus 664 ~ 664 (689)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.6e-06 Score=92.45 Aligned_cols=142 Identities=23% Similarity=0.256 Sum_probs=89.8
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCCh--h---------------------------------hHHHHHHHHH
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQ--Q---------------------------------KDDEFLELVN 559 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~--~---------------------------------~~~~~~~e~~ 559 (689)
+.||.-+.|+||+|++++|+.||||+-+..-... . .+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6789999999999999999999999864321100 0 0012334443
Q ss_pred HHh----cCCCCC------cceecEEEEeCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005587 560 NID----RIRHAN------IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629 (689)
Q Consensus 560 ~l~----~l~Hpn------Iv~l~~~~~~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~ 629 (689)
... .++|-+ |.+++-. -.....|+||||+|..+.|+-.-. ...++...+..-+.++..-+-+.|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~~~qIf~~- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAYLEQIFKT- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHHHHHHHhc-
Confidence 322 233444 3343322 234678999999998776653211 223554444443333322222223
Q ss_pred CCCCCcEEecccCCCeEecC----CCcEEEEeecCCccccC
Q 005587 630 ICQPPIVHRNFKSANILLDD----DLAVSVSDCGLAPLISS 666 (689)
Q Consensus 630 ~~~~~iiHrDlKp~NILl~~----~~~~kl~DFGla~~~~~ 666 (689)
|++|.|=.|.||++.. ++++.+-|||+.+.+..
T Consensus 321 ----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 ----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 7999999999999983 67899999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.2e-05 Score=75.90 Aligned_cols=140 Identities=19% Similarity=0.242 Sum_probs=88.3
Q ss_pred ccCCCccceEeecCCeEEEEEEeCCCcEEEEEEeccccCChh-hHH------HHHHHHHHHhcCCCC---CcceecEEEE
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQ-KDD------EFLELVNNIDRIRHA---NIVELKGYCA 577 (689)
Q Consensus 508 ~~~f~~~~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~-~~~------~~~~e~~~l~~l~Hp---nIv~l~~~~~ 577 (689)
..+|...+++-......|.+-+. +|+.+++|..+....-.+ ... ...+++..+.+++.. ....++-..+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35677777777777666666655 578899998754321111 111 122334434443322 2222222222
Q ss_pred -----eCCeEEEEEeccCCCCHHHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEEecccCCCeEecCCCc
Q 005587 578 -----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (689)
Q Consensus 578 -----~~~~~~lV~Ey~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~ 652 (689)
-....++||||++|..|.++.. ++. .++..+.+++.-+|.. |++|+|..|.|+++++++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-
Confidence 2245579999999988866532 221 2445667789999988 899999999999999665
Q ss_pred EEEEeecCCccc
Q 005587 653 VSVSDCGLAPLI 664 (689)
Q Consensus 653 ~kl~DFGla~~~ 664 (689)
++++||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 899999877643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=8.7e-07 Score=90.56 Aligned_cols=131 Identities=25% Similarity=0.373 Sum_probs=61.9
Q ss_pred CCCCCEEEccCCcCCCCCCCccc------cccccccccCccCCCCC-------------CcccCCCCCccEEEccCCcCC
Q 005587 102 FSSIRVIDLSNNHIGGSIPSILP------VTMQNFFLSDNQFSGSI-------------PSSLATLTLLTDMSLNNNLLS 162 (689)
Q Consensus 102 l~~L~~L~Ls~N~l~~~~p~~~~------~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L~Ls~N~l~ 162 (689)
.+.|++||||.|-|.-.-+..+. .+|++|+|.+|.+.-.- -...++-+.|+++..++|++.
T Consensus 91 ~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 91 CPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE 170 (382)
T ss_pred CCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc
Confidence 34555566666655533332222 44555566555554110 111233345566666666654
Q ss_pred CC----CChhhcCCCCCCEEEccCCCCCC----CCCCCccCCcccceeeccccccccc--c---cccCCcc-cccccccc
Q 005587 163 GE----IPDAFQSLTGLINLDLSSNNLSG----ELPPSLENLSQLTTLHLQNNQLSGT--L---DVLQDLP-LRDLNIEN 228 (689)
Q Consensus 163 g~----~p~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~--~---~~~~~l~-L~~L~Ls~ 228 (689)
.. +-..|...+.|+.+.++.|.|.- .+-..|..+++|+.|||.+|-|+.. . ..+..++ |++|++++
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d 250 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD 250 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence 21 11234445556666666665531 1112344556666666666655421 1 2233333 55666666
Q ss_pred ccCC
Q 005587 229 NLFS 232 (689)
Q Consensus 229 N~l~ 232 (689)
..+.
T Consensus 251 cll~ 254 (382)
T KOG1909|consen 251 CLLE 254 (382)
T ss_pred cccc
Confidence 5554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.1e-05 Score=78.86 Aligned_cols=144 Identities=17% Similarity=0.225 Sum_probs=83.9
Q ss_pred ceEeecCCeEEEEEEeCCCcEEEEEEeccccCChhhHHHHHHHHHHHhcCCCC--CcceecEEEEe---CCeEEEEEecc
Q 005587 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA--NIVELKGYCAE---HGQRLLIYEYC 589 (689)
Q Consensus 515 ~~iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~~~e~~~l~~l~Hp--nIv~l~~~~~~---~~~~~lV~Ey~ 589 (689)
+.|+.|..+.||+....+ +.+++|..... .....+.+|..++..+... .+.+++.+... ....+++|+|+
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 578999999999998877 68999987543 3345666777777766433 34566665433 34679999999
Q ss_pred CCCCHHH----------------H---HhcCcccCCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 005587 590 SNGTLQD----------------M---LHSDDELKNNLSWNT---------RIRM------------ALGAAR-ALEYLH 628 (689)
Q Consensus 590 ~ggsL~~----------------~---l~~~~~~~~~l~~~~---------~~~i------------~~qia~-aL~yLH 628 (689)
+|..+.. . ++..........+.. .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 1 111100001111110 0000 011222 333333
Q ss_pred hC----CCCCcEEecccCCCeEec-CCCcEEEEeecCCcc
Q 005587 629 EI----CQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPL 663 (689)
Q Consensus 629 ~~----~~~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~ 663 (689)
.. ....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 21 234699999999999999 667778999998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.2e-05 Score=75.23 Aligned_cols=154 Identities=21% Similarity=0.231 Sum_probs=96.2
Q ss_pred chhhHhhhccCCCccce---EeecCCeEEEEEEeCCCcEEEEEEeccccCChhhH----------------------HHH
Q 005587 500 TIASLQQYTNSFSQENL---IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKD----------------------DEF 554 (689)
Q Consensus 500 ~~~~l~~~~~~f~~~~~---iG~G~~G~Vy~~~~~~g~~vAvK~l~~~~~~~~~~----------------------~~~ 554 (689)
++..+....+...+.+. |+.|.-+.||+|.-.++..+|||+........... .-.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 44445444455555444 55677778999988889999999986432211110 012
Q ss_pred HHHHHHHhcCC--CCCcceecEEEEeCCeEEEEEeccCCCCH-HHHHhcCcccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005587 555 LELVNNIDRIR--HANIVELKGYCAEHGQRLLIYEYCSNGTL-QDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631 (689)
Q Consensus 555 ~~e~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~Ey~~ggsL-~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 631 (689)
.+|.+.|.++. +-.+.+-+++. .-.|||||+..... .-.|++ -.+.......+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 34566666553 33333333332 23699999965311 111211 12223356667777888888777632
Q ss_pred CCCcEEecccCCCeEecCCCcEEEEeecCCcccc
Q 005587 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 632 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 665 (689)
++||+||..=|||+. ++.+.|+|||-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 899999999999999 8899999999988665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 689 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-22 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-05 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-04 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 689 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 9e-71 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 3e-65 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-57 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-44 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-40 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-37 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-33 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-38 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-38 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-35 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-35 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-35 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-34 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-32 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-28 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-37 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 9e-37 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-35 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-35 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-35 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-34 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-34 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-34 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 8e-34 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-33 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 4e-33 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-32 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-32 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-31 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-28 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-26 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-24 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-20 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-17 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-15 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-10 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-08 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-28 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-27 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-25 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 9e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-23 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-22 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-21 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-25 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-24 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-24 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-24 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-22 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-21 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-20 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-17 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-11 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-06 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-23 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 9e-23 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-20 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-20 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-20 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-20 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-13 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-24 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-24 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-23 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-21 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-20 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-16 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-15 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 8e-13 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-23 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 5e-22 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-20 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-20 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-20 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-20 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-20 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-19 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-11 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-11 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-05 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-22 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 7e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-10 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-04 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-22 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-20 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-20 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-20 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-19 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-18 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-17 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-09 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-04 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 9e-22 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-21 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-21 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-18 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-16 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-12 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-09 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-05 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-21 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 4e-21 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-21 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-18 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-08 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-21 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-21 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-21 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-21 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-20 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-20 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-20 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-20 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-20 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-20 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-20 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-19 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-12 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-20 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-20 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-20 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-20 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-20 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-20 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-20 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-20 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-20 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-20 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-20 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-20 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 7e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 8e-20 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-18 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-15 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-20 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-20 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-20 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-19 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-19 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-19 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-19 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-19 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-19 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-19 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 7e-16 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-14 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-10 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-09 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-07 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-16 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-15 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-14 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-13 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 7e-12 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-09 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-19 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 7e-19 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 9e-19 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-17 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-17 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-15 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-14 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-10 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-06 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-12 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-18 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-18 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-18 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-17 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-18 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-16 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-14 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-13 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-18 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-16 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-14 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-10 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-08 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-18 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-17 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-15 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-09 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-05 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-18 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-18 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-18 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-18 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-13 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 6e-13 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 8e-18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-16 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-18 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-16 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-15 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 8e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-08 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-17 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-15 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-17 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-17 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-17 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-17 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-17 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-17 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-17 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 4e-17 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-15 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-15 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-04 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-17 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-15 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-14 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-10 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-07 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-17 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-16 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-15 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 9e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-12 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-17 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-13 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-12 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-07 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-17 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-13 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 9e-17 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-16 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-16 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-16 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-15 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-12 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-08 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-06 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-16 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-16 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-16 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-16 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-16 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 4e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-04 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-16 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-16 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 5e-16 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-16 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-16 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-16 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-16 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-09 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-06 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-04 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-15 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-15 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-15 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-15 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-10 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-13 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-13 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-08 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-15 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-15 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-15 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-15 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-06 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 8e-15 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-13 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-13 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 9e-15 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-12 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-14 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-12 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-04 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-14 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-14 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-14 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-09 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-14 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-14 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-14 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-13 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-08 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 9e-08 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-04 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-14 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-14 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-13 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-13 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-13 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-13 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-13 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-13 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-13 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-13 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-13 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-07 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-11 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-10 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 9e-09 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-13 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 7e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-04 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 9e-13 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-12 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-12 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-12 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-12 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-12 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-12 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-12 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 8e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 8e-10 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-12 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-12 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-12 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-12 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-10 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-12 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 5e-12 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-12 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-12 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 6e-12 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-12 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-12 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-09 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-12 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-12 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-08 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-11 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-11 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-11 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-11 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-11 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-11 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-11 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-11 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-11 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-11 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-11 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 7e-11 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-11 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-11 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 8e-11 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-10 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-07 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-10 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-10 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 8e-06 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-09 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-09 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-09 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-09 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-09 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-09 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-09 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-09 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 9e-09 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-08 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-08 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-08 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-08 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 8e-04 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-08 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-08 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-08 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-05 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 5e-08 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-07 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-08 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 8e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-08 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-07 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-07 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-07 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-07 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-07 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-07 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-07 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-07 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-04 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-07 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-07 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-07 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-07 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-06 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 3e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 4e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 4e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 4e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 7e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 8e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 8e-05 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-04 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 1e-04 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-04 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-04 | |
| 2grx_C | 229 | Protein TONB; beta barrel, outer membrane, heteroc | 2e-04 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 2e-06 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-06 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-06 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-06 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 9e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-05 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-05 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-05 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-05 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-04 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 2e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-04 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 5e-04 | |
| 2uv9_A | 1878 | Fatty acid synthase alpha subunits; fungal, dehydr | 7e-04 | |
| 2uv8_A | 1887 | Fatty acid synthase subunit alpha (FAS2); fatty ac | 9e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 9e-71
Identities = 69/172 (40%), Positives = 104/172 (60%), Gaps = 1/172 (0%)
Query: 496 ARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFL 555
+ F++ LQ +++FS +N++G G G VY+ +L DG L+AVK+L K +Q + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQFQ 75
Query: 556 ELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIR 615
V I H N++ L+G+C +RLL+Y Y +NG++ L E + L W R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
+ALG+AR L YLH+ C P I+HR+ K+ANILLD++ V D GLA L+
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-65
Identities = 60/180 (33%), Positives = 98/180 (54%), Gaps = 5/180 (2%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE 553
+ + L++ TN+F + LIG G+ G VY+ L DG +A+K+ S Q +E
Sbjct: 24 FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEE 81
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR 613
F + + RH ++V L G+C E + +LIY+Y NG L+ L+ D ++SW R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVS 673
+ + +GAAR L YLH I+HR+ KS NILLD++ ++D G++ + + +S
Sbjct: 142 LEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-57
Identities = 60/188 (31%), Positives = 98/188 (52%), Gaps = 13/188 (6%)
Query: 494 TTARSFTIASLQQYTNSFSQE------NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRA-- 545
T SF+ L+ TN+F + N +G G G VY+ + + +AVKKL
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68
Query: 546 SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
++++ +F + + + + +H N+VEL G+ ++ L+Y Y NG+L D L D
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
LSW+ R ++A GAA + +LHE +HR+ KSANILLD+ +SD GLA
Sbjct: 129 -PLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 666 SGSVSQVS 673
+ + ++
Sbjct: 185 KFAQTVMT 192
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 51/196 (26%), Positives = 80/196 (40%), Gaps = 22/196 (11%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE 553
++ +L + + G G V++AQ + +AVK Q K
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIF----PIQDKQSW 63
Query: 554 FLEL-VNNIDRIRHANIVELKGYCAE----HGQRLLIYEYCSNGTLQDMLHSDDELKNNL 608
E V ++ ++H NI++ G LI + G+L D L N +
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVV 118
Query: 609 SWNTRIRMALGAARALEYLHE-------ICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
SWN +A AR L YLHE +P I HR+ KS N+LL ++L ++D GLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 662 PLISSGSVSQVSHNLT 677
+G + +H
Sbjct: 179 LKFEAGKSAGDTHGQV 194
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 35 VTNPNDVAAINSLYAALGSP-VLPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLGG 93
+ NP D A+ + LG+P L W+ + D C +W GV C+
Sbjct: 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTT-DCCNRTWLGVLCD---------------- 44
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGS--IPSILP--VTMQNFFLSD-NQFSGSIPSSLATL 148
+ +DLS ++ IPS L + ++ N G IP ++A L
Sbjct: 45 ----TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
T L + + + +SG IPD + L+ LD S N LSG LPPS+ +L L + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 209 LSGTL-DVLQDLP--LRDLNIENNLFSGPIPE 237
+SG + D + I N +G IP
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 5/163 (3%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
+ N+ G + + L ++ +D S N + G++P + + N+ SG+IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 144 SLATLT-LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTL 202
S + + L T M+++ N L+G+IP F +L L +DLS N L G+ + +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 203 HLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
HL N L+ L + L L++ NN G +P+ + Q+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 36/152 (23%), Positives = 59/152 (38%), Gaps = 6/152 (3%)
Query: 90 NLGGELGENLGAFSS-IRVIDLSNNHIGGSIP-SILPVTMQNFFLSDNQFSGSIPSSLAT 147
+ G + ++ G+FS + +S N + G IP + + + LS N G +
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+ L N L+ ++ L LDL +N + G LP L L L +L++ N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 208 QLSG---TLDVLQDLPLRDLNIENNLFSGPIP 236
L G LQ + L P+P
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-38
Identities = 58/175 (33%), Positives = 91/175 (52%), Gaps = 7/175 (4%)
Query: 77 NASDIIAIILNGANLGGELGENLGAFS-SIRVIDLSNNHIGGSIPSIL----PVTMQNFF 131
+ + L+ GEL E+L S S+ +DLS+N+ G I L T+Q +
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
L +N F+G IP +L+ + L + L+ N LSG IP + SL+ L +L L N L GE+P
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 192 SLENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L + L TL L N L+G + L + L +++ NN +G IP+ + ++ N
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-38
Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 4/174 (2%)
Query: 75 QCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFL 132
Q + + + L G++ L S + + LS N++ G+IPS L +++ L
Sbjct: 390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
N G IP L + L + L+ N L+GEIP + T L + LS+N L+GE+P
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 193 LENLSQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
+ L L L L NN SG + L D L L++ NLF+G IP M +
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG 563
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-36
Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLS 133
N S+++++ L+ L G + +LG+ S +R + L N + G IP L T++ L
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
N +G IPS L+ T L +SL+NN L+GEIP L L L LS+N+ SG +P L
Sbjct: 475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
Query: 194 ENLSQLTTLHLQNNQLSGTL-DVLQDLPLRDLNIENNLFSGPIPEKM 239
+ L L L N +GT+ + I N +G +
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQS---GKIAANFIAGKRYVYI 578
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 40/227 (17%)
Query: 53 SPVLPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGE--------------- 97
+LP W ++ +PC ++ GV C + +I L+ L
Sbjct: 27 KNLLPDWSSNK-NPC--TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLF 83
Query: 98 -----------NLGAFSSIRVIDLSNNHIGGSIPSILPV----TMQNFFLSDNQFSGSIP 142
+S+ +DLS N + G + ++ + ++ +S N
Sbjct: 84 LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143
Query: 143 -SSLATLTLLTDMSLNNNLLSGEIPDAFQ---SLTGLINLDLSSNNLSGELPPSLENLSQ 198
S L L + L+ N +SG + L +L +S N +SG++ +
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVN 201
Query: 199 LTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L L + +N S + L D L+ L+I N SG +
Sbjct: 202 LEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTE 248
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-35
Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 8/169 (4%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
L+G + G + G+ S + + LS+N+ G +P + M+ LS N+FSG +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 143 SSLATLTL-LTDMSLNNNLLSGEIPDAF--QSLTGLINLDLSSNNLSGELPPSLENLSQL 199
SL L+ L + L++N SG I L L L +N +G++PP+L N S+L
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSEL 420
Query: 200 TTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFR 246
+LHL N LSGT+ L L LRDL + N+ G IP++++ +
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-35
Identities = 56/157 (35%), Positives = 81/157 (51%), Gaps = 11/157 (7%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLA 146
G + S++ + L+ N G IP L LS N F G++P
Sbjct: 258 QFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 147 TLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLENLS-QLTTLHL 204
+ +LL ++L++N SGE+P D + GL LDLS N SGELP SL NLS L TL L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 205 QNNQLSGTL--DVLQDLP--LRDLNIENNLFSGPIPE 237
+N SG + ++ Q+ L++L ++NN F+G IP
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 9/160 (5%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSI 141
+ ++ N + LG S+++ +D+S N + G + ++ +S NQF G I
Sbjct: 205 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 142 PSSLATLTLLTDMSLNNNLLSGEIPDA-FQSLTGLINLDLSSNNLSGELPPSLENLSQLT 200
P L L +SL N +GEIPD + L LDLS N+ G +PP + S L
Sbjct: 264 PPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 201 TLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSGPIPE 237
+L L +N SG L D L + L+ L++ N FSG +PE
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-32
Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 86 LNGANLGGELGENLGA-FSSIRVIDLSNNHIGGSIPSILPVT-----MQNFFLSDNQFSG 139
++ L + G +S+ V+DLS N I G+ ++ +++ +S N+ SG
Sbjct: 133 VSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISG 192
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQL 199
+ ++ L + +++N S IP + L +LD+S N LSG+ ++ ++L
Sbjct: 193 DVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTEL 249
Query: 200 TTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPE 237
L++ +NQ G + L L+ L++ N F+G IP+
Sbjct: 250 KLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPD 287
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 2/160 (1%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLAT 147
L GE+ + L ++ + L N + G IPS L + LS+N+ +G IP +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
L L + L+NN SG IP LI LDL++N +G +P ++ S +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572
Query: 208 QLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK 247
+ + F G E++ ++
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 43/138 (31%), Positives = 62/138 (44%), Gaps = 2/138 (1%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLS 133
N G E L S+ ++++ GG +M +S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
N SG IP + ++ L ++L +N +SG IPD L GL LDLSSN L G +P ++
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 194 ENLSQLTTLHLQNNQLSG 211
L+ LT + L NN LSG
Sbjct: 701 SALTMLTEIDLSNNNLSG 718
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-31
Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 54/229 (23%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPS-------------- 121
++ + L+ + G + LG S+ +DL+ N G+IP+
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570
Query: 122 --ILPVTMQNFFL--------SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQS 171
V ++N + + +F G L L+ ++ + + G F +
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 172 LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-------------TLDV--- 215
++ LD+S N LSG +P + ++ L L+L +N +SG LD+
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690
Query: 216 ---------LQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKD---GNP 251
+ L L ++++ NN SGPIPE M Q F NP
Sbjct: 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE-MGQFETFPPAKFLNNP 738
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 12/179 (6%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPS---ILPVTMQNFFL 132
+ +IL+ +L GE+ L +++ I LSNN + G IP L + L
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE-NLAILKL 521
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
S+N FSG+IP+ L L + LN NL +G IP A + +++N ++G+
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVY 577
Query: 193 LENLSQLTTLHLQNN--QLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
++N H N + G + L L NI + ++ G +
Sbjct: 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 59/157 (37%), Positives = 85/157 (54%), Gaps = 3/157 (1%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+ IGAG G+V+RA+ G +AVK L ++ ++ +EFL V + R+RH NIV
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G + ++ EY S G+L +LH + L R+ MA A+ + YLH P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
PIVHRN KS N+L+D V V D GL+ L +S +S
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 45/184 (24%), Positives = 73/184 (39%), Gaps = 22/184 (11%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRH 566
++ LIG G G+VY+ L D + +AVK S + + E + + + H
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEH 66
Query: 567 ANIVELKGYCAE-----HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
NI + LL+ EY NG+L L + W + R+A
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVT 121
Query: 622 RALEYLHE------ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHN 675
R L YLH +P I HR+ S N+L+ +D +SD GL+ ++ + +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 676 LTIM 679
Sbjct: 182 DNAA 185
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 32/150 (21%), Positives = 63/150 (42%), Gaps = 6/150 (4%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+ G +++ + G + VK L R S +K +F E + H N++ +
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 574 GYCAE--HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
G C LI + G+L ++LH + + ++ AL AR + +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-L 130
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+P I S ++++D+D+ +S +
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVK 160
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 47/167 (28%), Positives = 69/167 (41%), Gaps = 20/167 (11%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVEL 572
+G G G V+R G+ +AVK SS+ + F E + N +RH NI+
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 573 KGYC----AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
Q LI Y G+L D L L + +R+ L A L +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 629 E-----ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
+P I HR+ KS NIL+ + ++D GLA + S +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVEL 572
+ IG G G V+R + G+ +AVK SS+++ F E + +RH NI+
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 573 KGYCAEHG----QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ Q L+ +Y +G+L D L+ + ++ I++AL A L +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLH 156
Query: 629 E-----ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+P I HR+ KS NIL+ + ++D GLA S +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 20/165 (12%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVEL 572
IG G G V+ + G+ +AVK + ++ F E + +RH NI+
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVF----FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 573 KGYC----AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
Q LI +Y NG+L D L L + +++A + L +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLH 151
Query: 629 E-----ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+P I HR+ KS NIL+ + ++D GLA S +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 9/160 (5%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
E ++G G G V +A+ K +A+K+++ S+ + F+ + + R+ H NIV+L
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G C L+ EY G+L ++LH + + + L ++ + YLH +
Sbjct: 68 GACLNP--VCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 634 PIVHRNFKSANILLDDDLAVS-VSDCGLAPLISSGSVSQV 672
++HR+ K N+LL V + D G A I + +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 12/202 (5%)
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQ---ENLIGAGMLGSVYRAQLPDGKLL 536
G + S +A+ F S T LQ++ F Q LIG G G VY + G++
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGEV- 58
Query: 537 AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQD 596
A++ +D ++ + F V + RH N+V G C +I C TL
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 597 MLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVS 656
++ K L N ++A + + YLH I+H++ KS N+ D+ V ++
Sbjct: 119 VVRDA---KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGK-VVIT 171
Query: 657 DCGLAPLISSGSVSQVSHNLTI 678
D GL + + L I
Sbjct: 172 DFGLFSISGVLQAGRREDKLRI 193
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKL-----DKRASSQQKDDEFLELVNNIDRIRHA 567
E IG G G V++ + + D ++A+K L + +K EF V + + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
NIV+L G ++ E+ G L L + + W+ ++R+ L A +EY+
Sbjct: 84 NIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138
Query: 628 HEICQPPIVHRNFKSANILLD-----DDLAVSVSDCGLA 661
PPIVHR+ +S NI L + V+D GL+
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 16/167 (9%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKD--DEFLELVNNIDRIRHANIVE 571
E +IG G G VYRA G +AVK + + ++H NI+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L+G C + L+ E+ G L +L + + + A+ AR + YLH+
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 632 QPPIVHRNFKSANILLDDDLA--------VSVSDCGLAPLISSGSVS 670
PI+HR+ KS+NIL+ + + ++D GLA +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYC 576
IG+G G+VY+ + G + AVK L+ A + Q+ F V + + RH NI+ GY
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 577 AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIV 636
Q ++ ++C +L LH+ + I +A AR ++YLH I+
Sbjct: 90 TAP-QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 637 HRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
HR+ KS NI L +D V + D GLA S S S
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 9/158 (5%)
Query: 514 ENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
++G G G + G+++ +K+L + Q+ FL+ V + + H N+++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVLKF 72
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
G + + I EY GTL+ ++ S D + W+ R+ A A + YLH +
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
I+HR+ S N L+ ++ V V+D GLA L+
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 30/168 (17%), Positives = 59/168 (35%), Gaps = 10/168 (5%)
Query: 95 LGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLL 151
+ N + +D ++++ + ++++N +S + L+ L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 152 TDMSLNNNLLSGEI-PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
+ + N PD F L L LDLS L P + +LS L L++ +N
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 211 GTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK----DGNPF 252
+ L L+ L+ N +++ P+ N F
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 36/168 (21%), Positives = 63/168 (37%), Gaps = 7/168 (4%)
Query: 76 CNASDIIAIILNGANLGGEL-GENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFL 132
+ + +NL + ++ +D+S+ H + I +++ +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 133 SDNQFSGSI-PSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
+ N F + P L LT + L+ L P AF SL+ L L++S NN
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 192 SLENLSQLTTLHLQNNQLSGT-LDVLQDLP--LRDLNIENNLFSGPIP 236
+ L+ L L N + + LQ P L LN+ N F+
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 43/220 (19%), Positives = 75/220 (34%), Gaps = 26/220 (11%)
Query: 65 DPCGESWQG--VQCNASDIIAII-----------LNGANLGGELGENLGAFSSIRVIDLS 111
+PC E QC + I L+ L + +F ++V+DLS
Sbjct: 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 112 NNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAF 169
I + L+ N + + L+ L + L+
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 170 QSLTGLINLDLSSNNL-SGELPPSLENLSQLTTLHLQNNQLSG----TLDVLQDLPLRD- 223
L L L+++ N + S +LP NL+ L L L +N++ L VL +PL +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 224 -LNIENNLFSGPIPEKMLQIPNFRK---DGNPFNSTVAPS 259
L++ N + I + K N + V +
Sbjct: 181 SLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 31/163 (19%), Positives = 59/163 (36%), Gaps = 5/163 (3%)
Query: 87 NGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSS- 144
NG + G ++ +S++ +DLS N + + L + +++ + S
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLH 203
+L L + +++ F L+ L L ++ N+ P L LT L
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 204 LQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L QL L L+ LN+ +N F + +
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-26
Identities = 32/151 (21%), Positives = 64/151 (42%), Gaps = 8/151 (5%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ S + + L+ N I ++Q + + + L L ++++
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 157 -NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT----TLHLQNNQLSG 211
+N + S ++P+ F +LT L +LDLSSN + L L Q+ +L L N ++
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 212 T-LDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
+++ L L + NN S + + +Q
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 33/160 (20%), Positives = 53/160 (33%), Gaps = 9/160 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIG--GSIPSIL--PVTMQNFFLSDNQFSGSI 141
L + G + S+ +DLS N + G +++ LS N +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 142 PSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT 200
S+ L L + ++ L F SL LI LD+S + LS L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 201 TLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSGPIPE 237
L + N D+ +L L L++ P
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-20
Identities = 27/155 (17%), Positives = 46/155 (29%), Gaps = 8/155 (5%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLT 149
++ + +++ L + I Q+ L + +F L +L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--GELPPSLENLSQLTTLHLQNN 207
L G + L L LDLS N LS G S + L L L N
Sbjct: 329 -----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 208 QLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
+ L L L+ +++ +
Sbjct: 384 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 31/203 (15%), Positives = 64/203 (31%), Gaps = 41/203 (20%)
Query: 92 GGELGENLGAFSSIRVIDLSNNHIGGSIPSI------LPVTMQNFFLSDNQFSGSIPSSL 145
+L E +++ +DLS+N I + +P+ + LS N + P +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 146 ATLTLLTDMSLNNNLLSGEIPDA----------------------------FQSLTGLIN 177
+ L ++L NN S + +L GL N
Sbjct: 198 KEIRLHK-LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 178 LDLSSNNLS------GELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLF 231
L + L+ ++ L+ +++ L + + D + + L + N F
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 232 SGPIPEKMLQIPNFRKDGNPFNS 254
K+ + N +
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGN 339
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-15
Identities = 19/143 (13%), Positives = 42/143 (29%), Gaps = 30/143 (20%)
Query: 91 LGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATL 148
L + ++ +DLS + P+ ++Q +S N F L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 517
Query: 149 TLLTDMSLNNNLLSGEIPDAFQSL-TGLINLDLSSNNLSG-------------------- 187
L + + N + Q + L L+L+ N+ +
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 577
Query: 188 ------ELPPSLENLSQLTTLHL 204
P + + + +L++
Sbjct: 578 VERMECATPSDKQGMP-VLSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 24/197 (12%), Positives = 53/197 (26%), Gaps = 40/197 (20%)
Query: 84 IILNGANLGGELGEN-LGAFSSIRVIDLSNNHIGGS--IPSILPVTMQN---FFLSDNQF 137
+ L + + + + + V L + ++ + + +
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 138 S------GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
+ I LT ++ SL + + ++ G +L+L + + P
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFG-QFPT 321
Query: 192 --------------------SLENLSQLTTLHLQNNQLSG---TLDVLQDLP-LRDLNIE 227
S +L L L L N LS L+ L++
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 228 NNLFSGPIPEKMLQIPN 244
N + L +
Sbjct: 382 FNGVIT-MSSNFLGLEQ 397
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 17/103 (16%), Positives = 40/103 (38%), Gaps = 6/103 (5%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI---LPVTMQNFFLSDNQFSGS 140
+ ++ N +S++V+D S NHI S P ++ L+ N F+ +
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558
Query: 141 IPSS--LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLS 181
L + + + + P Q + +++L+++
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-28
Identities = 41/190 (21%), Positives = 69/190 (36%), Gaps = 9/190 (4%)
Query: 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQ 136
++I + L L N +S + +D+ N I P + ++ L N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 137 FSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL 196
S + A T LT++ L +N + + F LI LDLS N LS + L
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 197 SQLTTLHLQNNQLSG----TLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK---DG 249
L L L NN++ LD+ + L+ L + +N P I +
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 250 NPFNSTVAPS 259
++
Sbjct: 205 VQLGPSLTEK 214
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-27
Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 3/143 (2%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
S V D S+ + +P LP + L+ NQ ++ + LT + + N +S
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-L 221
P+ Q L L L+L N LS + + LT LHL +N + + L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 222 RDLNIENNLFSGPIPEKMLQIPN 244
L++ +N S +Q+ N
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLEN 146
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 43/167 (25%), Positives = 67/167 (40%), Gaps = 15/167 (8%)
Query: 86 LNGANLGGEL-GENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSG--S 140
L +G EL G+ +I I LS N + ++Q L S
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 141 IPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--------GELPPS 192
PS L LT + L+NN ++ D + L L LDL NNL+ G
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 193 LENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFSGPIPE 237
L+ LS L L+L++N ++V +DL L+ +++ N +
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 29/174 (16%), Positives = 62/174 (35%), Gaps = 15/174 (8%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFF--------LSDN 135
+ + ++ G +++ + LSN+ S+ ++ T + L+ N
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT--SLRTLTNETFVSLAHSPLHILNLTKN 391
Query: 136 QFSGSIPSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLE 194
+ S + + L L + L N + E+ ++ L + + LS N S
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 195 NLSQLTTLHLQNNQLSG---TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
+ L L L+ L + Q L L L++ NN + + + +
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 46/167 (27%), Positives = 69/167 (41%), Gaps = 15/167 (8%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
L + + + V+DL N IG + ++N +LS N++
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 143 SSLATLTLLTDMSLNNNLLSG--EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT 200
+S A + L + L L P FQ L L LDLS+NN++ LE L +L
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 201 TLHLQNNQLS---------GTLDVLQDLP-LRDLNIENNLFSGPIPE 237
L LQ+N L+ G + L+ L L LN+E+N F E
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-24
Identities = 37/169 (21%), Positives = 65/169 (38%), Gaps = 17/169 (10%)
Query: 84 IILNGANLGGELGENLGAF---SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFS 138
++L L + + F ++ ++DLSNN+I +L ++ L N +
Sbjct: 459 LMLRRVALKN-VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 139 --------GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP 190
G L L+ L ++L +N + F+ L L +DL NNL+
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 191 PSLENLSQLTTLHLQNNQLSGT-LDVLQDLP--LRDLNIENNLFSGPIP 236
N L +L+LQ N ++ V L +L++ N F
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 32/163 (19%), Positives = 59/163 (36%), Gaps = 11/163 (6%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
L ++ ++ +DLS+N + + +Q LS+N+
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163
Query: 144 SLATLTL--LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL---ENLSQ 198
L L + L++N + P F ++ L L L++ L L L +
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223
Query: 199 LTTLHLQNNQLSG----TLDVLQDLPLRDLNIENNLFSGPIPE 237
+ L L N+QLS T L+ L L++ N + +
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-24
Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 18/170 (10%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPV-----TMQNFFLSDNQFSGS 140
L+ + A + + L+N +G S+ L + +++N LS++Q S +
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 141 IPSSLATLTL--LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
++ L LT + L+ N L+ D+F L L L NN+ SL L
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297
Query: 199 LTTLHLQNNQLSGTL----------DVLQDLP-LRDLNIENNLFSGPIPE 237
+ L+L+ + ++ Q L L LN+E+N G
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN 347
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-23
Identities = 35/172 (20%), Positives = 60/172 (34%), Gaps = 18/172 (10%)
Query: 99 LGAFSSIRVIDLSNNHIGG--SIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
S++ + L + S PS + LS+N + L L L +
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509
Query: 155 SLNNNLLS--------GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206
L +N L+ G + L+ L L+L SN ++L +L + L
Sbjct: 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 207 NQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKML----QIPNFRKDGNPF 252
N L+ V + L+ LN++ NL + + + NPF
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 34/153 (22%), Positives = 57/153 (37%), Gaps = 17/153 (11%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
++++ ++DLS N++ ++ FFL N SL L + ++L +
Sbjct: 247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306
Query: 160 L---------LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
L +FQ L L +L++ N++ G L L L L N+ S
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366
Query: 211 ------GTLDVLQDLPLRDLNIENNLFSGPIPE 237
T L PL LN+ N S +
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 29/157 (18%), Positives = 60/157 (38%), Gaps = 9/157 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
++ A+L + + +++ +N I G ++ + ++ LS++ S +
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 144 SLA----TLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQ 198
+ + L ++L N +S DAF L L LDL N + EL L
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 199 LTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSG 233
+ ++L N+ + +P L+ L +
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-21
Identities = 32/183 (17%), Positives = 61/183 (33%), Gaps = 17/183 (9%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPS-----------ILP 124
+++ + L+ NL ++ + L N+I L
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304
Query: 125 VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNN 184
+ +S S L L +++ +N + G + F L L L LS++
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364
Query: 185 LSGELPPS--LENL--SQLTTLHLQNNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEK 238
S + +L S L L+L N++S D L L L++ N + +
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
Query: 239 MLQ 241
+
Sbjct: 425 EWR 427
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 25/158 (15%), Positives = 46/158 (29%), Gaps = 8/158 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
L G L S + +++L +N + ++ L N + S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 144 SLATLTLLTDMSLNNNLLSGEIPDAFQ-SLTGLINLDLSSNNLSGELPPSLE-----NLS 197
L ++L NL++ F + L LD+ N N +
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638
Query: 198 QLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPI 235
L ++ L T P+R + + S
Sbjct: 639 HTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAHH 676
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 22/182 (12%), Positives = 63/182 (34%), Gaps = 19/182 (10%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLS 133
+ SD+I +N + ++ I +N+I + + ++ F++
Sbjct: 156 EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMG 214
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
++ F + + +L L ++++ + +LP L
Sbjct: 215 NSPFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
Query: 194 ENLSQLTTLHLQNNQLSGTLDVLQDLP----------LRDLNI-ENNLFSGPIPEKMLQI 242
+ L ++ +++ N+ + D ++ + I NNL + P+ + ++
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329
Query: 243 PN 244
Sbjct: 330 KK 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 31/175 (17%), Positives = 67/175 (38%), Gaps = 26/175 (14%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPV----TMQNFFLSDNQFSG-------SIP 142
+ + ++N + IP+I M S N+ +
Sbjct: 371 NFCGFT---EQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG-------ELPPSLEN 195
+ ++ ++L+NN +S + F + + L +++L N L+ + + +N
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 196 LSQLTTLHLQNNQLSGTLDVLQD--LP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
LT++ L+ N+L+ D + LP L +++ N FS P + L +
Sbjct: 487 TYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 29/173 (16%), Positives = 66/173 (38%), Gaps = 17/173 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHI--------GGSIPSILPVT--MQNFFLSDN 135
+ +L L A +++I+++ N + PV +Q ++ N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 136 QF-SGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL- 193
+ + +SL + L + N L G++P AF S L +L+L+ N ++ +P +
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFC 373
Query: 194 ENLSQLTTLHLQNNQLSGTLDVLQ--DLP-LRDLNIENNLFSGPIPEKMLQIP 243
Q+ L +N+L ++ + + ++ N + +
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 37/172 (21%), Positives = 61/172 (35%), Gaps = 22/172 (12%)
Query: 89 ANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSG------- 139
L ++ I+LSNN I + + + L N +
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQ--SLTGLINLDLSSNNLSGELPPSLENLS 197
+ LLT + L N L+ + D F+ +L L+ +DLS N+ S P N S
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536
Query: 198 QLTTLHLQN------NQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L ++N N+ + + P L L I +N + EK+
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-22
Identities = 23/161 (14%), Positives = 61/161 (37%), Gaps = 21/161 (13%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSI--LPVTMQNFFLSDNQFSGSIPSSLA--TLTLLT 152
G+ + ++L+ N I + ++N + N+ IP+ ++++++
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMS 405
Query: 153 DMSLNNNLLSGEIPDAFQS-------LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
+ + N + F + +++LS+N +S S L++++L
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 206 NNQLSG-TLDVLQDLP--------LRDLNIENNLFSGPIPE 237
N L+ + L+D L +++ N + +
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDD 506
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 31/177 (17%), Positives = 54/177 (30%), Gaps = 32/177 (18%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNF---------FLSD 134
I L+ + E S + I+L N + + L +NF L
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497
Query: 135 NQFSGSIPSSLA--TLTLLTDMSLNNNLLSGEIPDAFQSLTGLI------NLDLSSNNLS 186
N+ + + TL L + L+ N S P + + L D N
Sbjct: 498 NKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
Query: 187 GELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP------LRDLNIENNLFSGPIPE 237
E P + LT L + +N + + + L+I++N
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-------VNEKITPNISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 27/196 (13%), Positives = 55/196 (28%), Gaps = 11/196 (5%)
Query: 59 WVASAGDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGS 118
W A G S QG G + G +L + + + L G
Sbjct: 39 WDALNGKNW--SQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGR 96
Query: 119 IPSILP--VTMQNFFLSDNQFSG----SIPSSLATLTLLTDMSLNNNLLSGEIPDA--FQ 170
+P + ++ L + P ++ D +
Sbjct: 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156
Query: 171 SLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENN 229
+ LI ++S+ + S + T + +N ++ + L LR + N+
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNS 216
Query: 230 LFSGPIPEKMLQIPNF 245
F + + N
Sbjct: 217 PFVAENICEAWENENS 232
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-17
Identities = 15/121 (12%), Positives = 32/121 (26%), Gaps = 14/121 (11%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPS---------ILPVTMQNFFLSDNQFSGSIPSSLATLT 149
+ IDLS N P+ + N+ P +
Sbjct: 509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIR-NQRDAQGNRTLREWPEGITLCP 566
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
LT + + +N + + + + LD+ N + + L ++
Sbjct: 567 SLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
Query: 210 S 210
Sbjct: 624 Q 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 13/101 (12%), Positives = 30/101 (29%), Gaps = 11/101 (10%)
Query: 171 SLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD------VLQDLPLRDL 224
S + L L SG +P ++ L++L L L ++ + ++
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 225 NIENNLFSGPIP-----EKMLQIPNFRKDGNPFNSTVAPSR 260
+ E + + +P ++ S
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 16/97 (16%), Positives = 27/97 (27%), Gaps = 9/97 (9%)
Query: 85 ILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSS 144
G E E + S+ + + +N I I P + + DN S
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP-NISVLDIKDNPNISIDLSY 606
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLS 181
+ L + Q + G LD+
Sbjct: 607 VCPYIEAGMYMLFYDKT--------QDIRGCDALDIK 635
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 39/161 (24%), Positives = 63/161 (39%), Gaps = 8/161 (4%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
IG G G V+ +L L AVK + K FL+ + + H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHP 172
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
NIV L G C + ++ E G L ++ L T ++M AA +EYL
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYL 229
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+HR+ + N L+ + + +SD G++ + G
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 3/144 (2%)
Query: 106 RVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEI 165
+ + N + IP LP + + S N ++ + L LT + L +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 166 PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRD 223
D FQS L L L++N L +L L L +S L + L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 224 LNIENNLFSGPIPEKMLQIPNFRK 247
L + +N S K +
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKV 157
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 30/190 (15%), Positives = 55/190 (28%), Gaps = 10/190 (5%)
Query: 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQ 136
+ + + L ++ +DL+ I + L+ N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 137 FSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL 196
++L+ L + +S + L +L L SN++S P
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 197 SQLTTLHLQNNQLS----GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK---DG 249
+L L QNN + + LQ LN+ N +G I F+ G
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGG 211
Query: 250 NPFNSTVAPS 259
+
Sbjct: 212 TQNLLVIFKG 221
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 32/163 (19%), Positives = 61/163 (37%), Gaps = 10/163 (6%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
+ ++DL+ + + LS + S L L ++L N
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGN 459
Query: 160 LLSGEI---PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDV 215
++ Q+L L L LS +LS + +L + + L +N+L+ +++
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
Query: 216 LQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNST 255
L L LN+ +N S +P + + R NP + T
Sbjct: 520 LSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 39/164 (23%), Positives = 58/164 (35%), Gaps = 13/164 (7%)
Query: 86 LNGANLGGELGEN-LGAFSSIRVIDLSNNHIGGSIPSI-----LPVTMQNFFLSDNQFSG 139
+ G ELG L ++R +DLS++ I S L +Q+ LS N+
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS-HLQSLNLSYNEPLS 390
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
+ L + L L + FQ+L L L+LS + L + L
Sbjct: 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 199 LTTLHLQNNQLSG----TLDVLQDLP-LRDLNIENNLFSGPIPE 237
L L+LQ N + LQ L L L + S
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 8/142 (5%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSI---PSSLATLTLLTD 153
++V++LS++ + S + +Q+ L N F +SL TL L
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT- 212
+ L+ LS AF SL + ++DLS N L+ +L +L + L+L +N +S
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539
Query: 213 LDVLQDLP-LRDLNIENNLFSG 233
+L L R +N+ N
Sbjct: 540 PSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 39/169 (23%), Positives = 68/169 (40%), Gaps = 8/169 (4%)
Query: 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLS 133
+ +I L FS ++ +DL+ H+ +PS L T++ LS
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLS 309
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEI-PDAFQSLTGLINLDLSSNNL--SGELP 190
N+F S + LT +S+ N E+ ++L L LDLS +++ S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 191 PSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFSGPIPE 237
L NLS L +L+L N+ + ++ P L L++ +
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 30/155 (19%), Positives = 61/155 (39%), Gaps = 10/155 (6%)
Query: 84 IILNGANLGGELGENLG--AFSSIRVIDLSNNHIGGSIPSILP----VTMQNFFLSDNQF 137
+ G + + L S+ + + P++ +++++ L + F
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF 266
Query: 138 SGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLS 197
++ + L ++ L LS E+P L+ L L LS+N S N
Sbjct: 267 FNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFP 325
Query: 198 QLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
LT L ++ N L L++L LR+L++ ++
Sbjct: 326 SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-19
Identities = 31/160 (19%), Positives = 54/160 (33%), Gaps = 9/160 (5%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP----VTMQNFFLSDNQFSGSIPSSL 145
N + + + ++ I L ++ D P+
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248
Query: 146 ATLTL--LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLH 203
L + ++L + + F +GL LDL++ +LS ELP L LS L L
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLV 307
Query: 204 LQNNQLSGTLD-VLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L N+ + P L L+I+ N + L+
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 24/159 (15%), Positives = 52/159 (32%), Gaps = 13/159 (8%)
Query: 98 NLGAFS---SIRVIDLSNNHIGGSIPSILPV----TMQNFFLSDNQFSGSIPSSLATLTL 150
L ++V+D NN I + T + L+ N +G P + +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 151 LT-DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLS--QLTTLHLQNN 207
+ + NLL ++ L + P E L + +++LQ +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 208 QLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
+ L++L++ S +P ++ +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLST 302
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 26/175 (14%), Positives = 51/175 (29%), Gaps = 9/175 (5%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLA 146
N + N ++ +D ++ + ++++ +S
Sbjct: 386 NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL 445
Query: 147 TLTLLTDMSL-NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
LT L + + N+ + + F + T L LDLS L + L +L L++
Sbjct: 446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS 505
Query: 206 NNQLSG-TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNST 255
+N L L L L+ N + N
Sbjct: 506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 29/146 (19%), Positives = 52/146 (35%), Gaps = 4/146 (2%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+ + +P +P + +N LS N S + + L + L+ +
Sbjct: 12 PNITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-L 221
A+ L L NL L+ N + P S L+ L L +L+ + L L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 222 RDLNIENNLFSG-PIPEKMLQIPNFR 246
+ LN+ +N +P + N
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLV 156
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 40/193 (20%), Positives = 69/193 (35%), Gaps = 13/193 (6%)
Query: 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQ 136
S I L+ L + FS ++ +DLS I + N L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 137 FSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG-ELPPSLEN 195
P S + LT L ++ L+ L L L+++ N + +LP N
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 196 LSQLTTLHLQNNQLSG----TLDVLQDLP--LRDLNIENNLFSGPIPEKMLQIPNFRK-- 247
L+ L + L N + L L++ P L++ N I ++ Q +
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELT 210
Query: 248 -DGNPFNSTVAPS 259
GN +S + +
Sbjct: 211 LRGNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-21
Identities = 30/153 (19%), Positives = 62/153 (40%), Gaps = 11/153 (7%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
A+ + + L+ N I P +++N + + + + L L +
Sbjct: 74 KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133
Query: 155 SLNNNLLSG-EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT----TLHLQNNQL 209
++ +N + ++P F +LT L+++DLS N + L+ L + +L + N +
Sbjct: 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI 193
Query: 210 SG-TLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
Q + L +L + N S I + LQ
Sbjct: 194 DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 30/149 (20%), Positives = 52/149 (34%), Gaps = 9/149 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILP----VTMQNFFLSDNQFSGSIPSSLATLTLLT 152
A S+ +DLS N + S ++++ LS N + ++ L L
Sbjct: 344 FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ 402
Query: 153 DMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
+ ++ L AF SL L+ LD+S N + L+ L TL + N
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 212 TL--DVLQDLP-LRDLNIENNLFSGPIPE 237
+V + L L++
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 23/128 (17%), Positives = 43/128 (33%), Gaps = 3/128 (2%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
++ N + +S+ + ++ N + S + N LS Q
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTL 202
TL L +++++N L + L L LD S N + L
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550
Query: 203 HLQNNQLS 210
+L NN ++
Sbjct: 551 NLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 6e-16
Identities = 31/159 (19%), Positives = 48/159 (30%), Gaps = 8/159 (5%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
L N + +++ + L+ I Q+ + Q L
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL--SQLTTLH 203
L L +L N S I +L L LDLS N LS S +L + L L
Sbjct: 328 PFLKSL---TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 204 LQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L N L L+ L+ +++
Sbjct: 383 LSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-15
Identities = 21/141 (14%), Positives = 41/141 (29%), Gaps = 10/141 (7%)
Query: 103 SSIRVIDLSNNHIGGSIPSIL-PVTMQNFFLSDNQFSGSIP-------SSLATLTLLTDM 154
+D+S N I + + L N S +I + L L+
Sbjct: 181 QVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240
Query: 155 SLNNNLLSGEIPDAFQSLTGL--INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212
+ L P + L + L+ N + L+ ++ + L +
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL 300
Query: 213 LDVLQDLPLRDLNIENNLFSG 233
DV + + L+I
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 27/156 (17%), Positives = 48/156 (30%), Gaps = 18/156 (11%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSI------LPVTMQNFFLSDNQFSGSIPSSLAT 147
+L +++ +DLS N+I + P + +S N +
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203
Query: 148 LTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGEL------PPSLENLSQLT 200
+ L ++L N S I Q+L GL L E P +E L +T
Sbjct: 204 IKLHE-LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 201 TLHL---QNNQLSGTLDVLQDLP-LRDLNIENNLFS 232
N S + L + +++
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 15/165 (9%)
Query: 516 LIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G +VY+ +A +L R ++ + F E + ++H NIV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 575 YC---AEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNL--SWNTRIRMALGAARALEYLH 628
+ + +++ E ++GTL+ L +K + SW +I + L++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQFLH 146
Query: 629 EICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPLISSGSVSQV 672
PPI+HR+ K NI + +V + D GLA L + V
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV 190
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-22
Identities = 25/169 (14%), Positives = 54/169 (31%), Gaps = 17/169 (10%)
Query: 82 IAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFS 138
L ++ I++ + N++ S M N+
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586
Query: 139 GSIPSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPP--SLEN 195
+ T LTD+ L+ N + EIP D + L S N L +P + ++
Sbjct: 587 --HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
Query: 196 LSQLTTLHLQNNQLSG-------TLDVLQDLPLRDLNIENNLFSGPIPE 237
+ + ++ N++ ++D + + + + N E
Sbjct: 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE 691
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 34/175 (19%), Positives = 57/175 (32%), Gaps = 22/175 (12%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFS----- 138
+ + + + LS N I + + LS+N +
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 139 --GSIPSSLATLTLLTDMSLNNNLLSGEIPD--AFQSLTGLINLDLSSNNLSGELPPSLE 194
+ LLT + L N L+ + D +L L N+D+S N S P
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPL 773
Query: 195 NLSQLTTLHLQ------NNQLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
N SQL ++ N++ + P L L I +N + EK+
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTP 827
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 24/177 (13%), Positives = 58/177 (32%), Gaps = 19/177 (10%)
Query: 77 NASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSD 134
N SD++ +N + ++ I N I I + +Q + ++
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFAN 457
Query: 135 NQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLE 194
+ F+ + D + + ++ +L L +++L + +LP L
Sbjct: 458 SPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY 512
Query: 195 NLSQLTTLHLQNNQLSGTLDVLQDLP-----------LRDLNIENNLFSGPIPEKML 240
+L +L +L++ N+ + D ++ + N L
Sbjct: 513 DLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASL 569
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 36/192 (18%), Positives = 58/192 (30%), Gaps = 33/192 (17%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFF----------LSDN 135
L+ + E S I I LSNN + SIP + L N
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 136 QFSGSIPSSLA--TLTLLTDMSLNNNLLSGEIPDAFQSLTGLI------NLDLSSNNLSG 187
+ + S+ TL L++M ++ N S P + + L D N +
Sbjct: 739 KLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796
Query: 188 ELPPSLENLSQLTTLHLQNNQLSG----TLDVLQDLPLRDLNIENNLFSGPI----PEKM 239
+ P + L L + +N + L L + D N S + P
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIAD----NPNISIDVTSVCPYIE 852
Query: 240 LQIPNFRKDGNP 251
+ D
Sbjct: 853 AGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 26/177 (14%), Positives = 61/177 (34%), Gaps = 19/177 (10%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT-----------MQNFFLSD 134
L +L + L ++ ++++ N + T +Q F++
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 135 NQFSGSIPS-SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL 193
N S SL + L + +N + +AF + L +L L N + E+P
Sbjct: 558 NNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDF 614
Query: 194 -ENLSQLTTLHLQNNQLSGTLDV--LQDLP-LRDLNIENNLFSGPIPEKMLQIPNFR 246
Q+ L +N+L ++ + + + ++ N + +++
Sbjct: 615 CAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-20
Identities = 27/224 (12%), Positives = 66/224 (29%), Gaps = 33/224 (14%)
Query: 52 GSPVLPGWVASAGDPCGESWQGVQC-NASDIIAIILNGANLGGELGENLGAFSSIRVIDL 110
+ W + GV N + + L G G + + +G + ++V+
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 111 SNNHIGGSIPSILPVTM---------QNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ S + + + L LL D N +
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG---------- 211
D+ SL + +N ++ + +++ L++L ++ N+ +
Sbjct: 415 KPIKKDSRISLKDT-QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472
Query: 212 ---TLDVLQDLP--------LRDLNIENNLFSGPIPEKMLQIPN 244
++ L D+ + N +P+ + +P
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-19
Identities = 30/192 (15%), Positives = 61/192 (31%), Gaps = 45/192 (23%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVT--MQNFFLSDNQFSGSIPS--SLATLTLLTDM 154
G + + L N I T ++ S N+ IP+ + ++ ++ +
Sbjct: 591 FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSV 649
Query: 155 SLNNNLLSGEIPDAFQSLTG-----LINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
+ N + E + S+ + LS N + S ++T+ L NN +
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709
Query: 210 SG--------------------TLDV----LQDLP----------LRDLNIENNLFSGPI 235
+ T+D+ L L L ++++ N FS
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-F 768
Query: 236 PEKMLQIPNFRK 247
P + L +
Sbjct: 769 PTQPLNSSQLKA 780
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 9/113 (7%), Positives = 35/113 (30%), Gaps = 3/113 (2%)
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS 192
+ ++ ++ + + ++ + + + L L+ G +P +
Sbjct: 284 KNWRYYSGTINNTIHSLN-WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 193 LENLSQLTTLHLQNNQLSGTLDV--LQDLPLRDLNIENNLFSGPIPEKMLQIP 243
+ L++L L + + + + ++L + + L
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYD 395
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 22/140 (15%), Positives = 40/140 (28%), Gaps = 9/140 (6%)
Query: 106 RVIDLSNNHIGGSIPSILPVTMQ-NFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGE 164
+D N + ++ NF + + L +T +SL G
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--------GTLDVL 216
+PDA LT L L +++ + + + +++ L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 217 QDLPLRDLNIENNLFSGPIP 236
L I N PI
Sbjct: 399 NLSDLLQDAINRNPEMKPIK 418
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 10/77 (12%), Positives = 25/77 (32%), Gaps = 2/77 (2%)
Query: 85 ILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQF-SGSIPS 143
G + + + S+ + + +N I + L + ++DN S + S
Sbjct: 788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNISIDVTS 846
Query: 144 SLATLTLLTDMSLNNNL 160
+ + L +
Sbjct: 847 VCPYIEAGMYVLLYDKT 863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 7/159 (4%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDK-RASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G + + DGK+L K+LD + +K E VN + ++H NIV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE-VNLLRELKHPNIVRYY 71
Query: 574 G-YCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L I EYC G L ++ + + L +R+ AL+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 632 QPP--IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
++HR+ K AN+ LD V + D GLA +++ +
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 50/244 (20%), Positives = 89/244 (36%), Gaps = 24/244 (9%)
Query: 428 RRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTST 487
H +S+ ++ P P + +E + +
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKA-------GSENLYFQGAN 62
Query: 488 KTAKPFTTARSFTIASLQQYTNSFSQENL-----IGAGMLGSVYRAQL--PDGKLL--AV 538
+ + ++Q S + IG G G VY L DGK + AV
Sbjct: 63 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122
Query: 539 KKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-GQRLLIYEYCSNGTLQDM 597
K L++ + FL + H N++ L G C G L++ Y +G L++
Sbjct: 123 KSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 598 LHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSD 657
+ ++ +N + I L A+ +++L VHR+ + N +LD+ V V+D
Sbjct: 182 IRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVAD 235
Query: 658 CGLA 661
GLA
Sbjct: 236 FGLA 239
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-22
Identities = 26/138 (18%), Positives = 59/138 (42%), Gaps = 3/138 (2%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ +I+ + ++N H P ++ + + +L+ LT LT + +
Sbjct: 60 TGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+++ I +L + ++DLS N ++ P L+ L +L +L++Q + + +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRGI 177
Query: 217 QDLP-LRDLNIENNLFSG 233
+D P L L + G
Sbjct: 178 EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 23/130 (17%), Positives = 58/130 (44%), Gaps = 5/130 (3%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNL 160
+S+ I L+N ++ + I +++ +++ + + ++ L+ L + +
Sbjct: 43 MNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKD 99
Query: 161 LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP 220
++ + LT L LD+S + + + L ++ ++ L N + L+ LP
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP 159
Query: 221 -LRDLNIENN 229
L+ LNI+ +
Sbjct: 160 ELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 20/126 (15%), Positives = 51/126 (40%), Gaps = 25/126 (19%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
+ G ++ + NL +S+ ++D+S++ SI + +
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAH----------------------DDSILTKI 132
Query: 146 ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205
TL + + L+ N +I ++L L +L++ + + + +E+ +L L+
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAF 189
Query: 206 NNQLSG 211
+ + G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 14/67 (20%), Positives = 30/67 (44%), Gaps = 7/67 (10%)
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LR 222
IPD+ + +N L ++ + + ++ LT + L N ++ L ++ ++
Sbjct: 16 NIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTGIEYAHNIK 69
Query: 223 DLNIENN 229
DL I N
Sbjct: 70 DLTINNI 76
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-22
Identities = 35/162 (21%), Positives = 70/162 (43%), Gaps = 11/162 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ + + + L+ N I P ++ F NQ + P +A +T L + +
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
NN ++ P +L+ L L++ +N +S ++++L++L L++ +NQ+S + VL
Sbjct: 229 GNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVL 283
Query: 217 QDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNS 254
+L L L + NN E + + N N
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 9/142 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
SI + ++ + SI I +T ++ L+ NQ + P L+ L LT++
Sbjct: 38 VTQEELESITKLVVAGEKV-ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+ N ++ A Q+LT L L L+ +N+S L NL+++ +L+L N L
Sbjct: 95 IGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP 150
Query: 216 LQDLP-LRDLNIENNLFSGPIP 236
L ++ L L + + P
Sbjct: 151 LSNMTGLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 29/141 (20%), Positives = 64/141 (45%), Gaps = 7/141 (4%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ + +++ ++L+ N I P V + N ++ N+ + S+L LT L ++ L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYL 117
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N + +S +LT + +L+L +N+ L N++ L L + +++ + +
Sbjct: 118 NEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD-VTPI 173
Query: 217 QDLP-LRDLNIENNLFSGPIP 236
+L L L++ N P
Sbjct: 174 ANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 4e-20
Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 9/142 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIP-SILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L +++R + L+ ++I P + L M + L N S S L+ +T L ++
Sbjct: 104 SALQNLTNLRELYLNEDNISDISPLANLT-KMYSLNLGANHNL-SDLSPLSNMTGLNYLT 161
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+ + + P +LT L +L L+ N + L +L+ L NQ++ +
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD-ITP 216
Query: 216 LQDLP-LRDLNIENNLFSGPIP 236
+ ++ L L I NN + P
Sbjct: 217 VANMTRLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 28/135 (20%), Positives = 59/135 (43%), Gaps = 8/135 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+ + + + + NN I + + ++ + + NQ S +++ LT L ++
Sbjct: 215 TPVANMTRLNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLN 271
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+ +N +S +L+ L +L L++N L E + L+ LTTL L N ++ +
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRP 328
Query: 216 LQDLP-LRDLNIENN 229
L L + + N
Sbjct: 329 LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 31/115 (26%), Positives = 53/115 (46%), Gaps = 6/115 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L S + +++ N I I ++ +T ++ + NQ S S L L+ L +
Sbjct: 237 SPLANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLF 293
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
LNNN L E + LT L L LS N+++ + P L +LS++ + N +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRP-LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 27/142 (19%), Positives = 57/142 (40%), Gaps = 8/142 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ L + + ++ ++ + + SI + LT L ++L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N N ++ P +L L NL + +N ++ +L+NL+ L L+L + +S + L
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISD-ISPL 128
Query: 217 QDLP-LRDLNIENNLFSGPIPE 237
+L + LN+ N +
Sbjct: 129 ANLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 16/87 (18%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
++ ++ PDA L I L +++ + E L +T L + +++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 211 GTLDVLQDLP-LRDLNIENNLFSGPIP 236
++ ++ L L LN+ N + P
Sbjct: 58 -SIQGIEYLTNLEYLNLNGNQITDISP 83
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 8/57 (14%), Positives = 22/57 (38%), Gaps = 4/57 (7%)
Query: 174 GLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENN 229
G L ++ ++ P +L++ LQ ++ + ++L + L +
Sbjct: 1 GAATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGE 54
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 14/162 (8%)
Query: 514 ENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+G G G V + G+ +AVK L + D + + + + H N
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHEN 84
Query: 569 IVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV+ KG C E G LI E+ +G+L++ L + KN ++ +++ A+ + ++Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDY 141
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
L VHR+ + N+L++ + V + D GL I +
Sbjct: 142 LGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ ++ +G G G VY L AVK L + + EFL+ + I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 276
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N+V+L G C +I E+ + G L D L + + +S + MA + A+EYL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYL 334
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ +HRN + N L+ ++ V V+D GL+
Sbjct: 335 EKKN---FIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 47/226 (20%), Positives = 77/226 (34%), Gaps = 46/226 (20%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
PP P P P + +L
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYN---------------------------------TL 31
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEFLELVNNI 561
+ E IG G VYRA L DG +A+KK + ++ + D E ++ +
Sbjct: 32 ANFR----IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKE-IDLL 86
Query: 562 DRIRHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
++ H N+++ L I E G L M+ + K + T + +
Sbjct: 87 KQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
ALE++H ++HR+ K AN+ + V + D GL SS
Sbjct: 146 CSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 36/147 (24%), Positives = 63/147 (42%), Gaps = 7/147 (4%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI- 564
YT F + IG+G GSV++ DG + A+K+ K + + L V +
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 565 RHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+H+++V +LI EYC+ G+L D + + + + + L R
Sbjct: 69 QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDD 650
L Y+H +VH + K +NI +
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRT 151
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-21
Identities = 35/154 (22%), Positives = 57/154 (37%), Gaps = 7/154 (4%)
Query: 107 VIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP 166
+ IP LP + +N LS N S + L + L+ +
Sbjct: 11 TYQCMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 167 DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDL 224
A+QSL+ L L L+ N + + LS L L L+ + + L L++L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 225 NIENN-LFSGPIPEKMLQIPNFRK---DGNPFNS 254
N+ +N + S +PE + N N S
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 34/153 (22%), Positives = 66/153 (43%), Gaps = 11/153 (7%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
GA+ + + L+ N I ++Q + + + L L ++
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 155 SLNNNLL-SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT----TLHLQNNQL 209
++ +NL+ S ++P+ F +LT L +LDLSSN + L L Q+ +L L N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 210 SG-TLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
+ +++ L L + NN S + + +Q
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 28/146 (19%), Positives = 53/146 (36%), Gaps = 8/146 (5%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSIL---PVTMQNFFLSDNQFSGSIPSSLATLTL 150
+ N + +D ++++ + + +S + L+
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 151 LTDMSLNNNLLSGEI-PDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQ 208
L + + N PD F L L LDLS L +L P+ +LS L L++ +NQ
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQ 505
Query: 209 LSG-TLDVLQDLP-LRDLNIENNLFS 232
L + L L+ + + N +
Sbjct: 506 LKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 27/122 (22%), Positives = 50/122 (40%), Gaps = 8/122 (6%)
Query: 98 NLGAF---SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS-SLATLTLL 151
F ++ +D+S+ H + I +++ ++ N F + L L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLS 210
T + L+ L P AF SL+ L L+++SN L +P + L+ L + L N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
Query: 211 GT 212
+
Sbjct: 532 CS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 30/145 (20%), Positives = 54/145 (37%), Gaps = 7/145 (4%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIP-SSLATLTLLTDMS 155
++ + ++L N G P++ +++ + N+ + L +L L D+S
Sbjct: 298 KDFSYNFGWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL-DLS 355
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD- 214
N G + T L LDLS N + + + L QL L Q++ L +
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 215 -VLQDLP-LRDLNIENNLFSGPIPE 237
V L L L+I +
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNG 439
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 26/137 (18%), Positives = 54/137 (39%), Gaps = 8/137 (5%)
Query: 103 SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQF-SGSIPSSLATLTLLTDMSLNNN 159
SS++ + ++ + T++ ++ N S +P + LT L + L++N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 160 LLSGEIPDAFQSLTGL----INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+ + L + ++LDLS N ++ + P +L L L+NN S +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 216 LQDLPLRDLNIENNLFS 232
L L + +
Sbjct: 219 TCIQGLAGLEVHRLVLG 235
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 33/180 (18%), Positives = 54/180 (30%), Gaps = 22/180 (12%)
Query: 95 LGENLGAFSSIRVIDLSNNHIGGSIPSI------LPVTMQNFFLSDNQFSGSIPSSLATL 148
L E +++ +DLS+N I + +P+ + LS N + I
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 149 TLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDL------SSNNLSGELPPSLENLSQLTT 201
L ++L NN S + Q L GL L + NL +LE L LT
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 202 LHLQNNQL-------SGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
+ L + L ++ L + + F
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV-SVTIERVKDFSYNFGWQHLELVNCKFGQ 318
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 28/192 (14%), Positives = 45/192 (23%), Gaps = 59/192 (30%)
Query: 100 GAFS--SIRVIDLSNNHIGGSIPSILPVTMQN---------FFLSDNQFSGSIPSSLATL 148
GAF + + L NN ++ + F ++ S+L L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 149 TLLTDMSLN---NNLLSGEIPDAFQ-------------------------SLTGLINLDL 180
LT + +I D F L ++
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
Query: 181 SSNNLSGELPPSLE----------------NLSQLTTLHLQNNQLSG---TLDVLQDLP- 220
SL+ +L L L L N LS
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 221 LRDLNIENNLFS 232
L+ L++ N
Sbjct: 375 LKYLDLSFNGVI 386
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDR 563
F + ++G+G G+VY+ P+G+ + A+K+L + A+S + + E L+ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ + ++ L G C LI + G L D + K+N+ + + A+
Sbjct: 74 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 129
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ YL + +VHR+ + N+L+ V ++D GLA L+ +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 514 ENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+IG G G VY L DGK + AVK L++ + FL + H N+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNV 88
Query: 570 VELKGYCAE-HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ L G C G L++ Y +G L++ + ++ +N + I L A+ ++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLA 145
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
VHR+ + N +LD+ V V+D GLA
Sbjct: 146 SKK---FVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL-AVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ ++ +G G G VY L AVK L + + EFL+ + I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 69
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N+V+L G C +I E+ + G L D L + + +S + MA + A+EYL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYL 127
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ +HR+ + N L+ ++ V V+D GL+
Sbjct: 128 EKKN---FIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 514 ENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+G G GSV + G+++AVKKL + S+++ +F + + ++H N
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDN 72
Query: 569 IVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV+ KG C G+R LI EY G+L+D L K + ++ + +EY
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEY 129
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
L +HR+ + NIL++++ V + D GL ++
Sbjct: 130 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 514 ENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+G G GSV + G+++AVKKL + S+++ +F + + ++H N
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSLQHDN 103
Query: 569 IVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV+ KG C G+R LI EY G+L+D L K + ++ + +EY
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEY 160
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
L +HR+ + NIL++++ V + D GL ++
Sbjct: 161 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ + IG+G G V+ + +A+K + + A S++ +F+E + ++ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 64
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L G C E L+ E+ +G L D L + + T + M L + YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE 121
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
E C ++HR+ + N L+ ++ + VSD G+ +
Sbjct: 122 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 154
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 514 ENLIGAGMLGSVYRAQLP-----DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +G G GSV + G L+AVK+L + S + +F + + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQILKALHSDF 85
Query: 569 IVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
IV+ +G G++ L+ EY +G L+D L + L + + + + +EY
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEY 142
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
L VHR+ + NIL++ + V ++D GLA L+
Sbjct: 143 LGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +GAG G V+ +AVK L + + S FL N + +++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V L + +I EY NG+L D L + L+ N + MA A + ++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
E +HR+ ++ANIL+ D L+ ++D GLA LI
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 16/167 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-----PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
+ +G G G V G+++AVK L A Q + + + ++ +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG-WKQEIDILRT 89
Query: 564 IRHANIVELKGYCAEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
+ H +I++ KG C + G L+ EY G+L+D L ++++ + A
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQIC 144
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ YLH +HR+ + N+LLD+D V + D GLA + G
Sbjct: 145 EGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 9/156 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +G+G G V + +AVK + + + S+ EF + + ++ H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPK 64
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+ G C++ ++ EY SNG L + L S + L + + M + +L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLE 121
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+HR+ + N L+D DL V VSD G+ +
Sbjct: 122 SHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +G G G V+ +A+K L S + FL+ + ++RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 240
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L +E ++ EY S G+L D L + L + MA A + Y+
Sbjct: 241 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE 297
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ VHR+ ++ANIL+ ++L V+D GLA
Sbjct: 298 RMN---YVHRDLRAANILVGENLVCKVADFGLA 327
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 20/193 (10%)
Query: 485 TSTKTAKPFTTARSFTIASLQQYTNSFSQE---------NLIGAGMLGSVYRAQL--PDG 533
K +P A T + SF++E +IG+G G V +L P
Sbjct: 16 FQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ 75
Query: 534 KLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591
+ + A+K L + +Q+ D FL + + + H NI+ L+G +++ EY N
Sbjct: 76 RDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651
G+L L + D + + M G + YL ++ VHR+ + N+L+D +L
Sbjct: 135 GSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNL 188
Query: 652 AVSVSDCGLAPLI 664
VSD GL+ ++
Sbjct: 189 VCKVSDFGLSRVL 201
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 39/164 (23%), Positives = 66/164 (40%), Gaps = 8/164 (4%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
L + + + L N I P + N L++NQ P ++ L LT ++L
Sbjct: 259 APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N +S P SLT L L +N +S SL NL+ + L +NQ+S L L
Sbjct: 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTPL 371
Query: 217 QDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPS 259
+L + L + + ++ + N + +AP+
Sbjct: 372 ANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPA 415
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-20
Identities = 39/141 (27%), Positives = 58/141 (41%), Gaps = 9/141 (6%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
L +++ + L NN I P + LS N S S+L+ LT L +S
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF 163
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N + +LT L LD+SSN +S L L+ L +L NNQ+S + L
Sbjct: 164 GNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPL 217
Query: 217 QDLP-LRDLNIENNLFSGPIP 236
L L +L++ N
Sbjct: 218 GILTNLDELSLNGNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 42/141 (29%), Positives = 61/141 (43%), Gaps = 8/141 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
L +++ + +NN I P + + L+ NQ +LA+LT LTD+ L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 250
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
NN +S P LT L L L +N +S L L+ LT L L NQL + +
Sbjct: 251 ANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED-ISPI 305
Query: 217 QDLP-LRDLNIENNLFSGPIP 236
+L L L + N S P
Sbjct: 306 SNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 17/145 (11%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT----MQNFFLSDNQFSGSIPSSLATLTLLT 152
L +S++ + N + + P+ ++ +S N+ S S LA LT L
Sbjct: 150 SALSGLTSLQQLSFGNQ-----VTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLE 202
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212
+ NN +S P LT L L L+ N L +L +L+ LT L L NNQ+S
Sbjct: 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN- 257
Query: 213 LDVLQDLP-LRDLNIENNLFSGPIP 236
L L L L +L + N S P
Sbjct: 258 LAPLSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-18
Identities = 30/141 (21%), Positives = 59/141 (41%), Gaps = 8/141 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
A + L ++ ++ + + L LT ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINF 75
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+NN L+ P ++LT L+++ +++N ++ L NL+ LT L L NNQ++ +D L
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD-IDPL 130
Query: 217 QDLP-LRDLNIENNLFSGPIP 236
++L L L + +N S
Sbjct: 131 KNLTNLNRLELSSNTISDISA 151
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 6/162 (3%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ ++ + L N+I P +Q F +N+ S SSLA LT + +S
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSA 360
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+N +S P +LT + L L+ + N+S T+ L +
Sbjct: 361 GHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS 418
Query: 217 QDLPLRDLNIENNL--FSGPIPEKMLQIPNFRKDGNPFNSTV 256
+ +I NL ++ + Q K F+ TV
Sbjct: 419 DGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
D + L L ++ + L + L +
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--ID 62
Query: 192 SLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIP 236
+E L+ LT ++ NNQL+ + L++L L D+ + NN + P
Sbjct: 63 GVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP 107
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 14/159 (8%)
Query: 514 ENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++G G GSV L DG L AVK + SSQ++ +EFL + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 570 VELKGYCAEHGQR-----LLIYEYCSNGTLQDML--HSDDELKNNLSWNTRIRMALGAAR 622
+ L G C E + ++I + G L L + ++ T ++ + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+EYL +HR+ + N +L DD+ V V+D GL+
Sbjct: 159 GMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
IG G G V G +AVK + K ++ Q FL + + ++RH+N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ---AFLAEASVMTQLRHSN 247
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+V+L G E L ++ EY + G+L D L S ++ L + ++ +L A+EYL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL 305
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
VHR+ + N+L+ +D VSD GL
Sbjct: 306 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 39/156 (25%), Positives = 61/156 (39%), Gaps = 10/156 (6%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ +G G V + L DG A+K++ QQ +E + H NI
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNI 88
Query: 570 VELKGYCAEHGQR----LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
+ L YC L+ + GTL + + + N L+ + + + LG R LE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+H HR+ K NILL D+ + D G
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +GAG G V+ A +AVK + + S + FL N + ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTLQHDK 244
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L + +I E+ + G+L D L SD+ + I + A + ++
Sbjct: 245 LVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+ +HR+ ++ANIL+ L ++D GLA +I
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 11/159 (6%)
Query: 513 QENLIGAGMLGSVYRAQLPDGKLL---AVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++ +G+G G+V + K++ AVK L A+ DE L N + ++ + I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V + G C +L+ E G L L + + I + + ++YL E
Sbjct: 81 VRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEE 135
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
VHR+ + N+LL +SD GL+ + +
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 9/156 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +G G G V + +A+K + + + S+ EF+E + + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 80
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L G C + +I EY +NG L + L + M A+EYL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE 137
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
+HR+ + N L++D V VSD GL+ +
Sbjct: 138 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 13/165 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDR 563
+ ++G+G+ G+V++ P+G+ + +K + + S +Q + + I
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS 71
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ HA+IV L G C L+ +Y G+L D + + L + + A+
Sbjct: 72 LDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKG 127
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ YL E +VHRN + N+LL V V+D G+A L+
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 15/157 (9%)
Query: 517 IGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+G G GSV AQL DG + AVK L + +EFL + H ++ +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 573 KGYCAEHGQR------LLIYEYCSNGTLQDML--HSDDELKNNLSWNTRIRMALGAARAL 624
G + ++I + +G L L E NL T +R + A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
EYL +HR+ + N +L +D+ V V+D GL+
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
IG G G V G +AVK + A++Q FL + + ++RH+N
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSN 75
Query: 569 IVELKGYCAEHGQRLLI-YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+V+L G E L I EY + G+L D L S ++ L + ++ +L A+EYL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL 133
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
VHR+ + N+L+ +D VSD GL
Sbjct: 134 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 11/164 (6%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRI 564
+ S + ++GAG G V +L P K + A+K L + +Q+ D FL + + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQF 103
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H NI+ L+G + +++ EY NG+L L D + + M G A +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGM 160
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+YL ++ VHR+ + NIL++ +L VSD GL ++
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 9/143 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
IP+ LP T+ L N P + + L + L+NN +S PDAFQ L L +
Sbjct: 25 EIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS----GTLDVLQDLPLRDLNIENNLFS 232
L L N ++ ELP SL E L L L L N+++ L +L L L +N L +
Sbjct: 85 LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLY-DNKLQT 142
Query: 233 GP--IPEKMLQIPNFRKDGNPFN 253
+ I NPF
Sbjct: 143 IAKGTFSPLRAIQTMHLAQNPFI 165
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 12/160 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRI 564
IG G G V++ P+ L A+K S ++ FL+ + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQF 73
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H +IV+L G E+ +I E C+ G L+ L +L + I A + AL
Sbjct: 74 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 129
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
YL VHR+ + N+L+ + V + D GL+ +
Sbjct: 130 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 12/161 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL---AVKKLDKRASSQQKDDEFLELVNNIDR 563
+ +++ +IGAG G VY+ L GK A+K L + +Q+ D FL + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQ 102
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
H NI+ L+G +++ ++I EY NG L L D S + M G A
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAG 159
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
++YL + VHR+ + NIL++ +L VSD GL+ ++
Sbjct: 160 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 8e-20
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 24/169 (14%)
Query: 100 GAFS--SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPS-SLATLTLLTDMSL 156
GAF + + +S + IP LP T+ L N+ +I L + L + L
Sbjct: 167 GAFDGLKLNYLRISEAKLT-GIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS------ 210
+N + + L L L L +N LS +P L +L L ++L N ++
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 211 --GTLDVLQDLPLRDLNIENN-LFSGPIPEKM---------LQIPNFRK 247
++ +++ NN + + +Q N++K
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYKK 332
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 35/162 (21%), Positives = 55/162 (33%), Gaps = 26/162 (16%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+RV+ S+ + ++P + L +N S L L + L NN +S
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 164 EIPDAFQSLTGLINLDLSSNNLS---GELPPSLE------------------NLSQLTTL 202
AF L L L +S N+L LP SL L + +
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152
Query: 203 HLQNNQLSGTL---DVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
+ N L + L L L I +G IP+ + +
Sbjct: 153 EMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLPE 193
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 33/139 (23%), Positives = 56/139 (40%), Gaps = 14/139 (10%)
Query: 100 GAFS---SIRVIDLSNNHIG-GSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
G FS ++ I++ N + + + +S+ + + IP L L +
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNE 197
Query: 154 MSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG 211
+ L++N + I + L L L N + + SL L L LHL NN+LS
Sbjct: 198 LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR 255
Query: 212 TLDVLQDLP-LRDLNIENN 229
L DL L+ + + N
Sbjct: 256 VPAGLPDLKLLQVVYLHTN 274
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLL---AVKKLDKRASSQQKDDEFL---ELVNNIDRIRHA 567
+++IG G G V +A++ L A+K++ + AS D F E++ + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGH--HP 86
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS------------DDELKNNLSWNTRIR 615
NI+ L G C G L EY +G L D L + + LS +
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
A AR ++YL + +HR+ + NIL+ ++ ++D GL+
Sbjct: 147 FAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLS 189
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLL----AVKKLDKRASSQQKDDEFLELVNNIDR 563
F + ++G+G G+VY+ P+G+ + A+K+L + A+S + + E L+ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ + ++ L G C LI + G L D + K+N+ + + A+
Sbjct: 74 VDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 129
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ YL + +VHR+ + N+L+ V ++D GLA L+ +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 35/157 (22%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY +A+K +++ AS +++ + FL + + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 91
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDML------HSDDELKNNLSWNTRIRMALGAARAL 624
L G ++ L+I E + G L+ L +++ + S + I+MA A +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
YL+ VHR+ + N ++ +D V + D G+
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 45/156 (28%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 514 ENLIGAGMLGSVYRAQLPDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ +IG G G VY + D A+K L + QQ + FL + + H N+
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGLNHPNV 84
Query: 570 VELKGYC-AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ L G G ++ Y +G L + S + N + I L AR +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLA 141
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
E VHR+ + N +LD+ V V+D GLA I
Sbjct: 142 EQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 35/158 (22%), Positives = 65/158 (41%), Gaps = 11/158 (6%)
Query: 514 ENLIGAGMLGSVYRAQL-PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+ +G G GSV + K + A+K L K+ + + +E + + ++ + IV
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
L G C +L+ E G L L E + + + + ++YL E
Sbjct: 74 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK 129
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
VHR+ + N+LL + +SD GL+ + +
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +G G G V+ +A+K L S + FL+ + ++RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 323
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L +E ++ EY S G+L D L + L + MA A + Y+
Sbjct: 324 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE 380
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ VHR+ ++ANIL+ ++L V+D GLA
Sbjct: 381 RMN---YVHRDLRAANILVGENLVCKVADFGLA 410
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 42/165 (25%), Positives = 65/165 (39%), Gaps = 12/165 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKD-DEFLELVNNIDR 563
+G G G V R + P GK + AVK L SQ + D+F+ VN +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+ H N++ L G ++ E G+L D L + + T R A+ A
Sbjct: 78 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 133
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ YL +HR+ + N+LL V + D GL +
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 37/176 (21%), Positives = 71/176 (40%), Gaps = 24/176 (13%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
Y F +G G G V+ A+ D A+K++ ++ E V + ++
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE-VKALAKLE 61
Query: 566 HANIVELKGYCAE---------HGQRLLIY---EYCSNGTLQDMLH---SDDELKNNLSW 610
H IV E ++ +Y + C L+D ++ + +E + ++
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 611 NTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
+ +++A A+E+LH ++HR+ K +NI D V V D GL +
Sbjct: 122 HIFLQIAE----AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 2e-19
Identities = 43/266 (16%), Positives = 83/266 (31%), Gaps = 15/266 (5%)
Query: 409 IPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVE 468
+ + + + S+ P P P P
Sbjct: 232 LWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDG 291
Query: 469 KVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQY----TNSFSQENLIGAGMLGS 524
+ + T+ + ++ N + +G G GS
Sbjct: 292 YTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGS 351
Query: 525 VYRAQLPDGK---LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581
V + K +A+K L K+ + + +E + + ++ + IV L G C
Sbjct: 352 VRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A 409
Query: 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFK 641
+L+ E G L L E + + + + ++YL E VHRN
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLA 463
Query: 642 SANILLDDDLAVSVSDCGLAPLISSG 667
+ N+LL + +SD GL+ + +
Sbjct: 464 ARNVLLVNRHYAKISDFGLSKALGAD 489
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 42/143 (29%), Positives = 59/143 (41%), Gaps = 6/143 (4%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
+ V D + SIPS L M++ LS N+ + L L + L ++ ++
Sbjct: 5 DASGVCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLS--GTLDVLQDL 219
DAF SL L +LDLS N+LS L S LS L L+L N G + +L
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ 241
L+ L I N I
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFA 145
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 40/180 (22%), Positives = 66/180 (36%), Gaps = 30/180 (16%)
Query: 102 FSSIRVIDLSNNHI-----GGSIPSILPVTMQNFFLSDNQFS--GSIPSSLATLTLLTDM 154
S+ +DLS N + S ++Q LS N L TL LT +
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS---GELPPSLE--------------NLS 197
++ N +PD+ Q + L+LSS + +P +LE L
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLP 451
Query: 198 QLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFN 253
+L L++ N+L TL P L + I N ++ + +K NP++
Sbjct: 452 RLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-16
Identities = 25/155 (16%), Positives = 58/155 (37%), Gaps = 14/155 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFF---LSDNQFSGSI- 141
+ L +L ++ I + N+ + +P +++ LS+N
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 142 --PSSLATLTLLTDMSLNNNLLS--GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLS 197
+ L + L+ N L + + +L L +LD+S N +P S +
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410
Query: 198 QLTTLHLQNNQLS----GTLDVLQDLPLRDLNIEN 228
++ L+L + + L+ L + + N+++
Sbjct: 411 KMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDS 445
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 30/150 (20%), Positives = 56/150 (37%), Gaps = 8/150 (5%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ + + S + + + + VT++ + + + + L + +++ N+ +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPS---LENLSQLTTLHLQNNQLS---GTLDV 215
Q L L LDLS N + E + L TL L N L T ++
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 216 LQDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L L L L+I N F P+P+
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 30/170 (17%), Positives = 63/170 (37%), Gaps = 14/170 (8%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
L A ++++V+ L ++ I ++++ LSDN S S L+ L ++L
Sbjct: 46 LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105
Query: 157 NNNLLSG-EIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS---- 210
N + F +LT L L + + E+ L+ L L ++ L
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
Query: 211 GTLDVLQDLPLRDLN------IENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
+L ++D+ L+ + + L++ + F+
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP 215
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 26/169 (15%), Positives = 60/169 (35%), Gaps = 18/169 (10%)
Query: 103 SSIRVIDLSNNHIGGSIPSILP----VTMQNFFLSDNQFSGSIP-SSLATLTLLTDMSLN 157
SS++ ++L N ++ +Q + + + I A LT L ++ +
Sbjct: 98 SSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG------ 211
L + +S+ + +L L + + L + LS + L L++ L+
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 212 ----TLDVLQDLPLRDLNIENNLFSG--PIPEKMLQIPNFRKDGNPFNS 254
++ L R + + F+ + +L++ D N
Sbjct: 217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
++ V+D+SNN++ S LP +Q ++S N+ ++P + + +L M ++ N
Sbjct: 428 CIPQTLEVLDVSNNNLD-SFSLFLP-RLQELYISRNKLK-TLPDA-SLFPVLLVMKISRN 483
Query: 160 LLSGEIPDAFQSLTGLINLDLSSNNL 185
L F LT L + L +N
Sbjct: 484 QLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 29/171 (16%), Positives = 57/171 (33%), Gaps = 22/171 (12%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPS 143
+ L+ + L SS+R ++L + ++ S LPV + + F GS+ +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236
Query: 144 SLATLTLLTDMSLNNNLLSGEIPD--------------------AFQSLTGLINLDLSSN 183
+ LL + L E D + L +
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 184 NLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFS 232
L +L L ++ + ++N+++ Q L L L++ NL
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 18/179 (10%), Positives = 51/179 (28%), Gaps = 24/179 (13%)
Query: 86 LNGANLGGELGEN-LGAFSSIRVIDLSNNHIGGSIPSILPV--TMQNFFLSDNQFSGSIP 142
+ E+ +S+ +++ + L + + L ++ + +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS-------GELPPSLEN 195
L+ + + L + L+ + + S EL L
Sbjct: 190 IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRY 249
Query: 196 LSQLTTLHLQNNQLSGTLDV-------------LQDLPLRDLNIENNLFSGPIPEKMLQ 241
+ +L+ + + L+G D ++ + +R L+I +
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYS 307
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 33/142 (23%), Positives = 52/142 (36%), Gaps = 9/142 (6%)
Query: 106 RVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEI 165
R+ ++ +P +L T + LS N SS L L + L + I
Sbjct: 7 RIAFYRFCNLT-QVPQVLN-TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 166 -PDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL---DVLQDLP 220
+AF++L L LDL S+ + L P + L L L L LS + ++L
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 221 -LRDLNIENNLFSGPIPEKMLQ 241
L L++ N
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFG 145
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 4e-19
Identities = 31/156 (19%), Positives = 59/156 (37%), Gaps = 10/156 (6%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMS 155
+++++L + + +I + N L ++ P + L L ++
Sbjct: 44 FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103
Query: 156 LNNNLLSGEI--PDAFQSLTGLINLDLSSNNLSG-ELPPSLENLSQLTTLHLQNNQLS-- 210
L LS + F++L L LDLS N + L PS L+ L ++ +NQ+
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 211 --GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPN 244
L+ LQ L ++ N + + N
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 5e-16
Identities = 37/162 (22%), Positives = 62/162 (38%), Gaps = 11/162 (6%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSG-SIPSSLATLTLLTDMSLNNN 159
+ +I LS N + + + + L+ N+FS S + + L + L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 160 LLSGEI-----PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD 214
+L D F+ L+ L L L+ N L+ P +L+ L L L +N+L+ L
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 215 VLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNST 255
L L+I N P P+ + + N F
Sbjct: 521 HNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-15
Identities = 29/142 (20%), Positives = 56/142 (39%), Gaps = 8/142 (5%)
Query: 98 NLGAFSSIRVIDLSNNHIG----GSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
+L I ++I + + ++++ LS TL L
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG- 211
++L N ++ +AF L L L+LS N L EL + L ++ + LQ N ++
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 212 TLDVLQDLP-LRDLNIENNLFS 232
+ L L+ L++ +N +
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 32/156 (20%), Positives = 60/156 (38%), Gaps = 20/156 (12%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSI--PSSLATLTLL 151
AF ++R++DL ++ I + + + L S ++ L L
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125
Query: 152 TDMSL-NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ--LTTLHLQNNQ 208
T + L N + S + +F L L ++D SSN + LE L L+ L N
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185
Query: 209 LS--------GTLDVLQDLPLRDLNIENNLFSGPIP 236
L ++ +++ L L++ N ++ I
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT 221
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 28/135 (20%), Positives = 52/135 (38%), Gaps = 11/135 (8%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMSLNN 158
++V++L+ N I I + N LS N S+ L + + L
Sbjct: 289 LKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQD 218
N ++ F+ L L LDL N L+ ++ + + + L N+L TL + +
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKI-N 400
Query: 219 LPLRDLNIENNLFSG 233
L +++ N
Sbjct: 401 LTANLIHLSENRLEN 415
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 7e-12
Identities = 31/138 (22%), Positives = 49/138 (35%), Gaps = 20/138 (14%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S+ + L N + + + L L+ L + LN+N L+
Sbjct: 451 PSLEQLFLGENMLQLAWETELC-----------------WDVFEGLSHLQVLYLNHNYLN 493
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLR 222
P F LT L L L+SN L+ L + + L L + NQL + + L
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLS 550
Query: 223 DLNIENNLFSGPIPEKML 240
L+I +N F
Sbjct: 551 VLDITHNKFICECELSTF 568
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 25/157 (15%), Positives = 43/157 (27%), Gaps = 27/157 (17%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNF---FLSDNQFSGSIPSSLATLTL--LTDMSLN 157
++ +DLS N I + + S NQ L L L+ SL
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182
Query: 158 NNLLSGEIPDAFQSLTGLI-NLDLSSNNLSG-----------------ELPPSLENLSQL 199
N L + + N+ L ++SG SL +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242
Query: 200 TTLHLQNNQLS----GTLDVLQDLPLRDLNIENNLFS 232
+ + T L +R L++ +
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 27/149 (18%), Positives = 55/149 (36%), Gaps = 11/149 (7%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
L A + S ++V+ L++N++ P + ++ L+ N+ + +
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH 521
Query: 144 SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP----PSLENLSQL 199
+ L + ++ N L PD F SL+ LD++ N E + N + +
Sbjct: 522 N-DLPANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFICECELSTFINWLNHTNV 577
Query: 200 TTLHLQNNQLSGTLDVLQDLPLRDLNIEN 228
T + D + L L+ E
Sbjct: 578 TIAGPPADIYCVYPDSFSGVSLFSLSTEG 606
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 40/157 (25%), Positives = 62/157 (39%), Gaps = 16/157 (10%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY Q+ +AVK L + S Q + D FL I + H NIV
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS---DDELKNNLSWNTRIRMALGAARALEYL 627
G + R ++ E + G L+ L ++L+ + +A A +YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 628 HEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLA 661
E +HR+ + N LL + D G+A
Sbjct: 157 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 12/157 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRI 564
++G G G VY G+ + AVK K+ + ++F+ + +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNL 70
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H +IV+L G E +I E G L L + KN+L T + +L +A+
Sbjct: 71 DHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAM 126
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
YL I VHR+ NIL+ V + D GL+
Sbjct: 127 AYLESIN---CVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 9e-19
Identities = 30/168 (17%), Positives = 64/168 (38%), Gaps = 9/168 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ L SI + +NN+I + +N +L++N+ + + + + L
Sbjct: 93 QELLVGPSIETLHAANNNI-SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 157 NNNLLSG-EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
N + + S L +L+L N + ++ + ++L TL L +N+L+
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPE 209
Query: 216 LQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNSTVAPS 259
Q + +++ NN I + + N GN F+
Sbjct: 210 FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 30/146 (20%), Positives = 53/146 (36%), Gaps = 7/146 (4%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSG-SIPSSLATLTLLTDMS 155
+ I L+NN I +Q L N+ + A+ L ++
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L N + ++ L LDLSSN L+ + P ++ + +T + L+NN+L
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA 232
Query: 216 LQDLP-LRDLNIENNLFSGPIPEKML 240
L+ L ++ N F
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFF 258
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 31/111 (27%), Positives = 47/111 (42%), Gaps = 8/111 (7%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
++D+ ++ S + + ++ L+ N LS T L L+LSSN L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74
Query: 192 SLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
LE+LS L TL L NN + L P + L+ NN S + Q
Sbjct: 75 DLESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNISR-VSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 25/149 (16%), Positives = 58/149 (38%), Gaps = 10/149 (6%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
+L + S++R +DL+NN++ + +++ ++N S + S ++ L
Sbjct: 75 DLESLSTLRTLDLNNNYV-QELLV--GPSIETLHAANNNIS-RVSCS--RGQGKKNIYLA 128
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSG-ELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
NN ++ + + LDL N + + L L+LQ N + +
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187
Query: 217 QDLP-LRDLNIENNLFSGPIPEKMLQIPN 244
L+ L++ +N + + +
Sbjct: 188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAG 215
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 23/135 (17%), Positives = 54/135 (40%), Gaps = 13/135 (9%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
L F+ + +++LS+N + + ++ ++ L++N L + +
Sbjct: 54 LAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG--TLDV 215
NN +S Q N+ L++N ++ S++ L L+ N++ ++
Sbjct: 108 NNNISRVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 216 LQDLP-LRDLNIENN 229
L LN++ N
Sbjct: 165 AASSDTLEHLNLQYN 179
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQL 199
+I + ++ L + QS + LDLS N LS L ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 200 TTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232
L+L +N L L+ L LR L++ NN
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-14
Identities = 26/150 (17%), Positives = 51/150 (34%), Gaps = 6/150 (4%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLT 152
E + ++ ++L N I + + ++ LS N+ + + + +T
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS-GELPPSLENLSQLTTLHLQNNQLSG 211
+SL NN L I A + L + DL N G L ++ T+ Q +
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KL 275
Query: 212 TLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
T ++ + L +P
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 29/148 (19%), Positives = 61/148 (41%), Gaps = 14/148 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
+ ++L L + +++ +DLS N + + L ++ LS N
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74
Query: 144 SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLH 203
L +L+ L + LNNN + E+ + L ++NN+S + S ++
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVSCS--RGQGKKNIY 126
Query: 204 LQNNQLSGTLD-VLQDLP-LRDLNIENN 229
L NN+++ D ++ L+++ N
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLN 154
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 16/178 (8%), Positives = 36/178 (20%), Gaps = 7/178 (3%)
Query: 94 ELGENLGAFSSIRVIDLSNNHI-GGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLT 152
+ + L ++ DL N G++ + ++ + T+ T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG----ELPPSLENLSQLTTLHLQNNQ 208
L L + + + G L EN ++ + Q
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 209 LSG-TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTS 264
V L + + +
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 11/157 (7%), Positives = 35/157 (22%), Gaps = 11/157 (7%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQF-------S 138
+ + G+N + + +P+ + ++ +
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 139 GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
+ ++ I I L+ L ++ ++
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 199 LTTL---HLQNNQLSGTLDVLQDLPLRDLNIENNLFS 232
L + +L + L L ++
Sbjct: 386 LDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEM 422
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 36/143 (25%), Positives = 59/143 (41%), Gaps = 7/143 (4%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
+ ++P +P Q FL N+ S +S LT + L++N+L+
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL--DVLQDL 219
AF L L LDLS N + P+ L +L TLHL L L + + L
Sbjct: 70 RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGL 128
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ 241
L+ L +++N +P+ +
Sbjct: 129 AALQYLYLQDNALQA-LPDDTFR 150
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 36/141 (25%), Positives = 60/141 (42%), Gaps = 15/141 (10%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTM---QNFFLSDNQFSGSIPS-SLATLTLLT 152
F + + L + + L + Q +L DN ++P + L LT
Sbjct: 99 ATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLT 156
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG 211
+ L+ N +S AF+ L L L L N ++ + P + +L +L TL+L N LS
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS- 214
Query: 212 TL--DVLQDLP-LRDLNIENN 229
L + L L L+ L + +N
Sbjct: 215 ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 9/117 (7%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTD 153
G F +++ + L +N + ++P + N FL N+ S + L L
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQL 209
+ L+ N ++ P AF+ L L+ L L +NNLS LP L L L L L +N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 46/195 (23%), Positives = 80/195 (41%), Gaps = 25/195 (12%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
Y + F + ++G G G V +A+ D + A+KK+ +++K L V + +
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLN 60
Query: 566 HANIVELKGYCAEHGQRLL----------IY---EYCSNGTLQDMLHSDDELKN-NLSWN 611
H +V E + ++ EYC NGTL D++HS++ + + W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 612 TRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
R L AL Y+H I+HR+ K NI +D+ V + D GLA +
Sbjct: 121 L-FRQIL---EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 672 VSHNLTIMRAGGVTH 686
+ + +
Sbjct: 174 KLDSQNLPGSSDNLT 188
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 22/166 (13%)
Query: 514 ENLIGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+G G VY+ L +A+K L +A +++ F R++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHP 72
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS------------DDELKNNLSWNTRIR 615
N+V L G + +I+ YCS+G L + L D +K+ L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ A +EYL +VH++ + N+L+ D L V +SD GL
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 39/167 (23%), Positives = 78/167 (46%), Gaps = 10/167 (5%)
Query: 503 SLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
S+++Y + IG G G + DG+ +K+++ S ++ +E V +
Sbjct: 22 SMEKYV----RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
++H NIV+ + E+G ++ +YC G L +++ + + +
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQIC 135
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
AL+++H+ I+HR+ KS NI L D V + D G+A +++S
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-18
Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 12/160 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL--PDGKLL--AVKKLDKRASSQQKDDEFLELVNNIDRI 564
IG G G V++ P+ + A+K S ++ FL+ + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQF 448
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H +IV+L G E+ +I E C+ G L+ L K +L + I A + AL
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTAL 504
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664
YL VHR+ + N+L+ + V + D GL+ +
Sbjct: 505 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 39/164 (23%), Positives = 61/164 (37%), Gaps = 12/164 (7%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS- 162
S I ++ + S+P+ +P + L N+ LT LT +SL++N LS
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 163 -GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDL 219
G + T L LDLS N + + + L QL L Q++ L V L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ-IPNFRK---DGNPFNSTVAP 258
L L+I + + + + GN F P
Sbjct: 126 RNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLP 168
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 32/151 (21%), Positives = 53/151 (35%), Gaps = 26/151 (17%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQNFF---------LSDNQFSGSIPSSLAT 147
G F + + LS+N + S Q+ F LS N ++ S+
Sbjct: 46 GVFDKLTQLTKLSLSSNGL-----SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 99
Query: 148 LTLLTDMSLNNNLLSGEIPD--AFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHL 204
L L + ++ L ++ + F SL LI LD+S + LS L L +
Sbjct: 100 LEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKM 157
Query: 205 QNNQLSGTL--DVLQDLP-LRDLNIENNLFS 232
N D+ +L L L++
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 17/146 (11%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPS-SLATLTLL 151
F ++ +D+S+ H + L +++ ++ N F + L L
Sbjct: 120 SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS-SLEVLKMAGNSFQENFLPDIFTELRNL 177
Query: 152 TDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQL 209
T + L+ L ++ AF SL+ L L++S NN L + L+ L L N +
Sbjct: 178 TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
Query: 210 SG-TLDVLQDLP--LRDLNIENNLFS 232
LQ P L LN+ N F+
Sbjct: 236 MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 26/141 (18%), Positives = 47/141 (33%), Gaps = 17/141 (12%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNF------FLSDNQFSGSIPSS--LATLTLLTDM 154
+S++ +DLS N + + + + +L L +
Sbjct: 78 TSLKYLDLSFNGV-----ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYL 131
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG-T 212
+++ F L+ L L ++ N+ P L LT L L QL +
Sbjct: 132 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 191
Query: 213 LDVLQDLP-LRDLNIENNLFS 232
L L+ LN+ +N F
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFF 212
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 29/147 (19%), Positives = 53/147 (36%), Gaps = 9/147 (6%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSG-SIPSSLATLTLLTDM 154
+ I L+NN I + + L N+ + A+ L +
Sbjct: 116 CSRGQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD 214
+L N + ++ L LDLSSN L+ + P ++ + +T + L+NN+L
Sbjct: 175 NLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEK 231
Query: 215 VLQDLP-LRDLNIENNLFSGPIPEKML 240
L+ L ++ N F
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFF 258
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
++D+ ++ S + + ++ L+ N LS T L L+LSSN L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74
Query: 192 SLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
LE+LS L TL L NN + L V + L+ NN S + Q
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELLVGPS--IETLHAANNNISR-VSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 26/150 (17%), Positives = 51/150 (34%), Gaps = 6/150 (4%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLT 152
E + ++ ++L N I + + ++ LS N+ + + + +T
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS-GELPPSLENLSQLTTLHLQNNQLSG 211
+SL NN L I A + L + DL N G L ++ T+ Q +
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL- 275
Query: 212 TLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241
T ++ + L +P
Sbjct: 276 TGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 24/138 (17%), Positives = 56/138 (40%), Gaps = 15/138 (10%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+L F+ + +++LS+N + + ++ ++ L++N L + +
Sbjct: 52 ADLAPFTKLELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLH 105
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG--T 212
NN +S Q N+ L++N ++ L S++ L L+ N++
Sbjct: 106 AANNNISRVSCSRGQGKK---NIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNF 161
Query: 213 LDVLQDLP-LRDLNIENN 229
++ L LN++ N
Sbjct: 162 AELAASSDTLEHLNLQYN 179
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 2/94 (2%)
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQL 199
+I + ++ L + QS + LDLS N LS L ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 200 TTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232
L+L +N L L+ L LR L++ NN
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 28/148 (18%), Positives = 60/148 (40%), Gaps = 14/148 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPS 143
+ ++L L + +++ +DLS N + + L ++ LS N
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL- 74
Query: 144 SLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLH 203
L +L+ L + LNNN + E+ + L ++NN+S + ++
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVSC--SRGQGKKNIY 126
Query: 204 LQNNQLSGTLD-VLQDLP-LRDLNIENN 229
L NN+++ D ++ L+++ N
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLN 154
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 23/163 (14%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V+ A+ + L+AVK L K + + D F + ++H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKD-FQREAELLTNLQHEHIV 80
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTRIRMAL 618
+ G C + ++++EY +G L L + K L + + +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
A + YL VHR+ + N L+ +L V + D G++
Sbjct: 141 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 40/157 (25%), Positives = 62/157 (39%), Gaps = 16/157 (10%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G VY Q+ +AVK L + S Q + D FL I + H NIV
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS---DDELKNNLSWNTRIRMALGAARALEYL 627
G + R ++ E + G L+ L ++L+ + +A A +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 628 HEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLA 661
E +HR+ + N LL + D G+A
Sbjct: 198 EENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 37/142 (26%), Positives = 56/142 (39%), Gaps = 9/142 (6%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+RV+ S+ + +P LP L +N+ + L L + L NN +S
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL--DVLQDLP- 220
P AF L L L LS N L ELP + L L + N+++ + V L
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQ 146
Query: 221 LRDLNIENN-LFSGPIPEKMLQ 241
+ + + N L S I Q
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 17/144 (11%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMSL 156
G S+ + L N I + + + N LS N S SLA L ++ L
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-------LENLSQLTTLHLQNNQL 209
NNN L ++P + + L +NN+S + + + + + L +N +
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
Query: 210 SGTL---DVLQDLP-LRDLNIENN 229
+ + + + N
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 36/145 (24%), Positives = 62/145 (42%), Gaps = 19/145 (13%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQNF------FLSDNQFSGSIPSSLATLTL 150
F+ + V++L N + I Q ++D + +IP L
Sbjct: 139 SVFNGLNQMIVVELGTNPL--KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPS 193
Query: 151 LTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQ 208
LT++ L+ N ++ ++ + + L L L LS N++S + SL N L LHL NN+
Sbjct: 194 LTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNK 251
Query: 209 LSGTLDVLQDLP-LRDLNIENNLFS 232
L L D ++ + + NN S
Sbjct: 252 LVKVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 27/137 (19%), Positives = 49/137 (35%), Gaps = 29/137 (21%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
+++ + + N I + + F+G L + + L N
Sbjct: 118 KMPKTLQELRVHENEI--------------TKVRKSVFNG--------LNQMIVVELGTN 155
Query: 160 LLSGEI--PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVL 216
L AFQ + L + ++ N++ +P L LT LHL N+++ L
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASL 212
Query: 217 QDLP-LRDLNIENNLFS 232
+ L L L + N S
Sbjct: 213 KGLNNLAKLGLSFNSIS 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 28/149 (18%), Positives = 57/149 (38%), Gaps = 19/149 (12%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTD 153
G F ++ + L NN I I + +LS NQ +P + L +
Sbjct: 70 GDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQE 125
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL-SGELPP-SLENLSQLTTLHLQNNQLS- 210
+ ++ N ++ F L +I ++L +N L S + + + + +L+ + + + ++
Sbjct: 126 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185
Query: 211 ---GTLDVLQDLPLRDLNIEN---NLFSG 233
G L +L L I G
Sbjct: 186 IPQGLPPSLTELHLDGNKITKVDAASLKG 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 15/160 (9%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPV------TMQNFFLSDNQF-- 137
+ A+ E + F ++ +DLS+N G I + T+Q L +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 138 -SGSIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLEN 195
SG + A L + L++N L + + L +L+LS L ++P L
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272
Query: 196 LSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGP 234
++L+ L L N+L +LP + +L+++ N F
Sbjct: 273 PAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 23/147 (15%), Positives = 41/147 (27%), Gaps = 16/147 (10%)
Query: 102 FSSIRVIDLSNNHIGG------SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+ +++L N + L ++ ++ + L+ +
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 156 LNNNLLSGEI-------PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
L++N GE P F +L L + SG QL L L +N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 209 LSGTLDVLQDLP---LRDLNIENNLFS 232
L L LN+
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 31/164 (18%), Positives = 53/164 (32%), Gaps = 19/164 (11%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIP-SILPVTMQN---FFLSDNQFSGSIPSSLATL----- 148
+ S ++ + L N + G+ P +L T + L + ++ + LA L
Sbjct: 90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148
Query: 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS----LENLSQLTTLHL 204
L +S+ + + L LDLS N GE L L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 205 QNNQLSGTLDVLQDL-----PLRDLNIENNLFSGPIPEKMLQIP 243
+N + V L L+ L++ +N P
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 33/196 (16%), Positives = 64/196 (32%), Gaps = 28/196 (14%)
Query: 65 DPCGESWQGVQCNASDIIAIILNGANL-----GGELGENLGAFS------SIRVIDLSNN 113
DP + C + + + G +L + +LG F+ S++ + +
Sbjct: 19 DPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAA 78
Query: 114 HIGGSIPSILPVTM-----QNFFLSDNQFSGSIPSSLATLTL--LTDMSLNNNLLSGEIP 166
I I + Q L + + +G+ P L T L ++L N +
Sbjct: 79 RIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA 138
Query: 167 DAFQ----SLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-- 220
+ GL L ++ + + L+TL L +N G ++ L
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 221 ----LRDLNIENNLFS 232
L+ L + N
Sbjct: 199 KFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 22/128 (17%), Positives = 42/128 (32%), Gaps = 11/128 (8%)
Query: 130 FFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD---AFQSLTGLINLDLSSNNLS 186
D + + + L +++ + I ++GL L L + ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 187 GELPPSLENL--SQLTTLHLQNNQLSGTLDVLQDLP------LRDLNIENNLFSGPIPEK 238
G PP L L L+L+N + L +L L+ L+I E+
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 239 MLQIPNFR 246
+ P
Sbjct: 169 VRVFPALS 176
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 27/118 (22%), Positives = 45/118 (38%), Gaps = 8/118 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLI 176
+P + P + LS N + +S + L L + + I + F+ L+ LI
Sbjct: 24 QVPEL-PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 177 NLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL---DVLQDLP-LRDLNIENN 229
L L N +L L+ L L L L G + + + L L L + +N
Sbjct: 83 ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 14/136 (10%)
Query: 103 SSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPS-SLATLTLLTDMSLNN 158
S ++ DLS + I ++ + ++ L+ N+ + I + LT L ++L+
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS----GTL 213
N L F++L L LDLS N++ L S L L L L NQL G
Sbjct: 333 NFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIF 391
Query: 214 DVLQDLPLRDLNIENN 229
D L L+ + + N
Sbjct: 392 DRLT--SLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 31/169 (18%), Positives = 59/169 (34%), Gaps = 21/169 (12%)
Query: 100 GAFSSI---RVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPSS-LATLTLL 151
+FS + + + + G I + L ++ L NQF + + L L
Sbjct: 48 TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS-SLIILKLDYNQFL-QLETGAFNGLANL 105
Query: 152 TDMSLNNNLL-SGEIP-DAFQSLTGLINLDLSSNNLSGELPPS--LENLSQLTTLHLQNN 207
++L L + + F+ LT L L L NN+ ++ P+ N+ + L L N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFN 164
Query: 208 QLS----GTLDVLQDLPLRDLNIENN--LFSGPIPEKMLQIPNFRKDGN 250
++ L Q L + + + N K+ +
Sbjct: 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 35/206 (16%), Positives = 58/206 (28%), Gaps = 36/206 (17%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP-------VTMQNFFLSDNQF-SGSIPS-SLAT 147
F SS+ ++ L N L ++ L+ +
Sbjct: 73 NTFRGLSSLIILKLDYNQF-----LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
Query: 148 LTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENL--SQLTTLHL 204
LT L + L +N + P F ++ LDL+ N + L N T L L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187
Query: 205 QNNQLS------------GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK--DGN 250
+ L G + L++ N F + ++ K
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTS--ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 251 PFNSTVAPSRPPTSSVTPPPAPPFFG 276
NS S ++ P F G
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 11/94 (11%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPS-SLATLTLLT 152
AF + + ++LS N +G SI S + ++ LS N ++ S L L
Sbjct: 317 NAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLK 374
Query: 153 DMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNL 185
+++L+ N L +PD F LT L + L +N
Sbjct: 375 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 28/167 (16%)
Query: 517 IGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFL---ELVNNIDRIRHA 567
+G G G V A + +AVK L + A+ + + +++ +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGH--HL 91
Query: 568 NIVELKGYCAEHGQ-RLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTRI 614
N+V L G C + G ++I E+C G L L +D K+ L+ I
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ A+ +E+L +HR+ + NILL + V + D GLA
Sbjct: 152 CYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 32/210 (15%)
Query: 478 AEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQE---------NLIGAGMLGSVYRA 528
A G+ S K + + I + Q ++++ +G G G V+ A
Sbjct: 2 AMGSGSSLSPTEGKG-SGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 529 QLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQR 582
+ + L+AVK L K AS + D F + ++H +IV G C E
Sbjct: 61 ECHNLLPEQDKMLVAVKAL-KEASESARQD-FQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 583 LLIYEYCSNGTLQDML-----------HSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L+++EY +G L L +D L + +A A + YL +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
VHR+ + N L+ L V + D G++
Sbjct: 179 ---FVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 41/172 (23%), Positives = 70/172 (40%), Gaps = 25/172 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD------GKLLAVKKLDKRASSQQKDDEFL---ELVN 559
N+ +GAG G V A +AVK L A + +K+ + ++++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMS 104
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML----------HSDDELKNNLS 609
++ + H NIV L G C G L+I EYC G L + L + + S
Sbjct: 105 HLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 610 WNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ + A+ + +L +HR+ + N+LL + + D GLA
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 29/168 (17%)
Query: 517 IGAGMLGSVYRAQLPDGKLL--------AVKKLDKRASSQQKDDEFL---ELVNNIDRIR 565
+G G G V A+ AVK L A+ + D + E++ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK-- 99
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTR 613
H NI+ L G C + G +I EY S G L++ L + + +++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ AR +EYL +HR+ + N+L+ ++ + ++D GLA
Sbjct: 160 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 40/200 (20%), Positives = 71/200 (35%), Gaps = 18/200 (9%)
Query: 484 KTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLD 542
+T T ++ + + + +G G G V+R + G AVKK+
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR 92
Query: 543 KRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSD 601
+ E + + IV L G G + I+ E G+L ++
Sbjct: 93 LEVFRVE------E-LVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQM 144
Query: 602 DELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGL 660
L + + + AL LEYLH I+H + K+ N+LL D ++ D G
Sbjct: 145 GCLPEDRALYY-LGQAL---EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGH 197
Query: 661 APLISSGSVSQVSHNLTIMR 680
A + + + +
Sbjct: 198 ALCLQPDGLGKSLLTGDYIP 217
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 14/144 (9%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ + ++ +P + + L +NQ +S L L + L+ N +
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS-------GTL 213
AF L L L+L N L+ +P + LS+L L L+NN + +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 214 DVLQDLPLRDLN----IENNLFSG 233
L+ L L +L I F G
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 39/165 (23%), Positives = 65/165 (39%), Gaps = 40/165 (24%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN-------------------F------- 130
GAF ++ + L NN I SIPS + + F
Sbjct: 130 GAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188
Query: 131 --FLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE 188
L+ IP+ L L L ++ L+ N LS P +FQ L L L + + +
Sbjct: 189 YLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-V 245
Query: 189 LPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
+ + +NL L ++L +N L+ L D+ L L +++ +N
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 32/115 (27%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
GAF S++R ++L+ ++ IP++ P+ + LS N S P S L L +
Sbjct: 179 GAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQL 209
+ + + +AF +L L+ ++L+ NNL+ LP L L +HL +N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 40/181 (22%), Positives = 73/181 (40%), Gaps = 32/181 (17%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR 565
+ F + LIG+G G V++A+ DGK +K++ + E V + ++
Sbjct: 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-----NNEKAERE-VKALAKLD 62
Query: 566 HANIVELKGY---------------CAEHGQRLLIY-EYCSNGTLQDML--HSDDELKNN 607
H NIV G + L I E+C GTL+ + ++L
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 608 LSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
L+ ++ ++Y+H +++R+ K +NI L D V + D GL + +
Sbjct: 123 LALELFEQITK----GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 668 S 668
Sbjct: 176 G 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 8e-18
Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 11/119 (9%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPS--SLATLTLLTDMSLNNNLLSGEIP-DAFQSLTG 174
++P LP LS N S + + + LT L + L++N L+ I +AF +
Sbjct: 32 NVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 175 LINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
L LDLSSN+L L +L L L L NN + + + +D+ L+ L + N
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 19/170 (11%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPS-SLATLTLLTDMS 155
S ++DLS+N++ P + N LS N + I S + + L +
Sbjct: 36 SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS---- 210
L++N L F L L L L +N++ + + E+++QL L+L NQ+S
Sbjct: 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPV 153
Query: 211 GTLDVLQDLP-LRDLNIENNLFSGPIPEKM------LQIPNFRKDGNPFN 253
+ LP L L++ +N +P NP
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKK-LPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 32/161 (19%), Positives = 65/161 (40%), Gaps = 15/161 (9%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158
L S+ ++S N + ++ P+ ++ S N + + + LT + L +
Sbjct: 182 LSLIPSLFHANVSYNLLS-TLAI--PIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 235
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTLDVLQ 217
N L+ + + GL+ +DLS N L ++ + +L L++ NN+L Q
Sbjct: 236 NNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQ 292
Query: 218 DLP-LRDLNIENNLFSGPIPEKMLQIPNFRK---DGNPFNS 254
+P L+ L++ +N + Q D N +
Sbjct: 293 PIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT 332
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 32/166 (19%), Positives = 59/166 (35%), Gaps = 7/166 (4%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLT 149
N+ L L ++ +D S+N I + + V + L N + L
Sbjct: 192 NVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNNLT-DTA-WLLNYP 248
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
L ++ L+ N L + F + L L +S+N L L + + L L L +N L
Sbjct: 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
Query: 210 SGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ-IPNFRKDGNPFN 253
L +L +++N + + N N ++
Sbjct: 308 LHVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 33/140 (23%), Positives = 58/140 (41%), Gaps = 11/140 (7%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMS 155
L +F + +++L++ I I + ++ N P + LLT +
Sbjct: 65 LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123
Query: 156 LNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSG-T 212
L N LS +P F + L L +S+NNL + + + L L L +N+L+
Sbjct: 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVD 181
Query: 213 LDVLQDLPLRDLNIENNLFS 232
L ++ L N+ NL S
Sbjct: 182 LSLIPS--LFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 35/144 (24%), Positives = 60/144 (41%), Gaps = 15/144 (10%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSL-ATLTLLTDMSLNN 158
+I+ + + N I +P + + L N S S+P + LT +S++N
Sbjct: 93 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 150
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQD 218
N L D FQ+ T L NL LSSN L+ + S + L ++ N LS L
Sbjct: 151 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNLLS----TLAI 203
Query: 219 LP-LRDLNIENNLFSGPIPEKMLQ 241
+ +L+ +N + + +
Sbjct: 204 PIAVEELDASHNSINV-VRGPVNV 226
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 31/139 (22%), Positives = 55/139 (39%), Gaps = 9/139 (6%)
Query: 108 IDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP- 166
ID+ + I + ++ + L + + ++LN+ + EI
Sbjct: 28 IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDT 86
Query: 167 DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL--DVLQDLP-LR 222
AF + L + N + LPP +N+ LT L L+ N LS +L + + P L
Sbjct: 87 YAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 144
Query: 223 DLNIENNLFSGPIPEKMLQ 241
L++ NN I + Q
Sbjct: 145 TLSMSNNNLER-IEDDTFQ 162
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 9/130 (6%)
Query: 118 SIPSILPV--TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGL 175
I S L + + TL ++ N+ + S +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 176 INLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLF 231
L+L+ + E+ + + L++ N + L V Q++P L L +E N
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 232 SGPIPEKMLQ 241
S +P +
Sbjct: 130 SS-LPRGIFH 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 16/111 (14%), Positives = 39/111 (35%), Gaps = 5/111 (4%)
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS- 192
I S+L + D+ ++ +L + ++ + +LP +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64
Query: 193 LENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
L++ Q+ L+L + Q+ ++ L + N +P + Q
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQ 114
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 16/110 (14%), Positives = 37/110 (33%), Gaps = 9/110 (8%)
Query: 103 SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNL 160
+ + +SNN + ++ T++ LS N + + L ++ L++N
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329
Query: 161 LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
+ + + L NL LS N+ + + +
Sbjct: 330 IV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQH 374
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 38/227 (16%), Positives = 78/227 (34%), Gaps = 23/227 (10%)
Query: 448 PPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQY 507
P + + P + + +S+ R ++I
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI------ 60
Query: 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH- 566
IG+G V++ ++ A+K ++ + Q D + + +++++
Sbjct: 61 ------LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 567 -ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
I+ L Y Q + + C N L L K ++ R A+
Sbjct: 115 SDKIIRLYDYE-ITDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 169
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672
+H+ IVH + K AN L+ D + + + D G+A + + S V
Sbjct: 170 TIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV 212
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 29/168 (17%)
Query: 517 IGAGMLGSVYRAQLPDGKLL--------AVKKLDKRASSQQKDDEFL---ELVNNIDRIR 565
+G G G V A+ AVK L A+ + D + E++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK-- 145
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTR 613
H NI+ L G C + G +I EY S G L++ L + + +++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ AR +EYL +HR+ + N+L+ ++ + ++D GLA
Sbjct: 206 VSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 34/124 (27%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 109 DLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDA 168
+ ++ ++P LP LS+N ++L T LT ++L+ L+ ++
Sbjct: 16 NCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-V 72
Query: 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLN 225
+L L LDLS N L LP + L LT L + N+L+ +L L+ L L++L
Sbjct: 73 DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELY 130
Query: 226 IENN 229
++ N
Sbjct: 131 LKGN 134
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 37/140 (26%), Positives = 54/140 (38%), Gaps = 11/140 (7%)
Query: 98 NLGAFS---SIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSL-ATLTLL 151
L + +DLS+N + S+P + + +S N+ + S+P L L
Sbjct: 69 KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGEL 126
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS 210
++ L N L P L L L++NNL+ ELP L L L TL LQ N L
Sbjct: 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
Query: 211 GTLDVLQDLP-LRDLNIENN 229
L + N
Sbjct: 186 TIPKGFFGSHLLPFAFLHGN 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 24/178 (13%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+++L+ F L+G G G VY+ + + G+L A+K +D DE E+
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD------VTGDEEEEIKQ 69
Query: 560 NI----DRIRHANIVE-----LKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLS 609
I H NI +K +L L+ E+C G++ D++ +
Sbjct: 70 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 610 WNTRI-RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
W I R L R L +LH+ ++HR+ K N+LL ++ V + D G++ +
Sbjct: 130 WIAYICREIL---RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 29/168 (17%)
Query: 517 IGAGMLGSVYRAQLPDGKLL--------AVKKLDKRASSQQKDDEFL---ELVNNIDRIR 565
+G G G V A+ AVK L A+ + D + E++ I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGK-- 133
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDML------------HSDDELKNNLSWNTR 613
H NI+ L G C + G +I EY S G L++ L + + LS
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ A AR +EYL +HR+ + N+L+ +D + ++D GLA
Sbjct: 194 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 45/171 (26%), Positives = 76/171 (44%), Gaps = 30/171 (17%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
+G G G V +A K +AVK L + AS + D L N + ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPHVI 89
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDML--------------------HSDDELKNNLSW 610
+L G C++ G LLI EY G+L+ L D + L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 611 NTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
I A ++ ++YL E+ +VHR+ + NIL+ + + +SD GL+
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 42/176 (23%), Positives = 67/176 (38%), Gaps = 29/176 (16%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFL---ELVN 559
N S +GAG G V A +AVK L A +++ + ++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLS 81
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDML--------------HSDDELK 605
+ H NIV L G C G L+I EYC G L + L ++ +
Sbjct: 82 YLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L + + A+ + +L +HR+ + NILL + D GLA
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 192
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 34/173 (19%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFL---ELVNNIDRIRHA 567
+G+G G V A +AVK L ++A S +++ + +++ + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGS--HE 109
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDML-------------------HSDDELKNNL 608
NIV L G C G LI+EYC G L + L ++E N L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
++ + A A+ +E+L VHR+ + N+L+ V + D GLA
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 39/233 (16%), Positives = 73/233 (31%), Gaps = 51/233 (21%)
Query: 448 PPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQY 507
P P P P P +P V ++ + + R
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPE----VLVDPRSRRRYVRGR---------- 47
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---R 563
+G G + ++ A K + K + E ++ I
Sbjct: 48 --------FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRS 97
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR- 622
+ H ++V G+ ++ ++ E C +L ++ R + AR
Sbjct: 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR------------RKALTEPEARY 145
Query: 623 -------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+YLH ++HR+ K N+ L++DL V + D GLA +
Sbjct: 146 YLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 40/169 (23%), Positives = 66/169 (39%), Gaps = 11/169 (6%)
Query: 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI- 564
+ SF + + +G G G V++ + DG+L AVK+ + L V + +++
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 565 RHANIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
+H V L+ E G L + E C +LQ +L A
Sbjct: 115 QHPCCVRLEQ-AWEEGGILYLQTELCG-PSLQQHCE---AWGASLPEAQVWGYLRDTLLA 169
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672
L +LH +VH + K ANI L + D GL + + +V
Sbjct: 170 LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 33/171 (19%), Positives = 60/171 (35%), Gaps = 29/171 (16%)
Query: 94 ELGENLGAFSSIRVIDLSNN--------HIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
L ++ + + +R + + + + S + N L S+P
Sbjct: 141 ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTL 202
+S+A L L + + N+ LS + A L L LDL PP + L L
Sbjct: 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 203 HLQN-NQLSGTLDVLQDLP--------LRDLNIENNLFSGPIPEKMLQIPN 244
L++ + L LP L L++ + +P + Q+P
Sbjct: 259 ILKDCSNLL-------TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 25/158 (15%), Positives = 55/158 (34%), Gaps = 14/158 (8%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTM------QNFFLSDNQFSGSIPSSLAT 147
+ +++ + L I LP ++ ++ + ++ S ++ ++
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGI-----RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
L L ++ L P F L L L + LP + L+QL L L+
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287
Query: 208 QLSGTL-DVLQDLP-LRDLNIENNLFSGPIPEKMLQIP 243
L ++ LP + + +L + + + P
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 28/157 (17%), Positives = 53/157 (33%), Gaps = 31/157 (19%)
Query: 94 ELGENLGAFSSI--RVIDLSNNHIGGSIPSIL--PVTMQNFFLSDNQFSGSIPSSLATLT 149
+ L + ++L + + P +Q+ + +P ++
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL---------ENLSQLT 200
L ++L N L +P + SL L L + + ELP L + L L
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 201 TLHLQNNQLSGTLDVLQDLP--------LRDLNIENN 229
+L L+ ++ LP L+ L I N+
Sbjct: 187 SLRLEWTG-------IRSLPASIANLQNLKSLKIRNS 216
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 12/94 (12%), Positives = 24/94 (25%), Gaps = 7/94 (7%)
Query: 139 GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
GS + ++ + D N D + + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 199 LTTLHLQNNQLSGTLDVLQDLP---LRDLNIENN 229
L T D+L+D L + +
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSV 91
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 4e-17
Identities = 30/148 (20%), Positives = 62/148 (41%), Gaps = 12/148 (8%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158
L S+ ++S N + ++ P+ ++ S N + + + LT + L +
Sbjct: 188 LSLIPSLFHANVSYNLLS-TLAI--PIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 241
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTLDVLQ 217
N L+ + + GL+ +DLS N L ++ + +L L++ NN+L Q
Sbjct: 242 NNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQ 298
Query: 218 DLP-LRDLNIENNLFSGPIPEKMLQIPN 244
+P L+ L++ +N + Q
Sbjct: 299 PIPTLKVLDLSHNHLLH-VERNQPQFDR 325
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 2e-16
Identities = 32/166 (19%), Positives = 59/166 (35%), Gaps = 7/166 (4%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLT 149
N+ L L ++ +D S+N I + + V + L N + L
Sbjct: 198 NVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPVNVELTILKLQHNNLT-DTA-WLLNYP 254
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
L ++ L+ N L + F + L L +S+N L L + + L L L +N L
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313
Query: 210 SGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ-IPNFRKDGNPFN 253
L +L +++N + + N N ++
Sbjct: 314 LHVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 35/140 (25%), Positives = 60/140 (42%), Gaps = 11/140 (7%)
Query: 99 LGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMS 155
L +F + +++L++ I I + ++ N P + LLT +
Sbjct: 71 LDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 156 LNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLSGTL 213
L N LS +P F + L L +S+NNL + + + L L L +N+L+ +
Sbjct: 130 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HV 186
Query: 214 DVLQDLP-LRDLNIENNLFS 232
D L +P L N+ NL S
Sbjct: 187 D-LSLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 37/145 (25%), Positives = 62/145 (42%), Gaps = 17/145 (11%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSL-ATLTLLTDMSLNN 158
+I+ + + N I +P + + L N S S+P + LT +S++N
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 156
Query: 159 NLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQ 217
N L I D FQ+ T L NL LSSN L+ + SL + L ++ N LS L
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS----TLA 208
Query: 218 DLP-LRDLNIENNLFSGPIPEKMLQ 241
+ +L+ +N + + +
Sbjct: 209 IPIAVEELDASHNSINV-VRGPVNV 232
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 32/140 (22%), Positives = 59/140 (42%), Gaps = 11/140 (7%)
Query: 108 IDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSS-LATLTLLTDMSLNNNLLSGEIP 166
ID+ + I + ++ +P++ L + + ++LN+ + EI
Sbjct: 34 IDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EID 91
Query: 167 -DAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLSGTLD--VLQDLP-L 221
AF + L + N + LPP + +N+ LT L L+ N LS +L + + P L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
Query: 222 RDLNIENNLFSGPIPEKMLQ 241
L++ NN I + Q
Sbjct: 150 TTLSMSNNNLER-IEDDTFQ 168
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 22/130 (16%), Positives = 47/130 (36%), Gaps = 9/130 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTL--LTDMSLNNNLLSGEIPDAFQSLTGL 175
I S L + + + + + +TL ++ N+ + S +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 176 INLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLF 231
L+L+ + E+ + + L++ N + L V Q++P L L +E N
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 232 SGPIPEKMLQ 241
S +P +
Sbjct: 136 SS-LPRGIFH 144
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 17/118 (14%), Positives = 43/118 (36%), Gaps = 8/118 (6%)
Query: 128 QNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG 187
N ++ I S+L + D+ ++ +L + ++ +
Sbjct: 7 YNVKPRQPEYK-CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR- 64
Query: 188 ELPPS-LENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
+LP + L++ Q+ L+L + Q+ + ++ L + N +P + Q
Sbjct: 65 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQ 120
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 18/108 (16%), Positives = 40/108 (37%), Gaps = 8/108 (7%)
Query: 103 SSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNL 160
+ + +SNN + ++ T++ LS N + + L ++ L++N
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335
Query: 161 LSGEIPDAFQSLTGLINLDLSSNNLSG-ELPPSLENLSQLTTLHLQNN 207
+ + + L NL LS N+ L N+++ +
Sbjct: 336 IV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 18/168 (10%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTD 153
A S + V+ L + +I +I + +S + ++ + LT
Sbjct: 170 EALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 154 MSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG 211
+S+ + L+ +P A + L L L+LS N +S + L L +L + L QL+
Sbjct: 229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV 286
Query: 212 -TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ-IPNFRK---DGNPFN 253
+ L LR LN+ N + + E + + N D NP
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLTT-LEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 34/140 (24%), Positives = 57/140 (40%), Gaps = 10/140 (7%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPSSLATLTLLTDMSL 156
G + R++DL N I ++ + + L++N S P + L L + L
Sbjct: 29 GIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGL 87
Query: 157 NNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-- 213
+N L IP F L+ L LD+S N + L ++L L +L + +N L +
Sbjct: 88 RSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISH 145
Query: 214 DVLQDLP-LRDLNIENNLFS 232
L L L +E +
Sbjct: 146 RAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 32/152 (21%), Positives = 64/152 (42%), Gaps = 14/152 (9%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPS-SLATLTLL 151
F +++ +++ +N + I L +++ L + SIP+ +L+ L L
Sbjct: 122 YMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN-SLEQLTLEKCNLT-SIPTEALSHLHGL 178
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
+ L + ++ +F+ L L L++S + P+ LT+L + + L+
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA 238
Query: 212 -TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
++ L LR LN+ N S I ML
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPIST-IEGSMLH 269
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 29/129 (22%), Positives = 56/129 (43%), Gaps = 6/129 (4%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIP 142
++ + N ++ + +++ ++ ++P + + LS N S
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 143 SSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTT 201
S L L L ++ L L+ P AF+ L L L++S N L+ L S+ ++ L T
Sbjct: 266 SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324
Query: 202 LHLQNNQLS 210
L L +N L+
Sbjct: 325 LILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 31/143 (21%), Positives = 51/143 (35%), Gaps = 30/143 (20%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ R + ++P +P + L N+ ++
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGIPTETRLLDLGKNRIK-TLN------------------- 48
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG-TLDVLQDL 219
D F S L L+L+ N +S + P + NL L TL L++N+L L V L
Sbjct: 49 ----QDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGL 103
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ 241
L L+I N + + M Q
Sbjct: 104 SNLTKLDISENKIVI-LLDYMFQ 125
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 30/171 (17%)
Query: 517 IGAGMLGSVYRAQLPDGK------LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIV 570
IG G G V++A+ P ++AVK L + AS+ + D F + + NIV
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNIV 113
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHS--------------------DDELKNNLSW 610
+L G CA L++EY + G L + L S LS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 611 NTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
++ +A A + YL E VHR+ + N L+ +++ V ++D GL+
Sbjct: 174 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 56/282 (19%), Positives = 88/282 (31%), Gaps = 39/282 (13%)
Query: 399 HRSEMRRMGAIPHAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPP 458
H G E+ R ++ + +P + + P
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQ----------RRAFIRSLRDDPSQS 51
Query: 459 PPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIG 518
+ A+ F Q+Y IG
Sbjct: 52 ANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY----QKYD--PKDV--IG 103
Query: 519 AGMLGSVYRA-QLPDGKLLAVKKLDKRA---SSQQKDDEFLELVNNIDRIR----HANIV 570
G+ V R G AVK ++ A S +Q ++ +R H +I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLS-WNTR--IRMALGAARALEYL 627
L L+++ G L D L K LS TR +R L A+ +L
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLE---AVSFL 216
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
H IVHR+ K NILLDD++ + +SD G + + G
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK 255
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 42/143 (29%), Positives = 62/143 (43%), Gaps = 6/143 (4%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
+ S+ + SIPS L +++ LS+N+ + S L L + L +N ++
Sbjct: 31 DRNGICKGSSGSLN-SIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN 89
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS--GTLDVLQDL 219
D+F SL L +LDLS N LS L S + LS LT L+L N G + L
Sbjct: 90 TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHL 148
Query: 220 P-LRDLNIENNLFSGPIPEKMLQ 241
L+ L + N I K
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFA 171
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 28/149 (18%), Positives = 55/149 (36%), Gaps = 21/149 (14%)
Query: 100 GAF---SSIRVIDLSNNHI----GGSIPSILPVTMQNFFLSDNQFSGSIPS-SLATLTLL 151
F SS+ ++L N S+ S L + + F+ I A LT L
Sbjct: 118 SWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFL 176
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQL- 209
++ ++ + L P + +S+ + +L L L ++ S + L L++ L
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD 235
Query: 210 --------SGTLDVLQDLP-LRDLNIENN 229
+G + L R++ I +
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDE 264
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 21/148 (14%), Positives = 52/148 (35%), Gaps = 22/148 (14%)
Query: 100 GAFSSI---RVIDLSNNHIGGSIPSILPVTMQN---FFLSDNQFSGSIPS-SLATLTLLT 152
F+ + +++ + + S ++QN L Q + + + +
Sbjct: 168 KDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVE 225
Query: 153 DMSLNNNLLSG----EIP----DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204
+ L + L E+ ++ N+ ++ +L ++ L +S L L
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEF 284
Query: 205 QNNQLSGTL--DVLQDLP-LRDLNIENN 229
NQL ++ + L L+ + + N
Sbjct: 285 SRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 18/99 (18%), Positives = 34/99 (34%), Gaps = 14/99 (14%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP----------VTMQNFFLSDNQFSGSIPSSLA 146
SS+ ++L + + S L T +N ++D + L
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLN 274
Query: 147 TLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL 185
++ L ++ + N L F LT L + L +N
Sbjct: 275 QISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 33/124 (26%), Positives = 51/124 (41%), Gaps = 5/124 (4%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
IP LP + +N LS N S + L + L+ + A+QSL+ L
Sbjct: 21 KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENN-LFSG 233
L L+ N + L LS L L L+ + L L++LN+ +N + S
Sbjct: 81 LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 234 PIPE 237
+PE
Sbjct: 140 KLPE 143
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 32/144 (22%), Positives = 67/144 (46%), Gaps = 17/144 (11%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSLAT-LTLLT 152
GA+ + + L+ N I S+ ++Q + + S+ + L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLK 127
Query: 153 DMSLNNN-LLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLT----TLHLQN 206
++++ +N + S ++P+ F +LT L +LDLSSN + + L L Q+ +L L
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 207 NQLSG-TLDVLQDLPLRDLNIENN 229
N ++ +++ L++L ++ N
Sbjct: 187 NPMNFIQPGAFKEIRLKELALDTN 210
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 32/146 (21%), Positives = 59/146 (40%), Gaps = 21/146 (14%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSIL---PVTMQNFFLSDNQFSGSIPSS--LATLTLL 151
GAF SS++ + ++ S+ + T++ ++ N S + LT L
Sbjct: 94 GAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNL 151
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGL----INLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+ L++N + + L + ++LDLS N ++ + P +L L L N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN 210
Query: 208 QLS----GTLDVLQDLPLRDLNIENN 229
QL G D L L+ + + N
Sbjct: 211 QLKSVPDGIFDRLTS--LQKIWLHTN 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 36/240 (15%), Positives = 70/240 (29%), Gaps = 37/240 (15%)
Query: 447 PPPPPPPPPPPPPPPPPPPVVEKVIVK-------PIVPAEGTAVKTSTKTAKPFTTARSF 499
P P P +K+I K P+ T F
Sbjct: 3 PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNT--FEWQCKLPAIKPKTEF 60
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRAQ------LPDGKLLAVKKLDKRASSQQKDDE 553
+ S +L+G G VY A + + +K ++ +
Sbjct: 61 QLGS-----KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYI 113
Query: 554 FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN-LSWNT 612
+L+ + ++ +L+ E S GTL + ++ +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 613 RIRMALGAARALEYLHEICQPPIVHRNFKSANILL-----------DDDLAVSVSDCGLA 661
I A+ +E +H+ I+H + K N +L D +++ D G +
Sbjct: 174 VISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 37/157 (23%), Positives = 63/157 (40%), Gaps = 20/157 (12%)
Query: 513 QENLIGAGMLGSVYRA-QLPDGKLLAVK--KLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++G G G VY L + +A+K SQ +E + ++H NI
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE----IALHKHLKHKNI 81
Query: 570 VELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDD---ELKNNLSWNTRIRMALGAARALE 625
V+ G + I+ E G+L +L S + ++ G L+
Sbjct: 82 VQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LK 136
Query: 626 YLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLA 661
YLH+ IVHR+ K N+L++ + +SD G +
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTS 170
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 15/154 (9%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
S ++ + +S+N + S+P+ LP + + +N+ + S+P+ + L L ++ N L
Sbjct: 180 PSGLQELSVSDNQLA-SLPT-LPSELYKLWAYNNRLT-SLPALPSGLKELI---VSGNRL 233
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP- 220
+ +P + L L +S N L+ LP L +L + NQL+ + L L
Sbjct: 234 T-SLPV---LPSELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLTRLPESLIHLSS 285
Query: 221 LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
+N+E N S + + +I + P
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 35/184 (19%), Positives = 65/184 (35%), Gaps = 40/184 (21%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
+ V+++ + + ++P LP + + DN + S+P+ L L ++ N L+
Sbjct: 40 NGNAVLNVGESGL-TTLPDCLPAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT 94
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL--------------SQLTTLHLQNNQ 208
+P L L +L LP L L L L + +NQ
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQ 152
Query: 209 LSG---------TLDV----LQDLP-----LRDLNIENNLFSGPIPEKMLQIPNFRKDGN 250
L+ L L LP L++L++ +N + +P ++ N
Sbjct: 153 LASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNN 211
Query: 251 PFNS 254
S
Sbjct: 212 RLTS 215
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 9e-15
Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 50/190 (26%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S + + + N + S+P + P +Q +SDNQ + S+P+ + L L NN L+
Sbjct: 121 SGLCKLWIFGNQLT-SLPVLPP-GLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT 174
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL-----------------SQLTTLHLQ 205
+P +GL L +S N L+ LP L S L L +
Sbjct: 175 -SLPM---LPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVS 229
Query: 206 NNQLSG---------TLDV----LQDLP-----LRDLNIENNLFSGPIPEKMLQIPNFRK 247
N+L+ L V L LP L L++ N + +PE ++ + +
Sbjct: 230 GNRLTSLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETT 288
Query: 248 ---DGNPFNS 254
+GNP +
Sbjct: 289 VNLEGNPLSE 298
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 33/165 (20%), Positives = 57/165 (34%), Gaps = 38/165 (23%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
L + + H+ LP + ++ NQ + S+P L L+
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHL-----PALPSGLCKLWIFGNQLT-SLPVLPPGLQELS- 147
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL----------------- 196
+++N L+ +P L L +N L+ LP L
Sbjct: 148 --VSDNQLA-SLPALPSELC---KLWAYNNQLT-SLPMLPSGLQELSVSDNQLASLPTLP 200
Query: 197 SQLTTLHLQNNQLSGTLDVLQDLP--LRDLNIENNLFSGPIPEKM 239
S+L L NN+L+ L LP L++L + N + +P
Sbjct: 201 SELYKLWAYNNRLT----SLPALPSGLKELIVSGNRLTS-LPVLP 240
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 6e-12
Identities = 30/137 (21%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S ++ + +S N + S+P LP ++ +S N+ + S+P + L L S+ N L+
Sbjct: 221 SGLKELIVSGNRLT-SLPV-LPSELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT 274
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-- 220
+P++ L+ ++L N LS E + L ++T+ + + P
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLS-ERTL--QALREITSAPGYSGPIIRFDMAGASAPRE 330
Query: 221 LRDLNIENNLFSGPIPE 237
R L++ + P E
Sbjct: 331 TRALHLAAADWLVPARE 347
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 28/150 (18%), Positives = 54/150 (36%), Gaps = 10/150 (6%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S ++ + +S N + S+P + + + + NQ + +P SL L+ T ++L N LS
Sbjct: 241 SELKELMVSGNRLT-SLPMLPS-GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLR 222
A + +T + S + + LHL + P
Sbjct: 298 ERTLQALREIT---SAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354
Query: 223 DL----NIENNLFSGPIPEKMLQIPNFRKD 248
+N +++ + NF KD
Sbjct: 355 RWHMFGQEDNADAFSLFLDRLSETENFIKD 384
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 20/103 (19%), Positives = 36/103 (34%), Gaps = 18/103 (17%)
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+ ++ G L++ + L+ LP L + +TTL + +N L+
Sbjct: 26 GRAAVVQKMRACL--NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT------ 74
Query: 217 QDLP-----LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
LP LR L + N + +P + NP
Sbjct: 75 -SLPALPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTH 115
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 33/169 (19%), Positives = 68/169 (40%), Gaps = 24/169 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL--------AVKKLDKRASSQQKDDEFLELVNN 560
+G G +++ + +K LDK + + F E +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASM 65
Query: 561 IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
+ ++ H ++V G C + +L+ E+ G+L L + KN ++ ++ +A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQL 122
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLD--------DDLAVSVSDCGLA 661
A A+ +L E ++H N + NILL + + +SD G++
Sbjct: 123 AAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 16/171 (9%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
SF ++++G G G++ + D + +AVK++ D E ++L+ D H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE-CFSFADRE-VQLLRESD--EHPNV 80
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ + + + E C+ TLQ+ + D L T ++ L +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTT---SGLAHLHS 136
Query: 630 ICQPPIVHRNFKSANILL-----DDDLAVSVSDCGLAPLISSGSVSQVSHN 675
+ IVHR+ K NIL+ + +SD GL ++ G S +
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 32/170 (18%), Positives = 65/170 (38%), Gaps = 22/170 (12%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEF--------LELVNNIDR----- 563
+ G + + D K A+KK +K +++D ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 564 --IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
I++ + +G + + +IYEY N ++ L N + I++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 622 R----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
+ + Y+H + I HR+ K +NIL+D + V +SD G + +
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 37/156 (23%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
+ +G G G VY+A+ G L A K ++ + ++E + + I+ H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDH 75
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL-GAARALE 625
IV+L G G+ ++ E+C G + ++ EL L+ +I++ AL
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGLT-EPQIQVVCRQMLEALN 131
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+LH I+HR+ K+ N+L+ + + ++D G++
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
+P +P + +L NQF+ +P L+ LT + L+NN +S +F ++T L+
Sbjct: 24 VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT 82
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS----GTLDVLQDL 219
L LS N L +PP + L L L L N +S G + L L
Sbjct: 83 LILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSAL 128
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 47/222 (21%), Positives = 84/222 (37%), Gaps = 35/222 (15%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
P P P + A +
Sbjct: 10 HDYDIPTTENLYFQGAMDPMPAGGR--------------------AGSLKDPDVAELFFK 49
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID- 562
FS IG G G+VY A+ + + +++A+KK+ S +Q ++++ +++ +
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRF 107
Query: 563 --RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
++RH N ++ +G C L+ EYC G+ D+L + + AL
Sbjct: 108 LQKLRHPNTIQYRG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGAL- 164
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ L YLH ++HR+ K+ NILL + V + D G A
Sbjct: 165 --QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 27/158 (17%), Positives = 51/158 (32%), Gaps = 7/158 (4%)
Query: 107 VIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP 166
++D S N + +P L +S N S S + +L+ L + +++N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDI 62
Query: 167 DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRD 223
F+ L LDLS N L ++ L L L N ++ L+
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
Query: 224 LNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRP 261
L + + + + + P
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP 157
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 26/135 (19%), Positives = 54/135 (40%), Gaps = 10/135 (7%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIP---SSLATLTLLTDMSL 156
S +D SNN + ++ ++ L NQ + + L + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDI 381
Query: 157 -NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
N++ E L++L++SSN L+ + L ++ L L +N++
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQ 439
Query: 216 LQDLP-LRDLNIENN 229
+ L L++LN+ +N
Sbjct: 440 VVKLEALQELNVASN 454
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 23/146 (15%), Positives = 54/146 (36%), Gaps = 11/146 (7%)
Query: 103 SSIRVIDLSNNHIGG----SIPSILPVTMQNFFLSD---NQFSGSIPSSLATLTLLTDMS 155
+++ +SN + G +++ + + F + + +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS---GT 212
+ ++ ++LD S+N L+ + + +L++L TL LQ NQL
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI 366
Query: 213 LDVLQDLP-LRDLNIENNLFSGPIPE 237
++ + L+ L+I N S +
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 21/164 (12%), Positives = 47/164 (28%), Gaps = 19/164 (11%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
F ++ + LS H+ S + + L + L SL
Sbjct: 109 KEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL 168
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGEL-----------PPSLENLSQLTTLHLQ 205
+ + + ++ +L +N+ L L+ +L+ L L
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228
Query: 206 NNQLSGT-----LDVLQDLPLRDLNIENNLFSGPIPEKMLQIPN 244
N + + L ++ + +I N G + +
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 39/155 (25%), Positives = 63/155 (40%), Gaps = 21/155 (13%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRH 566
+G G G+VY A+ +LA+K L K + + + + R +RH
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG------VEHQLRREVEIQSHLRH 68
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
NI+ L GY + + LI EY GT+ L + + A AL Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----TYITELANALSY 124
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
H ++HR+ K N+LL + ++D G +
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
F++ IG G G V++ K++A+K +D ++ +DE ++ I +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQCDS 79
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSD--DELKNNLSWNTRIRMALGAARA 623
+ + G +L +I EY G+ D+L DE + T +R L +
Sbjct: 80 PYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA----TILREIL---KG 131
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
L+YLH +HR+ K+AN+LL + V ++D G+A ++
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 33/160 (20%), Positives = 65/160 (40%), Gaps = 11/160 (6%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH--ANIVEL 572
IG+G V++ ++ A+K ++ + Q D + + +++++ I+ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
Y ++ E C N L L K ++ R A+ +H+
Sbjct: 94 YDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 633 PPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672
IVH + K AN L+ D + + + D G+A + + S V
Sbjct: 148 --IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV 184
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 40/176 (22%), Positives = 71/176 (40%), Gaps = 12/176 (6%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+ S + + +++G G +V+R + G L A+K + + + D + E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE-FE 59
Query: 560 NIDRIRHANIVELKGYCAEHGQRL--LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA 617
+ ++ H NIV+L E R LI E+C G+L +L + L + + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVL 118
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSV 669
+ +L E IVHRN K NI+ D ++D G A +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR----HAN 568
++ G VY AQ + G+ A+K+L + + ++ + ++ H N
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-----AIIQEVCFMKKLSGHPN 87
Query: 569 IVELKGYCAEHGQR-------LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
IV+ + + L+ G L + L E + LS +T +++
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTC 146
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
RA++++H +PPI+HR+ K N+LL + + + D G A
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 34/164 (20%), Positives = 67/164 (40%), Gaps = 11/164 (6%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH--AN 568
+S IG+G V++ ++ A+K ++ + Q D + + +++++
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
I+ L Y ++ E C N L L K ++ R A+ +H
Sbjct: 71 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH 125
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672
+ IVH + K AN L+ D + + + D G+A + + S V
Sbjct: 126 QHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV 165
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 38/184 (20%), Positives = 70/184 (38%), Gaps = 19/184 (10%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDD 552
T F + + + + +G+G G V A+K + K + S +
Sbjct: 22 ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS 81
Query: 553 EFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT 612
+ LE V + + H NI++L + + L+ E G L D + + +
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFN--- 134
Query: 613 RIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLIS 665
A + + YLH+ IVHR+ K N+LL + D + + D GL+ +
Sbjct: 135 -EVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190
Query: 666 SGSV 669
+
Sbjct: 191 NQKK 194
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 41/193 (21%), Positives = 79/193 (40%), Gaps = 23/193 (11%)
Query: 501 IASLQQYTNSFSQENLIGAGM--LGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL 557
++S + +IG G L +V A+ P G+ + V++++ ++ L
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN---LEACSNEMVTFL 73
Query: 558 VNNID---RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDML--HSDDELKNNLSWN 611
+ H NIV + L ++ + + G+ +D++ H D +
Sbjct: 74 QGELHVSKLFNHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA--- 129
Query: 612 TRIRMAL-GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG-LAPLISSGSV 669
I L G +AL+Y+H + VHR+ K+++IL+ D V +S +IS G
Sbjct: 130 --IAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 670 SQVSHNLTIMRAG 682
+V H+
Sbjct: 185 QRVVHDFPKYSVK 197
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 34/135 (25%), Positives = 59/135 (43%), Gaps = 10/135 (7%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
I + + +I + + + L DNQ + + + L LT +T++
Sbjct: 35 VTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQIT-DL-APLKNLTKITELE 91
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L+ N L A L + LDL+S ++ ++ P L LS L L+L NQ++ +
Sbjct: 92 LSGNPLK--NVSAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT-NISP 146
Query: 216 LQDLP-LRDLNIENN 229
L L L+ L+I N
Sbjct: 147 LAGLTNLQYLSIGNA 161
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 24/139 (17%), Positives = 54/139 (38%), Gaps = 6/139 (4%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L ++++ + + N + + + ++ + DN+ S I S LA+L L ++
Sbjct: 145 SPLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVH 201
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L NN +S P + + L + L++ ++ + NL + + +
Sbjct: 202 LKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATI 259
Query: 216 LQDLPLRDLNIENNLFSGP 234
+ N+ NL S
Sbjct: 260 SDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 15/75 (20%), Positives = 33/75 (44%), Gaps = 6/75 (8%)
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
++ PD +L I + +N++ + +L +TTL ++ T++
Sbjct: 4 TQPTAINVIFPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG 58
Query: 216 LQDLP-LRDLNIENN 229
+Q L L L +++N
Sbjct: 59 VQYLNNLIGLELKDN 73
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 23/119 (19%), Positives = 42/119 (35%), Gaps = 21/119 (17%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L S + + +N I I + + + L +NQ S + S LA + L ++
Sbjct: 167 TPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQIS-DV-SPLANTSNLFIVT 223
Query: 156 LNNNLLSGEIPDAFQSLTGLI-----------------NLDLSSNNLSGELPPSLENLS 197
L N ++ + +L N +S NL+ L + N+S
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVS 282
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 37/155 (23%), Positives = 75/155 (48%), Gaps = 17/155 (10%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
F +G G GSVY+A G+++A+K++ + + E++ I +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-------ESDLQEIIKEISIMQQCDS 83
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
++V+ G ++ ++ EYC G++ D++ ++ T ++ L + LEY
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEY 140
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LH + +HR+ K+ NILL+ + ++D G+A
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
+I S+ +++ IG G G+VY A + G+ +A+++++ Q+ + ++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELII 65
Query: 559 NNID---RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSD--DELKNNLSWNT 612
N I ++ NIV G L ++ EY + G+L D++ DE
Sbjct: 66 NEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDE-----GQIA 119
Query: 613 RI-RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ R L +ALE+LH ++HR+ KS NILL D +V ++D G
Sbjct: 120 AVCRECL---QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 46/174 (26%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
L+G G VYRA+ + G +A+K +DK+A + +V + ++H
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG------MVQRVQNEVKIHCQLKHP 71
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------SDDELKNNLSWNTRIRMALGAA 621
+I+EL Y + L+ E C NG + L S++E A
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE----------------AR 115
Query: 622 R-------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ YLH I+HR+ +N+LL ++ + ++D GLA +
Sbjct: 116 HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 16/161 (9%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G+G G V+ + G +K ++K S + E + + + H NI+++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE-IEVLKSLDHPNIIKIFEV 88
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEYLHEIC 631
++ ++ E C G L + + S LS + AL Y H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSE----GYVAELMKQMMNALAYFHSQ- 143
Query: 632 QPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV 669
+VH++ K NIL + + D GLA L S
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 24/186 (12%)
Query: 495 TARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDE 553
T F S +++ + + ++G G G V G+ AVK + KR Q+ D E
Sbjct: 12 TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 554 FLELVNNID---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSW 610
L + ++ H NI++L + + G L+ E + G L D + S + S
Sbjct: 72 SLL--REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFS- 124
Query: 611 NTRIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPL 663
A R + Y+H+ IVHR+ K N+LL D + + D GL+
Sbjct: 125 ---EVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 664 ISSGSV 669
+
Sbjct: 179 FEASKK 184
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 34/117 (29%), Positives = 48/117 (41%), Gaps = 8/117 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
+IPS +P + L N+ S + LT L + LN+N L F+ L L
Sbjct: 30 AIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLET 89
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS----GTLDVLQDLPLRDLNIENN 229
L ++ N L LP + + L L L L NQL D L L L++ N
Sbjct: 90 LWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK--LTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 16/147 (10%)
Query: 100 GAFSSIR---VIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152
AF + ++ L++N + ++P+ + ++ +++DN+ ++P + L L
Sbjct: 55 KAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLA 112
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS- 210
++ L+ N L P F SLT L L L N L LP + + L+ L L L NNQL
Sbjct: 113 ELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR 171
Query: 211 ---GTLDVLQDLPLRDLNIENNLFSGP 234
G D L +L L+ N L P
Sbjct: 172 VPEGAFDKLTELKTLKLD-NNQLKRVP 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 9/115 (7%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152
G F ++ + L N + S+P + + L N+ S+P + LT L
Sbjct: 103 GVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK 160
Query: 153 DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
++ L NN L AF LT L L L +N L + ++L +L L LQ N
Sbjct: 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 31/131 (23%), Positives = 52/131 (39%), Gaps = 9/131 (6%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
L + I NN + +P LP+++++ +N L L LT + +
Sbjct: 190 ELQNLPFLTAIYADNNSLK-KLPD-LPLSLESIVAGNNILE--ELPELQNLPFLTTIYAD 245
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQ 217
NNLL +PD L L++ N L+ +LP ++L+ L + LS L
Sbjct: 246 NNLLK-TLPD---LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLY 300
Query: 218 DLPLRDLNIEN 228
L I +
Sbjct: 301 YLNASSNEIRS 311
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 41/181 (22%), Positives = 71/181 (39%), Gaps = 34/181 (18%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
EL E + S+ V + + + S LP ++ +S+NQ +P L + L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKAL-----SDLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKI 157
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-- 211
+ ++NN L ++PD L + +N L E P L+NL LT ++ NN L
Sbjct: 158 IDVDNNSLK-KLPD---LPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLKKLP 211
Query: 212 -------TLDV----LQDLP-------LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFN 253
++ L++LP L + +NNL +P+ + N
Sbjct: 212 DLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLT 270
Query: 254 S 254
Sbjct: 271 D 271
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 34/148 (22%), Positives = 58/148 (39%), Gaps = 21/148 (14%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLS 162
S+ +++SNN + +P++ P ++ S N + +P L L + N L
Sbjct: 317 PSLEELNVSNNKLI-ELPALPP-RLERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR 370
Query: 163 GEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-- 220
E PD +S+ DL N+ E+P +N L LH++ N L D+P
Sbjct: 371 -EFPDIPESVE-----DLRMNSHLAEVPELPQN---LKQLHVETNPLR----EFPDIPES 417
Query: 221 LRDLNIENNLFSGPIPEKMLQIPNFRKD 248
+ DL + + P D
Sbjct: 418 VEDLRMNSERVVDPYEFAHETTDKLEDD 445
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 24/133 (18%), Positives = 51/133 (38%), Gaps = 17/133 (12%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+ + S NH+ +P LP ++ + N P ++ L +N++L
Sbjct: 336 PPRLERLIASFNHL-AEVPE-LPQNLKQLHVEYNPLR-EFPDIPESVEDLR---MNSHLA 389
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP- 220
+P+ Q+L L + +N L E P E+ + L + + ++ + +
Sbjct: 390 E--VPELPQNLK---QLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTD 440
Query: 221 -LRDLNIENNLFS 232
L D E++
Sbjct: 441 KLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 26/135 (19%), Positives = 49/135 (36%), Gaps = 14/135 (10%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
E+ S + + + P P + ++ ++ + L
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAP---PGNGEQREMAVSRLRDCLDRQAHEL----- 76
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
LNN LS +P+ L +L S N+L+ ELP ++L L + LS
Sbjct: 77 -ELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 130
Query: 214 DVLQDLPLRDLNIEN 228
+L+ L + + +E
Sbjct: 131 PLLEYLGVSNNQLEK 145
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 20/124 (16%), Positives = 43/124 (34%), Gaps = 14/124 (11%)
Query: 142 PSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTT 201
P +++ L + ++NL E+P +++ + + PP ++
Sbjct: 5 PRNVSNTFLQEPLRHSSNL--TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 202 LHLQNNQLSG--TLDV----LQDLP-----LRDLNIENNLFSGPIPEKMLQIPNFRKDGN 250
L++ L++ L LP L L N + +PE + + D N
Sbjct: 63 SRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNN 121
Query: 251 PFNS 254
+
Sbjct: 122 NLKA 125
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 9/77 (11%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSL 145
L + E+ E +++ + + N + P I ++++ ++ + +
Sbjct: 382 LRMNSHLAEVPELPQ---NLKQLHVETNPL-REFPDIPE-SVEDLRMNSERVVDPYEFAH 436
Query: 146 ATLTLLTDMSLNNNLLS 162
T L D ++
Sbjct: 437 ETTDKLEDDVFEHHHHH 453
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSS--LATLTLLTDMSLNNNLLSGEIPDAFQSLTGL 175
IP +P+ L+DN+ I S L L + L N L+G P+AF+ + +
Sbjct: 22 EIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 176 INLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS----GTLDVLQDLPLRDLNIENN 229
L L N + E+ + L QL TL+L +NQ+S G+ + L L LN+ +N
Sbjct: 81 QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS--LTSLNLASN 136
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 42/175 (24%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 502 ASLQQYTNS---FSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLEL 557
+S ++ + + + +IG+G V A P + +A+K+++ ++ EL
Sbjct: 5 SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDEL 60
Query: 558 VNNID---RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWN-- 611
+ I + H NIV L L+ + S G++ D++ + S
Sbjct: 61 LKEIQAMSQCHHPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119
Query: 612 -----TRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
T +R L LEYLH+ Q +HR+ K+ NILL +D +V ++D G++
Sbjct: 120 ESTIATILREVL---EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 27/216 (12%), Positives = 52/216 (24%), Gaps = 34/216 (15%)
Query: 477 PAEGTAVKTSTKTAKPFTTARSFTIAS-LQQYTNSFSQENLIGAGMLGSVYRA-QLPDGK 534
+ A TA + T+ S L Q + G V+ + +
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 535 LLAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANIVELKGYC----------------- 576
A+K A + + + + E R+ + E +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 577 ---------AEHGQRLLIYEY--CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
LL+ L L + + + R
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L +VH +F N+ + D + + D
Sbjct: 209 NLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 31/165 (18%), Positives = 60/165 (36%), Gaps = 29/165 (17%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVE 571
+G G + ++ A K + K + E ++ I + H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRSLAHQHVVG 79
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------A 623
G+ ++ ++ E C +L ++ R + AR
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKR------------RKALTEPEARYYLRQIVLG 127
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+YLH ++HR+ K N+ L++DL V + D GLA +
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 40/175 (22%), Positives = 71/175 (40%), Gaps = 12/175 (6%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVN 559
+ S + + +++G G +V+R + G L A+K + + + D + E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE-FE 59
Query: 560 NIDRIRHANIVELKGYCAEHGQRL--LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA 617
+ ++ H NIV+L E R LI E+C G+L +L + L + + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVL 118
Query: 618 LGAARALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGS 668
+ +L E IVHRN K NI+ D ++D G A +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
+ S ++ + N++I S+ + T ++ LS NQ S + S L LT L ++S
Sbjct: 35 VSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELS 91
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
+N N L + + S L L L +N L SL +L L L ++NN+L ++ +
Sbjct: 92 VNRNRLK-NL-NGIPSAC-LSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM 145
Query: 216 LQDLP-LRDLNIENN 229
L L L L++ N
Sbjct: 146 LGFLSKLEVLDLHGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 33/136 (24%), Positives = 59/136 (43%), Gaps = 13/136 (9%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSI--LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDM 154
++ +L + + S L +QNF ++ S+ + + T L ++
Sbjct: 13 FPDPGLANAVKQNLGKQSV-TDLVSQKELS-GVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 155 SLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD 214
L++N +S ++ + LT L L ++ N L L + + L+ L L NN+L D
Sbjct: 69 HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNG-IPSAC-LSRLFLDNNELR-DTD 122
Query: 215 VLQDLP-LRDLNIENN 229
L L L L+I NN
Sbjct: 123 SLIHLKNLEILSIRNN 138
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 23/155 (14%), Positives = 44/155 (28%), Gaps = 25/155 (16%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
L + + + ++ N + ++ I + FL +N+ SL L L +S+
Sbjct: 79 SPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSI 135
Query: 157 NNNLLSGEIP---------------------DAFQSLTGLINLDLSSNNLSGELPPSLEN 195
NN L I L + +DL+ E
Sbjct: 136 RNNKLK-SIVMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPE 194
Query: 196 LSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNL 230
L T+ + + + D + L
Sbjct: 195 LYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 12/75 (16%), Positives = 32/75 (42%), Gaps = 6/75 (8%)
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
++ PD L + +L +++ + + LS + + N+ + +L
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG 58
Query: 216 LQDLP-LRDLNIENN 229
+Q L++L++ +N
Sbjct: 59 MQFFTNLKELHLSHN 73
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 48/196 (24%), Positives = 75/196 (38%), Gaps = 31/196 (15%)
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNS------FSQENLIGAGMLGSVYRAQ-LPD 532
G + T + A+L+ + IG G G V A+
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 533 GKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVELKGYCAEHGQRL-LIYEY 588
G+ +AVK +D R K L N + +H N+VE+ G+ L ++ E+
Sbjct: 70 GRQVAVKMMDLR-----KQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEF 123
Query: 589 CSNGTLQDMLHSD--DELKNNLSWNTRI-RMALGAARALEYLHEICQPPIVHRNFKSANI 645
G L D++ +E + L +AL YLH ++HR+ KS +I
Sbjct: 124 LQGGALTDIVSQVRLNE-----EQIATVCEAVL---QALAYLH---AQGVIHRDIKSDSI 172
Query: 646 LLDDDLAVSVSDCGLA 661
LL D V +SD G
Sbjct: 173 LLTLDGRVKLSDFGFC 188
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 30/144 (20%), Positives = 48/144 (33%), Gaps = 16/144 (11%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPS-SLATLTLLTDMSLNNNLLS 162
S RV + + IPS LP + I + + L + ++ N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 163 GEIP-DAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQLS-------GTL 213
I D F +L L + + N + P +NL L L + N +
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 214 DVLQDLPLRDLN----IENNLFSG 233
L ++D IE N F G
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 32/135 (23%), Positives = 52/135 (38%), Gaps = 14/135 (10%)
Query: 103 SSIRVIDLS-NNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
++D+ N +I +I L +L+ N S+ L +
Sbjct: 128 LQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSD 186
Query: 158 NNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTLDV 215
NN L E+P D F +G + LD+S + LP LENL +L N + L
Sbjct: 187 NNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT 241
Query: 216 LQDLP-LRDLNIENN 229
L+ L L + ++
Sbjct: 242 LEKLVALMEASLTYP 256
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 36/160 (22%), Positives = 59/160 (36%), Gaps = 27/160 (16%)
Query: 100 GAFSSIRVIDLSNNHIGGSIPSILPVTMQNF------FLSDNQFSGSIPS-SLATLTLLT 152
G S+ R ++L N+I I T ++ L N I + L L
Sbjct: 72 GIPSNTRYLNLMENNI----QMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLN 126
Query: 153 DMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQ-NNQL 209
+ L +N L+ IP AF+ L+ L L L +N + +P + + L L L +L
Sbjct: 127 TLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKL 184
Query: 210 SG-TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
+ + L L+ LN+ +PN
Sbjct: 185 EYISEGAFEGLFNLKYLNLGMCNIK--------DMPNLTP 216
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 25/102 (24%), Positives = 49/102 (48%), Gaps = 8/102 (7%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP 191
L +P+ L L L ++ ++ N P +F L+ L L + ++ +S +
Sbjct: 203 LGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIER 259
Query: 192 -SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
+ + L+ L L+L +N LS +L D+ L L +L++ +N
Sbjct: 260 NAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 34/115 (29%), Positives = 57/115 (49%), Gaps = 7/115 (6%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
GAF +++ ++L +I +P++ P+ ++ +S N F P S L+ L +
Sbjct: 190 GAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPS-LENLSQLTTLHLQNNQL 209
+ N+ +S +AF L L+ L+L+ NNLS LP L L LHL +N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 25/106 (23%), Positives = 43/106 (40%), Gaps = 9/106 (8%)
Query: 131 FLSDNQFSGSIPSSL-ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGEL 189
+ S +P + + L +L N + D F+ L L L L N++ ++
Sbjct: 60 VCTRRGLS-EVPQGIPSNTRYL---NLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QI 114
Query: 190 PP-SLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNIENNLFS 232
+ L+ L TL L +N L+ + L LR+L + NN
Sbjct: 115 EVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE 160
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-15
Identities = 32/145 (22%), Positives = 54/145 (37%), Gaps = 35/145 (24%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSS--------LATLTL------------------L 151
IP +P L++N+F+ + ++ L + +
Sbjct: 25 KIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLS 210
++ L +N L F+ L L L L SN ++ + S LS + L L +NQ++
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 211 ----GTLDVLQDLPLRDLNIENNLF 231
G D L L LN+ N F
Sbjct: 143 TVAPGAFDTLHS--LSTLNLLANPF 165
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.7 bits (188), Expect = 1e-14
Identities = 31/134 (23%), Positives = 60/134 (44%), Gaps = 8/134 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
AF+ +L + ++ ++ +++ S+ + L +T + L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N N L+ +I +L L L L N + +L L++L +L +L L++N +S ++ L
Sbjct: 73 NGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 127
Query: 217 QDLP-LRDLNIENN 229
LP L L + NN
Sbjct: 128 VHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 42/232 (18%), Positives = 70/232 (30%), Gaps = 8/232 (3%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L + + L NN I I + +T + L DNQ S I LA LT L ++
Sbjct: 125 NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLY 181
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L+ N +S ++ A L L L+L S + NL T+ + L +
Sbjct: 182 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII 239
Query: 216 LQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFF 275
D N++ +L + ++P T
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGT 299
Query: 276 GPRPVSGSSPVSRTPPSQHTPGKQADGPTALEDSNSGKKKSSTTKKIVWISI 327
+ + P G G + N G + + T +
Sbjct: 300 VIKTKVEAGTRITAPKPPTKQGYVFKGWYT--EKNGGHEWNFNTDYMSGNDF 349
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 35/152 (23%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
I V++++ N + S+P LP +++ DN+ S ++P A+L L ++NN L
Sbjct: 79 PPQITVLEITQNALI-SLPE-LPASLEYLDACDNRLS-TLPELPASLKHL---DVDNNQL 132
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPL 221
+ +P+ L ++ +N L+ LP + L L ++NNQL+ ++ + L
Sbjct: 133 T-MLPELPALLE---YINADNNQLT-MLPELPTS---LEVLSVRNNQLTFLPELPES--L 182
Query: 222 RDLNIENNLFSGPIPEKMLQIPNFRKDGNPFN 253
L++ NL +P ++ + + F
Sbjct: 183 EALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 28/146 (19%), Positives = 51/146 (34%), Gaps = 8/146 (5%)
Query: 103 SSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDM----SLNN 158
+S+ V+ + NN + +P LP +++ +S N S+P+ +
Sbjct: 160 TSLEVLSVRNNQLT-FLPE-LPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRE 216
Query: 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQD 218
N ++ IP+ SL + L N LS + SL + H S +
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275
Query: 219 LPLRDLNIENNLFSGPIPEKMLQIPN 244
L + F + QI +
Sbjct: 276 LHRPLADAVTAWFPENKQSDVSQIWH 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 34/139 (24%), Positives = 51/139 (36%), Gaps = 31/139 (22%)
Query: 119 IPSILPVTMQNFFLSDNQFSGSIP-------SSLATLTLLTDMSLNNNLLSGEIPDAFQS 171
+ +LP+ NF LS N F +I S+ N N + +
Sbjct: 1 MSIMLPIN-NNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL-- 57
Query: 172 LTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG---------TLDV----LQD 218
+ L L+ NLS LP +L Q+T L + N L LD L
Sbjct: 58 INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALISLPELPASLEYLDACDNRLST 114
Query: 219 LP-----LRDLNIENNLFS 232
LP L+ L+++NN +
Sbjct: 115 LPELPASLKHLDVDNNQLT 133
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 23/129 (17%), Positives = 31/129 (24%), Gaps = 5/129 (3%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLL 151
N + + N I IP + L DN S I SL+ T
Sbjct: 198 VPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
D S Q+ D + + + N S
Sbjct: 257 PDYHGPRIYFSMSDG--QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSA 314
Query: 212 TLDVLQDLP 220
LD L D
Sbjct: 315 FLDRLSDTV 323
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 48/165 (29%), Positives = 70/165 (42%), Gaps = 22/165 (13%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR---I-----RHA 567
+G G+ V R P K AVK +D +E EL + I H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLS-WNTR--IRMALGAARAL 624
NI++LK + L+++ G L D L K LS TR +R L +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLE---VI 137
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
LH++ IVHR+ K NILLDDD+ + ++D G + + G
Sbjct: 138 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 41/235 (17%), Positives = 75/235 (31%), Gaps = 21/235 (8%)
Query: 448 PPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQY 507
P P P P + + G +S F + + ++
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151
Query: 508 TNSFSQ----ENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ +G G G V+R + G A K + + D E + I
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVR--KEIQ 206
Query: 563 ---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
+RH +V L + + ++IYE+ S G L + + + + +R
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 620 AARALEYLHEICQPPIVHRNFKSANILL--DDDLAVSVSDCGLAPLISSGSVSQV 672
L ++HE VH + K NI+ + + D GL + +V
Sbjct: 267 ---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 28/181 (15%)
Query: 489 TAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASS 547
TA R FTI + F +G G G+VY A+ + ++A+K L K
Sbjct: 1 TALAEMPKRKFTI-------DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE 53
Query: 548 QQKDDEFLELVNNIDR-------IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS 600
++ + + + R +RH NI+ + Y + + L+ E+ G L L
Sbjct: 54 KEG------VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK 107
Query: 601 DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660
S A AL Y HE ++HR+ K N+L+ + ++D G
Sbjct: 108 HGRFDEQRSA----TFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGW 160
Query: 661 A 661
+
Sbjct: 161 S 161
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 42/199 (21%), Positives = 74/199 (37%), Gaps = 42/199 (21%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNN-IDR 563
Q N E ++G G G+V G+ +AVK++ +F ++ I
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---------DFCDIALMEIKL 61
Query: 564 IR----HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
+ H N++ + E C N LQD++ E KN N +++
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLV----ESKNVSDENLKLQKEYN 116
Query: 620 AAR-------ALEYLHEICQPPIVHRNFKSANILLD-------------DDLAVSVSDCG 659
+ +LH + I+HR+ K NIL+ ++L + +SD G
Sbjct: 117 PISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 660 LAPLISSGSVSQVSHNLTI 678
L + SG S ++
Sbjct: 174 LCKKLDSGQSSFRTNLNNP 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 37/117 (31%), Positives = 57/117 (48%), Gaps = 8/117 (6%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+PS +P + L + ++ LT LT ++L+ N L F LT L
Sbjct: 28 SVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGT 87
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQL----SGTLDVLQDLPLRDLNIENN 229
L L++N L+ LP + ++L+QL L+L NQL SG D L L++L + N
Sbjct: 88 LGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK--LKELRLNTN 141
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 38/117 (32%), Positives = 56/117 (47%), Gaps = 11/117 (9%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPSILP---VTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152
G F + + + L+NN + S+P + + +L NQ S+PS + LT L
Sbjct: 77 GVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK 134
Query: 153 DMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
++ LN N L IP AF LT L L LS+N L + + L +L T+ L NQ
Sbjct: 135 ELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 35/184 (19%), Positives = 71/184 (38%), Gaps = 19/184 (10%)
Query: 494 TTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDD 552
++ + + ++ ++G G G V + + AVK ++K ++ +
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 553 EFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT 612
L V + ++ H NI++L + ++ E + G L D + + S
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFS--- 119
Query: 613 RIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLIS 665
A + + Y+H+ IVHR+ K NILL + D + + D GL+
Sbjct: 120 -EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 666 SGSV 669
+
Sbjct: 176 QNTK 179
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 35/169 (20%), Positives = 62/169 (36%), Gaps = 35/169 (20%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G G V + + AVK ++K ++ + L V + ++ H NI++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------RMALGAAR----A 623
+ ++ E + G L D I A +
Sbjct: 90 LEDSSSFYIVGELYTGGELFD----------------EIIKRKRFSEHDAARIIKQVFSG 133
Query: 624 LEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV 669
+ Y+H+ IVHR+ K NILL + D + + D GL+ +
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 26/135 (19%), Positives = 55/135 (40%), Gaps = 10/135 (7%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
++ + + ++ N + S P + + N + I ++ T LT++ +
Sbjct: 101 DVTPLTKLTYLNCDTNKLTKLDVSQNP-LLTYLNCARNTLT-EID--VSHNTQLTELDCH 156
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQ 217
N ++ T L LD S N ++ EL + L L+ N ++ LD+ Q
Sbjct: 157 LNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQ 210
Query: 218 DLPLRDLNIENNLFS 232
++ L L+ +N +
Sbjct: 211 NIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 29/140 (20%), Positives = 59/140 (42%), Gaps = 12/140 (8%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSI-LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ +++ +D N+ I + I + + N + ++ L+ T LT ++
Sbjct: 37 SEEQLATLTSLDCHNSSI-TDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
++N L+ + LT L L+ +N L+ +L S LT L+ N L+ +DV
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCARNTLT-EIDVS 145
Query: 217 QDLPLRDLNIENNLFSGPIP 236
+ L +L+ N +
Sbjct: 146 HNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 25/136 (18%), Positives = 56/136 (41%), Gaps = 10/136 (7%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ + + + ++N+I ++ + N+ + ++ + LT LT ++
Sbjct: 58 TGIEKLTGLTKLICTSNNIT-TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNC 113
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+ N L+ ++ L L+ + N L+ E+ + + +QLT L N+ LDV
Sbjct: 114 DTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT 167
Query: 217 QDLPLRDLNIENNLFS 232
L L+ N +
Sbjct: 168 PQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 33/140 (23%), Positives = 52/140 (37%), Gaps = 20/140 (14%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVT----MQNFFLSDNQFSGSIPSSLATLTLLTD 153
+L + +D S+N + + + VT + F S N + + S TL+ LT
Sbjct: 207 DLNQNIQLTFLDCSSNKL-----TEIDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTT 258
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
+ L EI T LI EL + + +QL L Q ++ L
Sbjct: 259 LHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-EL 312
Query: 214 DVLQDLP-LRDLNIENNLFS 232
D L P L L + N +
Sbjct: 313 D-LSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 17/162 (10%), Positives = 49/162 (30%), Gaps = 10/162 (6%)
Query: 98 NLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157
++ + + ++D I + + +L++ + + + ++ T L +S
Sbjct: 292 DVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCV 347
Query: 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT-TLHLQNNQLSGTLDVL 216
N + + + + L N + +P + LT + G +
Sbjct: 348 NAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNI 404
Query: 217 QDLPLRDLNIENNLFS-GPIPEKMLQIP-NFRKDGNPFNSTV 256
+ + N + + + F + TV
Sbjct: 405 EPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTV 446
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 17/85 (20%), Positives = 38/85 (44%), Gaps = 6/85 (7%)
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+ + + L L +LD +++++ ++ +E L+ LT L +N
Sbjct: 20 FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSN 74
Query: 208 QLSGTLDVLQDLPLRDLNIENNLFS 232
++ TLD+ Q+ L L ++N +
Sbjct: 75 NIT-TLDLSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 7/66 (10%)
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRD 223
PD + + S E L+ LT+L N+ ++ + ++ L L
Sbjct: 15 FPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTK 68
Query: 224 LNIENN 229
L +N
Sbjct: 69 LICTSN 74
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 5e-14
Identities = 43/162 (26%), Positives = 67/162 (41%), Gaps = 15/162 (9%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL--- 572
+G G G V R G+ +A+K+ + S + ++ LE + + ++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLE-IQIMKKLNHPNVVSAREV 80
Query: 573 ---KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
A + LL EYC G L+ L+ E L + + AL YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 630 ICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAPLISSGS 668
I+HR+ K NI+L L + D G A + G
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 48/241 (19%), Positives = 72/241 (29%), Gaps = 56/241 (23%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
P + V F
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAA------PGTASLVPDYWIDGSNRDALSDF----- 54
Query: 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
+ E +G G VYR Q K A+K L K + E + + R
Sbjct: 55 --FE--VESE--LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE----IGVLLR 104
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------R 615
+ H NI++LK + L+ E + G L D RI R
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFD----------------RIVEKGYYSER 148
Query: 616 MALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGS 668
A A + A+ YLHE IVHR+ K N+L D + ++D GL+ ++
Sbjct: 149 DAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 669 V 669
+
Sbjct: 206 L 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 44/240 (18%), Positives = 81/240 (33%), Gaps = 34/240 (14%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIA 502
M+ PP P P P PPP P + P P + K + I
Sbjct: 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAI- 59
Query: 503 SLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
+ Y ++G G+ G V + + A+K L ++++ +
Sbjct: 60 -IDDY---KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ-- 113
Query: 562 DRIRHANIVELKGYCAEHGQR----LLIYEYCSNGTLQDMLHSDDELKNNLSWNTR---- 613
+IV + L++ E G L + + + ++ R
Sbjct: 114 ----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASE 165
Query: 614 -IRMALGAARALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV 669
++ A++YLH I I HR+ K N+L + + ++D G A +S +
Sbjct: 166 IMKSIGE---AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 516 LIGAGMLGSVYRAQLPDGKL---LAVKKLDKRASSQQKDDEFLEL----VNNIDRIRHAN 568
+G G + +VY A+ D L +A+K + ++ +E L+ V+N ++ H N
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIF---IPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
IV + E L+ EY TL + + S LS +T I +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH 128
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
++ IVHR+ K NIL+D + + + D G+A +S S++Q
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 28/212 (13%), Positives = 65/212 (30%), Gaps = 35/212 (16%)
Query: 482 AVKTSTKTAKPFTTARSFTIAS-LQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVK 539
+ S + + T + F + S L + + + ++G + A G+ V
Sbjct: 45 SAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVH 104
Query: 540 KLDKRASSQQKDDE--------------------------FLELVNNIDRIRHANIVELK 573
+ F+ + + + ++ ++
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 574 GYCAEHG--QRLLIYE--YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ R +Y + T ++L S +L + R+++ L R L LH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+VH + +I+LD V ++
Sbjct: 225 YG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 253
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 38/200 (19%), Positives = 70/200 (35%), Gaps = 35/200 (17%)
Query: 486 STKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKR 544
S + F + + ++++++ + +G G V R G A K ++ +
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65
Query: 545 ASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDEL 604
S + + +++H NIV L E L+++ + G L +
Sbjct: 66 KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE-------- 117
Query: 605 KNNLSWNTRI--------RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DD 649
I A + ++ Y H IVHRN K N+LL
Sbjct: 118 --------DIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 166
Query: 650 DLAVSVSDCGLAPLISSGSV 669
AV ++D GLA ++
Sbjct: 167 GAAVKLADFGLAIEVNDSEA 186
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 40/122 (32%), Positives = 49/122 (40%), Gaps = 7/122 (5%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P L N LT LT + L N L F LT L
Sbjct: 21 SVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQL----SGTLDVLQDLPLRDLNIENNLFS 232
L+LS+N L LP + + L+QL L L NQL G D L L L N L S
Sbjct: 81 LNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQ-NQLKS 138
Query: 233 GP 234
P
Sbjct: 139 VP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 124 PVTMQNFFLSDNQFSGSIPSSL-ATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLS 181
++ LS NQ S+P+ + LT L +++LN N L +PD F LT L +L L
Sbjct: 75 LTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132
Query: 182 SNNLSGELPPSLENLSQLTTLHLQNNQ 208
N L + L+ L + L +N
Sbjct: 133 QNQLKSVPDGVFDRLTSLQYIWLHDNP 159
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 38/234 (16%), Positives = 73/234 (31%), Gaps = 52/234 (22%)
Query: 455 PPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQE 514
+ + + P + + S+ +
Sbjct: 4 HHHHSSGRENLYFQGIAINP----------------------GMYVRKKEGKIGESYFKV 41
Query: 515 NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFL--------ELVNNID--- 562
+G+G G V + A+K + K + + + E+ N I
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
+ H NI++L + L+ E+ G L + + + ++ A +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFD----ECDAANIMK 153
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV 669
+ YLH+ IVHR+ K NILL + L + + D GL+ S
Sbjct: 154 QILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 38/182 (20%), Positives = 61/182 (33%), Gaps = 39/182 (21%)
Query: 508 TNSFSQE----NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ FS +G G V R G A K ++ + S + +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI-------- 614
+++H NIV L E L+++ + G L + I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE----------------DIVAREFYSE 104
Query: 615 RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSG 667
A + ++ Y H IVHRN K N+LL AV ++D GLA ++
Sbjct: 105 ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 668 SV 669
Sbjct: 162 EA 163
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 31/134 (23%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+ AF+ +L + ++ ++ +++ S+ + L +T + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
N N L+ +I +L L L L N + +L L++L +L +L L++N +S ++ L
Sbjct: 76 NGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DINGL 130
Query: 217 QDLP-LRDLNIENN 229
LP L L + NN
Sbjct: 131 VHLPQLESLYLGNN 144
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 8/136 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
L + + L NN I I + +T + L DNQ S I LA LT L ++
Sbjct: 128 NGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLY 184
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L+ N +S ++ A L L L+L S + NL T+ + L T ++
Sbjct: 185 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEI 241
Query: 216 LQDLP-LRDLNIENNL 230
+ D N++ +L
Sbjct: 242 ISDDGDYEKPNVKWHL 257
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 39/124 (31%), Positives = 56/124 (45%), Gaps = 12/124 (9%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P Q +L DNQ + P +L L ++ L +N L F SLT L
Sbjct: 33 SVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV 92
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQLS------GTLDVLQDLPLRDLNIENNL 230
LDL +N L+ LP ++ + L L L + N+L+ L L L L N L
Sbjct: 93 LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQ----NQL 147
Query: 231 FSGP 234
S P
Sbjct: 148 KSIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 24/85 (28%), Positives = 39/85 (45%), Gaps = 3/85 (3%)
Query: 125 VTMQNFFLSDNQFSGSIPSSL-ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183
+ L NQ + +PS++ L L ++ + N L+ E+P + LT L +L L N
Sbjct: 88 TQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
Query: 184 NLSGELPPSLENLSQLTTLHLQNNQ 208
L + + LS LT +L N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 25/115 (21%), Positives = 40/115 (34%), Gaps = 6/115 (5%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
+P LP + LS N S ++ L+ L + L++N + F L
Sbjct: 45 HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY 104
Query: 178 LDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRDLNIENN 229
LD+S N L + ++ L L L N +L L L +
Sbjct: 105 LDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAA 156
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 28/147 (19%), Positives = 61/147 (41%), Gaps = 21/147 (14%)
Query: 99 LGAFSS---IRVIDLSNNHIGGSIPSI--LPVTMQNFFLSDNQF----SGSIPSSLATLT 149
S+ ++ + L N + + + + M + D S + + A
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTG-LINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
+ ++L++N+L+ F+ L + LDL +N + +P + +L L L++ +NQ
Sbjct: 429 SILVLNLSSNMLT---GSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 209 LS----GTLDVLQDLPLRDLNIENNLF 231
L G D L L+ + + +N +
Sbjct: 485 LKSVPDGVFDRLTS--LQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 27/136 (19%), Positives = 51/136 (37%), Gaps = 11/136 (8%)
Query: 102 FSSIRVIDLSNNHIGG--SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
F+ + + LS + + P + + N F+ S+ +TL L + L N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 160 LLSGEIPDAFQSLTGLINLDLSSNNL----SGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L + +L+ +L S + + L+L +N L T V
Sbjct: 388 GLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML--TGSV 444
Query: 216 LQDLP--LRDLNIENN 229
+ LP ++ L++ NN
Sbjct: 445 FRCLPPKVKVLDLHNN 460
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 22/140 (15%), Positives = 47/140 (33%), Gaps = 14/140 (10%)
Query: 108 IDLSNNHIGGSI----PSILPVTMQNFFLSD---NQFSGSIPSSLATLTLLTDMSLNNNL 160
+++ N I I + +++ + F S + + + L+ +
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340
Query: 161 LSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL------SGTLD 214
S + L+ + N + + L +L TL LQ N L +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 215 VLQDLPLRDLNIENNLFSGP 234
+ L D+++ N+L S
Sbjct: 401 NMSSLETLDVSL-NSLNSHA 419
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 34/171 (19%), Positives = 61/171 (35%), Gaps = 26/171 (15%)
Query: 100 GAFSSI---RVIDLSNNHIGGSIPSILP-------VTMQNFFLSDNQFSGSIPSSLATLT 149
S + RV+ LS+N I L ++ +S N+ +I +
Sbjct: 70 PDISFLSELRVLRLSHNRI-----RSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMA 121
Query: 150 LLTDMSLNNNLLSGEIPDA--FQSLTGLINLDLSSNNLSGELPPSLENLSQLT-TLHLQN 206
L + L+ N +P F +LT L L LS+ + +L L L +
Sbjct: 122 SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVS 180
Query: 207 NQLS-GTLDVLQDLPLRDLNIE---NNLFSGPIPEKMLQIPNFRKDGNPFN 253
+ G + LQ L++ N+LFS + + + + + N
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 38/187 (20%), Positives = 64/187 (34%), Gaps = 22/187 (11%)
Query: 490 AKPFTTARSFTIASLQQYTNSFSQE----NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKR 544
P + I + F +IG G V R G+ AVK +D
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 545 ASSQQKDDEFLELVNNID---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSD 601
+ +L ++H +IVEL + G +++E+ L +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 602 DELKNNLSWNTRIRMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVS 654
+ S +A R AL Y H+ I+HR+ K +LL ++ V
Sbjct: 121 ADAGFVYSE----AVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVK 173
Query: 655 VSDCGLA 661
+ G+A
Sbjct: 174 LGGFGVA 180
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.6 bits (172), Expect = 8e-13
Identities = 26/116 (22%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMS 155
++ +RV+ L++ + + + + + + LS N+ ++P +LA L L +
Sbjct: 435 VLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG-ELPPSLENLSQLTTLHLQNNQLS 210
++N L + +L L L L +N L L + +L L+LQ N L
Sbjct: 493 ASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 9/134 (6%)
Query: 124 PVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183
P+ ++F + + L + L+ + + L + +LDLS N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHN 473
Query: 184 NLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSG-PIPEKMLQ 241
L LPP+L L L L +N L +D + +LP L++L + NN + ++
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 242 IPNFRK---DGNPF 252
P GN
Sbjct: 532 CPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 23/115 (20%), Positives = 38/115 (33%), Gaps = 31/115 (26%)
Query: 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTD 153
L L A + V+ S+N + ++ +A L L +
Sbjct: 477 ALPPALAALRCLEVLQASDNAL-ENVD-----------------------GVANLPRLQE 512
Query: 154 MSLNNNLLSG-EIPDAFQSLTGLINLDLSSNNLS------GELPPSLENLSQLTT 201
+ L NN L S L+ L+L N+L L L ++S + T
Sbjct: 513 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 41/172 (23%), Positives = 72/172 (41%), Gaps = 41/172 (23%)
Query: 514 ENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKD--DEFLELVNNIDRIRHANIV 570
++G+G V+ Q GKL A+K + K + + +E + + +I+H NIV
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE----IAVLKKIKHENIV 69
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------RMALGAAR 622
L+ L+ + S G L D RI + A +
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFD----------------RILERGVYTEKDASLVIQ 113
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSG 667
A++YLHE IVHR+ K N+L +++ + ++D GL+ + +G
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 42/244 (17%), Positives = 87/244 (35%), Gaps = 15/244 (6%)
Query: 432 HEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAK 491
+D+ + ++ + + V ++ T+ A
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 492 PFTTARSFTIASLQQYTN--SFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQ 548
P A + + S+ ++G G G V++ + G LA K + R
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---G 126
Query: 549 QKDDEFLEL-VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNN 607
KD E ++ ++ ++++ HAN+++L +L+ EY G L D + +
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 608 LSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL--DDDLAVSVSDCGLAPLIS 665
L ++ + ++H++ I+H + K NIL D + + D GLA
Sbjct: 187 LDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 666 SGSV 669
Sbjct: 241 PREK 244
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 37/169 (21%), Positives = 58/169 (34%), Gaps = 37/169 (21%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G G V A Q A KK+ K F + + + + H NI+ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR--FKQEIEIMKSLDHPNIIRLYET 74
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------RMALGAAR----A 623
++ L+ E C+ G L + R+ A + A
Sbjct: 75 FEDNTDIYLVMELCTGGELFE----------------RVVHKRVFRESDAARIMKDVLSA 118
Query: 624 LEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV 669
+ Y H++ + HR+ K N L D + + D GLA G +
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 36/167 (21%), Positives = 62/167 (37%), Gaps = 35/167 (20%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G G V R ++ G+ A ++ + S + + ++H NIV L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--------RMALGAAR----A 623
+E G LI++ + G L + I A + A
Sbjct: 79 ISEEGHHYLIFDLVTGGELFE----------------DIVAREYYSEADASHCIQQILEA 122
Query: 624 LEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSG 667
+ + H++ +VHRN K N+LL AV ++D GLA +
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 41/187 (21%), Positives = 78/187 (41%), Gaps = 22/187 (11%)
Query: 497 RSFTIASLQQYTNSFSQE----NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKR---ASSQ 548
T+ Y + E +G+G G V A + K +A++ + KR S
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 549 QKDDEFLELVNNID---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
++ D L + I+ ++ H I+++K + + ++ E G L D +
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG----N 233
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAP 662
L T A++YLHE I+HR+ K N+LL ++D + ++D G +
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 663 LISSGSV 669
++ S+
Sbjct: 291 ILGETSL 297
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 34/107 (31%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P + L N+ LT LT +SL+ N + F LT L
Sbjct: 21 SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTI 80
Query: 178 LDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQL----SGTLDVLQDL 219
L L N L LP + + L+QL L L NQL G D L L
Sbjct: 81 LYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSL 126
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
+ F ++G G G V+ Q+ GKL A KKL+K+ ++K + + I ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRI---RMALGAAR 622
IV L Y E L L+ + G + H + N N R A+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDI--RYH----IYNVDEDNPGFQEPRAIFYTAQ 297
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LE+LH+ I++R+ K N+LLDDD V +SD GLA
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 44/169 (26%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
+G G G V A + +AVK +D ++ NI + + H
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDM--------KRAVDCPENIKKEICINKMLNHE 65
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
N+V+ G+ E + L EYCS G L D + I M A+
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP------------DIGMPEPDAQRFFHQ 113
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ YLH I I HR+ K N+LLD+ + +SD GLA + +
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 50/165 (30%), Positives = 70/165 (42%), Gaps = 26/165 (15%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-------LELVNN 560
N FS +IG G G VY + D GK+ A+K LDK+ ++ + L LV+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 561 IDRIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
D IV + Y +L I + + G L L M
Sbjct: 249 GD---CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-------DMRFY 297
Query: 620 AAR---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
AA LE++H +V+R+ K ANILLD+ V +SD GLA
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 10/107 (9%)
Query: 128 QNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP-DAFQSLTGLINLDLSSNNLS 186
++F ++ IPS + L L L IP AF +L + + +S +
Sbjct: 14 EDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLR-TIPSHAFSNLPNISRIYVSIDVTL 68
Query: 187 GELPP-SLENLSQLTTLHLQNNQLSGTL--DVLQDLP-LRDLNIENN 229
+L S NLS++T + ++N + + D L++LP L+ L I N
Sbjct: 69 QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 25/159 (15%), Positives = 59/159 (37%), Gaps = 23/159 (14%)
Query: 100 GAFS---SIRVIDLSNNHIGGSIPSILPVTMQN------FFLSDNQFSGSIP--SSLATL 148
+F + I++ N ++ I P ++ + + P + + +
Sbjct: 74 HSFYNLSKVTHIEIRNTR---NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129
Query: 149 TLLTDMSLNNNLLSGEIP-DAFQSLTG-LINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206
+ + + +N IP +AFQ L + L L +N + + N ++L ++L
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188
Query: 207 NQLSGTL--DVLQDLP--LRDLNIENNLFSGPIPEKMLQ 241
N+ + D + L++ + +P K L+
Sbjct: 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 15/142 (10%)
Query: 103 SSIRVIDLSNNHIGGSIPSI----LPVTMQNFFLSDNQFSGSIPS-SLATLTLLTDMSL- 156
S + + L H+ +IPS LP + ++S + + S S L+ +T + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP--SLENLSQLTTLHLQNNQLSGTL- 213
N L+ PDA + L L L + + L P + + L + +N ++
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 214 -DVLQDLP--LRDLNIENNLFS 232
+ Q L L + NN F+
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT 169
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 26/217 (11%), Positives = 65/217 (29%), Gaps = 37/217 (17%)
Query: 489 TAKPFTTARSFTIASL-QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRAS 546
+ + T + F + S + + + ++G + A G+ V
Sbjct: 57 STSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER 116
Query: 547 SQQKDDEFLE-----------------------LVNNIDRIRHANIVELKGYCAEHGQRL 583
+ ++ + D ++ ++ + +
Sbjct: 117 PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM-IRVRLDERDM 175
Query: 584 LIYEY--------CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ + T ++L S +L + R+++ L R L LH +
Sbjct: 176 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232
Query: 636 VHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672
VH + +I+LD V ++ + +VS +
Sbjct: 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPI 269
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 35/172 (20%)
Query: 516 LIGAGMLGSVYRAQLPDGKL---LAVKKLDKRASSQQKDDEFLELVNNIDRIR------- 565
++G G + V+ A+ D + +AVK L + +D F R R
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLR---ADLARDPSFYL------RFRREAQNAA 67
Query: 566 ---HANIVELKGYCAEHGQRLLIY----EYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
H IV + + EY TL+D++H+ + ++ I +
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIA 123
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS 670
A +AL + H+ I+HR+ K ANI++ AV V D G+A I+ S
Sbjct: 124 DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 49/165 (29%), Positives = 71/165 (43%), Gaps = 15/165 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
N+F Q ++G G G V Q+ GK+ A KKL+K+ ++K + I +++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
+V L Y E L L+ + G L H + R AA
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEA---RAVFYAAEICC 297
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
LE LH IV+R+ K NILLDD + +SD GLA + G
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 67.1 bits (163), Expect = 5e-12
Identities = 21/94 (22%), Positives = 38/94 (40%), Gaps = 6/94 (6%)
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPP-SLENLS 197
L LT++ + N + + L L NL + + L + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 198 QLTTLHLQNNQLSGTL--DVLQDLPLRDLNIENN 229
+L+ L+L N L +L +Q L L++L + N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 19/103 (18%), Positives = 29/103 (28%), Gaps = 7/103 (6%)
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG-TL 213
+ L L L + + L L L +L L + + L
Sbjct: 16 TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 214 DVLQDLP-LRDLNIENNLFSG--PIPEKMLQIPNFRKDGNPFN 253
D P L LN+ N + L + GNP +
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 35/197 (17%), Positives = 60/197 (30%), Gaps = 45/197 (22%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVEL 572
IG G G V A + + A+K ++K Q + + + ++ H NI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG------------- 619
+ L+ E C G L D L+ + ++ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 620 ----------------AAR-------ALEYLHEICQPPIVHRNFKSANILL--DDDLAVS 654
+ AL YLH I HR+ K N L + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 655 VSDCGLAPLISSGSVSQ 671
+ D GL+ + +
Sbjct: 211 LVDFGLSKEFYKLNNGE 227
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 44/239 (18%), Positives = 80/239 (33%), Gaps = 37/239 (15%)
Query: 441 MMMMPPPPPPPPPPPPPPPPPPPP-----PVVEKVIVKPIVPAEGTAVKTSTKTAKPFTT 495
++ +P P P P P + + + +G + P++
Sbjct: 9 LVEIPRAPDIDPLEALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSF 68
Query: 496 ARSFTIASL--QQYTNSFSQENLIGAGMLGSVYRA--QLPDGKLLAVKKLDKRASSQQKD 551
+ QY + I G LG +Y A + +G+ + +K L S D
Sbjct: 69 LPQLNPGDIVAGQYE----VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSG---D 119
Query: 552 DEFLELVN----NIDRIRHANIVEL--KGYCAEHGQRLLIY---EYCSNGTLQDMLHSDD 602
E + + + H +IV++ + + Y EY +L+
Sbjct: 120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---- 175
Query: 603 ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L I L AL YLH I +V+ + K NI+L ++ + + D G
Sbjct: 176 --GQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 44/169 (26%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
+G G G V A + +AVK +D ++ NI + + H
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDM--------KRAVDCPENIKKEICINKMLNHE 65
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
N+V+ G+ E + L EYCS G L D + I M A+
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP------------DIGMPEPDAQRFFHQ 113
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ YLH I I HR+ K N+LLD+ + +SD GLA + +
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 40/162 (24%), Positives = 58/162 (35%), Gaps = 16/162 (9%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN-ID---RIRHANIVE 571
+G+G V + + G A K + KR S + E + + ++ H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L +LI E S G L D L K +LS + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 632 QPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSV 669
I H + K NI+L + + D GLA I G
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 39/162 (24%), Positives = 58/162 (35%), Gaps = 16/162 (9%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN-ID---RIRHANIVE 571
+G+G V + + G A K + KR S + E + + ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L +LI E S G L D L K +LS + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 632 QPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSV 669
I H + K NI+L + + D GLA I G
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 42/166 (25%), Positives = 63/166 (37%), Gaps = 24/166 (14%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNN-ID---RIRHANIVE 571
+G+G V + Q GK A K + KR S + E + ++ IRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEYL 627
L +LI E S G L D L + L A + + YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 628 HEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGSV 669
H I H + K NI+L + + + D G+A I +G+
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-12
Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 6/110 (5%)
Query: 124 PVTMQNFFLSDNQFS-GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSS 182
P ++ L + + + G I A L +SL N L + + L L L+LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80
Query: 183 NNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRDLNIENN 229
N + G L E L LT L+L N+L TL+ L+ L L+ L++ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 36/156 (23%), Positives = 60/156 (38%), Gaps = 33/156 (21%)
Query: 77 NASDIIAIILNGANLGGELGENLGA-FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDN 135
+ + ++L+ E L A F ++ + L N + S+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----GLISV------------- 64
Query: 136 QFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--GELPPSL 193
S+L L L + L+ N + G + + L L +L+LS N L L P L
Sbjct: 65 -------SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-L 116
Query: 194 ENLSQLTTLHLQNNQLSGTLD----VLQDLP-LRDL 224
+ L L +L L N +++ D V + LP L L
Sbjct: 117 KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 41/192 (21%), Positives = 73/192 (38%), Gaps = 29/192 (15%)
Query: 492 PFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQK 550
P A +Y+ +S + +G+G G V+ A K + VK + K +
Sbjct: 7 PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 551 DDEFLEL------VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDEL 604
E +L + + R+ HANI+++ G L+ E +G +L
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL---------DL 117
Query: 605 KNNLSWNTRIRMALGAAR--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVS 656
+ + R + A A+ YL I+HR+ K NI++ +D + +
Sbjct: 118 FAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172
Query: 657 DCGLAPLISSGS 668
D G A + G
Sbjct: 173 DFGSAAYLERGK 184
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 9e-12
Identities = 29/120 (24%), Positives = 53/120 (44%), Gaps = 14/120 (11%)
Query: 132 LSDNQFS-GSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP 190
L +++ + G + L +S N L+ I + L L L+LS N +SG L
Sbjct: 24 LDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLE 81
Query: 191 PSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
E LT L+L N++ T++ L+ L L+ L++ N + + ++R+
Sbjct: 82 VLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC----EV----TNLNDYRE 133
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 28/134 (20%), Positives = 51/134 (38%), Gaps = 28/134 (20%)
Query: 77 NASDIIAIILNGANLG-GELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDN 135
SD+ ++L+ + G+L F + + N + SI
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV----GLTSI------------- 57
Query: 136 QFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--GELPPSL 193
++L L L + L++N +SG + + L +L+LS N + + P L
Sbjct: 58 -------ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-L 109
Query: 194 ENLSQLTTLHLQNN 207
+ L L +L L N
Sbjct: 110 KKLENLKSLDLFNC 123
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 39/163 (23%), Positives = 68/163 (41%), Gaps = 25/163 (15%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVELK 573
+G G G V + G +AVK L+++ ++ + N+ RH +I++L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+ ++ EY S G L D + R+ AR A++
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQILSAVD 125
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
Y H +VHR+ K N+LLD + ++D GL+ ++S G
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 31/171 (18%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKL---LAVKKLDKRASSQQKDDEFLELVNNIDRIR----- 565
L+G G +G VY A+ D +A+K + + SS D F R++
Sbjct: 39 RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSS---DPVFRT------RMQREART 87
Query: 566 -----HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
++V + + GQ + + L ML L+ + +
Sbjct: 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQI 143
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
AL+ H HR+ K NIL+ D + D G+A + ++Q
Sbjct: 144 GSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 37/171 (21%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-------IRHA 567
L+G G G V AVK L K+ + + E N+ + +RH
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGE-----ANVKKEIQLLRRLRHK 66
Query: 568 NIVELKG-YCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
N+++L E Q++ ++ EYC G +Q+ML D + R + A
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEML---DSVPEK-------RFPVCQAHGYF 115
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
LEYLH IVH++ K N+LL + +S G+A + +
Sbjct: 116 CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 34/144 (23%), Positives = 55/144 (38%), Gaps = 14/144 (9%)
Query: 107 VIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIP 166
++ L+ I + V + L + I + ATL + ++N + ++
Sbjct: 1 MVKLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD 58
Query: 167 DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS--GTLDVLQDLP-LRD 223
F L L L +++N + + L LT L L NN L G LD L L L
Sbjct: 59 G-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 117
Query: 224 LNIENNLFSGPIPEKMLQIPNFRK 247
L I N P+ K ++R
Sbjct: 118 LCILRN----PVTNK----KHYRL 133
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 36/167 (21%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL----VNNIDRIRHANIVE 571
IG G V A+ + G+ +A+K +DK Q + L+ V + + H NIV+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDK----TQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 572 LKGY-CAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR------- 622
L + E + L LI EY S G + D L + RM AR
Sbjct: 79 L--FEVIETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIV 124
Query: 623 -ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
A++Y H+ IVHR+ K+ N+LLD D+ + ++D G + + G
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 38/163 (23%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 511 FSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRH 566
F + + +GAG G V++ P G ++A K + + K +++ +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQIIRELQVLHECNS 90
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI--RMALGAARAL 624
IV G G+ + E+ G+L D LK +I ++++ + L
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA-PLISS 666
YL E + I+HR+ K +NIL++ + + D G++ LI S
Sbjct: 145 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 35/162 (21%), Positives = 59/162 (36%), Gaps = 18/162 (11%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA-NIVELKG 574
+G G V + G+ A K L KR Q E L + ++ + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEYLHEI 630
+ +LI EY + G + + EL +S + + + YLH+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC--LPELAEMVSE----NDVIRLIKQILEGVYYLHQN 150
Query: 631 CQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV 669
IVH + K NILL + + D G++ I
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 30/147 (20%), Positives = 64/147 (43%), Gaps = 9/147 (6%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G+G G V++ + G ++AVK++ + + ++ ++L + IV+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELK-NNLSWNTRIRMALGAARALEYLHEICQPP 634
+ + E + + L +M + +AL YL E +
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKE--KHG 145
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLA 661
++HR+ K +NILLD+ + + D G++
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 34/166 (20%), Positives = 71/166 (42%), Gaps = 16/166 (9%)
Query: 503 SLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI 561
S++ + +G G G V + + +P G+++AVK++ +SQ++ ++L ++
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 562 DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI------R 615
+ V G G + E D K + I +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTS-------LDKFYKQVIDKGQTIPEDILGK 113
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+A+ +ALE+LH ++HR+ K +N+L++ V + D G++
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 16/159 (10%)
Query: 97 ENLGAFSSIRVIDLSNNH-----IGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLL 151
+ ++L + ++ ++ ++ LS N I SSL+ + L
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTL--KACKHLALSTNNIE-KI-SSLSGMENL 72
Query: 152 TDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS- 210
+SL NL+ +I + L L +S N ++ L +E L L L++ NN+++
Sbjct: 73 RILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN 129
Query: 211 -GTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNFRK 247
G +D L L L DL + N E +R
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENN-ATSEYRI 167
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 33/135 (24%), Positives = 59/135 (43%), Gaps = 3/135 (2%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
IG G GSV + P G+++AVK++ +++ ++L + IV+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
G + E S + + L + + ++ L +AL +L E + I
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--I 147
Query: 636 VHRNFKSANILLDDD 650
+HR+ K +NILLD
Sbjct: 148 IHRDIKPSNILLDRS 162
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 38/183 (20%), Positives = 65/183 (35%), Gaps = 24/183 (13%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELV 558
T+ + + + +G+G V + + G A K + KR + + E +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 559 NN-ID---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
+ I+H N++ L +LI E + G L D L + L
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-------- 113
Query: 615 RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISS 666
A + + YLH + I H + K NI+L + + D GLA I
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 667 GSV 669
G+
Sbjct: 171 GNE 173
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 38/172 (22%), Positives = 67/172 (38%), Gaps = 22/172 (12%)
Query: 513 QENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIV 570
QE+++G G V L + AVK ++K+ + F E V + + + H N++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-RSRVFRE-VEMLYQCQGHRNVL 74
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----ALEY 626
EL + E + L++E G++ +H + + + A + AL++
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNE----LEASVVVQDVASALDF 126
Query: 627 LHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSVSQVSHN 675
LH I HR+ K NIL + V + D L I
Sbjct: 127 LHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 35/156 (22%), Positives = 70/156 (44%), Gaps = 11/156 (7%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGY 575
+G+G G V+R + G++ K ++ K E ++ ++++ H ++ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNE-ISIMNQLHHPKLINLHDA 116
Query: 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPI 635
+ + +LI E+ S G L D + ++D + +R A L+++HE I
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH---SI 170
Query: 636 VHRNFKSANILL--DDDLAVSVSDCGLAPLISSGSV 669
VH + K NI+ +V + D GLA ++ +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 39/179 (21%), Positives = 63/179 (35%), Gaps = 29/179 (16%)
Query: 503 SLQQYTNSFSQE----NLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLEL 557
L + + F+ IG G R AVK +DK ++ E L
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR 71
Query: 558 VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA 617
+H NI+ LK + ++ E G L D + + S R A
Sbjct: 72 Y-----GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSE----REA 118
Query: 618 LGAAR----ALEYLHEICQPPIVHRNFKSANILL----DDDLAVSVSDCGLAPLISSGS 668
+EYLH +VHR+ K +NIL + ++ + D G A + + +
Sbjct: 119 SAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 35/175 (20%), Positives = 71/175 (40%), Gaps = 42/175 (24%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLEL------VNNIDRIRHANI 569
+G+G G V A + K +A+K + KR + E + + ++ H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI----RMALGAAR--- 622
+++K + + ++ E G L D ++ R+ +
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFD----------------KVVGNKRLKEATCKLYF 120
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAPLISSGSV 669
A++YLHE I+HR+ K N+LL ++D + ++D G + ++ S+
Sbjct: 121 YQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 34/183 (18%), Positives = 64/183 (34%), Gaps = 55/183 (30%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKR-----------------ASSQQKDDEFLEL 557
IG G G V A D A+K L K+ + +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 558 VNNIDR-------IRHANIVELKGYCA-EHGQRLLIY---EYCSNGTLQDMLHSDDELKN 606
+ + + + H N+V+L + +Y E + G + ++
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVP-------- 129
Query: 607 NLSWNTRIRMALGAAR--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658
T ++ AR +EYLH I+HR+ K +N+L+ +D + ++D
Sbjct: 130 -----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 659 GLA 661
G++
Sbjct: 182 GVS 184
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 37/163 (22%), Positives = 67/163 (41%), Gaps = 25/163 (15%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVELK 573
+G G G V + G +AVK L+++ + + N+ RH +I++L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+ ++ EY S G L D + + R+ +R ++
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDEKESRRLFQQILSGVD 130
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
Y H +VHR+ K N+LLD + ++D GL+ ++S G
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 37/174 (21%), Positives = 62/174 (35%), Gaps = 42/174 (24%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
Q Y + L G G + + AVK + KR + + E + +
Sbjct: 8 QHYDLDLKDKPL-GEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKE-ITALKL 61
Query: 564 IR-HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI-------- 614
H NIV+L + L+ E + G L + RI
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE----------------RIKKKKHFSE 105
Query: 615 RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLA 661
A R A+ ++H++ +VHR+ K N+L +D+L + + D G A
Sbjct: 106 TEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 30/189 (15%), Positives = 61/189 (32%), Gaps = 31/189 (16%)
Query: 72 QGVQCNASDIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNHIGGS----IPSIL 123
+G+ + + L +L L L A + + +SNN I + + L
Sbjct: 135 EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGL 194
Query: 124 PV---TMQNFFLSDNQFS----GSIPSSLATLTLLTDMSLNNNLLSGE-----IPDAFQS 171
++ L + + +A+ L +++L +N L P
Sbjct: 195 KDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHP 254
Query: 172 LTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGT-----LDVLQD--LP 220
+ L L + ++ + L L L L L N+L + L +
Sbjct: 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314
Query: 221 LRDLNIENN 229
L L +++
Sbjct: 315 LESLWVKSC 323
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 34/153 (22%), Positives = 55/153 (35%), Gaps = 23/153 (15%)
Query: 103 SSIRVIDLSNNHIG-GSIPSILPV--TMQNFFLSDNQFS----GSIPSSLATLTLLTDMS 155
I+ +D+ + +LP+ Q L D + I S+L L +++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 156 LNNNLLSGE----IPDAFQSL-TGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQN 206
L +N L + Q+ + L L + L+G L +L L L LHL +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 207 NQLSGT-----LDVLQD--LPLRDLNIENNLFS 232
N L + L D L L +E S
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 30/178 (16%), Positives = 62/178 (34%), Gaps = 31/178 (17%)
Query: 86 LNGANLGGE----LGENLGAFSSIRVIDLSNNHIGGS-IPSILPV------TMQNFFLSD 134
+ + + L L A S++ + L+ N +G + +++ ++
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322
Query: 135 NQFSG----SIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQS-LTGLINLDLSSNNL 185
F+ S LA L ++ ++NN L + + L L L+ ++
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 186 SGE----LPPSLENLSQLTTLHLQNNQLSGT-----LDVLQD--LPLRDLNIENNLFS 232
S L +L L L L NN L ++ ++ L L + + +S
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 31/152 (20%), Positives = 57/152 (37%), Gaps = 26/152 (17%)
Query: 104 SIRVIDLSNNHIG----GSIPSILPV--TMQNFFLSDNQFSGSIPSSLATLTL-----LT 152
I+ + L N + G + S L T+Q LSDN + L L L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 153 DMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLE-NLSQLTTLH 203
+ L LS + ++ L +S+N+++ L L+ + QL L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 204 LQNNQLSGT-----LDVLQDLP-LRDLNIENN 229
L++ ++ ++ LR+L + +N
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSN 237
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 33/160 (20%), Positives = 54/160 (33%), Gaps = 26/160 (16%)
Query: 99 LGAFSSIRVIDLSNNHIG----GSIPSILPV--TMQNFFLSDNQFSGSIPSSLATL---- 148
L +V+ L + + I S L V + L N+ +
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 149 -TLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE-----LPPSLENLSQ 198
+ +SL N L+G + ++L L L LS N L L+ +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 199 LTTLHLQNNQLSGT-----LDVLQDLP-LRDLNIENNLFS 232
L L L+ LS VL+ P ++L + NN +
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 18/188 (9%)
Query: 477 PAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQL-PDGKL 535
AE S + A+P R F ++G G +V A+ +
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRP-------EDFKFGKILGEGSFSTVVLARELATSRE 57
Query: 536 LAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELKGYCAEHGQRL-LIYEYCSNGT 593
A+K L+KR ++ ++ ++ R+ H V+L + + ++L Y NG
Sbjct: 58 YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGE 116
Query: 594 LQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAV 653
L + TR A ALEYLH I+HR+ K NILL++D+ +
Sbjct: 117 LLKYIRKIGSFDETC---TRFYTA-EIVSALEYLHGK---GIIHRDLKPENILLNEDMHI 169
Query: 654 SVSDCGLA 661
++D G A
Sbjct: 170 QITDFGTA 177
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 29/159 (18%), Positives = 58/159 (36%), Gaps = 18/159 (11%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID---RIRHANIVEL 572
+G G G V+R + K K + + D ++ I RH NI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVK--KEISILNIARHRNILHL 66
Query: 573 KGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
+ ++I+E+ S + + +++ N + + AL++LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQFLHSH-- 121
Query: 633 PPIVHRNFKSANILL--DDDLAVSVSDCGLAPLISSGSV 669
I H + + NI+ + + + G A + G
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 41/190 (21%), Positives = 66/190 (34%), Gaps = 50/190 (26%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
Y S++ L G G+ G V G+ A+K L ++Q+ D +
Sbjct: 28 DDYQ--LSKQVL-GLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASG---- 80
Query: 564 IRHANIVELKGYC--AEHGQR--LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI----- 614
+IV + HG+R L+I E G L RI
Sbjct: 81 --GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----------------RIQERGD 122
Query: 615 -----RMALGAAR----ALEYLHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAP 662
R A R A+++LH I HR+ K N+L + D + ++D G A
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 663 LISSGSVSQV 672
+ ++
Sbjct: 180 ETTQNALQTP 189
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 30/138 (21%), Positives = 52/138 (37%), Gaps = 22/138 (15%)
Query: 95 LGENLGAFSSIRVIDLSNNHIG-----GSIPSILPV--TMQNFFLSDNQFSG----SIPS 143
+ + + + + N I + L ++ L DN F+ ++
Sbjct: 179 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238
Query: 144 SLATLTLLTDMSLNNNLLSGE----IPDAFQSL--TGLINLDLSSNNLSGE----LPPSL 193
+L + L ++ LN+ LLS + DAF L GL L L N + + L +
Sbjct: 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298
Query: 194 -ENLSQLTTLHLQNNQLS 210
E + L L L N+ S
Sbjct: 299 DEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 30/184 (16%), Positives = 56/184 (30%), Gaps = 30/184 (16%)
Query: 97 ENLGAFSSIRVIDLSNNHIGG----SIPSILPV--TMQNFFLSDNQF-----SGSIPSSL 145
+ +R I N + + + N + L
Sbjct: 153 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212
Query: 146 ATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLS 197
A L + L +N + + A +S L L L+ LS + + L
Sbjct: 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 272
Query: 198 --QLTTLHLQNNQLS--GTLDVLQDLP-----LRDLNIENNLFS--GPIPEKMLQIPNFR 246
L TL LQ N++ + + L L + N FS + +++ ++ + R
Sbjct: 273 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR 332
Query: 247 KDGN 250
G
Sbjct: 333 GRGE 336
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 29/180 (16%), Positives = 55/180 (30%), Gaps = 39/180 (21%)
Query: 77 NASDIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFL 132
+ I+L+G +G E L EN+ + + + + S+ G I
Sbjct: 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR----- 84
Query: 133 SDNQFSGSIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE 188
+ +L L + L++N + D T L +L L +N L +
Sbjct: 85 -------LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 137
Query: 189 -------------LPPSLENLSQLTTLHLQNNQLS--GTL---DVLQDLP-LRDLNIENN 229
+ +N L ++ N+L Q L + + N
Sbjct: 138 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 197
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 28/131 (21%), Positives = 47/131 (35%), Gaps = 24/131 (18%)
Query: 104 SIRVIDLSNNHIGG----SIPSILPV--TMQNFFLSDNQFSG----SIPSSLATLTLLTD 153
SI L + I S+ ++L +++ LS N + ++A+ L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 154 MSLNNN---LLSGEIPDAFQSL-------TGLINLDLSSNNLSGE----LPPSLENLSQL 199
++ + EIP+A + L L + LS N L L + L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 200 TTLHLQNNQLS 210
L+L NN L
Sbjct: 125 EHLYLHNNGLG 135
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 40/128 (31%), Positives = 60/128 (46%), Gaps = 15/128 (11%)
Query: 94 ELGEN----LGAF---SSIRVIDLSNNHIGGSIPS---ILPVTMQNFFLSDNQFSGSIPS 143
LG N + A +++ + L+ N + S+P+ ++ L +NQ S+P
Sbjct: 69 ALGGNKLHDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPD 126
Query: 144 SL-ATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTT 201
+ LT LT ++L +N L F LT L LDLS N L LP + + L+QL
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKD 185
Query: 202 LHLQNNQL 209
L L NQL
Sbjct: 186 LRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 46/138 (33%), Positives = 62/138 (44%), Gaps = 11/138 (7%)
Query: 103 SSIRVIDLSNNHIGGSIPSI-LPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+SI I +N+ I S+ I ++ L N+ I + L LT LT + L N L
Sbjct: 41 NSIDQIIANNSDIK-SVQGIQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLILTGNQL 97
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQLTTLHLQNNQL----SGTLDVL 216
F LT L L L N L LP + + L+ LT L+L +NQL G D L
Sbjct: 98 QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKL 156
Query: 217 QDLPLRDLNIENNLFSGP 234
+L DL+ N L S P
Sbjct: 157 TNLTELDLS-YNQLQSLP 173
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 11/117 (9%)
Query: 100 GAF---SSIRVIDLSNNHIGGSIPS---ILPVTMQNFFLSDNQFSGSIPSSL-ATLTLLT 152
G F ++++ + L N + S+P + L+ NQ S+P + LT LT
Sbjct: 103 GVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLT 160
Query: 153 DMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
++ L+ N L +P+ F LT L +L L N L + L+ L + L +N
Sbjct: 161 ELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 34/165 (20%), Positives = 66/165 (40%), Gaps = 30/165 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID----- 562
+ + IG G G V++ + G+++A+KK + E ++ I
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF--------LESEDDPVIKKIALREIR 54
Query: 563 ---RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT---RIRM 616
+++H N+V L + L++EYC +LH D + + +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L +A+ + H+ +HR+ K NIL+ + + D G A
Sbjct: 111 TL---QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 34/165 (20%), Positives = 65/165 (39%), Gaps = 30/165 (18%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI------ 561
+ L+G G G V + + G+++A+KK + + ++V I
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF--------LESDDDKMVKKIAMREIK 76
Query: 562 --DRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNT---RIRM 616
++RH N+V L C + + L++E+ +L + N L + +
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ + + H I+HR+ K NIL+ V + D G A
Sbjct: 133 II---NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 26/163 (15%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVELK 573
+G G G V A + +A+K + ++ + +E ++ + +RH +I++L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+++ EY G L D + RM R A+E
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKK------------RMTEDEGRRFFQQIICAIE 122
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
Y H IVHR+ K N+LLDD+L V ++D GL+ +++ G+
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 29/159 (18%), Positives = 58/159 (36%), Gaps = 29/159 (18%)
Query: 517 IGAGMLGSVYRA-QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG- 574
+G G+ G V + + A+K L ++++ + +IV +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ------CPHIVRIVDV 79
Query: 575 YCAEHGQRLLIY---EYCSNGTLQDMLHSDDELKNNLSWNTR-----IRMALGAARALEY 626
Y + R + E G L + + + ++ R ++ A++Y
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASEIMKSIGE---AIQY 132
Query: 627 LHEICQPPIVHRNFKSANILL---DDDLAVSVSDCGLAP 662
LH I I HR+ K N+L + + ++D G A
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 30/102 (29%), Positives = 42/102 (41%), Gaps = 12/102 (11%)
Query: 511 FSQENL-----IGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVN 559
F ++ L +G G G V A + +AVK L + A+ + EL
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 560 NIDRIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHS 600
I H N+V L G C + G L +I E+C G L L S
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 35/169 (20%), Positives = 62/169 (36%), Gaps = 32/169 (18%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELV----NNIDRIRHA--N 568
L+G+G GSVY + D +A+K ++K S + V + ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 569 IVELKGYCAEHGQRLLIYEYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
++ L + +LI E L D + L+ L AR
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------ARSFFWQ 157
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSG 667
A+ + H ++HR+ K NIL+D + + + D G L+
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 34/165 (20%)
Query: 517 IGAGMLGSVYRAQ---LPDGKLLAVKKLDK--RASSQQKDDEFL-ELVNNIDRIRHANIV 570
+G G G VY+A+ D K A+K+++ + S ++ L EL +H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-------KHPNVI 81
Query: 571 ELKGYCAEHGQRL--LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA------- 621
L+ H R L+++Y D+ H + + + +++ G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 622 -RALEYLHEICQPPIVHRNFKSANILLDDDL----AVSVSDCGLA 661
+ YLH ++HR+ K ANIL+ + V ++D G A
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 29/223 (13%), Positives = 56/223 (25%), Gaps = 50/223 (22%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
+ P PP V I + +
Sbjct: 1 IAFDALREPDRESSAPPDDVQLVPGARIA-----------------------NGRYRL-- 35
Query: 504 LQQYTNSFSQENLIGAGMLGSVYRAQLPDGKL---LAVKKLDKR-ASSQQKDDEFLELVN 559
G ++A D L +A+ +D + E L
Sbjct: 36 ----------LIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 560 NIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
+ RI + + L++ E+ G+LQ++ + + S IR
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQS 137
Query: 620 AARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAP 662
A A + H + + + + D V ++ P
Sbjct: 138 LAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 48/316 (15%), Positives = 90/316 (28%), Gaps = 21/316 (6%)
Query: 351 RGEVDRIFKRHQVGAFRGNNREEARDNGTLALPTNQMEKDASVKPKEDHRSEMRRMGAIP 410
G D K + + ++++ + + P +K + R +
Sbjct: 190 NGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWD 249
Query: 411 HAQNEQERNKQRMSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKV 470
+ L P PP E+
Sbjct: 250 LTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERA 309
Query: 471 IVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQL 530
+ A + + F+ ++G G G V ++
Sbjct: 310 KIGQGTKAPEEKTANTISKFDNNGNRDRMKL-------TDFNFLMVLGKGSFGKVMLSER 362
Query: 531 PD-GKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVELKGYCAEHGQRL-LIY 586
+L AVK L K Q D E + + + + +L C + RL +
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVM 421
Query: 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGAARALEYLHEICQPPIVHRNFKSANI 645
EY + G L M H + A A L +L I++R+ K N+
Sbjct: 422 EYVNGGDL--MYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNV 473
Query: 646 LLDDDLAVSVSDCGLA 661
+LD + + ++D G+
Sbjct: 474 MLDSEGHIKIADFGMC 489
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 40/165 (24%), Positives = 62/165 (37%), Gaps = 31/165 (18%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLEL-VNNIDRIRHANIVELK 573
IG+G G + +L+AVK +++ DE ++ + N +RH NIV K
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIER----GAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------ALE 625
+I EY S G L + + + R + AR +
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICN------------AGRFSEDEARFFFQQLLSGVS 130
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLA--VSVSDCGLAPLISSGS 668
Y H + I HR+ K N LLD A + + D G + S
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 37/168 (22%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE------------FLE 556
+ + +G G G VY+A+ G+++A+K++ +DE E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIREISLLKE 75
Query: 557 LVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR--- 613
L H NIV L L++E+ +D+ DE K L +
Sbjct: 76 L-------HHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIY 124
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ L R + + H+ I+HR+ K N+L++ D A+ ++D GLA
Sbjct: 125 LYQLL---RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 42/247 (17%), Positives = 68/247 (27%), Gaps = 76/247 (30%)
Query: 442 MMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTI 501
M+ P PP PP P PPP K +
Sbjct: 2 MLTKPLQGPPAPPGTPTPPP--------------------GGKDREAFEAEYRLGP---- 37
Query: 502 ASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLE---- 556
L+G G G+V+ L D +A+K + +
Sbjct: 38 --------------LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 557 ------LVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGT-LQDMLHSDDELKNNLS 609
V H ++ L + +L+ E L D +
Sbjct: 84 EVALLWKVGAGGG--HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--------- 132
Query: 610 WNTRIRMALGAAR--------ALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGL 660
+ + G +R A+++ H +VHR+ K NIL+D + D G
Sbjct: 133 ---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS 186
Query: 661 APLISSG 667
L+
Sbjct: 187 GALLHDE 193
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 33/90 (36%), Positives = 45/90 (50%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P T Q +L DNQ + P LT LT + L+NN L+ F LT L
Sbjct: 23 SVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQ 82
Query: 178 LDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
L L+ N L + +NL LT + L NN
Sbjct: 83 LSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 39/241 (16%), Positives = 71/241 (29%), Gaps = 88/241 (36%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
P P +
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSI---------------------------------- 33
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE---------- 553
+ + + +G G G VY+A + +A+K++ + ++E
Sbjct: 34 ----DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIREV 84
Query: 554 --FLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWN 611
EL +H NI+ELK + + LI+EY +++LK + N
Sbjct: 85 SLLKEL-------QHRNIIELKSVIHHNHRLHLIFEYA-----------ENDLKKYMDKN 126
Query: 612 TRIRMALGAA------RALEYLHEICQPPIVHRNFKSANILLDDDLAVS-----VSDCGL 660
+ M + + + + H +HR+ K N+LL A + D GL
Sbjct: 127 PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
Query: 661 A 661
A
Sbjct: 184 A 184
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 35/178 (19%), Positives = 69/178 (38%), Gaps = 32/178 (17%)
Query: 84 IILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSIL-------PVTMQNFFLSDNQ 136
+ G+N + E + +DLS N++ L P ++ + LS N
Sbjct: 6 TLHPGSNP---VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS 62
Query: 137 FSGSIPSSLATL-----TLLTDMSLNNNLLSGE----IPDAFQSL-TGLINLDLSSNNLS 186
L + +T ++L+ N LS + + ++ + LDL N+ S
Sbjct: 63 LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
Query: 187 GE----LPPSLENL-SQLTTLHLQNNQLSGT-----LDVLQDLP--LRDLNIENNLFS 232
+ + NL + +T+L+L+ N L + +L +P + LN+ N +
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 24/148 (16%), Positives = 51/148 (34%), Gaps = 23/148 (15%)
Query: 103 SSIRVIDLSNNHIGGS----IPSIL---PVTMQNFFLSDNQFSGS----IPSSLATLTLL 151
+S+ +DLS N +G + I P + + L N G + +L L
Sbjct: 196 ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHL 255
Query: 152 TDMSLNNNLLSGEIPD-------AFQSLTGLINLDLSSNNLSGELPPSLENLSQ-----L 199
+ L+ +++ + AF ++ +I +D + + + NL +
Sbjct: 256 QTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKA 315
Query: 200 TTLHLQNNQLSGTLDVLQDLPLRDLNIE 227
L N L ++ ++ E
Sbjct: 316 DVPSLLNQCLIFAQKHQTNIEDLNIPDE 343
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 37/195 (18%), Positives = 76/195 (38%), Gaps = 34/195 (17%)
Query: 72 QGVQCNASDIIAIILNGANLGGELGENLGAF-----SSIRVIDLSNNHIGG----SIPSI 122
Q + + ++ L+G +LG + + L +++ ++LS N + +
Sbjct: 44 QAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103
Query: 123 L---PVTMQNFFLSDNQFSGS----IPSSLATLTL-LTDMSLNNNLLSGE----IPDAFQ 170
L P T+ L N FS + + L +T ++L N L + +
Sbjct: 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163
Query: 171 SL-TGLINLDLSSNNLSGE----LPPSLENL-SQLTTLHLQNNQLSGT-----LDVLQDL 219
++ + +L+L NNL+ + L L ++ + +T+L L N L + +
Sbjct: 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223
Query: 220 P--LRDLNIENNLFS 232
P + LN+ N
Sbjct: 224 PNHVVSLNLCLNCLH 238
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 16/90 (17%)
Query: 156 LNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGELPPSL-----ENLSQLTTLHLQN 206
+N L + + G+ +LDLS NNL L + +T+L+L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 207 NQLSGT-----LDVLQDLP--LRDLNIENN 229
N L + +L +P + LN+ N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGN 90
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 19/190 (10%)
Query: 480 GTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVK 539
+ + +Q +++ +IG G G V++A+L + +A+K
Sbjct: 11 NGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK 70
Query: 540 KLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL------LIYEYCSNGT 593
K+ Q K + EL + ++H N+V+LK + +G + L+ EY T
Sbjct: 71 KV-----LQDKRFKNREL-QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-T 123
Query: 594 LQDMLHSDDELKNNLSWNTRIRMAL-GAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652
+ +LK + I++ + R+L Y+H I I HR+ K N+LLD
Sbjct: 124 VYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSG 179
Query: 653 V-SVSDCGLA 661
V + D G A
Sbjct: 180 VLKLIDFGSA 189
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 42/155 (27%), Positives = 63/155 (40%), Gaps = 22/155 (14%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELK 573
L+G G G V + G+ A+K L K + + N + RH + LK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 574 GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRI---RMALGAAR---ALEY 626
Y + RL + EY + G L H LS R A AL+Y
Sbjct: 215 -YSFQTHDRLCFVMEYANGGEL--FFH--------LSRERVFSEDRARFYGAEIVSALDY 263
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LH + +V+R+ K N++LD D + ++D GL
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 30/186 (16%), Positives = 52/186 (27%), Gaps = 15/186 (8%)
Query: 482 AVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKL 541
A+K + + A + + Q ++ +
Sbjct: 35 AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDES 94
Query: 542 DKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI-YEYCSNGTLQDML-- 598
S + + + + L I + C L+D +
Sbjct: 95 TDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 599 ---HSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655
D E L +I A A+E+LH ++HR+ K +NI D V V
Sbjct: 155 RCSLEDREHGVCLHIFIQI------AEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 205
Query: 656 SDCGLA 661
D GL
Sbjct: 206 GDFGLV 211
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 54.4 bits (132), Expect = 4e-08
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 37/166 (22%)
Query: 511 FSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDE------------FLELV 558
+ IG G G VY+AQ G+ A+KK+ +K+DE EL
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIREISILKEL- 57
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR---IR 615
+H+NIV+L + +L++E+ QD+ D + L T +
Sbjct: 58 ------KHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLL 107
Query: 616 MALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L + Y H+ ++HR+ K N+L++ + + ++D GLA
Sbjct: 108 QLL---NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 4e-08
Identities = 22/171 (12%), Positives = 55/171 (32%), Gaps = 31/171 (18%)
Query: 67 CGESWQGVQCNASDIIAIILNGANL-------GGELGENLGAFSSIRVIDLSNNHIGGS- 118
SW D+ ++ L L +++ +++ + + S
Sbjct: 154 QEISW----IEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSV 209
Query: 119 IPSILPVTMQN------FFLSDNQFSGSIPSSLA------TLTLLTDMSLNNNLLSGEIP 166
+ IL + N + ++ + L + + + +
Sbjct: 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269
Query: 167 DAF---QSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLS 210
+ F L L +D+S+ L+ E L ++ + L ++++ N LS
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 6e-05
Identities = 18/144 (12%), Positives = 49/144 (34%), Gaps = 21/144 (14%)
Query: 85 ILNGANLGGELGENLGA--FSSIRVIDL---SNNHIGGSIPSILPV--------TMQNFF 131
+ L + E++ ++ + L ++ ++ ++
Sbjct: 199 EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLG 258
Query: 132 LSDNQFSGSIPSSLAT---LTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNN 184
+ D + + L L M ++ +L+ E + D + L +++ N
Sbjct: 259 IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318
Query: 185 LSGELPPSLENLSQLTTLHLQNNQ 208
LS E+ L+ S + + ++Q
Sbjct: 319 LSDEMKKELQK-SLPMKIDVSDSQ 341
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 5e-08
Identities = 37/180 (20%), Positives = 64/180 (35%), Gaps = 48/180 (26%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEFLELVN------ 559
+ + IG G G+VY+A+ G +A+K + +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN-------GGGGGGGLPISTVRE 61
Query: 560 -----NIDRIRHANIVELK----GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLS 609
++ H N+V L + ++ L++E+ D +L+ L
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----------DQDLRTYLD 110
Query: 610 WNTRIRMALGAA--------RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ R L++LH C IVHR+ K NIL+ V ++D GLA
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA 167
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-08
Identities = 29/90 (32%), Positives = 45/90 (50%)
Query: 118 SIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLIN 177
S+P+ +P Q +L++NQ + P L L + N+N L+ F LT L
Sbjct: 26 SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ 85
Query: 178 LDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
LDL+ N+L + +NL LT ++L NN
Sbjct: 86 LDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 24/71 (33%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 140 SIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSL-ENLSQ 198
S+P+ + T + LNNN ++ P F L L L +SN L+ +P + + L+Q
Sbjct: 26 SVPAGIPTDK--QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 199 LTTLHLQNNQL 209
LT L L +N L
Sbjct: 83 LTQLDLNDNHL 93
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 472 VKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENLIGAGMLGSVYRAQL- 530
V+ V +K T + + S++ +IG G G VY+A+L
Sbjct: 17 VQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLC 76
Query: 531 PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL------L 584
G+L+A+KK+ Q K + EL + ++ H NIV L+ + G++ L
Sbjct: 77 DSGELVAIKKV-----LQDKRFKNREL-QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130
Query: 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL-GAARALEYLHEICQPPIVHRNFKSA 643
+ +Y T+ + K L +++ + R+L Y+H I HR+ K
Sbjct: 131 VLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQ 185
Query: 644 NILLDDDLAV-SVSDCGLAPLISSG 667
N+LLD D AV + D G A + G
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRG 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 37/162 (22%), Positives = 64/162 (39%), Gaps = 26/162 (16%)
Query: 511 FSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHAN 568
F +IG G G V +L + K+ A+K L+K ++ + ++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
I L Y + L L+ +Y G +L LS R+ AR
Sbjct: 136 ITTLH-YAFQDDNNLYLVMDYYVGG----------DLLTLLS-KFEDRLPEEMARFYLAE 183
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
A++ +H++ VHR+ K NIL+D + + ++D G
Sbjct: 184 MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 9e-08
Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 33/168 (19%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-- 565
+ + + +G G +VY+A+ +++A+KK+ K + D N +R
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGI-----NRTALREI 63
Query: 566 -------HANIVELKGYCAEHGQRLLIYEYCSN---GTLQDMLH--SDDELKNNLSWNTR 613
H NI+ L L++++ ++D + +K ++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK---AY--- 117
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ M L + LEYLH+ I+HR+ K N+LLD++ + ++D GLA
Sbjct: 118 MLMTL---QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 42/155 (27%), Positives = 62/155 (40%), Gaps = 23/155 (14%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIVELK 573
L+G G G V + G+ A+K L K + + + + RH + LK
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 574 GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRI---RMALGAAR---ALEY 626
Y + RL + EY + G L H LS R A ALEY
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL--FFH--------LSRERVFTEERARFYGAEIVSALEY 120
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LH +V+R+ K N++LD D + ++D GL
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 35/164 (21%), Positives = 63/164 (38%), Gaps = 26/164 (15%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
+ F +IG G V ++ G++ A+K ++K ++ + ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
I +L + + L L+ EY G +L LS R+ AR
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGG----------DLLTLLS-KFGERIPAEMARFYL 168
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
A++ +H + VHR+ K NILLD + ++D G
Sbjct: 169 AEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 35/164 (21%), Positives = 62/164 (37%), Gaps = 28/164 (17%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
+ +IG G G V + K+ A+K L K ++ D F +I
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
+V+L Y + + L ++ EY G L ++ + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYT 174
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
AL+ +H + +HR+ K N+LLD + ++D G
Sbjct: 175 AEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 2e-07
Identities = 37/169 (21%), Positives = 68/169 (40%), Gaps = 37/169 (21%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE------------FL 555
+F + IG G G VY+A+ G+++A+KK+ + E
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-----RLDTETEGVPSTAIREISLLK 57
Query: 556 ELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN---GTLQDMLHSDDELKNNLSWNT 612
EL H NIV+L + L++E+ + + L S+
Sbjct: 58 EL-------NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-- 108
Query: 613 RIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ L + L + H ++HR+ K N+L++ + A+ ++D GLA
Sbjct: 109 -LFQLL---QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 2e-07
Identities = 36/167 (21%), Positives = 69/167 (41%), Gaps = 38/167 (22%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE------------FLEL 557
+ + IG G G+V++A+ +++A+K++ DDE EL
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALREICLLKEL 58
Query: 558 VNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR---I 614
+H NIV L + L++E+C QD+ D +L +
Sbjct: 59 -------KHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 615 RMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L + L + H ++HR+ K N+L++ + + +++ GLA
Sbjct: 108 FQLL---KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 35/173 (20%), Positives = 61/173 (35%), Gaps = 42/173 (24%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEF-----------LE 556
+ F Q +G G +VY+ G +A+K++ ++ E
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIREISLMKE 59
Query: 557 LVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDM-----LHSDDELKNNLSWN 611
L +H NIV L + L++E+ D+ + L N
Sbjct: 60 L-------KHENIVRLYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELN 108
Query: 612 TR---IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L + L + HE I+HR+ K N+L++ + + D GLA
Sbjct: 109 LVKYFQWQLL---QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 45/222 (20%), Positives = 80/222 (36%), Gaps = 45/222 (20%)
Query: 457 PPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYTNSFSQENL 516
P E + + + + K + T + + S + F +
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL-------QDFDLLRV 59
Query: 517 IGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHAN 568
IG G V +L ++ A++ + K + +D + E +N H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPF 114
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR----- 622
+V L C + RL + EY + G L M H + ++ AR
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQ----------RKLPEEHARFYSAE 161
Query: 623 ---ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
AL YLHE I++R+ K N+LLD + + ++D G+
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 40/163 (24%), Positives = 66/163 (40%), Gaps = 38/163 (23%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHA 567
+IG G V +L ++ A+K + K + +D + E +N H
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HP 70
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---- 622
+V L C + RL + EY + G L M H + ++ AR
Sbjct: 71 FLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQR----------KLPEEHARFYSA 117
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
AL YLHE I++R+ K N+LLD + + ++D G+
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 34/168 (20%), Positives = 70/168 (41%), Gaps = 37/168 (22%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEF-----------LE 556
++ + + +G G +VY+ + L+A+K++ + ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIREVSLLKD 56
Query: 557 LVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTR--- 613
L +HANIV L L++EY +D+ D+ N ++ +
Sbjct: 57 L-------KHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLF 105
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ L R L Y H ++HR+ K N+L+++ + ++D GLA
Sbjct: 106 LFQLL---RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 30/151 (19%), Positives = 56/151 (37%), Gaps = 22/151 (14%)
Query: 104 SIRVIDLSNNHIGG-SIPSILPV--TMQNFFLSDNQFSGSIPSSLATL-----TLLTDMS 155
++ ++L++ + + ++LPV + L N L L +T +
Sbjct: 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLR 161
Query: 156 LNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNN 207
L+NN L+ + + T + +L L L E L L+ QL L++ N
Sbjct: 162 LSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYN 221
Query: 208 QLSGT-----LDVLQDLP-LRDLNIENNLFS 232
T ++ P L L++ N S
Sbjct: 222 GAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 24/135 (17%), Positives = 47/135 (34%), Gaps = 17/135 (12%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATL- 148
LG + L + + + + +++ L+ + + + +A +
Sbjct: 37 KLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVL 96
Query: 149 ----TLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSL-EN 195
L +++L + L + F L L N+L E L L +
Sbjct: 97 GSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR---KLGLQLNSLGPEACKDLRDLLLHD 153
Query: 196 LSQLTTLHLQNNQLS 210
Q+TTL L NN L+
Sbjct: 154 QCQITTLRLSNNPLT 168
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 40/169 (23%), Positives = 75/169 (44%), Gaps = 20/169 (11%)
Query: 505 QQYTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKK--LDKRASSQQKDDEFLELVNNI 561
++ + F E + G G G+V + G +A+KK D R ++ E L+++ ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRE-LQIMQDL 73
Query: 562 DRIRHANIVELKGYCAEHGQR-------LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRI 614
+ H NIV+L+ Y G+R ++ EY + TL + + I
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL-I 131
Query: 615 RMAL-GAARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLA 661
++ L R++ LH + HR+ K N+L++ D + + D G A
Sbjct: 132 KVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSA 179
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 38/173 (21%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKK--LDKRASSQQKDDEF----LELVNNI 561
+ + + IG G G V++A+ G+ +A+KK ++ + + F L + +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN------EKEGFPITALREIKIL 70
Query: 562 DRIRHANIVELKGYCAEHGQRL--------LIYEYCSN---GTLQDMLH--SDDELKNNL 608
++H N+V L C L++++C + G L ++L + E+K
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--- 127
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
++M L L Y+H I+HR+ K+AN+L+ D + ++D GLA
Sbjct: 128 ---RVMQMLL---NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 6e-07
Identities = 28/190 (14%), Positives = 51/190 (26%), Gaps = 53/190 (27%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKL------DKRASSQQKDDEFLE---------LVNNI 561
IG G+ G V++ D +A+K + S Q+ +E L L++
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 562 DRIRHANIVELKG------------------YCAEHG------------QRLLIYEYCSN 591
R + L Y + G Q ++ E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL 651
G + + S T + +L + HR+ N+LL
Sbjct: 147 GIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTS 199
Query: 652 AVSVSDCGLA 661
+
Sbjct: 200 LKKLHYTLNG 209
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 7e-07
Identities = 35/178 (19%), Positives = 67/178 (37%), Gaps = 46/178 (25%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ--LPDGKLLAVKK--LDKRASSQQKDDEFL--------E 556
+ IG G G V++A+ G+ +A+K+ + +E +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTIREVA 63
Query: 557 LVNNIDRIRHANIVELK----GYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWN 611
++ +++ H N+V L + +L L++E+ D +L L
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----------DQDLTTYLDKV 112
Query: 612 TRIRMALGAA--------RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ R L++LH +VHR+ K NIL+ + ++D GLA
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 54/225 (24%)
Query: 449 PPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASLQQYT 508
P P P PPP +++ + P +S AKP
Sbjct: 4 QPQEPELMNANPAPPPAPSQQINLGP----------SSNPHAKP---------------- 37
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIR 565
+ F +IG G G V A+ AVK L K+A ++K+++ + N+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 566 HANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR-- 622
H +V L + + +L + +Y + G L H E AR
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPR----------ARFY 144
Query: 623 ------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
AL YLH + IV+R+ K NILLD + ++D GL
Sbjct: 145 AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 38/177 (21%), Positives = 71/177 (40%), Gaps = 39/177 (22%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI------ 561
+ F IG G G V Q D K+ A+K ++K+ ++ + V N+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE------VRNVFKELQI 68
Query: 562 -DRIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALG 619
+ H +V L Y + + + ++ + G +L+ +L N +
Sbjct: 69 MQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGG----------DLRYHLQQNVHFKEE-- 115
Query: 620 AAR--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ AL+YL I+HR+ K NILLD+ V ++D +A ++ +
Sbjct: 116 TVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 2e-06
Identities = 13/60 (21%), Positives = 18/60 (30%)
Query: 433 EIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
+ M + + P PPP P P P P P ++ K K K
Sbjct: 36 SVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKK 95
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 3e-06
Identities = 16/48 (33%), Positives = 18/48 (37%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
PPP P P P P P P PP VI KP + +P
Sbjct: 53 PPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQP 100
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 14/48 (29%), Positives = 16/48 (33%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
P P P P P P PP P V+EK KP +
Sbjct: 57 PVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDV 104
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 12/59 (20%), Positives = 17/59 (28%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
P P P P PP P P K KP+ + + + T +
Sbjct: 63 PEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPA 121
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 13/54 (24%), Positives = 17/54 (31%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTA 496
+ P P P P P PP P K KP + + KP +
Sbjct: 57 PVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESR 110
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 15/59 (25%), Positives = 22/59 (37%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
P P P P P P P V++ + + P E TA T+ + T A+
Sbjct: 74 EAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAAT 132
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 13/52 (25%), Positives = 16/52 (30%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTA 496
P P P P P P PP PVV + P K + +
Sbjct: 56 EPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPV 107
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 12/59 (20%), Positives = 17/59 (28%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
P P P P P P P + K V + + + P S A+
Sbjct: 73 KEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAA 131
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 15/49 (30%), Positives = 17/49 (34%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
P P P P P P P PP V KP + VK + K
Sbjct: 54 PPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKR 102
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 14/59 (23%), Positives = 18/59 (30%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIAS 503
P PP P P P P P + V P S + TA + +S
Sbjct: 68 IPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSS 126
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 13/57 (22%), Positives = 14/57 (24%)
Query: 444 MPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFT 500
P P P P P PP P K KP + A F
Sbjct: 60 EPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFE 116
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 13/62 (20%), Positives = 20/62 (32%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFTIASL 504
P P P P P P P + V+ + + T+ T A S + S+
Sbjct: 80 EKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPASPFENTAPARLTSSTATAATSKPVTSV 139
Query: 505 QQ 506
Sbjct: 140 AS 141
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 14/59 (23%), Positives = 21/59 (35%)
Query: 434 IDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
I ++ + + PP PPP P P P P + + + V E K K
Sbjct: 35 ISVTMVTPADLEPPQAVQPPPEPVVEPEPEPEPIPEPPKEAPVVIEKPKPKPKPKPKPV 93
|
| >2grx_C Protein TONB; beta barrel, outer membrane, heterocomplex, inter-protein beta sheet, protein-protein, metal transport; HET: GCN KDO GMH FTT DAO MYR FCI; 3.30A {Escherichia coli} SCOP: d.212.1.2 PDB: 1xx3_A Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 10/50 (20%), Positives = 13/50 (26%)
Query: 443 MMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKP 492
P P P PP P P P K V + ++
Sbjct: 63 PEPEPIPEPPKEAPVVIEKPKPKPKPKPKPVKKVQEQPKRDVKPVESRPA 112
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 22/118 (18%), Positives = 42/118 (35%), Gaps = 12/118 (10%)
Query: 134 DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG--ELPP 191
S + +L S L I + L +L+LS+N L ++
Sbjct: 135 KGLRSDPDLVAQNIDVVLNRRSCMAATLRI-IEENIPELL---SLNLSNNRLYRLDDMSS 190
Query: 192 SLENLSQLTTLHLQNNQLS--GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRK 247
++ L L+L N+L LD ++ L L +L ++ N + + +
Sbjct: 191 IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN----SLCDTFRDQSTYIS 244
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 25/163 (15%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
+ F + +G G G V + G A+K LDK+ + K E I +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---- 622
+V+L+ ++ ++ EY + G + L AR
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP------------HARFYAA 148
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
EYLH + +++R+ K N+L+D + V+D G A
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 28/158 (17%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHA 567
++G G G V A++ + G L AVK L K Q D E L L N H
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-----HP 84
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---A 623
+ +L C + RL + E+ + G L M H + + + R AA A
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEA-----RARFYAAEIISA 136
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L +LH+ I++R+ K N+LLD + ++D G+
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 37/163 (22%), Positives = 58/163 (35%), Gaps = 38/163 (23%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDE-------FLELVNNIDRIRHA 567
++G G G V ++ +L AVK L K Q D E L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-----PP 81
Query: 568 NIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR---- 622
+ +L C + RL + EY + G L M H R A
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQV----------GRFKEPHAVFYAA 128
Query: 623 ----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L +L I++R+ K N++LD + + ++D G+
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 516 LIGAGMLGSVY----RAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHANIV 570
++G G G V+ + +L A+K L K A+ + +D ++ +I + H IV
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 571 ELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMA---LGAARALEY 626
+L Y + +L LI ++ G L E+ + +A L AL++
Sbjct: 90 KLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEED-VKFYLAELAL----ALDH 141
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LH + I++R+ K NILLD++ + ++D GL+
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 1e-05
Identities = 40/275 (14%), Positives = 75/275 (27%), Gaps = 78/275 (28%)
Query: 35 VTNPNDVAAI-NSLYAALGSPVLPGWVASAGDP-CGESWQGVQ-CNASDIIAIILNGA-- 89
V+ + +L P V G G++W + C + + +
Sbjct: 131 VSRLQPYLKLRQALLEL--RPA--KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 90 -NLG-----GELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNF------FLSDNQF 137
NL + E L ID N S + + + + L +
Sbjct: 187 LNLKNCNSPETVLEMLQKLL--YQID-PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 138 SGSIPSSLATL-----------------TLLT--DMSLNNNLLSGE-----IPDAFQSLT 173
+ L L LLT + + L + + +LT
Sbjct: 244 ----ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 174 GLINLDLSSNNLS---GELPPSLENLSQL-----------------TTLHLQNNQLSGT- 212
L L +LP + + H+ ++L+
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
Query: 213 ---LDVLQDLPLRDLNIENNLF--SGPIPEKMLQI 242
L+VL+ R + ++F S IP +L +
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL 394
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 5e-05
Identities = 24/205 (11%), Positives = 63/205 (30%), Gaps = 56/205 (27%)
Query: 466 VVEKVIVKPIVPAEGTAVKTSTKTAKPFTTARSFT---------IASLQQYTNSFSQENL 516
++ + + P+ T + + + + + F L+Q
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRD-RLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 517 IGA-GMLGSVYRAQLPDGK-LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK- 573
+ G+LGS GK +A+ + ++ I L
Sbjct: 153 VLIDGVLGS--------GKTWVALDVC--------LSYKVQCKMDF-------KIFWLNL 189
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHS-DDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
C L + LQ +L+ D + ++ I++ + + + L +
Sbjct: 190 KNCNSPETVLEM--------LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ--AELRRL-- 237
Query: 633 PPIVHRNFKSANILLDDDLAVSVSD 657
+ + +++ ++L + V +
Sbjct: 238 --LKSKPYENCLLVLLN-----VQN 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-05
Identities = 88/626 (14%), Positives = 175/626 (27%), Gaps = 158/626 (25%)
Query: 108 IDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD 167
+D IL V F + + + ++L+ +++ ++S D
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAF-VDNFDCK-DVQDMP--KSILSKEEIDHIIMS---KD 59
Query: 168 AFQSLTGLINLDLSSNN------LSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPL 221
A L LS + L + + L ++ + + Q S + +
Sbjct: 60 AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL--MSPIKTEQRQPSMMTRMYIEQ-- 115
Query: 222 RD-LNIENNLFSG---PIPEKMLQIPNFRKDGNPFNSTVAPSRPPTSSVTPPPAPPFFGP 277
RD L +N +F+ + L++ R + P G
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKL-----------------RQALLELRPAKNVLIDG- 157
Query: 278 RPVSGSSPVSRTPPSQHTPGKQADGPTALEDSNSGKKKSSTTKKIVWISIAGV----LLF 333
V GS GK AL+ S K + KI W+++ +
Sbjct: 158 --VLGS-------------GKTW---VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVL 199
Query: 334 VILALVFLLFMPRCIKR--------------RGEVDRIFKRHQ----------VGAFRGN 369
+L + P R + E+ R+ K V
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV-----Q 254
Query: 370 NRE--EARDNG--TLALPTNQMEKDASVKPKEDHRSEMRRMGAIPHAQNEQERNK---QR 422
N + A + L + D H S + + + K R
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 423 MSTIPRRDDHEIDMSSLDMMMMPPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTA 482
+PR E+ ++ P +I + I T
Sbjct: 315 PQDLPR----EVLTTN--------------------------PRRLSIIAESIRDGLATW 344
Query: 483 VKTSTKTAKPFTTARSFTIASL-----QQYTNSFS--QENL-IGAGMLGSVYRAQLPDGK 534
TT ++ L ++ + S + I +L ++ +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 535 LLAVKKLDKRASSQQKDDEF--------LELVNNIDRIR--HANIVE----LKGYCAEHG 580
++ V KL K + +++ E LEL ++ H +IV+ K + ++
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 581 QRLLI--YEYCSNG---TLQDMLHSDDELKN---NLSW-NTRIRMALGAARALEYLHEIC 631
+ Y Y G + + + + +IR A A +
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSD 657
Q ++ + N + L ++ D
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILD 550
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 36/158 (22%), Positives = 59/158 (37%), Gaps = 28/158 (17%)
Query: 516 LIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNI--DRIRHANIVEL 572
++G G G V+ A+ + A+K L K D E + + H + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 573 KGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--------A 623
+ + L + EY + G L M H + L A
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDL--MYHIQSC----------HKFDLSRATFYAAEIILG 130
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L++LH IV+R+ K NILLD D + ++D G+
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 31/161 (19%)
Query: 516 LIGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKDD-EFLELVNNI-DRIRHANI 569
++G G G V++ + GK+ A+K L K + D + NI + ++H I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 570 VELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR------ 622
V+L Y + G +L LI EY S G L + L A
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGEL--FMQ--------LE--REGIFMEDTACFYLAEI 130
Query: 623 --ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
AL +LH+ I++R+ K NI+L+ V ++D GL
Sbjct: 131 SMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 27/164 (16%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRH 566
F +G G G V+ + +G+ A+K L K + K E + + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 567 ANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR--- 622
I+ + + Q++ +I +Y G EL + L + R + A+
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIEGG----------ELFSLLRKSQRFPNPV--AKFYA 112
Query: 623 -----ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
ALEYLH I++R+ K NILLD + + ++D G A
Sbjct: 113 AEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 44/169 (26%), Positives = 68/169 (40%), Gaps = 46/169 (27%)
Query: 516 LIGAGMLGSVYRAQLPDGK----LLAVKKLDKRASSQQKDDEF---------LELVNNID 562
++G G G V+ + G L A+K L K A+ QK LE +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAKTTEHTRTERQVLEHIRQ-- 117
Query: 563 RIRHANIVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM-ALGA 620
+V L Y + +L LI +Y + G L H LS +
Sbjct: 118 ---SPFLVTLH-YAFQTETKLHLILDYINGGEL--FTH--------LS---QRERFTEHE 160
Query: 621 AR--------ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ ALE+LH++ I++R+ K NILLD + V ++D GL+
Sbjct: 161 VQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 22/137 (16%), Positives = 43/137 (31%), Gaps = 23/137 (16%)
Query: 74 VQCNASDIIAIILNGANLGGE-----LGENLGAFSSIRVIDLSNNHIGG----SIPSILP 124
+Q N D+ + LN E L + ++ + ++ +L
Sbjct: 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLK 90
Query: 125 V--TMQNFFLSDNQFSGSIPSSLA-------TLTLLTDMSLNNNLLSG----EIPDAFQS 171
V T+++ + N SGS +L +L L + + L EI + +
Sbjct: 91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIEL-RIDNQSQPLGNNVEMEIANMLEK 149
Query: 172 LTGLINLDLSSNNLSGE 188
T L+
Sbjct: 150 NTTLLKFGYHFTQQGPR 166
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 33/152 (21%), Positives = 60/152 (39%), Gaps = 20/152 (13%)
Query: 517 IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE--FLELVNNIDRIRHANIVELK 573
IG+G G +Y + G+ +A+K + Q E +++ I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV-----GIPTIR 71
Query: 574 GYCAEHGQRLLIYEYCSNG-TLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQ 632
AE +++ E G +L+D+ + S T + +A +EY+H
Sbjct: 72 WCGAEGDYNVMVMELL--GPSLEDLF---NFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 633 PPIVHRNFKSANILL---DDDLAVSVSDCGLA 661
+HR+ K N L+ V + D GLA
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 36/167 (21%), Positives = 64/167 (38%), Gaps = 37/167 (22%)
Query: 517 IGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID--RI---------- 564
I +G G+V +G +A+K++ S + + ++ R+
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILS---DSFLCKRVLREIRLLNHF 86
Query: 565 RHANIVELKG-YCAEHGQRL----LIYEYCSNGT-LQDMLHSDDELKNNLSWNTRIRM-- 616
H NI+ L+ + + L+ E T L ++H + +S I+
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQ---RIVIS-PQHIQYFM 140
Query: 617 --ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L L LHE +VHR+ NILL D+ +++ D LA
Sbjct: 141 YHIL---LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA 181
|
| >2uv9_A Fatty acid synthase alpha subunits; fungal, dehydratase, enoyl reductase, ketoacyl synthase, ketoacyl reductase; 3.1A {Thermomyces lanuginosus} PDB: 2uvb_A* Length = 1878 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 14/61 (22%), Positives = 17/61 (27%), Gaps = 1/61 (1%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTT-ARSFTIAS 503
P P P P P P V P+ + + K K T S I
Sbjct: 115 AAPAAPAAPAAAPAPAPASAGPAAPVQDAPVTATDVIRALVAQKLKKELTEIPPSKAIKD 174
Query: 504 L 504
L
Sbjct: 175 L 175
|
| >2uv8_A Fatty acid synthase subunit alpha (FAS2); fatty acid biosynthesis, malonyl/palmitoyl transferase, phosphopantetheine, transferase; HET: GVL FMN; 3.10A {Saccharomyces cerevisiae} PDB: 2vkz_A* 3hmj_A* Length = 1887 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 13/61 (21%), Positives = 20/61 (32%), Gaps = 1/61 (1%)
Query: 445 PPPPPPPPPPPPPPPPPPPPPVVEKVIVKPIVPAEGTAVKTSTKTAKPFTT-ARSFTIAS 503
P P P P P ++ +P+ + V + K K + S TI
Sbjct: 115 ASAPAPAAAAPAPVAAAAPAAAAAEIADEPVKASLLLHVLVAHKLKKSLDSIPMSKTIKD 174
Query: 504 L 504
L
Sbjct: 175 L 175
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 689 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-35 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-31 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-30 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-30 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-29 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-27 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-26 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-24 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-23 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-21 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-21 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-21 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1jvra_ | 137 | a.61.1.2 (A:) HTLV-II matrix protein {Human T-cell | 2e-04 | |
| d1jvra_ | 137 | a.61.1.2 (A:) HTLV-II matrix protein {Human T-cell | 2e-04 | |
| d1jvra_ | 137 | a.61.1.2 (A:) HTLV-II matrix protein {Human T-cell | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 4e-04 | |
| d2gqba1 | 130 | a.282.1.1 (A:1-130) Hypothetical protein RPA2825 { | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 9/168 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ IG+G G+VY+ + +AVK L+ A + Q+ F V + + RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
I+ GY Q ++ ++C +L LH ++ I +A A+ ++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNL 676
I+HR+ KS NI L +DL V + D GLA + S S S L
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-36
Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 9/160 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +GAG G V+ +AVK L + D FL N + +++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQR 69
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V L +I EY NG+L D L + L+ N + MA A + ++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
E +HR+ ++ANIL+ D L+ ++D GLA LI
Sbjct: 127 E---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-35
Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 5/163 (3%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ IG G G + + DGK+L K+LD + ++ + + VN + ++H NI
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 570 VELKGYCAEHGQRLL--IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
V + L + EYC G L ++ + + L +R+ AL+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 628 HE--ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
H ++HR+ K AN+ LD V + D GLA +++ +
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 3e-35
Identities = 45/196 (22%), Positives = 81/196 (41%), Gaps = 20/196 (10%)
Query: 499 FTIASLQQYTNSFSQE---------NLIGAGMLGSVYRAQLP----DGKLLAVKKLDKRA 545
FT + F++E +IGAG G V L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 546 SSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELK 605
+ +Q+ +FL + + + H N++ L+G + ++I E+ NG+L L +D
Sbjct: 67 TEKQRR-DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--- 122
Query: 606 NNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+ + M G A ++YL VHR+ + NIL++ +L VSD GL+ +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 666 SGSVSQVSHNLTIMRA 681
+ + +
Sbjct: 180 DDTSDPTYTSALGGKI 195
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 8e-35
Identities = 31/165 (18%), Positives = 69/165 (41%), Gaps = 8/165 (4%)
Query: 504 LQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
++ + F + + +GAG G V++ P G ++A K + ++ + + + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLH 59
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
IV G G+ + E+ G+L +L + ++++ +
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIK 115
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
L YL E I+HR+ K +NIL++ + + D G++ +
Sbjct: 116 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-34
Identities = 36/163 (22%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ + IG+G G V+ + +A+K + + +++F+E + ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPK 61
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L G C E L++E+ +G L D L + L + T + M L + YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLE 118
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
E ++HR+ + N L+ ++ + VSD G+ + +
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-34
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 9/163 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
+ +G G G V + +A+K + + +DEF+E + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEK 60
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L G C + +I EY +NG L + L ++ + M A+EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671
+HR+ + N L++D V VSD GL+ + +
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (325), Expect = 1e-33
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 9/160 (5%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKR-ASSQQKDDEFLELVNNIDRIRHAN 568
FS IG G G+VY A+ + + +++A+KK+ S +K + ++ V + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
++ +G L+ EYC + K L + GA + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
++HR+ K+ NILL + V + D G A +++ +
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 18/164 (10%)
Query: 514 ENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+ IG G G V+R + G+ +AVK R +++ + +RH NI+
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFI 63
Query: 574 GYCAEHG----QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
+ Q L+ +Y +G+L D L+ + ++ I++AL A L +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHM 118
Query: 630 IC-----QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+P I HR+ KS NIL+ + ++D GLA S +
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 11/159 (6%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
IG G G V G +AVK + A++Q FL + + ++RH+N
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSN 61
Query: 569 IVELKGYCAEHGQRL-LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+V+L G E L ++ EY + G+L D L S ++ L + ++ +L A+EYL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL 119
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
VHR+ + N+L+ +D VSD GL SS
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-33
Identities = 37/158 (23%), Positives = 66/158 (41%), Gaps = 11/158 (6%)
Query: 513 QENLIGAGMLGSVYRAQLPD---GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
++ +G+G G+V + K +AVK L A+ DE L N + ++ + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V + G C E +L+ E G L L ++ I + + ++YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE- 124
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
+ VHR+ + N+LL +SD GL+ + +
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-33
Identities = 52/192 (27%), Positives = 77/192 (40%), Gaps = 28/192 (14%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD------GKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ ++G+G G V A +AVK L ++A S +++ EL
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-------------------DDE 603
H NIV L G C G LI+EYC G L + L S ++E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 604 LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663
N L++ + A A+ +E+L VHR+ + N+L+ V + D GLA
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 664 ISSGSVSQVSHN 675
I S S V N
Sbjct: 214 IMSDSNYVVRGN 225
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-32
Identities = 41/166 (24%), Positives = 68/166 (40%), Gaps = 9/166 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S E +G G G V+ +A+K L + FL+ + ++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEK 73
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+V+L ++ EY S G+L D L + + MA A + Y+
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVE 130
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
+ VHR+ ++ANIL+ ++L V+D GLA LI +
Sbjct: 131 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 32/155 (20%), Positives = 64/155 (41%), Gaps = 11/155 (7%)
Query: 517 IGAGMLGSVYRAQL---PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G GSV + +A+K L K+ + + +E + + ++ + IV L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
G C + +L+ E G L L + + + + + ++YL +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLE---EK 128
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
VHR+ + N+LL + +SD GL+ + +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-32
Identities = 45/186 (24%), Positives = 69/186 (37%), Gaps = 25/186 (13%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
N S +GAG G V A +AVK L A +++ + + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLS 81
Query: 563 RI-RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS--------------DDELKNN 607
+ H NIV L G C G L+I EYC G L + L ++ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 608 LSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
L + + A+ + +L +HR+ + NILL + D GLA I +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 668 SVSQVS 673
S V
Sbjct: 199 SNYVVK 204
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (308), Expect = 1e-31
Identities = 50/201 (24%), Positives = 83/201 (41%), Gaps = 30/201 (14%)
Query: 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEF 554
+ SL+ N+ IG G G V++A+ P ++AVK L + AS+ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DF 63
Query: 555 LELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHS-------------- 600
+ + NIV+L G CA L++EY + G L + L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 601 ------DDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654
LS ++ +A A + YL E VHR+ + N L+ +++ V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 655 VSDCGLAPLISSGSVSQVSHN 675
++D GL+ I S + N
Sbjct: 181 IADFGLSRNIYSADYYKADGN 201
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (307), Expect = 1e-31
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 9/161 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ ++ +G G G VY +AVK L + + +EFL+ + I+H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 73
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N+V+L G C +I E+ + G L D L + + +S + MA + A+EYL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYL 131
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ +HR+ + N L+ ++ V V+D GL+ L++ +
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-31
Identities = 38/154 (24%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 515 NLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
+G G G VY+AQ + L A K +D + S+++ ++++ ++ + H NIV+L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 574 GYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQP 633
++ E+C+ G + ++ EL+ L+ + + AL YLH+
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---N 129
Query: 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
I+HR+ K+ NIL D + ++D G++ +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-31
Identities = 40/153 (26%), Positives = 62/153 (40%), Gaps = 9/153 (5%)
Query: 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDK-RASSQQKDDEFLELVNNIDRIRHAN 568
F +G G G+VY A+ +LA+K L K + + + V +RH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
I+ L GY + + LI EY GT+ L + A AL Y H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH 123
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
++HR+ K N+LL + ++D G +
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWS 153
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 18/168 (10%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDGKLL---AVKKLDKRASSQQKDDEFLELVNNIDRIR 565
N +++IG G G V +A++ L A+K++ + AS D EL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 566 HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------------SDDELKNNLSWNTR 613
H NI+ L G C G L EY +G L D L + + LS
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 614 IRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ A AR ++YL Q +HR+ + NIL+ ++ ++D GL+
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 174
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPDG-----KLLAVKKLDKRASSQQKDDEFLELVNNIDR 563
+ +++ +IGAG G VY+ L +A+K L + +Q+ +FL + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQ 65
Query: 564 IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
H NI+ L+G +++ ++I EY NG L L D S + M G A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAG 122
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVS 673
++YL VHR+ + NIL++ +L VSD GL+ ++ + +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 5e-30
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 9/165 (5%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+ +G G G V A + +AVK +D + + + + + + H N+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENV 65
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+ G+ E + L EYCS G L D + + R + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
I I HR+ K N+LLD+ + +SD GLA + + ++ +
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 7e-30
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 12/171 (7%)
Query: 514 ENLIGAGMLGSVYRAQLPDGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
+IG G G VY L D AVK L R + + +FL + H N+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 570 VELKGYCAEH-GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ L G C G L++ Y +G L++ + ++ +N + I L A+ +
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGM---K 144
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIM 679
+ VHR+ + N +LD+ V V+D GLA + V +
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 8e-30
Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 11/165 (6%)
Query: 514 ENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+ IG G +VY+ + +A +L R ++ + F E + ++H NIV
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 573 KGYCAEHGQR----LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
+ +L+ E ++GTL+ L + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 629 EICQPPIVHRNFKSANILLDD-DLAVSVSDCGLAPLISSGSVSQV 672
PPI+HR+ K NI + +V + D GLA L + V
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV 173
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 9e-30
Identities = 39/167 (23%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 500 TIASLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELV 558
+I S+ +++ IG G G+VY A + G+ +A+++++ + Q K + + +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEI 68
Query: 559 NNIDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMAL 618
+ ++ NIV + ++ EY + G+L D++ + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCR 123
Query: 619 GAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+ALE+LH ++HR+ KS NILL D +V ++D G I+
Sbjct: 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 118 bits (297), Expect = 1e-29
Identities = 47/169 (27%), Positives = 66/169 (39%), Gaps = 12/169 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDK-RASSQQKDDEFLELVNNIDRIR- 565
N FS +IG G G VY + D GK+ A+K LDK R +Q + L + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 566 --HANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARA 623
IV + + I + + G L L S A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILG 119
Query: 624 LEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQV 672
LE++H +V+R+ K ANILLD+ V +SD GLA S
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-29
Identities = 46/179 (25%), Positives = 71/179 (39%), Gaps = 22/179 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRA------QLPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ +G G G V A + + +AVK L + A+ + EL I
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 563 RIRHANIVELKGYCAEHGQRLLI-YEYCSNGTLQDMLHS------------DDELKNNLS 609
H N+V L G C + G L++ E+C G L L S +D K+ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 610 WNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
I + A+ +E+L +HR+ + NILL + V + D GLA I
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 4e-29
Identities = 39/172 (22%), Positives = 71/172 (41%), Gaps = 9/172 (5%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNI-DRIRHAN 568
F ++G G +V A+ L + A+K L+KR ++ ++ ++ R+ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
V+L + + Y NG L + + ALEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLH 125
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIMR 680
I+HR+ K NILL++D+ + ++D G A ++S S +++
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-28
Identities = 40/164 (24%), Positives = 63/164 (38%), Gaps = 12/164 (7%)
Query: 517 IGAGMLGSVYRAQLP----DGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRHANIVE 571
+G G G V R + +AVK L SQ + D+F+ VN + + H N++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
L G ++ E G+L D L + + T R A+ A + YL
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-- 129
Query: 632 QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHN 675
+HR+ + N+LL V + D GL + V
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 5e-28
Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 12/170 (7%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRI 564
IG G G V++ +A+K K +S ++FL+ + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQF 65
Query: 565 RHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
H +IV+L G E+ +I E C+ G L+ L +L + I A + AL
Sbjct: 66 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 121
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
YL VHR+ + N+L+ + V + D GL+ + + + S
Sbjct: 122 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 111 bits (278), Expect = 8e-28
Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 16/167 (9%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR------ 563
+ + ++G G+ V R P K AVK +D +E EL +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 564 --IRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
H NI++LK + L+++ G L D L K LS ++
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALL 120
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+ LH++ IVHR+ K NILLDDD+ + ++D G + + G
Sbjct: 121 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 37/179 (20%), Positives = 71/179 (39%), Gaps = 16/179 (8%)
Query: 509 NSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+ +G G G VY +A+K +++ AS +++ EFL + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMK 78
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------SDDELKNNLSWNTRIRM 616
++V L G ++ L+I E + G L+ L +++ + S + I+M
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHN 675
A A + YL VHR+ + N ++ +D V + D G+ I +
Sbjct: 139 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 111 bits (277), Expect = 1e-27
Identities = 33/154 (21%), Positives = 66/154 (42%), Gaps = 7/154 (4%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG G G VY+AQ G+ A+KK+ + + ++ + ++H+NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
+ +L++E+ + + + L T L + Y H+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
++HR+ K N+L++ + + ++D GLA
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 37/169 (21%), Positives = 76/169 (44%), Gaps = 11/169 (6%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVK---KLDKRASSQQKDDEFLELVNNIDRIRH 566
F + ++G+G G+VY+ +P+G+ + + K + A+S + + E L+ + + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
++ L G C LI + G L D + K+N+ + + A+ + Y
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNY 126
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHN 675
L +VHR+ + N+L+ V ++D GLA L+ + +
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 111 bits (279), Expect = 2e-27
Identities = 33/159 (20%), Positives = 69/159 (43%), Gaps = 11/159 (6%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
+G+G G V+R G++ K ++ + ++ ++++ H ++ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKLINLHD 93
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
+ + +LI E+ S G L D + ++ +S I A L+++HE
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 635 IVHRNFKSANILLD--DDLAVSVSDCGLAPLISSGSVSQ 671
IVH + K NI+ + +V + D GLA ++ + +
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 3e-27
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 6/163 (3%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
+ + +++G G V A+ KL+A+K + K+ + + K+ + + +I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKK-ALEGKEGSMENEIAVLHKIKH 66
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
NIV L G LI + S G L D + K + R+ A++Y
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKY 122
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669
LH++ + LD+D + +SD GL+ + GSV
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 110 bits (277), Expect = 4e-27
Identities = 33/176 (18%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ + +G G G V+R G A K + + + + + + +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+V L + + ++IYE+ S G L + + + N +S + + + L ++
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHM 140
Query: 628 HEICQPPIVHRNFKSANILL--DDDLAVSVSDCGLAPLISSGSVSQVSHNLTIMRA 681
HE VH + K NI+ + + D GL + +V+ A
Sbjct: 141 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-26
Identities = 45/187 (24%), Positives = 72/187 (38%), Gaps = 23/187 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQLP--------DGKLLAVKKLDKRASSQQKDDEFLELVNN 560
+ +G G G V A+ +AVK L A+ + D E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 561 IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLH------------SDDELKNNL 608
+H NI+ L G C + G +I EY S G L++ L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 609 SWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
S + A AR +EYL +HR+ + N+L+ +D + ++D GLA I
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 669 VSQVSHN 675
+ + N
Sbjct: 190 YYKKTTN 196
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 4e-25
Identities = 28/162 (17%), Positives = 62/162 (38%), Gaps = 12/162 (7%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
+G G G V+R K K + + + Q + ++ ++ RH NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHE 68
Query: 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPP 634
+ ++I+E+ S + + +++ L+ + AL++LH
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 635 IVHRNFKSANILLD--DDLAVSVSDCGLAPLISSGSVSQVSH 674
I H + + NI+ + + + G A + G ++
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-25
Identities = 33/159 (20%), Positives = 67/159 (42%), Gaps = 7/159 (4%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANI 569
F + IG G G VY+A+ G+++A+KK+ ++ + ++ + + H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 570 VELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHE 629
V+L + L++E+ + M S + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 630 ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
++HR+ K N+L++ + A+ ++D GLA
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 8e-25
Identities = 36/174 (20%), Positives = 65/174 (37%), Gaps = 13/174 (7%)
Query: 503 SLQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNN 560
SLQ + +G G G V+ + +G+ A+K L K + K + +
Sbjct: 2 SLQDFQ----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 57
Query: 561 IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGA 620
+ + H I+ + G + Q +I +Y G L +L A
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYA 110
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
A L + I++R+ K NILLD + + ++D G A + + +
Sbjct: 111 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGT 164
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-24
Identities = 35/180 (19%), Positives = 65/180 (36%), Gaps = 14/180 (7%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
++ + IG G G V A + +A+KK+ Q L + + R RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRH 65
Query: 567 ANIVELKGYCA----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
NI+ + E + + + + L +L +LS + R
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILR 120
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIMRAG 682
L+Y+H ++HR+ K +N+LL+ + + D GLA + +
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-24
Identities = 35/154 (22%), Positives = 57/154 (37%), Gaps = 10/154 (6%)
Query: 511 FSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDE--FLELVNNIDRIRHA 567
F ++G G G V+ A+ + A+K L K D E +E H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
+ + + EY + G L + S + + A L++L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFL 119
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
H IV+R+ K NILLD D + ++D G+
Sbjct: 120 HSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 150
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-24
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 510 SFSQENLIGAGMLGSVYRAQLPD-GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN 568
S++ +IG G G VY+A+L D G+L+A+KK+ + + ++ + + ++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR------KLDHCN 74
Query: 569 IVELKGYCAEHGQR------LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
IV L+ + G++ L+ +Y + H K L R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDCGLAPLISSGS 668
+L Y+H I HR+ K N+LLD D + + D G A + G
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 98.7 bits (245), Expect = 1e-23
Identities = 42/181 (23%), Positives = 74/181 (40%), Gaps = 13/181 (7%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIR 565
++ + ++G G + V+ A+ L + +AVK L + F N +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 566 HANIVELKGYCAEHGQRL----LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAA 621
H IV + ++ EY TL+D++H++ ++ I + A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 121
Query: 622 RALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIMRA 681
+AL + H+ I+HR+ K ANI++ AV V D G+A I+ S I A
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 682 G 682
Sbjct: 179 Q 179
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 5e-23
Identities = 42/176 (23%), Positives = 65/176 (36%), Gaps = 25/176 (14%)
Query: 511 FSQENL---------IGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNN 560
F QEN+ +G+G V + + G A K + KR + + E +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 561 ----IDRIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRM 616
+ I+H N++ L +LI E + G L D L K +L+
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEF 118
Query: 617 ALGAARALEYLHEICQPPIVHRNFKSANILLDDD----LAVSVSDCGLAPLISSGS 668
+ YLH I H + K NI+L D + + D GLA I G+
Sbjct: 119 LKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 1e-22
Identities = 38/174 (21%), Positives = 73/174 (41%), Gaps = 16/174 (9%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK 573
IG G G V++A+ G+ +A+KK+ + L + + ++H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 574 GYCAEH--------GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALE 625
C G L++++C + + + + + R+ L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVM---QMLLN 128
Query: 626 YLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSHNLTIM 679
L+ I + I+HR+ K+AN+L+ D + ++D GLA S SQ + +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 1e-22
Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 515 NLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDD---EFLELVNNIDRIRHANIV 570
+ +G G +VY+A+ +++A+KK+ S+ KD L + + + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 571 ELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEI 630
L L++++ + + L+ + L + LEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 631 CQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667
I+HR+ K N+LLD++ + ++D GLA S
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 4e-22
Identities = 30/167 (17%), Positives = 56/167 (33%), Gaps = 4/167 (2%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
+ +G+G G+V A G +A+KKL + S+ + + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 568 NIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYL 627
N++ L ++ L + + + L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 628 HEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQVSH 674
H HR+ K N+ +++D + + D GLA S V
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 181
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 5e-22
Identities = 36/155 (23%), Positives = 59/155 (38%), Gaps = 9/155 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRH 566
N F L+G G G V + G+ A+K L K + + + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ LK H + + EY + G L L + T R A +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-------TEERARFYGAEIVSA 117
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
L + +V+R+ K N++LD D + ++D GL
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.5 bits (234), Expect = 1e-21
Identities = 34/155 (21%), Positives = 62/155 (40%), Gaps = 9/155 (5%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKD-DEFLELVNNIDRIRH 566
+ F + +G G G V + G A+K LDK+ + K + L + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+V+L+ ++ ++ EY + G + L S A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEY 156
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
LH + +++R+ K N+L+D + V+D G A
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA 188
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 2e-21
Identities = 32/176 (18%), Positives = 61/176 (34%), Gaps = 19/176 (10%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
++G G+ G V + + A+K L +++ E+ + + +IV +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------EVELHWRASQCPHIVRI 70
Query: 573 KGYC----AEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
A L++ E G L + D + + A++YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 629 EICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAPLISSGSVSQVSHNLTIMRA 681
I I HR+ K N+L + + ++D G A +S + A
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 92.9 bits (230), Expect = 2e-21
Identities = 29/169 (17%), Positives = 55/169 (32%), Gaps = 18/169 (10%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHAN-IVE 571
IG G G ++ L + + +A+K +R+ + Q DE+ + I
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTY----KLLAGCTGIPN 65
Query: 572 LKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC 631
+ + E +L+ + + D S T A ++ +HE
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 632 QPPIVHRNFKSANILLDDDL-----AVSVSDCGLAPLISSGSVSQVSHN 675
+V+R+ K N L+ + V D G+ Q
Sbjct: 122 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 3e-21
Identities = 34/162 (20%), Positives = 67/162 (41%), Gaps = 16/162 (9%)
Query: 515 NLIGAGMLGSVYRAQ--LPDGKLLAVKKLDKRASSQQKDDEFL---ELVNNIDRIRHANI 569
IG G G V++A+ G+ +A+K++ + + + ++ +++ H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 570 VELKGYCA-----EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
V L C + L++E+ + + + T M R L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGL 129
Query: 625 EYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666
++LH +VHR+ K NIL+ + ++D GLA + S
Sbjct: 130 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.2 bits (228), Expect = 4e-21
Identities = 30/172 (17%), Positives = 52/172 (30%), Gaps = 16/172 (9%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHA 567
N + IG+G G +Y + G+ +A+K + K + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGG 62
Query: 568 NIVELKGYCAEHGQRLLIY-EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ +C G ++ E S T + +A +EY
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEY 118
Query: 627 LHEICQPPIVHRNFKSANIL---LDDDLAVSVSDCGLAPLISSGSVSQVSHN 675
+H +HR+ K N L V + D GLA Q
Sbjct: 119 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.4 bits (221), Expect = 2e-20
Identities = 30/165 (18%), Positives = 58/165 (35%), Gaps = 14/165 (8%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI------RHAN 568
L+G+G GSVY + D +A+K ++K S + V + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 569 IVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
++ L + +LI E ++ + L A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 127
Query: 629 EICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQV 672
++HR+ K NIL+D + + + D G L+ +
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 3e-20
Identities = 29/166 (17%), Positives = 67/166 (40%), Gaps = 12/166 (7%)
Query: 504 LQQYTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNID 562
+Q+Y + IG G G+V++A+ +++A+K++ + L + +
Sbjct: 1 MQKYE----KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK 56
Query: 563 RIRHANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAAR 622
++H NIV L + L++E+C + + + +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLFQ 109
Query: 623 ALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
L+ L ++HR+ K N+L++ + + +++ GLA
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-19
Identities = 40/188 (21%), Positives = 70/188 (37%), Gaps = 19/188 (10%)
Query: 491 KPFTTARSFTIASLQQYTNSFSQEN-----LIGAGMLGSVYRAQL----PDGKLLAVKKL 541
+ T A+L + EN ++G G G V+ + GKL A+K L
Sbjct: 1 QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60
Query: 542 DKRASSQQKD--DEFLELVNNIDRIRHA-NIVELKGYCAEHGQRLLIYEYCSNGTLQDML 598
K Q+ + ++ IR + +V L + LI +Y + G L L
Sbjct: 61 KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL 120
Query: 599 HSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658
+ + + L + + I++R+ K NILLD + V ++D
Sbjct: 121 SQRERFTEHEVQIY-------VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 173
Query: 659 GLAPLISS 666
GL+ +
Sbjct: 174 GLSKEFVA 181
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 85.3 bits (210), Expect = 1e-18
Identities = 32/165 (19%), Positives = 66/165 (40%), Gaps = 20/165 (12%)
Query: 509 NSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-H 566
+ + +G G V+ A + + + + VK L K + + ++ +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGG 89
Query: 567 ANIVELKGYCAEHGQRL--LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARAL 624
NI+ L + R L++E+ +N + + + L+ +AL
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKAL 142
Query: 625 EYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGS 668
+Y H + I+HR+ K N+++D + + + D GLA G
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 9e-18
Identities = 23/155 (14%), Positives = 50/155 (32%), Gaps = 19/155 (12%)
Query: 515 NLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQK--------DDEFLELVNNIDRIRH 566
L+G G +V+ VK +S +K D F L R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
+ +L+G +Y + N L +++ + + + + + +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661
+ IVH + N+L+ ++ + D +
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSEEGIW-IIDFPQS 149
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (197), Expect = 8e-17
Identities = 32/160 (20%), Positives = 56/160 (35%), Gaps = 17/160 (10%)
Query: 516 LIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574
IG+G G V A + +A+KKL + +Q + + + H NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 575 YCA------EHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLH 628
E L+ E Q + D + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 629 EICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668
+HR+ K +NI++ D + + D GLA +
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (195), Expect = 1e-16
Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 4/159 (2%)
Query: 508 TNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH 566
+ + +G+G GSV A G +AVKKL + S + + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 567 ANIVELKGYCAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEY 626
N++ L + L ++ L+ + + R L+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 627 LHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665
+H HR+ K +N+ +++D + + D GLA
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTD 172
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.9 bits (193), Expect = 3e-16
Identities = 39/154 (25%), Positives = 61/154 (39%), Gaps = 26/154 (16%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLAT--------- 147
L + +++ +DL+NN I P + L NQ S P + T
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294
Query: 148 -----------LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENL 196
L LT ++L N +S P SLT L L ++N +S SL NL
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 197 SQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENN 229
+ + L +NQ+S L L +L + L + +
Sbjct: 351 TNINWLSAGHNQISD-LTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.3 bits (176), Expect = 4e-14
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 28/157 (17%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNL 160
+++ + L+ N + I ++ +T + + L++NQ S P L+ LT LT++ L N
Sbjct: 218 LTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 161 LSGEIP--------------------DAFQSLTGLINLDLSSNNLSGELPPSLENLSQLT 200
+S P +L L L L NN+S P + +L++L
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332
Query: 201 TLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIP 236
L NN++S + L +L + L+ +N S P
Sbjct: 333 RLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.7 bits (151), Expect = 4e-11
Identities = 41/148 (27%), Positives = 57/148 (38%), Gaps = 26/148 (17%)
Query: 108 IDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD 167
+ +NN I P + + L+ NQ +LA+LT LTD+ L NN +S P
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 258
Query: 168 AFQSLTGLINLDLSSNNLSGELP--------------------PSLENLSQLTTLHLQNN 207
LT L L L +N +S P + NL LT L L N
Sbjct: 259 -LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 208 QLSGTLDVLQDLP-LRDLNIENNLFSGP 234
+S + + L L+ L NN S
Sbjct: 318 NISD-ISPVSSLTKLQRLFFANNKVSDV 344
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 1e-07
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 11/98 (11%)
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204
L + T+ D +N D +L + L N++ + S +L Q+TTL
Sbjct: 1 LGSATITQDTPINQI-----FTDT--ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQA 51
Query: 205 QNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPEKMLQ 241
+ ++D ++ L L +N NN + P K L
Sbjct: 52 DRLGIK-SIDGVEYLNNLTQINFSNNQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 3e-06
Identities = 26/89 (29%), Positives = 35/89 (39%), Gaps = 4/89 (4%)
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
NN +S P T L L L+ N L +L +L+ LT L L NNQ+S +
Sbjct: 205 TNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 260
Query: 217 QDLPLRDLNIENNLFSGPIPEKMLQIPNF 245
L +L + N S P L
Sbjct: 261 GLTKLTELKLGANQISNISPLAGLTALTN 289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 9e-05
Identities = 15/74 (20%), Positives = 28/74 (37%), Gaps = 4/74 (5%)
Query: 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV 215
L ++ + L + L + +E L+ LT ++ NNQL+ +
Sbjct: 29 LGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPL 84
Query: 216 LQDLPLRDLNIENN 229
L D+ + NN
Sbjct: 85 KNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 24/73 (32%), Positives = 32/73 (43%), Gaps = 4/73 (5%)
Query: 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIE 227
LT L +L ++N +S P L+ L L L NQL + L L L DL++
Sbjct: 193 LAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLA 249
Query: 228 NNLFSGPIPEKML 240
NN S P L
Sbjct: 250 NNQISNLAPLSGL 262
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 71.6 bits (174), Expect = 5e-14
Identities = 28/181 (15%), Positives = 65/181 (35%), Gaps = 19/181 (10%)
Query: 514 ENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVEL 572
+G G +V+ A+ + + +A+K + + + + + + R+ A+ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 573 KGYCAEHGQRLLIY--EYCSNGTLQDM----------LHSDDELKNNLSWNTRIRMALGA 620
A H +LL + NG M + +++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 621 ARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLISSGSVSQVSHNLTIM 679
L+Y+H + I+H + K N+L++ D ++ +A L ++ + N
Sbjct: 135 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 680 R 680
R
Sbjct: 193 R 193
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.2 bits (170), Expect = 1e-13
Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 27/183 (14%)
Query: 37 NPNDVAAINSLYAALGSP-VLPGWVASAGDPCGESWQGVQCNASDIIAIILNGANLGGEL 95
NP D A+ + LG+P L W+ + D C +W GV C+
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPT-TDCCNRTWLGVLCDTD---------------- 46
Query: 96 GENLGAFSSIRVIDLSNNHIGGSIP-----SILPVTMQNFFLSDNQFSGSIPSSLATLTL 150
+ +DLS ++ P + LP + N G IP ++A LT
Sbjct: 47 ----TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210
L + + + +SG IPD + L+ LD S N LSG LPPS+ +L L + N++S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 211 GTL 213
G +
Sbjct: 163 GAI 165
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.9 bits (159), Expect = 3e-12
Identities = 19/56 (33%), Positives = 28/56 (50%), Gaps = 1/56 (1%)
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
+ L NN + G +P L L +L++S NNL GE+ P NL + NN+
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 61.3 bits (147), Expect = 9e-11
Identities = 19/61 (31%), Positives = 27/61 (44%), Gaps = 3/61 (4%)
Query: 179 DLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENN--LFSGPI 235
DL +N + G LP L L L +L++ N L G + +L NN L P+
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
Query: 236 P 236
P
Sbjct: 310 P 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.8 bits (143), Expect = 3e-10
Identities = 17/68 (25%), Positives = 29/68 (42%), Gaps = 3/68 (4%)
Query: 126 TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNL 185
+ L +N+ G++P L L L ++++ N L GEIP +L ++N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303
Query: 186 --SGELPP 191
LP
Sbjct: 304 LCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 12/77 (15%), Positives = 28/77 (36%), Gaps = 1/77 (1%)
Query: 67 CGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVT 126
G + ++ + L + G L + L + +++S N++ G IP +
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
Query: 127 -MQNFFLSDNQFSGSIP 142
++N+ P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.1 bits (165), Expect = 5e-13
Identities = 30/152 (19%), Positives = 51/152 (33%), Gaps = 2/152 (1%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
+RV+ S+ + +P LP L +N+ + L L + L NN +S
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL-SGTLDVLQDLPLR 222
P AF L L L LS N L + L +L + ++ + L + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 223 DLNIENNLFSGPIPEKMLQIPNFRKDGNPFNS 254
+L SG + +
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.7 bits (138), Expect = 1e-09
Identities = 32/165 (19%), Positives = 62/165 (37%), Gaps = 14/165 (8%)
Query: 90 NLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLT 149
G + I +++ +I +IP LP ++ L N+ + +SL L
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLN 195
Query: 150 LLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
L + L+ N +S + + L L L++N L P L + + ++L NN +
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNI 254
Query: 210 S--------GTLDVLQDLPLRDLNIENNLFSGPIPEKMLQIPNFR 246
S + +++ +N P+ +Q FR
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSN----PVQYWEIQPSTFR 295
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.7 bits (131), Expect = 1e-09
Identities = 21/111 (18%), Positives = 40/111 (36%), Gaps = 6/111 (5%)
Query: 97 ENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156
+L + +DLS+N + P++ + + + ++ L +
Sbjct: 14 CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73
Query: 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE------LPPSLENLSQLTT 201
NN L S L+ L+L N+L E L L ++S + T
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 1e-09
Identities = 27/116 (23%), Positives = 48/116 (41%), Gaps = 6/116 (5%)
Query: 106 RVIDLSNNHIGGSIPSILPVT-MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGE 164
RV+ L++ + + + + + + LS N+ P+ LA L L + + + E
Sbjct: 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALE 56
Query: 165 IPDAFQSLTGLINLDLSSNNL-SGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDL 219
D +L L L L +N L L + +L L+LQ N L + + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 27/104 (25%), Positives = 44/104 (42%), Gaps = 14/104 (13%)
Query: 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS 186
+ N S I S L +++++NN L E+P L L S N+L+
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA 317
Query: 187 GELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP--LRDLNIEN 228
E+P +NL LH++ N L D+P + DL + +
Sbjct: 318 -EVPELPQNL---KQLHVEYNPLRE----FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 3e-07
Identities = 19/81 (23%), Positives = 37/81 (45%), Gaps = 10/81 (12%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
S+ +++SNN + +P++ P ++ S N + +P L L + N L
Sbjct: 283 PPSLEELNVSNNKL-IELPALPP-RLERLIASFNHLA-EVPELPQNLKQL---HVEYNPL 336
Query: 162 SGEIPDAFQSLTGLINLDLSS 182
E PD +S+ +L ++S
Sbjct: 337 R-EFPDIPESVE---DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 5/59 (8%)
Query: 151 LTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQL 209
++ LNN LS +P+ L +L S N+L+ ELP ++L L + L
Sbjct: 40 AHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 16/73 (21%), Positives = 29/73 (39%), Gaps = 5/73 (6%)
Query: 173 TGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLPLRDLNIENNLFS 232
L+L++ LS LP +L +L N L+ ++ Q L ++ NNL +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLTELPELPQSLKSLLVDN-NNLKA 92
Query: 233 GPIPEKMLQIPNF 245
+L+
Sbjct: 93 LSDLPPLLEYLGV 105
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.2 bits (131), Expect = 8e-09
Identities = 29/139 (20%), Positives = 54/139 (38%), Gaps = 3/139 (2%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQ--NFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
+++ + L +N + + FL N+ S + L L + L+ N +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 162 SGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP- 220
+ P AF+ L L+ L L +NNLS +L L L L L +N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249
Query: 221 LRDLNIENNLFSGPIPEKM 239
L+ ++ +P+++
Sbjct: 250 LQKFRGSSSEVPCSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 6e-06
Identities = 33/174 (18%), Positives = 47/174 (27%), Gaps = 28/174 (16%)
Query: 107 VIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLT-------------- 152
+ ++P +P Q FL N+ S +S LT
Sbjct: 15 TTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 153 -----------DMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTT 201
+N L P F L L L L L P L+ L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 202 LHLQNNQLSGTLD--VLQDLPLRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFN 253
L+LQ+N L D L L + N S + + + N
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 7e-06
Identities = 26/141 (18%), Positives = 43/141 (30%), Gaps = 6/141 (4%)
Query: 73 GVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPV--TMQNF 130
+ ++ + L+G + S+ + L N + P +
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 131 FLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELP 190
+L N S +LA L L + LN+N + L SS+ + LP
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLP 265
Query: 191 PSLENLSQLTTLHLQNNQLSG 211
L L N L G
Sbjct: 266 QRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 7e-04
Identities = 20/85 (23%), Positives = 30/85 (35%)
Query: 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS 186
+ L P L L + L +N L D F+ L L +L L N +S
Sbjct: 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 187 GELPPSLENLSQLTTLHLQNNQLSG 211
+ L L L L N+++
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAH 191
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 3e-08
Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 127 MQNFFLSDNQFSGS-IPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLS 181
+Q+ + + S + L L + L++ L+ I A + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 182 SNNLSGELPPSLENLSQLTTLHLQNNQLSG 211
SN L + Q + +Q L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 6e-08
Identities = 22/106 (20%), Positives = 34/106 (32%), Gaps = 10/106 (9%)
Query: 124 PVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLD 179
+ + N L D ++L + L + +S + + L LD
Sbjct: 344 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 403
Query: 180 LSSNNLSGELPPSL-----ENLSQLTTLHLQNNQLSG-TLDVLQDL 219
LS+N L L + L L L + S D LQ L
Sbjct: 404 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 1e-07
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 23/102 (22%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLL 161
S +RV+ L++ + S S S+ ++L L ++ L+NN L
Sbjct: 368 GSVLRVLWLADCDVSDSSCS------------------SLAATLLANHSLRELDLSNNCL 409
Query: 162 SGEIPDAF-----QSLTGLINLDLSSNNLSGELPPSLENLSQ 198
Q L L L S E+ L+ L +
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 2e-07
Identities = 16/85 (18%), Positives = 33/85 (38%), Gaps = 11/85 (12%)
Query: 169 FQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSGT-----LDVLQDL 219
Q + L L L+ ++S L +L L L L NN L ++ ++
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 220 P--LRDLNIENNLFSGPIPEKMLQI 242
L L + + +S + +++ +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 21/118 (17%)
Query: 59 WVASAGDPCGESWQGVQCNASDIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNH 114
E QG+ S + + L ++ L L A S+R +DLSNN
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408
Query: 115 IGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSL 172
+G + L +++ LL + L + S E+ D Q+L
Sbjct: 409 LGDAGILQLVESVRQP-----------------GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 1e-04
Identities = 13/103 (12%), Positives = 27/103 (26%), Gaps = 19/103 (18%)
Query: 86 LNGANLGGE-LGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSS 144
+ L E L +V+ L + + + I S+
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK------------------DISSA 50
Query: 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSG 187
L L +++L +N L + + +L
Sbjct: 51 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.9 bits (117), Expect = 6e-07
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 12/89 (13%)
Query: 154 MSLNNNLLSGEIPDA------FQSLTGLINLDLSSNNLSGELPPSL-----ENLSQLTTL 202
+ LN+ LLS A GL L L N + + +L E + L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 203 HLQNNQLSGTLDVLQDLP-LRDLNIENNL 230
L N+ S DV+ ++ + L
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.6 bits (111), Expect = 3e-06
Identities = 9/67 (13%), Positives = 21/67 (31%), Gaps = 8/67 (11%)
Query: 151 LTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTL 202
+ SL + ++ E + + + LS N + E L ++ + L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 203 HLQNNQL 209
+
Sbjct: 65 EFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 15/104 (14%), Positives = 37/104 (35%), Gaps = 17/104 (16%)
Query: 127 MQNFFLSDNQFSGSIPSSLA------TLTLLTDMSLNNNLLSGEIPDA-----FQSLTGL 175
++ L+D S +++ L + L N + + + + L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 176 INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDL 219
+ L+L+ N E ++ + ++ + + LD L D+
Sbjct: 305 LFLELNGNRF-SEEDDVVDEIREVFSTRGRGE-----LDELDDM 342
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 11/84 (13%), Positives = 23/84 (27%), Gaps = 10/84 (11%)
Query: 171 SLTGL-INLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL-----DVLQDLP-LRD 223
S+ G + LD + + L + + L N + + + L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 224 LNIENN---LFSGPIPEKMLQIPN 244
+ IPE + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQ 87
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.3 bits (116), Expect = 6e-07
Identities = 19/119 (15%), Positives = 43/119 (36%), Gaps = 7/119 (5%)
Query: 132 LSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE-LP 190
L+ + L + ++ + + + + F S + ++DLS++ + L
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLH 64
Query: 191 PSLENLSQLTTLHLQNNQLSGT-LDVLQDLP-LRDLNIE--NNLFSGPIPEKMLQIPNF 245
L S+L L L+ +LS ++ L L LN+ + + +
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 8e-07
Identities = 27/97 (27%), Positives = 40/97 (41%), Gaps = 4/97 (4%)
Query: 110 LSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAF 169
L + + S L +LS S + LA L+ LT + ++N +S P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 170 QSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206
SL LI + L +N +S L N S L + L N
Sbjct: 192 ASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 6e-06
Identities = 18/78 (23%), Positives = 36/78 (46%), Gaps = 6/78 (7%)
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRD 223
PD +L I + +N++ + + +L +TTL ++ T++ +Q L L
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEGVQYLNNLIG 67
Query: 224 LNIENNLFSGPIPEKMLQ 241
L +++N + P K L
Sbjct: 68 LELKDNQITDLAPLKNLT 85
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 4/61 (6%)
Query: 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIE 227
+L+ L L N +S L +L L +HL+NNQ+S + L + L + +
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLT 225
Query: 228 N 228
N
Sbjct: 226 N 226
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 4e-06
Identities = 22/90 (24%), Positives = 31/90 (34%), Gaps = 1/90 (1%)
Query: 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS 186
+Q +L N+ P L L +SL NN L+ L L L L N+L
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
Query: 187 GELPPSLENLSQLTTLHLQNNQLSGTLDVL 216
+P L L N ++L
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGNPWLCNCEIL 214
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 6e-05
Identities = 12/58 (20%), Positives = 25/58 (43%), Gaps = 1/58 (1%)
Query: 102 FSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
+S ++ ++ ++P LP LS+N ++L T LT ++L+
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+ +++ + L+ +P L LS N L +L ++LT L+L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 208 Q 208
+
Sbjct: 66 E 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 8e-04
Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 169 FQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSG-TLDVLQDLP-LRDLNI 226
+ + ++ NL+ LPP L T LHL N L +L L L LN+
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 227 ENNLFSGPIPEKMLQ 241
+ + + L
Sbjct: 63 DRAELTKLQVDGTLP 77
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 4e-06
Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 5/111 (4%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163
S + +DL S P ++ + + + ++ + L ++L+NN L
Sbjct: 23 SQQALDLKGLR---SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYR 79
Query: 164 --EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGT 212
++ Q L L+LS N L E +L L L N LS T
Sbjct: 80 LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 1e-05
Identities = 12/44 (27%), Positives = 18/44 (40%)
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQ 208
D F +G + LD+S + LENL +L N +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 10/56 (17%), Positives = 18/56 (32%), Gaps = 1/56 (1%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN 159
S RV + + IPS LP + + + L + ++ N
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 7/65 (10%), Positives = 17/65 (26%), Gaps = 3/65 (4%)
Query: 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS 186
+ +N + + ++ + ++L L NL
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
Query: 187 GELPP 191
+LP
Sbjct: 237 -KLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 2e-05
Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 5/93 (5%)
Query: 154 MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL 213
+ L L+ E + + LDL + + L Q + +N++ L
Sbjct: 1 VKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 56
Query: 214 DVLQDLP-LRDLNIENNLFSGPIPEKMLQIPNF 245
D L L+ L + NN +P+
Sbjct: 57 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 16/70 (22%), Positives = 29/70 (41%), Gaps = 6/70 (8%)
Query: 165 IPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRD 223
D +L + L N++ S +L Q+TTL + ++D ++ L L
Sbjct: 12 FTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQ 66
Query: 224 LNIENNLFSG 233
+N NN +
Sbjct: 67 INFSNNQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 13/37 (35%), Positives = 18/37 (48%), Gaps = 2/37 (5%)
Query: 166 PDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTL 202
+LT L LD+SSN +S L L+ L +L
Sbjct: 165 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.5 bits (98), Expect = 5e-05
Identities = 31/162 (19%), Positives = 53/162 (32%), Gaps = 27/162 (16%)
Query: 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIP----SSLATLTLLTD------ 153
+D + + IP +P+ L+DN+ L L L
Sbjct: 9 EGTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 154 ---------------MSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQ 198
+ L N + F L L L+L N +S +P S E+L+
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 199 LTTLHLQNNQLSGTLDVLQDLPL-RDLNIENNLFSGPIPEKM 239
LT+L+L +N + + R ++ P K+
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV 169
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 8/64 (12%), Positives = 24/64 (37%), Gaps = 4/64 (6%)
Query: 148 LTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207
+L ++ + L + + +++++ ++ L +T L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78
Query: 208 QLSG 211
+L+
Sbjct: 79 KLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 14/39 (35%), Positives = 18/39 (46%), Gaps = 2/39 (5%)
Query: 168 AFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQN 206
LT L NL LS N++S +L L L L L +
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 39.7 bits (91), Expect = 4e-04
Identities = 17/72 (23%), Positives = 28/72 (38%), Gaps = 11/72 (15%)
Query: 165 IPDA---FQSLTGLINLDLSSNNLSGELPP------SLENLSQLTTLHLQNNQLSGTLDV 215
I DA F+ ++ + L G +PP +L L L L N + +
Sbjct: 7 IKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS 65
Query: 216 LQDLP-LRDLNI 226
L + LR L++
Sbjct: 66 LSGMENLRILSL 77
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 689 | |||
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.86 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.83 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.82 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.79 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.66 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.64 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.62 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.59 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.58 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.57 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.52 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.49 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.32 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.31 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.14 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.13 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.03 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.97 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.91 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.65 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.57 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.41 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.06 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.02 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.0 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.5 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.26 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.03 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=268.01 Aligned_cols=174 Identities=18% Similarity=0.285 Sum_probs=151.1
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEE
Q ss_conf 315977444471028738999993-8996999999335458856699999999998138998720001799959969999
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV 585 (689)
..++|+..+.||+|+||+||+|+. .+|+.||+|++..... .....++.+|+.++++++|||||+++++|.+.++.++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 75688897897127780999999989996999999875409-78999999999999867999999499999989999999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 81368899889983195457899999999999999999999994999981980446898586699949998614776556
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~ 665 (689)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EECCCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 9767998689987424----99999999999999999999999859--99714457799468789989995487762567
Q ss_pred CCCCCEEECCCCEEEECCCCCCC
Q ss_conf 99842011562349921102337
Q 005587 666 SGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
.... ....++..|+|||++.+.
T Consensus 157 ~~~~-~~~~GT~~Y~APEvl~~~ 178 (322)
T d1s9ja_ 157 DSMA-NSFVGTRSYMSPERLQGT 178 (322)
T ss_dssp HHTC----CCSSCCCCHHHHHCS
T ss_pred CCCC-CCCCCCCCCCCCHHHCCC
T ss_conf 8862-111377141194687589
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=255.86 Aligned_cols=172 Identities=20% Similarity=0.347 Sum_probs=152.9
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEE
Q ss_conf 5977444471028738999993-899699999933545885669999999999813899872000179995996999981
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (689)
++|.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 57589889840768199999988999899999984524--3169999999999986799799929999998999999998
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECC--CCCEEEEEECCCCCCC
Q ss_conf 36889988998319545789999999999999999999999499998198044689858669--9949998614776556
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD--DLAVSVSDCGLAPLIS 665 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~--~~~~ki~DFGla~~~~ 665 (689)
||++|+|.+++... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECC
T ss_conf 57998899999762---37899999999999999999999756---9760001546736416889869995452104425
Q ss_pred CCCCCEEECCCCEEEECCCCCCC
Q ss_conf 99842011562349921102337
Q 005587 666 SGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
.........++..|+|||++.+.
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~ 200 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGK 200 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTC
T ss_pred CCCCCCEECCCCCCCCHHHHCCC
T ss_conf 65432000686242188997589
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=260.60 Aligned_cols=173 Identities=24% Similarity=0.318 Sum_probs=149.4
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEE
Q ss_conf 15977444471028738999993-89969999993354588566999999999981389987200017999599699998
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (689)
.++|+..+.||+|+||+||+|+. .+|+.||||++..... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEE
T ss_conf 7460899897217480999999999997999999845664-127999999999998579988846965404674367988
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 13688998899831954578999999999999999999999949999819804468985866999499986147765569
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~ 666 (689)
||+++|+|.+++.. ...+++.....|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECC
T ss_conf 64589808999753----79999999999999999999999975---983575468997887899879832314224046
Q ss_pred CCC---CEEECCCCEEEECCCCCCC
Q ss_conf 984---2011562349921102337
Q 005587 667 GSV---SQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 667 ~~~---~~~~~~~~~~~ape~~~~~ 688 (689)
... .....+|..|+|||++.++
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~ 180 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRR 180 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCS
T ss_pred CCCCCCCCCEEECCCCCCHHHHCCC
T ss_conf 8865311132557474287286189
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=254.43 Aligned_cols=172 Identities=21% Similarity=0.348 Sum_probs=153.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEE
Q ss_conf 5977444471028738999993-899699999933545885669999999999813899872000179995996999981
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||.||+|+. .+|+.||||.+.... ......+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 03599899931778299999998999799999988726--4679999999999986799798919999998999999998
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEEC--CCCCEEEEEECCCCCCC
Q ss_conf 3688998899831954578999999999999999999999949999819804468985866--99949998614776556
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD--DDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld--~~~~~ki~DFGla~~~~ 665 (689)
||++|+|.+.+... ...+++.....|+.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECC
T ss_conf 28998088889863---89989999999999999999999977---9265131445531134678848995256303437
Q ss_pred CCCCCEEECCCCEEEECCCCCCC
Q ss_conf 99842011562349921102337
Q 005587 666 SGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 666 ~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
.........++..|+|||++.++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~ 203 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDRE 203 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTC
T ss_pred CCCCEEECCCCCCCCCHHHHCCC
T ss_conf 88720100476453489997479
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=255.50 Aligned_cols=170 Identities=23% Similarity=0.356 Sum_probs=149.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEE
Q ss_conf 5977444471028738999993-899699999933545885669999999999813899872000179995996999981
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (689)
++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 053887898128582999999989998999999843017--279999999999986799988058577988999899997
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 36889988998319545789999999999999999999999499998198044689858669994999861477655699
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~ 667 (689)
|+++|+|.+++.. ..+++.....|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 98 y~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ECCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 0379808988641-----5999999999999999999999987---9722677688868878996864251564132136
Q ss_pred C-CCEEECCCCEEEECCCCCCC
Q ss_conf 8-42011562349921102337
Q 005587 668 S-VSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 668 ~-~~~~~~~~~~~~ape~~~~~ 688 (689)
. ......++..|+|||++.++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~ 191 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRK 191 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSS
T ss_pred CCCCCCCCCCCCCCCHHHHCCC
T ss_conf 6644444447773682664479
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=256.03 Aligned_cols=218 Identities=25% Similarity=0.535 Sum_probs=191.7
Q ss_pred CCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCCCCCCCCEEEECC----CEEEEEECCCCCCC--CCCCCCCCCCCCCE
Q ss_conf 69986699999999980999-9999989999999999862793099----86799914998876--45735569999979
Q 005587 35 VTNPNDVAAINSLYAALGSP-VLPGWVASAGDPCGESWQGVQCNAS----DIIAIILNGANLGG--ELGENLGAFSSIRV 107 (689)
Q Consensus 35 ~~~~~~~~aL~~~~~~l~~~-~l~~W~~~~~~~C~~~w~gv~C~~~----~v~~l~L~~~~l~g--~lp~~l~~L~~L~~ 107 (689)
.|.++|++||++||+++.+| .+.+|+. ++|||.++|.||+|+.. +|+.|+|.++++.| .+|+.+++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCC-CCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 9898999999999997799986778899-999988948896974899947988998989988888879847846753352
Q ss_pred EECCC-CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf 98317-868997788632--354530035755789999656799976699846886787787111299999789832787
Q 005587 108 IDLSN-NHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNN 184 (689)
Q Consensus 108 L~Ls~-N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~ 184 (689)
|+|++ |++.|.+|..+. .+|++|+|++|++.+..+..+..+..|+.+++++|.+.+.+|..+..++.|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCC
T ss_conf 02026543330024311454200110203564344332222201110011112245555685122067400000023553
Q ss_pred CCCCCCCCCCCCCCC-CEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCC
Q ss_conf 877789875477665-556611444555532-13774335212556547899761158988732---3688678
Q 005587 185 LSGELPPSLENLSQL-TTLHLQNNQLSGTLD-VLQDLPLRDLNIENNLFSGPIPEKMLQIPNFR---KDGNPFN 253 (689)
Q Consensus 185 l~g~ip~~~~~l~~L-~~L~Ls~N~l~g~~~-~~~~~~L~~L~ls~N~l~g~~P~~l~~l~~l~---~~~n~~~ 253 (689)
+.+.+|..+..+..+ +.+++++|++++..+ .+..+....++++.|.+.|.+|..+..+..+. ..+|.+.
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~ 234 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 35620312144311232310224643533243322222223333334332222222222222111222222222
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=258.87 Aligned_cols=180 Identities=22% Similarity=0.368 Sum_probs=152.9
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEE--CCEEEEE
Q ss_conf 5977444471028738999993-899699999933545885669999999999813899872000179995--9969999
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--HGQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~--~~~~~lV 585 (689)
++|++.+.||+|+||.||+|+. .+|+.||||.+......+.....+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 8136889988998319545789999999999999999999999499--99819804468985866999499986147765
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC--QPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 586 ~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
||||++|+|.+++.........+++..++.|+.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCC-CCEEECCCCEEEECCCCCCC
Q ss_conf 56998-42011562349921102337
Q 005587 664 ISSGS-VSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 664 ~~~~~-~~~~~~~~~~~~ape~~~~~ 688 (689)
+.... ......++..|+|||++.++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~ 189 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRM 189 (269)
T ss_dssp C-----------CCCSCCCHHHHTTC
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 24577755667788232799998399
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=256.34 Aligned_cols=171 Identities=30% Similarity=0.446 Sum_probs=146.1
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEE
Q ss_conf 15977444471028738999993899699999933545885669999999999813899872000179995996999981
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (689)
.++|...+.||+|+||+||+|++. ..||||.+..........+.|.+|+.++.+++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 36889988998319545789999999999999999999999499998198044689858669994999861477655699
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~ 667 (689)
|+++|+|.++++.. ...++|..++.|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf 58998889998523---57899999999999999998887509---9951614789979818997887500221333556
Q ss_pred CCC---EEECCCCEEEECCCCCC
Q ss_conf 842---01156234992110233
Q 005587 668 SVS---QVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 668 ~~~---~~~~~~~~~~ape~~~~ 687 (689)
... ....++..|+|||++.+
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp --------CCCCGGGCCHHHHTT
T ss_pred CCCCCCCCCCCCCCCCCHHHHHC
T ss_conf 77631256655743179999950
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=256.84 Aligned_cols=172 Identities=24% Similarity=0.447 Sum_probs=144.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CC---CEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEE
Q ss_conf 59774444710287389999938-99---699999933545885669999999999813899872000179995996999
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DG---KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~-~g---~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~l 584 (689)
++|+..++||+|+||+||+|+.+ ++ ..||||++.... .....++|.+|+.++++++|||||+++|+|...+..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 04278569802788299999995799788999999978445-98999999999999985799888618999962887799
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 98136889988998319545789999999999999999999999499998198044689858669994999861477655
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~ 664 (689)
|||||++|+|.+++... ...++|..++.|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCEEEECCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 99722798530021045---67999999999999999988988527---9835761504489889991998884431575
Q ss_pred CCCCCCEE------ECCCCEEEECCCCCC
Q ss_conf 69984201------156234992110233
Q 005587 665 SSGSVSQV------SHNLTIMRAGGVTHR 687 (689)
Q Consensus 665 ~~~~~~~~------~~~~~~~~ape~~~~ 687 (689)
........ ..++..|+|||++.+
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQY 207 (299)
T ss_dssp -----------------CGGGSCHHHHHS
T ss_pred CCCCCCCEEEECCCCCCCCCCCCHHHHHC
T ss_conf 67777653650256668830038788836
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=257.44 Aligned_cols=171 Identities=22% Similarity=0.400 Sum_probs=149.3
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEEC
Q ss_conf 59774444710287389999938996999999335458856699999999998138998720001799959969999813
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 588 (689)
++|+..+.||+|+||+||+|++.+++.||||++.... ...++|.+|+..+.+++|||||+++|+|...+..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEE
T ss_conf 9958888982088829999998899999999987886---7689999999999966899756535243159933799983
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 68899889983195457899999999999999999999994999981980446898586699949998614776556998
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~~ 668 (689)
+++|+|.+++... ...++|..++.|+.|+|.||.|||+. +|+||||||+|||+|.++.+||+|||+|+.+....
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf 6999189975201---34788999999999999987765316---43104431532666688776865532100236887
Q ss_pred CCE--EECCCCEEEECCCCCCC
Q ss_conf 420--11562349921102337
Q 005587 669 VSQ--VSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 669 ~~~--~~~~~~~~~ape~~~~~ 688 (689)
... ...++..|+|||++.++
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~ 177 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFS 177 (263)
T ss_dssp ---------CTTSCCHHHHTTC
T ss_pred CEEECCEECCCCCCCHHHHCCC
T ss_conf 3350430017666785786079
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=259.30 Aligned_cols=172 Identities=25% Similarity=0.394 Sum_probs=147.9
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEE
Q ss_conf 159774444710287389999938-9969999993354588566999999999981389987200017999599699998
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (689)
.++|...+.||+|+||+||+|+.. +++.||||++.... ...++|.+|+.++++++|||||+++++|.+.+..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC---CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 799398659820888089999999999699999977761---03999999999998679998826775274578547876
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 13688998899831954578999999999999999999999949999819804468985866999499986147765569
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~ 666 (689)
||+++|+|.+++.... ...++|..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 93 E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ECCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 3146760677753035--54157999999999999978889878---930576045768998999289832445465378
Q ss_pred CCCCEE--ECCCCEEEECCCCCC
Q ss_conf 984201--156234992110233
Q 005587 667 GSVSQV--SHNLTIMRAGGVTHR 687 (689)
Q Consensus 667 ~~~~~~--~~~~~~~~ape~~~~ 687 (689)
...... ..++..|+|||++.+
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~ 190 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAY 190 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHH
T ss_pred CCCEEECCCCCCCCCCCHHHHCC
T ss_conf 87221035566546669278727
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=253.26 Aligned_cols=173 Identities=25% Similarity=0.302 Sum_probs=150.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEE
Q ss_conf 5977444471028738999993-89969999993354588-566999999999981389987200017999599699998
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (689)
++|+..+.||+|+||.||+|+. .+|+.||||++.+.... ......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 13688998899831954578999999999999999999999949999819804468985866999499986147765569
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~ 666 (689)
|||++|+|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 03579860555532----56775999999999996521134315---962246477784765899888820565200356
Q ss_pred -CCCCEEECCCCEEEECCCCCCC
Q ss_conf -9842011562349921102337
Q 005587 667 -GSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 667 -~~~~~~~~~~~~~~ape~~~~~ 688 (689)
........++..|+|||++.+.
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~ 180 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDN 180 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSS
T ss_pred CCCCCCCCEECHHHHHHHHCCCC
T ss_conf 78620551008899666650489
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=253.80 Aligned_cols=172 Identities=24% Similarity=0.311 Sum_probs=149.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEE
Q ss_conf 59774444710287389999938-9969999993354588-566999999999981389987200017999599699998
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAVK~i~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (689)
++|.+.+.||+|+||.||+|+.+ +++.||+|.+...... ......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 13688998899831954578999999999999999999999949999819804468985866999499986147765569
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~ 666 (689)
||+++|+|.+++.. ...+++.....|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 50479858988750----48999999999999999999999988---946522023441466899871155563354488
Q ss_pred CCCCEEECCCCEEEECCCCCCC
Q ss_conf 9842011562349921102337
Q 005587 667 GSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 667 ~~~~~~~~~~~~~~ape~~~~~ 688 (689)
... ....++..|+|||++.+.
T Consensus 159 ~~~-~~~~Gt~~Y~APE~~~~~ 179 (263)
T d2j4za1 159 SRR-TTLCGTLDYLPPEMIEGR 179 (263)
T ss_dssp CCC-EETTEEGGGCCHHHHTTC
T ss_pred CCC-CCCCCCCCCCCHHHHCCC
T ss_conf 852-355788763499997589
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=250.03 Aligned_cols=173 Identities=22% Similarity=0.320 Sum_probs=145.6
Q ss_pred CCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEE----CCEEEEE
Q ss_conf 774444710287389999938-99699999933545885669999999999813899872000179995----9969999
Q 005587 511 FSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE----HGQRLLI 585 (689)
Q Consensus 511 f~~~~~lG~G~~g~Vy~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~----~~~~~lV 585 (689)
|+..+.||+|+||+||+|+.. ++..||+|.+..........+.+.+|++++++++|||||++++++.. ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEEC-CCCCEEEEEECCCCCC
Q ss_conf 813688998899831954578999999999999999999999949999819804468985866-9994999861477655
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD-DDLAVSVSDCGLAPLI 664 (689)
Q Consensus 586 ~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld-~~~~~ki~DFGla~~~ 664 (689)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .++|+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 957898948999751----35546999999999999999999978-9979968767435116679998898005765423
Q ss_pred CCCCCCEEECCCCEEEECCCCCCCC
Q ss_conf 6998420115623499211023379
Q 005587 665 SSGSVSQVSHNLTIMRAGGVTHRNF 689 (689)
Q Consensus 665 ~~~~~~~~~~~~~~~~ape~~~~~~ 689 (689)
.... .....++..|+|||++...|
T Consensus 166 ~~~~-~~~~~GT~~Y~aPE~~~~~~ 189 (270)
T d1t4ha_ 166 RASF-AKAVIGTPEFMAPEMYEEKY 189 (270)
T ss_dssp CTTS-BEESCSSCCCCCGGGGGTCC
T ss_pred CCCC-CCCCCCCCCCCCHHHHCCCC
T ss_conf 6876-67755381300898847899
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=256.22 Aligned_cols=171 Identities=26% Similarity=0.406 Sum_probs=145.7
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEE
Q ss_conf 15977444471028738999993899699999933545885669999999999813899872000179995996999981
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (689)
.++|+..+.||+|+||.||+|++++++.||||++.... ...++|.+|+.++.+++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEE
T ss_conf 89938867981079828999999999999999986476---888999999999986799988578731045-97699999
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 36889988998319545789999999999999999999999499998198044689858669994999861477655699
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~ 667 (689)
|+++|+|.+++.... ...++|..+++|+.||++||.|||+. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ECCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf 578982888875147--89887889999999999999999748---9546756422515620244042341014773588
Q ss_pred CCCE--EECCCCEEEECCCCCC
Q ss_conf 8420--1156234992110233
Q 005587 668 SVSQ--VSHNLTIMRAGGVTHR 687 (689)
Q Consensus 668 ~~~~--~~~~~~~~~ape~~~~ 687 (689)
.... ...++..|+|||++.+
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHH
T ss_pred CCCCCCCCCCCCCCCCHHHHHC
T ss_conf 6442035677444458289837
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=256.33 Aligned_cols=174 Identities=27% Similarity=0.406 Sum_probs=152.3
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEE
Q ss_conf 3159774444710287389999938-996999999335458856699999999998138998720001799959969999
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV 585 (689)
..+.|+..+.||+|+||+||+|+.. +++.||||.+..... ......+.+|+.++++++|||||++++++.+.+..++|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHH-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 76666998899406583999999999998999999815773-12899999999999867998999198999989988898
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEEC---CCCCEEEEEECCCC
Q ss_conf 813688998899831954578999999999999999999999949999819804468985866---99949998614776
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLD---DDLAVSVSDCGLAP 662 (689)
Q Consensus 586 ~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld---~~~~~ki~DFGla~ 662 (689)
||||+||+|.+++.. ...+++.....|+.|++.||.|||+. +|+||||||+|||+. +++.+||+|||+|+
T Consensus 86 mE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp ECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEE
T ss_conf 852689848886530----36788789999999999998752413---05568704630011046888249983154358
Q ss_pred CCCCCCCCEEECCCCEEEECCCCCCC
Q ss_conf 55699842011562349921102337
Q 005587 663 LISSGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
............++..|+|||++.++
T Consensus 159 ~~~~~~~~~~~~GT~~y~APE~~~~~ 184 (307)
T d1a06a_ 159 MEDPGSVLSTACGTPGYVAPEVLAQK 184 (307)
T ss_dssp --------------CTTSCHHHHTTC
T ss_pred ECCCCCEEEEEEECCCCCCCHHHCCC
T ss_conf 72589704400328422591887379
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-45 Score=251.00 Aligned_cols=168 Identities=26% Similarity=0.390 Sum_probs=146.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCH-HHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEE
Q ss_conf 5977444471028738999993-899699999933545885-66999999999981389987200017999599699998
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~-~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (689)
+.|+..+.||+|+||.||+|+. .+++.||||++....... .....+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 13688998899831954578999999999999999999999949999819804468985866999499986147765569
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~ 666 (689)
|||++|+|..++.. ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 80699945789973----79999999999999999999999868---976667884217987999789844365334677
Q ss_pred CCCCEEECCCCEEEECCCCC
Q ss_conf 98420115623499211023
Q 005587 667 GSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 667 ~~~~~~~~~~~~~~ape~~~ 686 (689)
.. ...++..|+|||++.
T Consensus 168 ~~---~~~GT~~Y~APE~~~ 184 (309)
T d1u5ra_ 168 AN---SFVGTPYWMAPEVIL 184 (309)
T ss_dssp BC---CCCSCGGGCCHHHHT
T ss_pred CC---CCCCCCCCCCHHHHH
T ss_conf 87---313476636889983
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=253.96 Aligned_cols=173 Identities=23% Similarity=0.307 Sum_probs=149.0
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEE
Q ss_conf 5977444471028738999993-89969999993354588-566999999999981389987200017999599699998
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||+||+|+. .+++.||||.+...... ......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 13688998899831954578999999999999999999999949999819804468985866999499986147765569
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~ 666 (689)
||+++|+|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf 70489877776531----59999999999999999999762165---088476774123668885388603210242256
Q ss_pred CCCC---EEECCCCEEEECCCCCCC
Q ss_conf 9842---011562349921102337
Q 005587 667 GSVS---QVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 667 ~~~~---~~~~~~~~~~ape~~~~~ 688 (689)
.... ....++..|+|||++.+.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~ 185 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEK 185 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTC
T ss_pred CCCCCCCCCCCCCCCCCCCEEECCC
T ss_conf 7764333555677552584400268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=249.35 Aligned_cols=175 Identities=22% Similarity=0.325 Sum_probs=153.2
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCH----HHHHHHHHHHHHHHCCCCCCCCEECEEEEECCE
Q ss_conf 315977444471028738999993-899699999933545885----669999999999813899872000179995996
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ----QKDDEFLELVNNIDRIRHANIVELKGYCAEHGQ 581 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~----~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~ 581 (689)
..+.|+..+.||+|+||+||+|+. .+|+.||||.+.+..... ...+.+.+|+.++++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCC----CEEEEE
Q ss_conf 9999813688998899831954578999999999999999999999949999819804468985866999----499986
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL----AVSVSD 657 (689)
Q Consensus 582 ~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~----~~ki~D 657 (689)
.++|||||++|+|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+|||++.++ .+|++|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEECCCCCCCCCHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECC
T ss_conf 9999986778643100103----56421557899999999998766625---4221133301279825898666469643
Q ss_pred ECCCCCCCCCCCCEEECCCCEEEECCCCCCC
Q ss_conf 1477655699842011562349921102337
Q 005587 658 CGLAPLISSGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
||+|+.+..+.......++..|+|||++.++
T Consensus 161 fG~a~~~~~~~~~~~~~~t~~y~APE~~~~~ 191 (293)
T d1jksa_ 161 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191 (293)
T ss_dssp CTTCEECTTSCBCSCCCCCGGGCCHHHHTTC
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 3442105777631224777743099998189
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-45 Score=248.82 Aligned_cols=171 Identities=27% Similarity=0.263 Sum_probs=144.6
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCH-HHHHHH---HHHHHHHHCCCCCCCCEECEEEEECCEEE
Q ss_conf 5977444471028738999993-899699999933545885-669999---99999981389987200017999599699
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-QKDDEF---LELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~-~~~~~~---~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (689)
++|++.++||+|+||.||+|+. .+|+.||||.+....... .....+ ..++..++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 99813688998899831954578999999999999999999999949999819804468985866999499986147765
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
+||||+++|+|.+++.. ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 99991489838999873----25532789999999999999999977---962204442216785889679822010233
Q ss_pred CCCCCCCEEECCCCEEEECCCCCC
Q ss_conf 569984201156234992110233
Q 005587 664 ISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 664 ~~~~~~~~~~~~~~~~~ape~~~~ 687 (689)
+...... ...++..|+|||++..
T Consensus 157 ~~~~~~~-~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 157 FSKKKPH-ASVGTHGYMAPEVLQK 179 (364)
T ss_dssp CSSSCCC-SCCSCGGGCCHHHHST
T ss_pred CCCCCCC-CCCCCCCCCHHHHHHC
T ss_conf 3788643-3113455421687603
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=252.30 Aligned_cols=170 Identities=22% Similarity=0.336 Sum_probs=146.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEE
Q ss_conf 5977444471028738999993-899699999933545885669999999999813899872000179995996999981
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (689)
+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 37598479930778199999999999399999987289--9999999999999986799998849889800995899996
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 36889988998319545789999999999999999999999499998198044689858669994999861477655699
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~ 667 (689)
||++|+|.+++... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 90 y~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 90 FCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred CCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC
T ss_conf 27998188999862---89999999999999999999999988---9887140700314878999899716123035778
Q ss_pred C-CCEEECCCCEEEECCCCC
Q ss_conf 8-420115623499211023
Q 005587 668 S-VSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 668 ~-~~~~~~~~~~~~ape~~~ 686 (689)
. ......++..|+|||++.
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHT
T ss_pred CCCCCCCCCCCCCCCHHHHH
T ss_conf 64100102562647999983
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-45 Score=248.89 Aligned_cols=171 Identities=23% Similarity=0.305 Sum_probs=148.5
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEE
Q ss_conf 5977444471028738999993-89969999993354588-566999999999981389987200017999599699998
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 13688998899831954578999999999999999999999949999819804468985866999499986147765569
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~ 666 (689)
||++||+|..++... ..+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EECCCCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 503786322343222----2111007999999998765541247---677055681050386899889831752167124
Q ss_pred CCCCEEECCCCEEEECCCCCCC
Q ss_conf 9842011562349921102337
Q 005587 667 GSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 667 ~~~~~~~~~~~~~~ape~~~~~ 688 (689)
.. ....++..|+|||++.++
T Consensus 157 ~~--~~~~Gt~~Y~APE~l~~~ 176 (316)
T d1fota_ 157 VT--YTLCGTPDYIAPEVVSTK 176 (316)
T ss_dssp CB--CCCCSCTTTCCHHHHTTC
T ss_pred CC--CCCCCCCCCCCHHHHCCC
T ss_conf 56--434576343599998389
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=249.12 Aligned_cols=176 Identities=28% Similarity=0.416 Sum_probs=146.1
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC-C-----CEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEECEEEEECC
Q ss_conf 1597744447102873899999389-9-----6999999335458856699999999998138-9987200017999599
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPD-G-----KLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG 580 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~~~-g-----~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~~ 580 (689)
.++|+..+.||+|+||+||+|+... + ..||||.+..... ......+.+|+..+.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 899397019830788199999985788554204999999663358-7899999999999997158996868778886299
Q ss_pred EEEEEEECCCCCCHHHHHHCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf 69999813688998899831954-------------------57899999999999999999999994999981980446
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDE-------------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFK 641 (689)
Q Consensus 581 ~~~lV~Ey~~~GsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlk 641 (689)
..++|||||++|+|.++++.... ....++|..++.|+.|++.||.|||+. +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 589999727999599999862577751022100001222001257789999999999999999999739---90505270
Q ss_pred CCCEEECCCCCEEEEEECCCCCCCCCCCCEE---ECCCCEEEECCCCCC
Q ss_conf 8985866999499986147765569984201---156234992110233
Q 005587 642 SANILLDDDLAVSVSDCGLAPLISSGSVSQV---SHNLTIMRAGGVTHR 687 (689)
Q Consensus 642 p~NILld~~~~~ki~DFGla~~~~~~~~~~~---~~~~~~~~ape~~~~ 687 (689)
|+|||++.++.+||+|||+|+.......... ..++..|+|||++.+
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCC
T ss_conf 3214434598289851422220457786156234357876578388727
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=247.87 Aligned_cols=170 Identities=24% Similarity=0.368 Sum_probs=149.0
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEEC
Q ss_conf 59774444710287389999938996999999335458856699999999998138998720001799959969999813
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 588 (689)
++|+..+.||+|+||+||+|+.++++.||||.++.... ..++|.+|+..+++++|||||+++|+|.+.+..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEC
T ss_conf 99799689820788399999988998999999874757---789999999999966898601588998507816999970
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 68899889983195457899999999999999999999994999981980446898586699949998614776556998
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~~ 668 (689)
+++|+|..++... ...+++..+++|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC
T ss_conf 4899388864102---46776899999999999999987546---84346654135887699847988614420235787
Q ss_pred CCE--EECCCCEEEECCCCCC
Q ss_conf 420--1156234992110233
Q 005587 669 VSQ--VSHNLTIMRAGGVTHR 687 (689)
Q Consensus 669 ~~~--~~~~~~~~~ape~~~~ 687 (689)
... ...++..|+|||++.+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMY 175 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHH
T ss_pred CEEECCCCCCCCCCCCHHHCC
T ss_conf 225246578877578078637
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=246.89 Aligned_cols=173 Identities=25% Similarity=0.423 Sum_probs=145.9
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCC-----CEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEE
Q ss_conf 5977444471028738999993899-----69999993354588566999999999981389987200017999599699
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDG-----KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~~g-----~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (689)
+.|+..++||+|+||.||+|.++++ ..||||++..... .....+|.+|+.++.+++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 9968615981177909999999689987879999999884459-689999999999998568987832367783388038
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 99813688998899831954578999999999999999999999949999819804468985866999499986147765
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
+||||+.+|++.+++... ...++|..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEECCCCCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 999721357402221023---45420899999999999854121212---342576564427888998499845510300
Q ss_pred CCCCCCC----EEECCCCEEEECCCCCCC
Q ss_conf 5699842----011562349921102337
Q 005587 664 ISSGSVS----QVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 664 ~~~~~~~----~~~~~~~~~~ape~~~~~ 688 (689)
+...... ....++..|+|||++.++
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 188 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYR 188 (283)
T ss_dssp --------------CCCGGGSCHHHHHSC
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCC
T ss_conf 35787652674267777343488887049
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=245.72 Aligned_cols=165 Identities=23% Similarity=0.331 Sum_probs=139.9
Q ss_pred CEEEECCCEEEEEEEEC---CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEECCCC
Q ss_conf 44710287389999938---996999999335458856699999999998138998720001799959969999813688
Q 005587 515 NLIGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYCSN 591 (689)
Q Consensus 515 ~~lG~G~~g~Vy~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 591 (689)
+.||+|+||+||+|.+. .++.||||++..........++|.+|+.++++++|||||+++|+|... ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059-77999974788
Q ss_pred CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCCCCCE
Q ss_conf 99889983195457899999999999999999999994999981980446898586699949998614776556998420
Q 005587 592 GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVSQ 671 (689)
Q Consensus 592 GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~~~~~ 671 (689)
|+|.++++. ...++|..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 968999752----25789999999999999997668747---95567776113102356751234134533134323443
Q ss_pred ----EECCCCEEEECCCCCC
Q ss_conf ----1156234992110233
Q 005587 672 ----VSHNLTIMRAGGVTHR 687 (689)
Q Consensus 672 ----~~~~~~~~~ape~~~~ 687 (689)
...++..|+|||++.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~ 184 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINY 184 (277)
T ss_dssp EC----CCCGGGCCHHHHHH
T ss_pred CCCCCCCCCCEECCCHHHCC
T ss_conf 22445677842039166537
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=243.36 Aligned_cols=173 Identities=17% Similarity=0.234 Sum_probs=151.7
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEE
Q ss_conf 3159774444710287389999938-996999999335458856699999999998138998720001799959969999
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP-DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV 585 (689)
..++|.+.+.||+|+||+||+|... +++.||||.+... ..+...+.+|+.++.+++|||||++++++.+.+..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC---CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 701058878983177839999999899969999997578---66599999999999857997989098999889988999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECC--CCCEEEEEECCCCC
Q ss_conf 8136889988998319545789999999999999999999999499998198044689858669--99499986147765
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD--DLAVSVSDCGLAPL 663 (689)
Q Consensus 586 ~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~--~~~~ki~DFGla~~ 663 (689)
||||+||+|.+++... ...+++.....|+.|++.||.|||+. +|+||||||+|||++. ...+||+|||+++.
T Consensus 80 mE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 80 FEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp ECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EECCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHC
T ss_conf 9538998088998753---89999999999999999999999876---99751355444344378851899764411100
Q ss_pred CCCCCCCEEECCCCEEEECCCCCCC
Q ss_conf 5699842011562349921102337
Q 005587 664 ISSGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 664 ~~~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
...........++..|+|||++.++
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~ 178 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTC
T ss_pred CCCCCCCCCCCCCCCCCCCHHCCCC
T ss_conf 3467753212233222340210487
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-44 Score=246.62 Aligned_cols=171 Identities=20% Similarity=0.288 Sum_probs=148.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEE
Q ss_conf 5977444471028738999993-89969999993354588-566999999999981389987200017999599699998
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 586 (689)
++|++.+.||+|+||.||+|+. .+|+.||||++...... ......+.+|+.+++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 13688998899831954578999999999999999999999949999819804468985866999499986147765569
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISS 666 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~ 666 (689)
||+.+|+|.+++.. ...+++.....|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf 23346622666751----58989999999999999989999859---986176799993607789788610103332256
Q ss_pred CCCCEEECCCCEEEECCCCCCC
Q ss_conf 9842011562349921102337
Q 005587 667 GSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 667 ~~~~~~~~~~~~~~ape~~~~~ 688 (689)
.. ....++..|+|||++.+.
T Consensus 194 ~~--~~~~Gt~~Y~APE~~~~~ 213 (350)
T d1rdqe_ 194 RT--WTLCGTPEALAPEIILSK 213 (350)
T ss_dssp CB--CCCEECGGGCCHHHHTTC
T ss_pred CC--CCCCCCCCCCCHHHHCCC
T ss_conf 66--433676356788997179
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=244.45 Aligned_cols=171 Identities=19% Similarity=0.323 Sum_probs=141.8
Q ss_pred CCCCCCCE-EEECCCEEEEEEEEC---CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEE
Q ss_conf 59774444-710287389999938---99699999933545885669999999999813899872000179995996999
Q 005587 509 NSFSQENL-IGAGMLGSVYRAQLP---DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~-lG~G~~g~Vy~~~~~---~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~l 584 (689)
++|...+. ||+|+||.||+|.++ ++..||||.+.... .....++|.+|+.++++++|||||+++|+|.. +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 47188784873060809999999608976899999988203-97899999999999986799888068656036-80799
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 98136889988998319545789999999999999999999999499998198044689858669994999861477655
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 585 V~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~ 664 (689)
||||+++|+|.+++... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 vmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf 99807899689975212---56999999999999999987899868---8105767646604546885420331342115
Q ss_pred CCCCCCE----EECCCCEEEECCCCCC
Q ss_conf 6998420----1156234992110233
Q 005587 665 SSGSVSQ----VSHNLTIMRAGGVTHR 687 (689)
Q Consensus 665 ~~~~~~~----~~~~~~~~~ape~~~~ 687 (689)
....... ...++..|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINF 186 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHC
T ss_conf 543432113562113743358688727
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.2e-44 Score=242.48 Aligned_cols=172 Identities=25% Similarity=0.389 Sum_probs=151.9
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCH-------HHHHHHHHHHHHHHCCC-CCCCCEECEEEEE
Q ss_conf 15977444471028738999993-899699999933545885-------66999999999981389-9872000179995
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ-------QKDDEFLELVNNIDRIR-HANIVELKGYCAE 578 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~-------~~~~~~~~e~~~l~~l~-Hpniv~l~~~~~~ 578 (689)
.++|+..+.||+|+||+||+|+. .+|+.||||++....... .....+.+|+..+++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEE
Q ss_conf 99699998136889988998319545789999999999999999999999499998198044689858669994999861
Q 005587 579 HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDC 658 (689)
Q Consensus 579 ~~~~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DF 658 (689)
.+..|+|||||++|+|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCC
T ss_conf 7605999976898668999986----59999999999999999999999875---9943234625489868998387124
Q ss_pred CCCCCCCCCCCCEEECCCCEEEECCCCC
Q ss_conf 4776556998420115623499211023
Q 005587 659 GLAPLISSGSVSQVSHNLTIMRAGGVTH 686 (689)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~ape~~~ 686 (689)
|+++.+..+.......++..|+|||++.
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~ 182 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIE 182 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred HHEEECCCCCCEEEEECCCCCCCHHHHH
T ss_conf 0316726887213452467888988860
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=248.21 Aligned_cols=170 Identities=26% Similarity=0.417 Sum_probs=146.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEEC
Q ss_conf 59774444710287389999938996999999335458856699999999998138998720001799959969999813
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 588 (689)
++|++.+.||+|+||.||+|+..+++.||||++.... ...+.|.+|+..+++++|+|||+++|+|.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEE
T ss_conf 9979846993079809999999999999999988044---888999999999986666788689999823-975999994
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 68899889983195457899999999999999999999994999981980446898586699949998614776556998
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~~ 668 (689)
+++|+|..++.... ...++|..++.|+.||+.||.|||+. +|+||||||+|||+|.++.+||+|||+|+.+....
T Consensus 93 ~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC
T ss_conf 47994354200003--55305999999999999999987541---14335312307999899929984425554256887
Q ss_pred CC--EEECCCCEEEECCCCCC
Q ss_conf 42--01156234992110233
Q 005587 669 VS--QVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 669 ~~--~~~~~~~~~~ape~~~~ 687 (689)
.. ....++..|+|||++.+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~ 188 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALY 188 (285)
T ss_dssp --------CCGGGSCHHHHHH
T ss_pred CEEECCCCCCCCCCCHHHHHC
T ss_conf 335245455665458089837
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=242.85 Aligned_cols=175 Identities=25% Similarity=0.418 Sum_probs=149.7
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CCC--EEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEECEEEEECCEEEE
Q ss_conf 59774444710287389999938-996--999999335458856699999999998138-99872000179995996999
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGK--LLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHGQRLL 584 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~--~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~~~~~l 584 (689)
++|+..++||+|+||.||+|++. ++. .||||++..... ....++|.+|++.+.++ +|||||+++|+|.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 99688779820788289999998999699999999782338-57999999999999862289988367888841873699
Q ss_pred EEECCCCCCHHHHHHCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCC
Q ss_conf 981368899889983195------------45789999999999999999999999499998198044689858669994
Q 005587 585 IYEYCSNGTLQDMLHSDD------------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLA 652 (689)
Q Consensus 585 V~Ey~~~GsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~ 652 (689)
||||+++|+|.++++... .....++|..+++++.|+|.||.|+|+. +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCC
T ss_conf 9980289869999864035555512310123457899999999999999998766308---9545550520489868876
Q ss_pred EEEEEECCCCCCCCCCCCEEECCCCEEEECCCCCC
Q ss_conf 99986147765569984201156234992110233
Q 005587 653 VSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 653 ~ki~DFGla~~~~~~~~~~~~~~~~~~~ape~~~~ 687 (689)
+||+|||+|+............++..|+|||++.+
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~ 200 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY 200 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHH
T ss_pred EEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCC
T ss_conf 38743443224442234553013775555387526
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-44 Score=243.22 Aligned_cols=183 Identities=27% Similarity=0.360 Sum_probs=152.8
Q ss_pred HHHHHHHCCCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECE
Q ss_conf 4448553159774444710287389999938------9969999993354588566999999999981389987200017
Q 005587 501 IASLQQYTNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKG 574 (689)
Q Consensus 501 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~ 574 (689)
+.+++...++|+..+.||+|+||.||+|+.. +++.||||++.... .....++|.+|+.++++++||||+++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCCCCCEE
T ss_conf 331138988938867982078839999998887657788299999988210-8579999999999999668997655246
Q ss_pred EEEECCEEEEEEECCCCCCHHHHHHCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 99959969999813688998899831954--------------------5789999999999999999999999499998
Q 005587 575 YCAEHGQRLLIYEYCSNGTLQDMLHSDDE--------------------LKNNLSWNTRIRMALGAARALEYLHEICQPP 634 (689)
Q Consensus 575 ~~~~~~~~~lV~Ey~~~GsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 634 (689)
+|...+..++||||+++|+|.++++.... ....++|..++.|+.|++.||.|||+. +
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---C
T ss_conf 6605980389998158992999998527554210000111001210346788989999999999999985541357---8
Q ss_pred CEEECCCCCCEEECCCCCEEEEEECCCCCCCCCCCC---EEECCCCEEEECCCCCC
Q ss_conf 198044689858669994999861477655699842---01156234992110233
Q 005587 635 IVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 635 IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~~~~---~~~~~~~~~~ape~~~~ 687 (689)
|+||||||+|||+|.++.+||+|||+|+.+.+.... ....++.+|+|||++.+
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred EEEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCC
T ss_conf 68548840116898999289833144211367764111577776767679899726
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=238.98 Aligned_cols=170 Identities=26% Similarity=0.350 Sum_probs=138.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECC----EEEE
Q ss_conf 597744447102873899999389969999993354588566999999999981389987200017999599----6999
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----QRLL 584 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~----~~~l 584 (689)
++|...+.||+|+||.||+|++ +|+.||||++.... .....+..|+..+.+++|||||+++++|...+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 6899988982078819999999-99899999987200---4679999999999627998683268899837986048999
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCEEECCCCCCEEECCCCCEEEEEEC
Q ss_conf 98136889988998319545789999999999999999999999499-----9981980446898586699949998614
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC-----QPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 585 V~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~IiHrDlkp~NILld~~~~~ki~DFG 659 (689)
|||||++|+|.++++. ..++|..+++++.++|.||.|+|+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEECCCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf 9964669898999865-----89998999999999999999988766520468986615317313578688776887638
Q ss_pred CCCCCCCCCCC-----EEECCCCEEEECCCCCC
Q ss_conf 77655699842-----01156234992110233
Q 005587 660 LAPLISSGSVS-----QVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 660 la~~~~~~~~~-----~~~~~~~~~~ape~~~~ 687 (689)
+++.+...... ....++..|+|||++.+
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCC
T ss_conf 662346777620013552503547678221056
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=238.80 Aligned_cols=169 Identities=19% Similarity=0.246 Sum_probs=142.5
Q ss_pred CCCCCCC-CEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHC-CCCCCCCEECEEEEE----CC
Q ss_conf 1597744-4471028738999993-899699999933545885669999999999813-899872000179995----99
Q 005587 508 TNSFSQE-NLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR-IRHANIVELKGYCAE----HG 580 (689)
Q Consensus 508 ~~~f~~~-~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~-l~Hpniv~l~~~~~~----~~ 580 (689)
.++|.+. ++||+|+||.||+|+. .+++.||||++... ..+.+|+..+.+ .+|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCC
T ss_conf 148798107965454869999998899989999998974-------7799999999986699997829899950346897
Q ss_pred EEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECC---CCCEEEEE
Q ss_conf 699998136889988998319545789999999999999999999999499998198044689858669---99499986
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVSD 657 (689)
Q Consensus 581 ~~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~---~~~~ki~D 657 (689)
..|+|||||+||+|.+++.... ...+++.....|+.|++.||.|||+. +|+||||||+|||++. .+.+||+|
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEEECCCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 8999997789984999998627--87757999999999999999999976---986444100220113555566311354
Q ss_pred ECCCCCCCCCCCCEEECCCCEEEECCCCCCC
Q ss_conf 1477655699842011562349921102337
Q 005587 658 CGLAPLISSGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 658 FGla~~~~~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
||+|+............++..|+|||++.+.
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 188 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGG
T ss_pred CCEEEECCCCCCCCCCCCCCCCCCCHHHCCC
T ss_conf 5512333688864322677563792777489
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=238.17 Aligned_cols=173 Identities=20% Similarity=0.268 Sum_probs=145.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHH-CCCCCCCCEECEEEEECCEEEEE
Q ss_conf 5977444471028738999993-89969999993354588-566999999999981-38998720001799959969999
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNID-RIRHANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~-~~~~~~~~~e~~~l~-~l~Hpniv~l~~~~~~~~~~~lV 585 (689)
++|...+.||+|+||+||+|+. .+++.||||++.+.... ......+..|...+. .++|||||++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 81368899889983195457899999999999999999999994999981980446898586699949998614776556
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLIS 665 (689)
Q Consensus 586 ~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~ 665 (689)
|||+++|+|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEECCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf 750379808998640----47899999999999999999999868---93403476540444489963015553023235
Q ss_pred CCC-CCEEECCCCEEEECCCCCCC
Q ss_conf 998-42011562349921102337
Q 005587 666 SGS-VSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 666 ~~~-~~~~~~~~~~~~ape~~~~~ 688 (689)
... ......++..|+|||++.++
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~ 178 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQ 178 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTC
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 665334545787776899998279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=238.69 Aligned_cols=173 Identities=20% Similarity=0.339 Sum_probs=146.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEE
Q ss_conf 5977444471028738999993-899699999933545885669999999999813899872000179995996999981
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (689)
++|+..+.||+|+||+||+|+. .+|+.||||++...........++.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 36889988998319545789999999999999999999999499998198044689858669994999861477655699
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~ 667 (689)
|+.++ +.+.+.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ECCCC-HHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf 23774-455544202--56888899999999999999986528---8992135711401134676210357861343688
Q ss_pred -CCCEEECCCCEEEECCCCCC
Q ss_conf -84201156234992110233
Q 005587 668 -SVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 668 -~~~~~~~~~~~~~ape~~~~ 687 (689)
.......++..|+|||++..
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTT
T ss_pred CCCCEEECCCCEEEEHHHHCC
T ss_conf 641001036521541122136
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=237.93 Aligned_cols=171 Identities=22% Similarity=0.387 Sum_probs=143.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CCC----EEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEE
Q ss_conf 59774444710287389999938-996----9999993354588566999999999981389987200017999599699
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP-DGK----LLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~----~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (689)
++|+..++||+|+||+||+|+.. +|+ .||||++..... ....++|.+|+.++++++|||||+++|+|.+. ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEE
T ss_conf 9997831982089929999999589988989999999651349-79999999999999867998881589999619-836
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 99813688998899831954578999999999999999999999949999819804468985866999499986147765
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
+++||+.+|+|.+.+... ...+++..+++|+.|||.||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEECCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEE
T ss_conf 999842687401011133---45799999999999999999999876---950476212031167998758602552223
Q ss_pred CCCCCCCE---EECCCCEEEECCCCCC
Q ss_conf 56998420---1156234992110233
Q 005587 664 ISSGSVSQ---VSHNLTIMRAGGVTHR 687 (689)
Q Consensus 664 ~~~~~~~~---~~~~~~~~~ape~~~~ 687 (689)
+....... ...++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 187 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILH 187 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHC
T ss_conf 354445322365105864467088746
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=236.94 Aligned_cols=178 Identities=21% Similarity=0.286 Sum_probs=147.8
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECC
Q ss_conf 3159774444710287389999938------9969999993354588566999999999981389987200017999599
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG 580 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~ 580 (689)
..++|...+.||+|+||.||+|.+. ++..||||++.... .......|.+|+.++++++|||||+++|+|...+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 689918835982078818999998786447789689999987012-8689999999999999769998841254784288
Q ss_pred EEEEEEECCCCCCHHHHHHCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEE
Q ss_conf 6999981368899889983195------4578999999999999999999999949999819804468985866999499
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDD------ELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVS 654 (689)
Q Consensus 581 ~~~lV~Ey~~~GsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~k 654 (689)
..++||||+++|+|.++++... .....+++..+.+|+.|+|+||.|||+. +|+||||||+|||+|.++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEE
T ss_conf 10677760489988999875033211344468879999999999999999987647---965432867754035996499
Q ss_pred EEEECCCCCCCCCCCC---EEECCCCEEEECCCCCCC
Q ss_conf 9861477655699842---011562349921102337
Q 005587 655 VSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 655 i~DFGla~~~~~~~~~---~~~~~~~~~~ape~~~~~ 688 (689)
|+|||+|+.+...... ....++..|+|||.+.++
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~ 210 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 210 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred EEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCC
T ss_conf 9424542023577630313402316323788887369
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=231.67 Aligned_cols=167 Identities=25% Similarity=0.413 Sum_probs=139.9
Q ss_pred CCEEEECCCEEEEEEEECCC----CEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEE-CCEEEEEEEC
Q ss_conf 44471028738999993899----699999933545885669999999999813899872000179995-9969999813
Q 005587 514 ENLIGAGMLGSVYRAQLPDG----KLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQRLLIYEY 588 (689)
Q Consensus 514 ~~~lG~G~~g~Vy~~~~~~g----~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~Ey 588 (689)
.++||+|+||+||+|++.++ ..||||++.... ......+|.+|++.+++++|||||+++|++.. .+..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 669813688099999997799879999999988436-9789999999999998678999867867898069943899987
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 68899889983195457899999999999999999999994999981980446898586699949998614776556998
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~~ 668 (689)
|++|+|.++++.. ...+++..+++++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EECCCHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 4067414421013---45404899999999988765200336---76257766875767799988991065232255665
Q ss_pred CCE-----EECCCCEEEECCCCCC
Q ss_conf 420-----1156234992110233
Q 005587 669 VSQ-----VSHNLTIMRAGGVTHR 687 (689)
Q Consensus 669 ~~~-----~~~~~~~~~ape~~~~ 687 (689)
... ...++..|+|||++..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~ 208 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT 208 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH
T ss_pred CCCCEECCCCCCCCCCCCHHHHHC
T ss_conf 553100256555645567688743
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-43 Score=237.48 Aligned_cols=167 Identities=22% Similarity=0.311 Sum_probs=140.4
Q ss_pred CCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHH---HHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEECC
Q ss_conf 44471028738999993-8996999999335458856---6999999999981389987200017999599699998136
Q 005587 514 ENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQ---KDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEYC 589 (689)
Q Consensus 514 ~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~---~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 589 (689)
.++||+|+||+||+|+. .+|+.||||++........ ....+.+|+.++++++|||||++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 88998899831954578999999999999999999999949999819804468985866999499986147765569984
Q 005587 590 SNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGSV 669 (689)
Q Consensus 590 ~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~~~ 669 (689)
.++++..+... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred CCHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf 45077655412----66778999999999999999886316---355035776258853778411465761000578755
Q ss_pred -CEEECCCCEEEECCCCCC
Q ss_conf -201156234992110233
Q 005587 670 -SQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 670 -~~~~~~~~~~~ape~~~~ 687 (689)
.....++..|+|||++..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFG 174 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTT
T ss_pred CCCCEECCHHHCCHHHHCC
T ss_conf 4330204733363999726
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=236.21 Aligned_cols=178 Identities=25% Similarity=0.363 Sum_probs=144.4
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEECEEEEEC
Q ss_conf 3159774444710287389999938------996999999335458856699999999998138-998720001799959
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQLP------DGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~ 579 (689)
..++|+..+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|+..+.++ +|+|||.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf 6799798449841678399999986777555783999999860017-178999999999988614998499741154047
Q ss_pred -CEEEEEEECCCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEE
Q ss_conf -969999813688998899831954------------5789999999999999999999999499998198044689858
Q 005587 580 -GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646 (689)
Q Consensus 580 -~~~~lV~Ey~~~GsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NIL 646 (689)
...++|||||++|+|.++++.... ....++|..++.|+.|+++||.|||+. +|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEE
T ss_conf 9757999984589929999985366666532220233214689999999999999999988737---9717867731065
Q ss_pred ECCCCCEEEEEECCCCCCCCCCCC---EEECCCCEEEECCCCCCC
Q ss_conf 669994999861477655699842---011562349921102337
Q 005587 647 LDDDLAVSVSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 647 ld~~~~~ki~DFGla~~~~~~~~~---~~~~~~~~~~ape~~~~~ 688 (689)
++.++.+||+|||+|+........ ....++..|+|||++.++
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 211 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 211 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC
T ss_pred ECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCC
T ss_conf 779982898457520011356652224751667210203686468
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-42 Score=236.04 Aligned_cols=172 Identities=21% Similarity=0.288 Sum_probs=148.7
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEEC
Q ss_conf 59774444710287389999938996999999335458856699999999998138998720001799959969999813
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYEY 588 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 588 (689)
++|...+.||+|+||+||+|+.++|+.||||++............+.+|+.++++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 68899889983195457899999999999999999999994999981980446898586699949998614776556998
Q 005587 589 CSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSGS 668 (689)
Q Consensus 589 ~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~~ 668 (689)
+.++.+..+... ...+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+|++|||+|.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EHHHHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 004567899860----47751445689999999999986057---48826787750568689978732366430114676
Q ss_pred C-CEEECCCCEEEECCCCCC
Q ss_conf 4-201156234992110233
Q 005587 669 V-SQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 669 ~-~~~~~~~~~~~ape~~~~ 687 (689)
. .....++..|+|||++..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~ 174 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMG 174 (286)
T ss_dssp -------CCCTTCCHHHHTT
T ss_pred CCCCEECCCCHHHHHHHHHC
T ss_conf 54101024311013788717
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.7e-42 Score=232.16 Aligned_cols=174 Identities=22% Similarity=0.287 Sum_probs=147.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEECEEEEECC----E
Q ss_conf 15977444471028738999993-89969999993354588-566999999999981389987200017999599----6
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----Q 581 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~----~ 581 (689)
.++|.+.+.||+|+||.||+|+. .+|+.||||.+...... ......+.+|+..+++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCC
Q ss_conf 99998136889988998319545789999999999999999999999499998198044689858669994999861477
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla 661 (689)
.|+||||++||+|.+++.. ...+++.....|+.|++.||.|||+. +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEEHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf 9999977889871011203----58999999999999999999999857---9527634675566575432010034443
Q ss_pred CCCCCCC----CCEEECCCCEEEECCCCCCC
Q ss_conf 6556998----42011562349921102337
Q 005587 662 PLISSGS----VSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 662 ~~~~~~~----~~~~~~~~~~~~ape~~~~~ 688 (689)
+...... ......++..|+|||++.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 189 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189 (277)
T ss_dssp EECC----------------TTCCHHHHTTC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 2212354433334642576243699998399
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-42 Score=233.03 Aligned_cols=172 Identities=23% Similarity=0.326 Sum_probs=143.3
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC----CCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEE
Q ss_conf 1597744447102873899999389----969999993354588566999999999981389987200017999599699
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPD----GKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (689)
.++|++.+.||+|+||.||+|+... +..||||.+.... .......+.+|+..+++++|||||++++++. .+..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEE
T ss_conf 899698779930788299999993699644999999936566-8799999999999998689999856988995-37479
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 99813688998899831954578999999999999999999999949999819804468985866999499986147765
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
+||||+++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 999840698077654224---78999999999999998775230226---744141026553206789678765034213
Q ss_pred CCCCCCC--EEECCCCEEEECCCCCC
Q ss_conf 5699842--01156234992110233
Q 005587 664 ISSGSVS--QVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 664 ~~~~~~~--~~~~~~~~~~ape~~~~ 687 (689)
+...... ....++..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~ 183 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINF 183 (273)
T ss_dssp -------------CCGGGCCHHHHHH
T ss_pred CCCCCCEECCCEECCCCCCHHHHHCC
T ss_conf 36776233054005831032667516
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=230.60 Aligned_cols=168 Identities=26% Similarity=0.350 Sum_probs=138.5
Q ss_pred CCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEEC------CEE
Q ss_conf 977444471028738999993-8996999999335458856699999999998138998720001799959------969
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------GQR 582 (689)
Q Consensus 510 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~------~~~ 582 (689)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|+.++++++|+|||++++++... .+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 76751698217683999999999997999999881606------899999999866898987387899744765773189
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCC-CEEEEEECCC
Q ss_conf 999813688998899831954578999999999999999999999949999819804468985866999-4999861477
Q 005587 583 LLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLA 661 (689)
Q Consensus 583 ~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~-~~ki~DFGla 661 (689)
++|||||++|.+..+.+ .......+++..+..|+.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 95 ~lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHH-HHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf 99984168860788886-310368999999999999999999999866---87645788603787358971167336605
Q ss_pred CCCCCCCCCEEECCCCEEEECCCCCC
Q ss_conf 65569984201156234992110233
Q 005587 662 PLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~ape~~~~ 687 (689)
+.+..........++..|+|||++..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFG 196 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTT
T ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHC
T ss_conf 44047765320025555568277640
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=231.25 Aligned_cols=176 Identities=26% Similarity=0.377 Sum_probs=147.7
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE------CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEECEEEEECC
Q ss_conf 15977444471028738999993------8996999999335458856699999999998138-9987200017999599
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL------PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEHG 580 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~~ 580 (689)
.++|+..+.||+|+||.||+|++ .+++.||||+++.... .....++.+|+..+.++ +|||||+++++|.+..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 899698549820688299999980664477886999999874248-7799999999999876269998878998983199
Q ss_pred EEEEEEECCCCCCHHHHHHCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEE
Q ss_conf 69999813688998899831954--------------5789999999999999999999999499998198044689858
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDE--------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANIL 646 (689)
Q Consensus 581 ~~~lV~Ey~~~GsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NIL 646 (689)
..++|||||++|+|.++++.... ....+++..+..|+.||++||.|||.. +++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCC
T ss_conf 7899997379987999998535665444445332223345889999999999999999988757---9266624102100
Q ss_pred ECCCCCEEEEEECCCCCCCCCCCCEE---ECCCCEEEECCCCCC
Q ss_conf 66999499986147765569984201---156234992110233
Q 005587 647 LDDDLAVSVSDCGLAPLISSGSVSQV---SHNLTIMRAGGVTHR 687 (689)
Q Consensus 647 ld~~~~~ki~DFGla~~~~~~~~~~~---~~~~~~~~ape~~~~ 687 (689)
++.++.+|++|||+++.......... ..++..|+|||++.+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 221 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCC
T ss_conf 00257521023401023367886158620135968767788617
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=231.23 Aligned_cols=170 Identities=21% Similarity=0.290 Sum_probs=146.6
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECC-----
Q ss_conf 315977444471028738999993-89969999993354588566999999999981389987200017999599-----
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----- 580 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~----- 580 (689)
..+.|+..+.||+|+||+||+|.. .+|+.||||++..........+.+.+|+.++++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEEC
Q ss_conf -6999981368899889983195457899999999999999999999994999981980446898586699949998614
Q 005587 581 -QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 581 -~~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFG 659 (689)
+.++||||+ +++|..+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEECC-CCCHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 1599998405-5218999874-----0226999999999999999998737---87645668511112100122113431
Q ss_pred CCCCCCCCCCCEEECCCCEEEECCCCCC
Q ss_conf 7765569984201156234992110233
Q 005587 660 LAPLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 660 la~~~~~~~~~~~~~~~~~~~ape~~~~ 687 (689)
+|+...... ....++..|+|||++.+
T Consensus 167 ~a~~~~~~~--~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 167 LARQADSEM--TGYVVTRWYRAPEVILN 192 (346)
T ss_dssp TCEECCSSC--CSSCSCGGGCCTHHHHT
T ss_pred CEECCCCCC--CCCCCCCCCCCHHHHCC
T ss_conf 022068763--10245533358899817
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=230.65 Aligned_cols=172 Identities=21% Similarity=0.284 Sum_probs=142.9
Q ss_pred HCCCCCCCCEEEECCCEEEEEEE-ECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECC----E
Q ss_conf 31597744447102873899999-389969999993354588566999999999981389987200017999599----6
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQ-LPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHG----Q 581 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~----~ 581 (689)
.+++|...+.||+|+||+||+|+ ..+|+.||||++.... .....+.+.+|+.++++++|||||++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 3898599789940648099999999999499999980310-958999999999999976898988588899505645541
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCC
Q ss_conf 99998136889988998319545789999999999999999999999499998198044689858669994999861477
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla 661 (689)
.+++++|+.+|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 85 ~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEECCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCE
T ss_conf 4999996259865664405-----8999999999999999999999978---9867778764378879997787545705
Q ss_pred CCCCCCCC----CEEECCCCEEEECCCCCC
Q ss_conf 65569984----201156234992110233
Q 005587 662 PLISSGSV----SQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 662 ~~~~~~~~----~~~~~~~~~~~ape~~~~ 687 (689)
+....... .....++..|+|||++..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 186 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLN 186 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred EECCCCCCCCEEECCCCCCCEECHHHHHHC
T ss_conf 650477764101011026520003878604
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=234.36 Aligned_cols=167 Identities=28% Similarity=0.431 Sum_probs=142.7
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEE-CCEEEEEEE
Q ss_conf 5977444471028738999993899699999933545885669999999999813899872000179995-996999981
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE-HGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~-~~~~~lV~E 587 (689)
++|+..+.||+|+||.||+|++ .|..||||+++... ..+++.+|++.+++++|||||+++|+|.+ .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 9948857982079808999999-99099999988577----799999999999867898985498788723892899996
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 36889988998319545789999999999999999999999499998198044689858669994999861477655699
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~ 667 (689)
|+++|+|.+++.... ...++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred CCCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC
T ss_conf 369998999987457--88889999999999998523211337---6553666567601468997763245600344787
Q ss_pred CCCEEECCCCEEEECCCCCC
Q ss_conf 84201156234992110233
Q 005587 668 SVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 668 ~~~~~~~~~~~~~ape~~~~ 687 (689)
. ....++..|+|||++.+
T Consensus 157 ~--~~~~~~~~y~aPE~l~~ 174 (262)
T d1byga_ 157 Q--DTGKLPVKWTAPEALRE 174 (262)
T ss_dssp -------CCTTTSCHHHHHH
T ss_pred C--CCCCCCCCCCCHHHHHC
T ss_conf 7--65566646778178727
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.7e-41 Score=227.55 Aligned_cols=164 Identities=20% Similarity=0.326 Sum_probs=142.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-CCCCCEECEEEEEC--CEEEE
Q ss_conf 5977444471028738999993-89969999993354588566999999999981389-98720001799959--96999
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEH--GQRLL 584 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~-Hpniv~l~~~~~~~--~~~~l 584 (689)
++|++.++||+|+||+||+|+. .+++.||||++... ...++.+|+.++.+++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEE
T ss_conf 6718978983174819999998899979999998889-----99999999999985157998767999998168771268
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCC-CEEEEEECCCCC
Q ss_conf 9813688998899831954578999999999999999999999949999819804468985866999-499986147765
Q 005587 585 IYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL-AVSVSDCGLAPL 663 (689)
Q Consensus 585 V~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~-~~ki~DFGla~~ 663 (689)
||||+++|+|..+. ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 110 v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 110 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEECCCCCHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf 88631798589974-------6899999999999999999887643---3443456441237748998366415654266
Q ss_pred CCCCCCCEEECCCCEEEECCCCCC
Q ss_conf 569984201156234992110233
Q 005587 664 ISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 664 ~~~~~~~~~~~~~~~~~ape~~~~ 687 (689)
+.+........++..|+|||++..
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~ 203 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVD 203 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 468874443224864247610268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=229.33 Aligned_cols=175 Identities=25% Similarity=0.373 Sum_probs=146.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEECC--------CCEEEEEEECCCCCCHHHHHHHHHHHHHHHCC-CCCCCCEECEEEEEC
Q ss_conf 597744447102873899999389--------96999999335458856699999999998138-998720001799959
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLPD--------GKLLAVKKLDKRASSQQKDDEFLELVNNIDRI-RHANIVELKGYCAEH 579 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~~--------g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l-~Hpniv~l~~~~~~~ 579 (689)
++|.+.+.||+|+||.||+|+... +..||||++..... .....++.+|...+.++ +|||||+++++|.+.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 9969700985167828999998578755566754999999881128-688999999999999813999697346522018
Q ss_pred CEEEEEEECCCCCCHHHHHHCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEE
Q ss_conf 969999813688998899831954------------57899999999999999999999994999981980446898586
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDE------------LKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILL 647 (689)
Q Consensus 580 ~~~~lV~Ey~~~GsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILl 647 (689)
+..++||||+++|+|.+++..... ....+++..+++++.|++.||.|||+. +|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEEE
T ss_conf 868999973699909999986067764322233457434679999999999999999876637---97863022102245
Q ss_pred CCCCCEEEEEECCCCCCCCCCCC---EEECCCCEEEECCCCCC
Q ss_conf 69994999861477655699842---01156234992110233
Q 005587 648 DDDLAVSVSDCGLAPLISSGSVS---QVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 648 d~~~~~ki~DFGla~~~~~~~~~---~~~~~~~~~~ape~~~~ 687 (689)
+.++.+||+|||+++........ ....++..|+|||++.+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 211 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCC
T ss_conf 4789767622111011355555431466788846632667517
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=230.00 Aligned_cols=172 Identities=19% Similarity=0.252 Sum_probs=142.6
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCH----HHHHHHHHHHHHHHCCC--CCCCCEECEEEEECC
Q ss_conf 15977444471028738999993-899699999933545885----66999999999981389--987200017999599
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQ----QKDDEFLELVNNIDRIR--HANIVELKGYCAEHG 580 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~----~~~~~~~~e~~~l~~l~--Hpniv~l~~~~~~~~ 580 (689)
.++|.+.++||+|+||.||+|+. .+|+.||||++....... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEECCCC-CCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCC-CCEEEEEE
Q ss_conf 69999813688-99889983195457899999999999999999999994999981980446898586699-94999861
Q 005587 581 QRLLIYEYCSN-GTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDD-LAVSVSDC 658 (689)
Q Consensus 581 ~~~lV~Ey~~~-GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~-~~~ki~DF 658 (689)
..++||||+.+ +++.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEEECCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 689999833686228999861----58999999999999999999999877---97556676111477447884897754
Q ss_pred CCCCCCCCCCCCEEECCCCEEEECCCCCC
Q ss_conf 47765569984201156234992110233
Q 005587 659 GLAPLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 659 Gla~~~~~~~~~~~~~~~~~~~ape~~~~ 687 (689)
|+|+....... ....++..|+|||++.+
T Consensus 156 G~a~~~~~~~~-~~~~GT~~y~aPE~~~~ 183 (273)
T d1xwsa_ 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRY 183 (273)
T ss_dssp TTCEECCSSCB-CCCCSCGGGSCHHHHHH
T ss_pred CCCEECCCCCC-CCCCCCCCCCCHHHHCC
T ss_conf 65353244455-66565877479999848
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-41 Score=227.90 Aligned_cols=176 Identities=22% Similarity=0.314 Sum_probs=141.4
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEE-CC-CCEEEEEEECCCCCCHHHHHHHHHHHHHH---HCCCCCCCCEECEEEEE---
Q ss_conf 315977444471028738999993-89-96999999335458856699999999998---13899872000179995---
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PD-GKLLAVKKLDKRASSQQKDDEFLELVNNI---DRIRHANIVELKGYCAE--- 578 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~-g~~vAVK~i~~~~~~~~~~~~~~~e~~~l---~~l~Hpniv~l~~~~~~--- 578 (689)
..++|++.+.||+|+||+||+|+. ++ ++.||||++............+.+|+..+ +..+|||||+++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEE
Q ss_conf --996999981368899889983195457899999999999999999999994999981980446898586699949998
Q 005587 579 --HGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVS 656 (689)
Q Consensus 579 --~~~~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~ 656 (689)
....+++|||+.+|.+....... ...+++.....|+.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEEC
T ss_conf 6674699999740587144444303---78999899999999999999999758---89835798627898589975421
Q ss_pred EECCCCCCCCCCCCEEECCCCEEEECCCCCCC
Q ss_conf 61477655699842011562349921102337
Q 005587 657 DCGLAPLISSGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 657 DFGla~~~~~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
|||+++............+|..|+|||++.+.
T Consensus 159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~ 190 (305)
T d1blxa_ 159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 190 (305)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC
T ss_pred CHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCC
T ss_conf 00010110023457776548511483100179
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=222.47 Aligned_cols=173 Identities=17% Similarity=0.305 Sum_probs=149.9
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEEEEEE
Q ss_conf 5977444471028738999993-899699999933545885669999999999813899872000179995996999981
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRLLIYE 587 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 587 (689)
++|++.+.||+|+||+||+|+. .+++.||||+++..........++.+|+.++++++|||||++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 36889988998319545789999999999999999999999499998198044689858669994999861477655699
Q 005587 588 YCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPLISSG 667 (689)
Q Consensus 588 y~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~~~~ 667 (689)
|+.++++..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ECCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf 0233222112123----56540367899999999998774339---9860014676121133782665204601104688
Q ss_pred C-CCEEECCCCEEEECCCCCCC
Q ss_conf 8-42011562349921102337
Q 005587 668 S-VSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 668 ~-~~~~~~~~~~~~ape~~~~~ 688 (689)
. .......+.++++||++..+
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~ 176 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTC
T ss_pred CCCCEEECCCCCHHHHHHHCCC
T ss_conf 7510010344310146675069
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=227.95 Aligned_cols=172 Identities=23% Similarity=0.317 Sum_probs=141.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC--CC--CEEEEEEECCCCCC-HHHHHHHHHHHHHHHCCCCCCCCEECEEEEECCEEE
Q ss_conf 59774444710287389999938--99--69999993354588-566999999999981389987200017999599699
Q 005587 509 NSFSQENLIGAGMLGSVYRAQLP--DG--KLLAVKKLDKRASS-QQKDDEFLELVNNIDRIRHANIVELKGYCAEHGQRL 583 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~~--~g--~~vAVK~i~~~~~~-~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~~~~~ 583 (689)
++|+..+.||+|+||.||+|++. ++ ..||||++...... ....++|.+|+.++++++|||||+++|+|.+. ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf 8919978980388839999999889990799999999835557989999999999999868999987898777401-001
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 99813688998899831954578999999999999999999999949999819804468985866999499986147765
Q 005587 584 LIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 584 lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
+||||+++|++.+.+... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEECCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 146542386125444212---68999999999999999999875217---875205668881565565433256115553
Q ss_pred CCCCCCCE----EECCCCEEEECCCCCC
Q ss_conf 56998420----1156234992110233
Q 005587 664 ISSGSVSQ----VSHNLTIMRAGGVTHR 687 (689)
Q Consensus 664 ~~~~~~~~----~~~~~~~~~ape~~~~ 687 (689)
+....... ...++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 188 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKT 188 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH
T ss_pred CCCCCCCCEECCCCCCCCCCCCHHHHHC
T ss_conf 0358875265476325731079999837
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=223.54 Aligned_cols=172 Identities=22% Similarity=0.335 Sum_probs=142.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEE--------C
Q ss_conf 5977444471028738999993-899699999933545885669999999999813899872000179995--------9
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAE--------H 579 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~--------~ 579 (689)
++|++.+.||+|+||+||+|+. .+|+.||||++......+....++.+|+.++++++|+|++++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred CEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEEC
Q ss_conf 96999981368899889983195457899999999999999999999994999981980446898586699949998614
Q 005587 580 GQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCG 659 (689)
Q Consensus 580 ~~~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFG 659 (689)
...++||||+.++.+...... ...+++.....|+.|++.||.|||+. +|+||||||+|||++.++.+|++|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEECCCCCCCCHHHHC----CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEECC
T ss_conf 638999853578741012220----34433089999999999999885229---98856767222036689968763135
Q ss_pred CCCCCCCCC-----CCEEECCCCEEEECCCCCC
Q ss_conf 776556998-----4201156234992110233
Q 005587 660 LAPLISSGS-----VSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 660 la~~~~~~~-----~~~~~~~~~~~~ape~~~~ 687 (689)
+++.+.... ......++..|+|||++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~ 195 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTT
T ss_pred EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCC
T ss_conf 002235544432113566024978742899707
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=223.19 Aligned_cols=171 Identities=20% Similarity=0.244 Sum_probs=148.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEEC------C
Q ss_conf 15977444471028738999993-8996999999335458856699999999998138998720001799959------9
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH------G 580 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~------~ 580 (689)
.++|++.++||+|+||+||+|+. .+|+.||||++............+.+|+.++++++|||||++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECC
Q ss_conf 69999813688998899831954578999999999999999999999949999819804468985866999499986147
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGl 660 (689)
..|+||||+.++ +.+.+. ..+++.....++.|++.||.|||+. +|+||||||+|||++.++..|++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEEEECCCHH-HHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHH
T ss_conf 269998414467-787650------3899999999999999999886522---112456776321136544313201023
Q ss_pred CCCCCCCCCCEEECCCCEEEECCCCCCC
Q ss_conf 7655699842011562349921102337
Q 005587 661 APLISSGSVSQVSHNLTIMRAGGVTHRN 688 (689)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~ape~~~~~ 688 (689)
++............++..|+|||++.+.
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~ 193 (355)
T d2b1pa1 166 ARTAGTSFMMTPYVVTRYYRAPEVILGM 193 (355)
T ss_dssp ---------------CCTTCCHHHHTTC
T ss_pred HHCCCCCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 2114666553322146555581331477
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=223.56 Aligned_cols=171 Identities=20% Similarity=0.279 Sum_probs=145.5
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEECEEEEEC-----C
Q ss_conf 315977444471028738999993-8996999999335458856699999999998138998720001799959-----9
Q 005587 507 YTNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELKGYCAEH-----G 580 (689)
Q Consensus 507 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~~~~~~~-----~ 580 (689)
..++|+..+.||+|+||+||+|+. .+|+.||||++..........+.+.+|+.++++++|||+|++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred EEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECC
Q ss_conf 69999813688998899831954578999999999999999999999949999819804468985866999499986147
Q 005587 581 QRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGL 660 (689)
Q Consensus 581 ~~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGl 660 (689)
..++++||+.+|+|.+++.. ..+++..+..|+.|++.||.|||+. +|+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEECCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 64999996258862320022-----4530999999999999999999738---876516677633455432200132100
Q ss_pred CCCCCCCCCCEEECCCCEEEECCCCCC
Q ss_conf 765569984201156234992110233
Q 005587 661 APLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 661 a~~~~~~~~~~~~~~~~~~~ape~~~~ 687 (689)
|....... ....++..|+|||+..+
T Consensus 168 a~~~~~~~--~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 168 ARHTDDEM--TGYVATRWYRAPEIMLN 192 (348)
T ss_dssp --CCTGGG--SSSCHHHHTSCHHHHTT
T ss_pred HCCCCCCC--CCCCCCCCCCCCHHHCC
T ss_conf 01257544--44345435558355337
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=220.95 Aligned_cols=172 Identities=23% Similarity=0.280 Sum_probs=144.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEE----CCCCEEEEEEECCCCCC--HHHHHHHHHHHHHHHCCCC-CCCCEECEEEEECCE
Q ss_conf 5977444471028738999993----89969999993354588--5669999999999813899-872000179995996
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL----PDGKLLAVKKLDKRASS--QQKDDEFLELVNNIDRIRH-ANIVELKGYCAEHGQ 581 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vAVK~i~~~~~~--~~~~~~~~~e~~~l~~l~H-pniv~l~~~~~~~~~ 581 (689)
++|+..+.||+|+||+||+|+. .+|+.||||.+...... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEEEEECCC
Q ss_conf 99998136889988998319545789999999999999999999999499998198044689858669994999861477
Q 005587 582 RLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSVSDCGLA 661 (689)
Q Consensus 582 ~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki~DFGla 661 (689)
.++||||+.+|+|.+++... ..+.......++.|++.||.|+|+. +|+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEEECCCCCHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 00123123411799998730----4543788888899999999885149---9896547732012469998887413202
Q ss_pred CCCCCCCC--CEEECCCCEEEECCCCCC
Q ss_conf 65569984--201156234992110233
Q 005587 662 PLISSGSV--SQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 662 ~~~~~~~~--~~~~~~~~~~~ape~~~~ 687 (689)
+.+..... .....++..|++||++..
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~ 204 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRG 204 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHHC
T ss_conf 2203444432212223333310687605
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-37 Score=210.82 Aligned_cols=169 Identities=15% Similarity=0.189 Sum_probs=139.8
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCC-CCCCEECEEEEECCEEEEE
Q ss_conf 15977444471028738999993-899699999933545885669999999999813899-8720001799959969999
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRH-ANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~H-pniv~l~~~~~~~~~~~lV 585 (689)
.++|.+.+.||+|+||+||+|+. .+|+.||||.+..... ...+.+|++.+..+.| +|++.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
T ss_conf 9806997998417882999999988997999999750258----299999999999964899987799996018811799
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECC-----CCCEEEEEECC
Q ss_conf 8136889988998319545789999999999999999999999499998198044689858669-----99499986147
Q 005587 586 YEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD-----DLAVSVSDCGL 660 (689)
Q Consensus 586 ~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~-----~~~~ki~DFGl 660 (689)
|||+ +|+|.+++... ...+++.....++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 80 me~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEC-CCCHHHHHHHH---CCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCE
T ss_conf 9964-88879999752---03110689999999999999999977---96626677131523475434479568723660
Q ss_pred CCCCCCCCC--------CEEECCCCEEEECCCCCC
Q ss_conf 765569984--------201156234992110233
Q 005587 661 APLISSGSV--------SQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 661 a~~~~~~~~--------~~~~~~~~~~~ape~~~~ 687 (689)
|+.+..... .....+|..|+|||++.+
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~ 187 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred EEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCC
T ss_conf 57714676654111024676277510267989648
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-36 Score=205.52 Aligned_cols=168 Identities=18% Similarity=0.202 Sum_probs=135.0
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCCCCCCCEEC-EEEEECCEEEEEE
Q ss_conf 5977444471028738999993-8996999999335458856699999999998138998720001-7999599699998
Q 005587 509 NSFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIRHANIVELK-GYCAEHGQRLLIY 586 (689)
Q Consensus 509 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~Hpniv~l~-~~~~~~~~~~lV~ 586 (689)
+.|++.+.||+|+||.||+|+. .+|+.||||.+..... ..++..|+++++.++|+|+|..+ .+....+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
T ss_conf 889996898507880999999988998999999721005----8889999999997038996017999995198778999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECC---CCCEEEEEECCCCC
Q ss_conf 136889988998319545789999999999999999999999499998198044689858669---99499986147765
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDD---DLAVSVSDCGLAPL 663 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~---~~~~ki~DFGla~~ 663 (689)
||+ +|++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. +..+|++|||+|+.
T Consensus 83 e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEC-CCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEE
T ss_conf 873-87133324430---68876899999999999999999979---944266787660643357776156504675134
Q ss_pred CCCCCCC--------EEECCCCEEEECCCCCC
Q ss_conf 5699842--------01156234992110233
Q 005587 664 ISSGSVS--------QVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 664 ~~~~~~~--------~~~~~~~~~~ape~~~~ 687 (689)
+...... ....++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLG 187 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT
T ss_pred CCCCCCCCCEECCCCCCCCCCCCCCCHHHHHC
T ss_conf 25544554100013577678735329999918
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4.7e-32 Score=181.29 Aligned_cols=169 Identities=14% Similarity=0.142 Sum_probs=128.8
Q ss_pred CCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-----------CCCCCEECEEEE
Q ss_conf 977444471028738999993-89969999993354588566999999999981389-----------987200017999
Q 005587 510 SFSQENLIGAGMLGSVYRAQL-PDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-----------HANIVELKGYCA 577 (689)
Q Consensus 510 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~-----------Hpniv~l~~~~~ 577 (689)
+|.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++ |+|||++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 5799899750778189999999999799999983431---3368999999999984014555554227676478998763
Q ss_pred E--CCEEEEEEECCCCCCHHH-HHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCC---
Q ss_conf 5--996999981368899889-9831954578999999999999999999999949999819804468985866999---
Q 005587 578 E--HGQRLLIYEYCSNGTLQD-MLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDL--- 651 (689)
Q Consensus 578 ~--~~~~~lV~Ey~~~GsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~--- 651 (689)
. ....+++++++..+.... ..... ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred ECCCCCEEEEEEECCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHEEEECCCCCC
T ss_conf 125652023432000354200000122--346786899999999999998887640--5864656770570563057656
Q ss_pred ---CEEEEEECCCCCCCCCCCCEEECCCCEEEECCCCCC
Q ss_conf ---499986147765569984201156234992110233
Q 005587 652 ---AVSVSDCGLAPLISSGSVSQVSHNLTIMRAGGVTHR 687 (689)
Q Consensus 652 ---~~ki~DFGla~~~~~~~~~~~~~~~~~~~ape~~~~ 687 (689)
.++++|||.|....... ....++..|+|||++..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~--~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLLG 203 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC--CSCCSCGGGCCHHHHHT
T ss_pred CCCEEEEEECCCCCCCCCCC--CCCCCCCCCCCHHHCCC
T ss_conf 44305675314421234454--22366521057132146
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.4e-27 Score=156.65 Aligned_cols=174 Identities=24% Similarity=0.239 Sum_probs=147.1
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 9867999149988764573556999997998317868997788632-354530035755789999656799976699846
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLN 157 (689)
Q Consensus 79 ~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~-~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls 157 (689)
.+++.|+|++|.+.+..+..|.++++|+.|+|++|+++ .+|.... ++|+.|+|++|++++ ++..+..+++|+.|+++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
T ss_conf 68898988499289859778634565522135665444-43111112232111112222211-11121222222222222
Q ss_pred CCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCC-CCCCCCCCCCCCCCC
Q ss_conf 886787787111299999789832787877789875477665556611444555532-137743-352125565478997
Q 005587 158 NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDLNIENNLFSGPI 235 (689)
Q Consensus 158 ~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~-~~~~~~-L~~L~ls~N~l~g~~ 235 (689)
+|.+....+..+..+.++..|++++|.+....+..+..+++|+.+++++|++++.++ .+..++ |+.|+|++|+|+ .+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l 187 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CC
T ss_conf 23110110011222211112212434210221233322111000000015652237200134212423430139785-56
Q ss_pred CCCCCCCC---CCCCCCCCCCCC
Q ss_conf 61158988---732368867888
Q 005587 236 PEKMLQIP---NFRKDGNPFNST 255 (689)
Q Consensus 236 P~~l~~l~---~l~~~~n~~~~~ 255 (689)
|..+.+++ .+.+.+|+|.|.
T Consensus 188 p~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCBCCS
T ss_pred CHHHCCCCCCCEEEECCCCCCCC
T ss_conf 86677788899998369998788
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=2.2e-28 Score=162.10 Aligned_cols=178 Identities=25% Similarity=0.476 Sum_probs=142.9
Q ss_pred CCEEEEEECC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 9867999149-988764573556999997998317868997788632--3545300357557899996567999766998
Q 005587 79 SDIIAIILNG-ANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155 (689)
Q Consensus 79 ~~v~~l~L~~-~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ 155 (689)
.++++|+|++ |.+.|.+|+.+++|++|++|+|++|++.+..+..+. ..|+.++++.|.+.+.+|..+.+++.|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf 53352020265433300243114542001102035643443322222011100111122455556851220674000000
Q ss_pred CCCCCCCCCCCHHHCCCCCC-CEEECCCCCCCCCCCCC-----------------------CCCCCCCCEEECCCCCCCC
Q ss_conf 46886787787111299999-78983278787778987-----------------------5477665556611444555
Q 005587 156 LNNNLLSGEIPDAFQSLTGL-INLDLSSNNLSGELPPS-----------------------LENLSQLTTLHLQNNQLSG 211 (689)
Q Consensus 156 Ls~N~l~g~~P~~l~~l~~L-~~L~Ls~N~l~g~ip~~-----------------------~~~l~~L~~L~Ls~N~l~g 211 (689)
+++|.+.+.+|..+..+..+ +.++++.|++++..|.. +..+.+|+.+++++|.+.+
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 23553356203121443112323102246435332433222222233333343322222222222221112222222222
Q ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCCCC
Q ss_conf 532137743-352125565478997611589887---323688678888
Q 005587 212 TLDVLQDLP-LRDLNIENNLFSGPIPEKMLQIPN---FRKDGNPFNSTV 256 (689)
Q Consensus 212 ~~~~~~~~~-L~~L~ls~N~l~g~~P~~l~~l~~---l~~~~n~~~~~~ 256 (689)
.++.+..++ ++.|++++|+++|.+|..+.++++ |++.+|.+.+.+
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~i 284 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred CCCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCC
T ss_conf 2222224554444447657066608768847999998979588351668
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=1.2e-27 Score=158.30 Aligned_cols=137 Identities=11% Similarity=0.088 Sum_probs=104.6
Q ss_pred CCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCC----------------HHHHHHHHHHHHHHHCCCCCCCCEECEE
Q ss_conf 744447102873899999389969999993354588----------------5669999999999813899872000179
Q 005587 512 SQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASS----------------QQKDDEFLELVNNIDRIRHANIVELKGY 575 (689)
Q Consensus 512 ~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~----------------~~~~~~~~~e~~~l~~l~Hpniv~l~~~ 575 (689)
.+.+.||+|+||+||+|+..+|+.||||.++..... ......+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCEEECCCCCEEE
Q ss_conf 99599699998136889988998319545789999999999999999999999499998198044689858669994999
Q 005587 576 CAEHGQRLLIYEYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEICQPPIVHRNFKSANILLDDDLAVSV 655 (689)
Q Consensus 576 ~~~~~~~~lV~Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~IiHrDlkp~NILld~~~~~ki 655 (689)
. . .+++|||++++.+.+ +++.....++.|+++++.|||.. +|+||||||+|||++++ .+++
T Consensus 83 ~--~--~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred C--C--CEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEE
T ss_conf 2--8--889999504565420-----------01578999999999999998268---88983689036114289-8999
Q ss_pred EEECCCCCCCCC
Q ss_conf 861477655699
Q 005587 656 SDCGLAPLISSG 667 (689)
Q Consensus 656 ~DFGla~~~~~~ 667 (689)
+|||+|+.....
T Consensus 144 iDFG~a~~~~~~ 155 (191)
T d1zara2 144 IDFPQSVEVGEE 155 (191)
T ss_dssp CCCTTCEETTST
T ss_pred EECCCCCCCCCC
T ss_conf 877884308998
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.94 E-value=3.8e-26 Score=150.41 Aligned_cols=179 Identities=20% Similarity=0.276 Sum_probs=144.5
Q ss_pred CCCCCCCCCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CC--CCCCCCCCCCCCCCCC
Q ss_conf 99999998627930998679991499887645735569999979983178689977886-32--3545300357557899
Q 005587 64 GDPCGESWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI-LP--VTMQNFFLSDNQFSGS 140 (689)
Q Consensus 64 ~~~C~~~w~gv~C~~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~-~~--~~L~~L~Ls~N~l~g~ 140 (689)
+..|.|+|..|.|+.. ++. .+|..+. +.+++|+|++|+|++.++.. +. .+|+.|+|++|.+...
T Consensus 3 P~~C~C~~~~v~Cs~~----------~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~ 69 (192)
T d1w8aa_ 3 PAMCHCEGTTVDCTGR----------GLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69 (192)
T ss_dssp CTTSEEETTEEECTTS----------CCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB
T ss_pred CCCCEECCCEEEEECC----------CCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCC
T ss_conf 9998976999997089----------967-0298989--78788984898775530200257876272130136322121
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 99656799976699846886787787111299999789832787877789875477665556611444555532137743
Q 005587 141 IPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP 220 (689)
Q Consensus 141 ~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~ 220 (689)
.+..|..+++|+.|+|++|++....|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|.+....+......
T Consensus 70 ~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~ 149 (192)
T d1w8aa_ 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE 149 (192)
T ss_dssp CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHH
T ss_pred CCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHH
T ss_conf 21222112222101003553443497998079746552457745353597785687533420003644343530277764
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf -35212556547899761158988732368867888
Q 005587 221 -LRDLNIENNLFSGPIPEKMLQIPNFRKDGNPFNST 255 (689)
Q Consensus 221 -L~~L~ls~N~l~g~~P~~l~~l~~l~~~~n~~~~~ 255 (689)
+..+.+..|.+....|..+..+.-+++..|.+.|.
T Consensus 150 ~l~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 150 WLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp HHHHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCCC
T ss_pred HHHHHCCCCCCEEECCCHHHCCCEEEECCHHHCCCC
T ss_conf 235403568982768984336988614487557589
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.6e-25 Score=146.02 Aligned_cols=184 Identities=19% Similarity=0.255 Sum_probs=147.3
Q ss_pred CCCCEEEEC-----------CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCC-CCC
Q ss_conf 986279309-----------9867999149988764573556999997998317868997788632--35453003-575
Q 005587 70 SWQGVQCNA-----------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFL-SDN 135 (689)
Q Consensus 70 ~w~gv~C~~-----------~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~L-s~N 135 (689)
.|.-|.|+. ..++.|+|++|.+....+..+.+++.|++|++++|.+....+..+. ..+..++. ..|
T Consensus 12 ~~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 12 PKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp SSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred CCEEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 99699847999894497889998889774881798797786414213000013445433211121222222222222102
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-
Q ss_conf 5789999656799976699846886787787111299999789832787877789875477665556611444555532-
Q 005587 136 QFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD- 214 (689)
Q Consensus 136 ~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~- 214 (689)
.++...+..|.++++|+.|++++|.+....+..+..+..|+.+++++|++++..+..|..+.+|+.|++++|.+++.++
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHH
T ss_conf 23544620101010277875688544320135332000121102001431445805740434050223141765662566
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCC
Q ss_conf 137743-352125565478997611589887---323688678
Q 005587 215 VLQDLP-LRDLNIENNLFSGPIPEKMLQIPN---FRKDGNPFN 253 (689)
Q Consensus 215 ~~~~~~-L~~L~ls~N~l~g~~P~~l~~l~~---l~~~~n~~~ 253 (689)
.+..++ |+.+++++|++++..|..|..+++ +++.+|.+.
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred HHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCC
T ss_conf 6546563413142114346628167665320002333335221
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=6e-24 Score=138.92 Aligned_cols=175 Identities=18% Similarity=0.325 Sum_probs=92.8
Q ss_pred CCCCCCCCCCCEEEEC-----------CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCC
Q ss_conf 9999999986279309-----------9867999149988764573556999997998317868997788632--35453
Q 005587 63 AGDPCGESWQGVQCNA-----------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQN 129 (689)
Q Consensus 63 ~~~~C~~~w~gv~C~~-----------~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~ 129 (689)
.+-.|.|.|.+|.|+. ..++.|+|++|.+....+..|.+++.|+.|++++|.+....|..+. ..|+.
T Consensus 4 ~p~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~ 83 (305)
T d1xkua_ 4 CPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 83 (305)
T ss_dssp CCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCCCCEECCCEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCE
T ss_conf 99988955999985599988519888999798978499189869657604656523112344344523566527985578
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCC--CCCCCCCCCCCCCCEEECCCC
Q ss_conf 003575578999965679997669984688678778711129999978983278787--778987547766555661144
Q 005587 130 FFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLS--GELPPSLENLSQLTTLHLQNN 207 (689)
Q Consensus 130 L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~--g~ip~~~~~l~~L~~L~Ls~N 207 (689)
|++++|+++ .+|..+ ...+..|++++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|
T Consensus 84 L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n 160 (305)
T d1xkua_ 84 LYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160 (305)
T ss_dssp EECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred ECCCCCCCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 315687567-676400--11132321024610234444540133110000123333346777642234565671203467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 4555532137743352125565478997611589
Q 005587 208 QLSGTLDVLQDLPLRDLNIENNLFSGPIPEKMLQ 241 (689)
Q Consensus 208 ~l~g~~~~~~~~~L~~L~ls~N~l~g~~P~~l~~ 241 (689)
.++.....+ ...++.|++++|..++..+..+..
T Consensus 161 ~l~~l~~~~-~~~L~~L~l~~n~~~~~~~~~~~~ 193 (305)
T d1xkua_ 161 NITTIPQGL-PPSLTELHLDGNKITKVDAASLKG 193 (305)
T ss_dssp CCCSCCSSC-CTTCSEEECTTSCCCEECTGGGTT
T ss_pred CCCCCCCCC-CCCCCEEECCCCCCCCCCHHHHHC
T ss_conf 745167101-776678989788677888267641
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=8.1e-22 Score=127.78 Aligned_cols=169 Identities=22% Similarity=0.260 Sum_probs=137.7
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 9867999149988764573556999997998317868997788632--35453003575578999965679997669984
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (689)
Q Consensus 79 ~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~L 156 (689)
.+...++.++++++ .+|+.+. +.|++|+|++|.+++..+..+. .+|++|+|++|+++ .++ .++.+++|+.|+|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEEC
T ss_pred CCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCC
T ss_conf 89869980699988-6196757--68898988499289859778634565522135665444-431-1111223211111
Q ss_pred CCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCC-CCCCCCCCCCCCCC
Q ss_conf 68867877871112999997898327878777898754776655566114445555321-37743-35212556547899
Q 005587 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDV-LQDLP-LRDLNIENNLFSGP 234 (689)
Q Consensus 157 s~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~-~~~~~-L~~L~ls~N~l~g~ 234 (689)
++|.++ .++..+..+++|+.|++++|.+....+..+..+.++..|++++|.++...+. +..++ ++.+++++|++++.
T Consensus 85 s~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163 (266)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCC
T ss_conf 222221-1111212222222222222311011001122221111221243421022123332211100000001565223
Q ss_pred CCCCCCCCC---CCCCCCCCCC
Q ss_conf 761158988---7323688678
Q 005587 235 IPEKMLQIP---NFRKDGNPFN 253 (689)
Q Consensus 235 ~P~~l~~l~---~l~~~~n~~~ 253 (689)
.+..|..++ .|++.+|.+.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~ 185 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLY 185 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCEEECCCCCCC
T ss_conf 7200134212423430139785
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.3e-22 Score=131.90 Aligned_cols=179 Identities=21% Similarity=0.240 Sum_probs=116.7
Q ss_pred CCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 62793099867999149988764573556999997998317868997788632--3545300357557899996567999
Q 005587 72 QGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLT 149 (689)
Q Consensus 72 ~gv~C~~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~ 149 (689)
.+..|....-..++.++.++. .+|..+. +.++.|+|++|+++...+..+. .+|++|++++|.+....+..+..++
T Consensus 4 ~~C~C~~~~~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~ 80 (284)
T d1ozna_ 4 GACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (284)
T ss_dssp TTCEEECSSSCEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCCEECCCCCEEEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 988986999969984799989-4497889--9988897748817987977864142130000134454332111212222
Q ss_pred CCCEEECC-CCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCC-CCCCCC
Q ss_conf 76699846-886787787111299999789832787877789875477665556611444555532-137743-352125
Q 005587 150 LLTDMSLN-NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDLNI 226 (689)
Q Consensus 150 ~L~~L~Ls-~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~-~~~~~~-L~~L~l 226 (689)
.+..++.. .|.+....|..|.++++|+.|++++|.+....+..+..+.+|+.+++++|.+++.++ .+...+ |+.|++
T Consensus 81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l 160 (284)
T d1ozna_ 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (284)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCC
T ss_conf 22222222102235446201010102778756885443201353320001211020014314458057404340502231
Q ss_pred CCCCCCCCCCCCCCCCCCCC---CCCCCCC
Q ss_conf 56547899761158988732---3688678
Q 005587 227 ENNLFSGPIPEKMLQIPNFR---KDGNPFN 253 (689)
Q Consensus 227 s~N~l~g~~P~~l~~l~~l~---~~~n~~~ 253 (689)
++|++++..+..|..+++|. +.+|.+.
T Consensus 161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~ 190 (284)
T d1ozna_ 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCHHHHCCCCCCCHHHHHHCCCC
T ss_conf 417656625666546563413142114346
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.86 E-value=3.1e-21 Score=124.74 Aligned_cols=131 Identities=26% Similarity=0.397 Sum_probs=116.2
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCC
Q ss_conf 9799831786899778863235453003575578999-965679997669984688678778711129999978983278
Q 005587 105 IRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSI-PSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183 (689)
Q Consensus 105 L~~L~Ls~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~-p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N 183 (689)
.+.+++++|+|+ .+|..++.++++|+|++|++++.+ +..|..+++|+.|+|++|.+....+..|..+++|+.|+|++|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CCEEEEECCCCC-CCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
T ss_conf 999997089967-0298989787889848987755302002578762721301363221212122211222210100355
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCC-CCCCCCCCCCCCCCCC
Q ss_conf 7877789875477665556611444555532-137743-3521255654789976
Q 005587 184 NLSGELPPSLENLSQLTTLHLQNNQLSGTLD-VLQDLP-LRDLNIENNLFSGPIP 236 (689)
Q Consensus 184 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~-~~~~~~-L~~L~ls~N~l~g~~P 236 (689)
+++...|..|.++++|+.|+|++|+|++..+ .|..++ |+.|++++|.+.....
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3443497998079746552457745353597785687533420003644343530
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.83 E-value=8.5e-20 Score=117.20 Aligned_cols=81 Identities=21% Similarity=0.390 Sum_probs=62.2
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99867999149988764573556999997998317868997788632--3545300357557899996567999766998
Q 005587 78 ASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155 (689)
Q Consensus 78 ~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ 155 (689)
..+++.|++.++++.. + +.+..|++|++|+|++|++++..| +. .+|++|++++|.+.+. + .++.+++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred HCCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCC
T ss_conf 5787899899989877-6-242458999989681881798863--34771101030134333222-2-111233433344
Q ss_pred CCCCCCCCC
Q ss_conf 468867877
Q 005587 156 LNNNLLSGE 164 (689)
Q Consensus 156 Ls~N~l~g~ 164 (689)
+++|.+++.
T Consensus 117 ~~~~~~~~~ 125 (384)
T d2omza2 117 LFNNQITDI 125 (384)
T ss_dssp CCSSCCCCC
T ss_pred CCCCCCCCC
T ss_conf 332222222
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.82 E-value=2.4e-19 Score=114.86 Aligned_cols=174 Identities=20% Similarity=0.290 Sum_probs=102.0
Q ss_pred CCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 862793099867999149988764573556999997998317868997788632--354530035755789999656799
Q 005587 71 WQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATL 148 (689)
Q Consensus 71 w~gv~C~~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l 148 (689)
-.+..|.. ..++-+++++. .+|..+. +.|++|+|++|+++...+..+. .+|++|++++|.+....|..|..+
T Consensus 5 p~~c~c~~---~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l 78 (305)
T d1xkua_ 5 PFRCQCHL---RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL 78 (305)
T ss_dssp CTTCEEET---TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTC
T ss_pred CCCCEECC---CEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCC
T ss_conf 99889559---99985599988-5198889--997989784991898696576046565231123443445235665279
Q ss_pred CCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC---CCCCCCC-CCCC
Q ss_conf 97669984688678778711129999978983278787778987547766555661144455553---2137743-3521
Q 005587 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTL---DVLQDLP-LRDL 224 (689)
Q Consensus 149 ~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~---~~~~~~~-L~~L 224 (689)
+.|+.|++++|+++ .+|..+ ...+..|+++.|.+.+..+..+.....+..++...|...... ..+..++ |+.+
T Consensus 79 ~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l 155 (305)
T d1xkua_ 79 VKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 155 (305)
T ss_dssp TTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEE
T ss_pred CCCCEECCCCCCCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 85578315687567-676400--111323210246102344445401331100001233333467776422345656712
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 25565478997611589887323688678
Q 005587 225 NIENNLFSGPIPEKMLQIPNFRKDGNPFN 253 (689)
Q Consensus 225 ~ls~N~l~g~~P~~l~~l~~l~~~~n~~~ 253 (689)
++++|.++......+.++..+.+.+|...
T Consensus 156 ~l~~n~l~~l~~~~~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 156 RIADTNITTIPQGLPPSLTELHLDGNKIT 184 (305)
T ss_dssp ECCSSCCCSCCSSCCTTCSEEECTTSCCC
T ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 03467745167101776678989788677
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=6e-19 Score=112.76 Aligned_cols=158 Identities=25% Similarity=0.376 Sum_probs=126.5
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 98679991499887645735569999979983178689977886323545300357557899996567999766998468
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (689)
Q Consensus 79 ~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~ 158 (689)
..++.|++.++.+.... .+..+++|+.|+|++|++++..+-..-.+|+.|++++|++++ ++ .+..+++|+.|++++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred CCCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCC
T ss_conf 48458978279888744--476489989876989602586011358621201433333212-22-121222111223456
Q ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCC
Q ss_conf 86787787111299999789832787877789875477665556611444555532137743-35212556547899761
Q 005587 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIPE 237 (689)
Q Consensus 159 N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~-L~~L~ls~N~l~g~~P~ 237 (689)
|.+. .+ ..+..++.++.++++.|.+++ +..+..+++|+.+++++|++++..+ +..++ |+.|++++|+++ .+|
T Consensus 122 ~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i~-~l~- 194 (210)
T d1h6ta2 122 NGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLR- 194 (210)
T ss_dssp SCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-BCG-
T ss_pred CCCC-CC-CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCEEECCCCCCC-CCH-
T ss_conf 5322-11-220111112221122233345--4310001332100134643025645-367898999989799899-872-
Q ss_pred CCCCCCCCCC
Q ss_conf 1589887323
Q 005587 238 KMLQIPNFRK 247 (689)
Q Consensus 238 ~l~~l~~l~~ 247 (689)
.+..+++|+.
T Consensus 195 ~l~~l~~L~~ 204 (210)
T d1h6ta2 195 ALAGLKNLDV 204 (210)
T ss_dssp GGTTCTTCSE
T ss_pred HHCCCCCCCE
T ss_conf 1169999899
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=3.9e-19 Score=113.77 Aligned_cols=188 Identities=14% Similarity=0.103 Sum_probs=117.1
Q ss_pred CCCCCCCCEEEEC-----------CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CC--CCCCCCC
Q ss_conf 9999986279309-----------98679991499887645735569999979983178689977886-32--3545300
Q 005587 66 PCGESWQGVQCNA-----------SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSI-LP--VTMQNFF 131 (689)
Q Consensus 66 ~C~~~w~gv~C~~-----------~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~-~~--~~L~~L~ 131 (689)
.|.|++..|.|.. .++++|+|++|.+....+..|.++++|++|+|++|.+...++.. +. ..++++.
T Consensus 5 ~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~ 84 (242)
T d1xwdc1 5 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 84 (242)
T ss_dssp SEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred CCCCCCCEEEEECCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCC
T ss_conf 28873999998189988768888998899987699189649668614643232110221124201001122222222211
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH-HHCCCCCCCEEECCCCCCCCCCCCCCCCCC-CCCEEECCCCC
Q ss_conf 35-7557899996567999766998468867877871-112999997898327878777898754776-65556611444
Q 005587 132 LS-DNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPD-AFQSLTGLINLDLSSNNLSGELPPSLENLS-QLTTLHLQNNQ 208 (689)
Q Consensus 132 Ls-~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~-~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~-~L~~L~Ls~N~ 208 (689)
+. .|++....+..|.++++|+.|++++|.+....+. .+..+..+..+..+++.+...-+..|..+. .+..|++++|+
T Consensus 85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~ 164 (242)
T d1xwdc1 85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 164 (242)
T ss_dssp EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf 11123432222221222222222234211112554333222111122222221211122222222223310012200123
Q ss_pred CCCCCCC-CCCCCCC-CCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCC
Q ss_conf 5555321-3774335-212556547899761158988---7323688678
Q 005587 209 LSGTLDV-LQDLPLR-DLNIENNLFSGPIPEKMLQIP---NFRKDGNPFN 253 (689)
Q Consensus 209 l~g~~~~-~~~~~L~-~L~ls~N~l~g~~P~~l~~l~---~l~~~~n~~~ 253 (689)
++..... +....+. .+++++|+++...+..|..++ .|++.+|.+.
T Consensus 165 l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 214 (242)
T d1xwdc1 165 IQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214 (242)
T ss_dssp CCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
T ss_conf 33322222220111012123543246424788668999998989799289
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=9.1e-19 Score=111.83 Aligned_cols=60 Identities=18% Similarity=0.230 Sum_probs=33.7
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99867999149988764573556999997998317868997788632354530035755789
Q 005587 78 ASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSG 139 (689)
Q Consensus 78 ~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~~~L~~L~Ls~N~l~g 139 (689)
..+++.|+|++|.+.+.. .++++++|++|++++|.+.+..+-..-.+|+.|++++|.+++
T Consensus 65 L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~l~~l~~L~~L~~~~~~~~~ 124 (384)
T d2omza2 65 LNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 124 (384)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 899998968188179886--334771101030134333222211123343334433222222
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.79 E-value=1.9e-18 Score=110.14 Aligned_cols=155 Identities=28% Similarity=0.482 Sum_probs=125.5
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 9867999149988764573556999997998317868997788632--35453003575578999965679997669984
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (689)
Q Consensus 79 ~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~L 156 (689)
.+++.|++.++++.. + +.+..+++|++|+|++|++++..| +. ++|+.|++++|.+.. ++ .+..++.|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCC
T ss_conf 687899899999977-5-202137886757545655667640--1677522311112222222-21-1111223222111
Q ss_pred CCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCC
Q ss_conf 6886787787111299999789832787877789875477665556611444555532137743-352125565478997
Q 005587 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPI 235 (689)
Q Consensus 157 s~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~-L~~L~ls~N~l~g~~ 235 (689)
++|.+... ..+..+++|+.|++++|.+. .++ .+..+++|+.|++.+|++++..+ +..++ |+.|++++|++++ +
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i~~-i 187 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKVSD-I 187 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-C
T ss_pred CCCCCCCC--CCCCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCEEECCCCCCCC-C
T ss_conf 22222232--10001223677643111100-234-33321111112234555567701-1679989999787997998-8
Q ss_pred CCCCCCCCCCC
Q ss_conf 61158988732
Q 005587 236 PEKMLQIPNFR 246 (689)
Q Consensus 236 P~~l~~l~~l~ 246 (689)
+ .+..+++|+
T Consensus 188 ~-~l~~L~~L~ 197 (199)
T d2omxa2 188 S-VLAKLTNLE 197 (199)
T ss_dssp G-GGGGCTTCS
T ss_pred C-CCCCCCCCC
T ss_conf 1-012789989
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=3.4e-17 Score=103.58 Aligned_cols=166 Identities=20% Similarity=0.298 Sum_probs=96.2
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 98679991499887645735569999979983178689977886323545300357557899996567999766998468
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNN 158 (689)
Q Consensus 79 ~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~ 158 (689)
.+++.|++.++++.. + +.+..+++|+.|+|++|.+.+..|-....+++++++++|.++. ++ .+..+++|+.+++++
T Consensus 41 ~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~ 116 (227)
T d1h6ua2 41 DGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS 116 (227)
T ss_dssp HTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGGGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTT
T ss_pred CCCCEEECCCCCCCC-C-HHHHCCCCCCEEECCCCEEECCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCC
T ss_conf 886899777999976-6-4574488883763578532025431123343201211122222-22-222222221221222
Q ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCC-
Q ss_conf 86787787111299999789832787877789875477665556611444555532137743-3521255654789976-
Q 005587 159 NLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIP- 236 (689)
Q Consensus 159 N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~-L~~L~ls~N~l~g~~P- 236 (689)
+...+.. .+.....+..+.++.+.+.... .+..+++|+.|++++|.+....+ +..++ |+.|++++|++++..+
T Consensus 117 ~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l~~l 191 (227)
T d1h6ua2 117 TQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISPL 191 (227)
T ss_dssp SCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGGG
T ss_pred CCCCCCC--HHCCCCCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCCCHH-HCCCCCCEECCCCCCCCCCCHHH
T ss_conf 4433110--0000230122200000000000--00102111002333333331001-05646335644588841778534
Q ss_pred CCCCCCCCCCCCCCCCC
Q ss_conf 11589887323688678
Q 005587 237 EKMLQIPNFRKDGNPFN 253 (689)
Q Consensus 237 ~~l~~l~~l~~~~n~~~ 253 (689)
..+.++..|.+.+|.+.
T Consensus 192 ~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 192 ASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp GGCTTCCEEECTTSCCC
T ss_pred CCCCCCCEEECCCCCCC
T ss_conf 47999998979599689
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=6e-17 Score=102.31 Aligned_cols=141 Identities=26% Similarity=0.387 Sum_probs=79.7
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 99867999149988764573556999997998317868997788632-35453003575578999965679997669984
Q 005587 78 ASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSL 156 (689)
Q Consensus 78 ~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~-~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~L 156 (689)
..+++.|+|++|.+.+.. .++.+++|+.|++++|++++ +|.... ++|+.|++++|.+.. + ..+..++.|+.+++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCC
T ss_conf 899898769896025860--11358621201433333212-2212122211122345653221-1-22011111222112
Q ss_pred CCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCC
Q ss_conf 6886787787111299999789832787877789875477665556611444555532137743-35212556
Q 005587 157 NNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIEN 228 (689)
Q Consensus 157 s~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~-L~~L~ls~ 228 (689)
++|.+++ +..+..+++|+.+++++|++++ ++. +.++++|+.|++++|+++.. +.+..++ |+.|++++
T Consensus 142 ~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 142 GNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFS 209 (210)
T ss_dssp CSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEE
T ss_pred CCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCEEECCCCCCCCC-HHHCCCCCCCEEECCC
T ss_conf 2233345--4310001332100134643025-645-36789899998979989987-2116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=9.1e-17 Score=101.37 Aligned_cols=157 Identities=25% Similarity=0.411 Sum_probs=96.3
Q ss_pred ECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 149988764573556999997998317868997788632--354530035755789999656799976699846886787
Q 005587 86 LNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSG 163 (689)
Q Consensus 86 L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g 163 (689)
+..+.+.+.++ ...+..|+.|++++|.+.. +++ +. ++|++|+|++|++++..+ ++.+++|+.|++++|.+.
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~~-l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~- 97 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 97 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-
T ss_pred HCCCCCCCCCC--HHHHCCCCEEECCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC-
T ss_conf 67787788559--8794687899899999977-520-2137886757545655667640--167752231111222222-
Q ss_pred CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCC-CCCCC
Q ss_conf 787111299999789832787877789875477665556611444555532137743-3521255654789976-11589
Q 005587 164 EIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFSGPIP-EKMLQ 241 (689)
Q Consensus 164 ~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~-L~~L~ls~N~l~g~~P-~~l~~ 241 (689)
.++ .+.+++.|+.|++++|.+.. + ..+..+++|+.|++++|.+... +.+..++ ++.|++.+|++++..+ ..+.+
T Consensus 98 ~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~l~~l~~l~~ 173 (199)
T d2omxa2 98 DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTDLKPLANLTT 173 (199)
T ss_dssp CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCCCGGGTTCTT
T ss_pred CCC-CCCCCCCCCCCCCCCCCCCC-C-CCCCHHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 221-11112232221112222223-2-1000122367764311110023-433321111112234555567701167998
Q ss_pred CCCCCCCCCCCC
Q ss_conf 887323688678
Q 005587 242 IPNFRKDGNPFN 253 (689)
Q Consensus 242 l~~l~~~~n~~~ 253 (689)
+..|++.+|.+.
T Consensus 174 L~~L~ls~N~i~ 185 (199)
T d2omxa2 174 LERLDISSNKVS 185 (199)
T ss_dssp CCEEECCSSCCC
T ss_pred CCEEECCCCCCC
T ss_conf 999978799799
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=2.3e-17 Score=104.54 Aligned_cols=113 Identities=25% Similarity=0.257 Sum_probs=78.6
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCC
Q ss_conf 3556999997998317868997788632--35453003575578999965679997669984688678778711129999
Q 005587 97 ENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTG 174 (689)
Q Consensus 97 ~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~ 174 (689)
+.+.+...|+.|||++|+++ .++..+. .+|+.|+|++|.++. + +.|..+++|+.|++++|.++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCC-C-CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 75168574848978899788-657620041459989897997876-4-77445761306431021345777632233453
Q ss_pred CCEEECCCCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 9789832787877789--87547766555661144455553
Q 005587 175 LINLDLSSNNLSGELP--PSLENLSQLTTLHLQNNQLSGTL 213 (689)
Q Consensus 175 L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~g~~ 213 (689)
|+.|++++|+++ .++ ..+..+++|+.|++++|.++...
T Consensus 89 L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~ 128 (162)
T d1a9na_ 89 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKK 128 (162)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred CCCCEECCCCCC-CCCCCCCCCCCCCCCHHHCCCCCCCCCC
T ss_conf 443420300016-6542110013653206640799634561
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.66 E-value=3.1e-15 Score=93.35 Aligned_cols=140 Identities=26% Similarity=0.408 Sum_probs=95.3
Q ss_pred EECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 30998679991499887645735569999979983178689977886323545300357557899996567999766998
Q 005587 76 CNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMS 155 (689)
Q Consensus 76 C~~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~ 155 (689)
|...++..|+|++++++ .+|+. +++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. +. +.|++|+
T Consensus 35 c~~~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~ 104 (353)
T d1jl5a_ 35 CLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSD-LP--PLLEYLG 104 (353)
T ss_dssp HHHHTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCS-CC--TTCCEEE
T ss_pred HHHCCCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH-HHHHHHHHHHCCCC-HHHH-HC--CCCCCCC
T ss_conf 98769989993799988-78898---789888989999796-336203-32033266551432-0321-02--2111113
Q ss_pred CCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCCCCCCC
Q ss_conf 46886787787111299999789832787877789875477665556611444555532137743-352125565478
Q 005587 156 LNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 156 Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~-L~~L~ls~N~l~ 232 (689)
+++|.+. .+|. ++.++.|+.|++++|.+.. .+... ..+..+.+.++..... ..+..++ ++.++++.|.+.
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~---~~l~~l~~~~~~~~~~-~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCS
T ss_pred CCCCCCC-CCCC-HHHHCCCEEECCCCCCCCC-CCCCC---CCCCCHHHCCCCCCCC-CCCCCCCCCEECCCCCCCCC
T ss_conf 3455432-2210-0110131231135651001-32233---3321000012222233-32000122200111233443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=7.7e-16 Score=96.51 Aligned_cols=165 Identities=25% Similarity=0.366 Sum_probs=129.7
Q ss_pred CCCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9862793099867999149988764573556999997998317868997788632-354530035755789999656799
Q 005587 70 SWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP-VTMQNFFLSDNQFSGSIPSSLATL 148 (689)
Q Consensus 70 ~w~gv~C~~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~-~~L~~L~Ls~N~l~g~~p~~l~~l 148 (689)
+..|+ ....++..|++++|.+.+..+ +..++.|+.+++++|.++ .++.... .+|+.++++++...+. ..+...
T Consensus 55 ~l~~l-~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~l~l~~~~~~~~--~~~~~~ 128 (227)
T d1h6ua2 55 TIEGV-QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDV--TPLAGL 128 (227)
T ss_dssp CCTTG-GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCEEECTTSCCCCC--GGGTTC
T ss_pred CCHHH-HCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC--CHHCCC
T ss_conf 66457-448888376357853202543--112334320121112222-222222222221221222443311--000002
Q ss_pred CCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCCCC
Q ss_conf 976699846886787787111299999789832787877789875477665556611444555532137743-3521255
Q 005587 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLSGTLDVLQDLP-LRDLNIE 227 (689)
Q Consensus 149 ~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~~~~~~~~-L~~L~ls 227 (689)
+.+..+.++++.+.... .+..+.+|+.|++++|.+... + .+.++++|+.|++++|++++.. .+..++ |+.|+++
T Consensus 129 ~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~l~-~l~~l~~L~~L~Ls 203 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLK 203 (227)
T ss_dssp TTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECT
T ss_pred CCHHHHHCHHHHHCHHH--HHCCCCCCCCCCCCCCCCCCC-H-HHCCCCCCEECCCCCCCCCCCH-HHCCCCCCCEEECC
T ss_conf 30122200000000000--001021110023333333310-0-1056463356445888417785-34479999989795
Q ss_pred CCCCCCCCCCCCCCCCCCCC
Q ss_conf 65478997611589887323
Q 005587 228 NNLFSGPIPEKMLQIPNFRK 247 (689)
Q Consensus 228 ~N~l~g~~P~~l~~l~~l~~ 247 (689)
+|++++..| +.++++|..
T Consensus 204 ~N~lt~i~~--l~~l~~L~~ 221 (227)
T d1h6ua2 204 NNQISDVSP--LANTSNLFI 221 (227)
T ss_dssp TSCCCBCGG--GTTCTTCCE
T ss_pred CCCCCCCCC--CCCCCCCCE
T ss_conf 996899802--036999898
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.64 E-value=6.9e-16 Score=96.78 Aligned_cols=100 Identities=27% Similarity=0.396 Sum_probs=54.2
Q ss_pred CEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCC
Q ss_conf 7998317868997788632--35453003575578999965679997669984688678778711129999978983278
Q 005587 106 RVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183 (689)
Q Consensus 106 ~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N 183 (689)
++|+|++|+++ .++. +. ..|++|++++|.++ .+|..++.+++|+.|++++|.++. +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCC
T ss_conf 98986899898-8710-105898898979787168-652156554313545324321123-57-4123355576888898
Q ss_pred CCCCCCC--CCCCCCCCCCEEECCCCCCCC
Q ss_conf 7877789--875477665556611444555
Q 005587 184 NLSGELP--PSLENLSQLTTLHLQNNQLSG 211 (689)
Q Consensus 184 ~l~g~ip--~~~~~l~~L~~L~Ls~N~l~g 211 (689)
+++. ++ ..+..+++|+.|++++|.++.
T Consensus 76 ~i~~-~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQ-SAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCS-SSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCC-CCCCHHHCCCCCCCEEECCCCCCCC
T ss_conf 6588-8882565379999999897996886
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.62 E-value=6.3e-16 Score=96.97 Aligned_cols=100 Identities=30% Similarity=0.426 Sum_probs=58.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 53003575578999965679997669984688678778711129999978983278787778987547766555661144
Q 005587 128 QNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNN 207 (689)
Q Consensus 128 ~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N 207 (689)
+.|+|++|+++ .++ .+..++.|++|++++|.++ .+|..+..+++|+.|++++|.++ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCC
T ss_conf 98986899898-871-0105898898979787168-65215655431354532432112-357-4123355576888898
Q ss_pred CCCCCC--CCCCCCC-CCCCCCCCCCCC
Q ss_conf 455553--2137743-352125565478
Q 005587 208 QLSGTL--DVLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 208 ~l~g~~--~~~~~~~-L~~L~ls~N~l~ 232 (689)
+++... ..+..++ |+.+++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf 6588888256537999999989799688
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.7e-16 Score=98.16 Aligned_cols=104 Identities=25% Similarity=0.224 Sum_probs=44.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 54530035755789999656799976699846886787787111299999789832787877789875477665556611
Q 005587 126 TMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205 (689)
Q Consensus 126 ~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 205 (689)
++++|+|++|+++ .++..+..++.|+.|+|++|.++ .++ .|..+++|+.|++++|+++...+..+..+++|+.|+++
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCEEC
T ss_conf 4848978899788-65762004145998989799787-647-74457613064310213457776322334534434203
Q ss_pred CCCCCCCC--CCCCCCC-CCCCCCCCCCCC
Q ss_conf 44455553--2137743-352125565478
Q 005587 206 NNQLSGTL--DVLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 206 ~N~l~g~~--~~~~~~~-L~~L~ls~N~l~ 232 (689)
+|+++... ..+..++ |+.|++++|.++
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 000166542110013653206640799634
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1e-14 Score=90.66 Aligned_cols=165 Identities=15% Similarity=0.153 Sum_probs=115.5
Q ss_pred EEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 93099867999149988764573556999997998317868997788632--354530035755789999-656799976
Q 005587 75 QCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIP-SSLATLTLL 151 (689)
Q Consensus 75 ~C~~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p-~~l~~l~~L 151 (689)
.|++.. ..++.++.++. .+|+.+. ++++.|+|++|.+....+..|. .+|++|+|++|.+...++ ..|..++.+
T Consensus 5 ~C~C~~-~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l 80 (242)
T d1xwdc1 5 ICHCSN-RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80 (242)
T ss_dssp SEEECS-SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTC
T ss_pred CCCCCC-CEEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCC
T ss_conf 288739-99998189988-7688889--9889998769918964966861464323211022112420100112222222
Q ss_pred CEEECC-CCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCC-CCCCCCC--CCCCCC
Q ss_conf 699846-8867877871112999997898327878777898-7547766555661144455553-2137743--352125
Q 005587 152 TDMSLN-NNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSGTL-DVLQDLP--LRDLNI 226 (689)
Q Consensus 152 ~~L~Ls-~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~~-~~~~~~~--L~~L~l 226 (689)
+.+++. .|.+....+..|..+++|+.|++++|.+....+. .+..+..+..+...++.+.... ..+..++ +..+++
T Consensus 81 ~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l 160 (242)
T d1xwdc1 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 160 (242)
T ss_dssp CEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEC
T ss_conf 22111112343222222122222222223421111255433322211112222222121112222222222331001220
Q ss_pred CCCCCCCCCCCCCCCCCC
Q ss_conf 565478997611589887
Q 005587 227 ENNLFSGPIPEKMLQIPN 244 (689)
Q Consensus 227 s~N~l~g~~P~~l~~l~~ 244 (689)
++|+++ .++....+...
T Consensus 161 ~~n~l~-~i~~~~~~~~~ 177 (242)
T d1xwdc1 161 NKNGIQ-EIHNCAFNGTQ 177 (242)
T ss_dssp CSSCCC-EECTTTTTTCC
T ss_pred CCCCCC-CCCCCCCCCHH
T ss_conf 012333-32222222011
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.2e-14 Score=90.38 Aligned_cols=107 Identities=22% Similarity=0.241 Sum_probs=75.5
Q ss_pred CCCCEEEECCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 986279309986799914998876457355699999799831786-8997788632354530035755789999656799
Q 005587 70 SWQGVQCNASDIIAIILNGANLGGELGENLGAFSSIRVIDLSNNH-IGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATL 148 (689)
Q Consensus 70 ~w~gv~C~~~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~-l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l 148 (689)
.+.+|+|...+++ .+|..+..+++|+.|++++|+ +. ..-+..|.++
T Consensus 9 ~~~~l~c~~~~~~-----------~~p~~l~~l~~l~~L~l~~n~~l~----------------------~i~~~~f~~l 55 (156)
T d2ifga3 9 GSSGLRCTRDGAL-----------DSLHHLPGAENLTELYIENQQHLQ----------------------HLELRDLRGL 55 (156)
T ss_dssp SSSCEECCSSCCC-----------TTTTTSCSCSCCSEEECCSCSSCC----------------------EECGGGSCSC
T ss_pred CCCEEEECCCCCC-----------CCCCCCCCCCCCCEEECCCCCCCC----------------------CCCCHHHCCC
T ss_conf 9996985289976-----------586002576565743168986644----------------------3692122566
Q ss_pred CCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 97669984688678778711129999978983278787778987547766555661144455
Q 005587 149 TLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQNNQLS 210 (689)
Q Consensus 149 ~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 210 (689)
++|+.|+|++|.|+...|..|..+++|+.|+|++|+|+ .+|.......+|+.|+|++|.|.
T Consensus 56 ~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 56 GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 66672162021247742011124554333322678785-15745633532124335798633
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.57 E-value=9e-14 Score=85.73 Aligned_cols=98 Identities=29% Similarity=0.427 Sum_probs=50.2
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCC
Q ss_conf 99799831786899778863235453003575578999965679997669984688678778711129999978983278
Q 005587 104 SIRVIDLSNNHIGGSIPSILPVTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSN 183 (689)
Q Consensus 104 ~L~~L~Ls~N~l~g~ip~~~~~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N 183 (689)
+|+.|||++|.++ .+|. +.++|++|+|++|+++ .+|..+ .+|+.|++++|.++ .++. + .+.|++|++++|
T Consensus 39 ~l~~LdLs~~~L~-~lp~-~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n 108 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE-LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNN 108 (353)
T ss_dssp TCSEEECTTSCCS-CCCS-CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSS
T ss_pred CCCEEEECCCCCC-CCCC-CCCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHH-H--CCCCCCCCCCCC
T ss_conf 9989993799988-7889-8789888989999796-336203---32033266551432-0321-0--221111133455
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 787778987547766555661144455553
Q 005587 184 NLSGELPPSLENLSQLTTLHLQNNQLSGTL 213 (689)
Q Consensus 184 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~ 213 (689)
.+. .+|. ++.+++|+.|++++|.+...+
T Consensus 109 ~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~ 136 (353)
T d1jl5a_ 109 QLE-KLPE-LQNSSFLKIIDVDNNSLKKLP 136 (353)
T ss_dssp CCS-SCCC-CTTCTTCCEEECCSSCCSCCC
T ss_pred CCC-CCCC-HHHHCCCEEECCCCCCCCCCC
T ss_conf 432-2210-011013123113565100132
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=4.4e-14 Score=87.34 Aligned_cols=105 Identities=20% Similarity=0.190 Sum_probs=85.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 453003575578999965679997669984688-6787787111299999789832787877789875477665556611
Q 005587 127 MQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNN-LLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHLQ 205 (689)
Q Consensus 127 L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N-~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 205 (689)
...++++++.+. ..|..+..+++|+.|++++| .++...+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECC
T ss_conf 996985289976-5860025765657431689866443692122566666721620212477420111245543333226
Q ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 444555532-137743352125565478
Q 005587 206 NNQLSGTLD-VLQDLPLRDLNIENNLFS 232 (689)
Q Consensus 206 ~N~l~g~~~-~~~~~~L~~L~ls~N~l~ 232 (689)
+|+|+...+ .+..++|..|+|++|.|.
T Consensus 89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 7878515745633532124335798633
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.49 E-value=4.4e-17 Score=103.05 Aligned_cols=113 Identities=23% Similarity=0.328 Sum_probs=74.6
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCC
Q ss_conf 4573556999997998317868997788632--35453003575578999965679997669984688678778711129
Q 005587 94 ELGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQS 171 (689)
Q Consensus 94 ~lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~ 171 (689)
.++..+..|++|+.|+|++|++. .++. +. .+|+.|+|++|.++ .+|..+..+++|+.|++++|.++. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~~-l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCCC-HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred HHHHHHHCCCCCCEEECCCCCCC-CCCC-CCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCC
T ss_conf 02467762604615199446899-8644-247825357341353432-100003322123333333322222-2-22222
Q ss_pred CCCCCEEECCCCCCCCCCC--CCCCCCCCCCEEECCCCCCCCC
Q ss_conf 9999789832787877789--8754776655566114445555
Q 005587 172 LTGLINLDLSSNNLSGELP--PSLENLSQLTTLHLQNNQLSGT 212 (689)
Q Consensus 172 l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~g~ 212 (689)
+++|+.|++++|+++. ++ ..+..+++|+.|++++|.+...
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred CCCCCCCCCCCCHHCC-CCCCCCCCCCCCCCEEECCCCCCCCC
T ss_conf 2234111234102125-54221236777630234279843467
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.43 E-value=3.9e-16 Score=98.07 Aligned_cols=103 Identities=29% Similarity=0.353 Sum_probs=47.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 35453003575578999965679997669984688678778711129999978983278787778987547766555661
Q 005587 125 VTMQNFFLSDNQFSGSIPSSLATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGELPPSLENLSQLTTLHL 204 (689)
Q Consensus 125 ~~L~~L~Ls~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~L 204 (689)
.+|+.|+|++|+++ .++ .|..+++|+.|+|++|.++ .+|..+..+.+|+.|++++|.++. ++ .+..+++|+.|++
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCC
T ss_conf 04615199446899-864-4247825357341353432-100003322123333333322222-22-2222223411123
Q ss_pred CCCCCCCCC--CCCCCCC-CCCCCCCCCCCC
Q ss_conf 144455553--2137743-352125565478
Q 005587 205 QNNQLSGTL--DVLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 205 s~N~l~g~~--~~~~~~~-L~~L~ls~N~l~ 232 (689)
++|+++... ..+..++ |+.|++++|.+.
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred CCCHHCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 4102125542212367776302342798434
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.32 E-value=1.2e-14 Score=90.31 Aligned_cols=153 Identities=23% Similarity=0.326 Sum_probs=61.0
Q ss_pred CEEEEEECCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCC---C-------CC--CCCCCCCCCCCCCCCC---
Q ss_conf 867999149988764----573556999997998317868997788---6-------32--3545300357557899---
Q 005587 80 DIIAIILNGANLGGE----LGENLGAFSSIRVIDLSNNHIGGSIPS---I-------LP--VTMQNFFLSDNQFSGS--- 140 (689)
Q Consensus 80 ~v~~l~L~~~~l~g~----lp~~l~~L~~L~~L~Ls~N~l~g~ip~---~-------~~--~~L~~L~Ls~N~l~g~--- 140 (689)
.++.|+|++|.+... +...+...+.|+.|+++++.+...... . +. ++|+.|+|++|.+...
T Consensus 32 ~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 111 (344)
T d2ca6a1 32 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111 (344)
T ss_dssp CCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH
T ss_pred CCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 97889784983778999999999985899888888777543345421067879998875477756330000134554333
Q ss_pred -CCCCCCCCCCCCEEECCCCCCCCCCCH-------------HHCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEE
Q ss_conf -996567999766998468867877871-------------112999997898327878777----89875477665556
Q 005587 141 -IPSSLATLTLLTDMSLNNNLLSGEIPD-------------AFQSLTGLINLDLSSNNLSGE----LPPSLENLSQLTTL 202 (689)
Q Consensus 141 -~p~~l~~l~~L~~L~Ls~N~l~g~~P~-------------~l~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L 202 (689)
+...+...++|+.|++++|.+...-.. .......|+.+++++|.+... +...+..+..|+.|
T Consensus 112 ~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L 191 (344)
T d2ca6a1 112 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191 (344)
T ss_dssp HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEE
T ss_pred CHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHHHHCCC
T ss_conf 10111002343210000024666654311112122221100014676421110136501355433221111233321335
Q ss_pred ECCCCCCCCC-----C-CCCCCCC-CCCCCCCCCCCC
Q ss_conf 6114445555-----3-2137743-352125565478
Q 005587 203 HLQNNQLSGT-----L-DVLQDLP-LRDLNIENNLFS 232 (689)
Q Consensus 203 ~Ls~N~l~g~-----~-~~~~~~~-L~~L~ls~N~l~ 232 (689)
+|++|.+... + ..+...+ |+.|++++|.++
T Consensus 192 ~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp ECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred CCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCC
T ss_conf 4333222222232002433211012112223333222
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=8.9e-14 Score=85.73 Aligned_cols=166 Identities=18% Similarity=0.235 Sum_probs=82.0
Q ss_pred CEEEEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCC--CCCCCCCCCCC-CCCCC-CCCCCCCCCCCCEE
Q ss_conf 867999149988764-573556999997998317868997788632--35453003575-57899-99656799976699
Q 005587 80 DIIAIILNGANLGGE-LGENLGAFSSIRVIDLSNNHIGGSIPSILP--VTMQNFFLSDN-QFSGS-IPSSLATLTLLTDM 154 (689)
Q Consensus 80 ~v~~l~L~~~~l~g~-lp~~l~~L~~L~~L~Ls~N~l~g~ip~~~~--~~L~~L~Ls~N-~l~g~-~p~~l~~l~~L~~L 154 (689)
++..|+|+++.+... +...+..+++|+.|+|+++.+++..+..+. ++|++|+|+++ .++.. +..-+..+++|+.|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCC
T ss_conf 78878898984577799999974877651452346798678999851899757151001341235540365788743565
Q ss_pred ECCCC-CCCCC-CCHHHCC-CCCCCEEECCCC--CCCC-CCCCCCCCCCCCCEEECCCC-CCCCC-CCCCCCCC-CCCCC
Q ss_conf 84688-67877-8711129-999978983278--7877-78987547766555661144-45555-32137743-35212
Q 005587 155 SLNNN-LLSGE-IPDAFQS-LTGLINLDLSSN--NLSG-ELPPSLENLSQLTTLHLQNN-QLSGT-LDVLQDLP-LRDLN 225 (689)
Q Consensus 155 ~Ls~N-~l~g~-~P~~l~~-l~~L~~L~Ls~N--~l~g-~ip~~~~~l~~L~~L~Ls~N-~l~g~-~~~~~~~~-L~~L~ 225 (689)
+++++ .++.. +...+.. .+.|+.|++++. .++. .+...+.++++|+.|++++| .+++. +..+..++ |+.|+
T Consensus 127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~ 206 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 206 (284)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEE
T ss_conf 22453323332200010001111101221355424444434342323222123553223477830333321357687798
Q ss_pred CCC-CCCCCCCCCCCCCCCCC
Q ss_conf 556-54789976115898873
Q 005587 226 IEN-NLFSGPIPEKMLQIPNF 245 (689)
Q Consensus 226 ls~-N~l~g~~P~~l~~l~~l 245 (689)
+++ +.+++.....+.++++|
T Consensus 207 L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 207 LSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp CTTCTTCCGGGGGGGGGCTTC
T ss_pred CCCCCCCCHHHHHHHHCCCCC
T ss_conf 999997873789997269998
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.14 E-value=1.4e-12 Score=79.43 Aligned_cols=134 Identities=24% Similarity=0.349 Sum_probs=54.7
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCC----C--CCCCCCCCCCCCCCCCCCC-------------CCCCCCCCCEEECCCC
Q ss_conf 5699999799831786899778863----2--3545300357557899996-------------5679997669984688
Q 005587 99 LGAFSSIRVIDLSNNHIGGSIPSIL----P--VTMQNFFLSDNQFSGSIPS-------------SLATLTLLTDMSLNNN 159 (689)
Q Consensus 99 l~~L~~L~~L~Ls~N~l~g~ip~~~----~--~~L~~L~Ls~N~l~g~~p~-------------~l~~l~~L~~L~Ls~N 159 (689)
+...+.|+.|+|++|.+...--..+ . ++|+.|++++|.+...-.. .....+.|+.+++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
T ss_conf 75477756330000134554333101110023432100000246666543111121222211000146764211101365
Q ss_pred CCCCC----CCHHHCCCCCCCEEECCCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----C-CCCCCCC-CCCC
Q ss_conf 67877----871112999997898327878777-----898754776655566114445555----3-2137743-3521
Q 005587 160 LLSGE----IPDAFQSLTGLINLDLSSNNLSGE-----LPPSLENLSQLTTLHLQNNQLSGT----L-DVLQDLP-LRDL 224 (689)
Q Consensus 160 ~l~g~----~P~~l~~l~~L~~L~Ls~N~l~g~-----ip~~~~~l~~L~~L~Ls~N~l~g~----~-~~~~~~~-L~~L 224 (689)
.+... +...+.....|+.|+|+.|.+... +...+..+++|+.|++++|.++.. + ..+...+ |+.|
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L 248 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred CCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
T ss_conf 01355433221111233321335433322222223200243321101211222333322222222344433232211110
Q ss_pred CCCCCCCC
Q ss_conf 25565478
Q 005587 225 NIENNLFS 232 (689)
Q Consensus 225 ~ls~N~l~ 232 (689)
++++|.++
T Consensus 249 ~Ls~n~i~ 256 (344)
T d2ca6a1 249 GLNDCLLS 256 (344)
T ss_dssp ECTTCCCC
T ss_pred HHHCCCCC
T ss_conf 30047567
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=4.1e-12 Score=77.05 Aligned_cols=151 Identities=20% Similarity=0.276 Sum_probs=67.2
Q ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCC-CCCCCC--CCCCCCCCCCC-CCCCC-CCCCCCC-CCCC
Q ss_conf 98679991499887645735569999979983178-68997-788632--35453003575-57899-9965679-9976
Q 005587 79 SDIIAIILNGANLGGELGENLGAFSSIRVIDLSNN-HIGGS-IPSILP--VTMQNFFLSDN-QFSGS-IPSSLAT-LTLL 151 (689)
Q Consensus 79 ~~v~~l~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N-~l~g~-ip~~~~--~~L~~L~Ls~N-~l~g~-~p~~l~~-l~~L 151 (689)
.+++.|+|.++.+.+..+..++.+++|+.|+|+++ .++.. +..... ++|++|+|+++ .++.. +...+.. .+.|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 77651452346798678999851899757151001341235540365788743565224533233322000100011111
Q ss_pred CEEECCCC--CCCCC-CCHHHCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCC-CCCCCC-CCCCCCC-CCCC
Q ss_conf 69984688--67877-8711129999978983278-787778987547766555661144-455553-2137743-3521
Q 005587 152 TDMSLNNN--LLSGE-IPDAFQSLTGLINLDLSSN-NLSGELPPSLENLSQLTTLHLQNN-QLSGTL-DVLQDLP-LRDL 224 (689)
Q Consensus 152 ~~L~Ls~N--~l~g~-~P~~l~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~Ls~N-~l~g~~-~~~~~~~-L~~L 224 (689)
+.|++++. .++.. +...+..+++|+.|++++| .+++.....+.++++|++|+++++ .++... ..+..++ |+.|
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L 230 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL 230 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred CHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEE
T ss_conf 01221355424444434342323222123553223477830333321357687798999997873789997269998989
Q ss_pred CCCCC
Q ss_conf 25565
Q 005587 225 NIENN 229 (689)
Q Consensus 225 ~ls~N 229 (689)
+++++
T Consensus 231 ~l~~~ 235 (284)
T d2astb2 231 QVFGI 235 (284)
T ss_dssp ECTTS
T ss_pred EEECC
T ss_conf 64488
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=1.6e-12 Score=79.23 Aligned_cols=107 Identities=23% Similarity=0.341 Sum_probs=46.5
Q ss_pred CEEEEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCC----CCCCCC--CCCCCCCCCCCCCCCC----CCCCCC-C
Q ss_conf 867999149988764-573556999997998317868997----788632--3545300357557899----996567-9
Q 005587 80 DIIAIILNGANLGGE-LGENLGAFSSIRVIDLSNNHIGGS----IPSILP--VTMQNFFLSDNQFSGS----IPSSLA-T 147 (689)
Q Consensus 80 ~v~~l~L~~~~l~g~-lp~~l~~L~~L~~L~Ls~N~l~g~----ip~~~~--~~L~~L~Ls~N~l~g~----~p~~l~-~ 147 (689)
++..||++++.+++. +..-+..+++++.|+|++|.++.. +...+. ++|++|+|++|.++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCC----CCHHHCCCCCCCEEECCCCCCC
Q ss_conf 99766998468867877----8711129999978983278787
Q 005587 148 LTLLTDMSLNNNLLSGE----IPDAFQSLTGLINLDLSSNNLS 186 (689)
Q Consensus 148 l~~L~~L~Ls~N~l~g~----~P~~l~~l~~L~~L~Ls~N~l~ 186 (689)
..+|+.|+|++|.++.. ++..+..+++|++|++++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 8877887788877543221012110000343200244433202
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.97 E-value=5.4e-09 Score=60.73 Aligned_cols=145 Identities=12% Similarity=0.094 Sum_probs=89.3
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-CCCCCEECEEEEECCEEEEEE
Q ss_conf 1597744447102873899999389969999993354588566999999999981389-987200017999599699998
Q 005587 508 TNSFSQENLIGAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLIY 586 (689)
Q Consensus 508 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~-Hpniv~l~~~~~~~~~~~lV~ 586 (689)
-+.|......+-++...||+... +++.+.+|+...... .....+.+|...+..+. +--+.+++.++...+..++||
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCC--CCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEE
T ss_conf 13527997678998771899990-898699998488765--325569999999998760699872899975089649999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q ss_conf 136889988998319545789999999999999999999999499-----------------------------------
Q 005587 587 EYCSNGTLQDMLHSDDELKNNLSWNTRIRMALGAARALEYLHEIC----------------------------------- 631 (689)
Q Consensus 587 Ey~~~GsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------- 631 (689)
++++|..+.+..... .. ...++.++++.+..||...
T Consensus 90 ~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 90 SEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EECCCCCCCCCCCCC------CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 860433435433440------26---999999899999998556842143576446565557789987765555430332
Q ss_pred ---------------------CCCCEEECCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf ---------------------998198044689858669994999861477655
Q 005587 632 ---------------------QPPIVHRNFKSANILLDDDLAVSVSDCGLAPLI 664 (689)
Q Consensus 632 ---------------------~~~IiHrDlkp~NILld~~~~~ki~DFGla~~~ 664 (689)
...++|+|+.+.|||++++...-|.||+.+..-
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred CCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCCC
T ss_conf 320057999999998449867817898600476423649965999602314418
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=1e-11 Score=75.02 Aligned_cols=108 Identities=26% Similarity=0.400 Sum_probs=64.9
Q ss_pred CCCEEECCCCCCCCCC-CCCCC--CCCCCCCCCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCHHHC-C
Q ss_conf 9979983178689977-88632--354530035755789----9996567999766998468867877----871112-9
Q 005587 104 SIRVIDLSNNHIGGSI-PSILP--VTMQNFFLSDNQFSG----SIPSSLATLTLLTDMSLNNNLLSGE----IPDAFQ-S 171 (689)
Q Consensus 104 ~L~~L~Ls~N~l~g~i-p~~~~--~~L~~L~Ls~N~l~g----~~p~~l~~l~~L~~L~Ls~N~l~g~----~P~~l~-~ 171 (689)
.|+.||++.|++++.. ...++ .+++.|+|++|.++. .+...+..+++|+.|+|++|.++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 99997898327878777----89875477665556611444555
Q 005587 172 LTGLINLDLSSNNLSGE----LPPSLENLSQLTTLHLQNNQLSG 211 (689)
Q Consensus 172 l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g 211 (689)
..+|+.|+|++|.++.. ++..+..+++|+.|++++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf 88778877888775432210121100003432002444332023
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=2.2e-10 Score=67.95 Aligned_cols=91 Identities=19% Similarity=0.304 Sum_probs=49.0
Q ss_pred CCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCC
Q ss_conf 67999766998468867877871112999997898327878777--89875477665556611444555532--137743
Q 005587 145 LATLTLLTDMSLNNNLLSGEIPDAFQSLTGLINLDLSSNNLSGE--LPPSLENLSQLTTLHLQNNQLSGTLD--VLQDLP 220 (689)
Q Consensus 145 l~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~Ls~N~l~g~--ip~~~~~l~~L~~L~Ls~N~l~g~~~--~~~~~~ 220 (689)
+..+..+..+++.+|... .++..+..+++|++|+|++|+++.. ++..+..+++|+.|+|++|.++...+ .+....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred HHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCC
T ss_conf 554664011225556766-6078897487878863777666677315889865885610004357213423442220331
Q ss_pred CCCCCCCCCCCCCCCC
Q ss_conf 3521255654789976
Q 005587 221 LRDLNIENNLFSGPIP 236 (689)
Q Consensus 221 L~~L~ls~N~l~g~~P 236 (689)
++.+++++|.++....
T Consensus 117 L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 117 LEELWLDGNSLSDTFR 132 (162)
T ss_dssp CSSCCCTTSTTSSSSS
T ss_pred CCEEECCCCCCCCCCC
T ss_conf 0426648997676766
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.65 E-value=8.1e-08 Score=54.58 Aligned_cols=142 Identities=18% Similarity=0.192 Sum_probs=78.8
Q ss_pred EEECCC-EEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC--CCCCCEECEEEEECCEEEEEEECCCCCC
Q ss_conf 710287-3899999389969999993354588566999999999981389--9872000179995996999981368899
Q 005587 517 IGAGML-GSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR--HANIVELKGYCAEHGQRLLIYEYCSNGT 593 (689)
Q Consensus 517 lG~G~~-g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~--Hpniv~l~~~~~~~~~~~lV~Ey~~~Gs 593 (689)
+..|.. ..||+....++..+.+|....... ..+..|...+..+. .-.+.+++.++.+.+..++||||++|..
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred CCCCCCCCEEEEEEECCCCEEEEEECCCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 6786547758999938987899995896677-----68999999999998659998861322245661599987441355
Q ss_pred HHHH-----------------HHCCCCCCC--CCCHHHHHHHHH--------------------HHHHHHHHHHHCC---
Q ss_conf 8899-----------------831954578--999999999999--------------------9999999999499---
Q 005587 594 LQDM-----------------LHSDDELKN--NLSWNTRIRMAL--------------------GAARALEYLHEIC--- 631 (689)
Q Consensus 594 L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~--------------------~ia~aL~yLH~~~--- 631 (689)
+.+. +|....... ...+.....-.. .....+..+....
T Consensus 93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 93 LLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC
T ss_conf 43221268999999999999873688544887554124688999999875411011340112137999999998718765
Q ss_pred -CCCCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf -99819804468985866999499986147765
Q 005587 632 -QPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 632 -~~~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
.+.++|+|+.+.|||++++..+-|+||+.+..
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 795678678887635773796589998533265
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=6.4e-09 Score=60.35 Aligned_cols=65 Identities=28% Similarity=0.268 Sum_probs=29.1
Q ss_pred CCCCCCCEEECCCCCCCCC--CCHHHCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEECCCCCCCC
Q ss_conf 7999766998468867877--871112999997898327878777898-75477665556611444555
Q 005587 146 ATLTLLTDMSLNNNLLSGE--IPDAFQSLTGLINLDLSSNNLSGELPP-SLENLSQLTTLHLQNNQLSG 211 (689)
Q Consensus 146 ~~l~~L~~L~Ls~N~l~g~--~P~~l~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g 211 (689)
..++.|+.|+|++|+++.. ++..+..+++|+.|+|++|.++. ++. .+.....|+.|++++|.+..
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCC-CHHHHHHHCCCCCEEECCCCCCCC
T ss_conf 74878788637776666773158898658856100043572134-234422203310426648997676
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.41 E-value=8.7e-07 Score=49.20 Aligned_cols=77 Identities=16% Similarity=0.031 Sum_probs=45.0
Q ss_pred CEEEECCCEEEEEEEECC-CCEEEEEEECCC--C---CCHHHHHHHHHHHHHHHCCC---CCCCCEECEEEEECCEEEEE
Q ss_conf 447102873899999389-969999993354--5---88566999999999981389---98720001799959969999
Q 005587 515 NLIGAGMLGSVYRAQLPD-GKLLAVKKLDKR--A---SSQQKDDEFLELVNNIDRIR---HANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 515 ~~lG~G~~g~Vy~~~~~~-g~~vAVK~i~~~--~---~~~~~~~~~~~e~~~l~~l~---Hpniv~l~~~~~~~~~~~lV 585 (689)
+.||.|..-.||+....+ ++.+.||.-... . .......+...|...+..+. ...+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EECCCCCC
Q ss_conf 81368899
Q 005587 586 YEYCSNGT 593 (689)
Q Consensus 586 ~Ey~~~Gs 593 (689)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EECCCCCC
T ss_conf 71357765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.06 E-value=4.3e-07 Score=50.79 Aligned_cols=10 Identities=10% Similarity=0.614 Sum_probs=4.2
Q ss_pred CCCCEEECCC
Q ss_conf 9997998317
Q 005587 103 SSIRVIDLSN 112 (689)
Q Consensus 103 ~~L~~L~Ls~ 112 (689)
+.|+.|+|++
T Consensus 15 ~~L~~L~L~~ 24 (167)
T d1pgva_ 15 TDLKEVNINN 24 (167)
T ss_dssp SSCCEEECTT
T ss_pred CCCCEEEECC
T ss_conf 9981978279
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.02 E-value=5.3e-05 Score=39.86 Aligned_cols=136 Identities=15% Similarity=0.132 Sum_probs=72.4
Q ss_pred EEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-----CCCCCEEC--EEEEECCEEEEEEECCCCCCHH
Q ss_conf 3899999389969999993354588566999999999981389-----98720001--7999599699998136889988
Q 005587 523 GSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-----HANIVELK--GYCAEHGQRLLIYEYCSNGTLQ 595 (689)
Q Consensus 523 g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~-----Hpniv~l~--~~~~~~~~~~lV~Ey~~~GsL~ 595 (689)
-.||+++.++|..+++|....... ...++..|...+..+. .+..+..- ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred CEEEEEECCCCCEEEEEEECCCCC---CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCC
T ss_conf 026999838999799998478778---89999999999999985599878752068980566534799998652776889
Q ss_pred -----H---------HHHC----CC-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHH----CCCC
Q ss_conf -----9---------9831----95-4578999999-------------------99999999999999994----9999
Q 005587 596 -----D---------MLHS----DD-ELKNNLSWNT-------------------RIRMALGAARALEYLHE----ICQP 633 (689)
Q Consensus 596 -----~---------~l~~----~~-~~~~~l~~~~-------------------~~~i~~~ia~aL~yLH~----~~~~ 633 (689)
. .+|. .. ......++.. +..+...+.+.+..+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 99999999989999998863035786556778978876656899987476998898999999999999999845456871
Q ss_pred CCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 819804468985866999499986147765
Q 005587 634 PIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 634 ~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
++||+|+.+.|||++++ ..+.||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 20247888042878389--35886520146
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.00 E-value=3.2e-07 Score=51.47 Aligned_cols=19 Identities=21% Similarity=0.186 Sum_probs=7.8
Q ss_pred CCCCCCCCCEEECCCCCCC
Q ss_conf 5569999979983178689
Q 005587 98 NLGAFSSIRVIDLSNNHIG 116 (689)
Q Consensus 98 ~l~~L~~L~~L~Ls~N~l~ 116 (689)
.+...+.|+.|+|++|.+.
T Consensus 39 ~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 39 AACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp HHTTCSCCCEEECTTSCCB
T ss_pred HHHHCCCCCEEECCCCCCC
T ss_conf 9763776454012015621
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.75 E-value=0.0004 Score=35.28 Aligned_cols=163 Identities=15% Similarity=0.156 Sum_probs=77.3
Q ss_pred CCHHHHHHHCCCCCCCCEE-----EECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHC--CCCCCCCE
Q ss_conf 3244485531597744447-----1028738999993899699999933545885669999999999813--89987200
Q 005587 499 FTIASLQQYTNSFSQENLI-----GAGMLGSVYRAQLPDGKLLAVKKLDKRASSQQKDDEFLELVNNIDR--IRHANIVE 571 (689)
Q Consensus 499 ~~~~~l~~~~~~f~~~~~l-----G~G~~g~Vy~~~~~~g~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~--l~Hpniv~ 571 (689)
.+.++++.....|.++++. ..|---+.|+.+..+|+ +++|+...... ......+..-+..+.. +..|..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~-~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE-KNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCCC-HHHHHHHHHHHHHHHHCCCCCCCCCE
T ss_conf 89999999998679998568523788852673899978972-89998078999-88999999998754302555455641
Q ss_pred EC-E--EEEECCEEEEEEECCCCCCHHH--------------HHHCC----C-CCCCCCCHH------------------
Q ss_conf 01-7--9995996999981368899889--------------98319----5-457899999------------------
Q 005587 572 LK-G--YCAEHGQRLLIYEYCSNGTLQD--------------MLHSD----D-ELKNNLSWN------------------ 611 (689)
Q Consensus 572 l~-~--~~~~~~~~~lV~Ey~~~GsL~~--------------~l~~~----~-~~~~~l~~~------------------ 611 (689)
.. | +....+....++.++.+..... .++.. . .........
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCH
T ss_conf 04897621341255024531146553332046788888998764544432024531011101200245677776531141
Q ss_pred HHHHHHHHHHHHHHHHHH-CCCCCCEEECCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 999999999999999994-9999819804468985866999499986147765
Q 005587 612 TRIRMALGAARALEYLHE-ICQPPIVHRNFKSANILLDDDLAVSVSDCGLAPL 663 (689)
Q Consensus 612 ~~~~i~~~ia~aL~yLH~-~~~~~IiHrDlkp~NILld~~~~~ki~DFGla~~ 663 (689)
.....+......+.-.+. ....++||+|+.++||+++.+...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 27999999987642048554545033378636564020454126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.50 E-value=0.00034 Score=35.65 Aligned_cols=72 Identities=13% Similarity=0.129 Sum_probs=39.1
Q ss_pred CEEEECCCEEEEEEEECCC--------CEEEEEEECCCCCCHHHHHHHHHHHHHHHCCC-CCCCCEECEEEEECCEEEEE
Q ss_conf 4471028738999993899--------69999993354588566999999999981389-98720001799959969999
Q 005587 515 NLIGAGMLGSVYRAQLPDG--------KLLAVKKLDKRASSQQKDDEFLELVNNIDRIR-HANIVELKGYCAEHGQRLLI 585 (689)
Q Consensus 515 ~~lG~G~~g~Vy~~~~~~g--------~~vAVK~i~~~~~~~~~~~~~~~e~~~l~~l~-Hpniv~l~~~~~~~~~~~lV 585 (689)
..|+-|-.=.+|+....++ +.|.++... .... .....+|..+++.+. +.-..++++++.. .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CCCH---HHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEE
T ss_conf 991785334348999688775445789817999659-9611---65899999999999757999808998189----569
Q ss_pred EECCCCCCH
Q ss_conf 813688998
Q 005587 586 YEYCSNGTL 594 (689)
Q Consensus 586 ~Ey~~~GsL 594 (689)
+||++|..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEECCCCC
T ss_conf 997345548
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.26 E-value=9.1e-06 Score=43.87 Aligned_cols=10 Identities=20% Similarity=0.541 Sum_probs=3.9
Q ss_pred CCCCEEECCC
Q ss_conf 9997998317
Q 005587 103 SSIRVIDLSN 112 (689)
Q Consensus 103 ~~L~~L~Ls~ 112 (689)
+.|+.|+|++
T Consensus 17 ~~L~~L~L~~ 26 (166)
T d1io0a_ 17 PDLEEVNLNN 26 (166)
T ss_dssp TTCCEEECTT
T ss_pred CCCCEEECCC
T ss_conf 9986887689
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.03 E-value=8.5e-06 Score=44.03 Aligned_cols=37 Identities=16% Similarity=0.214 Sum_probs=15.7
Q ss_pred CEEEEEECC-CCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 867999149-988764----5735569999979983178689
Q 005587 80 DIIAIILNG-ANLGGE----LGENLGAFSSIRVIDLSNNHIG 116 (689)
Q Consensus 80 ~v~~l~L~~-~~l~g~----lp~~l~~L~~L~~L~Ls~N~l~ 116 (689)
.++.|+|++ +.++.. +...+...++|+.|+|++|.++
T Consensus 18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred CCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 986887689999898999999988841982574301589611
|